{"heart failure with preserved ejection fraction": 0.02573996251498714, "peak early diastolic mitral flow velocity": 0.01021350731657758, "peak early diastolic mitral annular velocity": 0.01040772814398129, "heart failure with reduced ejection fraction": 0.009251313905761147, "global left ventricular longitudinal systolic strain": 0.007244786763153264, "heart failure and reduced ejection fraction": 0.005746944243488771, "\u03b2 - adrenergic receptor blocker therapy": 0.0033586542377857967, "left anterior descending coronary artery occlusion": 0.003586436892464345, "scale prospective randomized multicenter trial paradigm": 0.003673814687687774, "heart failure or coronary heart disease": 0.002239102825190531, "ring annuloplasty for ischemic mitral regurgitation": 0.0024030609370775243, "heart rate and aortic blood flow": 0.0021181952976064393, "emergency department in acute heart failure": 0.0011493888486977543, "dose nesiritide in acute heart failure": 0.0011116135381155656, "canine model of chronic heart failure": 0.0011034639622175282, "mice model of hypertensive heart disease": 0.0011272883064790008, "biventricular pacing on left heart twist": 0.0011272883064790008, "porcine model of right heart failure": 0.001095091082703307, "valve plasty for degenerative mitral regurgitation": 0.0011954789641547817, "valve plasty and annular size reduction": 0.0011195514125952656, "blocker therapy in chronic heart failure": 0.0011272883064790008, "kinase a nor soluble guanylate cyclase": 0.0011116135381155656, "diastolic pressure and myocardial oxygen consumption": 0.0012074644605255438, "ejection time in acute heart failure": 0.001095091082703307, "resynchronization therapy in mild heart failure": 0.0011765703985760724, "arterial coupling in hypertensive heart failure": 0.0011765703985760724, "control via the targeting of chromatin": 0.0011116135381155656, "stress echocardiography and cardiopulmonary exercise testing": 0.0012511947883093663, "crossover study with masked outcome assessments": 0.0011765703985760724, "time interval between local myocyte depolarization": 0.0011954789641547817, "filling time by controlling heart rate": 0.0011116135381155656, "increase in the ratio of peak": 0.0010290152499740676, "endothelial function in chronic heart failure": 0.001163281740379088, "rat model of postischemic heart failure": 0.0011195514125952656, "reduction program for congestive heart failure": 0.001169998296135779, "hospital stay for congestive heart failure": 0.0011421981408131245, "plateau phase of ventricular action potentials": 0.001169998296135779, "kidney infection or urinary tract infection": 0.0011493888486977543, "oxygen uptake and higher metabolic exercise": 0.0011493888486977543, "heart failure and mechanical support devices": 0.0011564142382201434, "implementation strategies in improving physician adherence": 0.0012408347797347112, "exercise protocol with respiratory gas analysis": 0.0011765703985760724, "heart failure with systolic dysfunction treatment": 0.0011893051989229418, "recommendations on the treatment of anemia": 0.0005710990704065622, "nucleolin as a regulator of growth": 0.0005388119933541983, "plasticity in the setting of disease": 0.0005475455413516535, "apoptosis during the development of pacing": 0.0005710990704065622, "dogs during the development of heart": 0.0005475455413516535, "apoptosis in the pathogenesis of heart": 0.0005558067690577828, "physician at the time of discharge": 0.0005388119933541983, "survival from the time of inclusion": 0.0005432411583292699, "survival at the time of admission": 0.0005342505951449326, "levels at the time of admission": 0.0005246977664040327, "observation at the time of surgery": 0.0005388119933541983, "association of the score with death": 0.0005432411583292699, "time from the treatment of heart": 0.0005295488244016098, "variation in the use of guideline": 0.0005342505951449326, "hospitalization through the date of death": 0.0005674170731431989, "% with the majority of patients": 0.0005246977664040327, "resistin as a link between inflammation": 0.0005597757062976328, "adaptation of the myocardium in response": 0.0005636441532395004, "case of a patient with diagnosis": 0.0005295488244016098, "peptides at the point of care": 0.0005145076249870338, "values before the administration of contrast": 0.0005782071191100717, "dysfunction during the onset of heart": 0.0005517319811087641, "data on the potential of diuretics": 0.0005388119933541983, "hrqol in a cohort of patients": 0.0005145076249870338, "supplementation during a program of exercise": 0.0005782071191100717, "insight into the potential of mirnas": 0.0005475455413516535, "trends in the risk of heart": 0.0005035890173865145, "improvements in the treatment of heart": 0.0005558067690577828, "causes for a worsening of heart": 0.0005246977664040327, "strategies for the treatment of end": 0.0005432411583292699, "role in the progression of heart": 0.0005295488244016098, "periods on the basis of heart": 0.0005145076249870338, "reduction in the ratio of phosphocreatine": 0.0005674170731431989, "review of the effects of air": 0.0005091458294913794, "impact of the intervention on adherence": 0.0005597757062976328, "women with a history of hypertension": 0.0005475455413516535, "preserved left ventricular ejection fraction": 0.02023724916885251, "early diastolic mitral flow velocity": 0.008213183120274803, "post - myocardial infarction heart": 0.005388119933541983, "left ventricular assist device implantation": 0.005746944243488771, "left ventricular diastolic end diameter": 0.005597757062976328, "post - acute care transfer": 0.0049782246538245, "- acute care transfer policy": 0.005091458294913794, "chronic advanced heart failure patients": 0.005597757062976328, "annular size reduction by surgery": 0.0032055035708695953, "dual energy x - ray": 0.0022494850208873043, "clinical practice guidelines grading system": 0.0028734721217443856, "restrictive red blood cell transfusion": 0.002779033845288914, "red blood cell transfusion strategy": 0.00271620579164635, "low left ventricular ejection fraction": 0.002779033845288914, "identified strong reliable mortality predictors": 0.002941425996440181, "recapitulates conserved developmental chromatin remodeling": 0.0031020869493367785, "conserved developmental chromatin remodeling events": 0.0030038261713469057, "left bundle branch block pattern": 0.002647744122008049, "preserved left ventricular ejection fractions": 0.0029082043509477203, "low co - morbidity burden": 0.0024591485859853444, "novel heart failure mice model": 0.0025984381463718064, "left ventricular assist device use": 0.0026940599667709913, "acute right ventricular pressure overload": 0.0028370853657159944, "vascular endothelial growth factor blockade": 0.0028734721217443856, "- adrenergic receptor blocker therapy": 0.00275865990554382, "assessing left ventricular filling pressure": 0.0028734721217443856, "stable severe systolic heart failure": 0.0027377277067582675, "early transmitral blood flow velocity": 0.00275865990554382, "early diastolic mitral annulus velocity": 0.002798878531488164, "estimating pulmonary capillary wedge pressure": 0.0029082043509477203, "tricuspid annular plane systolic excursion": 0.0028554953520328113, "undergoing left ventricular assist device": 0.0028370853657159944, "shortens left ventricular ejection time": 0.002798878531488164, "impaired cardiac metabolic gene expression": 0.0028554953520328113, "impaired cardiac energy metabolism gene": 0.002798878531488164, "cardiac energy metabolism gene expression": 0.0028370853657159944, "using cardiac magnetic resonance t1": 0.00271620579164635, "cardiac magnetic resonance t1 mapping": 0.00275865990554382, "cardiac magnetic resonance t1 time": 0.0026940599667709913, "outperformed left ventricular ejection fraction": 0.002941425996440181, "+9.2 \u00b1 9.5 % increase": 0.0023259465276312015, "restoring mitochondrial oxidative phosphorylation capacity": 0.0031020869493367785, "isolated coronary artery bypass grafting": 0.002818220766197502, "pathological cardiac gene expression programme": 0.0029249957403394474, "using trichrome blue histologic analysis": 0.002818220766197502, "induced pulmonary artery systolic pressure": 0.0028554953520328113, "impaired right ventricular pump function": 0.002818220766197502, "targeted pulmonary arterial hypertension medication": 0.0030038261713469057, "selective \u03b2 - blocker metoprolol": 0.002647744122008049, "increased vascular endothelial growth factor": 0.0028910355955503587, "vascular endothelial growth factor protein": 0.0028554953520328113, "left bundle branch block type": 0.0025725381249351686, "improved left ventricular filling pressure": 0.0028554953520328113, "left ventricular filling pressure response": 0.0028554953520328113, "proximal left anterior descending artery": 0.002818220766197502, "vasopressin type 2 receptor antagonist": 0.002779033845288914, "acute ischemic right heart failure": 0.0026940599667709913, "mean \u00b1 sd testosterone levels": 0.0025725381249351686, "ejection fraction 63 % \u00b1": 0.002427961502182354, "reduced left ventricular ejection fraction": 0.0028554953520328113, "single center retrospective observational study": 0.002941425996440181, "receiving ventricular assist device support": 0.0028734721217443856, "chronic \u03b2 - adrenergic receptor": 0.002623488832020163, "acute autonomic nervous system modulation": 0.0028370853657159944, "dual x - ray absorptiometry": 0.002517945086932572, "relative appendicular lean mass index": 0.00275865990554382, "non - linear hr variability": 0.002517945086932572, "- linear hr variability measures": 0.002647744122008049, "non - ischemic heart failure": 0.002545729147456897, "- ischemic heart failure samples": 0.002647744122008049, "symptomatic chronic advanced heart failure": 0.0028554953520328113, "post - myocardial infarction patients": 0.00275865990554382, "- myocardial infarction heart failure": 0.00275865990554382, "myocardial infarction heart failure patients": 0.0028910355955503587, "large idiopathic dilated cardiomyopathy cohort": 0.0029249957403394474, "obese body mass index categories": 0.002647744122008049, "overweight body mass index strata": 0.002671252975724663, "decreased mitochondrial energy production precede": 0.0029732629973073543, "reduced mitochondrial complex v activity": 0.002818220766197502, "provided left ventricular function assessment": 0.0029082043509477203, "using cardiopulmonary exercise testing guide": 0.0028910355955503587, "cardiopulmonary exercise testing guide exercise": 0.002941425996440181, "prospective randomized multicenter trial paradigm": 0.0029732629973073543, "ambulatory patients with heart failure": 0.002223227076231131, "medical treatment for heart failure": 0.0021729646333170797, "young adults with heart failure": 0.0020987910656161306, "precapillary ph with heart failure": 0.0021552479734167932, "dependent patients with heart failure": 0.0022069279244350563, "beneficial effect of exercise training": 0.002223227076231131, "intensive transitions of care program": 0.0022069279244350563, "deficient adult patients with heart": 0.0016297234749878095, "many multisite studies in practice": 0.001616435980062595, "complementary model system of zebrafish": 0.0016793271188928983, "recent hospital discharge in patients": 0.0016551959433262922, "natriuretic peptide levels in patients": 0.0016674203071733484, "effects via stimulation of endothelial": 0.0016674203071733484, "predictive cutoff value for plasma": 0.001616435980062595, "predictive cutoff value for admission": 0.0016551959433262922, "hypertensive heart disease by angiotensin": 0.0017022512194295963, "acute kidney injury during spironolactone": 0.0017022512194295963, "ventricular filling pressure in patients": 0.0016909324597185011, "systolic pressure relationship in heart": 0.0016793271188928983, "isolated hr reduction by ivabradine": 0.0016297234749878095, "isolated hr reduction in patients": 0.0016027517854347976, "higher serum levels of brain": 0.001527437488474138, "higher serum levels of creatinine": 0.0016027517854347976, "structured exercise programme for patients": 0.0017132972112196868, "embryonic gene programs in heart": 0.0015886464732048295, "medications among outpatients with heart": 0.0016909324597185011, "resistant volume overload in heart": 0.001616435980062595, "cardiac resynchronization therapy in dialysis": 0.0017449226105686322, "acute heart failure in patients": 0.0015740932992120977, "coronary artery disease in patients": 0.0016297234749878095, "accurate risk stratification of patient": 0.0016793271188928983, "acute care surgery in heart": 0.001510767052159543, "extracorporeal membrane oxygenation as bridge": 0.0017449226105686322, "right heart failure with therapy": 0.0015886464732048295, "deleterious \u03b21ar overstimulation in heart": 0.0017022512194295963, "discharge among patients with heart": 0.0016297234749878095, "readmission among patients with heart": 0.0016551959433262922, "proportional hazard models with time": 0.0016426366240549605, "outcomes among patients with heart": 0.001616435980062595, "- adrenoceptor blockade with esmolol": 0.0016426366240549605, "congestive heart failure in survivors": 0.0016551959433262922, "- hct exposure to anthracyclines": 0.0015886464732048295, "large outcomes trial of heart": 0.0015435228749611013, "recent onset af at risk": 0.0014372681495627027, "congestive heart failure in humans": 0.001616435980062595, "composite quality measure for heart": 0.0016297234749878095, "volume within strata of hospital": 0.0015886464732048295, "myocardial infarction patients with heart": 0.0017022512194295963, "indeterminable anaerobic threshold in heart": 0.0017240832730466317, "systolic heart failure after pressure": 0.0016551959433262922, "respiratory gas analysis at baseline": 0.0016426366240549605, "little hr reduction with beta": 0.0015435228749611013, "% of patients with heart": 0.0009711846008729415, "treatment of anemia in patients": 0.0010493955328080653, "anemia in patients with heart": 0.0010290152499740676, "quality of life in patients": 0.001007178034773029, "symptoms in patients with heart": 0.0010493955328080653, "management of patients with heart": 0.0010685011902898652, "global changes in chromatin subproteomes": 0.0011272883064790008, "mortality in patients with heart": 0.0010590976488032196, "common applications of readmission metrics": 0.0011421981408131245, "differential impact on hospital performance": 0.0011493888486977543, "different approaches to computing readmissions": 0.001169998296135779, "medical management of heart failure": 0.0010864823166585398, "protective effects of exercise training": 0.0011195514125952656, "limited mortality at hospital discharge": 0.0011195514125952656, "mild restriction of leaflet motion": 0.0010776239867083966, "prognostic factor in heart failure": 0.0010776239867083966, "reliable measure of health status": 0.0010685011902898652, "equivalent dose of metoprolol succinate": 0.0011195514125952656, "acute treatment of heart failure": 0.0010590976488032196, "independent association between spironolactone use": 0.0011954789641547817, "proangiogenic effects of b act": 0.0010393752585487225, "cardiac angiogenesis in heart failure": 0.0011034639622175282, "responsible diagnosis of heart failure": 0.0011116135381155656, "twofold increase in lung weight": 0.0010493955328080653, "groups versus the sham group": 0.0010182916589827587, "left ventricle in heart failure": 0.0010493955328080653, "rates across the respective age": 0.0010493955328080653, "outcomes in patients with heart": 0.0010493955328080653, "standard error of measurement value": 0.0010864823166585398, "excessive secretion of arginine vasopressin": 0.0011493888486977543, "cardiac dysfunction during insulin resistance": 0.001163281740379088, "care for patients with heart": 0.0010182916589827587, "older patients with breast cancer": 0.0010685011902898652, "trend toward an inverse association": 0.0010864823166585398, "promising biomarker in heart failure": 0.001095091082703307, "higher frequency of diabetes mellitus": 0.0011034639622175282, "predictive value for heart failure": 0.0010776239867083966, "frequent comorbidities in heart failure": 0.0011195514125952656, "myocardial dd of collagen deposition": 0.001095091082703307, "significant decrease in re -": 0.0010182916589827587, "heterogenous improvement in ejection fraction": 0.001163281740379088, "compelling improvement after device implantation": 0.0011830041306335854, "human resistin in heart failure": 0.0010493955328080653, "fold induction of serum resistin": 0.0010590976488032196, "free probability after catheter ablation": 0.0011272883064790008, "clinical burden in adult medicine": 0.0010685011902898652, "cellular responses to heart failure": 0.0010864823166585398, "molecular scaffolds in heart pathology": 0.0011116135381155656, "beneficial adaptation to stress conditions": 0.0011421981408131245, "prognostic indicator in heart failure": 0.0011034639622175282, "epigenetic changes in chromatin structure": 0.0011348341462863979, "ventricular tissue from control animals": 0.0011195514125952656, "contemporary trends in heart failure": 0.001095091082703307, "thromboembolic events in heart failure": 0.0011116135381155656, "sympathetic control of heart rate": 0.0010685011902898652, "prospective assessment of body composition": 0.0011421981408131245, "slower increase in heart rate": 0.0010290152499740676, "diuretic use in heart failure": 0.0010290152499740676, "remarkable increase in camp hydrolysis": 0.0011116135381155656, "efficacy of eplerenone in patients": 0.0010776239867083966, "similar improvements in shuttle walk": 0.001095091082703307, "emotional status in heart failure": 0.0010685011902898652, "potential candidates for cell therapy": 0.0011034639622175282, "better tools for risk stratification": 0.001095091082703307, "dietary interventions in heart failure": 0.0011116135381155656, "significant difference in outcome ratings": 0.0011348341462863979, "older adults with heart failure": 0.0010493955328080653, "significant improvement in outcome ratings": 0.0011421981408131245, "reciprocal regulation in mouse hearts": 0.0011034639622175282, "physician within the first month": 0.0010590976488032196, "trend toward a higher baseline": 0.0010393752585487225, "right ventricle in heart failure": 0.0010590976488032196, "statistical standards in biomarker studies": 0.0011421981408131245, "new targets in disease management": 0.0010685011902898652, "therapeutic targets for heart failure": 0.0011034639622175282, "ventricular hypertrophy in heart failure": 0.0011272883064790008, "impact of carvedilol and metoprolol": 0.0010864823166585398, "inappropriate therapy in heart failure": 0.0011116135381155656, "absolute risk of heart failure": 0.0010393752585487225, "elevated levels of plasma norepinephrine": 0.0011272883064790008, "advanced stages of heart failure": 0.0010590976488032196, "elevated levels of plasma catecholamines": 0.0011272883064790008, "mortality within a few years": 0.0010182916589827587, "various measures of hr dynamics": 0.0010493955328080653, "linear measures of hr variability": 0.0010685011902898652, "early measurement of hr variability": 0.0010864823166585398, "routine measurement of hr variability": 0.0011034639622175282, "clinical tool for risk stratification": 0.0011034639622175282, "bioinformatic analysis of microarray data": 0.0011348341462863979, "worldwide increase in life expectancy": 0.0011034639622175282, "public reporting on quality aims": 0.0010590976488032196, "modest effects on heart failure": 0.0010493955328080653, "standard therapy with beta blockade": 0.0010864823166585398, "marked decreases in heart failure": 0.0010685011902898652, "significant alterations in energy metabolism": 0.0011564142382201434, "expenditure on health per capita": 0.0010590976488032196, "greater risk of heart failure": 0.0010290152499740676, "cardiac dysfunction with conduction abnormalities": 0.0011893051989229418, "contextual factors on physician adherence": 0.0011348341462863979, "patients with an implantable cardioverter": 0.0011348341462863979, "nosignificant changes in control group": 0.0011116135381155656, "systolic function in hfpef patients": 0.0010864823166585398, "common form of heart failure": 0.0010182916589827587, "patients with respect to alterations": 0.0005475455413516535, "respect to alterations in body": 0.0005196876292743613, "changes in nps or adiponectin": 0.0005145076249870338, "requires a presence of signs": 0.0005091458294913794, "presence of signs and symptoms": 0.0005196876292743613, "treatment of anemia and iron": 0.0005091458294913794, "literature in the english language": 0.0005388119933541983, "language on anemia and iron": 0.0005035890173865145, "treatment in patients with heart": 0.0005295488244016098, "harms of treatments for anemia": 0.0005196876292743613, "treatments for anemia in adults": 0.0005246977664040327, "anemia in adults with heart": 0.0005035890173865145, "agents in adults with anemia": 0.0005091458294913794, "life in patients with heart": 0.0005035890173865145, "transfusions in patients with heart": 0.0005432411583292699, "conditioning for patients with heart": 0.0005475455413516535, "predictors of mortality in patients": 0.0005432411583292699, "predictors of mortality in heart": 0.0005295488244016098, "analysis of a new chromatin": 0.0005035890173865145, "studies in the complementary model": 0.0005388119933541983, "hospitals in an extreme decile": 0.0005196876292743613, "discharge in patients with heart": 0.0005295488244016098, "readmission to hospital for heart": 0.0005342505951449326, "studies with a contemporaneous control": 0.0005558067690577828, "mortality for recently discharged patients": 0.0005710990704065622, "reductions in the composite end": 0.0005246977664040327, "evaluate the relationship between sex": 0.0005517319811087641, "levels with the greatest difference": 0.0005432411583292699, "cause of morbidity and mortality": 0.0005295488244016098, "application in the clinical setting": 0.0005432411583292699, "catheterization during the same period": 0.0005558067690577828, "comparison of predictors of heart": 0.0005342505951449326, "death in patients with versus": 0.0005145076249870338, "study the impact of self": 0.00048559230043647075, "counseling on the primary outcome": 0.0005342505951449326, "correlation between changes in hdl": 0.0005388119933541983, "determination of a predictive cutoff": 0.0005475455413516535, "weight with a high incidence": 0.0005091458294913794, "deaths in the experimental procedures": 0.0005517319811087641, "% in women and men": 0.0004416357764713315, "practice for a limited number": 0.0005145076249870338, "prolapse of a degenerative mitral": 0.0005342505951449326, "lesions in the major branches": 0.0005145076249870338, "hypertension with vasodilators and diuretics": 0.0005782071191100717, "reasons for the modest reduction": 0.0005295488244016098, "reduction by the surgical ring": 0.0005196876292743613, "evaluation of the surgical indications": 0.0005558067690577828, "approach for the acute treatment": 0.0005295488244016098, "safety of spironolactone in adults": 0.0005388119933541983, "adults with newly diagnosed heart": 0.0005342505951449326, "patients with a median follow": 0.0005145076249870338, "risks of hospitalization or death": 0.0005342505951449326, "outcomes for patients with heart": 0.0005295488244016098, "relevance in the clinical follow": 0.0005295488244016098, "nonsurvivors with a similar distribution": 0.0005636441532395004, "relationship as a possible index": 0.0005295488244016098, "% of the left ventricle": 0.0004790893831875676, "implantation of a novel bottleneck": 0.0005388119933541983, "levels to survival in patients": 0.0005196876292743613, "indicator in patients with heart": 0.0005295488244016098, "investigate the association of hypoalbuminemia": 0.0005849991480678895, "approaches to these difficult problems": 0.0005558067690577828, "differences in presentation and outcomes": 0.0005636441532395004, "minutes of exercise per week": 0.0005091458294913794, "improve the management of patients": 0.0005388119933541983, "embolism to the pulmonary arteries": 0.0005388119933541983, "quality of life for people": 0.00049782246538245, "life for people with heart": 0.00049782246538245, "assess the benefits of participation": 0.0005475455413516535, "participation in a structured exercise": 0.0005558067690577828, "programme for patients with heart": 0.0005342505951449326, "relation to sustainability with commissioning": 0.000581640870189544, "assess the association between frailty": 0.0005558067690577828, "association between frailty and risk": 0.0005475455413516535, "assessed the association between frailty": 0.0005636441532395004, "improving the prognosis of patients": 0.0005432411583292699, "use of antagonists and inhibitors": 0.0005342505951449326, "induction of a fetal gene": 0.0004918297171970689, "mir-25 by a specific antagomir": 0.0005196876292743613, "expression of the bhlh transcription": 0.0005475455413516535, "base of treatment of heart": 0.00049782246538245, "includes the use of angiotensin": 0.0005246977664040327, "blockers in case of angiotensin": 0.0005246977664040327, "cause of death in patients": 0.00049782246538245, "death in patients with type": 0.0005035890173865145, "action through activation of p38": 0.0005295488244016098, "variation in rates of guideline": 0.0005246977664040327, "treatment for outpatients with heart": 0.0005475455413516535, "examine the association between treatment": 0.0005674170731431989, "rates of treatment with angiotensin": 0.0005432411583292699, "medications for patients with heart": 0.0005432411583292699, "quality of care for patients": 0.0005091458294913794, "trastuzumab in the adjuvant setting": 0.0005432411583292699, "age of the entire cohort": 0.00048559230043647075, "mortality in women with heart": 0.0005145076249870338, "recommendations for patients with heart": 0.0005597757062976328, "scores with mortality among postmenopausal": 0.0005710990704065622, "assessments of patients with heart": 0.0005388119933541983, "age of patients with heart": 0.00049782246538245, "rate for patients with heart": 0.0005091458294913794, "outcome in patients with heart": 0.0005196876292743613, "assess the relationship between pathobiology": 0.0005782071191100717, "disease in patients with thalassaemia": 0.0005517319811087641, "verify the impact of heart": 0.00049782246538245, "fraction on the clinical response": 0.0005342505951449326, "results of patients with baseline": 0.0005342505951449326, "site of the elastic n2bus": 0.0004918297171970689, "strain as a major predictor": 0.0005035890173865145, "failure during an average follow": 0.0005295488244016098, "reduction in the primary end": 0.0005091458294913794, "reduction in the primary outcome": 0.0005295488244016098, "component of the primary outcome": 0.0005295488244016098, "ratio for the primary outcome": 0.0005145076249870338, "fibrillation in patients with heart": 0.0005432411583292699, "administration of doxorubicin in rats": 0.0005517319811087641, "contents in addition to cytochrome": 0.0005388119933541983, "alleviating the decrement of heart": 0.0005388119933541983, "risk for the primary outcome": 0.0005091458294913794, "events after adjustment for age": 0.0005246977664040327, "kinases into a linear pathway": 0.0005145076249870338, "improve the potential for success": 0.0005342505951449326, "frame of a patient consultation": 0.0005246977664040327, "advantage of the faster turnaround": 0.0005388119933541983, "rethinking the quality of outcome": 0.0005342505951449326, "improve the quality of care": 0.0005035890173865145, "investigating the role of bets": 0.0005196876292743613, "model of neurohormonally induced heart": 0.0005558067690577828, "induction of a substantial subset": 0.0005342505951449326, "t1 in swine with heart": 0.00047229735422974975, "percentage of fibrosis of heart": 0.0005246977664040327, "increase by means of stress": 0.0005035890173865145, "echocardiography as a possible measure": 0.0005558067690577828, "use of devices in heart": 0.0004790893831875676, "become a cornerstone of heart": 0.0005145076249870338, "attention in the medical literature": 0.0005432411583292699, "hemostasis in patients with heart": 0.0005342505951449326, "dosages of carvedilol or metoprolol": 0.0005432411583292699, "events in patients with heart": 0.0005145076249870338, "medications to adults with heart": 0.0005295488244016098, "thirds of patients with heart": 0.0005145076249870338, "protein in the left ventricle": 0.0005145076249870338, "contractility of the left ventricle": 0.0005432411583292699, "addition to the left bundle": 0.0005035890173865145, "delay the onset of myofiber": 0.0005035890173865145, "test the effects of treatment": 0.0005145076249870338, "effects of treatment with ivabradine": 0.0005475455413516535, "treatment with ivabradine on exercise": 0.0005517319811087641, "filling in patients with heart": 0.0005196876292743613, "delay the onset of symptoms": 0.0005035890173865145, "rate at the same exercise": 0.0004918297171970689, "correlates of increase in exercise": 0.0005388119933541983, "angiography with a primary diagnosis": 0.0005475455413516535, "eliminate the need for angiography": 0.0005388119933541983, "angiography in a substantial proportion": 0.0005597757062976328, "stratification of patient with heart": 0.0005475455413516535, "subject of this brief review": 0.0005091458294913794, "reduced the rise in camp": 0.00048559230043647075, "underuse of eplerenone in patients": 0.0005388119933541983, "analysis of subgroups of patients": 0.0005342505951449326, "hospitalization for hyperkalemia or discontinuation": 0.0006007652342693811, "explore the relation of hemoglobin": 0.0005388119933541983, "effects of hrqol from exercise": 0.0005196876292743613, "structure in patients with heart": 0.0005295488244016098, "alterations in markers of skm": 0.0005145076249870338, "medicine as an adjunctive treatment": 0.0005432411583292699, "cardiomyopathy in patients with heart": 0.0005517319811087641, "enzymes in patients with heart": 0.0005196876292743613, "patients with newly diagnosed heart": 0.0005432411583292699, "variables with an important contribution": 0.0005636441532395004, "evaluating the effect of interventions": 0.0005558067690577828, "year of oht in recipients": 0.0004918297171970689, "interval from transplantation to consultation": 0.000581640870189544, "interval from consultation to operation": 0.0005597757062976328, "oxygenation as bridge to recovery": 0.0005342505951449326, "bridge to recovery in infarction": 0.0005295488244016098, "diagnosis of a posterior wall": 0.0005145076249870338, "half of patients with heart": 0.0005035890173865145, "given the lack of improvement": 0.0005145076249870338, "improvements from baseline in peak": 0.0005388119933541983, "agents in combination with anticoagulants": 0.0005674170731431989, "biomarkers in patients with heart": 0.0005342505951449326, "bolus of metoprolol or atropine": 0.0005246977664040327, "reduce the rate of death": 0.00048559230043647075, "rate of death or hospitalization": 0.0005295488244016098, "ratings from admission to discharge": 0.0005432411583292699, "insight on the possible contribution": 0.0005475455413516535, "contribution of nursing to outcomes": 0.0005432411583292699, "highlighting the contribution of nursing": 0.0005636441532395004, "readmission after discharge among patients": 0.0005710990704065622, "rates of death and readmission": 0.0005196876292743613, "analyze the effect of follow": 0.0005091458294913794, "discharge on the primary outcome": 0.0005295488244016098, "visits with a familiar physician": 0.0005295488244016098, "hospitalizations in patients with heart": 0.0005597757062976328, "demonstrated no change in type": 0.0005196876292743613, "instability in patients with heart": 0.0005388119933541983, "aim of the present study": 0.00048559230043647075, "definitions of the distinctive components": 0.0005674170731431989, "components of the right heart": 0.0005145076249870338, "consensus on a universal definition": 0.0005432411583292699, "insight into mechanisms of disease": 0.0005388119933541983, "result of shortcomings in research": 0.0005388119933541983, "provide an overview of biomarker": 0.0005295488244016098, "plasma by use of immunoprecipitation": 0.0005475455413516535, "fragments of the full length": 0.0005091458294913794, "development of a next generation": 0.0005295488244016098, "evaluate the effects of carvedilol": 0.0005388119933541983, "effects of carvedilol and metoprolol": 0.0005475455413516535, "blockers on the primary endpoint": 0.0005295488244016098, "investigate the occurrence of heart": 0.0005432411583292699, "users of bisphosphonates and raloxifene": 0.0005597757062976328, "% in the exposed group": 0.00047229735422974975, "reduce the risk of heart": 0.00048559230043647075, "alterations by metoprolol in heart": 0.0005388119933541983, "examine the reversibility of heart": 0.0005388119933541983, "rates of changes in pressure": 0.0005091458294913794, "reduction in the elevated levels": 0.0005295488244016098, "assess the association between psoriasis": 0.0005636441532395004, "disease from the general population": 0.0005432411583292699, "events as subjects without psoriasis": 0.0005475455413516535, "levels in patients with pad": 0.0005035890173865145, "remodeling of the arrhythmia substrate": 0.0005558067690577828, "activation of the renin- angiotensin": 0.0005475455413516535, "form the foundation of management": 0.0005342505951449326, "foundation of management of patients": 0.0005475455413516535, "revascularization with angioplasty and stenting": 0.0005882851992880362, "guidelines on evaluation and management": 0.0005597757062976328, "controls during this same time": 0.0005196876292743613, "race as an independent predictor": 0.0005295488244016098, "investigate the association between race": 0.0005636441532395004, "association between race and outcomes": 0.0005517319811087641, "explored an interaction with exercise": 0.0005517319811087641, "af at risk for stroke": 0.0004651893055262403, "control as an initial approach": 0.0005196876292743613, "increase in incidence and prevalence": 0.0005475455413516535, "causes of death and hospitalisation": 0.0005432411583292699, "consequence of the worldwide increase": 0.0005517319811087641, "preclude the provision of life": 0.0005196876292743613, "estimated the odds of future": 0.0005091458294913794, "point of death or hospitalization": 0.0005342505951449326, "analyze the relationship between length": 0.0005597757062976328, "relationship between length of stay": 0.0005432411583292699, "length of stay and rehospitalization": 0.0005475455413516535, "declines in length of stay": 0.00049782246538245, "decrease in length of stay": 0.00049782246538245, "outcomes of care for patients": 0.0005145076249870338, "costs for patients with heart": 0.0005145076249870338, "outcomes for medically managed diseases": 0.0005597757062976328, "reduction in mortality and hospitalizations": 0.0005746944243488772, "provide the background for aldosterone": 0.0005558067690577828, "improvement in survival of patients": 0.0005432411583292699, "survival of patients with heart": 0.0005246977664040327, "failure in the hypertrophied heart": 0.0005388119933541983, "rates of glycolysis and glucose": 0.0005246977664040327, "progression from hypertrophy to heart": 0.0005517319811087641, "search of the electronic databases": 0.0005388119933541983, "assessing the link between air": 0.0005196876292743613, "patients in the terminal phase": 0.0005196876292743613, "requires the collaboration of professionals": 0.0005746944243488772, "aims of the present consensus": 0.0005145076249870338, "safety of these antihyperglycemic agents": 0.0005636441532395004, "users of saxagliptin or sitagliptin": 0.0005432411583292699, "assess the impact of implementation": 0.0005432411583292699, "reduce the number of patients": 0.0005145076249870338, "shocks at end of life": 0.0004651893055262403, "objective of this clinical trial": 0.0005295488244016098, "patients as control without exercise": 0.0005475455413516535, "training of the lower limbs": 0.0005035890173865145, "evaluation of the muscular strength": 0.0005432411583292699, "association in the usual care": 0.0005145076249870338, "impact the effect of exercise": 0.0005145076249870338, "assessed the impact of hr": 0.0004918297171970689, "treatment of patients with heart": 0.0005295488244016098, "reduce the risk of hospital": 0.0005035890173865145, "evaluations at baseline and months": 0.0005388119933541983, "effect on quality of life": 0.0004918297171970689, "improvements in functioning and use": 0.0005432411583292699, "advancement of the pathophysiologic state": 0.0005674170731431989, "95 % confidence interval": 0.07381002966634355, "left ventricular ejection fraction": 0.06465743920250379, "patients with heart failure": 0.030215341043190864, "estimated glomerular filtration rate": 0.024092003819472754, "left ventricular assist device": 0.01247250310258467, "chronic obstructive pulmonary disease": 0.01103463962217528, "preserved left ventricular ejection": 0.008691858533268319, "left bundle branch block": 0.007769476806983532, "right ventricular contractile reserve": 0.008827711697740225, "diastolic mitral annular velocity": 0.008548009522318921, "- brain natriuretic peptide": 0.008057424278184231, "x - ray absorptiometry": 0.005667568250756997, "hour cumulative urine volume": 0.006109749953896552, "left ventricular assist devices": 0.006296373196848391, "95 % confidence intervals": 0.005901956606364827, "vascular endothelial growth factor": 0.00646574392025038, "post - myocardial infarction": 0.006109749953896552, "standard cardiac rehabilitation care": 0.006570546496219842, "standard criteria cardiac transplant": 0.006570546496219842, "early diastolic mitral flow": 0.006043068208638172, "diastolic mitral flow velocity": 0.006236251551292335, "peak early diastolic mitral": 0.006043068208638172, "end stage heart failure": 0.005749072598250811, "patients with chronic heart": 0.00453230115647863, "energy x - ray": 0.003225888516888459, "low left ventricular ejection": 0.00411606099989627, "proteins alter chromatin structure": 0.0043104959468335865, "receive cardiac resynchronization therapy": 0.004539336585145591, "left ventricular ejection fractions": 0.004345929266634159, "diastolic mitral valve tethering": 0.004236390595212879, "posteriorly displaced papillary muscles": 0.004478205650381062, "- myocardial infarction heart": 0.00411606099989627, "left ventricular filling pressure": 0.004274004761159461, "pulmonary capillary wedge pressure": 0.0043104959468335865, "showed good diagnostic performance": 0.0043104959468335865, "annular plane systolic excursion": 0.004236390595212879, "pulmonary arterial systolic pressure": 0.004380364330813228, "proximal left anterior descending": 0.004274004761159461, "ejection fraction \u226435 %": 0.0038327150655005407, "ventricular assist device implantation": 0.004446454152462262, "left ventricular ejection time": 0.00415750103419489, "95 % confidence level": 0.0037215144442099223, "angiotensin converting enzyme inhibitors": 0.004509153225916003, "cardiac magnetic resonance postcontrast": 0.004478205650381062, "cardiac magnetic resonance t1": 0.00411606099989627, "heart magnetic resonance imaging": 0.004236390595212879, "ventricular longitudinal systolic strain": 0.004509153225916003, "non - fatal stroke": 0.003533086211770652, "predicting adverse cv events": 0.004073166635931035, "left ventricular diastolic function": 0.004345929266634159, "mitochondrial oxidative phosphorylation capacity": 0.004732016522534342, "coronary artery bypass grafting": 0.004197582131232261, "channel mrna splice variants": 0.004073166635931035, "acute right heart failure": 0.003934637737576551, "angiotensin converting enzyme inhibitor": 0.004478205650381062, "multivariate logistic regression analysis": 0.004539336585145591, "left ventricular diastolic end": 0.00415750103419489, "ventricular diastolic end diameter": 0.0043104959468335865, "\u03b2 - adrenoceptor blockade": 0.003934637737576551, "angiotensin receptor neprilysin inhibitor": 0.004539336585145591, "risk of heart failure": 0.0037215144442099223, "major public health problem": 0.004028712139092116, "ischemic heart failure samples": 0.00415750103419489, "early rhythm control therapy": 0.004073166635931035, "post - acute care": 0.0034632178277910104, "- acute care transfer": 0.0037215144442099223, "acute care transfer policy": 0.0039825797230596, "chronic advanced heart failure": 0.00415750103419489, "advanced heart failure patients": 0.004197582131232261, "myocardial infarction heart failure": 0.004345929266634159, "primary study end point": 0.0038327150655005407, "heart failure disease management": 0.004236390595212879, "failure disease management programs": 0.004345929266634159, "patients with heart disease": 0.003021534104319086, "objective of this study": 0.0028745362991254055, "standard error of measurement": 0.0030870457499222025, "heart failure in patients": 0.0029509783031824136, "patients with acute heart": 0.0024591485859853444, "patients with advanced heart": 0.002545729147456897, "treatment of heart failure": 0.00248911232691225, "patients with systolic heart": 0.002545729147456897, "hospital adverse events averted": 0.0020987910656161306, "national patient safety initiatives": 0.0021729646333170797, "cachectic heart failure patients": 0.0021181952976064393, "dual energy x -": 0.001655111457576157, "non - diabetic patients": 0.0019163575327502704, "non - cachectic chf": 0.0017995880167098433, "heart failure show preserved": 0.0020365833179655174, "mild clinical diastolic dysfunction": 0.0021729646333170797, "- dilated left ventricle": 0.001942369201745883, "adult patients with heart": 0.0019673188687882757, "congestive heart failure exacerbation": 0.0022069279244350563, "clinical practice guidelines grading": 0.002190182165406614, "practice guidelines grading system": 0.0021552479734167932, "restrictive red blood cell": 0.0019912898615298, "red blood cell transfusion": 0.0019912898615298, "blood cell transfusion strategy": 0.0020987910656161306, "term mortality rates compared": 0.002058030499948135, "relative risk among trials": 0.0019912898615298, "data supporting iron use": 0.001942369201745883, "right ventricular assist devices": 0.0021181952976064393, "modern acute heart failure": 0.0019912898615298, "baseline glomerular filtration rate": 0.0021729646333170797, "identified strong reliable mortality": 0.002190182165406614, "strong reliable mortality predictors": 0.002190182165406614, "acute heart failure randomized": 0.002078750517097445, "heart failure randomized trial": 0.002078750517097445, "renal function in patients": 0.0019912898615298, "renal function end point": 0.001942369201745883, "cardiac chromatin identifies nucleolin": 0.002223227076231131, "heart failure involves changes": 0.002078750517097445, "conserved developmental chromatin remodeling": 0.002312828476440287, "developmental chromatin remodeling events": 0.0022696682925727957, "conducted extensive functional characterization": 0.0023531407971521447, "displayed severe developmental impairment": 0.0022696682925727957, "bone morphogenetic protein 4": 0.0020365833179655174, "limited data regarding risk": 0.002014356069546058, "data regarding risk factors": 0.002014356069546058, "present study population comprised": 0.0021552479734167932, "proportional hazards regression modeling": 0.0022545766129580015, "coronary artery bypass surgery": 0.002078750517097445, "increased systolic blood pressure": 0.0021370023805797303, "bundle branch block pattern": 0.002014356069546058, "improved outcomes among patients": 0.0021181952976064393, "term mortality as patients": 0.0019912898615298, "interaction term analysis showed": 0.0021181952976064393, "day readmission rates using": 0.002014356069546058, "produce different hospital rankings": 0.0021729646333170797, "rm interventions included home": 0.002078750517097445, "interventions included home telemonitoring": 0.002284396281626249, "chronic heart failure induced": 0.002058030499948135, "rapid right ventricular pacing": 0.002078750517097445, "pump sternal sparing approach": 0.002058030499948135, "pump dysfunction requiring pump": 0.0020987910656161306, "dysfunction requiring pump replacement": 0.002223227076231131, "ambulatory patients with heart": 0.002078750517097445, "- blocker dose changes": 0.001889189416918999, "\u03b2 - blocker dose": 0.0016945562380851515, "- blocker dose increase": 0.0019163575327502704, "\u03b2 - blocker uptitration": 0.0019163575327502704, "type natriuretic peptide levels": 0.0020987910656161306, "involving ventricular assist devices": 0.002190182165406614, "congestive heart failure declined": 0.0021370023805797303, "determined chf visit rates": 0.0019912898615298, "congestive heart failure visits": 0.0020987910656161306, "heart failure visits declined": 0.002058030499948135, "normal systolic ventricular function": 0.002190182165406614, "low systemic vascular resistance": 0.0021181952976064393, "abnormal liver texture changes": 0.002078750517097445, "primary outcome of death": 0.001942369201745883, "chronic heart failure promotes": 0.002078750517097445, "heart failure promotes restoration": 0.0021552479734167932, "protective effects via stimulation": 0.0021552479734167932, "novel heart failure mice": 0.001942369201745883, "heart failure mice model": 0.001942369201745883, "using simple experimental procedures": 0.002190182165406614, "predict heart failure risk": 0.0019912898615298, "prevalent coronary heart disease": 0.0021181952976064393, "simpler laboratory report model": 0.0020987910656161306, "temporary right ventricular support": 0.0021729646333170797, "chronic decompensated heart failure": 0.0021729646333170797, "right ventricular assist device": 0.0020987910656161306, "purpose of this study": 0.0018607572221049612, "ventricular assist device use": 0.002058030499948135, "selected cardiac surgery patients": 0.0021370023805797303, "used speckle tracking echocardiography": 0.002223227076231131, "acute right ventricular pressure": 0.0021181952976064393, "right ventricular pressure overload": 0.0021729646333170797, "left ventricular midpapillary level": 0.0021729646333170797, "varying regional strain contributions": 0.0022069279244350563, "medical treatment for heart": 0.002014356069546058, "size reduction by surgery": 0.0019673188687882757, "successful mitral valve plasty": 0.002078750517097445, "grade 4/6 holosystolic murmur": 0.002058030499948135, "underwent mitral valve plasty": 0.002058030499948135, "preserved mitral valve opening": 0.002078750517097445, "mitral filling flow volume": 0.0019912898615298, "limited mitral valve opening": 0.0020365833179655174, "diastolic mitral leaflet motions": 0.0021181952976064393, "after aggressive medical treatment": 0.0021552479734167932, "heart failure clinic outpatients": 0.0021181952976064393, "available outpatient models use": 0.0020987910656161306, "month risk of death": 0.0017995880167098433, "model included blood urea": 0.0019673188687882757, "included blood urea nitrogen": 0.0020365833179655174, "demonstrated excellent risk stratification": 0.002284396281626249, "resources within health systems": 0.0020987910656161306, "median left ventricular ejection": 0.0021181952976064393, "uncontrolled hypertension identify patients": 0.0022987776973955086, "demonstrated high internal consistency": 0.002223227076231131, "internal consistency among patients": 0.0021729646333170797, "offers excellent prognostic ability": 0.0021729646333170797, "interleukin receptor family member": 0.0021552479734167932, "left ventricular systolic dysfunction": 0.0022069279244350563, "lowest cardiovascular event rate": 0.0021181952976064393, "highest cardiovascular event rate": 0.0021370023805797303, "sst2 measurement identifies patients": 0.002190182165406614, "soluble guanylate cyclase altered": 0.0021370023805797303, "maximal ventricular power index": 0.0020987910656161306, "right heart filling pressures": 0.002058030499948135, "right ventricular fractional area": 0.0021370023805797303, "echocardiographic score allowed prediction": 0.002284396281626249, "lv assist device implantations": 0.002078750517097445, "93 heart failure admissions": 0.002014356069546058, "symptomatic systolic heart failure": 0.0021552479734167932, "diagnosed systolic heart failure": 0.0021181952976064393, "baseline serum creatinine level": 0.0020987910656161306, "% confidence interval 0.77": 0.0019912898615298, "incident systolic heart failure": 0.0020987910656161306, "endothelial growth factor blockade": 0.0021552479734167932, "growth factor blockade prevents": 0.0020987910656161306, "myocardial infarction heart contributes": 0.002239102825190531, "- adrenergic receptor blocker": 0.002058030499948135, "adrenergic receptor blocker therapy": 0.0021729646333170797, "revealed reduced cardiac diameters": 0.0021552479734167932, "b act via activation": 0.0018309375534367137, "heart failure via activation": 0.0020365833179655174, "oxidase inhibition preserves left": 0.0021370023805797303, "inhibition improves cardiomyocyte bioenergetics": 0.0023531407971521447, "stable severe systolic heart": 0.0020365833179655174, "severe systolic heart failure": 0.002058030499948135, "early transmitral blood flow": 0.0020365833179655174, "transmitral blood flow velocity": 0.0020987910656161306, "early diastolic mitral annulus": 0.002078750517097445, "diastolic mitral annulus velocity": 0.0021370023805797303, "estimating pulmonary capillary wedge": 0.002190182165406614, "decompensated systolic heart failure": 0.002190182165406614, "detecting normal filling pressures": 0.0021552479734167932, "arterial systolic pressure relationship": 0.002239102825190531, "right ventricular contractile function": 0.002223227076231131, "tricuspid annular plane systolic": 0.0021181952976064393, "type natriuretic peptide assessment": 0.0021729646333170797, "downward regression line shift": 0.002078750517097445, "fractional flow reserve measurements": 0.002190182165406614, "positron emission tomography imaging": 0.002190182165406614, "emission tomography imaging showed": 0.0021552479734167932, "competitive collateral growth patterns": 0.002223227076231131, "selective heart rate reduction": 0.002078750517097445, "preoperative serum albumin levels": 0.0021370023805797303, "% confidence interval 0.290": 0.002014356069546058, "instituting mechanical circulatory support": 0.002284396281626249, "underwent aortic valve surgery": 0.002078750517097445, "patients underwent lvad implantation": 0.002190182165406614, "1 dacron patch closure": 0.001889189416918999, "transcatheter aortic valve procedure": 0.002190182165406614, "bioprosthetic aortic valve replacement": 0.002223227076231131, "young adults with heart": 0.0019163575327502704, "adults with heart failure": 0.0019673188687882757, "population within cardiac rehabilitation": 0.0022545766129580015, "increased right grip strength": 0.002058030499948135, "acute heart failure complicating": 0.0021181952976064393, "complicating precapillary pulmonary hypertension": 0.002366008261267171, "major right ventricle overload": 0.002078750517097445, "right ventricle overload leads": 0.002078750517097445, "arterial tonometry study tested": 0.0020987910656161306, "precapillary ph with heart": 0.0019912898615298, "radial artery tonometry variables": 0.0021370023805797303, "reconstructed aortic pressure curve": 0.0021729646333170797, "right atrial mass removal": 0.0019673188687882757, "right atrium mass presented": 0.002014356069546058, "brief hypothermic circulatory arrest": 0.002190182165406614, "advanced chronic organ failure": 0.002078750517097445, "median body mass index": 0.001889189416918999, "relative minimal detectable change": 0.0021552479734167932, "failure risk among patients": 0.002014356069546058, "non - biological disease": 0.001942369201745883, "secondary outcome measures related": 0.0021552479734167932, "aim of this study": 0.0017316089138955052, "non - frail participants": 0.001942369201745883, "sub - groups based": 0.001766543105885326, "vasopressin receptor antagonist therapy": 0.002239102825190531, "beneficial new therapeutic approach": 0.0021729646333170797, "healthy heart muscle cells": 0.0019912898615298, "heart muscle cells developed": 0.0020365833179655174, "evoked spontaneous cardiac dysfunction": 0.002223227076231131, "converting enzyme inhibitors intolerance": 0.0022545766129580015, "past decades several studies": 0.0020365833179655174, "beta blockers decrease mortality": 0.0021181952976064393, "insulin receptor substrates 1": 0.002058030499948135, "causes myocardial insulin resistance": 0.002190182165406614, "box class o-1 signaling": 0.0019163575327502704, "impaired cardiac metabolic gene": 0.0020987910656161306, "cardiac metabolic gene expression": 0.0021370023805797303, "impaired cardiac energy metabolism": 0.0021552479734167932, "cardiac energy metabolism gene": 0.002078750517097445, "energy metabolism gene expression": 0.0021370023805797303, "neonatal rat ventricular cardiomyocytes": 0.002239102825190531, "chronic insulin exposure reduced": 0.0021181952976064393, "optimal combined treatment measure": 0.0021552479734167932, "multivariable hierarchical regression models": 0.002312828476440287, "level prescription rates ranged": 0.0020987910656161306, "adjusted median rate ratio": 0.0019912898615298, "angiotensin receptor blockers therapy": 0.0022069279244350563, "reduced ejection fraction exists": 0.0021181952976064393, "cardiotoxicity among older patients": 0.0021729646333170797, "adjuvant setting improves outcomes": 0.0021552479734167932, "chf among older patients": 0.001942369201745883, "older breast cancer patients": 0.0020365833179655174, "non - hf populations": 0.0018309375534367137, "mortality among postmenopausal women": 0.002190182165406614, "proportional hazards models adjusted": 0.002190182165406614, "higher dash diet scores": 0.0019163575327502704, "extended criteria cardiac transplantation": 0.0022696682925727957, "extended criteria cardiac transplant": 0.002190182165406614, "undergoing isolated heart transplant": 0.002190182165406614, "criteria cardiac transplant recipients": 0.002223227076231131, "criteria cardiac transplant survival": 0.002190182165406614, "post - transplant mortality": 0.002014356069546058, "advanced heart failure therapy": 0.002078750517097445, "post - transplant morbidity": 0.002014356069546058, "heart failure readmission quality": 0.0021370023805797303, "failure readmission quality improvement": 0.002239102825190531, "readmission quality improvement initiative": 0.002284396281626249, "hospital quality improvement initiative": 0.002239102825190531, "heart failure nurse practitioner": 0.0021181952976064393, "readmission rate for patients": 0.002058030499948135, "myocardial extracellular matrix accumulation": 0.002312828476440287, "estimate myocardial extracellular matrix": 0.0022545766129580015, "using cardiac magnetic resonance": 0.0021181952976064393, "magnetic resonance t1 mapping": 0.002058030499948135, "cardiac magnetic resonance imaging": 0.0021552479734167932, "magnetic resonance imaging including": 0.002190182165406614, "resonance imaging including t1": 0.002078750517097445, "imaging including t1 mapping": 0.0020365833179655174, "magnetic resonance t1 time": 0.0019912898615298, "right ventricular ejection fraction": 0.0021729646333170797, "recommend cardiac resynchronization therapy": 0.0022987776973955086, "end systolic volume index": 0.0019673188687882757, "rat metabolic risk model": 0.001942369201745883, "important metabolic risk factors": 0.0021181952976064393, "preserved ejection fraction development": 0.002239102825190531, "high muscle strip stiffness": 0.002014356069546058, "rats developed heart failure": 0.0020365833179655174, "patients with atrial fibrillation": 0.0021370023805797303, "systolic mitral annulus velocity": 0.0021181952976064393, "containing chronic heart failure": 0.0021181952976064393, "receiving implantable cardioverter defibrillator": 0.002366008261267171, "refractory congestive heart failure": 0.0021729646333170797, "diuretic resistant volume overload": 0.0021552479734167932, "transplant ineligible patients receiving": 0.0022545766129580015, "post - pd initiation": 0.0018309375534367137, "severe right ventricular dysfunction": 0.002190182165406614, "stage congestive heart failure": 0.002078750517097445, "dependent patients with heart": 0.002058030499948135, "ii receptor blocker use": 0.0019163575327502704, "demonstrated superior reverse remodeling": 0.0022545766129580015, "certain dialysis patients demonstrated": 0.002223227076231131, "sodium dash diet improves": 0.0019673188687882757, "dietary sodium restriction improves": 0.0021729646333170797, "parametrized diastolic filling formalism": 0.0022545766129580015, "pre - post comparisons": 0.001889189416918999, "connected elevated resistin levels": 0.0021552479734167932, "mouse model lacking murine": 0.0019912898615298, "model lacking murine resistin": 0.002058030499948135, "increased cardiac mrna levels": 0.002058030499948135, "cell adhesion genes compared": 0.0020365833179655174, "treated breast cancer patients": 0.002078750517097445, "patients maintaining sinus rhythm": 0.0021370023805797303, "larger randomized control studies": 0.0021370023805797303, "heart failure in rats": 0.0018607572221049612, "anti - neoplastic agent": 0.0019163575327502704, "mitochondrial oxidative stress induced": 0.002223227076231131, "restoring mitochondrial oxidative phosphorylation": 0.0023786103978458836, "significant cardioprotection via inhibition": 0.0022987776973955086, "isolated coronary artery bypass": 0.0020987910656161306, "heart failure \u226490 days": 0.001889189416918999, "developed acute kidney injury": 0.002058030499948135, "% confidence interval 1.38": 0.0019912898615298, "paediatric heart failure concern": 0.0021181952976064393, "new onset heart failure": 0.0019163575327502704, "targeting specific effector molecules": 0.0022069279244350563, "% intermediate frail according": 0.002078750517097445, "acute heart failure trials": 0.0019912898615298, "adverse event rates remain": 0.0019912898615298, "selecting appropriate end points": 0.0021181952976064393, "faster turnaround times provided": 0.0021181952976064393, "measuring heart failure care": 0.0020365833179655174, "inhibition halts heart failure": 0.002078750517097445, "pathological cardiac gene expression": 0.002190182165406614, "cardiac gene expression programme": 0.0021370023805797303, "activating transcription factor networks": 0.0022545766129580015, "promoting transcriptional pause release": 0.002239102825190531, "abrogate pathological gene expression": 0.0022069279244350563, "quantify myocardial t1 changes": 0.002078750517097445, "similar left ventricular tissue": 0.0020987910656161306, "using trichrome blue histologic": 0.0020987910656161306, "trichrome blue histologic analysis": 0.0021552479734167932, "quantify diffuse myocardial changes": 0.0021729646333170797, "myocardial delayed enhancement imaging": 0.002223227076231131, "contractile reserve in patients": 0.0020987910656161306, "induced pulmonary artery systolic": 0.0021370023805797303, "pulmonary artery systolic pressure": 0.0021552479734167932, "diagnosed pulmonary arterial hypertension": 0.0022696682925727957, "chronic thromboembolic pulmonary hypertension": 0.002326563480758176, "impaired right ventricular pump": 0.0020987910656161306, "right ventricular pump function": 0.0020987910656161306, "stable targeted pulmonary arterial": 0.0021552479734167932, "targeted pulmonary arterial hypertension": 0.0022545766129580015, "pulmonary arterial hypertension medication": 0.002284396281626249, "arterial hypertension medication underwent": 0.002284396281626249, "remained independent prognostic markers": 0.002239102825190531, "regulates cardiac sodium current": 0.0021181952976064393, "systolic human heart failure": 0.0020365833179655174, "increases alternative mrna splicing": 0.0021729646333170797, "human induced pluripotent stem": 0.002078750517097445, "induced pluripotent stem cell": 0.002058030499948135, "receptor potential cation channel": 0.0021370023805797303, "potential cation channel m7": 0.002014356069546058, "intrinsic left ventricular dysfunction": 0.002223227076231131, "chronic pulmonary arterial hypertension": 0.002239102825190531, "characteristics yielded hazard ratios": 0.0022069279244350563, "requires new prevention strategies": 0.0021552479734167932, "nonselective \u03b2 - blocker": 0.001942369201745883, "selective \u03b2 - blocker": 0.0018607572221049612, "\u03b2 - blocker metoprolol": 0.001889189416918999, "stable heart failure patients": 0.002058030499948135, "secondary outcomes included markers": 0.0021729646333170797, "competing priorities impact prescribing": 0.002239102825190531, "primary care clinicians caring": 0.002078750517097445, "increased vascular endothelial growth": 0.0022069279244350563, "endothelial growth factor protein": 0.0021370023805797303, "volume conductance catheter system": 0.0021552479734167932, "coronary artery ligation augmented": 0.0021552479734167932, "bundle branch block type": 0.001942369201745883, "block electrical activation sequence": 0.002190182165406614, "slows myofiber shortening velocity": 0.0021552479734167932, "lower body mass index": 0.0018607572221049612, "lower fat mass index": 0.0018309375534367137, "greater antecedent weight loss": 0.002078750517097445, "lean body mass ratio": 0.0018309375534367137, "increased body mass index": 0.0019673188687882757, "ivabradine increased exercise capacity": 0.002223227076231131, "improved left ventricular filling": 0.0021370023805797303, "ventricular filling pressure response": 0.0022069279244350563, "abnormal exercise hemodynamic status": 0.002190182165406614, "simple validated clinical tool": 0.002078750517097445, "left anterior descending artery": 0.0020987910656161306, "simple clinical prediction rule": 0.0020987910656161306, "japanese heart failure patients": 0.0020987910656161306, "congestive heart failure patients": 0.0021370023805797303, "diminished cyclic adenosine monophosphate": 0.0022696682925727957, "augmented cyclic guanosine monophosphate": 0.0022545766129580015, "fluorescence resonance energy transfer": 0.002223227076231131, "stimulation via catecholamine infusions": 0.002239102825190531, "synthesis via nitric oxide": 0.0019912898615298, "intracellular antiadrenergic therapeutic strategy": 0.0023786103978458836, "high risk for hyperkalemia": 0.0019912898615298, "pre - specified analysis": 0.001942369201745883, "exercise training in patients": 0.002058030499948135, "using linear mixed models": 0.0019673188687882757, "beneficial effect of exercise": 0.002058030499948135, "implantable cardiac arrhythmia devices": 0.002223227076231131, "total cost per patient": 0.001889189416918999, "severe heart failure appears": 0.0020365833179655174, "skeletal muscle sarcomere structure": 0.0021729646333170797, "co - ordinated fashion": 0.001889189416918999, "systemic adverse events evaluation": 0.0021552479734167932, "accepted peak oxygen consumption": 0.0021181952976064393, "refractory right heart failure": 0.002078750517097445, "after percutaneous coronary revascularization": 0.002326563480758176, "extra corporeal membrane oxygenation": 0.002190182165406614, "acute ischemic right heart": 0.0019912898615298, "ischemic right heart failure": 0.0020365833179655174, "non - diastolic abnormalities": 0.002058030499948135, "first acute myocardial infarction": 0.0021370023805797303, "linked administrative health data": 0.0021370023805797303, "mean \u00b1 sd testosterone": 0.001889189416918999, "\u00b1 sd testosterone levels": 0.001942369201745883, "incremental shuttle walk test": 0.002058030499948135, "testosterone group showed improvements": 0.002223227076231131, "tendency toward lower mitral": 0.0020365833179655174, "transforming growth factor beta": 0.0020987910656161306, "anterior descending coronary artery": 0.0021729646333170797, "descending coronary artery occlusion": 0.002190182165406614, "cell differentiation toward cardiomyocyte": 0.0022696682925727957, "optimizing cardiac progenitor function": 0.002223227076231131, "displayed permanent periodic breathing": 0.002223227076231131, "anti - inflammatory effects": 0.002014356069546058, "stable coronary artery disease": 0.002078750517097445, "improve cardiac autonomic balance": 0.0021370023805797303, "time domain heart rate": 0.001889189416918999, "domain heart rate variability": 0.002058030499948135, "power spectral analysis indicated": 0.0021370023805797303, "improves cardiac autonomic balance": 0.0021552479734167932, "chronic systolic heart failure": 0.002078750517097445, "patients underwent device implantation": 0.002223227076231131, "renal function in children": 0.0019912898615298, "stage heart failure supported": 0.002058030499948135, "pediatric mechanical cardiac support": 0.002190182165406614, "receiving ventricular assist device": 0.0021729646333170797, "ventricular assist device support": 0.0021370023805797303, "patients receiving extracorporeal membrane": 0.002284396281626249, "receiving extracorporeal membrane oxygenation": 0.002326563480758176, "extracorporeal membrane oxygenation membrane": 0.002312828476440287, "membrane oxygenation membrane support": 0.0022069279244350563, "ecmo+vad group included patients": 0.0021181952976064393, "sensitive outcome change scores": 0.0020987910656161306, "older adults with heart": 0.0019163575327502704, "using standardized nursing terminologies": 0.0022545766129580015, "standardized nursing terminologies makes": 0.0022545766129580015, "retrospective descriptive research design": 0.0022696682925727957, "future prospective experimental research": 0.0022545766129580015, "influences cardiac hypertrophic response": 0.0022545766129580015, "- adrenergic receptor agonist": 0.002058030499948135, "- adrenergic receptor stimulation": 0.0021370023805797303, "cardiac plasma membrane levels": 0.002078750517097445, "first month after discharge": 0.002014356069546058, "better outcomes among patients": 0.002078750517097445, "post - translational state": 0.0019912898615298, "- adrenergic receptor blockade": 0.002078750517097445, "adrenergic receptor blockade reduces": 0.002190182165406614, "- adrenergic receptor activation": 0.0021181952976064393, "post - translational states": 0.002014356069546058, "total myosin binding protein": 0.0020365833179655174, "mutant ri\u03b1 proteins demonstrated": 0.0021181952976064393, "myocardium displays altered expression": 0.002223227076231131, "post - translational modification": 0.0021370023805797303, "autonomic nervous system activity": 0.0021370023805797303, "acute \u03b2 - adrenoceptor": 0.001889189416918999, "acute autonomic nervous system": 0.002078750517097445, "autonomic nervous system modulation": 0.0021729646333170797, "related congestive heart failure": 0.0021181952976064393, "developing congestive heart failure": 0.0021729646333170797, "pre - hct exposure": 0.001766543105885326, "anti - oxidant defence": 0.001889189416918999, "chf predictive model performed": 0.002078750517097445, "right heart circulatory failure": 0.0020987910656161306, "foster collaborative research initiatives": 0.0022696682925727957, "class angiotensin receptor neprilysin": 0.0022069279244350563, "receptor neprilysin inhibitor composed": 0.002223227076231131, "angiotensin receptor antagonist valsartan": 0.0022696682925727957, "preserved ejection fraction outcomes": 0.002190182165406614, "ejection fraction outcomes trial": 0.0021181952976064393, "guided clinical trial design": 0.0020365833179655174, "reduced skeletal muscle mass": 0.0020365833179655174, "underwent cardiopulmonary exercise testing": 0.002284396281626249, "dual x - ray": 0.001518730142224595, "single tertiary referral centre": 0.0020987910656161306, "skeletal muscle mass assessed": 0.002058030499948135, "relative appendicular lean mass": 0.0020987910656161306, "appendicular lean mass index": 0.0020365833179655174, "low skeletal muscle mass": 0.001942369201745883, "skeletal muscle mass correlated": 0.0020987910656161306, "skeletal muscle mass t": 0.001889189416918999, "sarcopenic range muscle wasting": 0.0020987910656161306, "659 heart failure patients": 0.0019912898615298, "performed confirmatory factor analysis": 0.002223227076231131, "used exploratory factor analysis": 0.0021181952976064393, "separate sub - sample": 0.0018607572221049612, "showed excellent fit indices": 0.0020365833179655174, "concentric left ventricular hypertrophy": 0.002239102825190531, "outcome data among groups": 0.0019673188687882757, "lower systolic blood pressure": 0.002058030499948135, "elevated cardiac filling pressures": 0.0021552479734167932, "heart failure patients undergoing": 0.0021370023805797303, "undergoing either cardiac resynchronization": 0.0022987776973955086, "nationwide retrospective cohort study": 0.0022069279244350563, "20 weeks mi animals": 0.0017995880167098433, "elevated levels of plasma": 0.0019673188687882757, "- myosin heavy chain": 0.0018309375534367137, "complete reverse cardiac remodeling": 0.0021729646333170797, "using general linear models": 0.002014356069546058, "higher diastolic blood pressure": 0.0020987910656161306, "body mass index levels": 0.001889189416918999, "coronary artery calcium scores": 0.002078750517097445, "% confidence interval 0.50": 0.0019912898615298, "share many risk factors": 0.0019163575327502704, "logistic regression analysis established": 0.0022545766129580015, "hospital readmission reduction program": 0.002223227076231131, "day readmission rate following": 0.002078750517097445, "readmission rate following hospital": 0.0021729646333170797, "rate following hospital stay": 0.0020365833179655174, "indicating possible suboptimal care": 0.0021729646333170797, "intensive transitions of care": 0.002058030499948135, "- urbanized midwestern state": 0.0020365833179655174, "non - linear measures": 0.0018607572221049612, "non - linear hr": 0.001655111457576157, "- linear hr variability": 0.0019163575327502704, "linear hr variability measures": 0.002078750517097445, "term fractal scaling exponent": 0.002058030499948135, "- sudden cardiac death": 0.001889189416918999, "trials using hr variability": 0.002014356069546058, "- defined inclusion criteria": 0.0020365833179655174, "end stage kidney failure": 0.001942369201745883, "adequate blood pressure control": 0.0020987910656161306, "showed modest clinical benefit": 0.002078750517097445, "reveals several key genes": 0.0019673188687882757, "non - ischemic heart": 0.0018309375534367137, "- ischemic heart failure": 0.001942369201745883, "functional enrichment analysis revealed": 0.002239102825190531, "longitudinal analysis using medicare": 0.002190182165406614, "analysis using medicare data": 0.0020365833179655174, "retrospective matched cohort study": 0.0021552479734167932, "score matched control group": 0.002014356069546058, "negative binomial regression models": 0.0021729646333170797, "contemporary chronic heart failure": 0.0021552479734167932, "socioeconomic status versus whites": 0.0021552479734167932, "given similar cardiovascular mortality": 0.002223227076231131, "optimal therapy including anticoagulation": 0.0022696682925727957, "modern rhythm control therapy": 0.002058030499948135, "blinded outcome assessment trial": 0.0021181952976064393, "term ventricular assist device": 0.002078750517097445, "stage heart failure fall": 0.001942369201745883, "advanced structural heart disease": 0.0021370023805797303, "requires special therapeutic interventions": 0.002284396281626249, "ventricular action potential duration": 0.0022069279244350563, "type channel isoforms known": 0.002014356069546058, "common inpatient medical conditions": 0.0021729646333170797, "derived composite quality measure": 0.0021370023805797303, "higher estimated glomerular filtration": 0.002223227076231131, "non - aa participants": 0.0018607572221049612, "attain maximal spironolactone dose": 0.0021552479734167932, "achieved study drug dose": 0.001942369201745883, "derive less clinical benefit": 0.0020365833179655174, "free shotgun proteomics approach": 0.0021181952976064393, "associated signaling pathway changes": 0.002190182165406614, "pathway changes using ingenuity": 0.0020987910656161306, "changes using ingenuity pathway": 0.0020987910656161306, "using ingenuity pathway analysis": 0.0021181952976064393, "congestive heart failure phenotypes": 0.0021729646333170797, "ingenuity pathway analysis noted": 0.0021181952976064393, "care transfer policy led": 0.001942369201745883, "ami without major complications": 0.0020987910656161306, "costs across volume groups": 0.0019912898615298, "physician volume within strata": 0.002078750517097445, "symptomatic chronic advanced heart": 0.0021552479734167932, "- myocardial infarction patients": 0.0021181952976064393, "infarction heart failure patients": 0.0021370023805797303, "large idiopathic dilated cardiomyopathy": 0.002239102825190531, "idiopathic dilated cardiomyopathy cohort": 0.0022545766129580015, "including negative coronary angiography": 0.002239102825190531, "heart failure treatment eras": 0.0020365833179655174, "severe left ventricular dilatation": 0.0021552479734167932, "end point including death": 0.0019673188687882757, "recent enrollment period represented": 0.002190182165406614, "42 % risk reduction": 0.0017995880167098433, "maximal cardiopulmonary exercise test": 0.0022069279244350563, "cardiopulmonary exercise test investigations": 0.002312828476440287, "peak respiratory quotient \u22641.05": 0.0020987910656161306, "at multivariable logistic analysis": 0.0021552479734167932, "reduced peak oxygen uptake": 0.0019912898615298, "kidney index score value": 0.001942369201745883, "secondary study end point": 0.0019673188687882757, "associations among cardiorespiratory fitness": 0.002312828476440287, "measures included body mass": 0.002014356069546058, "included body mass index": 0.001942369201745883, "maximal treadmill exercise testing": 0.0021552479734167932, "obese body mass index": 0.0018607572221049612, "body mass index categories": 0.0019912898615298, "overweight body mass index": 0.0019912898615298, "body mass index strata": 0.001889189416918999, "decreased mitochondrial energy production": 0.0022696682925727957, "mitochondrial energy production precede": 0.002239102825190531, "reduced mitochondrial complex v": 0.0020987910656161306, "mitochondrial complex v activity": 0.0021181952976064393, "decreased mitochondrial oxidative metabolism": 0.002312828476440287, "guide health service planning": 0.002058030499948135, "relevant health service provision": 0.0021370023805797303, "health service provision related": 0.0021181952976064393, "total expenditure on health": 0.002014356069546058, "raised blood glucose levels": 0.002014356069546058, "lower gross national income": 0.002014356069546058, "national income per capita": 0.0019912898615298, "renal chloride channel gene": 0.002014356069546058, "tac cardiac functional deterioration": 0.002190182165406614, "health system data partners": 0.002014356069546058, "without prior cardiovascular disease": 0.002190182165406614, "prospective studies evaluating implementation": 0.002326563480758176, "studies evaluating implementation interventions": 0.0023531407971521447, "left ventricular function assessment": 0.002190182165406614, "25 heart failure patients": 0.0019673188687882757, "experiencing distressing implantable cardioverter": 0.0023786103978458836, "carotid baroreflex activation therapy": 0.0022069279244350563, "primary safety end point": 0.001942369201745883, "primary efficacy end points": 0.002014356069546058, "minute hall walk distance": 0.0019673188687882757, "trend toward fewer days": 0.0019163575327502704, "using cardiopulmonary exercise testing": 0.002223227076231131, "cardiopulmonary exercise testing guide": 0.002223227076231131, "exercise testing guide exercise": 0.0020987910656161306, "testing guide exercise rehabilitation": 0.0022069279244350563, "exercise patients used \u03b450%w": 0.0020365833179655174, "patients used \u03b450%w intensity": 0.002058030499948135, "reduced long axis function": 0.0019912898615298, "other cardiovascular risk factors": 0.0021370023805797303, "peripheral oedema allows assessment": 0.0021729646333170797, "regular physical activity controls": 0.0021552479734167932, "physical activity controls acquired": 0.0021729646333170797, "acquired cardiovascular risk factors": 0.002190182165406614, "exercise prevents cell senescence": 0.0021370023805797303, "certain malignancies including cancer": 0.0022069279244350563, "aerobic exercise per week": 0.0019673188687882757, "recommendations confer health benefits": 0.002223227076231131, "cardiac disease including heart": 0.0020987910656161306, "disease including heart failure": 0.0020987910656161306, "pre - participation screening": 0.002058030499948135, "detect congenital accessory pathways": 0.002190182165406614, "week aerobic training period": 0.0020365833179655174, "integrated dynamic resistance training": 0.002223227076231131, "perceived social support score": 0.002078750517097445, "higher exercise time associated": 0.0020987910656161306, "% confidence interval 0.99": 0.0019912898615298, "% confidence interval 0.66": 0.0019912898615298, "exercise training improves outcomes": 0.0021729646333170797, "implement exercise training therapy": 0.0021729646333170797, "recent onset heart failure": 0.0019912898615298, "blocker hypo - response": 0.0019163575327502704, "hr reduction with beta": 0.001889189416918999, "hr<70 versus \u226570 bpm": 0.0018309375534367137, "elevated left atrial pressure": 0.002058030499948135, "atrial pressure improve symptoms": 0.0021181952976064393, "canadian special access programme": 0.0021370023805797303, "6 min walk test": 0.001655111457576157, "min walk test distance": 0.001889189416918999, "incessant ventricular tachycardia storm": 0.002239102825190531, "prospective randomized multicenter trial": 0.0022545766129580015, "randomized multicenter trial paradigm": 0.0022069279244350563, "stabilized chronic heart failure": 0.0021181952976064393, "- specified subgroup analyses": 0.002058030499948135, "stable chronic heart failure": 0.0020365833179655174, "failure among older persons": 0.002014356069546058, "urban academic medical center": 0.002058030499948135, "indicate worse heart failure": 0.0020365833179655174, "percent lean body mass": 0.001889189416918999, "related serious adverse events": 0.002078750517097445, "among obese older patients": 0.0019912898615298, "aerobic exercise training increased": 0.0021729646333170797, "exercise training increased peak": 0.0021181952976064393, "left ventricular assist system": 0.002078750517097445, "88 % performance goal": 0.0018607572221049612, "adverse events included reoperation": 0.0021729646333170797, "favorable adverse event profile": 0.0020987910656161306, "management programs in heart": 0.0020365833179655174, "influence medical resource use": 0.002078750517097445, "diagnosis of heart failure": 0.00149346739614735, "target patient population is": 0.001527437488474138, "appropriate risk stratification is": 0.001616435980062595, "patients with an implantable": 0.001527437488474138, "development of heart failure": 0.001527437488474138, "treatment for heart failure": 0.001510767052159543, "dilated by another disease": 0.00149346739614735, "ventricular ejection fraction was": 0.0016027517854347976, "aortic valve replacement is": 0.001510767052159543, "receptor antagonist therapy is": 0.0015590628878230837, "programs in heart failure": 0.0014754891515912068, "maintenance of sinus rhythm": 0.001510767052159543, "velocity to peak early": 0.0014168920626892493, "failure with reduced ejection": 0.0015435228749611013, "patients at high risk": 0.001395567916578721, "effect of exercise training": 0.001510767052159543, "extracorporeal life support is": 0.0015590628878230837, "hospitalization for heart failure": 0.0016027517854347976, "abnormal hr variability have": 0.001527437488474138, "magnetic resonance angiography is": 0.0016027517854347976, "sickle cell disease has": 0.0014372681495627027, "secondary end point was": 0.0014372681495627027, "mass index categories were": 0.00149346739614735, "overall improvements for patients": 0.0010685011902898652, "failure patients with respect": 0.0010290152499740676, "body composition with regard": 0.0010182916589827587, "total adiponectin at baseline": 0.0010290152499740676, "symptoms of heart failure": 0.0009836594343941379, "iron deficiency in adult": 0.0009711846008729415, "english language on anemia": 0.0009956449307649, "anemia treatment in patients": 0.0010182916589827587, "language trials of blood": 0.0009711846008729415, "observational studies of transfusion": 0.001095091082703307, "small trial of patients": 0.0009581787663751352, "ischemic conditioning for patients": 0.0010776239867083966, "better ways to deal": 0.0008997940083549217, "current predictors of mortality": 0.0010493955328080653, "use of implantable cardioverter": 0.0010493955328080653, "high confidence in estimates": 0.0010182916589827587, "independent predictors of mortality": 0.0010864823166585398, "strong predictors of mortality": 0.0010393752585487225, "cystatin c from enrollment": 0.0009956449307649, "change in cystatin c": 0.0009154687767183569, "multihospital study to promote": 0.0010393752585487225, "multisite studies in practice": 0.0010290152499740676, "cellular plasticity in cardiomyocytes": 0.0011034639622175282, "global changes in chromatin": 0.001007178034773029, "quantitative proteomics to identify": 0.0010864823166585398, "model system of zebrafish": 0.0009836594343941379, "ischemic events in patients": 0.001007178034773029, "factors for the development": 0.001007178034773029, "therapy with a defibrillator": 0.0010182916589827587, "risk for subsequent heart": 0.0009836594343941379, "term mortality in patients": 0.0009956449307649, "term mortality after hospitalization": 0.001095091082703307, "p value for age": 0.0008275557287880785, "outcomes in heart failure": 0.0009836594343941379, "decrease in cd34+vegfr2 +": 0.0009836594343941379, "cell decrease in cd34+vegfr2": 0.0010182916589827587, "common applications of readmission": 0.0010776239867083966, "differential impact on hospital": 0.0010493955328080653, "different approaches to computing": 0.0010685011902898652, "hospital discharge in patients": 0.0010393752585487225, "beneficial effect on mortality": 0.0010393752585487225, "significant difference between numbers": 0.0011116135381155656, "blocker therapy in patients": 0.001007178034773029, "blocker uptitrations in patients": 0.0010590976488032196, "clinical outcome in patients": 0.0010182916589827587, "peptide levels in patients": 0.0009956449307649, "similar among all subgroups": 0.001007178034773029, "mortality among these subgroups": 0.0010493955328080653, "medical management of heart": 0.001007178034773029, "management of heart failure": 0.001007178034773029, "heart failure in children": 0.0009836594343941379, "important cause of morbidity": 0.0010182916589827587, "cognitive impairment at hospitalization": 0.0011195514125952656, "limited ability to augment": 0.0009956449307649, "protective effects of exercise": 0.0010393752585487225, "molecular pathways in patients": 0.0010393752585487225, "lower stimulation of phosphorylation": 0.001095091082703307, "higher amount of malondialdehyde": 0.0010590976488032196, "cutoff value for plasma": 0.0009581787663751352, "cutoff value for admission": 0.0009956449307649, "year survival of patients": 0.0009836594343941379, "area under the curve": 0.0009154687767183569, "cause mortality in patients": 0.001007178034773029, "model of hypertensive heart": 0.001007178034773029, "heart disease by angiotensin": 0.0010182916589827587, "therapeutic targets for hhd": 0.001007178034773029, "atherosclerosis risk in communities": 0.0010864823166585398, "largest increases in incidence": 0.0010393752585487225, "area under the receiver": 0.0009581787663751352, "over a mean follow": 0.000883271552942663, "heterogeneous group of patients": 0.0010493955328080653, "year survival in patients": 0.0009836594343941379, "limited mortality at hospital": 0.0010290152499740676, "effectiveness limits in models": 0.0010393752585487225, "limited number of patients": 0.0009956449307649, "noninvasive surrogates for changes": 0.0010776239867083966, "annuloplasty for ischemic mitral": 0.0010590976488032196, "combination of annular size": 0.001007178034773029, "history of successful valve": 0.001007178034773029, "restricted without any clear": 0.0010182916589827587, "mild restriction of leaflet": 0.001007178034773029, "opening without any clear": 0.0009836594343941379, "risk stratification for death": 0.0010290152499740676, "complex set of variables": 0.0009711846008729415, "hospitalization within the prior": 0.0010590976488032196, "available data to predict": 0.0009836594343941379, "renal disease in outpatients": 0.0010182916589827587, "prognostic factor in heart": 0.0009956449307649, "hazard models for time": 0.0009445947084594995, "preserved and reduced ejection": 0.0010393752585487225, "valid measure of patients": 0.0009836594343941379, "reliable measure of health": 0.0009956449307649, "equivalent dose of metoprolol": 0.0010290152499740676, "benefits across all study": 0.0009836594343941379, "acute treatment of heart": 0.0009711846008729415, "vasodilator effects in vivo": 0.001007178034773029, "conscious dogs with tachypacing": 0.0010493955328080653, "echocardiographic predictors of response": 0.0011272883064790008, "strain of left ventricle": 0.0009711846008729415, "echocardiographic score for prediction": 0.0011116135381155656, "57\u00b122 months of follow": 0.0009445947084594995, "randomized trials to reduce": 0.001007178034773029, "independent association between spironolactone": 0.001169998296135779, "kidney injury during spironolactone": 0.0010864823166585398, "beneficial effects of beta": 0.0009956449307649, "therapy on cardiac function": 0.001007178034773029, "remodeling in heart failure": 0.001007178034773029, "progression to heart failure": 0.0010182916589827587, "cardiac function in b": 0.0009303786110524806, "proangiogenic effects of b": 0.0009956449307649, "coronary perfusion in b": 0.0009581787663751352, "positive effects of b": 0.0009303786110524806, "cardiac angiogenesis in heart": 0.0010290152499740676, "responsible diagnosis of heart": 0.0010393752585487225, "higher risk of death": 0.0009154687767183569, "twofold increase in lung": 0.0009711846008729415, "groups versus the sham": 0.0009445947084594995, "patients with severe heart": 0.0009956449307649, "filling pressure in patients": 0.0010182916589827587, "flow velocity over tissue": 0.0009836594343941379, "transthoracic echocardiography with measurement": 0.0011765703985760724, "predictive value of e": 0.0009303786110524806, "pressure relationship in heart": 0.0010393752585487225, "line shift in nonsurvivors": 0.0009956449307649, "distribution along the regression": 0.0010685011902898652, "hazard ratios for variables": 0.001007178034773029, "heart failure in pigs": 0.0009303786110524806, "antiarrhythmic medication to prevent": 0.001095091082703307, "severe ischemia after bottleneck": 0.0010590976488032196, "rate reduction with ivabradine": 0.0010393752585487225, "left ventricle in heart": 0.0009581787663751352, "ventricle in heart failure": 0.0009956449307649, "hr reduction by ivabradine": 0.0009956449307649, "hr reduction in patients": 0.0009711846008729415, "albumin levels to survival": 0.0009956449307649, "prognostic indicator in patients": 0.0010590976488032196, "postoperative mortality in patients": 0.0010864823166585398, "postoperative survival of patients": 0.0010776239867083966, "patients with preoperative hypoalbuminemia": 0.0011421981408131245, "normalization of albumin levels": 0.0010493955328080653, "subgroup analysis of patients": 0.0010290152499740676, "effective way to improve": 0.0009711846008729415, "rates across the respective": 0.001007178034773029, "important outcomes in patients": 0.0010393752585487225, "prognostic value in patients": 0.0010182916589827587, "patients with precapillary ph": 0.0010290152499740676, "ph with heart failure": 0.0009303786110524806, "prognostic factors at admission": 0.0010493955328080653, "serum levels of brain": 0.0009303786110524806, "serum levels of creatinine": 0.0009956449307649, "prognostic factor in patients": 0.0010290152499740676, "large limits of agreement": 0.0009836594343941379, "exercise programme for patients": 0.0010493955328080653, "significant improvements with others": 0.001095091082703307, "risk for heart failure": 0.0009445947084594995, "mean age of participants": 0.0009711846008729415, "associated with a higher": 0.0009711846008729415, "sd decrease in score": 0.0009154687767183569, "cardiovascular disease at baseline": 0.0010776239867083966, "excessive secretion of arginine": 0.0010493955328080653, "marked resistance to pressure": 0.0010290152499740676, "vivo inhibition of mir-25": 0.0009836594343941379, "murine myocardium to heart": 0.0009956449307649, "mammalian myocardium with impact": 0.0010590976488032196, "gene programs in heart": 0.0009445947084594995, "treatment of chronic heart": 0.0009956449307649, "receptor blockers in case": 0.0009836594343941379, "major cause of death": 0.0009154687767183569, "insulin action through activation": 0.0010685011902898652, "cardiac dysfunction during insulin": 0.0010776239867083966, "level variation in use": 0.0009445947084594995, "outpatients with heart failure": 0.0010393752585487225, "level variation in rates": 0.0009711846008729415, "practice rates of treatment": 0.001007178034773029, "older patients with breast": 0.0009956449307649, "in this large cohort": 0.0009154687767183569, "dietary recommendations for patients": 0.001095091082703307, "dietary patterns with outcomes": 0.0010393752585487225, "diet scores with mortality": 0.0009956449307649, "lower mortality in women": 0.0009711846008729415, "trend toward an inverse": 0.0009581787663751352, "association with functional capacity": 0.001095091082703307, "promising biomarker in heart": 0.0010182916589827587, "cohort of ambulatory patients": 0.0010290152499740676, "hazard ratios for log2": 0.0009445947084594995, "higher frequency of diabetes": 0.0010182916589827587, "day readmissions as part": 0.0009711846008729415, "outpatient assessments of patients": 0.0010776239867083966, "average age of patients": 0.0009581787663751352, "medication changes at follow": 0.0010182916589827587, "heart disease in patients": 0.0009836594343941379, "predictive value for heart": 0.0009956449307649, "improved time to death": 0.0009445947084594995, "frequent comorbidities in heart": 0.0010493955328080653, "myocardial dd of collagen": 0.0009836594343941379, "cardiovascular events in patients": 0.0010685011902898652, "reduction in the primary": 0.0009711846008729415, "volume overload in heart": 0.0009711846008729415, "significant decrease in re": 0.0009956449307649, "average length of stay": 0.0009445947084594995, "viable option in refractory": 0.001007178034773029, "resynchronization therapy in dialysis": 0.0011034639622175282, "heterogenous improvement in ejection": 0.001095091082703307, "% increase in ejection": 0.0009445947084594995, "compelling improvement after device": 0.0010864823166585398, "dietary approaches to stop": 0.0009956449307649, "quantified via the parametrized": 0.0010493955328080653, "human resistin in chemotherapy": 0.0010393752585487225, "human resistin in heart": 0.0009581787663751352, "fold induction of serum": 0.0009581787663751352, "resistin levels in women": 0.0009711846008729415, "direct effects on macrophages": 0.0010290152499740676, "atrial fibrillation in patients": 0.0010493955328080653, "free probability after catheter": 0.0010493955328080653, "strain rate at systole": 0.0009445947084594995, "strain rate at diastole": 0.0009581787663751352, "sinus rhythm at follow": 0.0009445947084594995, "mitochondrial dysfunction in doxorubicin": 0.0011272883064790008, "possible mechanism of cardioprotection": 0.0011116135381155656, "cardioprotective effect of nicorandil": 0.0011034639622175282, "cumulative administration of doxorubicin": 0.0011272883064790008, "last dose of doxorubicin": 0.0009711846008729415, "nucleotides contents in addition": 0.0010590976488032196, "cytotoxic effect of doxorubicin": 0.0010493955328080653, "early risk of stroke": 0.0009154687767183569, "secondary outcome of death": 0.0009956449307649, "death from any cause": 0.0009154687767183569, "cardiovascular events after adjustment": 0.0011116135381155656, "history of myocardial infarction": 0.0010590976488032196, "clinical burden in adult": 0.0009711846008729415, "cardiac transplants in children": 0.0010493955328080653, "cardiac symptoms in children": 0.0010182916589827587, "small subgroup of children": 0.0009956449307649, "cardiomyopathic restriction to flow": 0.0010864823166585398, "particular topics of debate": 0.001007178034773029, "cellular responses to heart": 0.001007178034773029, "molecular scaffolds in heart": 0.0010182916589827587, "beneficial adaptation to stress": 0.0010493955328080653, "linear pathway to facilitate": 0.0010182916589827587, "promising field of investigation": 0.0010590976488032196, "prognostic indicator in heart": 0.0010290152499740676, "according to the biological": 0.001007178034773029, "feasible alternative to ascertain": 0.0010685011902898652, "pharmacologic studies of therapeutics": 0.0011034639622175282, "measurement of natriuretic peptides": 0.0010864823166585398, "hospital quality of care": 0.0009711846008729415, "pathological changes in cardiomyocytes": 0.0011116135381155656, "epigenetic changes in chromatin": 0.0010493955328080653, "cardiac tissue from mice": 0.0009711846008729415, "crucial role in chromatin": 0.0009836594343941379, "control via the targeting": 0.0009836594343941379, "tidal respiration for quantification": 0.001095091082703307, "myocardial t1 in swine": 0.0009445947084594995, "swine model of tachycardia": 0.0009956449307649, "ventricular tissue from control": 0.0010493955328080653, "percentage of myocardial collagen": 0.0010685011902898652, "failure without the use": 0.0009581787663751352, "new approach to assess": 0.0009445947084594995, "contemporary use of devices": 0.001007178034773029, "patients with systolic dysfunction": 0.0010776239867083966, "cause of cardiovascular hospitalization": 0.0011195514125952656, "important role in downregulation": 0.0010590976488032196, "mechanisms behind the development": 0.0010685011902898652, "distinct populations of patients": 0.0010590976488032196, "contemporary trends in heart": 0.0010182916589827587, "further adjustment for patient": 0.0010393752585487225, "risk of thromboembolic events": 0.0010290152499740676, "thromboembolic events in heart": 0.0010393752585487225, "equipotent dosages of carvedilol": 0.0010590976488032196, "thromboembolic events in patients": 0.0010685011902898652, "impact prescribing of guideline": 0.0010493955328080653, "parasympathetic tone by pyridostigmine": 0.0011116135381155656, "therapeutic alternative to slow": 0.0010493955328080653, "sympathetic control of heart": 0.0010182916589827587, "term administration of pyridostigmine": 0.0011034639622175282, "goal of this study": 0.000883271552942663, "prospective assessment of body": 0.0010393752585487225, "over a median follow": 0.0009154687767183569, "ventricular filling in patients": 0.0010493955328080653, "significant improvement between baseline": 0.0011272883064790008, "simultaneous reduction in exercise": 0.0010776239867083966, "increase in the ratio": 0.0009303786110524806, "slower increase in heart": 0.0009711846008729415, "heart rate during exercise": 0.0009956449307649, "independent correlates of increase": 0.0010776239867083966, "term treatment with ivabradine": 0.0010393752585487225, "clinical tool to predict": 0.0009711846008729415, "artery disease in patients": 0.0009956449307649, "% of the patients": 0.0008658044569477526, "substantial proportion of patients": 0.0010776239867083966, "failure patients in addition": 0.0010182916589827587, "diuretic use in heart": 0.0009303786110524806, "congestive symptoms in patients": 0.0010493955328080653, "risk patient with heart": 0.0009581787663751352, "patient with heart failure": 0.0009956449307649, "risk stratification of patient": 0.0010393752585487225, "adrenergic responses in cardiomyocytes": 0.0011116135381155656, "remarkable increase in camp": 0.001007178034773029, "catecholamine infusions in rats": 0.0010493955328080653, "specified analysis of subgroups": 0.0010493955328080653, "high risk of hyperkalemia": 0.0009836594343941379, "health status in patients": 0.0009836594343941379, "group effects on hrqol": 0.0009445947084594995, "beneficial effects of hrqol": 0.001007178034773029, "cost analysis of rhythm": 0.0009581787663751352, "treatment strategies in patients": 0.0010590976488032196, "care expenditures of patients": 0.0010290152499740676, "sarcomere structure in patients": 0.0010493955328080653, "detrimental alterations in skm": 0.0010393752585487225, "severe perturbations in components": 0.0010776239867083966, "sarcomeric microstructure at baseline": 0.0011034639622175282, "dilated cardiomyopathy in patients": 0.0010776239867083966, "adjunctive treatment for patients": 0.0010685011902898652, "metabolic enzymes in patients": 0.0010290152499740676, "exercise parameters for diagnosis": 0.0010685011902898652, "partial pressure of end": 0.0009581787663751352, "care surgery in heart": 0.0009303786110524806, "optimal treatment for end": 0.0009836594343941379, "membrane oxygenation as bridge": 0.0010393752585487225, "cardiac arrest in need": 0.0009445947084594995, "heart failure with therapy": 0.0009956449307649, "mortality outcomes of heart": 0.001007178034773029, "hazard ratio for death": 0.0009445947084594995, "fatality rate for patients": 0.0009956449307649, "week program of exercise": 0.0009711846008729415, "similar improvements in shuttle": 0.0010493955328080653, "form quality of life": 0.0009154687767183569, "emotional status in heart": 0.0009836594343941379, "potential candidates for cell": 0.0010290152499740676, "cardiac arrest in humans": 0.0009711846008729415, "better tools for risk": 0.0009303786110524806, "antiplatelet agents in combination": 0.0010776239867083966, "evidence points to alterations": 0.0010393752585487225, "absorption function in patients": 0.0010493955328080653, "dietary interventions in heart": 0.0010393752585487225, "ventricular cardiomyocytes in response": 0.0011116135381155656, "prognostic biomarkers in patients": 0.0010685011902898652, "great number of studies": 0.0009581787663751352, "sham levels by dnx": 0.000883271552942663, "intravenous bolus of metoprolol": 0.0010493955328080653, "resynchronization therapy in heart": 0.0010776239867083966, "therapy in heart failure": 0.0009711846008729415, "observational study in children": 0.0010493955328080653, "steady improvement in egfr": 0.0009956449307649, "ecmo+vad group until day": 0.0009711846008729415, "steady decline in egfr": 0.0009445947084594995, "social mandate to ensure": 0.0009711846008729415, "significant difference in outcome": 0.0010685011902898652, "inpatient records of patients": 0.0010290152499740676, "significant improvement in outcome": 0.0010776239867083966, "outcome ratings from admission": 0.0010393752585487225, "possible contribution of nursing": 0.0010590976488032196, "nursing care to outcomes": 0.0009711846008729415, "expressed in the heart": 0.0009445947084594995, "simultaneous activation of \u03b21ars": 0.0010590976488032196, "reciprocal regulation in mouse": 0.0010393752585487225, "\u03b21ar overstimulation in heart": 0.0010290152499740676, "physician continuity on death": 0.0010290152499740676, "urgent readmission after discharge": 0.0010776239867083966, "lower rates of death": 0.0009154687767183569, "influences outcomes after discharge": 0.0010864823166585398, "time diagnosis of heart": 0.0009581787663751352, "hazard models with time": 0.0009581787663751352, "dependent covariates to analyze": 0.0010493955328080653, "physician within the first": 0.0009956449307649, "western blots with site": 0.0009581787663751352, "repolarization instability in patients": 0.0011116135381155656, "min records of surface": 0.0009445947084594995, "surface ecgs at baseline": 0.0009711846008729415, "trend toward a higher": 0.0009303786110524806, "adrenoceptor blockade with esmolol": 0.0010776239867083966, "larger fluctuations in beat": 0.001007178034773029, "heart failure in survivors": 0.0009956449307649, "hct exposure to anthracyclines": 0.0010393752585487225, "right ventricle in heart": 0.0009711846008729415, "common language to describe": 0.001007178034773029, "neprilysin inhibitor in heart": 0.0010290152499740676, "pilot trial of heart": 0.0009154687767183569, "trial of heart failure": 0.0009445947084594995, "outcomes trial of heart": 0.0009581787663751352, "therapeutic implications of biomarkers": 0.0011116135381155656, "statistical standards in biomarker": 0.0010776239867083966, "new targets in disease": 0.0009445947084594995, "progression of heart failure": 0.0010182916589827587, "target genes by sequence": 0.0009711846008729415, "untranslated region of messenger": 0.0010590976488032196, "therapeutic targets for heart": 0.0010290152499740676, "system inhibitors in heart": 0.0009956449307649, "exercise capacity in adults": 0.001007178034773029, "cardiac filling during exercise": 0.0010493955328080653, "natriuretic peptides in plasma": 0.0010393752585487225, "patient plasma by use": 0.0009303786110524806, "ventricular hypertrophy in heart": 0.0010590976488032196, "similar rates of hypertension": 0.0010290152499740676, "inappropriate therapy in heart": 0.0010393752585487225, "failure patients with devices": 0.0010290152499740676, "different types of beta": 0.0009581787663751352, "risk of inappropriate therapy": 0.0010290152499740676, "general use of beta": 0.0008997940083549217, "lower rate in patients": 0.0009445947084594995, "absolute risk of heart": 0.0009445947084594995, "different mechanism of action": 0.0010290152499740676, "refill compliance for etidronate": 0.0010590976488032196, "subcellular alterations by metoprolol": 0.0011034639622175282, "negative rates of changes": 0.0009836594343941379, "elevated levels of epinephrine": 0.0010393752585487225, "mrna level for \u03b2": 0.0008472781190425757, "cardiac performance by \u03b2": 0.0009711846008729415, "advanced stages of heart": 0.0009711846008729415, "partial reversal of changes": 0.001007178034773029, "embedded within the population": 0.0010393752585487225, "cardiovascular events for psoriasis": 0.0010864823166585398, "cardiovascular events as subjects": 0.0010685011902898652, "diastolic dysfunction in patients": 0.0010685011902898652, "consecutive patients with pad": 0.0010290152499740676, "highest quartile of e": 0.0009303786110524806, "suboptimal care of patients": 0.001007178034773029, "transitions of care program": 0.001007178034773029, "management training of patients": 0.0010493955328080653, "patients with congestive heart": 0.0010393752585487225, "rate variability in risk": 0.0009711846008729415, "stratification of cardiac patients": 0.0010776239867083966, "mortality within a few": 0.0009445947084594995, "various measures of hr": 0.0009445947084594995, "linear measures of hr": 0.0009303786110524806, "early measurement of hr": 0.0009581787663751352, "measurement of hr variability": 0.0010290152499740676, "routine measurement of hr": 0.0009836594343941379, "clinical tool for risk": 0.0009445947084594995, "percutaneous revascularization with angioplasty": 0.0011765703985760724, "clinical benefit for patients": 0.0010290152499740676, "treatment plans for patients": 0.0010182916589827587, "bioinformatic analysis of microarray": 0.001095091082703307, "telehealth system with care": 0.001007178034773029, "inpatient admissions from baseline": 0.0010776239867083966, "hospital days for participants": 0.0010393752585487225, "fewer admissions for individuals": 0.0010590976488032196, "telehealth technology has potential": 0.0010864823166585398, "black race in patients": 0.0009445947084594995, "differential response to exercise": 0.0010685011902898652, "treatment of atrial fibrillation": 0.0010590976488032196, "patients with recent onset": 0.0009956449307649, "onset af at risk": 0.0008472781190425757, "electrocardiographic device to monitor": 0.0011116135381155656, "patients with ventricular assist": 0.0010590976488032196, "dependent increase in incidence": 0.0010493955328080653, "hospitalisation among the elderly": 0.0010685011902898652, "worldwide increase in life": 0.0009956449307649, "heart failure at rest": 0.0009303786110524806, "potent inhibition of l": 0.0009445947084594995, "heart failure in humans": 0.0009581787663751352, "complex situations in pediatrics": 0.0010590976488032196, "cell disease has life": 0.0009303786110524806, "public reporting on quality": 0.001007178034773029, "quality measure for heart": 0.0009836594343941379, "best quintile of hospitals": 0.0009956449307649, "best quintile of performance": 0.0010182916589827587, "composite measures of quality": 0.0010290152499740676, "efficacy of mineralocorticoid receptor": 0.0011116135381155656, "receptor antagonists in heart": 0.0010290152499740676, "higher throughout the trial": 0.001007178034773029, "higher rates of hyperkalemia": 0.0010182916589827587, "lower rates of hypokalemia": 0.0009956449307649, "end point of death": 0.000883271552942663, "pathway analysis of pressure": 0.0010182916589827587, "modest effects on heart": 0.0009581787663751352, "pathway alterations in tac": 0.0009956449307649, "increase rehospitalization of medicare": 0.0011116135381155656, "immediate declines in length": 0.0010182916589827587, "day decrease in length": 0.0009445947084594995, "day reduction in hospital": 0.0009836594343941379, "hospital length of stay": 0.0009581787663751352, "higher rate of rehospitalization": 0.0010590976488032196, "urgent need to improve": 0.0009445947084594995, "better outcomes for patients": 0.0010182916589827587, "standard therapy with beta": 0.0009956449307649, "infarction patients with heart": 0.0010393752585487225, "significant reduction in mortality": 0.0010776239867083966, "survival rates of patients": 0.0009956449307649, "substantial improvement in survival": 0.0010864823166585398, "reduction versus the previous": 0.0010290152499740676, "marked decreases in heart": 0.0009836594343941379, "term continuity of care": 0.0009581787663751352, "anaerobic threshold in heart": 0.0010182916589827587, "test investigations at study": 0.0010182916589827587, "failure mortality in men": 0.0009711846008729415, "men without a history": 0.0009303786110524806, "mortality risk in men": 0.0009303786110524806, "heart failure after pressure": 0.0010182916589827587, "significant alterations in energy": 0.0010685011902898652, "development of cardiac hypertrophy": 0.0010776239867083966, "% increase in e": 0.0008275557287880785, "% decrease in %": 0.0008275557287880785, "significant decrease in insulin": 0.0010493955328080653, "membrane translocation of glucose": 0.0010685011902898652, "mitochondrial oxidation of glucose": 0.0010776239867083966, "greater risk of heart": 0.0009303786110524806, "air pollution on heart": 0.0009445947084594995, "heart failure in mice": 0.0009303786110524806, "cardiac dysfunction with conduction": 0.0010864823166585398, "considerable number of patients": 0.0010493955328080653, "palliative care of patients": 0.001007178034773029, "overall management of patients": 0.0010393752585487225, "systematic review to identify": 0.0010290152499740676, "physician adherence to class": 0.0010182916589827587, "care education at discharge": 0.001007178034773029, "contextual factors on physician": 0.0010493955328080653, "timing of implantable cardioverter": 0.0010776239867083966, "sound mind to engage": 0.0009154687767183569, "defibrillator deactivation at implant": 0.0011034639622175282, "broader discussions about end": 0.0010290152499740676, "defibrillator shocks at end": 0.001007178034773029, "failure hospitalizations in patients": 0.001095091082703307, "exercise rehabilitation in patients": 0.0010864823166585398, "exercise rehabilitation in patient": 0.0010776239867083966, "nosignificant changes in control": 0.0010590976488032196, "systolic function in hfpef": 0.0009956449307649, "subtle changes on exercise": 0.0009956449307649, "lower volumes of exercise": 0.0009836594343941379, "cardiac death in athletes": 0.0009836594343941379, "nontraumatic death during sport": 0.0010493955328080653, "training for heart failure": 0.0009956449307649, "\u00ae system in heart": 0.0008658044569477526, "exercise training for heart": 0.001007178034773029, "high barriers to exercise": 0.0009836594343941379, "exercise training on outcomes": 0.0010290152499740676, "greater impact on patients": 0.0009956449307649, "individualized approaches to implement": 0.0011116135381155656, "beta blockers on exercise": 0.0009836594343941379, "gas analysis at baseline": 0.0009711846008729415, "target doses for beta": 0.0009303786110524806, "former versus the latter": 0.0009711846008729415, "kg increase in patients": 0.0009581787663751352, "transseptal catheterisation with transoesophageal": 0.0011893051989229418, "echocardiography evaluations at baseline": 0.0011272883064790008, "gastrointestinal bleeding at month": 0.0010776239867083966, "haemodynamic outcomes in patients": 0.0010685011902898652, "first results of studies": 0.0009711846008729415, "failure with systolic dysfunction": 0.0010685011902898652, "common form of heart": 0.0009154687767183569, "reduced quality of life": 0.0009581787663751352, "total score with exercise": 0.0009836594343941379, "significant effect on quality": 0.0010290152499740676, "term support to patients": 0.0009711846008729415, "effectiveness ratios from user": 0.0010393752585487225, "term improvements in functioning": 0.0010590976488032196, "effectiveness analyses of disease": 0.0010685011902898652, "medical management to alleviate": 0.0010493955328080653, "trends in patient safety": 0.00048559230043647075, "decade of national efforts": 0.00049782246538245, "database to assess national": 0.0005035890173865145, "trends in adverse event": 0.0004790893831875676, "decline in adverse event": 0.00048559230043647075, "ulcers in surgical patients": 0.0005035890173865145, "attention to these problems": 0.0005035890173865145, "progress in some areas": 0.00047229735422974975, "talk between the heart": 0.00047229735422974975, "tissue in cachectic heart": 0.0004918297171970689, "alterations in body composition": 0.0005246977664040327, "changes in body composition": 0.0005035890173865145, "biomarkers of neurohormonal stimulation": 0.0005597757062976328, "unaltered in all groups": 0.0004790893831875676, "prevalence of heart failure": 0.0005035890173865145, "combination with other factors": 0.0005196876292743613, "in the general population": 0.0004918297171970689, "fraction of a non": 0.0004329022284738763, "evidence of diastolic dysfunction": 0.0005342505951449326, "recommendations on the treatment": 0.0005295488244016098, "deficiency in adult patients": 0.0005091458294913794, "literature in the english": 0.0004918297171970689, "evaluated for this guideline": 0.0005091458294913794, "audience for this guideline": 0.0005035890173865145, "patients with coronary heart": 0.0005091458294913794, "recommends against the use": 0.00049782246538245, "benefits of anemia treatment": 0.0005091458294913794, "adults with heart disease": 0.0004918297171970689, "trials of blood transfusions": 0.0005091458294913794, "data on study design": 0.0004577343883591784, "occurred in a small": 0.00044989700417746083, "patients with the acute": 0.0004790893831875676, "trials of intravenous iron": 0.00049782246538245, "made in the pharmacological": 0.0005035890173865145, "resort to cardiac transplantation": 0.0005342505951449326, "admitted to the hospital": 0.00048559230043647075, "deal with this worldwide": 0.00048559230043647075, "impact on medical resources": 0.0005035890173865145, "role of the emergency": 0.0004651893055262403, "department in acute heart": 0.0004918297171970689, "categorization in the emergency": 0.0005246977664040327, "studies in this area": 0.0004577343883591784, "mortality in heart failure": 0.00049782246538245, "evaluated before the use": 0.00048559230043647075, "association between any predictor": 0.0005342505951449326, "study other potential predictors": 0.0005295488244016098, "nesiritide in acute heart": 0.0004918297171970689, "failure with renal dysfunction": 0.0005196876292743613, "randomized in an open": 0.0004651893055262403, "ratio to the dopamine": 0.0004651893055262403, "randomized in a double": 0.00047229735422974975, "ratio to active treatment": 0.0004918297171970689, "compared with the pooled": 0.00048559230043647075, "change in serum cystatin": 0.00048559230043647075, "nesiritide on secondary end": 0.0005035890173865145, "participants with acute heart": 0.0005145076249870338, "participating in a multihospital": 0.0005295488244016098, "adoption of heart failure": 0.0004918297171970689, "lessons for nurse leaders": 0.0004918297171970689, "studies in practice settings": 0.0005091458294913794, "involvement in a multisite": 0.00049782246538245, "proteomics of cardiac chromatin": 0.0005246977664040327, "nucleolin as a regulator": 0.00048559230043647075, "changes in global gene": 0.00047229735422974975, "accessibility on a genomic": 0.00049782246538245, "known about the global": 0.00047229735422974975, "changes in chromatin subproteomes": 0.0005342505951449326, "plasticity in the setting": 0.0004918297171970689, "proteins in this subproteome": 0.0005091458294913794, "expression during cardiac hypertrophy": 0.0005517319811087641, "defects in cardiac looping": 0.00049782246538245, "analysis of a new": 0.0004329022284738763, "subproteome in the normal": 0.0004918297171970689, "studies in the complementary": 0.0005091458294913794, "associated with the development": 0.0005246977664040327, "development of ischemic events": 0.0005196876292743613, "patients with ischemic cardiomyopathy": 0.0005517319811087641, "effect on the efficacy": 0.00047229735422974975, "efficacy of the device": 0.00047229735422974975, "interventions during the trial": 0.0005196876292743613, "predictors for the development": 0.0005196876292743613, "pattern on the baseline": 0.0004790893831875676, "attenuated after the development": 0.0005295488244016098, "ies in this population": 0.00047229735422974975, "difference in the risk": 0.00047229735422974975, "mortality in this population": 0.0005091458294913794, "attenuated in the older": 0.0004790893831875676, "outcome in heart failure": 0.00048559230043647075, "involved in the process": 0.0004790893831875676, "process of endothelial repair": 0.0005145076249870338, "factor in cardiovascular diseases": 0.0005342505951449326, "association between serial measurements": 0.0005597757062976328, "associated with an increase": 0.0005035890173865145, "mortality in nondiabetic patients": 0.0005342505951449326, "basis for these differences": 0.0005035890173865145, "implications of metric choice": 0.0005145076249870338, "choice for common applications": 0.0005196876292743613, "applications of readmission metrics": 0.0005432411583292699, "impact on hospital performance": 0.0005196876292743613, "differences in longitudinal performance": 0.0005597757062976328, "hospitals in an extreme": 0.0004790893831875676, "approaches to computing readmissions": 0.0005475455413516535, "choice for these applications": 0.0005145076249870338, "monitoring after recent hospital": 0.0005295488244016098, "hospital for heart failure": 0.00049782246538245, "potential to deliver specialised": 0.0005295488244016098, "needs of the heart": 0.0004416357764713315, "studies with a contemporaneous": 0.0005196876292743613, "support to the control": 0.00047229735422974975, "apoptosis in a canine": 0.0004651893055262403, "model of chronic heart": 0.00047229735422974975, "apoptosis during the development": 0.0005295488244016098, "dogs during the development": 0.0005035890173865145, "levels of these genes": 0.0004651893055262403, "genes by western blot": 0.0004651893055262403, "method from autopsy samples": 0.0005035890173865145, "unchanged during the pacing": 0.0005035890173865145, "compared to the control": 0.0004790893831875676, "found in the normal": 0.00044989700417746083, "numbers of apoptotic cells": 0.00049782246538245, "apoptosis in the pathogenesis": 0.0005145076249870338, "pathogenesis of heart failure": 0.0005145076249870338, "failure in this model": 0.0004651893055262403, "activation of other systems": 0.0005035890173865145, "incidence of pump dysfunction": 0.0005145076249870338, "uptitration after a hospitalization": 0.0005432411583292699, "months after an index": 0.0004651893055262403, "increase of \u226510 %": 0.0004329022284738763, "reductions in the composite": 0.0005035890173865145, "uptitration of neurohumoral blockers": 0.0005475455413516535, "patients with low co": 0.0004577343883591784, "associations with inhospital outcomes": 0.0005517319811087641, "findings from the get": 0.0004651893055262403, "differences in plasma b": 0.0004790893831875676, "levels with the greatest": 0.00048559230043647075, "patients above the median": 0.0004918297171970689, "p for heterogeneity =": 0.0004651893055262403, "in a large registry": 0.00044989700417746083, "difference in the ability": 0.0004918297171970689, "guidelines for the recognition": 0.0005196876292743613, "children with undiagnosed heart": 0.0005246977664040327, "application in the clinical": 0.0005035890173865145, "recommendations for advanced management": 0.0005597757062976328, "assessment of cognitive impairment": 0.0005388119933541983, "documented by the physician": 0.0005035890173865145, "physician at the time": 0.0004651893055262403, "discharge in a cohort": 0.0004651893055262403, "cohort of elderly patients": 0.00049782246538245, "association of cognitive impairment": 0.0005432411583292699, "intubations for congestive heart": 0.0005295488244016098, "treatment of congestive heart": 0.0005145076249870338, "presenting to the emergency": 0.0005035890173865145, "year of the study": 0.0004329022284738763, "% of all ed": 0.00036638758934942785, "rates of annual ed": 0.0004416357764713315, "context of significant liver": 0.0005091458294913794, "catheterization during the same": 0.0005246977664040327, "incidence of abnormal liver": 0.0005035890173865145, "compared with the pediatric": 0.0005035890173865145, "disease in the adults": 0.0004651893055262403, "derangement with hemodynamic features": 0.0005517319811087641, "ability to augment cardiac": 0.00049782246538245, "predictors of heart failure": 0.0005035890173865145, "recognized as a major": 0.0004651893055262403, "cause of cardiovascular morbidity": 0.0005342505951449326, "risk for adverse outcomes": 0.0004918297171970689, "patients having heart failure": 0.0005145076249870338, "counseling on the primary": 0.0004918297171970689, "followed for a median": 0.0004651893055262403, "predictors of primary outcome": 0.0005145076249870338, "adherence to prescribed medications": 0.0005432411583292699, "indicators of functional status": 0.0005246977664040327, "common to both patients": 0.0004790893831875676, "adherence to prescribed therapy": 0.0005246977664040327, "stimulation of endothelial cell": 0.0005246977664040327, "patients with cardiovascular disease": 0.0005475455413516535, "effects of exercise training": 0.0005091458294913794, "proteome of hdl particles": 0.0004918297171970689, "effect on hdl function": 0.00047229735422974975, "determination of a predictive": 0.0005145076249870338, "value for plasma n": 0.0004416357764713315, "admission to the emergency": 0.00049782246538245, "survival from the time": 0.00047229735422974975, "age of the patients": 0.00044989700417746083, "patients in this study": 0.00047229735422974975, "survival at the time": 0.0004577343883591784, "levels at the time": 0.0004416357764713315, "differences in those parameters": 0.0005246977664040327, "wk after the procedures": 0.0004790893831875676, "increases in lung weight": 0.00048559230043647075, "weight with a high": 0.0004416357764713315, "deaths in the experimental": 0.00049782246538245, "upregulated in the hearts": 0.0004918297171970689, "addition of salt loading": 0.00048559230043647075, "measured with a high": 0.0004577343883591784, "incorporated in a laboratory": 0.0005091458294913794, "results in an excellent": 0.0004790893831875676, "failure after the insertion": 0.0005035890173865145, "insertion of a left": 0.00044989700417746083, "shock after myocardial infarction": 0.0005342505951449326, "conjunction with a temporary": 0.0005091458294913794, "support at the time": 0.00044989700417746083, "duration of biventricular support": 0.0005342505951449326, "survival to hospital discharge": 0.0005196876292743613, "mortality at hospital discharge": 0.0005246977664040327, "based on a systematic": 0.0004651893055262403, "evidence on clinical effects": 0.0005091458294913794, "recommendations on the basis": 0.0005091458294913794, "% for medical therapy": 0.0004651893055262403, "practice for a limited": 0.00047229735422974975, "patients in many regions": 0.00048559230043647075, "limitations in economic models": 0.0005196876292743613, "lack of canadian data": 0.0004651893055262403, "point to the importance": 0.0004790893831875676, "effects of biventricular pacing": 0.0005246977664040327, "pacing on left heart": 0.0004577343883591784, "strain in a porcine": 0.00044989700417746083, "model of right heart": 0.0004577343883591784, "understanding of the mechanism": 0.0005196876292743613, "taken of the left": 0.0004329022284738763, "in an open chest": 0.00042363905952128787, "changes in rs synchrony": 0.0004790893831875676, "history of successful mitral": 0.0005091458294913794, "plasty for degenerative mitral": 0.0005196876292743613, "patients with a history": 0.0004790893831875676, "improve such functional ms": 0.00049782246538245, "prolapse of a degenerative": 0.00049782246538245, "sound in the apex": 0.0004329022284738763, "disappeared and postoperative echocardiography": 0.0005849991480678895, "opening with a mitral": 0.0004651893055262403, "obtained by a continuity": 0.00048559230043647075, "flow by continuous wave": 0.0004790893831875676, "resulting in a significant": 0.00049782246538245, "lesions in the major": 0.0004577343883591784, "disappeared with a reduction": 0.0005091458294913794, "reduction in blood pressure": 0.0005035890173865145, "improvement of the mitral": 0.0004918297171970689, "observation at the time": 0.0004790893831875676, "reasons for the modest": 0.00047229735422974975, "reduction by the surgical": 0.0004918297171970689, "restriction of leaflet motion": 0.0005145076249870338, "motion by the leaflet": 0.0004651893055262403, "disappeared after the surgery": 0.0005145076249870338, "patient with successful valve": 0.0005145076249870338, "years after valve plasty": 0.00048559230043647075, "according to the guideline": 0.00049782246538245, "patients with functional ms": 0.0005035890173865145, "addition to the leaflet": 0.0004790893831875676, "patient with a history": 0.00047229735422974975, "evaluation of the surgical": 0.00049782246538245, "hospitalization in heart failure": 0.0005295488244016098, "date for the cohort": 0.00044989700417746083, "history of atrial fibrillation": 0.0005196876292743613, "factor in heart failure": 0.0004790893831875676, "included in the analyses": 0.00048559230043647075, "patients with an egfr": 0.0004651893055262403, "epidemic of heart failure": 0.0004918297171970689, "class in both patients": 0.00047229735422974975, "measure of health status": 0.00048559230043647075, "responsiveness to clinical change": 0.0005342505951449326, "concentrations of the interleukin": 0.0005342505951449326, "therapy in chronic heart": 0.00048559230043647075, "prognosis in heart failure": 0.00049782246538245, "doses of \u03b2 -": 0.00037968253555614875, "subjects with heart failure": 0.0005035890173865145, "examined as a function": 0.00047229735422974975, "function of baseline sst2": 0.0004918297171970689, "dose of metoprolol succinate": 0.0005091458294913794, "patients with low sst2": 0.00047229735422974975, "patients with high sst2": 0.0004790893831875676, "ratios for cardiovascular events": 0.0005295488244016098, "approach for the acute": 0.00047229735422974975, "effects of a novel": 0.0004416357764713315, "hearts in experimental models": 0.0005145076249870338, "rise in the peak": 0.00042363905952128787, "inhibition of protein kinase": 0.0005091458294913794, "dogs with coronary microembolization": 0.0005475455413516535, "left and right heart": 0.0004577343883591784, "efficacy of a novel": 0.00044989700417746083, "donor to enhance myocardial": 0.0005035890173865145, "predictors of reverse remodeling": 0.0005295488244016098, "remodeling after cardiac resynchronization": 0.0005710990704065622, "studies of echocardiographic predictors": 0.0005597757062976328, "response after cardiac resynchronization": 0.0005636441532395004, "association of the score": 0.00048559230043647075, "hospitalization during 57\u00b122 months": 0.0005432411583292699, "remodeling with a sensitivity": 0.0005145076249870338, "spironolactone for systolic heart": 0.0005342505951449326, "failure in clinical practice": 0.0005091458294913794, "patients with baseline serum": 0.0005091458294913794, "association between spironolactone use": 0.0005558067690577828, "patients with a median": 0.00047229735422974975, "rates of severe hyperkalemia": 0.0005091458294913794, "injury during spironolactone use": 0.0005295488244016098, "within a diverse community": 0.00049782246538245, "spironolactone in clinical practice": 0.0005432411583292699, "angiogenesis in the post": 0.00048559230043647075, "contributes to the progression": 0.0005196876292743613, "crucial for the transition": 0.00049782246538245, "transition from compensatory hypertrophy": 0.0005636441532395004, "hypertrophy to cardiac failure": 0.0005196876292743613, "weeks after b treatment": 0.0004790893831875676, "effects of b act": 0.00042363905952128787, "start of the treatment": 0.00047229735422974975, "b on cardiac function": 0.0004651893055262403, "angiogenesis in heart failure": 0.0005145076249870338, "enhancement of cardiac angiogenesis": 0.0005432411583292699, "effects of this therapy": 0.0004790893831875676, "cohort of all adults": 0.0004577343883591784, "visit in the subsequent": 0.0004790893831875676, "hospitalized at the time": 0.00048559230043647075, "management of acute heart": 0.0004918297171970689, "function in cardiac volume": 0.00049782246538245, "myocytes with volume overload": 0.0005145076249870338, "increase in lung weight": 0.0004790893831875676, "versus the sham group": 0.0004651893055262403, "velocity of circumferential shortening": 0.0005558067690577828, "occurred in the absence": 0.0004790893831875676, "changes in the maximum": 0.00047229735422974975, "improvement in contractile function": 0.0005432411583292699, "paralleled by any attenuation": 0.0005145076249870338, "patients with a left": 0.0004577343883591784, "measurement of transmitral flow": 0.0005246977664040327, "relationship in heart failure": 0.0005145076249870338, "relevance in the clinical": 0.0004918297171970689, "two- to threefold increase": 0.00049782246538245, "increase in cardiac risk": 0.00048559230043647075, "retained in the multivariate": 0.0005091458294913794, "nonsurvivors with a similar": 0.0005035890173865145, "relationship as a possible": 0.00049782246538245, "index of the length": 0.00044989700417746083, "affected by the quality": 0.0004790893831875676, "crucial for the development": 0.0005035890173865145, "coated with a polytetrafluoroethylene": 0.0005517319811087641, "formed in a bottleneck": 0.00047229735422974975, "implanted in the proximal": 0.0004918297171970689, "medication to prevent sudden": 0.0005091458294913794, "time of the bottleneck": 0.00047229735422974975, "timing of myocardial infarction": 0.0005246977664040327, "modulated by the duration": 0.0004918297171970689, "duration of antiplatelet medication": 0.0005432411583292699, "% of the left": 0.00039191270050212794, "ventricle in the proximal": 0.0004918297171970689, "wk after the stent": 0.0004416357764713315, "implantation of a novel": 0.0004790893831875676, "stent in the proximal": 0.0004651893055262403, "feasible for the development": 0.0005091458294913794, "afterload of the heart": 0.00047229735422974975, "derived from the pressure": 0.0004918297171970689, "ivabradine in the shift": 0.0004790893831875676, "included in the echocardiographic": 0.0005342505951449326, "reduced in the ivabradine": 0.0004918297171970689, "resulting in a higher": 0.0004651893055262403, "unloading of the heart": 0.00047229735422974975, "contribute to the beneficial": 0.0005091458294913794, "effect of isolated hr": 0.0004651893055262403, "relation of preoperative serum": 0.0005196876292743613, "recognized as a prognostic": 0.00049782246538245, "hypoalbuminemia with postoperative mortality": 0.0005782071191100717, "support on postoperative survival": 0.0005342505951449326, "analyzed in both groups": 0.0004790893831875676, "normalization of albumin level": 0.0005196876292743613, "attention to albumin levels": 0.0005035890173865145, "correction of aortic valve": 0.00049782246538245, "in the present report": 0.0004651893055262403, "sternotomy for aortic valve": 0.0005035890173865145, "revision by open surgery": 0.00048559230043647075, "surgery for aortic valve": 0.00048559230043647075, "improvement in functional capacity": 0.0005388119933541983, "approaches to these difficult": 0.0005145076249870338, "alternatives to conventional surgery": 0.0005475455413516535, "outcomes of young adults": 0.00048559230043647075, "across the respective age": 0.0004918297171970689, "compared with the referent": 0.00049782246538245, "effects of nordic walking": 0.0004918297171970689, "care on functional capacity": 0.0005035890173865145, "alternative for this population": 0.0005246977664040327, "time in acute heart": 0.00044989700417746083, "patients with pulmonary hypertension": 0.0005475455413516535, "measured from the reconstructed": 0.0005246977664040327, "patients with unfavorable outcome": 0.0005342505951449326, "at the second evaluation": 0.00048559230043647075, "confirmed in this cohort": 0.00048559230043647075, "located in the left": 0.00044989700417746083, "followed by the right": 0.0004651893055262403, "embolize to the pulmonary": 0.0004918297171970689, "report of a patient": 0.00044989700417746083, "embolism to the pulmonary": 0.0004918297171970689, "prolapse through the tricuspid": 0.0005196876292743613, "performed on the same": 0.0004651893055262403, "occurred in the total": 0.0004651893055262403, "sample from the first": 0.0004651893055262403, "trial with large limits": 0.0004790893831875676, "information to the first": 0.00048559230043647075, "for the total sample": 0.0004577343883591784, "error of measurement value": 0.00049782246538245, "found between the first": 0.0004790893831875676, "found for the subgroups": 0.0004790893831875676, "patients with advanced copd": 0.0005035890173865145, "values of standard error": 0.00048559230043647075, "practice with these populations": 0.0005246977664040327, "patients with rheumatoid arthritis": 0.0005388119933541983, "elevations in tumor necrosis": 0.0005091458294913794, "agents to treat rheumatoid": 0.00049782246538245, "use of loop diuretics": 0.0004651893055262403, "antagonist with similar baseline": 0.0005295488244016098, "subjects with a history": 0.0004790893831875676, "associated with a dose": 0.00047229735422974975, "compared with no use": 0.0004577343883591784, "associated with a risk": 0.00047229735422974975, "people with heart failure": 0.0004918297171970689, "interventions in chronic disease": 0.0005295488244016098, "participation in a structured": 0.0005145076249870338, "improvements in functional capacity": 0.0005432411583292699, "sustainability of the intervention": 0.0005388119933541983, "completion of the study": 0.0004790893831875676, "failure in older adults": 0.0004790893831875676, "during a median follow": 0.00047229735422974975, "vasopressin in congestive heart": 0.0005246977664040327, "contribute to the pathophysiology": 0.0005342505951449326, "pathophysiology of congestive heart": 0.0005432411583292699, "inhibitors of the renin": 0.0004790893831875676, "secretion of arginine vasopressin": 0.0005342505951449326, "potential for deleterious effects": 0.0005342505951449326, "reactivation of embryonic gene": 0.0005196876292743613, "phenotype of pathological hypertrophy": 0.0005517319811087641, "induction of a fetal": 0.0004577343883591784, "mir-25 by a specific": 0.0004577343883591784, "myocardium to heart failure": 0.0005035890173865145, "expression of the bhlh": 0.00047229735422974975, "impact on embryonic gene": 0.00048559230043647075, "prevalence of chronic heart": 0.0005035890173865145, "% in the adult": 0.00040323606461105735, "blockade of the neuro": 0.0004651893055262403, "neglected for a long": 0.0004577343883591784, "time from the treatment": 0.0004790893831875676, "documented in a number": 0.00047229735422974975, "diabetes to heart failure": 0.0004918297171970689, "features of heart failure": 0.0004918297171970689, "mechanism of cardiac dysfunction": 0.0005295488244016098, "dysfunction during insulin resistance": 0.0005517319811087641, "association between treatment variation": 0.0005597757062976328, "calculated for each therapy": 0.0005035890173865145, "treatment of a patient": 0.00047229735422974975, "% for \u03b2 -": 0.00033572601159100957, "variation in the use": 0.0004577343883591784, "exists in the outpatient": 0.00048559230043647075, "patients with breast cancer": 0.0005035890173865145, "trastuzumab in the adjuvant": 0.0005035890173865145, "age of the entire": 0.0004329022284738763, "% in nontrastuzumab users": 0.0004918297171970689, "cohort of older breast": 0.00047229735422974975, "plays in the development": 0.00048559230043647075, "women with heart failure": 0.00048559230043647075, "associations of dietary patterns": 0.0005295488244016098, "hospitalization through the date": 0.0005295488244016098, "quartiles of the dash": 0.0004651893055262403, "toward an inverse association": 0.0005145076249870338, "support for the concept": 0.0004790893831875676, "signaling in the myocardium": 0.0005035890173865145, "biomarker in heart failure": 0.00049782246538245, "outcomes in a cohort": 0.0004577343883591784, "study of exercise training": 0.00049782246538245, "analyzed in a subset": 0.0004577343883591784, "patients with evaluable plasma": 0.0005196876292743613, "measures of functional capacity": 0.0005246977664040327, "ratios for log2 ng": 0.0004416357764713315, "adjustment for clinical variables": 0.0005342505951449326, "changes in the c": 0.00042363905952128787, "experience with extended criteria": 0.0005342505951449326, "excluded from the transplant": 0.0005091458294913794, "outcomes with this strategy": 0.0005035890173865145, "compared with the patients": 0.00049782246538245, "frequency of diabetes mellitus": 0.0005196876292743613, "adjustment for baseline characteristics": 0.0005597757062976328, "alternative for advanced heart": 0.0005196876292743613, "therapy in select patients": 0.00049782246538245, "part of a heart": 0.00041377786439403925, "part of a hospital": 0.0004416357764713315, "days of hospital discharge": 0.00049782246538245, "review of all heart": 0.00044989700417746083, "rate after the initiative": 0.0004918297171970689, "patients had blood work": 0.0004790893831875676, "discrepancy between the discharge": 0.0005342505951449326, "parallel with an increase": 0.0004918297171970689, "pathophysiology of heart failure": 0.0005295488244016098, "enrolled in this prospective": 0.0005091458294913794, "times below the median": 0.00047229735422974975, "risk of cardiac events": 0.00047229735422974975, "rest of the group": 0.0004329022284738763, "risk of heart disease": 0.0004651893055262403, "compliance in a single": 0.00047229735422974975, "value for heart failure": 0.0004790893831875676, "treatment in most subjects": 0.00049782246538245, "year for heart failure": 0.00047229735422974975, "choice of chelation regimens": 0.0005091458294913794, "impact of ejection fraction": 0.0005035890173865145, "fraction on the clinical": 0.00048559230043647075, "response to cardiac resynchronization": 0.0005517319811087641, "therapy in mild heart": 0.0004651893055262403, "evaluated in which patients": 0.0005035890173865145, "determined by a blinded": 0.0004790893831875676, "improvement in the clinical": 0.0005035890173865145, "fraction in a rat": 0.0004329022284738763, "comorbidities in heart failure": 0.0005196876292743613, "importance for myocardial dd": 0.0005091458294913794, "dd of collagen deposition": 0.0004918297171970689, "rats after heart failure": 0.00048559230043647075, "weeks with repeat metabolic": 0.0005035890173865145, "site of the elastic": 0.00044989700417746083, "strain as a major": 0.0004329022284738763, "predictor of cardiovascular events": 0.0005388119933541983, "relationship with adverse cardiovascular": 0.0005636441532395004, "events in atrial fibrillation": 0.0005145076249870338, "cardiology in a university": 0.00049782246538245, "method for cv events": 0.0004577343883591784, "hospitalisation for heart failure": 0.0005342505951449326, "hospitalisations for heart failure": 0.0005388119933541983, "failure during an average": 0.0004918297171970689, "benefit in the prediction": 0.0004918297171970689, "outcomes after cardiac resynchronization": 0.0005636441532395004, "duration on the effectiveness": 0.0005145076249870338, "effectiveness of cardiac resynchronization": 0.0005710990704065622, "assessed in a large": 0.00044989700417746083, "associated with a significant": 0.0005145076249870338, "patients in atrial fibrillation": 0.0005246977664040327, "reviewed by a panel": 0.00044989700417746083, "included in this study": 0.00047229735422974975, "component of the primary": 0.00048559230043647075, "ratio for the primary": 0.0004651893055262403, "benefit from implantable cardioverter": 0.0005517319811087641, "failure with peritoneal dialysis": 0.0005295488244016098, "overload in heart failure": 0.0004918297171970689, "therapy in severe end": 0.0004651893055262403, "% with the majority": 0.00044989700417746083, "improvement in diuretic response": 0.0005295488244016098, "decrease in re -": 0.00042363905952128787, "hospitalization from an average": 0.0005246977664040327, "treatment of diuretic refractory": 0.0005295488244016098, "consequences of cardiac resynchronization": 0.0005674170731431989, "assessment of these patients": 0.0005091458294913794, "evidence of reverse remodeling": 0.0005196876292743613, "improvement in ejection fraction": 0.0005295488244016098, "increase in ejection fraction": 0.0005145076249870338, "improvement after device implantation": 0.0005517319811087641, "risk for adverse events": 0.0004790893831875676, "coupling in hypertensive heart": 0.0005196876292743613, "failure of cardiovascular reserve": 0.0005342505951449326, "reserve in multiple domains": 0.0005035890173865145, "function with echocardiographic measures": 0.0005636441532395004, "constants through the analysis": 0.0005196876292743613, "defined as the ratio": 0.0004577343883591784, "mediator of insulin resistance": 0.0005196876292743613, "levels with the development": 0.0005035890173865145, "severity of heart failure": 0.0004918297171970689, "understanding of the role": 0.0004918297171970689, "role of human resistin": 0.00047229735422974975, "resistin in heart failure": 0.0004918297171970689, "transgenic for the human": 0.00048559230043647075, "induction of serum resistin": 0.0005035890173865145, "controls not expressing human": 0.0005145076249870338, "decline in ejection fraction": 0.0005091458294913794, "fraction in these women": 0.0004790893831875676, "contribute in the development": 0.0005145076249870338, "resistin as a link": 0.0004416357764713315, "outcomes of catheter ablation": 0.0005145076249870338, "ablation of atrial fibrillation": 0.0005246977664040327, "safety of catheter ablation": 0.0005035890173865145, "ablation for atrial fibrillation": 0.0005295488244016098, "factor for clinical deterioration": 0.0005342505951449326, "performed in a consecutive": 0.00049782246538245, "probability after catheter ablation": 0.0005432411583292699, "treated with a composite": 0.00048559230043647075, "composite of repeat procedures": 0.0005196876292743613, "ablation in this cohort": 0.0004790893831875676, "agent in the treatment": 0.00047229735422974975, "treatment of several cancers": 0.0005091458294913794, "in the present study": 0.0004577343883591784, "addition to cytochrome c": 0.00048559230043647075, "decrement of heart rate": 0.0004790893831875676, "state of mitochondrial oxidative": 0.0005295488244016098, "doxorubicin against the growth": 0.0005196876292743613, "effective against the development": 0.0005342505951449326, "improvement of hemodynamic perturbations": 0.0005636441532395004, "infarction after coronary artery": 0.0005295488244016098, "from the swedish web": 0.0004577343883591784, "risk for the primary": 0.0004577343883591784, "intervals for cardiovascular events": 0.0005432411583292699, "introduced into the statistical": 0.0005246977664040327, "adjustment for all confounders": 0.0005196876292743613, "events during the first": 0.0004790893831875676, "failure in the young": 0.0004577343883591784, "burden in adult medicine": 0.00048559230043647075, "cause of heart failure": 0.00047229735422974975, "result of congenital lesions": 0.0005091458294913794, "most of these lesions": 0.0004651893055262403, "expand on the management": 0.00048559230043647075, "management of congenital heart": 0.0005196876292743613, "lesions in this review": 0.00047229735422974975, "failure from cardiomyopathic restriction": 0.0005636441532395004, "aetiologies in some cases": 0.0004918297171970689, "debate in paediatric heart": 0.00049782246538245, "responses to heart failure": 0.00049782246538245, "scaffolds in heart pathology": 0.0005091458294913794, "cardiomyocytes to detect mechanical": 0.0005432411583292699, "adaptation of the myocardium": 0.0005091458294913794, "response to new conditions": 0.00049782246538245, "adaptation to stress conditions": 0.0005246977664040327, "kinases into a linear": 0.0004651893055262403, "investigation for the development": 0.0005342505951449326, "development of therapeutic strategies": 0.0005517319811087641, "deals with the case": 0.00044989700417746083, "case of a patient": 0.0004329022284738763, "based on the history": 0.0004577343883591784, "diagnosis of multiple myeloma": 0.0005145076249870338, "frailty in heart failure": 0.00048559230043647075, "indicator in heart failure": 0.00049782246538245, "defined as a biological": 0.0004790893831875676, "evaluated in the same": 0.0004651893055262403, "defined as the proportion": 0.0004918297171970689, "increase in the deficit": 0.0004790893831875676, "as the biological phenotype": 0.0005035890173865145, "future of acute heart": 0.0004651893055262403, "decade of acute heart": 0.0004651893055262403, "disappointments in large phase": 0.0005196876292743613, "role of appropriate timing": 0.00049782246538245, "timing of patient enrollment": 0.0005091458294913794, "success in future trials": 0.00048559230043647075, "peptides at the point": 0.0004651893055262403, "care in the emergency": 0.0004651893055262403, "tool in the diagnosis": 0.0004651893055262403, "diagnosis of acute heart": 0.00048559230043647075, "mixed on the absolute": 0.0004651893055262403, "risk of adverse outcomes": 0.00048559230043647075, "outcomes in other patients": 0.00049782246538245, "measured at the point": 0.0004651893055262403, "nps to clinical care": 0.0004577343883591784, "delivery in the emergency": 0.0004918297171970689, "risk of acute heart": 0.00044989700417746083, "frame of a patient": 0.0004416357764713315, "processes of care delivery": 0.00049782246538245, "advantage of the faster": 0.0004790893831875676, "quality of outcome measures": 0.0005035890173865145, "quality of care outcomes": 0.00048559230043647075, "objective of the measure": 0.00048559230043647075, "expansion to other conditions": 0.0005145076249870338, "mortality in modern society": 0.0005035890173865145, "consequence of pathological remodelling": 0.0005597757062976328, "remodelling of the heart": 0.00048559230043647075, "at the molecular level": 0.00047229735422974975, "targets for the prevention": 0.00049782246538245, "set of transcription factors": 0.0005091458294913794, "occur through an interplay": 0.00049782246538245, "interplay between these transcription": 0.0005517319811087641, "changes in chromatin structure": 0.0005196876292743613, "resulting in the suppression": 0.0005091458294913794, "profiling of cultured cardiomyocytes": 0.0005475455413516535, "cardiomyocytes in the presence": 0.0005196876292743613, "induction of a substantial": 0.00049782246538245, "effects on systemic blood": 0.0004918297171970689, "analysis of cardiac tissue": 0.00049782246538245, "bets in the mouse": 0.0004329022284738763, "readers in cardiac biology": 0.00049782246538245, "manipulation of cardiac gene": 0.0005091458294913794, "mri during tidal respiration": 0.0005091458294913794, "quantification of myocardial t1": 0.0005246977664040327, "swine with heart failure": 0.00048559230043647075, "purpose of this article": 0.0004790893831875676, "sequence to quantify myocardial": 0.0005246977664040327, "changes in a swine": 0.0004416357764713315, "minutes after the administration": 0.0005295488244016098, "administration of a gadolinium": 0.0005196876292743613, "compared between the baseline": 0.0005145076249870338, "fibrosis of heart failure": 0.0004918297171970689, "tissue from control animals": 0.0005035890173865145, "found between the baseline": 0.00049782246538245, "values before the administration": 0.0005295488244016098, "administration of contrast agent": 0.0005295488244016098, "animals with heart failure": 0.00049782246538245, "tissue from healthy control": 0.0005035890173865145, "use of a contrast": 0.0004329022284738763, "increases in the percentage": 0.0005035890173865145, "echocardiography as a possible": 0.0005196876292743613, "in this prospective study": 0.0004918297171970689, "panel of noninvasive assessments": 0.0005295488244016098, "basis of the assumption": 0.0004790893831875676, "according to an exercise": 0.00048559230043647075, "relevance in pulmonary hypertension": 0.0005432411583292699, "tool for prognostic assessment": 0.0005196876292743613, "assessment in pulmonary hypertension": 0.0005475455413516535, "devices in heart failure": 0.00048559230043647075, "cornerstone of heart failure": 0.0005091458294913794, "detection of fluid overload": 0.0005035890173865145, "portion of the health": 0.0004651893055262403, "achieved in the development": 0.0005035890173865145, "splicing of the type": 0.0004577343883591784, "trapped in the endoplasmic": 0.00049782246538245, "expression of exogenous variants": 0.0005295488244016098, "involved in the reduction": 0.0004918297171970689, "failure in pulmonary hypertension": 0.0005342505951449326, "attention in the medical": 0.00048559230043647075, "used in the management": 0.00047229735422974975, "concentrating on the pathophysiologic": 0.0005517319811087641, "failure in the setting": 0.00047229735422974975, "setting of pulmonary embolism": 0.0005145076249870338, "trends in heart failure": 0.0004790893831875676, "fraction after myocardial infarction": 0.0005475455413516535, "occurred in the epidemiology": 0.0005091458294913794, "epidemiology of myocardial infarction": 0.0005517319811087641, "changes in patient presentation": 0.0005246977664040327, "change in the case": 0.0004416357764713315, "events in heart failure": 0.0004790893831875676, "levels of various serum": 0.0004790893831875676, "resulted in a lower": 0.00044989700417746083, "reduction of sympathetic activity": 0.0005342505951449326, "caring for these patients": 0.0004918297171970689, "drugs for heart failure": 0.0004790893831875676, "indicated in the patient": 0.00048559230043647075, "structure of medical records": 0.0005091458294913794, "documentation of contextual reasons": 0.0005432411583292699, "dysfunction during the onset": 0.0005091458294913794, "onset of heart failure": 0.00047229735422974975, "control of the heart": 0.0004577343883591784, "increase in parasympathetic function": 0.0005475455413516535, "effects of the acetylcholinesterase": 0.0005432411583292699, "pyridostigmine on sympathovagal balance": 0.0005597757062976328, "function in the onset": 0.0004651893055262403, "wk of pyridostigmine administration": 0.0005432411583292699, "control of heart rate": 0.0004651893055262403, "protein in the left": 0.00044989700417746083, "means of the pressure": 0.0004651893055262403, "contractility of the left": 0.0004918297171970689, "dysfunction during the progression": 0.0005388119933541983, "delay in dyssynchronous heart": 0.0005145076249870338, "addition to the left": 0.0004577343883591784, "type of electrical activation": 0.0005145076249870338, "behavior of the heart": 0.0004651893055262403, "interval between local myocyte": 0.0005196876292743613, "models of dyssynchronous nonfailing": 0.0005432411583292699, "simulated in all models": 0.0004790893831875676, "changes in myofiber dynamics": 0.0005091458294913794, "onset of myofiber shortening": 0.0005091458294913794, "prognosis in advanced heart": 0.0005035890173865145, "function on body composition": 0.0005091458294913794, "assessment of body composition": 0.0005196876292743613, "associated with a lower": 0.0004790893831875676, "mediated by a higher": 0.0004577343883591784, "surrogate of enhanced catabolism": 0.0005295488244016098, "cardioprotective in the context": 0.0005246977664040327, "inhibition on hemodynamic status": 0.0005295488244016098, "tolerance in heart failure": 0.00049782246538245, "ivabradine on exercise capacity": 0.0005246977664040327, "optimization of diastolic filling": 0.0005342505951449326, "days in this double": 0.00044989700417746083, "assessment of myocardial function": 0.0005342505951449326, "difference in heart rate": 0.00048559230043647075, "rate at the same": 0.00042363905952128787, "time at the baseline": 0.0004577343883591784, "increase in heart rate": 0.00047229735422974975, "treatment in exertional increase": 0.0005295488244016098, "increase in exercise capacity": 0.0005145076249870338, "increase in peak oxygen": 0.0004790893831875676, "reflected by the ratio": 0.00047229735422974975, "absence of coronary artery": 0.00049782246538245, "failure of unclear etiology": 0.0005035890173865145, "cause of systolic heart": 0.0004790893831875676, "angiography with a primary": 0.00049782246538245, "stenosis in the left": 0.0004577343883591784, "validated in a separate": 0.0004790893831875676, "patients in the derivation": 0.00049782246538245, "in the prospective validation": 0.0005145076249870338, "angiography in a substantial": 0.0005091458294913794, "experience of a vasopressin": 0.0005035890173865145, "indication in japanese heart": 0.0005091458294913794, "indicated for the treatment": 0.0005035890173865145, "treatment of severe hyponatremia": 0.0005295488244016098, "hyponatremia in most countries": 0.0005196876292743613, "use in heart failure": 0.0004577343883591784, "data on the potential": 0.0004651893055262403, "occur in the absence": 0.0004577343883591784, "absence of fluid overload": 0.0004918297171970689, "knowledge on diuretic use": 0.0004918297171970689, "therapy to implantable defibrillators": 0.0005517319811087641, "appropriate to the level": 0.00048559230043647075, "subject of this brief": 0.0004651893055262403, "leading to a remarkable": 0.0004790893831875676, "increase in camp hydrolysis": 0.0005035890173865145, "stimulation of cgmp synthesis": 0.0005145076249870338, "overexpression in healthy cardiomyocytes": 0.0005636441532395004, "rise in camp levels": 0.00044989700417746083, "mechanism during cardiac stress": 0.0005246977664040327, "hospitalized for a cardiovascular": 0.0005342505951449326, "discontinuation of study medication": 0.0005432411583292699, "endpoint in all subgroups": 0.0004918297171970689, "subgroups at high risk": 0.00047229735422974975, "factor for poor outcomes": 0.00048559230043647075, "hrqol in a cohort": 0.0004329022284738763, "trial of exercise training": 0.00049782246538245, "according to the intention": 0.00049782246538245, "hrqol from exercise training": 0.0005091458294913794, "failure from the province": 0.0004918297171970689, "compared from a single": 0.00047229735422974975, "% of total expenditures": 0.0004790893831875676, "hospitalizations for noncardiovascular diagnoses": 0.0005915020653167927, "drugs in the rate": 0.0004329022284738763, "influence on the overall": 0.00048559230043647075, "perturbations in skeletal muscle": 0.0005295488244016098, "reversal of detrimental alterations": 0.0005432411583292699, "alterations in sarcomeric microstructure": 0.0005636441532395004, "markers of skm growth": 0.0004651893055262403, "medicine as an adjunctive": 0.0004918297171970689, "treatment for dilated cardiomyopathy": 0.0005475455413516535, "patients with dilated cardiomyopathy": 0.0005475455413516535, "studies on biomedical treatment": 0.0005246977664040327, "performed on the overall": 0.00048559230043647075, "effects on effective rate": 0.0004918297171970689, "improvement in effective rate": 0.0005145076249870338, "observed in the studies": 0.0004790893831875676, "treatment in all patients": 0.0004918297171970689, "compared with the controls": 0.00049782246538245, "intolerance in heart failure": 0.0005091458294913794, "feature of chronic heart": 0.00048559230043647075, "update on cardiopulmonary exercise": 0.0005388119933541983, "attention in the interpretation": 0.0005246977664040327, "interpretation of cardiopulmonary exercise": 0.0005710990704065622, "variables with an important": 0.0005035890173865145, "assessment with the inclusion": 0.0005145076249870338, "surgery in heart transplant": 0.0005035890173865145, "transplantation with medical therapy": 0.0005475455413516535, "consultation for abdominal problems": 0.0005432411583292699, "man with cardiac arrest": 0.0004790893831875676, "need of cardiopulmonary resuscitation": 0.0005517319811087641, "diagnosis of a posterior": 0.00048559230043647075, "obstruction of the right": 0.00048559230043647075, "admitted to the intensive": 0.0004918297171970689, "based on the acute": 0.0004416357764713315, "failure with therapy refractory": 0.0005246977664040327, "team for an extra": 0.0004329022284738763, "days after the emergency": 0.00048559230043647075, "focused on the importance": 0.0004918297171970689, "importance of diastolic dysfunction": 0.0005432411583292699, "dysfunction in the pathophysiology": 0.0005388119933541983, "abnormalities in cardiovascular function": 0.0005636441532395004, "discussion of novel treatment": 0.0005145076249870338, "promise for the future": 0.00047229735422974975, "outcomes of heart failure": 0.0004918297171970689, "impact on the incidence": 0.0004790893831875676, "hospitalized with an index": 0.00049782246538245, "associated with a multivariate": 0.0005196876292743613, "days of the index": 0.0004329022284738763, "declines in the incidence": 0.0004918297171970689, "problem with high mortality": 0.0005035890173865145, "attention to these high": 0.0004790893831875676, "therapy during exercise rehabilitation": 0.0005558067690577828, "rehabilitation in male patients": 0.0005246977664040327, "data for key health": 0.00044989700417746083, "improvements in shuttle walk": 0.0005091458294913794, "observed in both groups": 0.0004790893831875676, "exercise with testosterone group": 0.0005295488244016098, "baseline in peak oxygen": 0.0004790893831875676, "quality of life domains": 0.0004790893831875676, "apparent in the exercise": 0.00048559230043647075, "exercise with placebo group": 0.0005035890173865145, "shows for the first": 0.00044989700417746083, "supplementation during a program": 0.0005295488244016098, "program of exercise rehabilitation": 0.0005388119933541983, "impact on a range": 0.0004329022284738763, "range of key health": 0.00044989700417746083, "stimulation of peripheral muscles": 0.0005342505951449326, "status in heart failure": 0.0004790893831875676, "function in chronic heart": 0.0004918297171970689, "completion of training protocol": 0.0005246977664040327, "lack of effective evidence": 0.00049782246538245, "therapies in these patients": 0.0005035890173865145, "decline in atrial explant": 0.0004918297171970689, "functions after myocardial infarction": 0.0005517319811087641, "majority of potential candidates": 0.0005295488244016098, "candidates for cell therapy": 0.0005035890173865145, "phenotype of cardiac explant": 0.0005091458294913794, "used as a control": 0.0004329022284738763, "selected on the basis": 0.0004651893055262403, "basis of left ventricle": 0.0004790893831875676, "expression of pluripotency markers": 0.0005388119933541983, "protocols for clinical application": 0.0005388119933541983, "breathing with no heart": 0.0004790893831875676, "advantage of the period": 0.0004790893831875676, "part of this study": 0.0004416357764713315, "excluded from the final": 0.0004790893831875676, "presented in this report": 0.00048559230043647075, "phase of a pb": 0.00039191270050212794, "effect on pb characteristics": 0.0005091458294913794, "perfusion of the carotid": 0.00048559230043647075, "originating from the central": 0.0005091458294913794, "absence of atrial fibrillation": 0.0005196876292743613, "options for these patients": 0.00049782246538245, "patients in sinus rhythm": 0.00048559230043647075, "tools for risk stratification": 0.0005145076249870338, "need for antiplatelet agents": 0.0005091458294913794, "nutrition in heart failure": 0.00049782246538245, "recognized as a multisystem": 0.0005035890173865145, "disease with important comorbidities": 0.0005475455413516535, "alterations in intestinal morphology": 0.0005475455413516535, "overview of the sonographic": 0.0005035890173865145, "knowledge of nutritional abnormalities": 0.0005558067690577828, "effects in the treatment": 0.00048559230043647075, "interventions in heart failure": 0.0005196876292743613, "target of further heart": 0.0004790893831875676, "response to an increase": 0.0004790893831875676, "increase in ventricular wall": 0.0005091458294913794, "patients with coronary artery": 0.0005145076249870338, "derived from a great": 0.0004577343883591784, "amount of recent data": 0.0004651893055262403, "associated with the extent": 0.00049782246538245, "information for an unfavourable": 0.0005246977664040327, "balance in conscious rabbits": 0.0005091458294913794, "rabbits with chronic heart": 0.00049782246538245, "hallmark of chronic heart": 0.0004918297171970689, "levels by renal dnx": 0.00044989700417746083, "compared with the sham": 0.00047229735422974975, "due to a withdrawal": 0.00044989700417746083, "withdrawal of sympathetic tone": 0.0005196876292743613, "increase in parasympathetic tone": 0.0005295488244016098, "measured after an intravenous": 0.0005145076249870338, "response to intravenous atropine": 0.0005295488244016098, "reduction of sympathetic tone": 0.0005145076249870338, "failure with a narrow": 0.0004651893055262403, "failure with a wide": 0.00044989700417746083, "patients with a narrow": 0.00047229735422974975, "futility on the recommendation": 0.0005196876292743613, "recommendation of the data": 0.00049782246538245, "followed for a mean": 0.00044989700417746083, "effects of ventricular assist": 0.0005145076249870338, "oxygenation on renal function": 0.0005145076249870338, "function in pediatric heart": 0.0005035890173865145, "support on renal function": 0.0004918297171970689, "impact of ventricular assist": 0.0005091458294913794, "comparison of baseline characteristics": 0.0005558067690577828, "patients in the ecmo+vad": 0.00048559230043647075, "decline in renal function": 0.0004918297171970689, "group in the first": 0.0004416357764713315, "basis of these data": 0.00044989700417746083, "mandate to ensure effective": 0.0005035890173865145, "accountable for the outcomes": 0.0005091458294913794, "outcomes of nursing care": 0.00048559230043647075, "aspects of nursing care": 0.0004790893831875676, "difference in outcome ratings": 0.0005145076249870338, "improvement in outcome ratings": 0.0005196876292743613, "findings from this study": 0.00048559230043647075, "insight on the possible": 0.0004790893831875676, "contribute to the advancement": 0.0005145076249870338, "treatment of older adults": 0.0004918297171970689, "contribution of nursing care": 0.0005091458294913794, "actions on adenylyl cyclase": 0.0005035890173865145, "regulated by the actions": 0.00048559230043647075, "action on camp production": 0.0004918297171970689, "regulation in mouse hearts": 0.00049782246538245, "model of postischemic heart": 0.0005035890173865145, "restoration of cardiac plasma": 0.0005145076249870338, "overstimulation in heart failure": 0.0005295488244016098, "impact of physician continuity": 0.0005196876292743613, "continuity further influences outcomes": 0.0005558067690577828, "databases for all adults": 0.00048559230043647075, "within the first month": 0.00047229735422974975, "discharge on the primary": 0.00048559230043647075, "year before the index": 0.0004651893055262403, "in the first month": 0.0004416357764713315, "visits with a familiar": 0.00047229735422974975, "modulation of repolarization instability": 0.0005636441532395004, "aim of the present": 0.0004416357764713315, "records of surface ecgs": 0.0004790893831875676, "expressed as the sd": 0.00044989700417746083, "calculated as an index": 0.00047229735422974975, "toward a higher baseline": 0.00048559230043647075, "compared with the hfvt(-": 0.00048559230043647075, "consequence of heart rate": 0.0004918297171970689, "survivors of haematopoietic cell": 0.0005295488244016098, "association between the development": 0.0005432411583292699, "syndrome of right heart": 0.0004790893831875676, "definitions of the distinctive": 0.0005196876292743613, "components of the right": 0.0004790893831875676, "consensus on a universal": 0.00048559230043647075, "definition of right heart": 0.0004918297171970689, "nomenclature for right heart": 0.0005091458294913794, "failure with a view": 0.00044989700417746083, "education in an effort": 0.00047229735422974975, "inhibitor in heart failure": 0.00049782246538245, "composed of a neprilysin": 0.00048559230043647075, "promise in a pilot": 0.0004416357764713315, "tested in a large": 0.0004329022284738763, "treatment of acute heart": 0.00048559230043647075, "defined as the rapid": 0.0004577343883591784, "signs of heart failure": 0.00047229735422974975, "situation in which diagnosis": 0.0005091458294913794, "principles of pharmacologic treatment": 0.0005517319811087641, "biomarkers in chronic heart": 0.0005035890173865145, "understanding of chronic heart": 0.0005196876292743613, "progressed from the concept": 0.0005035890173865145, "focus of research investigations": 0.0005295488244016098, "window into the pathophysiology": 0.0005246977664040327, "biomarkers in the treatment": 0.0005035890173865145, "shortcomings in research studies": 0.0005295488244016098, "standards in biomarker studies": 0.0005196876292743613, "potential of a multimarker": 0.00049782246538245, "micrornas in heart failure": 0.00049782246538245, "targets in disease management": 0.0005145076249870338, "mortality in western society": 0.0005091458294913794, "subclass of cardiovascular diseases": 0.0005432411583292699, "expression of target genes": 0.00049782246538245, "role in diverse aspects": 0.0004790893831875676, "aspects of cardiac remodeling": 0.0005145076249870338, "overview of these mirnas": 0.00048559230043647075, "role in cardiac pathogenesis": 0.0005091458294913794, "insight into the potential": 0.00049782246538245, "targets for heart failure": 0.0004918297171970689, "inhibitors in heart failure": 0.0005035890173865145, "evidence for the treatment": 0.00049782246538245, "target in the treatment": 0.0004790893831875676, "evidence for these drugs": 0.00048559230043647075, "quantification with dual x": 0.00049782246538245, "measured by the rate": 0.0004577343883591784, "presence of separate scale": 0.00049782246538245, "validity of individual scales": 0.0005145076249870338, "understanding of the structure": 0.0005196876292743613, "use in clinical practice": 0.00048559230043647075, "contribute to the misdiagnosis": 0.0005196876292743613, "misdiagnosis of heart failure": 0.0005145076249870338, "consistent with this result": 0.0005035890173865145, "fragments of the full": 0.0004651893055262403, "improved with the use": 0.0004651893055262403, "development of a next": 0.0004651893055262403, "region of this molecule": 0.0004790893831875676, "hypertrophy in heart failure": 0.0005091458294913794, "occur in these patients": 0.0004790893831875676, "ratio of systolic blood": 0.0004790893831875676, "metoprolol on the endpoint": 0.00049782246538245, "metoprolol on inappropriate therapy": 0.0005432411583292699, "blockers on the primary": 0.0004790893831875676, "endpoint of inappropriate therapy": 0.0005342505951449326, "patients during a follow": 0.00048559230043647075, "adherence in this study": 0.0004790893831875676, "occurrence of heart failure": 0.0005035890173865145, "% in the exposed": 0.00042363905952128787, "% in the control": 0.00042363905952128787, "used for the same": 0.0004329022284738763, "trends in the risk": 0.0004416357764713315, "reduction in this risk": 0.00047229735422974975, "reversal of cardiac dysfunction": 0.0005246977664040327, "metoprolol in heart failure": 0.0005035890173865145, "reversibility of heart failure": 0.0005196876292743613, "changes in pressure development": 0.0005246977664040327, "levels of plasma norepinephrine": 0.0005246977664040327, "reduced in the infarcted": 0.00048559230043647075, "improvement of cardiac performance": 0.0005388119933541983, "blockade at advanced stages": 0.0005035890173865145, "stages of heart failure": 0.0004790893831875676, "reduction in the elevated": 0.0004918297171970689, "levels of plasma catecholamines": 0.0005246977664040327, "factor for cardiovascular disease": 0.0005342505951449326, "hazards of cardiovascular events": 0.0005295488244016098, "disease from the general": 0.00048559230043647075, "presence of diastolic dysfunction": 0.0005342505951449326, "patients with peripheral artery": 0.0005246977664040327, "defined by an ankle": 0.00044989700417746083, "associated with the highest": 0.0005035890173865145, "program for congestive heart": 0.0005091458294913794, "stay for congestive heart": 0.0004918297171970689, "patients with this condition": 0.0005091458294913794, "located in a community": 0.00047229735422974975, "diagnosis of congestive heart": 0.0005145076249870338, "monitoring of the patient": 0.0004918297171970689, "patient by the health": 0.0004651893055262403, "documented for those patients": 0.0005145076249870338, "participating in the pilot": 0.00049782246538245, "cost of the intervention": 0.00048559230043647075, "failure in a non": 0.00042363905952128787, "variability in risk stratification": 0.0005388119933541983, "within a few years": 0.0004416357764713315, "years after an ami": 0.0004416357764713315, "measures of hr dynamics": 0.0004790893831875676, "measures of hr variability": 0.00049782246538245, "power of various measures": 0.0004918297171970689, "remodeling of the arrhythmia": 0.0005091458294913794, "tool for risk stratification": 0.0005091458294913794, "form of peripheral arterial": 0.0005035890173865145, "resulting in the activation": 0.0005035890173865145, "activation of the renin-": 0.00048559230043647075, "provide more concrete data": 0.00049782246538245, "analysis of microarray data": 0.0005035890173865145, "interactors of the degs": 0.0004790893831875676, "part of the network": 0.00044989700417746083, "types of heart failure": 0.00047229735422974975, "effects of care management": 0.00049782246538245, "effects of an intervention": 0.00049782246538245, "individuals with congestive heart": 0.0005342505951449326, "system with care management": 0.0005035890173865145, "relationship between the intervention": 0.0005517319811087641, "reductions in the number": 0.00048559230043647075, "baseline to the study": 0.0004651893055262403, "controls during this same": 0.0004918297171970689, "number of hospital days": 0.0004790893831875676, "outcomes in chronic heart": 0.0004918297171970689, "race as an independent": 0.00047229735422974975, "outcomes in a contemporary": 0.00049782246538245, "association with exercise training": 0.0005388119933541983, "interactions with exercise training": 0.0005432411583292699, "% to usual care": 0.00041377786439403925, "interaction with exercise training": 0.0005388119933541983, "risk for all outcomes": 0.0004651893055262403, "prevalence of modifiable risk": 0.0005145076249870338, "safety of rhythm control": 0.00048559230043647075, "therapy in a prospective": 0.00048559230043647075, "end of the trial": 0.00042363905952128787, "trial for the composite": 0.0004790893831875676, "outcome of cardiovascular death": 0.0005246977664040327, "counted as a coprimary": 0.00047229735422974975, "control as an initial": 0.0004651893055262403, "therapy by antiarrhythmic drugs": 0.0005246977664040327, "implantation of a long": 0.00047229735422974975, "use of these devices": 0.0004577343883591784, "bleeding in this population": 0.0005035890173865145, "asked about the management": 0.00049782246538245, "management of gastrointestinal bleeding": 0.0005597757062976328, "array of diagnostic procedures": 0.0005196876292743613, "treatments for this complication": 0.0005295488244016098, "understanding of this topic": 0.0005035890173865145, "management of end stage": 0.0004790893831875676, "consequence of the worldwide": 0.0005091458294913794, "increase in life expectancy": 0.0005035890173865145, "improvements in the treatment": 0.0005145076249870338, "failure in recent years": 0.0004790893831875676, "phase of the disease": 0.0004577343883591784, "patients with end stage": 0.0004790893831875676, "causes for a worsening": 0.00047229735422974975, "worsening of heart failure": 0.00049782246538245, "strategies for the treatment": 0.0005091458294913794, "treatment of end stage": 0.00047229735422974975, "phase of ventricular action": 0.0005035890173865145, "coupling in the myocardium": 0.00049782246538245, "family of monomeric g": 0.0004651893055262403, "ability to inhibit cardiac": 0.00049782246538245, "inhibition of both channels": 0.0005035890173865145, "movement of both channels": 0.0004918297171970689, "rule out the possibility": 0.00048559230043647075, "mistargeting or altered regulation": 0.0005388119933541983, "age of legal majority": 0.0004651893055262403, "reporting on quality aims": 0.0004918297171970689, "measure for heart failure": 0.0004918297171970689, "variance in future hospital": 0.0005035890173865145, "cohort of older patients": 0.00048559230043647075, "treated at an acute": 0.00044989700417746083, "hospitals on the basis": 0.00047229735422974975, "performance on the composite": 0.0005091458294913794, "mortality at the worst": 0.00047229735422974975, "hospital in the worst": 0.0004651893055262403, "variation in future mortality": 0.0005145076249870338, "spironolactone in severe heart": 0.0005196876292743613, "antagonists in heart failure": 0.0005091458294913794, "race by treatment interaction": 0.0005145076249870338, "differences in baseline characteristics": 0.0005597757062976328, "categories of actin cytoskeleton": 0.0005295488244016098, "parallel with global attenuation": 0.0005295488244016098, "attenuation of mitochondrial proteome": 0.0005517319811087641, "% of nonmitochondrial protein": 0.0005145076249870338, "effects on heart failure": 0.00048559230043647075, "attenuation of global proteomics": 0.0005295488244016098, "alterations by the mitochondrial": 0.0005295488244016098, "many of the pathway": 0.00044989700417746083, "drugs for the treatment": 0.0004790893831875676, "length of stay increase": 0.0004790893831875676, "rehospitalization of medicare fee": 0.0005342505951449326, "policy as a quasi": 0.0004329022284738763, "associated with an absolute": 0.0005035890173865145, "reduction in hospital length": 0.0005091458294913794, "admissions to acute care": 0.00048559230043647075, "strata of hospital volume": 0.0004918297171970689, "relationship between physician volume": 0.0005517319811087641, "antagonism in heart failure": 0.0005035890173865145, "role in the progression": 0.0004790893831875676, "groups with heart failure": 0.0004918297171970689, "therapy with beta blockade": 0.00049782246538245, "randomized to the aldosterone": 0.0005145076249870338, "background for aldosterone antagonist": 0.0005517319811087641, "patients with reduced ejection": 0.0005196876292743613, "prognosis of a large": 0.0004577343883591784, "followed during the past": 0.00048559230043647075, "periods on the basis": 0.0004577343883591784, "basis of heart failure": 0.00047229735422974975, "devices at final evaluation": 0.0005035890173865145, "enrollment of older patients": 0.0005091458294913794, "dysfunction during the years": 0.0005091458294913794, "predictor of favorable outcome": 0.0005196876292743613, "decreases in heart failure": 0.00049782246538245, "improvement in the prognosis": 0.0005091458294913794, "cardiomyopathy during the past": 0.0005196876292743613, "replicated in the real": 0.00047229735422974975, "value of indeterminable anaerobic": 0.0005342505951449326, "threshold in heart failure": 0.00049782246538245, "investigations at study enrollment": 0.0005388119933541983, "achievement of anaerobic metabolism": 0.0005432411583292699, "composite of cardiovascular death": 0.0005342505951449326, "diet in renal disease": 0.0004651893055262403, "obtained for the secondary": 0.00049782246538245, "number of cardiovascular risk": 0.0005145076249870338, "history of cardiovascular disease": 0.0005342505951449326, "duration of maximal treadmill": 0.0005145076249870338, "during a mean follow": 0.0004577343883591784, "matched for the same": 0.0004577343883591784, "activity with the goal": 0.00047229735422974975, "development of systolic heart": 0.0005145076249870338, "alterations in energy metabolism": 0.0005295488244016098, "changes in energy metabolism": 0.0005091458294913794, "contribute to the development": 0.0005145076249870338, "failure in the hypertrophied": 0.0005091458294913794, "overload as a result": 0.0004577343883591784, "result of an abdominal": 0.00047229735422974975, "rates of energy substrate": 0.0004918297171970689, "assessment of cardiac function": 0.0005196876292743613, "decrease in % ejection": 0.00047229735422974975, "evidenced by a significant": 0.00049782246538245, "translocation of glucose transporter": 0.0005475455413516535, "reduction in mitochondrial oxidation": 0.0005475455413516535, "accompanied by an increase": 0.00049782246538245, "increase in myocardial glycolysis": 0.0005342505951449326, "concomitant with a reduction": 0.0005091458294913794, "reduction in the ratio": 0.00047229735422974975, "development of cardiac insulin": 0.0005196876292743613, "changes in the development": 0.00049782246538245, "contribute to the progression": 0.0005145076249870338, "hypertrophy to heart failure": 0.0005091458294913794, "reality of heart failure": 0.00048559230043647075, "planning in the prevention": 0.00049782246538245, "adequacy of relevant health": 0.0005035890173865145, "search of the electronic": 0.00048559230043647075, "developed and nondeveloped countries": 0.0005475455413516535, "confirmation on other populations": 0.0005342505951449326, "link between air pollution": 0.00049782246538245, "factor for cardiovascular health": 0.0005295488244016098, "review of the effects": 0.0004651893055262403, "effects of air pollution": 0.00048559230043647075, "pollution on heart failure": 0.00049782246538245, "professionals in public health": 0.0005196876292743613, "regulator of cytoskeletal actin": 0.0005246977664040327, "dysfunction with conduction abnormalities": 0.0005674170731431989, "mass in the transgenic": 0.00047229735422974975, "decreases in ejection fraction": 0.0005196876292743613, "future of advanced heart": 0.00048559230043647075, "developments in diagnostic procedure": 0.0005475455413516535, "addition to palliative care": 0.0005035890173865145, "patients in the terminal": 0.00048559230043647075, "recognition of advanced disease": 0.0005246977664040327, "vital in the determination": 0.00049782246538245, "determination of therapeutic options": 0.0005475455413516535, "professionals from multiple disciplines": 0.0005597757062976328, "experienced in the management": 0.0005145076249870338, "access to therapeutic options": 0.0005145076249870338, "aims of the present": 0.00044989700417746083, "results about the risk": 0.00047229735422974975, "uncertainty about the safety": 0.0005091458294913794, "safety of these antihyperglycemic": 0.0005342505951449326, "recorded as the principal": 0.0004918297171970689, "ratios from the disease": 0.0004790893831875676, "effectiveness of implementation strategies": 0.0005710990704065622, "recommendations in heart failure": 0.0005295488244016098, "search in the databases": 0.0004790893831875676, "impact of the intervention": 0.00049782246538245, "adherence to the cpgs": 0.0004651893055262403, "proportion of eligible patients": 0.0005246977664040327, "impact of implementation strategies": 0.0005432411583292699, "factors on physician adherence": 0.0005196876292743613, "findings through briefing reports": 0.0005342505951449326, "perceptions of implantable cardioverter": 0.0005597757062976328, "recommendation for implantable cardioverter": 0.0005746944243488772, "perspective on the timing": 0.0004918297171970689, "decisions about implantable cardioverter": 0.0005636441532395004, "identified in this study": 0.00048559230043647075, "information on implantable cardioverter": 0.0005597757062976328, "change in clinical status": 0.0004918297171970689, "objective of this clinical": 0.00049782246538245, "efficacy of carotid baroreflex": 0.0005196876292743613, "reduction of sympathetic outflow": 0.0005295488244016098, "improvements in the distance": 0.0005091458294913794, "associated with a trend": 0.0004790893831875676, "burden of heart failure": 0.0004790893831875676, "patient with chronic heart": 0.00049782246538245, "changes in control group": 0.00048559230043647075, "half of these patients": 0.00047229735422974975, "function in hfpef patients": 0.00049782246538245, "women with a history": 0.0004577343883591784, "cornerstone in the assessment": 0.0005145076249870338, "extent of the symptoms": 0.00047229735422974975, "presence of peripheral oedema": 0.0005145076249870338, "assessment of the patient": 0.0004918297171970689, "reduction in adverse events": 0.0005035890173865145, "events from coronary artery": 0.0005035890173865145, "beyond the cardiovascular system": 0.0005295488244016098, "cancer of the prostate": 0.00047229735422974975, "exercise below these recommendations": 0.0005475455413516535, "abnormalities of the heart": 0.00049782246538245, "cause of nontraumatic death": 0.0005035890173865145, "sport in young athletes": 0.0004790893831875676, "screening of young athletes": 0.0005035890173865145, "ability to detect congenital": 0.0005091458294913794, "system in heart failure": 0.0004790893831875676, "training of the lower": 0.0004651893055262403, "quality of life score": 0.0004651893055262403, "evaluation of the muscular": 0.00049782246538245, "resulted in an improvement": 0.00049782246538245, "improvement in peak work": 0.00048559230043647075, "quality of life assessment": 0.00049782246538245, "safe in this trial": 0.0004416357764713315, "intervention with augmented feedback": 0.0005475455413516535, "benefits in exercise capacity": 0.0005145076249870338, "validation in larger studies": 0.0005091458294913794, "adherence with exercise training": 0.0005295488244016098, "association between social support": 0.0005388119933541983, "surveys to assess social": 0.00048559230043647075, "levels of social support": 0.00048559230043647075, "interaction between the randomization": 0.0005517319811087641, "corresponded to a borderline": 0.0005091458294913794, "hospitalization in the exercise": 0.0005246977664040327, "association in the usual": 0.00048559230043647075, "patients with lower btes": 0.00048559230043647075, "therapy in clinical practice": 0.0005091458294913794, "readmissions in heart failure": 0.0005145076249870338, "effect on heart rate": 0.0004577343883591784, "impact of hr reduction": 0.00047229735422974975, "reduction with beta blockers": 0.0005091458294913794, "blockers on exercise capacity": 0.0005145076249870338, "capacity in recent onset": 0.00048559230043647075, "protocol with respiratory gas": 0.0005145076249870338, "participated in a quality": 0.0004918297171970689, "quality of care programme": 0.0004918297171970689, "interventions to reduce elevated": 0.0005295488244016098, "risk of hospital admission": 0.00049782246538245, "efficacy of therapeutic left": 0.0005091458294913794, "enrolled under the canadian": 0.0005035890173865145, "guidance under general anaesthesia": 0.0005388119933541983, "implanted in all patients": 0.0004918297171970689, "reduced from a mean": 0.00044989700417746083, "hospital with gastrointestinal bleeding": 0.0005597757062976328, "shift in the treatment": 0.00047229735422974975, "problem of current cardiology": 0.0005145076249870338, "occurred in the therapy": 0.0004790893831875676, "therapy in recent years": 0.0004790893831875676, "effect of natriuretic peptides": 0.0005196876292743613, "decrease in primary endpoint": 0.0005091458294913794, "contributed to this study": 0.0004918297171970689, "form of heart failure": 0.0004651893055262403, "determinant of reduced quality": 0.0005196876292743613, "correlated with the change": 0.00049782246538245, "change in thigh muscle": 0.00047229735422974975, "rotor with wide blood": 0.0004651893055262403, "aim of this single": 0.0004416357764713315, "adults with ejection fraction": 0.0005145076249870338, "effectiveness of disease management": 0.0005432411583292699, "based on a modified": 0.00044989700417746083, "projections of resource use": 0.0005035890173865145, "pairs of virtual cohorts": 0.00048559230043647075, "estimates of resource use": 0.0004918297171970689, "ratios from user inputs": 0.0004790893831875676, "effectiveness of heart failure": 0.0005196876292743613, "program in which short": 0.00047229735422974975, "value to the health": 0.00044989700417746083, "providers with a tool": 0.0004651893055262403, "analyses of disease management": 0.0005196876292743613, "nurses in all settings": 0.00047229735422974975, "advancement of the pathophysiologic": 0.0005432411583292699, "95 % confidence": 0.05461867810001319, "% confidence interval": 0.05303158082999139, "left ventricular ejection": 0.05016663115410103, "chronic heart failure": 0.04465817333051907, "ventricular ejection fraction": 0.04784920912379414, "methods and results": 0.04184042138850386, "preserved ejection fraction": 0.0453230115647863, "congestive heart failure": 0.04078975323666354, "patients with heart": 0.029693202275712417, "95 % ci": 0.01962353578222854, "heart failure patients": 0.028337841253784985, "acute heart failure": 0.02564412923811527, "reduced ejection fraction": 0.02803429388023293, "systolic heart failure": 0.02267027300302799, "type natriuretic peptide": 0.021851653519641183, "cardiac resynchronization therapy": 0.020835773210652372, "glomerular filtration rate": 0.0179216087537682, "ventricular assist device": 0.01770586981909448, "body mass index": 0.014896003118185413, "acute myocardial infarction": 0.016618437573754974, "estimated glomerular filtration": 0.017315026291333073, "advanced heart failure": 0.015585812689581742, "left ventricular assist": 0.014372681495627029, "quality of life": 0.01117200233863906, "ventricular assist devices": 0.01344120656532615, "right heart failure": 0.012147219112791442, "failure with preserved": 0.011335136501513994, "\u03b2 - blocker": 0.008793302144386268, "stage heart failure": 0.01079752810025906, "early diastolic mitral": 0.011335136501513994, "converting enzyme inhibitors": 0.010692062419318967, "type 2 diabetes": 0.008689335152274824, "coronary artery disease": 0.010060877046938919, "rhythm control therapy": 0.009918244438824745, "systolic blood pressure": 0.008623608897376216, "adjusted hazard ratio": 0.008373407499472324, "brain natriuretic peptide": 0.00885293490954724, "angiotensin receptor blockers": 0.009261137249766608, "cardiac magnetic resonance": 0.0089608043768841, "induced heart failure": 0.008373407499472324, "peak oxygen uptake": 0.007949443976483967, "idiopathic dilated cardiomyopathy": 0.009616510712608786, "coronary heart disease": 0.007084460313446246, "obstructive pulmonary disease": 0.007717614374805506, "left ventricular dysfunction": 0.007637187442370691, "proportional hazards models": 0.007553835260797716, "acute kidney injury": 0.0067484550626619125, "- adrenergic receptor": 0.0069778395828936045, "severe heart failure": 0.006866015825387675, "ischemic heart failure": 0.007084460313446246, "day readmission rate": 0.006866015825387675, "cardiopulmonary exercise testing": 0.007943232366024148, "% of patients": 0.004702952406025535, "left bundle branch": 0.005299629317655978, "bundle branch block": 0.00539876405012953, "\u03b2 - blockers": 0.004556190426673786, "annular size reduction": 0.005667568250756997, "adjusted odds ratio": 0.00539876405012953, "left ventricular filling": 0.005827107605237649, "angiotensin converting enzyme": 0.006174091499844405, "mineralocorticoid receptor antagonists": 0.0066696812286933934, "criteria cardiac transplant": 0.006043068208638172, "quality improvement initiative": 0.006236251551292335, "implantable cardioverter defibrillator": 0.0066696812286933934, "ventricular contractile reserve": 0.006296373196848391, "diastolic mitral annular": 0.005827107605237649, "mitral annular velocity": 0.005749072598250811, "peak oxygen consumption": 0.005749072598250811, "extracorporeal membrane oxygenation": 0.006518893899951238, "mechanical cardiac support": 0.0059738695845894, "sudden cardiac death": 0.005492812660310141, "skeletal muscle mass": 0.005492812660310141, "defibrillator deactivation discussions": 0.0066696812286933934, "disease management programs": 0.006043068208638172, "adverse event rates": 0.004049073037597148, "x - ray": 0.002675936697576619, "- ray absorptiometry": 0.0041196094952326056, "peripheral vascular disease": 0.00453230115647863, "hour cumulative urine": 0.004186703749736162, "cumulative urine volume": 0.004311804448688108, "coronary artery bypass": 0.004250676188067748, "among older patients": 0.0041196094952326056, "cd34+vegfr2 + cells": 0.004049073037597148, "primary end point": 0.003896120056264887, "morbidity and mortality": 0.004311804448688108, "% confidence intervals": 0.004250676188067748, "predictive cutoff value": 0.004311804448688108, "materials and methods": 0.004186703749736162, "mitral valve plasty": 0.004049073037597148, "developed heart failure": 0.004311804448688108, "aggressive medical treatment": 0.004582312465422414, "successful valve plasty": 0.004311804448688108, "mitral valve opening": 0.0041196094952326056, "mean pressure gradient": 0.004250676188067748, "heart failure hospitalization": 0.004630568624883304, "assist device implantation": 0.00448040218844205, "vascular endothelial growth": 0.00453230115647863, "endothelial growth factor": 0.00442646745477362, "- myocardial infarction": 0.004311804448688108, "myocardial infarction heart": 0.00453230115647863, "chronic myocardial ischemia": 0.00453230115647863, "standard cardiac rehabilitation": 0.004722279897636294, "cardiac rehabilitation care": 0.00453230115647863, "mean ejection fraction": 0.004250676188067748, "optimal combined treatment": 0.00448040218844205, "breast cancer patients": 0.004250676188067748, "dash diet scores": 0.0038127515356915906, "standard criteria cardiac": 0.00442646745477362, "magnetic resonance imaging": 0.00448040218844205, "risk of heart": 0.003527214304519152, "adverse cv events": 0.003896120056264887, "converting enzyme inhibitor": 0.00453230115647863, "ventricular diastolic function": 0.0046771886634692506, "transverse aortic constriction": 0.0046771886634692506, "pulmonary arterial hypertension": 0.004722279897636294, "human heart failure": 0.004049073037597148, "diastolic mitral flow": 0.004186703749736162, "mitral flow velocity": 0.0041196094952326056, "acute \u03b2 -": 0.003021534104319086, "low testosterone status": 0.004311804448688108, "improves exercise capacity": 0.00448040218844205, "heart rate variability": 0.004250676188067748, "group included patients": 0.004311804448688108, "hospitalized older adults": 0.00442646745477362, "- adrenoceptor blockade": 0.004311804448688108, "end stage heart": 0.003724000779546353, "cardiopulmonary exercise test": 0.004630568624883304, "study end point": 0.003724000779546353, "cardiovascular risk factors": 0.00453230115647863, "risk of death": 0.0031353016040170235, "failure with reduced": 0.003204140718514249, "length of stay": 0.0028226524522774014, "energy x -": 0.002110947740873139, "lv diastolic dysfunction": 0.0029135538026188244, "adults with heart": 0.002597413370843258, "management of patients": 0.0028337841253784986, "implantable cardioverter defibrillators": 0.0033586542377857967, "right ventricular assist": 0.0029135538026188244, "preserve renal function": 0.0028745362991254055, "compared with placebo": 0.002791135833157442, "cystatin c level": 0.0025418343571277273, "proteins alter chromatin": 0.0029135538026188244, "alter chromatin structure": 0.0029509783031824136, "gene expression profile": 0.0028745362991254055, "receive cardiac resynchronization": 0.0032055035708695953, "acute coronary syndromes": 0.0029135538026188244, "among study patients": 0.0027464063301550707, "subsequent heart failure": 0.0029135538026188244, "outcomes among patients": 0.0028745362991254055, "circulating progenitor cells": 0.003054874976948276, "improved functional capacity": 0.003054874976948276, "recent hospital discharge": 0.0029509783031824136, "implanted monitoring devices": 0.003054874976948276, "medical support provided": 0.0029135538026188244, "95 % cri": 0.0019063757678457953, "ventricular ejection fractions": 0.0031181257756461673, "recommended target dose": 0.0028745362991254055, "- blocker uptitrations": 0.0028337841253784986, "- blocker dose": 0.002419416387666344, "natriuretic peptide levels": 0.0029869347922947, "in heart failure": 0.0025418343571277273, "predict inhospital mortality": 0.003054874976948276, "pediatric heart failure": 0.0028745362991254055, "systemic vascular resistance": 0.003054874976948276, "minute walk test": 0.0025418343571277273, "induced no production": 0.002791135833157442, "hypertensive heart disease": 0.0029869347922947, "heart failure risk": 0.002649814658827989, "operating characteristic curve": 0.0031181257756461673, "integrated discrimination improvement": 0.0033103918866525845, "net reclassification improvement": 0.003177292946409659, "requiring biventricular support": 0.0031481865984241955, "transplantation eligibility status": 0.00323287196012519, "functional mitral stenosis": 0.0029869347922947, "ischemic mitral regurgitation": 0.0030870457499222025, "diastolic mitral valve": 0.0028337841253784986, "mitral valve tethering": 0.0028337841253784986, "anterior leaflet opening": 0.0029135538026188244, "posteriorly displaced papillary": 0.0031481865984241955, "displaced papillary muscles": 0.003021534104319086, "left ventricular dilatation": 0.003021534104319086, "diastolic volume index": 0.0028337841253784986, "mitral filling flow": 0.002699382025064765, "clear organic lesion": 0.0027464063301550707, "cause medical hospitalization": 0.0030870457499222025, "month event rates": 0.002597413370843258, "stage renal disease": 0.002699382025064765, "cardiovascular event rate": 0.0029509783031824136, "high sst2 treated": 0.002597413370843258, "multiparametric echocardiographic score": 0.0033586542377857967, "global longitudinal strain": 0.0029869347922947, "left atrial area": 0.0025418343571277273, "newly diagnosed heart": 0.002791135833157442, "diagnosed heart failure": 0.0028745362991254055, "fold increased risk": 0.002699382025064765, "ventricular filling pressure": 0.003054874976948276, "mitral annulus velocity": 0.0028745362991254055, "pulmonary capillary wedge": 0.0029509783031824136, "capillary wedge pressure": 0.0029135538026188244, "good diagnostic performance": 0.003021534104319086, "annular plane systolic": 0.0028337841253784986, "plane systolic excursion": 0.0029135538026188244, "pulmonary arterial systolic": 0.003021534104319086, "arterial systolic pressure": 0.0029869347922947, "left anterior descending": 0.0029135538026188244, "heart rate reduction": 0.0027464063301550707, "effective arterial elastance": 0.003054874976948276, "ejection fraction \u226435": 0.002791135833157442, "fraction \u226435 %": 0.002419416387666344, "isolated hr reduction": 0.002791135833157442, "aortic valve replacement": 0.0029135538026188244, "exercise per week": 0.002597413370843258, "hand grip strength": 0.002649814658827989, "ventricular ejection time": 0.0029509783031824136, "higher serum levels": 0.002699382025064765, "higher furosemide dose": 0.0028337841253784986, "right atrial myxoma": 0.002699382025064765, "% confidence level": 0.002649814658827989, "vasopressin receptor antagonist": 0.0031481865984241955, "embryonic gene programs": 0.0028745362991254055, "median rate ratio": 0.002597413370843258, "adjusted hazard ratios": 0.0028337841253784986, "extended criteria cardiac": 0.0029509783031824136, "chronic kidney disease": 0.0028337841253784986, "magnetic resonance postcontrast": 0.0031481865984241955, "myocardial extracellular matrix": 0.0031481865984241955, "magnetic resonance t1": 0.002791135833157442, "pulmonary vascular resistance": 0.0030870457499222025, "heart magnetic resonance": 0.0029135538026188244, "mild heart failure": 0.002649814658827989, "clinical composite response": 0.003021534104319086, "underlying myocardial dd": 0.0029135538026188244, "longitudinal systolic strain": 0.003054874976948276, "- fatal stroke": 0.002419416387666344, "consecutive case series": 0.0028745362991254055, "e - wave": 0.0019063757678457953, "serum resistin levels": 0.002791135833157442, "aortic blood flow": 0.002597413370843258, "adenine nucleotides contents": 0.003054874976948276, "mitochondrial oxidative phosphorylation": 0.0033586542377857967, "oxidative phosphorylation capacity": 0.00323287196012519, "creatine kinase activity": 0.0029135538026188244, "preoperative renal dysfunction": 0.0031181257756461673, "artery bypass grafting": 0.0028337841253784986, "primary isolated cabg": 0.002791135833157442, "onset heart failure": 0.002699382025064765, "maladaptive cardiac remodelling": 0.0031481865984241955, "severe pulmonary hypertension": 0.0030870457499222025, "pulmonary hypertension patients": 0.0031481865984241955, "unfolded protein response": 0.0029509783031824136, "channel mrna splice": 0.002699382025064765, "mrna splice variants": 0.0027464063301550707, "acute right heart": 0.002597413370843258, "cardiac sympathetic activity": 0.003054874976948276, "stable heart failure": 0.0027464063301550707, "adrenergic receptor haplotype": 0.0030870457499222025, "dyssynchronous heart failure": 0.003054874976948276, "lean body mass": 0.002419416387666344, "clinical prediction rule": 0.0029135538026188244, "multivariate logistic regression": 0.003177292946409659, "logistic regression analysis": 0.003054874976948276, "worsening renal function": 0.0029135538026188244, "\u00b1 6 %": 0.0014754891515912068, "chinese herbal medicine": 0.0028745362991254055, "ventricular diastolic end": 0.0029509783031824136, "diastolic end diameter": 0.0028337841253784986, "acute care surgery": 0.002649814658827989, "refractory cardiogenic shock": 0.003054874976948276, "key health outcomes": 0.002699382025064765, "shuttle walk test": 0.002597413370843258, "functional electrical stimulation": 0.0032055035708695953, "minute walked distance": 0.0028337841253784986, "transforming growth factor": 0.0029869347922947, "mesenchymal transition markers": 0.0031181257756461673, "cardiac autonomic balance": 0.0029509783031824136, "worsening heart failure": 0.0028745362991254055, "early physician follow": 0.0028337841253784986, "proportional hazard models": 0.0029869347922947, "autonomic nervous system": 0.0029135538026188244, "\u03b2 - adrenoceptor": 0.0025418343571277273, "angiotensin receptor neprilysin": 0.0031481865984241955, "receptor neprilysin inhibitor": 0.0030870457499222025, "inappropriate implantable cardioverter": 0.0033348406143466967, "patients receiving carvedilol": 0.0030870457499222025, "% lower rate": 0.002278095213336893, "retrospective cohort study": 0.0029869347922947, "myosin heavy chain": 0.002649814658827989, "peripheral artery disease": 0.0029509783031824136, "health care system": 0.002649814658827989, "major public health": 0.002699382025064765, "public health problem": 0.002791135833157442, "heart failure samples": 0.002791135833157442, "functional enrichment analysis": 0.0031181257756461673, "early rhythm control": 0.0027464063301550707, "terminal heart failure": 0.0028337841253784986, "versus best quintile": 0.0027464063301550707, "combined end point": 0.002649814658827989, "global proteomics changes": 0.0029509783031824136, "ingenuity pathway analysis": 0.0029869347922947, "- acute care": 0.002278095213336893, "acute care transfer": 0.002699382025064765, "care transfer policy": 0.0027464063301550707, "without major complications": 0.003021534104319086, "across hospital volume": 0.0028337841253784986, "hospital volume groups": 0.0028337841253784986, "chronic advanced heart": 0.0028337841253784986, "infarction heart failure": 0.0029135538026188244, "primary study end": 0.002597413370843258, "kidney index score": 0.002649814658827989, "lower total expenditure": 0.0028745362991254055, "health per capita": 0.002597413370843258, "assisted gait therapy": 0.002791135833157442, "peak quadriceps force": 0.002791135833157442, "adverse events occurred": 0.0028745362991254055, "versus \u226570 bpm": 0.002419416387666344, "right interatrial shunting": 0.0029869347922947, "principle cohort study": 0.0028337841253784986, "min walk test": 0.0023514762030127675, "aerobic exercise training": 0.0029509783031824136, "obese older patients": 0.0027464063301550707, "- primary outcome": 0.002597413370843258, "heart failure disease": 0.002791135833157442, "failure disease management": 0.0029869347922947, "mortality in patients": 0.0023259465276312015, "associated with mortality": 0.0024591485859853444, "outcomes in patients": 0.002288671941795892, "treatment of heart": 0.0022081788823566577, "characteristics and outcomes": 0.002545729147456897, "safety and efficacy": 0.0022494850208873043, "patient population is": 0.0018607572221049612, "predictors of mortality": 0.0019163575327502704, "reduce the risk": 0.001655111457576157, "patients with preserved": 0.0019163575327502704, "survival of patients": 0.0018309375534367137, "effectiveness and safety": 0.001942369201745883, "in this study": 0.0015676508020085118, "quality of care": 0.001655111457576157, "death or hospitalization": 0.001942369201745883, "compared with metoprolol": 0.001942369201745883, "barriers to exercise": 0.0018309375534367137, "national efforts dedicated": 0.00149346739614735, "improve patient safety": 0.0014168920626892493, "patient safety remain": 0.001395567916578721, "assess national trends": 0.0014168920626892493, "conditions requiring surgery": 0.001527437488474138, "large study sample": 0.0013249073294139945, "hospital adverse events": 0.0014372681495627027, "adverse events averted": 0.0014168920626892493, "measurable overall improvements": 0.0015740932992120977, "considerable national attention": 0.0015740932992120977, "national patient safety": 0.0014372681495627027, "patient safety initiatives": 0.00149346739614735, "cross - talk": 0.0011390476066684464, "cachectic heart failure": 0.0014372681495627027, "increased energy expenditure": 0.001527437488474138, "b natriuretic peptides": 0.0014168920626892493, "tested the hypothesis": 0.001395567916578721, "fat free mass": 0.0011757381015063838, "body fat distribution": 0.001395567916578721, "dual energy x": 0.0011757381015063838, "- diabetic patients": 0.0013496910125323826, "- cachectic chf": 0.0012413335931821176, "prior myocardial infarction": 0.001510767052159543, "stable body weight": 0.0013249073294139945, "diagnosis of heart": 0.0013249073294139945, "heart failure show": 0.0013249073294139945, "major underlying mechanism": 0.00149346739614735, "clinical diastolic dysfunction": 0.0015590628878230837, "diastolic dysfunction leading": 0.0015435228749611013, "guidelines based definition": 0.001510767052159543, "dilated left ventricle": 0.0014168920626892493, "treatment of anemia": 0.0013496910125323826, "clinical practice guideline": 0.001510767052159543, "provide clinical recommendations": 0.0015886464732048295, "guideline included mortality": 0.001527437488474138, "heart failure exacerbation": 0.00149346739614735, "venous thromboembolic events": 0.001527437488474138, "ischemic cerebrovascular events": 0.0015740932992120977, "target patient population": 0.0014754891515912068, "deficient adult patients": 0.0014567769013094122, "clinical practice guidelines": 0.001527437488474138, "practice guidelines grading": 0.001510767052159543, "guidelines grading system": 0.0014754891515912068, "restrictive red blood": 0.001395567916578721, "red blood cell": 0.001209708193833172, "blood cell transfusion": 0.0014168920626892493, "cell transfusion strategy": 0.0014754891515912068, "trigger hemoglobin threshold": 0.001527437488474138, "higher hemoglobin levels": 0.0014567769013094122, "clinical trial registries": 0.0014754891515912068, "observational studies suggests": 0.0015590628878230837, "liberal transfusion protocols": 0.0015435228749611013, "term mortality rates": 0.0013732031650775353, "less aggressive protocols": 0.0014754891515912068, "combined relative risk": 0.0014168920626892493, "risk among trials": 0.001298706685421629, "decreased mortality rates": 0.0014754891515912068, "acute coronary syndrome": 0.0014372681495627027, "intravenous iron found": 0.0014168920626892493, "term exercise tolerance": 0.0014372681495627027, "stimulating agent therapy": 0.0014754891515912068, "data supporting iron": 0.0013732031650775353, "supporting iron use": 0.0013496910125323826, "higher transfusion thresholds": 0.0015435228749611013, "consistently improve mortality": 0.0015590628878230837, "improve mortality rates": 0.0014372681495627027, "remote ischemic conditioning": 0.001527437488474138, "heart failure clinical": 0.0014168920626892493, "failure clinical trials": 0.0014372681495627027, "enriching patient identification": 0.0015886464732048295, "modern acute heart": 0.0013249073294139945, "appropriate risk stratification": 0.0015740932992120977, "implantable cardiac defibrillator": 0.0016027517854347976, "many current predictors": 0.0014372681495627027, "reviewers selected citations": 0.001527437488474138, "using multivariable regression": 0.0015590628878230837, "baseline glomerular filtration": 0.0015590628878230837, "10 % increase": 0.0011757381015063838, "strong reliable mortality": 0.0014754891515912068, "reliable mortality predictors": 0.0015435228749611013, "failure randomized trial": 0.0014567769013094122, "small studies suggest": 0.001395567916578721, "function in patients": 0.0013732031650775353, "min without bolus": 0.001298706685421629, "controlled clinical trial": 0.0014754891515912068, "1:1 allocation ratio": 0.0013732031650775353, "pooled placebo group": 0.0013732031650775353, "decongestion end point": 0.0014168920626892493, "serum cystatin c": 0.0012709171785638637, "renal function end": 0.0013249073294139945, "function end point": 0.0013249073294139945, "secondary end points": 0.0013732031650775353, "end points reflective": 0.001395567916578721, "conclusion and relevance": 0.0014567769013094122, "nesiritide enhanced decongestion": 0.0015886464732048295, "improved renal function": 0.0014372681495627027, "heart failure guidelines": 0.0014567769013094122, "many multisite studies": 0.0014168920626892493, "improving patient outcomes": 0.00149346739614735, "specific research questions": 0.001510767052159543, "utilizing voluntary testimonies": 0.0015740932992120977, "extend beyond meeting": 0.001395567916578721, "beyond meeting magnet": 0.001395567916578721, "cardiac chromatin identifies": 0.001527437488474138, "chromatin identifies nucleolin": 0.0015590628878230837, "failure involves changes": 0.0014567769013094122, "global gene expression": 0.0014168920626892493, "coordinate dna accessibility": 0.001527437488474138, "accompany heart failure": 0.0014372681495627027, "present study tests": 0.0013496910125323826, "conserved developmental chromatin": 0.0016027517854347976, "developmental chromatin remodeling": 0.001616435980062595, "chromatin remodeling events": 0.001510767052159543, "used quantitative proteomics": 0.001527437488474138, "extracted via detergent": 0.0014372681495627027, "using strong acid": 0.001298706685421629, "exhibited altered expression": 0.001527437488474138, "extensive functional characterization": 0.0016551959433262922, "nearly abolished protein": 0.0014567769013094122, "abolished protein expression": 0.001527437488474138, "gross morphological development": 0.0015740932992120977, "severe developmental impairment": 0.0015740932992120977, "abnormal chamber patterning": 0.001510767052159543, "bone morphogenetic protein": 0.00149346739614735, "protein 4 expression": 0.0013732031650775353, "decreased rrna transcription": 0.001527437488474138, "new chromatin subproteome": 0.0014754891515912068, "diseased mouse heart": 0.0013732031650775353, "complementary model system": 0.00149346739614735, "genomic reprogramming events": 0.001527437488474138, "myocardial ischemic events": 0.00149346739614735, "events in patients": 0.0013249073294139945, "limited data regarding": 0.0014168920626892493, "data regarding risk": 0.0013496910125323826, "regarding risk factors": 0.0014168920626892493, "present study population": 0.0014567769013094122, "proportional hazards regression": 0.0015740932992120977, "identify risk factors": 0.001395567916578721, "included previous revascularization": 0.0016297234749878095, "artery bypass surgery": 0.001395567916578721, "percutaneous coronary intervention": 0.001616435980062595, "increased systolic blood": 0.0014567769013094122, "branch block pattern": 0.0013732031650775353, "dependent analysis showed": 0.0014754891515912068, "contemporary heart failure": 0.00149346739614735, "increased increase rate": 0.0014372681495627027, "interaction term analysis": 0.0014754891515912068, "patients \u226475 years": 0.0013249073294139945, "older age group": 0.0012413335931821176, "associated with outcome": 0.0014372681495627027, "cd133 + cells": 0.0011757381015063838, "increased functional capacity": 0.0015435228749611013, "patients without diabetes": 0.0014754891515912068, "noted differential relations": 0.001527437488474138, "three readmission metrics": 0.0014754891515912068, "day readmission rates": 0.001395567916578721, "three disease groups": 0.0013732031650775353, "average hospital rates": 0.0014168920626892493, "extreme decile according": 0.0014567769013094122, "correlations among metrics": 0.00149346739614735, "hospital longitudinal change": 0.001527437488474138, "produce different hospital": 0.00149346739614735, "different hospital rankings": 0.001510767052159543, "readmission metric choice": 0.0014754891515912068, "deliver specialised care": 0.0014567769013094122, "heart failure population": 0.0014567769013094122, "strategies improve outcomes": 0.001510767052159543, "searching relevant articles": 0.001510767052159543, "observational cohort studies": 0.001527437488474138, "contemporaneous control group": 0.0015435228749611013, "interventions included home": 0.001510767052159543, "included home telemonitoring": 0.001527437488474138, "structured telephone support": 0.001527437488474138, "delivered via human": 0.0013496910125323826, "reaching statitistical significance": 0.0016297234749878095, "% credible interval": 0.0013496910125323826, "generally improved health": 0.0014754891515912068, "showed beneficial trends": 0.0014567769013094122, "recently discharged patients": 0.001527437488474138, "induced dilated cardiomyopathy": 0.0015590628878230837, "right ventricular pacing": 0.0014567769013094122, "interventricular septum biopsies": 0.0015886464732048295, "21 beagle dogs": 0.001209708193833172, "development of heart": 0.0013732031650775353, "evaluated protein levels": 0.0014567769013094122, "moderate heart failure": 0.0014168920626892493, "pump sternal sparing": 0.0013732031650775353, "sternal sparing approach": 0.0014567769013094122, "dysfunction requiring pump": 0.00149346739614735, "requiring pump replacement": 0.00149346739614735, "isolated pump replacement": 0.0014754891515912068, "angiotensin system blocker": 0.00149346739614735, "hospitalized for heart": 0.0014168920626892493, "in ambulatory patients": 0.0014168920626892493, "in consecutive patients": 0.0014372681495627027, "blocker dose changes": 0.0013732031650775353, "blocker dose increase": 0.001395567916578721, "compared with patients": 0.0014168920626892493, "patients without uptitration": 0.001527437488474138, "higher heart rate": 0.001298706685421629, "better renal function": 0.001395567916578721, "- blocker uptitration": 0.001395567916578721, "low co -": 0.0009531878839228976, "- morbidity burden": 0.0013249073294139945, "predicts clinical outcome": 0.0014754891515912068, "explored sex differences": 0.0014567769013094122, "determine prognostic significance": 0.0016027517854347976, "patients with reduced": 0.001395567916578721, "compute odds ratios": 0.0013496910125323826, "37 % female": 0.0010991627680482835, "48 % female": 0.0010991627680482835, "65 % female": 0.0010991627680482835, "higher admission median": 0.0014372681495627027, "difference among reduced": 0.0014567769013094122, "difference among preserved": 0.00149346739614735, "women vs men": 0.0011390476066684464, "article presents guidelines": 0.001510767052159543, "early medical management": 0.0014567769013094122, "emergency room practice": 0.0014372681495627027, "undiagnosed heart disease": 0.0014754891515912068, "received surgical palliation": 0.001527437488474138, "advanced management involving": 0.0015435228749611013, "involving ventricular assist": 0.001527437488474138, "elderly patients hospitalized": 0.0015435228749611013, "consecutive patients seen": 0.0014754891515912068, "determined chf visit": 0.0013732031650775353, "chf visit rates": 0.0012413335931821176, "performed regression analyses": 0.0015435228749611013, "\u00b1 14 years": 0.0010554738704365695, "heart failure visits": 0.0013732031650775353, "% relative decrease": 0.0013496910125323826, "annual ed visits": 0.0012709171785638637, "better chf treatments": 0.001395567916578721, "systolic ventricular function": 0.0015435228749611013, "significant liver disease": 0.0014754891515912068, "traditional heart failure": 0.0014754891515912068, "low systemic vascular": 0.001395567916578721, "preserved cardiac index": 0.0014372681495627027, "case cohort analysis": 0.0013732031650775353, "mean catheterization findings": 0.0015435228749611013, "central venous pressure": 0.0014372681495627027, "pressure 18 \u00b1": 0.0011757381015063838, "\u00b1 3 mm": 0.0008213183120274803, "index 2.7 \u00b1": 0.0010991627680482835, "\u00b1 0.7 l": 0.0008919788991922065, "abnormal liver texture": 0.0014168920626892493, "liver texture changes": 0.001395567916578721, "similar cardiac index": 0.001395567916578721, "cardiac index compared": 0.0014168920626892493, "distinct circulatory derangement": 0.0015886464732048295, "hemodynamic features similar": 0.001527437488474138, "augment cardiac output": 0.0014168920626892493, "hospitalization or death": 0.0014567769013094122, "versus without preserved": 0.0014567769013094122, "outcome of death": 0.0012709171785638637, "final multivariate models": 0.0014754891515912068, "80 % adherence": 0.001209708193833172, "co - morbidities": 0.0012709171785638637, "training in patients": 0.0013732031650775353, "failure promotes restoration": 0.001527437488474138, "density lipoprotein functional": 0.0015590628878230837, "lipoprotein functional properties": 0.0016027517854347976, "effects via stimulation": 0.0014372681495627027, "mediated protective effects": 0.001510767052159543, "respective molecular pathways": 0.0015435228749611013, "in healthy individuals": 0.0014168920626892493, "significantly improved hdl": 0.00149346739614735, "improved hdl function": 0.001395567916578721, "mediated dilatation improvement": 0.0015740932992120977, "mediated vascular effects": 0.0014754891515912068, "exerts beneficial effects": 0.0014754891515912068, "time of admission": 0.001298706685421629, "first research done": 0.0013496910125323826, "\u00b1 10.3 years": 0.0011390476066684464, "non - survivors": 0.0012413335931821176, "\u00b1 11.07 years": 0.0011757381015063838, "85.9 % sensitivity": 0.0013249073294139945, "39.1 % specificity": 0.0013249073294139945, "optimal cutoff level": 0.0013732031650775353, "novel heart failure": 0.0013496910125323826, "heart failure mice": 0.0013249073294139945, "failure mice model": 0.0013249073294139945, "mouse heart failure": 0.0013496910125323826, "new therapeutic targets": 0.0014372681495627027, "simple experimental procedures": 0.0015590628878230837, "combining salt loading": 0.0014168920626892493, "showed significant decreases": 0.001527437488474138, "infusion mouse model": 0.0013732031650775353, "predict heart failure": 0.001395567916578721, "various cardiovascular diseases": 0.0015740932992120977, "cardiac troponin t": 0.0013249073294139945, "antihypertensive medication use": 0.0015740932992120977, "prevalent coronary heart": 0.0014567769013094122, "participants developed incident": 0.0015740932992120977, "simpler laboratory report": 0.0014754891515912068, "laboratory report model": 0.0014372681495627027, "clinical characteristics results": 0.0015886464732048295, "right ventricular support": 0.0014754891515912068, "chronic decompensated heart": 0.001510767052159543, "decompensated heart failure": 0.001510767052159543, "hybrid system consisting": 0.0014567769013094122, "requiring isolated lvad": 0.0014372681495627027, "required biventricular support": 0.0015590628878230837, "\u00b1 11.9 days": 0.0010991627680482835, "however biventricular dysfunction": 0.0016027517854347976, "assist device use": 0.001298706685421629, "using simulation models": 0.0014372681495627027, "studies per outcome": 0.0013496910125323826, "made policy recommendations": 0.001510767052159543, "meet traditional cost": 0.001395567916578721, "using historical data": 0.001395567916578721, "number of patients": 0.0013249073294139945, "canadian data point": 0.0013496910125323826, "left heart twist": 0.0012709171785638637, "improves cardiac output": 0.0014372681495627027, "selected cardiac surgery": 0.0014567769013094122, "cardiac surgery patients": 0.0014567769013094122, "used speckle tracking": 0.001395567916578721, "speckle tracking echocardiography": 0.0016027517854347976, "right ventricular pressure": 0.00149346739614735, "ventricular pressure overload": 0.0015435228749611013, "inferior vena cava": 0.0013249073294139945, "pulmonary artery snared": 0.0014372681495627027, "ventricular midpapillary level": 0.0015590628878230837, "varying atrioventricular delay": 0.0015590628878230837, "regional circumferential strain": 0.0015740932992120977, "left ventricular base": 0.001395567916578721, "mixed linear models": 0.0013496910125323826, "free wall rs": 0.0011390476066684464, "open chest model": 0.0012709171785638637, "varying regional strain": 0.0014372681495627027, "regional strain contributions": 0.0015435228749611013, "reflect postsystolic function": 0.0015435228749611013, "treatment for heart": 0.0013496910125323826, "successful mitral valve": 0.0014372681495627027, "degenerative mitral regurgitation": 0.0016027517854347976, "mild mitral regurgitation": 0.0014754891515912068, "significant mitral stenosis": 0.001510767052159543, "degenerative mitral valve": 0.0014754891515912068, "third heart sound": 0.001298706685421629, "underwent mitral valve": 0.0014168920626892493, "2 chordal ruptures": 0.0013249073294139945, "underwent triangular resection": 0.0015590628878230837, "postoperative echocardiography confirmed": 0.0016909324597185011, "preserved mitral valve": 0.0014168920626892493, "mitral valve area": 0.001298706685421629, "filling flow volume": 0.0013496910125323826, "\u00d7 velocity time": 0.0012413335931821176, "velocity time integral": 0.0014168920626892493, "without major concerns": 0.0014168920626892493, "limited mitral valve": 0.0013732031650775353, "coronary angiography revealed": 0.0015435228749611013, "diastolic mitral leaflet": 0.0014567769013094122, "mitral leaflet motions": 0.0014168920626892493, "cardiac murmurs disappeared": 0.001510767052159543, "echocardiography 4 months": 0.0014754891515912068, "surgical ring implantation": 0.00149346739614735, "reports demonstrating development": 0.0016027517854347976, "following ring annuloplasty": 0.001510767052159543, "surgical indications need": 0.0014754891515912068, "fixed ring size": 0.0012413335931821176, "requires careful evaluation": 0.001510767052159543, "heart failure clinic": 0.0013732031650775353, "failure clinic outpatients": 0.00149346739614735, "most heart failure": 0.0013249073294139945, "risk stratification models": 0.00149346739614735, "available outpatient models": 0.001510767052159543, "collected clinical data": 0.0014372681495627027, "quality improvement database": 0.001527437488474138, "reached primary outcome": 0.0014372681495627027, "arbitrary start date": 0.0013732031650775353, "model included blood": 0.0013732031650775353, "included blood urea": 0.0013496910125323826, "blood urea nitrogen": 0.0013496910125323826, "concordance c statistics": 0.0014567769013094122, "demonstrated excellent risk": 0.001510767052159543, "excellent risk stratification": 0.0015435228749611013, "readily available data": 0.0014168920626892493, "resources within health": 0.0014372681495627027, "within health systems": 0.001395567916578721, "important prognostic factor": 0.001510767052159543, "composite end point": 0.0013496910125323826, "uncontrolled hypertension identify": 0.001616435980062595, "hypertension identify patients": 0.0015590628878230837, "commonly used criterion": 0.0014372681495627027, "used criterion standard": 0.0014372681495627027, "using spearman correlations": 0.001510767052159543, "category among patients": 0.0014372681495627027, "high internal consistency": 0.0014754891515912068, "consistency among patients": 0.00149346739614735, "excellent prognostic ability": 0.001527437488474138, "interleukin receptor family": 0.001510767052159543, "receptor family member": 0.0014168920626892493, "affect sst2 concentrations": 0.00149346739614735, "concentrations identify benefit": 0.0015740932992120977, "heart failure attributable": 0.00149346739614735, "ventricular systolic dysfunction": 0.0015886464732048295, "post hoc analysis": 0.001298706685421629, "baseline sst2 status": 0.0013732031650775353, "daily equivalent dose": 0.001395567916578721, "low sst2 titrated": 0.001298706685421629, "lowest cardiovascular event": 0.001510767052159543, "lowest cumulative hazard": 0.0014567769013094122, "highest cardiovascular event": 0.001527437488474138, "highest cumulative hazard": 0.0014754891515912068, "intermediate odds ratios": 0.0014567769013094122, "therapy exerted dose": 0.0013732031650775353, "measurement identifies patients": 0.0015740932992120977, "exerts positive inotropic": 0.0014754891515912068, "in adult mouse": 0.001209708193833172, "adult mouse ventricular": 0.0014372681495627027, "mouse ventricular myocytes": 0.00149346739614735, "dependently increased sarcomere": 0.0015740932992120977, "protein kinase a": 0.0012709171785638637, "soluble guanylate cyclase": 0.0014754891515912068, "left ventricular end": 0.0013732031650775353, "myocardial oxygen consumption": 0.0015435228749611013, "increasing ejection fraction": 0.001527437488474138, "maximal ventricular power": 0.0014754891515912068, "ventricular power index": 0.0014372681495627027, "in conscious dogs": 0.001298706685421629, "provided venoarterial dilation": 0.0015590628878230837, "right heart filling": 0.0013496910125323826, "heart filling pressures": 0.0014372681495627027, "stroke volume index": 0.0013496910125323826, "arterial pressure declined": 0.00149346739614735, "enhance myocardial function": 0.001510767052159543, "involved single parameters": 0.00149346739614735, "standard echocardiographic measurements": 0.0016793271188928983, "underwent baseline echocardiography": 0.0016297234749878095, "\u226515 % reduction": 0.0012413335931821176, "months of follow": 0.0012709171785638637, "lv reverse remodeling": 0.001395567916578721, "diastolic dimension index": 0.0014754891515912068, "right ventricular end": 0.001395567916578721, "diastolic area index": 0.0013732031650775353, "right atrial area": 0.001298706685421629, "ventricular fractional area": 0.001510767052159543, "fractional area change": 0.0014168920626892493, "change \u226535 %": 0.0011390476066684464, "echocardiographic score allowed": 0.0015740932992120977, "score allowed prediction": 0.0014567769013094122, "18 heart transplantations": 0.0014754891515912068, "lv assist device": 0.0012709171785638637, "assist device implantations": 0.001510767052159543, "93 heart failure": 0.0012709171785638637, "heart failure admissions": 0.0014567769013094122, "heart failure admission": 0.0014372681495627027, "initial functional class": 0.0014567769013094122, "undergo reverse remodeling": 0.00149346739614735, "predicts clinical outcomes": 0.00149346739614735, "symptomatic systolic heart": 0.00149346739614735, "diagnosed systolic heart": 0.0014567769013094122, "previous spironolactone use": 0.001510767052159543, "baseline serum creatinine": 0.0014754891515912068, "serum creatinine level": 0.0014168920626892493, "serum potassium level": 0.001395567916578721, "incident systolic heart": 0.0014372681495627027, "growth factor blockade": 0.0014168920626892493, "adrenergic receptor blocker": 0.001510767052159543, "receptor blocker therapy": 0.0014567769013094122, "improve myocardial perfusion": 0.001527437488474138, "induced myocardial infarction": 0.0015435228749611013, "heart failure rats": 0.0013249073294139945, "week treatment period": 0.001395567916578721, "reduced cardiac diameters": 0.0014754891515912068, "improved cardiac function": 0.0014754891515912068, "increased cardiac angiogenesis": 0.0015590628878230837, "vivo coronary perfusion": 0.0014372681495627027, "reduced cardiac fibrosis": 0.0014567769013094122, "untreated failing hearts": 0.0014567769013094122, "act via activation": 0.0013249073294139945, "adenoviral vector encoding": 0.00149346739614735, "histological analysis revealed": 0.0015590628878230837, "treated plus ad": 0.0012413335931821176, "promotes cardiac angiogenesis": 0.0015435228749611013, "failure via activation": 0.0014168920626892493, "emergency department volume": 0.001510767052159543, "influences patient outcomes": 0.001510767052159543, "925 ed visits": 0.0011757381015063838, "exhibited higher risk": 0.001395567916578721, "exhibited worse outcomes": 0.0014567769013094122, "repeat ed visits": 0.0012709171785638637, "oxidase inhibition preserves": 0.001527437488474138, "left ventricular systolic": 0.0014754891515912068, "cardiac volume overload": 0.0014372681495627027, "decrease mitochondrial respiration": 0.001616435980062595, "inhibition improves cardiomyocyte": 0.0016027517854347976, "improves cardiomyocyte bioenergetics": 0.0016426366240549605, "acf \u00b1 allopurinol": 0.001298706685421629, "37 % increase": 0.0011757381015063838, "lv ejection fraction": 0.0013732031650775353, "maximal systolic elastance": 0.00149346739614735, "isolated cardiomyocytes using": 0.0015435228749611013, "extracellular flux analyzer": 0.001510767052159543, "hospitalizations in patients": 0.001527437488474138, "severe systolic heart": 0.001395567916578721, "early transmitral blood": 0.0014372681495627027, "transmitral blood flow": 0.0014168920626892493, "blood flow velocity": 0.0013496910125323826, "diastolic mitral annulus": 0.0014567769013094122, "decompensated systolic heart": 0.001527437488474138, "sided cardiac catheterization": 0.0015435228749611013, "transmitral flow velocities": 0.001510767052159543, "mitral annulus velocities": 0.0014754891515912068, "\u00b1 8 %": 0.0007377445757956034, "negative predictive value": 0.0014754891515912068, "negative likelihood ratio": 0.0014754891515912068, "detecting normal filling": 0.0014567769013094122, "normal filling pressures": 0.0014567769013094122, "systolic pressure relationship": 0.0015590628878230837, "ventricular contractile function": 0.0015886464732048295, "derived pulmonary arterial": 0.00149346739614735, "tricuspid annular plane": 0.0014372681495627027, "better disclosing prognosis": 0.001510767052159543, "natriuretic peptide assessment": 0.0015590628878230837, "downward regression line": 0.0014567769013094122, "regression line shift": 0.001395567916578721, "improves prognostic resolution": 0.0015590628878230837, "bottleneck stent model": 0.0014168920626892493, "large animal model": 0.0013249073294139945, "novel therapeutic approaches": 0.001527437488474138, "novel percutaneous one-": 0.0014372681495627027, "myocardial ischemia using": 0.0014754891515912068, "proximal circumflex artery": 0.00149346739614735, "given antiarrhythmic medication": 0.0015740932992120977, "prevent sudden death": 0.0013732031650775353, "fractional flow reserve": 0.0014372681495627027, "flow reserve measurements": 0.0014754891515912068, "positron emission tomography": 0.001527437488474138, "emission tomography imaging": 0.001510767052159543, "showed severe ischemia": 0.0014168920626892493, "complete coronary occlusion": 0.001510767052159543, "significant collateral growth": 0.0015435228749611013, "competitive collateral growth": 0.0015435228749611013, "collateral growth patterns": 0.00149346739614735, "model 4 wk": 0.0010554738704365695, "vessel disease model": 0.0013732031650775353, "novel bottleneck stent": 0.0014168920626892493, "novel porcine model": 0.0013496910125323826, "reversible myocardial ischemia": 0.0015590628878230837, "new therapeutic approaches": 0.00149346739614735, "selective heart rate": 0.0013732031650775353, "isolated heart rate": 0.0013496910125323826, "ivabradine reduces afterload": 0.001527437488474138, "pressure volume relation": 0.0014567769013094122, "ivabradine 7.5 mg": 0.001298706685421629, "total arterial compliance": 0.0014754891515912068, "ivabradine improves tac": 0.0014372681495627027, "preoperative serum albumin": 0.00149346739614735, "serum albumin levels": 0.0013732031650775353, "investigate the association": 0.001510767052159543, "consecutive patients undergoing": 0.0015740932992120977, "preoperative clinical characteristics": 0.0016551959433262922, "normal albumin concentration": 0.001527437488474138, "normal albumin levels": 0.001395567916578721, "albumin levels compared": 0.0014372681495627027, "decreasing albumin levels": 0.0014754891515912068, "aortic valve insufficiency": 0.00149346739614735, "onset aortic insufficiency": 0.00149346739614735, "mechanical circulatory support": 0.0015590628878230837, "underwent aortic valve": 0.0014168920626892493, "aortic valve surgery": 0.0013732031650775353, "patients underwent lvad": 0.0014372681495627027, "underwent lvad implantation": 0.001510767052159543, "requiring surgical intervention": 0.0015740932992120977, "after medical therapy": 0.001395567916578721, "aortic valve procedures": 0.0014372681495627027, "bioprosthetic valve replacement": 0.0015740932992120977, "1 dacron patch": 0.001209708193833172, "dacron patch closure": 0.0013732031650775353, "aortic valve repairs": 0.0013732031650775353, "patients underwent transcatheter": 0.0015886464732048295, "transcatheter aortic valve": 0.00149346739614735, "aortic valve procedure": 0.0014168920626892493, "experienced significant improvement": 0.0016297234749878095, "aortic valve oversewing": 0.0014372681495627027, "bioprosthetic aortic valve": 0.00149346739614735, "restoring functional capacity": 0.0015435228749611013, "various transcatheter approaches": 0.0015886464732048295, "less invasive alternatives": 0.00149346739614735, "5 age groups": 0.0011390476066684464, "youngest age group": 0.0013249073294139945, "year mortality rates": 0.0013732031650775353, "respective age categories": 0.0014754891515912068, "referent age group": 0.0013249073294139945, "beyond divergent etiology": 0.0014754891515912068, "younger patients exhibited": 0.00149346739614735, "higher hospitalization rates": 0.001527437488474138, "within cardiac rehabilitation": 0.0015435228749611013, "\u00b1 11.4 years": 0.0011390476066684464, "functional capacity assessed": 0.001527437488474138, "nordic walking led": 0.0013249073294139945, "higher functional capacity": 0.00149346739614735, "reported physical activity": 0.00149346739614735, "\u00b1 118.5 minutes": 0.0012413335931821176, "\u00b1 125.6 minutes": 0.0012413335931821176, "increased right grip": 0.0013732031650775353, "right grip strength": 0.0013496910125323826, "\u00b1 3.5 kg": 0.0009531878839228976, "\u00b1 3.1 kg": 0.0009531878839228976, "fewer depressive symptoms": 0.0014754891515912068, "peak aerobic capacity": 0.001395567916578721, "improving functional capacity": 0.0015435228749611013, "precapillary pulmonary hypertension": 0.0016297234749878095, "experiencing heart failure": 0.00149346739614735, "major right ventricle": 0.001395567916578721, "right ventricle overload": 0.0014567769013094122, "decreased stroke volume": 0.0014372681495627027, "arterial tonometry study": 0.0014567769013094122, "carries prognostic value": 0.0014567769013094122, "radial artery tonometry": 0.0014372681495627027, "artery tonometry variables": 0.00149346739614735, "reconstructed aortic pressure": 0.0015435228749611013, "aortic pressure curve": 0.001395567916578721, "73 % sensitivity": 0.0012709171785638637, "89 % specificity": 0.0012709171785638637, "other prognostic factors": 0.0014567769013094122, "higher oxygen flow": 0.0013249073294139945, "documented prognostic factors": 0.0015435228749611013, "atrial myxoma complicated": 0.0014754891515912068, "cardiac benign tumors": 0.001395567916578721, "pulmonary arterial vasculature": 0.0015590628878230837, "pulmonary arteries treated": 0.00149346739614735, "right atrial mass": 0.001298706685421629, "atrial mass removal": 0.0013496910125323826, "right atrium mass": 0.001298706685421629, "left pulmonary artery": 0.001395567916578721, "right pulmonary artery": 0.0014168920626892493, "surgical tactics included": 0.0014754891515912068, "hypothermic circulatory arrest": 0.0015590628878230837, "advanced chronic organ": 0.0014168920626892493, "chronic organ failure": 0.001395567916578721, "chronic renal failure": 0.001395567916578721, "64 % men": 0.0009531878839228976, "median body mass": 0.0012709171785638637, "intraclass correlation coefficient": 0.001616435980062595, "error of measurement": 0.0013732031650775353, "minimal detectable change": 0.0014754891515912068, "statistical improvement occurred": 0.0015886464732048295, "third trial added": 0.001298706685421629, "similar values found": 0.0013732031650775353, "daily clinical practice": 0.0014372681495627027, "represents true change": 0.0014168920626892493, "risk among patients": 0.0013496910125323826, "rheumatoid arthritis starting": 0.0015435228749611013, "tumor necrosis factor": 0.001395567916578721, "treat rheumatoid arthritis": 0.00149346739614735, "- biological disease": 0.0013732031650775353, "biological disease modifying": 0.001527437488474138, "modifying antirheumatic drug": 0.001527437488474138, "propensity score decile": 0.0014372681495627027, "oral glucocorticoid dosage": 0.00149346739614735, "similar baseline covariates": 0.001510767052159543, "1\u22645 mg hr": 0.001007178034773029, "current economic climate": 0.0014567769013094122, "within acute hospital": 0.001395567916578721, "acute hospital facilities": 0.0014754891515912068, "specific health interventions": 0.0015435228749611013, "structured exercise programme": 0.0015435228749611013, "secondary outcome measures": 0.00149346739614735, "intervention post study": 0.0014372681495627027, "overall significant improvements": 0.0015886464732048295, "demonstrated significant improvements": 0.0016551959433262922, "showing minor improvement": 0.0014754891515912068, "participant satisfaction responses": 0.001616435980062595, "body composition study": 0.0014168920626892493, "adverse health outcomes": 0.0014372681495627027, "\u00b1 3 years": 0.001007178034773029, "- frail participants": 0.0013732031650775353, "per sd decrease": 0.0012413335931821176, "sub - groups": 0.0011390476066684464, "activated neurohormonal systems": 0.0015740932992120977, "sympathetic nervous systems": 0.001510767052159543, "improved clinical outcomes": 0.00149346739614735, "various physiologic processes": 0.0015435228749611013, "receptor antagonist therapy": 0.001510767052159543, "new therapeutic approach": 0.0014567769013094122, "pathological heart disease": 0.00149346739614735, "mutant mice overexpressing": 0.00149346739614735, "otherwise healthy heart": 0.0014372681495627027, "healthy heart muscle": 0.0013732031650775353, "heart muscle cells": 0.0013249073294139945, "fetal gene program": 0.0013249073294139945, "specific antagomir evoked": 0.0014754891515912068, "spontaneous cardiac dysfunction": 0.0015740932992120977, "bhlh transcription factor": 0.0014754891515912068, "postnatal mammalian myocardium": 0.0015590628878230837, "programs in heart": 0.001298706685421629, "enzyme inhibitors intolerance": 0.0015435228749611013, "beta receptor blockers": 0.0014168920626892493, "negative inotropic effect": 0.0014754891515912068, "past decades several": 0.0013732031650775353, "decades several studies": 0.0014372681495627027, "blockers decrease mortality": 0.001510767052159543, "causes heart failure": 0.0013732031650775353, "insulin receptor substrates": 0.001510767052159543, "regulating cellular metabolism": 0.0015590628878230837, "causes myocardial insulin": 0.0014754891515912068, "myocardial insulin resistance": 0.0015435228749611013, "reduced ventricular mass": 0.0014567769013094122, "developed cardiac apoptosis": 0.001510767052159543, "box class o-1": 0.0011757381015063838, "impaired cardiac metabolic": 0.00149346739614735, "cardiac metabolic gene": 0.0014168920626892493, "metabolic gene expression": 0.0014754891515912068, "impaired cardiac energy": 0.0014372681495627027, "cardiac energy metabolism": 0.0014754891515912068, "energy metabolism gene": 0.0014168920626892493, "metabolism gene expression": 0.00149346739614735, "activated protein kinase": 0.0014567769013094122, "using neonatal rat": 0.0013249073294139945, "neonatal rat ventricular": 0.0014567769013094122, "rat ventricular cardiomyocytes": 0.0015590628878230837, "chronic insulin exposure": 0.0014567769013094122, "prevented insulin action": 0.0014567769013094122, "medications among outpatients": 0.0015435228749611013, "combined treatment measure": 0.00149346739614735, "multivariable hierarchical regression": 0.0016551959433262922, "hierarchical regression models": 0.0015590628878230837, "randomly selected practices": 0.001510767052159543, "level prescription rates": 0.0014567769013094122, "adjusted median rate": 0.0013732031650775353, "receptor blockers therapy": 0.0014754891515912068, "care for patients": 0.001298706685421629, "adjuvant setting improves": 0.0014754891515912068, "setting improves outcomes": 0.0014754891515912068, "iii breast cancer": 0.001298706685421629, "included descriptive statistics": 0.0015740932992120977, "among trastuzumab users": 0.0014372681495627027, "weekly trastuzumab administration": 0.0016027517854347976, "older breast cancer": 0.0013496910125323826, "further studies need": 0.0013732031650775353, "current dietary recommendations": 0.0015740932992120977, "- hf populations": 0.0012709171785638637, "therefore evaluated associations": 0.0015886464732048295, "mortality among postmenopausal": 0.0015590628878230837, "among postmenopausal women": 0.00149346739614735, "last participant contact": 0.0014567769013094122, "calculate hazard ratios": 0.0014372681495627027, "dash diet score": 0.0012413335931821176, "diet score components": 0.001395567916578721, "whole grain intake": 0.0013249073294139945, "higher dash diet": 0.0012709171785638637, "modestly lower mortality": 0.0014567769013094122, "data provide support": 0.0013732031650775353, "dietary recommendations developed": 0.0016027517854347976, "potentially promising biomarker": 0.0015740932992120977, "term clinical outcomes": 0.0014168920626892493, "evaluable plasma samples": 0.0014567769013094122, "assess the relationship": 0.0014372681495627027, "in univariable analysis": 0.0014372681495627027, "in multivariable models": 0.0014372681495627027, "significantly affect reclassification": 0.0016551959433262922, "criteria cardiac transplantation": 0.0015886464732048295, "undergoing isolated heart": 0.0014754891515912068, "isolated heart transplant": 0.0014754891515912068, "cardiac transplant recipients": 0.0015435228749611013, "identify clinical variables": 0.001510767052159543, "clinical variables contributing": 0.0015740932992120977, "additional risk associated": 0.00149346739614735, "underwent heart transplant": 0.00149346739614735, "underwent standard criteria": 0.001510767052159543, "cardiac transplant survival": 0.001510767052159543, "included listing criteria": 0.0014754891515912068, "- transplant mortality": 0.0014168920626892493, "heart failure therapy": 0.001395567916578721, "- transplant morbidity": 0.0014168920626892493, "heart failure readmission": 0.0014754891515912068, "failure readmission quality": 0.001510767052159543, "readmission quality improvement": 0.0015740932992120977, "hospital quality improvement": 0.001527437488474138, "retrospective chart review": 0.00149346739614735, "heart failure discharges": 0.0014567769013094122, "heart failure nurse": 0.0013496910125323826, "failure nurse practitioner": 0.00149346739614735, "rate for patients": 0.001298706685421629, "extracellular matrix accumulation": 0.0016027517854347976, "extracellular matrix using": 0.00149346739614735, "resonance t1 mapping": 0.0013732031650775353, "confirmatory diagnostic tests": 0.0015435228749611013, "imaging including t1": 0.0013732031650775353, "including t1 mapping": 0.0013732031650775353, "invasive hemodynamic assessments": 0.0015886464732048295, "resonance t1 time": 0.001298706685421629, "left ventricular biopsies": 0.0014754891515912068, "pulmonary arterial coupling": 0.001510767052159543, "right ventricular ejection": 0.00149346739614735, "present preliminary study": 0.0014754891515912068, "abnormal cardiac t2": 0.0013496910125323826, "values determined changes": 0.0014754891515912068, "remove heart iron": 0.001298706685421629, "current guidelines recommend": 0.001527437488474138, "recommend cardiac resynchronization": 0.0016297234749878095, "severe systolic dysfunction": 0.001510767052159543, "blinded core laboratory": 0.0014372681495627027, "30 % subgroup": 0.0011757381015063838, "end systolic volume": 0.0013496910125323826, "systolic volume index": 0.001395567916578721, "\u00b1 17.6 ml": 0.001007178034773029, "\u00b1 42.4 g": 0.0009531878839228976, "time to death": 0.0011757381015063838, "reverse remodeling parameters": 0.0015435228749611013, "produced reverse remodeling": 0.001510767052159543, "similar clinical benefit": 0.0014567769013094122, "clinical benefit compared": 0.0014754891515912068, "myocardial titin hypophosphorylation": 0.0016426366240549605, "rat metabolic risk": 0.0013249073294139945, "metabolic risk model": 0.0013732031650775353, "important metabolic risk": 0.0014567769013094122, "metabolic risk factors": 0.0014168920626892493, "myocardial diastolic dysfunction": 0.0015886464732048295, "ejection fraction development": 0.0015435228749611013, "collagen cross -": 0.0012709171785638637, "fpassive)-sarcomere length relations": 0.0016426366240549605, "small muscle strips": 0.0013496910125323826, "increased lung weight": 0.001395567916578721, "left ventricular dd": 0.0013496910125323826, "high muscle strip": 0.001298706685421629, "muscle strip stiffness": 0.0014168920626892493, "elastic n2bus segment": 0.001395567916578721, "rats developed heart": 0.0013732031650775353, "week time span": 0.001209708193833172, "left ventricular mechanics": 0.00149346739614735, "predicting cv events": 0.0013732031650775353, "observational cohort study": 0.00149346739614735, "index beat method": 0.001298706685421629, "proportional hazards analyses": 0.0015435228749611013, "\u00b1 10 months": 0.0010991627680482835, "in direct comparison": 0.0013732031650775353, "systolic mitral annulus": 0.0014372681495627027, "containing chronic heart": 0.0014567769013094122, "prior stroke score": 0.0013249073294139945, "additional prognostic benefit": 0.0015435228749611013, "echocardiographic systolic parameters": 0.0016551959433262922, "scale clinical trial": 0.0013732031650775353, "receiving implantable cardioverter": 0.001616435980062595, "refractory congestive heart": 0.001510767052159543, "diuretic resistant volume": 0.0014754891515912068, "resistant volume overload": 0.0014754891515912068, "provide potential benefit": 0.0014754891515912068, "clinical status hospitalizations": 0.0015886464732048295, "transplant ineligible patients": 0.0015590628878230837, "ineligible patients receiving": 0.0015435228749611013, "clinical data reviewed": 0.0014168920626892493, "- pd initiation": 0.0012413335931821176, "\u00b1 6.0 %": 0.0008919788991922065, "right ventricular dysfunction": 0.0015435228749611013, "average weight loss": 0.0013496910125323826, "admissions per patient": 0.0014168920626892493, "reduced average length": 0.0014168920626892493, "\u00b1 2.3 days": 0.0010554738704365695, "objective criteriabased institution": 0.0016297234749878095, "diuretic refractory severe": 0.00149346739614735, "demonstrated favorable outcomes": 0.0015740932992120977, "improved clinical status": 0.0014567769013094122, "treatable pdrelated complications": 0.0016027517854347976, "stage congestive heart": 0.0014168920626892493, "potentially higher risks": 0.0014567769013094122, "bundle branch morphology": 0.0014567769013094122, "angiotensin ii receptor": 0.0014372681495627027, "ii receptor blocker": 0.0013496910125323826, "receptor blocker use": 0.0013732031650775353, "observed among dialysis": 0.0014372681495627027, "among dialysis patients": 0.0014372681495627027, "\u00b1 9.2 %": 0.0008919788991922065, "derived absolute improvements": 0.0015435228749611013, "year event rates": 0.0012709171785638637, "superior reverse remodeling": 0.001510767052159543, "\u00b1 9.5 %": 0.0008919788991922065, "9.5 % increase": 0.001209708193833172, "certain dialysis patients": 0.0014754891515912068, "demonstrated compelling improvement": 0.0016297234749878095, "worsened echocardiographic outcomes": 0.0016297234749878095, "sodium dash diet": 0.0012709171785638637, "improves diastolic function": 0.001510767052159543, "hypertensive heart failure": 0.00149346739614735, "dietary sodium restriction": 0.00149346739614735, "restricted dietary approaches": 0.0015435228749611013, "stop hypertension diet": 0.0014168920626892493, "central blood pressure": 0.0014168920626892493, "via radial arterial": 0.0013496910125323826, "radial arterial tonometry": 0.0014754891515912068, "parametrized diastolic filling": 0.0015590628878230837, "diastolic filling formalism": 0.001510767052159543, "mitral inflow velocity": 0.0014168920626892493, "previously published techniques": 0.0015740932992120977, "- post comparisons": 0.0013249073294139945, "brachial systolic pressure": 0.00149346739614735, "diastolic function improved": 0.001510767052159543, "\u00b1 8.1 g": 0.0008919788991922065, "\u00b1 37 g": 0.0008213183120274803, "restricted dash diet": 0.0013732031650775353, "humanized male mice": 0.0013496910125323826, "recent clinical studies": 0.0014372681495627027, "connected elevated resistin": 0.001510767052159543, "elevated resistin levels": 0.0014567769013094122, "humanized mouse model": 0.001395567916578721, "model lacking murine": 0.0013732031650775353, "lacking murine resistin": 0.0014372681495627027, "stimulated resistin levels": 0.00149346739614735, "resistin levels similar": 0.0014372681495627027, "- fold induction": 0.0012709171785638637, "expressing human resistin": 0.0014754891515912068, "cardiac mrna levels": 0.0013496910125323826, "cell adhesion genes": 0.0013496910125323826, "showed dramatic induction": 0.0014754891515912068, "also examined resistin": 0.0014168920626892493, "examined resistin levels": 0.0014567769013094122, "treated breast cancer": 0.001395567916578721, "women undergoing anthracycline": 0.0015590628878230837, "efficacy and safety": 0.0013496910125323826, "maintenance of sinus": 0.0013732031650775353, "free success rates": 0.0013249073294139945, "pharmaceutically assisted success": 0.0016027517854347976, "assisted success rate": 0.001395567916578721, "major complications occurred": 0.001527437488474138, "lv systolic indices": 0.0013496910125323826, "early transmitral flow": 0.0014168920626892493, "patients maintaining sinus": 0.00149346739614735, "maintaining sinus rhythm": 0.0014567769013094122, "larger randomized control": 0.0014754891515912068, "randomized control studies": 0.00149346739614735, "ameliorates mitochondrial dysfunction": 0.0016551959433262922, "- neoplastic agent": 0.0013249073294139945, "mitochondrial dysfunction induced": 0.0016027517854347976, "without doxorubicin treatment": 0.0015435228749611013, "caspase 3 expression": 0.0013732031650775353, "oxidative stress markers": 0.0014567769013094122, "mitochondrial oxidative stress": 0.0015590628878230837, "also preserved phosphocreatine": 0.0015590628878230837, "restoring mitochondrial oxidative": 0.0016027517854347976, "cardioprotection via inhibition": 0.0015740932992120977, "apoptotic signaling pathway": 0.001510767052159543, "mitochondrial ultrastructural changes": 0.0016551959433262922, "solid ehrlich carcinoma": 0.0014372681495627027, "changes without affecting": 0.0014754891515912068, "isolated coronary artery": 0.0014567769013094122, "heart failure \u226490": 0.001298706685421629, "failure \u226490 days": 0.0012709171785638637, "logistic regression models": 0.00149346739614735, "developed acute kidney": 0.0014168920626892493, "enormous clinical burden": 0.0014567769013094122, "atheromatous coronary disease": 0.0015435228749611013, "paediatric cardiac transplants": 0.0015590628878230837, "congenital heart lesions": 0.0014567769013094122, "poor myocardial function": 0.0014567769013094122, "poorly contracting ventricles": 0.0015435228749611013, "paediatric heart failure": 0.0014567769013094122, "heart failure concern": 0.001395567916578721, "versus dilated cardiomyopathy": 0.0015435228749611013, "new onset heart": 0.0012413335931821176, "anthracycline treated survivors": 0.0015740932992120977, "childhood malignant disease": 0.001510767052159543, "certain stimuli mediate": 0.0014372681495627027, "specific signalling pathways": 0.001527437488474138, "erk1/2 signalling pathway": 0.0014754891515912068, "targeting specific effector": 0.001510767052159543, "specific effector molecules": 0.001510767052159543, "erk1/2 scaffold proteins": 0.0014567769013094122, "therapeutic strategies capable": 0.0015590628878230837, "hypertensive cardiomyiopathy based": 0.001616435980062595, "inducible myocardial ischemia": 0.0015435228749611013, "normal coronary arteries": 0.0014567769013094122, "typical amyloidotic pattern": 0.001510767052159543, "important prognostic indicator": 0.0015590628878230837, "weak grip strength": 0.0013249073294139945, "unintentional weight loss": 0.0014754891515912068, "age 71 \u00b1": 0.0009531878839228976, "61 % male": 0.001007178034773029, "% intermediate frail": 0.0013732031650775353, "intermediate frail according": 0.001527437488474138, "0.1 unit increase": 0.001298706685421629, "% increased risk": 0.0012709171785638637, "measures predicted death": 0.0014567769013094122, "equally predict mortality": 0.0014754891515912068, "heart failure trials": 0.0013732031650775353, "therapeutics including calcium": 0.0015590628878230837, "recent studies including": 0.0014567769013094122, "selecting appropriate end": 0.0014754891515912068, "appropriate end points": 0.0014168920626892493, "failure in patients": 0.0013496910125323826, "risk of developing": 0.0013249073294139945, "developing heart failure": 0.0014567769013094122, "clinical care delivery": 0.0014168920626892493, "produce test results": 0.0013732031650775353, "community outpatient settings": 0.0015435228749611013, "designed clinical trials": 0.0014567769013094122, "take full advantage": 0.0013496910125323826, "faster turnaround times": 0.0014372681495627027, "measuring heart failure": 0.0014372681495627027, "heart failure care": 0.0013249073294139945, "operationalized hospital quality": 0.0015886464732048295, "expected future expansion": 0.0014754891515912068, "inhibition halts heart": 0.0014168920626892493, "halts heart failure": 0.0013496910125323826, "involves cardiac hypertrophy": 0.001527437488474138, "family bromodomain proteins": 0.001510767052159543, "lysine reader proteins": 0.0014168920626892493, "signal transduction cascade": 0.001510767052159543, "neurohormonally induced heart": 0.0015435228749611013, "induced heart disease": 0.001395567916578721, "pathological gene induction": 0.001510767052159543, "gene expression profiling": 0.0014754891515912068, "in vivo experiments": 0.0013496910125323826, "several pathological changes": 0.001527437488474138, "including cardiac hypertrophy": 0.0015435228749611013, "systemic blood pressure": 0.0014372681495627027, "detailed transcriptional analysis": 0.0016027517854347976, "pathological cardiac gene": 0.0014754891515912068, "cardiac gene expression": 0.0014372681495627027, "gene expression programme": 0.0014754891515912068, "further molecular analysis": 0.00149346739614735, "molecular analysis revealed": 0.001510767052159543, "mediated signal transduction": 0.001527437488474138, "activating transcription factor": 0.0015740932992120977, "transcription factor networks": 0.0015435228749611013, "including nuclear factor": 0.0014567769013094122, "activated t cells": 0.001298706685421629, "promoting transcriptional pause": 0.0015740932992120977, "transcriptional pause release": 0.0015435228749611013, "implicates epigenetic readers": 0.0015435228749611013, "cardiac gene control": 0.0013732031650775353, "dependent signal transduction": 0.0015435228749611013, "abrogate pathological gene": 0.00149346739614735, "pathological gene expression": 0.001527437488474138, "breathing pulse sequence": 0.0014567769013094122, "quantify myocardial t1": 0.0014168920626892493, "myocardial t1 changes": 0.001395567916578721, "induce heart failure": 0.0013732031650775353, "t mri scanner": 0.0011757381015063838, "chelate contrast agent": 0.0014168920626892493, "heart failure scans": 0.0013496910125323826, "heart failure myocardial": 0.0014567769013094122, "failure myocardial tissue": 0.0014754891515912068, "left ventricular tissue": 0.0014372681495627027, "trichrome blue histologic": 0.0014754891515912068, "blue histologic analysis": 0.0014567769013094122, "heart failure t1": 0.0012709171785638637, "\u00b1 94 ms": 0.0008919788991922065, "contrast agent administration": 0.0015435228749611013, "\u00b1 171 ms": 0.0009531878839228976, "myocardial collagen compared": 0.001527437488474138, "healthy control animals": 0.0014372681495627027, "diffuse myocardial changes": 0.00149346739614735, "myocardial changes associated": 0.0015435228749611013, "myocardial delayed enhancement": 0.0015590628878230837, "delayed enhancement imaging": 0.001510767052159543, "significant myocardial fibrosis": 0.0015740932992120977, "induced pulmonary artery": 0.0014567769013094122, "pulmonary artery systolic": 0.0014754891515912068, "artery systolic pressure": 0.0014567769013094122, "diagnosed pulmonary arterial": 0.001527437488474138, "thromboembolic pulmonary hypertension": 0.0016551959433262922, "right ventricular pump": 0.0014168920626892493, "ventricular pump function": 0.0014754891515912068, "targeted pulmonary arterial": 0.001510767052159543, "arterial hypertension medication": 0.0015886464732048295, "including stress echocardiography": 0.0016027517854347976, "\u00b1 1.8 years": 0.0010991627680482835, "factors predicting survival": 0.001510767052159543, "minute walking distance": 0.0014372681495627027, "year survival rates": 0.0013496910125323826, "remained independent prognostic": 0.0015740932992120977, "independent prognostic markers": 0.0015590628878230837, "preserved systolic function": 0.001510767052159543, "interesting therapeutic concepts": 0.0015886464732048295, "alone diagnostic devices": 0.0014567769013094122, "commoner among women": 0.0013732031650775353, "poses significant challenges": 0.001527437488474138, "regulates cardiac sodium": 0.0014567769013094122, "cardiac sodium current": 0.0014168920626892493, "systolic human heart": 0.0013732031650775353, "alternative mrna splicing": 0.0014754891515912068, "generating variants encoding": 0.001527437488474138, "human induced pluripotent": 0.0014754891515912068, "induced pluripotent stem": 0.0014567769013094122, "pluripotent stem cell": 0.001395567916578721, "protein kinase r": 0.0012709171785638637, "exogenous variants induced": 0.00149346739614735, "receptor potential cation": 0.0014754891515912068, "potential cation channel": 0.0014567769013094122, "cation channel m7": 0.001298706685421629, "kv4.3 mrna levels": 0.001298706685421629, "mrna levels resulting": 0.001395567916578721, "multiple cardiac genes": 0.0014168920626892493, "normal cardiac function": 0.0014372681495627027, "receives little attention": 0.0014754891515912068, "requires diagnostic procedures": 0.0015590628878230837, "chronic pulmonary arterial": 0.00149346739614735, "acute pulmonary embolism": 0.0014567769013094122, "examine clinical circumstances": 0.0015590628878230837, "clinical circumstances common": 0.0015435228749611013, "pulmonary embolism represent": 0.001527437488474138, "particularly high mortality": 0.001510767052159543, "possibly affect outcomes": 0.0014567769013094122, "data describing trends": 0.0014168920626892493, "evaluated temporal trends": 0.0014754891515912068, "characteristics yielded hazard": 0.0015590628878230837, "yielded hazard ratios": 0.001395567916578721, "requires new prevention": 0.0014372681495627027, "new prevention strategies": 0.0014754891515912068, "versus selective beta": 0.001395567916578721, "nonselective \u03b2 -": 0.0012709171785638637, "selective \u03b2 -": 0.0011757381015063838, "- blocker metoprolol": 0.0013732031650775353, "various serum factors": 0.001395567916578721, "label crossover study": 0.001395567916578721, "masked outcome assessments": 0.00149346739614735, "secondary outcomes included": 0.001510767052159543, "outcomes included markers": 0.0014754891515912068, "157 % \u00b1": 0.0008919788991922065, "\u00b1 13 %": 0.0008213183120274803, "receptor haplotype status": 0.0014754891515912068, "often contextual factors": 0.0014567769013094122, "competing priorities impact": 0.001510767052159543, "priorities impact prescribing": 0.0015435228749611013, "performance measurement systems": 0.0015740932992120977, "health care systems": 0.0013496910125323826, "primary care clinicians": 0.0014372681495627027, "identified biomedical reasons": 0.0015435228749611013, "reasons for nonprescribing": 0.00149346739614735, "clinician interviews identified": 0.0015740932992120977, "reasons per patient": 0.0013496910125323826, "common contextual reasons": 0.0014754891515912068, "prevents ventricular dysfunction": 0.0015886464732048295, "elevated sympathetic activity": 0.0015435228749611013, "reduced parasympathetic control": 0.0015740932992120977, "experimental evidence suggests": 0.0015590628878230837, "acetylcholinesterase inhibitor pyridostigmine": 0.0017449226105686322, "following myocardial infarction": 0.0015740932992120977, "cardiac sympathovagal balance": 0.0015435228749611013, "tachycardic response caused": 0.001510767052159543, "bradycardic response caused": 0.001510767052159543, "basal heart rate": 0.0012709171785638637, "reduced sympathetic control": 0.001510767052159543, "growth factor protein": 0.001395567916578721, "suggesting myocardial angiogenesis": 0.001616435980062595, "volume conductance catheter": 0.001510767052159543, "conductance catheter system": 0.001510767052159543, "higher stroke volume": 0.0013732031650775353, "coronary artery ligation": 0.0014567769013094122, "reduced sympathetic tone": 0.0014567769013094122, "attenuating cardiac remodeling": 0.0015590628878230837, "prolonged electromechanical delay": 0.0016027517854347976, "branch block type": 0.001298706685421629, "altered ventricular structure": 0.0015435228749611013, "reduced wall stiffness": 0.0014168920626892493, "local myocyte depolarization": 0.001527437488474138, "myofiber shortening onset": 0.0014754891515912068, "dyssynchronous failing heart": 0.001527437488474138, "induced remodeling aspects": 0.00149346739614735, "constructed additional models": 0.0015435228749611013, "four remodeling aspects": 0.0014372681495627027, "branch block electrical": 0.0014372681495627027, "block electrical activation": 0.001510767052159543, "electrical activation sequence": 0.0015590628878230837, "slows myofiber shortening": 0.0014754891515912068, "myofiber shortening velocity": 0.001527437488474138, "activated lateral wall": 0.0014168920626892493, "myofiber dynamics delay": 0.0014372681495627027, "thus giving rise": 0.0012709171785638637, "right ventricular function": 0.00149346739614735, "previous studies investigating": 0.0015590628878230837, "abnormal body composition": 0.0014754891515912068, "underwent prospective assessment": 0.0015886464732048295, "circulatory assist device": 0.0014754891515912068, "lower body mass": 0.0012413335931821176, "lower fat mass": 0.001209708193833172, "fat mass index": 0.001209708193833172, "greater antecedent weight": 0.0014754891515912068, "antecedent weight loss": 0.0014168920626892493, "body mass ratio": 0.0012413335931821176, "increased body mass": 0.0013496910125323826, "lower event rate": 0.0012709171785638637, "higher fat mass": 0.0012413335931821176, "free mass index": 0.0012413335931821176, "additive adverse impact": 0.0014372681495627027, "diastolic filling time": 0.0014168920626892493, "controlling heart rate": 0.0014168920626892493, "ivabradine 5 mg": 0.0012413335931821176, "demonstrated significant improvement": 0.0016426366240549605, "\u00b1 1.8 mets": 0.0010554738704365695, "\u00b1 1.9 mets": 0.0010554738704365695, "\u00b1 6.1 ml": 0.0009531878839228976, "\u00b1 3.3 ml": 0.0009531878839228976, "ratio of peak": 0.0011757381015063838, "velocity to peak": 0.0012709171785638637, "corrected chronotropic response": 0.0015740932992120977, "ivabradine increased exercise": 0.0015435228749611013, "increased exercise capacity": 0.001510767052159543, "filling pressure response": 0.0014754891515912068, "therapeutic treatments targeting": 0.0015886464732048295, "targeting abnormal exercise": 0.001510767052159543, "abnormal exercise hemodynamic": 0.0015435228749611013, "exercise hemodynamic status": 0.001510767052159543, "validated clinical tool": 0.0014372681495627027, "undergo coronary angiography": 0.001527437488474138, "undergone coronary angiography": 0.0015590628878230837, "% diameter stenosis": 0.0013496910125323826, "anterior descending artery": 0.00149346739614735, "defined prediction rule": 0.0014372681495627027, "separate cohort recruited": 0.0014754891515912068, "electrocardiographic q waves": 0.001527437488474138, "nondiabetes risk factors": 0.0014567769013094122, "independent predictor identified": 0.0015886464732048295, "prospective validation cohort": 0.0015435228749611013, "98 % sensitivity": 0.0012709171785638637, "18 % specificity": 0.0012709171785638637, "100 % sensitivity": 0.001298706685421629, "simple clinical prediction": 0.00149346739614735, "accurately identify patients": 0.001527437488474138, "potentially significant cost": 0.001527437488474138, "significant cost savings": 0.0014567769013094122, "japanese heart failure": 0.0014168920626892493, "type 2 receptor": 0.0012413335931821176, "2 receptor antagonist": 0.001395567916578721, "optimal diuretic therapy": 0.0014567769013094122, "serum sodium levels": 0.0013496910125323826, "newly introduced drug": 0.001395567916578721, "relieve congestive symptoms": 0.001510767052159543, "adverse neurohormonal activation": 0.0015886464732048295, "accurate risk stratification": 0.001527437488474138, "associated treatment strategies": 0.0015740932992120977, "human failing hearts": 0.0013732031650775353, "diminished cyclic adenosine": 0.001510767052159543, "cyclic adenosine monophosphate": 0.0015590628878230837, "augmented cyclic guanosine": 0.00149346739614735, "cyclic guanosine monophosphate": 0.0015590628878230837, "negative cross talk": 0.0013496910125323826, "fluorescence resonance energy": 0.0015435228749611013, "resonance energy transfer": 0.0014754891515912068, "video edge detection": 0.0013732031650775353, "stimulation via catecholamine": 0.0015435228749611013, "via catecholamine infusions": 0.001510767052159543, "camp hydrolytic activity": 0.0014567769013094122, "blunted cardiac \u03b2": 0.001298706685421629, "cardiac \u03b2 -": 0.0010991627680482835, "in diseased cardiomyocytes": 0.00149346739614735, "via nitric oxide": 0.0012709171785638637, "nitric oxide donors": 0.0013496910125323826, "partially restored \u03b2": 0.0013732031650775353, "healthy cardiomyocytes reduced": 0.0015590628878230837, "inotropic effect following": 0.00149346739614735, "following acute \u03b2": 0.001298706685421629, "affecting basal contractility": 0.0015435228749611013, "induced hypertrophic responses": 0.0015590628878230837, "important defense mechanism": 0.001510767052159543, "antagonizing excessive \u03b2": 0.0014567769013094122, "excessive \u03b2 -": 0.0011757381015063838, "activating myocardial pde2": 0.00149346739614735, "antiadrenergic therapeutic strategy": 0.0016297234749878095, "eplerenone in patients": 0.0014168920626892493, "receiving optimal therapy": 0.0014754891515912068, "- specified analysis": 0.0013732031650775353, "major safety measures": 0.001395567916578721, "primary composite endpoint": 0.00149346739614735, "meeting specific inclusion": 0.00149346739614735, "treatment group effects": 0.0014372681495627027, "linear mixed models": 0.0013496910125323826, "mixed models according": 0.0014168920626892493, "effect of exercise": 0.0013249073294139945, "control vs. rate": 0.0012709171785638637, "similar efficacy outcomes": 0.0014754891515912068, "2 treatment strategies": 0.0014168920626892493, "health care expenditures": 0.0014567769013094122, "control treatment strategies": 0.001527437488474138, "trial resource utilization": 0.00149346739614735, "\u00b1 9 years": 0.001007178034773029, "86 % male": 0.001007178034773029, "26 % \u00b1": 0.0008213183120274803, "fewer cardiac procedures": 0.0014567769013094122, "lower costs related": 0.0013496910125323826, "cardiac arrhythmia devices": 0.00149346739614735, "cost per patient": 0.0012709171785638637, "therapeutic strategy used": 0.0014754891515912068, "overall financial burden": 0.0014567769013094122, "skeletal muscle sarcomere": 0.0014754891515912068, "muscle sarcomere structure": 0.00149346739614735, "skm mitochondrial structure": 0.001510767052159543, "improved mitochondrial structure": 0.0015886464732048295, "maximum oxygen consumption": 0.00149346739614735, "western blot analysis": 0.001395567916578721, "report severe perturbations": 0.001510767052159543, "associated protein complex": 0.00149346739614735, "- ordinated fashion": 0.0013496910125323826, "reach statistical significance": 0.0015590628878230837, "initial results warrant": 0.0014372681495627027, "improving muscle function": 0.0014754891515912068, "versus biomedical treatment": 0.001510767052159543, "showed significant improvement": 0.0015590628878230837, "most adverse events": 0.0013496910125323826, "adverse events observed": 0.0014372681495627027, "without special treatment": 0.0014754891515912068, "systemic adverse events": 0.0014372681495627027, "adverse events evaluation": 0.0014754891515912068, "apparently healthy volunteers": 0.0015435228749611013, "key biosynthetic enzymes": 0.0014567769013094122, "lower median activities": 0.0014372681495627027, "newly diagnosed patients": 0.0014567769013094122, "cardiopulmonary exercise variables": 0.001616435980062595, "widely accepted peak": 0.0013732031650775353, "accepted peak oxygen": 0.0013732031650775353, "exercise oscillatory ventilation": 0.0015886464732048295, "different mechanisms underlie": 0.0015435228749611013, "different pathophysiological origin": 0.0016297234749878095, "heart transplant recipients": 0.001510767052159543, "orthotopic heart transplantation": 0.0015886464732048295, "including intravenous inotropes": 0.0015740932992120977, "inflammatory abdominal problems": 0.0015740932992120977, "abdominal problems occurred": 0.001510767052159543, "consultation and/or operation": 0.0015435228749611013, "patients undergoing oht": 0.0014372681495627027, "with similar incidence": 0.0014168920626892493, "refractory right heart": 0.0014168920626892493, "posterior wall infarction": 0.0014754891515912068, "cardiac catheterization showed": 0.0015590628878230837, "right coronary artery": 0.001395567916578721, "percutaneous coronary revascularization": 0.0016793271188928983, "hemodynamically stable situation": 0.0015886464732048295, "intensive care unit": 0.0013496910125323826, "therapy refractory cardiogenic": 0.0015590628878230837, "extra corporeal membrane": 0.0014567769013094122, "corporeal membrane oxygenation": 0.0015590628878230837, "emergency cardiac catheterization": 0.0016027517854347976, "extracorporeal life support": 0.001510767052159543, "ischemic right heart": 0.0013732031650775353, "successful reperfusion therapy": 0.0015590628878230837, "early research focused": 0.0014168920626892493, "- diastolic abnormalities": 0.0014754891515912068, "careful clinical evaluation": 0.001510767052159543, "invasive haemodynamic assessment": 0.0015886464732048295, "in this review": 0.001209708193833172, "novel treatment strategies": 0.00149346739614735, "linked administrative health": 0.001527437488474138, "administrative health data": 0.00149346739614735, "controlled feasibility study": 0.001527437488474138, "without intramuscular testosterone": 0.001616435980062595, "intramuscular testosterone supplementation": 0.0017132972112196868, "collected preliminary data": 0.00149346739614735, "age 67.2 years": 0.001209708193833172, "mean \u00b1 sd": 0.001007178034773029, "\u00b1 sd testosterone": 0.001298706685421629, "sd testosterone levels": 0.0014168920626892493, "\u00b1 2.6 nmol": 0.0010554738704365695, "incremental shuttle walk": 0.0014567769013094122, "100 % compliance": 0.0012709171785638637, "group showed improvements": 0.0014754891515912068, "elderly male patients": 0.001395567916578721, "peripheral muscles improves": 0.001510767052159543, "improves endothelial function": 0.0015435228749611013, "impaired systolic function": 0.00149346739614735, "fraction 63 %": 0.0011757381015063838, "63 % \u00b1": 0.0008213183120274803, "rated depression scores": 0.0014372681495627027, "mediated dilatation diameter": 0.001527437488474138, "toward lower mitral": 0.0013496910125323826, "lower mitral e": 0.001209708193833172, "also improves exercise": 0.0014168920626892493, "growth factor beta": 0.0013249073294139945, "improve cardiac functions": 0.0014754891515912068, "derived progenitor cells": 0.0014567769013094122, "cardiac explant c": 0.001298706685421629, "descending coronary artery": 0.00149346739614735, "coronary artery occlusion": 0.0014754891515912068, "developed infarcted animals": 0.001510767052159543, "left ventricle end": 0.0013249073294139945, "atrial explants produced": 0.0014567769013094122, "\u03b2 receptor type": 0.0012413335931821176, "differentiation toward cardiomyocyte": 0.0016426366240549605, "kit+ cell phenotype": 0.0013496910125323826, "optimizing cardiac progenitor": 0.0015435228749611013, "cardiac progenitor function": 0.001510767052159543, "cell expansion protocols": 0.0014567769013094122, "study breathing control": 0.0014372681495627027, "following cardiac arrest": 0.0014567769013094122, "pulseless ventricular fibrillation": 0.001616435980062595, "newly implanted cardioverter": 0.001527437488474138, "class iii heart": 0.0012413335931821176, "iii heart failure": 0.001298706685421629, "permanent periodic breathing": 0.001527437488474138, "final data analysis": 0.0013496910125323826, "cerebral blood flow": 0.0013496910125323826, "primary oscillations originating": 0.0015886464732048295, "central pattern generator": 0.0014754891515912068, "treating heart failure": 0.0014168920626892493, "much work remains": 0.001298706685421629, "including better tools": 0.0014168920626892493, "increasing evidence points": 0.00149346739614735, "different gastrointestinal regions": 0.001616435980062595, "disturbed intestinal barrier": 0.001527437488474138, "chronic inflammatory state": 0.00149346739614735, "particularly poor prognosis": 0.001510767052159543, "- inflammatory effects": 0.0014168920626892493, "heart failure research": 0.0014168920626892493, "stable coronary artery": 0.0014168920626892493, "ventricular wall stress": 0.0014372681495627027, "providing prognostic information": 0.0015886464732048295, "unfavourable clinical outcome": 0.0015435228749611013, "unilateral renal denervation": 0.001527437488474138, "renal denervation improves": 0.00149346739614735, "improves autonomic balance": 0.00149346739614735, "increased sympathetic tone": 0.00149346739614735, "sympathetic tone resulting": 0.00149346739614735, "protective mechanisms remain": 0.001527437488474138, "unilateral renal dnx": 0.0013732031650775353, "present study used": 0.0013249073294139945, "white rabbits undergoing": 0.0014567769013094122, "undergoing renal dnx": 0.0013732031650775353, "four treatment groups": 0.001395567916578721, "examined several markers": 0.0014567769013094122, "several markers indicative": 0.00149346739614735, "time domain heart": 0.001298706685421629, "domain heart rate": 0.001298706685421629, "power spectral analysis": 0.0014372681495627027, "spectral analysis indicated": 0.001510767052159543, "heart rate response": 0.0013496910125323826, "cardiac sympathetic tone": 0.0014567769013094122, "cardiac vagal tone": 0.0013249073294139945, "suggest renal dnx": 0.001298706685421629, "renal dnx improves": 0.0013249073294139945, "chronic systolic heart": 0.0014168920626892493, "randomized trial involving": 0.00149346739614735, "left ventricular dyssynchrony": 0.0015435228749611013, "patients underwent device": 0.0014754891515912068, "underwent device implantation": 0.0015435228749611013, "primary efficacy outcome": 0.0014567769013094122, "safety monitoring board": 0.0014372681495627027, "at study closure": 0.0012709171785638637, "primary outcome occurred": 0.0014567769013094122, "hospitalization for heart": 0.0014754891515912068, "single center retrospective": 0.001510767052159543, "retrospective observational study": 0.0016027517854347976, "receiving ventricular assist": 0.001527437488474138, "assist device support": 0.001395567916578721, "patients receiving extracorporeal": 0.0016027517854347976, "receiving extracorporeal membrane": 0.0016027517854347976, "membrane oxygenation membrane": 0.0015435228749611013, "oxygenation membrane support": 0.001527437488474138, "improvement in egfr": 0.0013496910125323826, "renal dysfunction improves": 0.00149346739614735, "sensitive outcome change": 0.0014567769013094122, "outcome change scores": 0.001395567916578721, "preliminary descriptive study": 0.0015435228749611013, "ensure effective practice": 0.0014754891515912068, "using standardized nursing": 0.00149346739614735, "standardized nursing terminologies": 0.001616435980062595, "retrospective descriptive research": 0.001616435980062595, "descriptive research design": 0.001510767052159543, "statistically significant improvement": 0.0016551959433262922, "study provide insight": 0.001395567916578721, "sensitive outcome measures": 0.00149346739614735, "prospective experimental research": 0.0016027517854347976, "regarding effective treatment": 0.0015435228749611013, "older adults hospitalized": 0.0014754891515912068, "reciprocal downregulation influences": 0.0016426366240549605, "influences cardiac hypertrophic": 0.0015740932992120977, "cardiac hypertrophic response": 0.0015435228749611013, "cardiac gene therapy": 0.0013732031650775353, "classic signaling paradigms": 0.001510767052159543, "human embryonic kidney": 0.0014168920626892493, "adrenergic receptor agonist": 0.001510767052159543, "show reciprocal regulation": 0.00149346739614735, "undergoing chronic \u03b2": 0.0013732031650775353, "chronic \u03b2 -": 0.0010991627680482835, "adrenergic receptor stimulation": 0.0015740932992120977, "postischemic heart failure": 0.00149346739614735, "cardiac plasma membrane": 0.0014372681495627027, "plasma membrane levels": 0.0014168920626892493, "produces beneficial effects": 0.001510767052159543, "deleterious \u03b21ar overstimulation": 0.0015886464732048295, "discharge among patients": 0.0014567769013094122, "readmission among patients": 0.00149346739614735, "linked administrative databases": 0.0015740932992120977, "saw unfamiliar physician(s": 0.00149346739614735, "month observation period": 0.0014567769013094122, "altered protein kinase": 0.0014168920626892493, "- translational state": 0.001395567916578721, "adrenergic receptor blockade": 0.001527437488474138, "reduces total mortality": 0.0014372681495627027, "halt disease progression": 0.0014567769013094122, "dependent protein kinase": 0.0014567769013094122, "adrenergic receptor activation": 0.0015590628878230837, "- translational states": 0.0014168920626892493, "human myocardial tissue": 0.0014372681495627027, "total myosin binding": 0.0013732031650775353, "myosin binding protein": 0.0014168920626892493, "site specific rii\u03b1": 0.0013249073294139945, "vivo phosphorylation sites": 0.00149346739614735, "specific monoclonal antibodies": 0.0015590628878230837, "monoclonal antibodies showed": 0.001527437488474138, "mutant ri\u03b1 proteins": 0.0013496910125323826, "failing myocardium displays": 0.001510767052159543, "displays altered expression": 0.001510767052159543, "- translational modification": 0.001527437488474138, "heart failure prone": 0.0013496910125323826, "signifies repolarization lability": 0.0016027517854347976, "nervous system activity": 0.0014372681495627027, "10 heart failure": 0.0012709171785638637, "spontaneous ventricular tachycardia": 0.0016297234749878095, "structurally normal hearts": 0.00149346739614735, "beat qt interval": 0.0012709171785638637, "rate atrial pacing": 0.0013249073294139945, "isoprenaline infusion increased": 0.0015740932992120977, "heart rate variation": 0.0013732031650775353, "nervous system modulation": 0.0014754891515912068, "related congestive heart": 0.0014567769013094122, "haematopoietic cell transplantation": 0.0016297234749878095, "developing congestive heart": 0.001510767052159543, "pre - hct": 0.001007178034773029, "- hct exposure": 0.001209708193833172, "16 candidate genes": 0.0013249073294139945, "- oxidant defence": 0.001298706685421629, "control study design": 0.0013732031650775353, "cumulative anthracycline exposure": 0.0016027517854347976, "stem cell source": 0.0012709171785638637, "doxorubicin efflux transporter": 0.0015590628878230837, "chf predictive model": 0.0013732031650775353, "predictive model performed": 0.00149346739614735, "propose fundamental definitions": 0.0015740932992120977, "right heart circulation": 0.0014372681495627027, "right heart circulatory": 0.0014372681495627027, "heart circulatory failure": 0.0014754891515912068, "foster collaborative research": 0.0015435228749611013, "collaborative research initiatives": 0.001616435980062595, "class angiotensin receptor": 0.00149346739614735, "natriuretic peptide system": 0.00149346739614735, "atrial natriuretic peptide": 0.00149346739614735, "neprilysin inhibitor prodrug": 0.001527437488474138, "angiotensin receptor antagonist": 0.0015740932992120977, "receptor antagonist valsartan": 0.0015435228749611013, "large outcomes trial": 0.0013732031650775353, "ejection fraction outcomes": 0.00149346739614735, "fraction outcomes trial": 0.0014372681495627027, "improve clinical symptoms": 0.0014754891515912068, "term survival rates": 0.0013496910125323826, "underlying clinical trials": 0.00149346739614735, "new pharmacologic targets": 0.0014754891515912068, "purely hemodynamic disorder": 0.001510767052159543, "interconnected molecular pathways": 0.0016027517854347976, "maladaptive molecular processes": 0.0015740932992120977, "molecular biomarkers provide": 0.001527437488474138, "important therapeutic implications": 0.001616435980062595, "guided clinical trials": 0.0014168920626892493, "potential therapeutic implications": 0.001616435980062595, "strict statistical standards": 0.001527437488474138, "guided clinical trial": 0.001395567916578721, "clinical trial design": 0.001395567916578721, "fastest growing subclass": 0.0014567769013094122, "small noncoding rnas": 0.0013732031650775353, "heart failure development": 0.0014754891515912068, "provide brief insight": 0.001395567916578721, "novel therapeutic targets": 0.0014754891515912068, "aldosterone system inhibitors": 0.0015435228749611013, "carries significant morbidity": 0.0015435228749611013, "direct renin inhibitors": 0.0014372681495627027, "neutral endopeptidase inhibitors": 0.0015886464732048295, "skeletal muscle abnormalities": 0.0015435228749611013, "peripheral muscle pump": 0.0014168920626892493, "promoting cardiac filling": 0.0014754891515912068, "acquired heart failure": 0.0014168920626892493, "reduced skeletal muscle": 0.0014372681495627027, "mass and/or metabolic": 0.001395567916578721, "design and patients": 0.0013496910125323826, "underwent cardiopulmonary exercise": 0.001616435980062595, "lean mass quantification": 0.0014567769013094122, "dual x -": 0.0009531878839228976, "magnetic resonance spectroscopy": 0.0015740932992120977, "australian reference data": 0.0014754891515912068, "single tertiary referral": 0.0014567769013094122, "tertiary referral centre": 0.0014567769013094122, "appendicular lean mass": 0.0014168920626892493, "lean mass index": 0.0012413335931821176, "matched reference values": 0.0014567769013094122, "low skeletal muscle": 0.0013496910125323826, "muscle mass t": 0.0011757381015063838, "young normal reference": 0.0014168920626892493, "normal reference mean": 0.001395567916578721, "sarcopenic range muscle": 0.0014372681495627027, "clinically significant wasting": 0.0015590628878230837, "muscle aerobic capacity": 0.0014372681495627027, "postexercise phosphocreatine resynthesis": 0.0016909324597185011, "adults versus controls": 0.0014168920626892493, "659 heart failure": 0.001298706685421629, "performed confirmatory factor": 0.0015435228749611013, "confirmatory factor analysis": 0.001527437488474138, "used exploratory factor": 0.0014372681495627027, "exploratory factor analysis": 0.001510767052159543, "separate scale dimensions": 0.0014754891515912068, "separate sub -": 0.001209708193833172, "sub - sample": 0.0011390476066684464, "individual scales showed": 0.0014567769013094122, "excellent fit indices": 0.001395567916578721, "contrasting groups validity": 0.001510767052159543, "type natriuretic peptides": 0.0014754891515912068, "common consensus regarding": 0.00149346739614735, "-80 \u00b0 c": 0.0008919788991922065, "mass spectrometric analysis": 0.001510767052159543, "customized homogeneous sandwich": 0.0015740932992120977, "sandwich alphalisa \u00ae": 0.0013732031650775353, "alphalisa \u00ae immunoassays": 0.0014567769013094122, "terminally processed forms": 0.00149346739614735, "low apparent concentration": 0.00149346739614735, "terminally truncated fragments": 0.0015590628878230837, "targeting nonterminal epitopes": 0.0015590628878230837, "central glycosylated region": 0.001510767052159543, "left ventricular hypertrophy": 0.001527437488474138, "relative wall thickness": 0.0014372681495627027, "data among groups": 0.001298706685421629, "lower systolic blood": 0.0013732031650775353, "less renal impairment": 0.001395567916578721, "elevated cardiac filling": 0.0014567769013094122, "cardiac filling pressures": 0.0014754891515912068, "equivalent adverse outcomes": 0.001510767052159543, "carvedilol and metoprolol": 0.0014754891515912068, "\u00b1 1.1 years": 0.0010991627680482835, "significantly decreased risk": 0.001527437488474138, "inappropriate therapy compared": 0.0015590628878230837, "inappropriate shock therapy": 0.001510767052159543, "inappropriate therapy caused": 0.001527437488474138, "nationwide retrospective cohort": 0.0015740932992120977, "general population comprised": 0.001527437488474138, "proportional hazard analyses": 0.001527437488474138, "commonly used bisphosphonates": 0.0015435228749611013, "observed across refill": 0.0014168920626892493, "across refill compliance": 0.0014567769013094122, "refill compliance strata": 0.0014567769013094122, "increasing refill compliance": 0.001527437488474138, "p for trend": 0.0010991627680482835, "matched control subjects": 0.0014567769013094122, "weeks infarcted rats": 0.0013732031650775353, "20 weeks mi": 0.0010991627680482835, "weeks mi animals": 0.0012709171785638637, "posterior wall thickness": 0.0014567769013094122, "dopamine without affecting": 0.00149346739614735, "increased mrna level": 0.0013732031650775353, "reverse cardiac remodeling": 0.00149346739614735, "incident cardiovascular events": 0.0015590628878230837, "independent risk factor": 0.0014372681495627027, "shown inconsistent results": 0.00149346739614735, "subclinical atherosclerosis using": 0.0016027517854347976, "general linear models": 0.001395567916578721, "8,009 reference subjects": 0.0014567769013094122, "higher diastolic blood": 0.0014168920626892493, "diastolic blood pressure": 0.0014567769013094122, "mass index levels": 0.001298706685421629, "adjusted carotid intima": 0.0014372681495627027, "coronary artery calcium": 0.0014372681495627027, "artery calcium scores": 0.001395567916578721, "predominantly mild disease": 0.00149346739614735, "subjects without psoriasis": 0.00149346739614735, "share many risk": 0.0012413335931821176, "many risk factors": 0.001298706685421629, "patients with pad": 0.001298706685421629, "transmitral e -": 0.0012413335931821176, "hospital readmission reduction": 0.0015590628878230837, "readmission reduction program": 0.0015435228749611013, "rate following hospital": 0.0014372681495627027, "following hospital stay": 0.0014372681495627027, "possible suboptimal care": 0.0014567769013094122, "significant economic considerations": 0.0016297234749878095, "center pilot project": 0.0013732031650775353, "cardiac specialty hospital": 0.00149346739614735, "ensure adequate self": 0.0013732031650775353, "percent relative reduction": 0.00149346739614735, "net economic savings": 0.0013732031650775353, "urbanized midwestern state": 0.00149346739614735, "abnormal hr variability": 0.0014372681495627027, "- linear measures": 0.001298706685421629, "reflecting rapid r": 0.0013249073294139945, "r interval oscillations": 0.0014372681495627027, "- linear hr": 0.0010991627680482835, "linear hr variability": 0.001395567916578721, "hr variability measures": 0.0014372681495627027, "term fractal scaling": 0.0013732031650775353, "fractal scaling exponent": 0.0014567769013094122, "better prognostic information": 0.0015435228749611013, "fatal arrhythmia events": 0.0014372681495627027, "future randomized trials": 0.0014567769013094122, "trials using hr": 0.0012413335931821176, "using hr variability": 0.0013732031650775353, "- defined inclusion": 0.0013496910125323826, "defined inclusion criteria": 0.00149346739614735, "routine clinical tool": 0.001395567916578721, "renal artery stenosis": 0.001395567916578721, "peripheral arterial disease": 0.001510767052159543, "pathophysiologic mechanism stems": 0.0015886464732048295, "renal underperfusion resulting": 0.0015590628878230837, "end stage kidney": 0.0012709171785638637, "stage kidney failure": 0.0013732031650775353, "computed tomographic angiography": 0.0015886464732048295, "magnetic resonance angiography": 0.0015590628878230837, "adequate blood pressure": 0.0014372681495627027, "blood pressure control": 0.0014168920626892493, "preventive measures form": 0.0014567769013094122, "based percutaneous revascularization": 0.0016426366240549605, "modest clinical benefit": 0.0014372681495627027, "small retrospective studies": 0.001510767052159543, "randomized clinical trials": 0.00149346739614735, "clinical trials failed": 0.0014168920626892493, "concrete data regarding": 0.0014372681495627027, "determining individualized assessment": 0.0016551959433262922, "several key genes": 0.001298706685421629, "key genes related": 0.001298706685421629, "differentially expressed genes": 0.0015590628878230837, "- ischemic heart": 0.0012709171785638637, "programmed cell death": 0.001395567916578721, "longitudinal analysis using": 0.001510767052159543, "analysis using medicare": 0.0014372681495627027, "using medicare data": 0.0013496910125323826, "healthcare utilization effects": 0.0015590628878230837, "combined care management": 0.0014567769013094122, "retrospective matched cohort": 0.001527437488474138, "matched cohort study": 0.0013732031650775353, "demonstration participating clinics": 0.0016297234749878095, "score matched control": 0.001395567916578721, "matched control group": 0.001395567916578721, "driven telehealth system": 0.0014567769013094122, "year study period": 0.001298706685421629, "negative binomial regression": 0.001527437488474138, "binomial regression models": 0.00149346739614735, "% lower risk": 0.0011390476066684464, "quarterly inpatient admissions": 0.0015590628878230837, "driven telehealth technology": 0.001527437488474138, "improve health outcomes": 0.0014372681495627027, "contemporary chronic heart": 0.00149346739614735, "exercise training response": 0.00149346739614735, "without exercise training": 0.0014754891515912068, "identified black patients": 0.0014754891515912068, "less ischemic etiology": 0.0014168920626892493, "lower socioeconomic status": 0.00149346739614735, "status versus whites": 0.0013732031650775353, "minute walk distance": 0.0013732031650775353, "after multivariable adjustment": 0.0015590628878230837, "similar cardiovascular mortality": 0.0015886464732048295, "modifiable risk factors": 0.0014372681495627027, "lower exercise performance": 0.00149346739614735, "optimal therapy including": 0.0014754891515912068, "therapy including anticoagulation": 0.0016027517854347976, "major cardiovascular complications": 0.001616435980062595, "prevent adverse outcomes": 0.0014567769013094122, "adverse outcomes related": 0.0014567769013094122, "preserve atrial structure": 0.0014754891515912068, "maintain sinus rhythm": 0.001395567916578721, "delayed rhythm control": 0.0014168920626892493, "otherwise effective rate": 0.0014567769013094122, "effective rate control": 0.0014168920626892493, "new antiarrhythmic drugs": 0.0014567769013094122, "modern rhythm control": 0.001395567916578721, "reduce cardiovascular complications": 0.0016297234749878095, "recent onset af": 0.0012413335931821176, "mandated usual care": 0.0013496910125323826, "blinded outcome assessment": 0.00149346739614735, "outcome assessment trial": 0.0014567769013094122, "composite primary outcome": 0.0014754891515912068, "underlying heart disease": 0.0014567769013094122, "care plus rhythm": 0.0012709171785638637, "operated electrocardiographic device": 0.0016426366240549605, "key secondary outcomes": 0.0014168920626892493, "secondary outcomes include": 0.00149346739614735, "include cognitive function": 0.00149346739614735, "prevent cardiovascular complications": 0.0016426366240549605, "cardiovascular complications associated": 0.0016793271188928983, "term ventricular assist": 0.0014372681495627027, "health care providers": 0.001395567916578721, "significant gastrointestinal bleeding": 0.0016551959433262922, "called end stage": 0.0012709171785638637, "advanced structural heart": 0.0014754891515912068, "structural heart disease": 0.0014567769013094122, "minimal physical exertion": 0.0014754891515912068, "maximal medical treatment": 0.0014754891515912068, "medical treatment according": 0.001510767052159543, "year mortality rate": 0.0013496910125323826, "special therapeutic interventions": 0.0016027517854347976, "correct reversible causes": 0.0014754891515912068, "poor patient compliance": 0.0014372681495627027, "describe current strategies": 0.001510767052159543, "ca2 + currents": 0.001209708193833172, "influx via l": 0.0011390476066684464, "ventricular action potentials": 0.0015435228749611013, "monomeric g proteins": 0.0013732031650775353, "regulates ventricular action": 0.001527437488474138, "ventricular action potential": 0.001527437488474138, "action potential duration": 0.0014754891515912068, "inhibit cardiac l": 0.001298706685421629, "type channel activity": 0.001395567916578721, "occurring rad variant": 0.001395567916578721, "type channel isoforms": 0.001395567916578721, "95 % inhibition": 0.0012413335931821176, "type channel inhibition": 0.0014372681495627027, "ethically complex situations": 0.001527437488474138, "religious beliefs preclude": 0.00149346739614735, "involving young adults": 0.0014168920626892493, "sickle cell disease": 0.0013496910125323826, "urgently recommend blood": 0.0014567769013094122, "recommend blood transfusions": 0.001527437488474138, "composite quality measures": 0.00149346739614735, "inpatient medical conditions": 0.001527437488474138, "select better hospitals": 0.0014372681495627027, "individual quality measures": 0.001510767052159543, "inferior hospitals based": 0.0014567769013094122, "derived composite quality": 0.0014754891515912068, "composite quality measure": 0.0014754891515912068, "composite measure predicts": 0.00149346739614735, "future hospital mortality": 0.0014754891515912068, "older patients treated": 0.0014168920626892493, "acute care hospital": 0.0013496910125323826, "existing quality indicators": 0.001510767052159543, "race influences efficacy": 0.0014567769013094122, "functional class iv": 0.0013496910125323826, "myocardial infarction compared": 0.0015590628878230837, "- aa participants": 0.001298706685421629, "non - aas": 0.001007178034773029, "attain maximal spironolactone": 0.0015435228749611013, "maximal spironolactone dose": 0.001510767052159543, "achieved study drug": 0.0013496910125323826, "study drug dose": 0.0012413335931821176, "less clinical benefit": 0.001395567916578721, "free shotgun proteomics": 0.0014372681495627027, "shotgun proteomics approach": 0.001510767052159543, "tac)-induced heart failure": 0.00149346739614735, "associated signaling pathway": 0.001527437488474138, "signaling pathway changes": 0.0014754891515912068, "changes using ingenuity": 0.0014372681495627027, "using ingenuity pathway": 0.0014372681495627027, "heart failure phenotypes": 0.0014567769013094122, "mitochondrial damage induced": 0.001527437488474138, "mitochondrial proteome changes": 0.0015590628878230837, "84 % protection": 0.0012413335931821176, "nonmitochondrial protein changes": 0.0015886464732048295, "included significant amelioration": 0.0016027517854347976, "actin cytoskeleton pathways": 0.001510767052159543, "induced proteomic alterations": 0.0015435228749611013, "perturbed mitochondrial function": 0.0015886464732048295, "potential clinical application": 0.0015590628878230837, "targeted peptide drugs": 0.0014168920626892493, "treatment heart failure": 0.0014372681495627027, "stay increase rehospitalization": 0.0015740932992120977, "skilled nursing facilities": 0.00149346739614735, "quasi - experiment": 0.0013249073294139945, "1.56 percentage points": 0.0014168920626892493, "0.81 percentage points": 0.0014168920626892493, "urinary tract infection": 0.0014372681495627027, "patients undergoing procedures": 0.0015590628878230837, "medically managed diseases": 0.00149346739614735, "acute care hospitals": 0.0013732031650775353, "costs across volume": 0.0013496910125323826, "across volume groups": 0.0013732031650775353, "examined physician volume": 0.0014754891515912068, "volume within strata": 0.0013732031650775353, "higher readmission rates": 0.0014567769013094122, "among noncardiologist physicians": 0.0015886464732048295, "major clinical trials": 0.001395567916578721, "clinical trials designed": 0.0014567769013094122, "analyze clinical outcomes": 0.0014754891515912068, "clinical outcomes using": 0.0014372681495627027, "myocardial infarction patients": 0.0015590628878230837, "aldosterone antagonist eplerenone": 0.0016027517854347976, "aldosterone antagonist therapy": 0.0015590628878230837, "improving survival rates": 0.0014567769013094122, "contemporary therapeutic options": 0.0015886464732048295, "thus examined changes": 0.001395567916578721, "dilated cardiomyopathy cohort": 0.0015435228749611013, "73 % men": 0.0009531878839228976, "negative coronary angiography": 0.0015435228749611013, "4 enrollment periods": 0.0013732031650775353, "heart failure treatment": 0.0014372681495627027, "failure treatment eras": 0.0014168920626892493, "patients receiving angiotensin": 0.0015590628878230837, "angiotensin receptors blockers": 0.0015590628878230837, "final evaluation increased": 0.00149346739614735, "trend toward enrollment": 0.0014372681495627027, "point including death": 0.001395567916578721, "recent enrollment period": 0.0014567769013094122, "powerful independent predictor": 0.0015590628878230837, "42 % risk": 0.001007178034773029, "% risk reduction": 0.0012709171785638637, "reflecting marked decreases": 0.001510767052159543, "controlled randomized trials": 0.001527437488474138, "indeterminable anaerobic threshold": 0.001616435980062595, "maximal cardiopulmonary exercise": 0.0015886464732048295, "stable clinical conditions": 0.00149346739614735, "exercise test investigations": 0.001527437488474138, "peak respiratory quotient": 0.0014754891515912068, "respiratory quotient \u22641.05": 0.00149346739614735, "urgent cardiac transplant": 0.0014754891515912068, "secondary end point": 0.0013496910125323826, "multivariable logistic analysis": 0.0015740932992120977, "reduced peak oxygen": 0.0013496910125323826, "higher metabolic exercise": 0.0014754891515912068, "index score value": 0.001298706685421629, "at multivariable analysis": 0.0014754891515912068, "ventilatory efficiency slope": 0.001527437488474138, "secondary study end": 0.0013496910125323826, "independent prognostic role": 0.001510767052159543, "heart failure mortality": 0.0014372681495627027, "among cardiorespiratory fitness": 0.0015740932992120977, "versus unfit men": 0.0012709171785638637, "cardiovascular disease underwent": 0.0015886464732048295, "measures included body": 0.0014168920626892493, "included body mass": 0.0013249073294139945, "maximal treadmill exercise": 0.00149346739614735, "treadmill exercise testing": 0.00149346739614735, "obese body mass": 0.0012413335931821176, "mass index categories": 0.001395567916578721, "overweight body mass": 0.0013732031650775353, "mass index strata": 0.001298706685421629, "risk factors present": 0.0013732031650775353, "decreased mitochondrial energy": 0.0015590628878230837, "mitochondrial energy production": 0.0015740932992120977, "energy production precede": 0.0014754891515912068, "energy metabolism precede": 0.0014754891515912068, "cardiac hypertrophy secondary": 0.0015435228749611013, "abdominal aortic constriction": 0.0015435228749611013, "energy substrate metabolism": 0.001510767052159543, "in vivo assessment": 0.0013249073294139945, "demonstrated diastolic dysfunction": 0.001616435980062595, "20 % increase": 0.0011757381015063838, "16 % decrease": 0.0011757381015063838, "% ejection fraction": 0.0013496910125323826, "marked cardiac insulin": 0.0014168920626892493, "2 weeks post": 0.0011390476066684464, "weeks post -": 0.0011390476066684464, "plasma membrane translocation": 0.0015435228749611013, "myocardial glycolysis rates": 0.001510767052159543, "reduced mitochondrial complex": 0.0015435228749611013, "mitochondrial complex v": 0.0014372681495627027, "complex v activity": 0.0013249073294139945, "decreased mitochondrial oxidative": 0.0016027517854347976, "mitochondrial oxidative metabolism": 0.001616435980062595, "early metabolic changes": 0.0014372681495627027, "guide health service": 0.0013732031650775353, "health service planning": 0.0014372681495627027, "relevant health service": 0.0014372681495627027, "health service provision": 0.0014567769013094122, "reduced gross income": 0.0013732031650775353, "including lower risk": 0.0013732031650775353, "raised blood glucose": 0.0013732031650775353, "blood glucose levels": 0.0013732031650775353, "gross national income": 0.001395567916578721, "income per capita": 0.001298706685421629, "renal chloride channel": 0.0014168920626892493, "chloride channel gene": 0.001395567916578721, "reported greater risk": 0.001395567916578721, "ambient air pollution": 0.001395567916578721, "recognised risk factor": 0.0014168920626892493, "new systematic review": 0.001395567916578721, "common disorder associated": 0.00149346739614735, "aggravate cardiovascular health": 0.0015740932992120977, "exacerbates heart failure": 0.0014754891515912068, "cytoskeletal actin dynamics": 0.001510767052159543, "produced cardiac dysfunction": 0.001527437488474138, "mildly increased heart": 0.0014168920626892493, "increased heart mass": 0.0013732031650775353, "eliminated cardiac hypertrophy": 0.0015590628878230837, "cardiac functional deterioration": 0.0015886464732048295, "mechanical support devices": 0.00149346739614735, "collaboration among cardiologists": 0.0016027517854347976, "medical staff responsible": 0.0014754891515912068, "regarding appropriate referrals": 0.0015740932992120977, "present consensus report": 0.0014567769013094122, "information regarding conditions": 0.0015886464732048295, "recent postmarketing trials": 0.001510767052159543, "hospitalized heart failure": 0.00149346739614735, "user cohort study": 0.001298706685421629, "18 health insurance": 0.0013496910125323826, "health system data": 0.0013249073294139945, "system data partners": 0.0013732031650775353, "acting insulin products": 0.0014372681495627027, "principal discharge diagnosis": 0.0015435228749611013, "553 saxagliptin users": 0.001395567916578721, "124 sitagliptin users": 0.001395567916578721, "disease risk score": 0.0013249073294139945, "saxagliptin versus sitagliptin": 0.0015590628878230837, "saxagliptin versus pioglitazone": 0.0015740932992120977, "saxagliptin versus insulin": 0.00149346739614735, "stratified hazard ratios": 0.0014567769013094122, "sitagliptin versus pioglitazone": 0.0015740932992120977, "sitagliptin versus insulin": 0.00149346739614735, "1:1 propensity score": 0.0013732031650775353, "prior cardiovascular disease": 0.001527437488474138, "large cohort study": 0.0013249073294139945, "selected antihyperglycemic agents": 0.0016027517854347976, "improving physician adherence": 0.0015435228749611013, "systematic review protocol": 0.00149346739614735, "identify implementation strategies": 0.001616435980062595, "improve physician adherence": 0.001510767052159543, "include prospective studies": 0.001510767052159543, "prospective studies evaluating": 0.0015590628878230837, "studies evaluating implementation": 0.0016027517854347976, "evaluating implementation interventions": 0.0016793271188928983, "common underlying characteristics": 0.0016027517854347976, "recommended pharmacological treatment": 0.0016551959433262922, "left ventricular function": 0.0014754891515912068, "ventricular function assessment": 0.0015740932992120977, "include clinical outcomes": 0.0014754891515912068, "determine patient awareness": 0.001510767052159543, "analyze interview data": 0.0014168920626892493, "25 heart failure": 0.0012709171785638637, "setting and participants": 0.0014567769013094122, "felt implantable cardioverter": 0.0015435228749611013, "previously established preferences": 0.001616435980062595, "within broader discussions": 0.00149346739614735, "life treatment preferences": 0.00149346739614735, "defibrillator deactivation preferences": 0.0016674203071733484, "distressing implantable cardioverter": 0.0016426366240549605, "carotid baroreflex activation": 0.0015435228749611013, "baroreflex activation therapy": 0.0015435228749611013, "decreased parasympathetic activity": 0.001616435980062595, "parasympathetic activity contribute": 0.0016297234749878095, "centrally mediated reduction": 0.001527437488474138, "increased parasympathetic activity": 0.001616435980062595, "chronic stable guideline": 0.0014567769013094122, "directed medical therapy": 0.0014567769013094122, "receive ongoing gdmt": 0.0013732031650775353, "gdmt plus bat": 0.0011757381015063838, "primary safety end": 0.0013249073294139945, "safety end point": 0.0012709171785638637, "primary efficacy end": 0.0013732031650775353, "efficacy end points": 0.0013496910125323826, "hall walk distance": 0.0013249073294139945, "control group patients": 0.0014168920626892493, "\u00b1 3.1 points": 0.0011390476066684464, "functional class ranking": 0.0014567769013094122, "significantly reduced n": 0.0014372681495627027, "toward fewer days": 0.001298706685421629, "fewer days hospitalized": 0.0014372681495627027, "improves functional status": 0.00149346739614735, "heart failure hospitalizations": 0.0015590628878230837, "using cardiopulmonary exercise": 0.0015590628878230837, "exercise testing guide": 0.0014168920626892493, "testing guide exercise": 0.0014168920626892493, "guide exercise rehabilitation": 0.0015435228749611013, "standard clinical practice": 0.00149346739614735, "prescribe exercise rehabilitation": 0.0016027517854347976, "limited maximal cpet": 0.0013732031650775353, "control without exercise": 0.0014567769013094122, "5 exercise patients": 0.0013496910125323826, "patients used \u03b450%w": 0.0013496910125323826, "used \u03b450%w intensity": 0.0013732031650775353, "12 w rehabilitation": 0.0013496910125323826, "two groups patients": 0.0013496910125323826, "distance 6 minutes": 0.0013249073294139945, "guiding exercise rehabilitation": 0.0015740932992120977, "newer imaging techniques": 0.0014567769013094122, "reduced long axis": 0.001298706685421629, "long axis function": 0.0013249073294139945, "other cardiovascular risk": 0.0014754891515912068, "single diagnostic test": 0.0014168920626892493, "thorough medical history": 0.0014567769013094122, "standing blood pressure": 0.0014372681495627027, "jugular venous pressure": 0.0014372681495627027, "peripheral oedema allows": 0.0014567769013094122, "oedema allows assessment": 0.0014567769013094122, "heart failure nurses": 0.0013732031650775353, "local cardiology services": 0.0014754891515912068, "regular physical activity": 0.0014754891515912068, "physical activity controls": 0.00149346739614735, "acquired cardiovascular risk": 0.001527437488474138, "50 % reduction": 0.001209708193833172, "recent evidence suggests": 0.0014567769013094122, "exercise prevents cell": 0.0014168920626892493, "prevents cell senescence": 0.0014567769013094122, "developing certain malignancies": 0.0015740932992120977, "certain malignancies including": 0.0015590628878230837, "malignancies including cancer": 0.0015435228749611013, "even lower volumes": 0.0013249073294139945, "recommendations confer health": 0.0015435228749611013, "confer health benefits": 0.0014168920626892493, "established cardiac disease": 0.001510767052159543, "cardiac disease including": 0.0014754891515912068, "disease including heart": 0.0014372681495627027, "including heart failure": 0.0014372681495627027, "rare with.estimates ranging": 0.001510767052159543, "aged recreational athletes": 0.00149346739614735, "sudden cardiac deaths": 0.001395567916578721, "cardiac deaths occur": 0.0013732031650775353, "- participation screening": 0.0014754891515912068, "detect congenital accessory": 0.001510767052159543, "congenital accessory pathways": 0.0015435228749611013, "limited value given": 0.0013496910125323826, "small pilot study": 0.001298706685421629, "week aerobic training": 0.001395567916578721, "aerobic training period": 0.0014372681495627027, "trainings per week": 0.0013249073294139945, "integrated dynamic resistance": 0.0015435228749611013, "dynamic resistance training": 0.001510767052159543, "patients underwent testing": 0.00149346739614735, "combined training resulted": 0.00149346739614735, "peak work rate": 0.001209708193833172, "+ 61 %": 0.0008213183120274803, "+ 44 %": 0.0008213183120274803, "resistance training intervention": 0.0015886464732048295, "augmented feedback resulted": 0.001510767052159543, "assess social support": 0.001395567916578721, "perceived social support": 0.0014567769013094122, "social support score": 0.0013732031650775353, "indicated higher levels": 0.0014372681495627027, "higher btes indicated": 0.001395567916578721, "higher exercise time": 0.0013732031650775353, "for cardiovascular death": 0.0014567769013094122, "usual care group": 0.0012709171785638637, "poor social support": 0.0013496910125323826, "lower exercise time": 0.0013496910125323826, "training improves outcomes": 0.00149346739614735, "facilitate individualized approaches": 0.0016426366240549605, "implement exercise training": 0.001510767052159543, "exercise training therapy": 0.0014754891515912068, "recent onset heart": 0.0013249073294139945, "blocker hypo -": 0.001209708193833172, "hypo - response": 0.0012413335931821176, "standardized exercise protocol": 0.0015590628878230837, "respiratory gas analysis": 0.0014567769013094122, "recommended target doses": 0.0014567769013094122, "resting hr<70 bpm": 0.001298706685421629, "hr<70 versus \u226570": 0.0012709171785638637, "similar dose uptitration": 0.0014567769013094122, "significantly larger hr": 0.0014372681495627027, "larger hr reduction": 0.0013496910125323826, "lower resting hr": 0.0012709171785638637, "in recent onset": 0.0012413335931821176, "aggressive dose uptitration": 0.001510767052159543, "little hr reduction": 0.0013496910125323826, "left atrial pressure": 0.0013732031650775353, "atrial pressure improve": 0.0014372681495627027, "pressure improve symptoms": 0.0014754891515912068, "canadian special access": 0.0014372681495627027, "special access programme": 0.0014567769013094122, "transoesophageal echocardiographic guidance": 0.0017240832730466317, "procedural adverse events": 0.0014754891515912068, "3 month follow": 0.001209708193833172, "6 min walk": 0.0010554738704365695, "walk test distance": 0.0013249073294139945, "right atrial pressure": 0.001395567916578721, "pulmonary arterial pressure": 0.001510767052159543, "ventricular tachycardia storm": 0.0015435228749611013, "failure 2 months": 0.0012709171785638637, "post - procedure": 0.0012709171785638637, "right interatrial shunt": 0.0014372681495627027, "interatrial shunt demonstrates": 0.0015590628878230837, "demonstrates initial safety": 0.001510767052159543, "scale randomised studies": 0.0014567769013094122, "receptor neprilysin inhibitors": 0.0015590628878230837, "neprilysin blocks renin": 0.0014372681495627027, "supports natural vasodilatory": 0.0015435228749611013, "prospective randomized multicenter": 0.001616435980062595, "randomized multicenter trial": 0.001527437488474138, "multicenter trial paradigm": 0.00149346739614735, "stabilized chronic heart": 0.0014567769013094122, "20 % decrease": 0.0011757381015063838, "specified subgroup analyses": 0.001510767052159543, "typical adverse event": 0.001395567916578721, "long time become": 0.0012709171785638637, "stable chronic heart": 0.0013732031650775353, "systolic dysfunction treatment": 0.0015590628878230837, "among older persons": 0.0013496910125323826, "factorial trial conducted": 0.0014754891515912068, "academic medical center": 0.0014372681495627027, "initially screened participants": 0.0015740932992120977, "older obese participants": 0.0014567769013094122, "higher scores indicate": 0.0014168920626892493, "indicate worse heart": 0.0013732031650775353, "worse heart failure": 0.0013496910125323826, "by main effects": 0.0012413335931821176, "main effects analysis": 0.001395567916578721, "kg body mass": 0.0011390476066684464, "statistically significant change": 0.0015886464732048295, "percent lean body": 0.001298706685421629, "intermuscular fat ratio": 0.0014372681495627027, "serious adverse events": 0.0014168920626892493, "conclusions and relevance": 0.0014754891515912068, "training increased peak": 0.0014372681495627027, "ventricular assist system": 0.0014754891515912068, "centrifugal flow pump": 0.001395567916578721, "magnetically levitated rotor": 0.001527437488474138, "support)-derived performance goal": 0.0016027517854347976, "optimal medical management": 0.00149346739614735, "% received transplants": 0.0014168920626892493, "survival 92 %": 0.0011757381015063838, "88 % performance": 0.0012709171785638637, "% performance goal": 0.0013249073294139945, "significantly reduced mortality": 0.0015740932992120977, "reduced mortality risk": 0.0014168920626892493, "key adverse events": 0.0013249073294139945, "adverse events included": 0.0014372681495627027, "events included reoperation": 0.001510767052159543, "month survival rates": 0.0013732031650775353, "favorable adverse event": 0.0014372681495627027, "adverse event profile": 0.001395567916578721, "influence medical resource": 0.00149346739614735, "medical resource use": 0.0013732031650775353, "based simulation tool": 0.001395567916578721, "cohort study designs": 0.0013732031650775353, "virtual cohorts used": 0.0013732031650775353, "replicating resource use": 0.0014567769013094122, "debilitating chronic disease": 0.001527437488474138, "enhancing medical management": 0.001527437488474138, "ultimately reduce morbidity": 0.001510767052159543, "play a role": 0.0007327751786988557, "symptoms of heart": 0.0008658044569477526, "anemia in patients": 0.000883271552942663, "anemia and iron": 0.0008275557287880785, "life in patients": 0.0008472781190425757, "symptoms in patients": 0.0009154687767183569, "confidence in estimates": 0.0009581787663751352, "male sex were": 0.0007838254010042559, "change in cystatin": 0.000883271552942663, "processes of care": 0.0008658044569477526, "changes in chromatin": 0.0009154687767183569, "development and disease": 0.0009581787663751352, "development of ies": 0.000883271552942663, "failure or death": 0.0008472781190425757, "mortality as patients": 0.0009303786110524806, "outcomes in heart": 0.0008658044569477526, "decrease in cd34+vegfr2": 0.0009581787663751352, "patients with diabetes": 0.0009445947084594995, "percent of hospitals": 0.0009154687767183569, "review and network": 0.000883271552942663, "provided during office": 0.0009445947084594995, "therapy in patients": 0.0008997940083549217, "mortality and readmissions": 0.0009956449307649, "outcome in patients": 0.0008997940083549217, "relationship between sex": 0.0009711846008729415, "levels in patients": 0.000883271552942663, "management of heart": 0.0008997940083549217, "550 dyn s": 0.0006714520231820191, "death in patients": 0.0008658044569477526, "prescribed therapy were": 0.0009581787663751352, "loading and uninephrectomy": 0.0009956449307649, "group of patients": 0.0008658044569477526, "survival in patients": 0.0009154687767183569, "bridge to transplantation": 0.0009836594343941379, "use and outcomes": 0.0008472781190425757, "develops after ring": 0.0008997940083549217, "reduction by surgery": 0.0009154687767183569, "old man had": 0.0007327751786988557, "after the surgery": 0.0008658044569477526, "incidence and predictors": 0.0009711846008729415, "need of diuretics": 0.0008658044569477526, "observed in patients": 0.0009154687767183569, "associated with heart": 0.0009303786110524806, "safety of spironolactone": 0.0009711846008729415, "associated with risk": 0.0009154687767183569, "risk of hyperkalemia": 0.0009154687767183569, "remodeling in heart": 0.0008997940083549217, "progression to heart": 0.0009154687767183569, "effects of b": 0.0007593650711122975, "function and remodeling": 0.0009581787663751352, "outcomes for patients": 0.0009303786110524806, "seen in medium": 0.0008064721292221147, "ischemia and heart": 0.000883271552942663, "reduction with ivabradine": 0.0009836594343941379, "ventricle in heart": 0.000883271552942663, "months of treatment": 0.0008997940083549217, "assessed by echocardiography": 0.0010182916589827587, "prognosis in patients": 0.0009303786110524806, "ph with heart": 0.0007838254010042559, "tonometric indices were": 0.0009581787663751352, "test in patients": 0.0008472781190425757, "chronic disease such": 0.0009154687767183569, "frailty and risk": 0.0008472781190425757, "risk for heart": 0.0008064721292221147, "assess the association": 0.0009445947084594995, "association between frailty": 0.001007178034773029, "years of age": 0.0007593650711122975, "number of studies": 0.0008658044569477526, "cause of death": 0.0008064721292221147, "outpatients with heart": 0.0009445947084594995, "blockers and \u03b2": 0.0008064721292221147, "adjusted for demographics": 0.0009836594343941379, "rates and risk": 0.0008064721292221147, "mortality in women": 0.000883271552942663, "associated with outcomes": 0.0009711846008729415, "reclassification of risk": 0.0009711846008729415, "performed at baseline": 0.0009303786110524806, "impact of heart": 0.0008275557287880785, "imaging on chelation": 0.0009154687767183569, "disease in patients": 0.0008997940083549217, "failure and arrhythmias": 0.0009581787663751352, "morphology and duration": 0.0009581787663751352, "duration and extent": 0.0008997940083549217, "examined the impact": 0.0008997940083549217, "majority of patients": 0.0009154687767183569, "inhibitor or angiotensin": 0.0009711846008729415, "occurred during follow": 0.0009445947084594995, "failure in rats": 0.0008275557287880785, "adjustment for age": 0.000883271552942663, "cardiac remodelling is": 0.0009445947084594995, "biological phenotype had": 0.0009711846008729415, "as a result": 0.0007327751786988557, "point of care": 0.0007838254010042559, "cause of mortality": 0.000883271552942663, "baseline and heart": 0.000883271552942663, "in the study": 0.0007593650711122975, "reserve in patients": 0.0008997940083549217, "on the basis": 0.0007593650711122975, "diagnostic features such": 0.0009711846008729415, "mortality and morbidity": 0.0009581787663751352, "cardiac washout was": 0.0008997940083549217, "treatment with carvedilol": 0.0009836594343941379, "contextual factors such": 0.0009581787663751352, "delay the onset": 0.0008275557287880785, "treatment with ivabradine": 0.0009836594343941379, "response to exercise": 0.0009154687767183569, "proportion of patients": 0.0009445947084594995, "patient with heart": 0.000883271552942663, "efficacy of eplerenone": 0.0009445947084594995, "risk for hyperkalemia": 0.0009303786110524806, "subgroups of patients": 0.0009303786110524806, "inclusion and exclusion": 0.0009581787663751352, "advances in treatment": 0.0009303786110524806, "limited data are": 0.0008472781190425757, "given the lack": 0.0008064721292221147, "program of exercise": 0.0008997940083549217, "exercise with testosterone": 0.0009956449307649, "risk for stroke": 0.0008275557287880785, "important comorbidities such": 0.0010182916589827587, "recent data is": 0.0008064721292221147, "compared with sham": 0.000883271552942663, "therapy in heart": 0.0008472781190425757, "occurs in patients": 0.000883271552942663, "function in children": 0.0009154687767183569, "admission to discharge": 0.0009445947084594995, "contribution of nursing": 0.0009581787663751352, "physician continuity further": 0.0010182916589827587, "month after discharge": 0.0009303786110524806, "form the foundation": 0.0008997940083549217, "trial of heart": 0.0008064721292221147, "symptoms and signs": 0.000883271552942663, "progression of heart": 0.0009154687767183569, "matched and sex": 0.0008275557287880785, "impact of carvedilol": 0.0009154687767183569, "treated with bisphosphonates": 0.0010182916589827587, "reversed by metoprolol": 0.0009445947084594995, "internal diameter were": 0.0009445947084594995, "levels of plasma": 0.0008472781190425757, "care of patients": 0.0008472781190425757, "transitions of care": 0.0008997940083549217, "measures of hr": 0.0008064721292221147, "measurement of hr": 0.0008658044569477526, "management and telehealth": 0.0009836594343941379, "training on outcomes": 0.0009154687767183569, "worsening of heart": 0.000883271552942663, "patient population has": 0.0009445947084594995, "ability to inhibit": 0.000883271552942663, "efficacy of mineralocorticoid": 0.0010290152499740676, "major complications had": 0.0009581787663751352, "rates of patients": 0.0008658044569477526, "fit men had": 0.0007327751786988557, "prevention and treatment": 0.0009711846008729415, "expenditure on health": 0.0009303786110524806, "cardiac pathophysiology is": 0.0009956449307649, "patient care is": 0.0008275557287880785, "assess the impact": 0.0008658044569477526, "clinical outcomes such": 0.0009445947084594995, "end of life": 0.0007327751786988557, "assess the safety": 0.0008658044569477526, "\u00b1 14 m": 0.0005475455413516535, "primary symptoms are": 0.0009154687767183569, "risk factors such": 0.0008658044569477526, "active individuals are": 0.0009445947084594995, "recreational athletes more": 0.0009956449307649, "training for heart": 0.000883271552942663, "% to +": 0.0005475455413516535, "support and barriers": 0.0009154687767183569, "reduction with beta": 0.0008997940083549217, "admitted to hospital": 0.0009154687767183569, "evaluate the cost": 0.0008658044569477526, "use and quality": 0.0008275557287880785, "use of evidence": 0.0008275557287880785, "database to assess": 0.0004416357764713315, "improvements for patients": 0.0004918297171970689, "admitted with pneumonia": 0.0004790893831875676, "patients with respect": 0.0004651893055262403, "respect to alterations": 0.00047229735422974975, "alterations in body": 0.00044989700417746083, "associated with changes": 0.0004790893831875676, "changes in body": 0.00041377786439403925, "neurohormones and adipokines": 0.0005091458294913794, "associated with body": 0.0004577343883591784, "composition with regard": 0.0004790893831875676, "chf and individuals": 0.00044989700417746083, "follow up body": 0.00040323606461105735, "correlation to changes": 0.00047229735422974975, "associated with plasma": 0.00047229735422974975, "adiponectin at baseline": 0.0004790893831875676, "correlate to changes": 0.0004577343883591784, "changes in nps": 0.00040323606461105735, "nps or adiponectin": 0.0004416357764713315, "adiponectin during follow": 0.0004918297171970689, "prevalence of heart": 0.00044989700417746083, "requires a presence": 0.00044989700417746083, "presence of signs": 0.0004329022284738763, "signs and symptoms": 0.0004416357764713315, "developed this guideline": 0.00048559230043647075, "guideline to present": 0.0004577343883591784, "present the evidence": 0.0004577343883591784, "deficiency in adult": 0.00044989700417746083, "language on anemia": 0.0004416357764713315, "includes all clinicians": 0.0004790893831875676, "grades the evidence": 0.00044989700417746083, "evidence and recommendations": 0.0005091458294913794, "use of erythropoiesis": 0.0004651893055262403, "agents in patients": 0.0004416357764713315, "benefits of anemia": 0.0004416357764713315, "treatment in patients": 0.0004651893055262403, "evaluate the benefits": 0.0004651893055262403, "benefits and harms": 0.0004416357764713315, "harms of treatments": 0.00044989700417746083, "treatments for anemia": 0.0004651893055262403, "anemia in adults": 0.00042363905952128787, "trials of blood": 0.00041377786439403925, "agents in adults": 0.00042363905952128787, "adults with anemia": 0.0004416357764713315, "studies of transfusion": 0.00047229735422974975, "data on study": 0.00039191270050212794, "assessed for quality": 0.0004577343883591784, "trial of patients": 0.0004329022284738763, "tolerance and quality": 0.0004651893055262403, "trials of erythropoiesis": 0.00048559230043647075, "associated with harms": 0.0004651893055262403, "transfusions in patients": 0.00048559230043647075, "confounded by indication": 0.00048559230043647075, "failure and iron": 0.00042363905952128787, "warrants further study": 0.00047229735422974975, "anemia and heart": 0.00042363905952128787, "conditioning for patients": 0.0004918297171970689, "fraction and patients": 0.0004651893055262403, "ways to deal": 0.00037968253555614875, "identification and enrollment": 0.0005145076249870338, "as the authors": 0.00040323606461105735, "review and meta": 0.00041377786439403925, "mortality in heart": 0.0004416357764713315, "conducted a meta": 0.00042363905952128787, "analysis to identify": 0.0004577343883591784, "addressed the association": 0.0004918297171970689, "predictor and mortality": 0.0004790893831875676, "found for age": 0.00039191270050212794, "shocks during follow": 0.0004577343883591784, "hours of admission": 0.0004416357764713315, "within each strategy": 0.0004577343883591784, "treatment or placebo": 0.0004577343883591784, "change in serum": 0.00041377786439403925, "c from enrollment": 0.0004329022284738763, "dopamine or nesiritide": 0.00047229735422974975, "study to promote": 0.00042363905952128787, "adoption of heart": 0.0004329022284738763, "lessons for nurse": 0.0004329022284738763, "studies in practice": 0.00044989700417746083, "issues and strategies": 0.0004651893055262403, "individuals and organizations": 0.0005145076249870338, "testimonies and conversations": 0.0005145076249870338, "conversations with participating": 0.0005295488244016098, "benefits of involvement": 0.0004790893831875676, "regulator of growth": 0.00044989700417746083, "plasticity in cardiomyocytes": 0.0005091458294913794, "mechanisms to coordinate": 0.00048559230043647075, "structure by changing": 0.0004651893055262403, "altering the gene": 0.0004329022284738763, "growth and plasticity": 0.0004651893055262403, "setting of disease": 0.0004416357764713315, "proteomics to identify": 0.00047229735422974975, "abundance during disease": 0.00048559230043647075, "of these proteins": 0.0004329022284738763, "hypertrophy and failure": 0.0004790893831875676, "knockdown of nucleolin": 0.00047229735422974975, "hearts of fish": 0.00040323606461105735, "looping and myocyte": 0.00044989700417746083, "underlying these defects": 0.00048559230043647075, "system of zebrafish": 0.00044989700417746083, "examine the role": 0.00042363905952128787, "shared between development": 0.00049782246538245, "factors and outcomes": 0.0004577343883591784, "identify the effect": 0.00044989700417746083, "compared with defibrillator": 0.0005035890173865145, "mortality after hospitalization": 0.0005246977664040327, "years after hospitalization": 0.0005035890173865145, "among the study": 0.00041377786439403925, "value for age": 0.00039191270050212794, "changes in circulating": 0.00047229735422974975, "outcome in heart": 0.00042363905952128787, "evaluated the association": 0.0004918297171970689, "capacity and outcomes": 0.0004651893055262403, "min in peak": 0.00036638758934942785, "found an interaction": 0.0004577343883591784, "cfus and diabetes": 0.0004329022284738763, "requires further examination": 0.0005091458294913794, "applications of readmission": 0.0005035890173865145, "impact on hospital": 0.0004416357764713315, "change and correlation": 0.00047229735422974975, "correlation between performance": 0.0005246977664040327, "deciles and level": 0.0004329022284738763, "level of agreement": 0.0004416357764713315, "conditions and metrics": 0.00047229735422974975, "using the ppr": 0.00039191270050212794, "approaches to computing": 0.0004790893831875676, "rankings and impact": 0.00044989700417746083, "placed on readmission": 0.0004651893055262403, "discharge in patients": 0.0004651893055262403, "readmission to hospital": 0.0004790893831875676, "hospital for heart": 0.0004416357764713315, "potential to deliver": 0.0004577343883591784, "care and management": 0.00044989700417746083, "way to meet": 0.00036638758934942785, "outcomes for adults": 0.00044989700417746083, "supplemented by hand": 0.0004577343883591784, "extracted and validity": 0.00047229735422974975, "trial of implanted": 0.0004416357764713315, "met the inclusion": 0.0004329022284738763, "effect on mortality": 0.00044989700417746083, "investigation of apoptosis": 0.00049782246538245, "participation of apoptosis": 0.00049782246538245, "development of pacing": 0.0004651893055262403, "blot and dna": 0.00037968253555614875, "increased in heart": 0.0004416357764713315, "increased in dogs": 0.0004329022284738763, "weeks of pacing": 0.00041377786439403925, "band of activated": 0.0004329022284738763, "difference between numbers": 0.00049782246538245, "favour of apoptosis": 0.00044989700417746083, "pathogenesis of heart": 0.0004651893055262403, "attributed to activation": 0.00048559230043647075, "incidence of pump": 0.0004329022284738763, "failure or driveline": 0.0004577343883591784, "avoids a redo": 0.00039191270050212794, "used this technique": 0.00044989700417746083, "technique to exchange": 0.0004651893055262403, "loss and transfusion": 0.0004577343883591784, "deaths or strokes": 0.0004329022284738763, "blocker and beta": 0.00042363905952128787, "blockers at guideline": 0.0004651893055262403, "assesses the impact": 0.00044989700417746083, "uptitrations in patients": 0.00048559230043647075, "correction for age": 0.0004416357764713315, "hospitalized with heart": 0.0004790893831875676, "failure and associations": 0.00048559230043647075, "differences in plasma": 0.0004651893055262403, "levels between reduced": 0.00047229735422974975, "evaluate the relationship": 0.0004918297171970689, "relates to sex": 0.00040323606461105735, "accounting for hospital": 0.0004790893831875676, "compared with men": 0.0004329022284738763, "fraction and sex": 0.00042363905952128787, "among all subgroups": 0.00044989700417746083, "p for heterogeneity": 0.00044989700417746083, "among these subgroups": 0.0004651893055262403, "failure in children": 0.00044989700417746083, "cause of morbidity": 0.0004416357764713315, "mortality in childhood": 0.00047229735422974975, "practitioners in office": 0.0004790893831875676, "based or emergency": 0.0004416357764713315, "disease and symptoms": 0.0004577343883591784, "relationships with mortality": 0.0005091458294913794, "read the article": 0.00042363905952128787, "impairment at hospitalization": 0.0005145076249870338, "time of discharge": 0.0004329022284738763, "analyzed the association": 0.00048559230043647075, "mortality or readmission": 0.00048559230043647075, "patients as having": 0.0004416357764713315, "for each year": 0.00039191270050212794, "calculated the percentage": 0.0004918297171970689, "perform a control": 0.0004329022284738763, "patients with failing": 0.0004651893055262403, "ability to augment": 0.0004416357764713315, "comparison of predictors": 0.00048559230043647075, "predictors of heart": 0.00044989700417746083, "patients with versus": 0.0004577343883591784, "ability to identify": 0.00044989700417746083, "studied the patients": 0.0004577343883591784, "patients having heart": 0.0004651893055262403, "study the impact": 0.00042363905952128787, "impact of self": 0.00040323606461105735, "gender and adherence": 0.0004577343883591784, "stimulation of endothelial": 0.00049782246538245, "impaired in patients": 0.0004577343883591784, "effects of exercise": 0.00044989700417746083, "evaluate the impact": 0.00044989700417746083, "pathways in patients": 0.0004577343883591784, "incubated with hdl": 0.0004416357764713315, "malondialdehyde and hdl": 0.0004790893831875676, "assessed by flow": 0.00042363905952128787, "proteome of hdl": 0.00041377786439403925, "profiled by shotgun": 0.00044989700417746083, "stimulation of phosphorylation": 0.0005196876292743613, "amount of malondialdehyde": 0.0004918297171970689, "bound to hdl(nyha": 0.0004329022284738763, "effect on hdl": 0.00039191270050212794, "correlation between changes": 0.0005035890173865145, "changes in hdl": 0.00040323606461105735, "production and flow": 0.00044989700417746083, "improved the hdl": 0.00042363905952128787, "value for plasma": 0.00042363905952128787, "value for admission": 0.00044989700417746083, "measured in plasma": 0.0004416357764713315, "patients with dyspnea": 0.0004651893055262403, "time of inclusion": 0.0004329022284738763, "point for predicting": 0.0004577343883591784, "years after admission": 0.0004651893055262403, "disease by angiotensin": 0.00047229735422974975, "investigate the pathophysiology": 0.0005246977664040327, "targets for hhd": 0.00041377786439403925, "develop a novel": 0.00041377786439403925, "infusion and uninephrectomy": 0.0005035890173865145, "infusion and salt": 0.0004329022284738763, "shortening and increases": 0.00048559230043647075, "increases in lung": 0.0004329022284738763, "after the addition": 0.0004416357764713315, "addition of salt": 0.00042363905952128787, "model to study": 0.00040323606461105735, "study the transition": 0.0004577343883591784, "transition from compensated": 0.0005035890173865145, "approach to predict": 0.00044989700417746083, "risk in communities": 0.00044989700417746083, "increases in incidence": 0.00047229735422974975, "associated with incident": 0.00048559230043647075, "age and race": 0.00037968253555614875, "% in women": 0.00035182462347885647, "women and men": 0.00039191270050212794, "survival after left": 0.00044989700417746083, "lvad and patients": 0.0004329022284738763, "survival to hospital": 0.0004577343883591784, "mortality at hospital": 0.0004651893055262403, "eligibility for heart": 0.0004651893055262403, "reviewed the evidence": 0.0004651893055262403, "effects and cost": 0.00042363905952128787, "complications after implantation": 0.0005295488244016098, "status and device": 0.0004329022284738763, "limits in models": 0.00042363905952128787, "conclude that evidence": 0.00047229735422974975, "selected and program": 0.0004577343883591784, "infrastructure and budget": 0.0004918297171970689, "effects of biventricular": 0.00048559230043647075, "establish a control": 0.00044989700417746083, "analysis of twist": 0.0004329022284738763, "correlated with twist": 0.0004651893055262403, "correlated with rs": 0.0004416357764713315, "surrogates for changes": 0.00047229735422974975, "changes in rs": 0.00039191270050212794, "lack of correlation": 0.00044989700417746083, "correlation of remaining": 0.00048559230043647075, "muscles with left": 0.0004329022284738763, "report the case": 0.00041377786439403925, "reported in patients": 0.0004577343883591784, "hypertension with vasodilators": 0.0005196876292743613, "vasodilators and diuretics": 0.00049782246538245, "reduction in blood": 0.0004416357764713315, "demonstrated a reduction": 0.00048559230043647075, "in this patient": 0.00041377786439403925, "surgery by echocardiography": 0.0005035890173865145, "time of surgery": 0.00041377786439403925, "confirmed no findings": 0.0004651893055262403, "restriction of leaflet": 0.00047229735422974975, "resection and edge": 0.0004416357764713315, "at this time": 0.00037968253555614875, "as the mitral": 0.00039191270050212794, "closure and opening": 0.00044989700417746083, "at the time": 0.00036638758934942785, "years after valve": 0.0004329022284738763, "at this point": 0.00039191270050212794, "evaluated in patients": 0.0004651893055262403, "stratification for death": 0.00048559230043647075, "hospitalization in heart": 0.00048559230043647075, "set of variables": 0.00042363905952128787, "using a quality": 0.00041377786439403925, "curves and log": 0.00040323606461105735, "data to predict": 0.00041377786439403925, "predictors of end": 0.0004329022284738763, "disease in outpatients": 0.00047229735422974975, "factor in heart": 0.00041377786439403925, "equation and patients": 0.0004651893055262403, "models for time": 0.00041377786439403925, "constructed and predictors": 0.00049782246538245, "associated with time": 0.0004577343883591784, "epidemic of heart": 0.0004329022284738763, "measure of patients": 0.00044989700417746083, "differences between patients": 0.0005091458294913794, "tested with interaction": 0.0004790893831875676, "curves for death": 0.00042363905952128787, "p=0.27 for interaction": 0.00047229735422974975, "measure of health": 0.0004329022284738763, "including the establishment": 0.0005035890173865145, "prognosis in heart": 0.0004416357764713315, "doses of \u03b2": 0.00035182462347885647, "subjects with heart": 0.00044989700417746083, "bb at enrollment": 0.00042363905952128787, "regimen and sst2": 0.00042363905952128787, "function of baseline": 0.0004577343883591784, "dose of metoprolol": 0.0004416357764713315, "found for heart": 0.00041377786439403925, "across all study": 0.00042363905952128787, "effects in vivo": 0.00041377786439403925, "limited by chemical": 0.00044989700417746083, "instability and cogeneration": 0.0005091458294913794, "cogeneration of nitrite": 0.0004790893831875676, "report on effects": 0.0004329022284738763, "inhibition of protein": 0.0004651893055262403, "dogs with tachypacing": 0.0004651893055262403, "assessed by end": 0.00041377786439403925, "donor to enhance": 0.00042363905952128787, "predictors of response": 0.00047229735422974975, "score for predicting": 0.0004577343883591784, "score for prediction": 0.0004577343883591784, "identify the association": 0.00048559230043647075, "score with death": 0.00042363905952128787, "trials to reduce": 0.00042363905952128787, "mortality in adults": 0.00044989700417746083, "studied the effectiveness": 0.0004918297171970689, "spironolactone in adults": 0.00048559230043647075, "identified all adults": 0.0004651893055262403, "regression with time": 0.0004577343883591784, "covariates to evaluate": 0.00047229735422974975, "association between spironolactone": 0.0005388119933541983, "use and death": 0.00039191270050212794, "risk of hospitalization": 0.0004790893831875676, "injury during spironolactone": 0.0005091458294913794, "cohort with incident": 0.0004577343883591784, "use of spironolactone": 0.0004651893055262403, "associated with risks": 0.0004651893055262403, "risks of hospitalization": 0.00048559230043647075, "benefits of spironolactone": 0.00049782246538245, "effects of beta": 0.00041377786439403925, "perfusion by enhancing": 0.00047229735422974975, "at the end": 0.00035182462347885647, "function in b": 0.00039191270050212794, "compared with vehicle": 0.0004651893055262403, "weeks after b": 0.00039191270050212794, "treated with drug": 0.0004329022284738763, "encoding a decoy": 0.00042363905952128787, "perfusion in b": 0.00040323606461105735, "compared with b": 0.00041377786439403925, "angiogenesis in heart": 0.0004651893055262403, "vary by emergency": 0.0004329022284738763, "interventions to improve": 0.00048559230043647075, "increased in human": 0.0004416357764713315, "human and rat": 0.00039191270050212794, "myocytes with volume": 0.0004577343883591784, "regurgitation and aortocaval": 0.0005091458294913794, "in the setting": 0.00040323606461105735, "setting of increased": 0.0004577343883591784, "increase in lung": 0.00042363905952128787, "absence of changes": 0.0004416357764713315, "function and efficiency": 0.0004790893831875676, "explain the failure": 0.00044989700417746083, "inhibition to improve": 0.0004651893055262403, "symptoms and hospitalizations": 0.0005145076249870338, "usefulness of tissue": 0.0004577343883591784, "imaging for assessing": 0.0004651893055262403, "pressure in patients": 0.0004577343883591784, "velocity over tissue": 0.0004577343883591784, "catheterization and transthoracic": 0.0005342505951449326, "echocardiography with measurement": 0.0005342505951449326, "compared with e": 0.00041377786439403925, "aucs of e": 0.00033572601159100957, "using a cutoff": 0.00040323606461105735, "value of e": 0.00035182462347885647, "performance for detecting": 0.0004918297171970689, "relationship in heart": 0.0004651893055262403, "function and prognosis": 0.00047229735422974975, "end of diastole": 0.00041377786439403925, "provides an index": 0.0004329022284738763, "shift in nonsurvivors": 0.0004651893055262403, "along the regression": 0.0004577343883591784, "ratios for variables": 0.0004577343883591784, "failure in pigs": 0.00041377786439403925, "using a stent": 0.00039191270050212794, "medication to prevent": 0.0004651893055262403, "duration of antiplatelet": 0.00048559230043647075, "measurements and positron": 0.0004918297171970689, "ischemia after bottleneck": 0.0004918297171970689, "wk after stenting": 0.0004329022284738763, "afterload of patients": 0.0004651893055262403, "among the patients": 0.0004416357764713315, "placebo or ivabradine": 0.0004651893055262403, "calculated at baseline": 0.00047229735422974975, "measured by arm": 0.00041377786439403925, "reduction by ivabradine": 0.0004790893831875676, "reduction in patients": 0.0004651893055262403, "levels to survival": 0.0004416357764713315, "indicator in patients": 0.0004651893055262403, "association of hypoalbuminemia": 0.0005196876292743613, "characteristics and laboratory": 0.0005196876292743613, "hypoalbuminemia before surgery": 0.0005196876292743613, "impact of normalization": 0.0004790893831875676, "analysis of patients": 0.0004577343883591784, "levels by correcting": 0.0004577343883591784, "way to improve": 0.00040323606461105735, "evaluated for lvad": 0.0004416357764713315, "insufficiency after left": 0.00048559230043647075, "accompanied by heart": 0.0004577343883591784, "capacity and symptoms": 0.0004651893055262403, "failure and sepsis": 0.0004416357764713315, "oversewing or leaflet": 0.0004651893055262403, "determine the characteristics": 0.0005145076249870338, "adhere to medication": 0.0004577343883591784, "% in ages": 0.00033572601159100957, "etiology and comorbidities": 0.00049782246538245, "differences in presentation": 0.0005035890173865145, "presentation and outcomes": 0.0004918297171970689, "walking in patients": 0.00044989700417746083, "minutes of exercise": 0.00044989700417746083, "symptoms of anxiety": 0.00044989700417746083, "care in improving": 0.0004329022284738763, "improve the management": 0.00047229735422974975, "value in patients": 0.0004329022284738763, "obtained at admission": 0.0004651893055262403, "specificity for identifying": 0.0005035890173865145, "factors at admission": 0.0004577343883591784, "levels of brain": 0.00041377786439403925, "levels of creatinine": 0.0004577343883591784, "dose and oxygen": 0.00041377786439403925, "dobutamine or norepinephrine": 0.0005091458294913794, "admission and follow": 0.0004577343883591784, "factor in patients": 0.0004416357764713315, "present a case": 0.00040323606461105735, "presented with prolapse": 0.0004790893831875676, "time to complete": 0.00042363905952128787, "sample and subgroups": 0.0004577343883591784, "limits of agreement": 0.00044989700417746083, "populations to define": 0.0004651893055262403, "change in repeated": 0.0004416357764713315, "associated with elevations": 0.00049782246538245, "elevations in tumor": 0.00044989700417746083, "showed no benefit": 0.0004329022284738763, "worsening of disease": 0.0004577343883591784, "studied the risk": 0.00042363905952128787, "among a group": 0.00039191270050212794, "receiving these agents": 0.00047229735422974975, "agents to treat": 0.00041377786439403925, "enter the study": 0.00041377786439403925, "stratified by propensity": 0.00048559230043647075, "use of loop": 0.00036638758934942785, "elevated in subjects": 0.0004577343883591784, "test for interaction": 0.0004577343883591784, "exercise to improve": 0.00044989700417746083, "life for people": 0.00041377786439403925, "people with heart": 0.0004329022284738763, "assess the benefits": 0.00044989700417746083, "benefits of participation": 0.0004918297171970689, "programme for patients": 0.00047229735422974975, "capacity and quality": 0.0004577343883591784, "satisfaction and sustainability": 0.0005246977664040327, "found in quality": 0.00042363905952128787, "improvements with others": 0.00048559230043647075, "evidence of perceived": 0.0004651893055262403, "met in relation": 0.00041377786439403925, "relation to sustainability": 0.00049782246538245, "sustainability with commissioning": 0.0005342505951449326, "programmes on completion": 0.00048559230043647075, "impact of frailty": 0.0004329022284738763, "assessed the association": 0.00048559230043647075, "age of participants": 0.00044989700417746083, "risk after adjusting": 0.0004577343883591784, "decrease in score": 0.0004329022284738763, "controlled for death": 0.0004577343883591784, "based on diabetes": 0.0004329022284738763, "disease at baseline": 0.00044989700417746083, "change in c": 0.00036638758934942785, "role of vasopressin": 0.00044989700417746083, "approaches to improving": 0.0004790893831875676, "improving the prognosis": 0.0004790893831875676, "prognosis of patients": 0.0004651893055262403, "interruption of activated": 0.0004918297171970689, "use of antagonists": 0.0004416357764713315, "antagonists and inhibitors": 0.00049782246538245, "secretion of arginine": 0.0004651893055262403, "reactivate the transcription": 0.0005091458294913794, "driving these gene": 0.0004416357764713315, "human and mouse": 0.00041377786439403925, "developed a phenotype": 0.0004651893055262403, "resistance to pressure": 0.00047229735422974975, "dysfunction and induction": 0.0004918297171970689, "inhibition of mir-25": 0.0004577343883591784, "sensitized the murine": 0.0004651893055262403, "myocardium to heart": 0.00044989700417746083, "integrate with micrornas": 0.00048559230043647075, "micrornas to induce": 0.00044989700417746083, "induce the expression": 0.0004651893055262403, "myocardium with impact": 0.00047229735422974975, "epidemiology and treatment": 0.00049782246538245, "use of bisoprolol": 0.0004329022284738763, "% of subjects": 0.00039191270050212794, "base of treatment": 0.0004329022284738763, "includes the use": 0.00042363905952128787, "use of angiotensin": 0.0004416357764713315, "blockers in case": 0.00042363905952128787, "case of angiotensin": 0.00044989700417746083, "blockers and mineralocorticoid": 0.0005196876292743613, "effectiveness of bisoprolol": 0.0005035890173865145, "bisoprolol in reducing": 0.00047229735422974975, "patients with type": 0.0004416357764713315, "diabetes to heart": 0.0004329022284738763, "hallmark of type": 0.00042363905952128787, "metabolism and survival": 0.0004790893831875676, "determine the role": 0.0004416357764713315, "mice and liver": 0.00040323606461105735, "features of heart": 0.0004329022284738763, "expression and activation": 0.0004918297171970689, "action through activation": 0.0004918297171970689, "activation of p38": 0.0004329022284738763, "dysfunction during insulin": 0.00049782246538245, "resistance and type": 0.00044989700417746083, "variation in use": 0.00042363905952128787, "use of recommended": 0.0004416357764713315, "variation in rates": 0.0004416357764713315, "rates of guideline": 0.0004416357764713315, "treatment for outpatients": 0.0004918297171970689, "examine the association": 0.0004790893831875676, "association between treatment": 0.0005145076249870338, "variation and practice": 0.00047229735422974975, "rates of treatment": 0.0004416357764713315, "treatment with angiotensin": 0.00049782246538245, "determined for patients": 0.0004790893831875676, "describes the likelihood": 0.00048559230043647075, "patient with given": 0.0004416357764713315, "% for angiotensin": 0.0004329022284738763, "% for \u03b2": 0.00029732629973073545, "use of guideline": 0.00042363905952128787, "medications for patients": 0.00048559230043647075, "component of improving": 0.00047229735422974975, "patients with breast": 0.0004577343883591784, "use of trastuzumab": 0.0004416357764713315, "associated with cardiotoxicity": 0.0005196876292743613, "associated with trastuzumab": 0.0005035890173865145, "diagnosed with stage": 0.0004577343883591784, "treated with chemotherapy": 0.0004918297171970689, "% in nontrastuzumab": 0.00044989700417746083, "increased the risk": 0.0004416357764713315, "rates of trastuzumb": 0.00044989700417746083, "treated with trastuzumab": 0.00048559230043647075, "confirm the role": 0.00042363905952128787, "frequency of administration": 0.0005035890173865145, "development of trastuzumab": 0.00049782246538245, "scores and mortality": 0.0004577343883591784, "women with heart": 0.00042363905952128787, "recommendations for patients": 0.0005091458294913794, "based on data": 0.00039191270050212794, "evidence on associations": 0.00048559230043647075, "patterns with outcomes": 0.00047229735422974975, "scores with mortality": 0.0004651893055262403, "date of death": 0.00039191270050212794, "calculated from food": 0.0004577343883591784, "for a median": 0.00037968253555614875, "years of follow": 0.00041377786439403925, "biomarker in heart": 0.0004416357764713315, "study of exercise": 0.0004329022284738763, "associated with measures": 0.00048559230043647075, "associated with death": 0.0004651893055262403, "ratios for log2": 0.00041377786439403925, "outcomes after adjustment": 0.0004918297171970689, "risk as assessed": 0.00042363905952128787, "assessed by changes": 0.00044989700417746083, "expand the transplant": 0.0004651893055262403, "pool by matching": 0.00042363905952128787, "donors and recipients": 0.0004651893055262403, "age or comorbidity": 0.0004416357764713315, "paucity of data": 0.00041377786439403925, "contributing to survival": 0.00048559230043647075, "second to determine": 0.00044989700417746083, "associated with assignment": 0.00049782246538245, "frequency of diabetes": 0.0004651893055262403, "in a multivariate": 0.0004329022284738763, "change in readmissions": 0.00047229735422974975, "readmissions and follow": 0.0004790893831875676, "visits as part": 0.00040323606461105735, "quantify the change": 0.00044989700417746083, "readmissions as part": 0.0004577343883591784, "assessments of patients": 0.0004790893831875676, "days of hospital": 0.00042363905952128787, "known about patient": 0.00044989700417746083, "quantified the change": 0.0004651893055262403, "events at follow": 0.00042363905952128787, "age of patients": 0.00041377786439403925, "cardiologist or heart": 0.0004651893055262403, "percent of patients": 0.00044989700417746083, "patients had blood": 0.0004416357764713315, "decreased in parallel": 0.0004651893055262403, "testing and medication": 0.00047229735422974975, "changes at follow": 0.0004329022284738763, "pathophysiology of heart": 0.00048559230043647075, "relationship between pathobiology": 0.0005342505951449326, "pathophysiology and prognosis": 0.0005145076249870338, "patients with suspected": 0.0004790893831875676, "patients with confirmed": 0.0004790893831875676, "quantified by tissuefaxs": 0.00048559230043647075, "associated with prognosis": 0.0004918297171970689, "treatment and risk": 0.0004416357764713315, "patients with thalassaemia": 0.00049782246538245, "verify the impact": 0.0004329022284738763, "value for heart": 0.00041377786439403925, "changes in treatment": 0.0004577343883591784, "year for heart": 0.00040323606461105735, "choice of chelation": 0.00044989700417746083, "influence the risk": 0.0004416357764713315, "compliance with treatment": 0.0004918297171970689, "impact of ejection": 0.0004416357764713315, "prolongation and ejection": 0.0004918297171970689, "assess the effect": 0.0004329022284738763, "results of patients": 0.00044989700417746083, "patients with baseline": 0.00047229735422974975, "trend for improvement": 0.0004651893055262403, "compared with subjects": 0.00047229735422974975, "contributes to heart": 0.0004577343883591784, "comorbidities in heart": 0.00047229735422974975, "dd of collagen": 0.00040323606461105735, "deposition and titin": 0.0004577343883591784, "rats after heart": 0.00042363905952128787, "groups of rats": 0.00040323606461105735, "weeks with repeat": 0.0004329022284738763, "assessed at euthanization": 0.0004918297171970689, "contributions of titin": 0.00047229735422974975, "measure of left": 0.00041377786439403925, "examine the ability": 0.00044989700417746083, "measured by index": 0.0004329022284738763, "stroke and hospitalisation": 0.00049782246538245, "hospitalisation for heart": 0.0004918297171970689, "hospitalisations for heart": 0.00049782246538245, "duration on outcomes": 0.0004577343883591784, "mortality or heart": 0.0004416357764713315, "for this substudy": 0.0004329022284738763, "extent of benefit": 0.0004329022284738763, "support the use": 0.00041377786439403925, "needs further investigation": 0.0005035890173865145, "overload in heart": 0.0004329022284738763, "complications of therapy": 0.00048559230043647075, "decrease in re": 0.00040323606461105735, "hospitalizations and length": 0.0005035890173865145, "option in refractory": 0.0004577343883591784, "usefulness and consequences": 0.0005035890173865145, "therapy in dialysis": 0.00044989700417746083, "deferred in dialysis": 0.0004577343883591784, "lack of benefit": 0.00041377786439403925, "performed a case": 0.00042363905952128787, "matching for age": 0.00042363905952128787, "blocker and angiotensin": 0.0004790893831875676, "assessed for evidence": 0.0004651893055262403, "improvement in ejection": 0.0004790893831875676, "in the case": 0.00036638758934942785, "increase in ejection": 0.0004577343883591784, "compared with dialysis": 0.00047229735422974975, "improvement after device": 0.00048559230043647075, "stiffness and function": 0.00047229735422974975, "approaches to stop": 0.0004416357764713315, "patients with treated": 0.0004651893055262403, "consumed the dash": 0.0004329022284738763, "resistin in chemotherapy": 0.00048559230043647075, "failure in humanized": 0.0004577343883591784, "treated for breast": 0.0004416357764713315, "mediator of insulin": 0.00044989700417746083, "development and severity": 0.00048559230043647075, "severity of heart": 0.0004329022284738763, "resistin in heart": 0.0004329022284738763, "resistin but transgenic": 0.0004790893831875676, "basal and inflammation": 0.00047229735422974975, "induction of serum": 0.0004416357764713315, "controls not expressing": 0.0004790893831875676, "treated with doxorubicin": 0.00048559230043647075, "levels in women": 0.00041377786439403925, "elevation in resistin": 0.0004651893055262403, "correlated with decline": 0.0004790893831875676, "decline in ejection": 0.00044989700417746083, "effects on macrophages": 0.00047229735422974975, "link between inflammation": 0.0004918297171970689, "outcomes of catheter": 0.0004577343883591784, "fibrillation in patients": 0.00048559230043647075, "investigate the efficacy": 0.00048559230043647075, "safety of catheter": 0.0004416357764713315, "patients with compensated": 0.0004918297171970689, "probability after catheter": 0.00049782246538245, "ablation and factors": 0.0004577343883591784, "relating to maintenance": 0.0004790893831875676, "strain and strain": 0.0004329022284738763, "echocardiography at baseline": 0.0005091458294913794, "months after ablation": 0.0004651893055262403, "lack of hypertension": 0.0004577343883591784, "associated with maintenance": 0.0005035890173865145, "rate at systole": 0.00041377786439403925, "rate at diastole": 0.00042363905952128787, "rhythm at follow": 0.00042363905952128787, "composite of repeat": 0.00044989700417746083, "procedures and pharmaceuticals": 0.0005196876292743613, "pharmaceuticals in patients": 0.0005035890173865145, "verify the benefit": 0.0004416357764713315, "dysfunction in doxorubicin": 0.00049782246538245, "mechanism of cardioprotection": 0.0005145076249870338, "effect of nicorandil": 0.0004577343883591784, "administration of doxorubicin": 0.0005145076249870338, "doxorubicin in rats": 0.00044989700417746083, "h after receiving": 0.0004329022284738763, "dose of doxorubicin": 0.00044989700417746083, "sacrificed and hearts": 0.0004651893055262403, "excised for estimation": 0.00047229735422974975, "contents in addition": 0.0004577343883591784, "addition to cytochrome": 0.00047229735422974975, "alleviating the decrement": 0.0004918297171970689, "decrement of heart": 0.0004416357764713315, "induced by doxorubicin": 0.00047229735422974975, "contents by restoring": 0.0004651893055262403, "capacity and creatine": 0.0004651893055262403, "effect of doxorubicin": 0.0004651893055262403, "development of doxorubicin": 0.00049782246538245, "rats as indicated": 0.0004329022284738763, "indicated by improvement": 0.00048559230043647075, "months of isolated": 0.0004416357764713315, "risk of stroke": 0.00040323606461105735, "rehospitalization for stroke": 0.0005091458294913794, "estimate the risk": 0.0004329022284738763, "adjusting for confounders": 0.0004918297171970689, "days of follow": 0.00040323606461105735, "events after adjustment": 0.0004790893831875676, "increased in patients": 0.0004651893055262403, "patients with estimated": 0.0004790893831875676, "burden in adult": 0.00041377786439403925, "cause of heart": 0.00040323606461105735, "transplants in children": 0.0004790893831875676, "symptoms in children": 0.0004577343883591784, "subgroup of children": 0.0004577343883591784, "restriction to flow": 0.00044989700417746083, "comprise those children": 0.0004790893831875676, "topics of debate": 0.00042363905952128787, "diagnosis and management": 0.00048559230043647075, "responses to heart": 0.0004416357764713315, "survivors of childhood": 0.00047229735422974975, "scaffolds in heart": 0.0004416357764713315, "ability of cardiomyocytes": 0.0004918297171970689, "cardiomyocytes to detect": 0.00048559230043647075, "myocardium in response": 0.00047229735422974975, "workload during stress": 0.00047229735422974975, "adaptation to stress": 0.0004577343883591784, "leading to heart": 0.00042363905952128787, "number of cases": 0.00041377786439403925, "requires a signalosome": 0.00047229735422974975, "drives the assembly": 0.00044989700417746083, "pathway to facilitate": 0.0004651893055262403, "role in determining": 0.00044989700417746083, "field of investigation": 0.00047229735422974975, "patient with diagnosis": 0.00047229735422974975, "frailty in heart": 0.00042363905952128787, "indicator in heart": 0.0004416357764713315, "accumulation of deficits": 0.00048559230043647075, "method has strengths": 0.0004577343883591784, "strengths and limitations": 0.0004918297171970689, "proportion of deficits": 0.00047229735422974975, "sex and ejection": 0.00042363905952128787, "alternative to ascertain": 0.00048559230043647075, "shaping the future": 0.0004416357764713315, "characterized by disappointments": 0.0005295488244016098, "studies of therapeutics": 0.0004790893831875676, "agents and antagonists": 0.00047229735422974975, "antagonists of endothelin": 0.0004918297171970689, "highlighted the role": 0.0004577343883591784, "points and sites": 0.00042363905952128787, "strategies to improve": 0.0004651893055262403, "improve the potential": 0.0004651893055262403, "potential for success": 0.0004651893055262403, "levels of nps": 0.00039191270050212794, "patients at risk": 0.00042363905952128787, "embolism or diabetes": 0.0004577343883591784, "like other biomarkers": 0.0004651893055262403, "measurement of nps": 0.0004416357764713315, "systems for measuring": 0.0004651893055262403, "settings to monitor": 0.00044989700417746083, "monitor the risk": 0.00042363905952128787, "use of protocol": 0.00041377786439403925, "within the time": 0.00041377786439403925, "accelerate the throughput": 0.0004918297171970689, "throughput and disposition": 0.00049782246538245, "rethinking the quality": 0.00047229735422974975, "quality of outcome": 0.0004416357764713315, "mortality and readmission": 0.0004918297171970689, "hospitals to improve": 0.0004577343883591784, "improve the quality": 0.00044989700417746083, "fibrosis and inflammation": 0.0004918297171970689, "associated with chromatin": 0.0004918297171970689, "family of acetyl": 0.00042363905952128787, "activate a signal": 0.0004329022284738763, "set of transcription": 0.0004577343883591784, "changes in cardiomyocytes": 0.0004918297171970689, "bets from chromatin": 0.00044989700417746083, "suppression of downstream": 0.0004918297171970689, "investigating the role": 0.00047229735422974975, "role of bets": 0.00037968253555614875, "hypertrophy of cardiomyocytes": 0.0005145076249870338, "achieved through knockdown": 0.00049782246538245, "presence or absence": 0.00044989700417746083, "abrogated the induction": 0.0004790893831875676, "induced in mice": 0.00041377786439403925, "toxicity or effects": 0.00044989700417746083, "tissue from mice": 0.00042363905952128787, "targets of bets": 0.00041377786439403925, "role in chromatin": 0.0004329022284738763, "factor of activated": 0.00044989700417746083, "via the targeting": 0.0004329022284738763, "targeting of chromatin": 0.00047229735422974975, "respiration for quantification": 0.0005196876292743613, "t1 in swine": 0.00036638758934942785, "swine with heart": 0.00042363905952128787, "sequence to quantify": 0.0004577343883591784, "model of tachycardia": 0.0004577343883591784, "implanted with pacemakers": 0.0004918297171970689, "min to induce": 0.00039191270050212794, "percentage of fibrosis": 0.00047229735422974975, "fibrosis of heart": 0.0004329022284738763, "tissue from control": 0.00044989700417746083, "administration of contrast": 0.00049782246538245, "animals with heart": 0.0004416357764713315, "compared with tissue": 0.0004577343883591784, "without the use": 0.00041377786439403925, "associated with increases": 0.0004918297171970689, "technique for detecting": 0.0004790893831875676, "approach to assess": 0.0004416357764713315, "increase by means": 0.0004329022284738763, "means of stress": 0.00041377786439403925, "used for factors": 0.00042363905952128787, "terms of medication": 0.00044989700417746083, "in the multivariate": 0.00044989700417746083, "adjusted for age": 0.00042363905952128787, "age and sex": 0.00036638758934942785, "increase during exercise": 0.00048559230043647075, "use of devices": 0.00040323606461105735, "devices in heart": 0.00042363905952128787, "become a cornerstone": 0.0004577343883591784, "cornerstone of heart": 0.0004577343883591784, "symptoms and mortality": 0.00047229735422974975, "collected in patients": 0.0004651893055262403, "data in patients": 0.00042363905952128787, "development of lifesaving": 0.0004918297171970689, "in this work": 0.00037968253555614875, "exposed to angiotensin": 0.00047229735422974975, "induced to overexpress": 0.00047229735422974975, "prevented the loss": 0.0004416357764713315, "role in downregulation": 0.00047229735422974975, "procedures and management": 0.0004918297171970689, "in this summary": 0.00041377786439403925, "structure and function": 0.00047229735422974975, "behind the development": 0.00047229735422974975, "populations of patients": 0.0004790893831875676, "represent a group": 0.0004329022284738763, "trends in heart": 0.00041377786439403925, "adjustment for patient": 0.00047229735422974975, "indicating a change": 0.00044989700417746083, "activity and hemostasis": 0.0004790893831875676, "hemostasis in patients": 0.00047229735422974975, "metoprolol in reducing": 0.00047229735422974975, "reducing the risk": 0.0004329022284738763, "events in heart": 0.00041377786439403925, "correlates with levels": 0.00047229735422974975, "serve as markers": 0.00042363905952128787, "markers for coagulability": 0.0004918297171970689, "study with masked": 0.0004329022284738763, "randomized to equipotent": 0.00048559230043647075, "dosages of carvedilol": 0.0004651893055262403, "carvedilol or metoprolol": 0.00048559230043647075, "activity as measured": 0.0004577343883591784, "markers of hemostasis": 0.0004651893055262403, "wk of treatment": 0.00041377786439403925, "medications to adults": 0.0004651893055262403, "prescribing of guideline": 0.00048559230043647075, "prescribed a \u03b2": 0.00040323606461105735, "reasons for nontreatment": 0.00048559230043647075, "identified from clinic": 0.00047229735422974975, "patients not receiving": 0.00047229735422974975, "drugs for heart": 0.00041377786439403925, "nonprescribing as chart": 0.0004790893831875676, "in these interviews": 0.00044989700417746083, "preferences and nonadherence": 0.0005091458294913794, "thirds of patients": 0.0004416357764713315, "receive these medications": 0.0004918297171970689, "tone by pyridostigmine": 0.00047229735422974975, "onset of heart": 0.00040323606461105735, "alternative to slow": 0.00044989700417746083, "improved by acetylcholinesterase": 0.0005295488244016098, "elicited in adult": 0.0004329022284738763, "methylatropine and propranolol": 0.0005196876292743613, "caused by methylatropine": 0.00048559230043647075, "caused by propranolol": 0.0004651893055262403, "reduced the basal": 0.0004329022284738763, "control of heart": 0.00042363905952128787, "reduced the myocyte": 0.00044989700417746083, "diameter and collagen": 0.0004651893055262403, "assessed by means": 0.0004329022284738763, "treated with pyridostigmine": 0.0005035890173865145, "administration of pyridostigmine": 0.0005295488244016098, "geometry and fiber": 0.0004416357764713315, "depolarization and myofiber": 0.0005035890173865145, "aspects in extending": 0.0004577343883591784, "culprit in extending": 0.0004577343883591784, "aspects of remodeling": 0.0004651893055262403, "onset of myofiber": 0.0004329022284738763, "examine the relationships": 0.0004918297171970689, "function on body": 0.00042363905952128787, "linked to weight": 0.00042363905952128787, "assessment of body": 0.0004416357764713315, "defined as death": 0.00042363905952128787, "risk of event": 0.00039191270050212794, "wasting of fat": 0.00040323606461105735, "tolerance in heart": 0.0004416357764713315, "test the effects": 0.00042363905952128787, "effects of treatment": 0.0004577343883591784, "ivabradine on exercise": 0.00047229735422974975, "filling in patients": 0.00044989700417746083, "time by controlling": 0.00044989700417746083, "onset of symptoms": 0.0004329022284738763, "assigned to ivabradine": 0.00047229735422974975, "undertaken at rest": 0.0004416357764713315, "improvement between baseline": 0.0005091458294913794, "reduction in exercise": 0.0004651893055262403, "difference in heart": 0.00044989700417746083, "increase in heart": 0.0004329022284738763, "rate during exercise": 0.0004577343883591784, "change with treatment": 0.0004651893055262403, "correlates of increase": 0.00047229735422974975, "increase in exercise": 0.0004577343883591784, "correlated with increase": 0.00048559230043647075, "tool to predict": 0.00041377786439403925, "predict the absence": 0.00044989700417746083, "prognostic and treatment": 0.00048559230043647075, "rule to exclude": 0.00041377786439403925, "derived a prediction": 0.0004577343883591784, "rule of having": 0.00040323606461105735, "eliminate the need": 0.0004416357764713315, "need for angiography": 0.0004577343883591784, "savings and risk": 0.00042363905952128787, "patients in addition": 0.0004577343883591784, "use in heart": 0.00037968253555614875, "failure and outcomes": 0.0004577343883591784, "potential of diuretics": 0.00047229735422974975, "diuretics to modulate": 0.0004651893055262403, "options and challenges": 0.00047229735422974975, "older have heart": 0.00042363905952128787, "ranging from medication": 0.0004790893831875676, "stratification of patient": 0.0004918297171970689, "failure and delivery": 0.0004577343883591784, "delivery of therapies": 0.0004651893055262403, "determination of risk": 0.0004651893055262403, "responses in cardiomyocytes": 0.0005035890173865145, "altered in heart": 0.00042363905952128787, "effects on beta": 0.00041377786439403925, "property of being": 0.0004329022284738763, "increase in camp": 0.00042363905952128787, "radioenzymatic- and fluorescence": 0.0005295488244016098, "expression and activity": 0.0004790893831875676, "infusions in rats": 0.0004329022284738763, "fold and camp": 0.00039191270050212794, "enhanced by stimulation": 0.0004790893831875676, "reduced the rise": 0.00042363905952128787, "rise in camp": 0.00037968253555614875, "levels and l": 0.00037968253555614875, "protection from norepinephrine": 0.0005196876292743613, "investigate the safety": 0.00047229735422974975, "days of inclusion": 0.0004329022284738763, "underuse of eplerenone": 0.00047229735422974975, "fear of inducing": 0.00042363905952128787, "analysis of subgroups": 0.0004651893055262403, "leading to study": 0.00042363905952128787, "discontinuation or hospitalization": 0.0005388119933541983, "risk of potassium": 0.0004329022284738763, "hospitalization for hyperkalemia": 0.0005295488244016098, "hyperkalemia or discontinuation": 0.0005246977664040327, "discontinuation of study": 0.00048559230043647075, "including an egfr": 0.0004329022284738763, "status in patients": 0.0004416357764713315, "impact on health": 0.00042363905952128787, "explore the relation": 0.0004577343883591784, "relation of hemoglobin": 0.00047229735422974975, "hrqol and training": 0.0004416357764713315, "changes in hrqol": 0.00042363905952128787, "cohort of patients": 0.0004416357764713315, "trial of exercise": 0.0004329022284738763, "effects on hrqol": 0.00042363905952128787, "correlation with baseline": 0.0004918297171970689, "hrqol as measured": 0.0004329022284738763, "effects of hrqol": 0.00042363905952128787, "hrqol from exercise": 0.00044989700417746083, "modulated by baseline": 0.0004651893055262403, "analysis of rhythm": 0.0004416357764713315, "strategies in patients": 0.00047229735422974975, "in a substudy": 0.00039191270050212794, "expenditures of patients": 0.00048559230043647075, "rhythm and rate": 0.00041377786439403925, "using a cost": 0.00037968253555614875, "utilization and unit": 0.0004577343883591784, "supplemented by disease": 0.0004790893831875676, "structure in patients": 0.0004651893055262403, "failure and type": 0.00042363905952128787, "alterations in skm": 0.0004416357764713315, "facilitate the reversal": 0.0004790893831875676, "in a pilot": 0.00035182462347885647, "immunohistochemistry and electron": 0.0005342505951449326, "perturbations in components": 0.0005035890173865145, "microstructure at baseline": 0.00049782246538245, "alterations in markers": 0.00047229735422974975, "markers of skm": 0.00040323606461105735, "means of improving": 0.0004416357764713315, "cardiomyopathy in patients": 0.00049782246538245, "evaluate the effectiveness": 0.00049782246538245, "treatment for patients": 0.00047229735422974975, "verify the efficacy": 0.00044989700417746083, "enzymes in patients": 0.00044989700417746083, "evaluating the changes": 0.00047229735422974975, "period in patients": 0.0004416357764713315, "measured in serum": 0.0004329022284738763, "serum and leukocytes": 0.0004577343883591784, "leukocytes of participants": 0.00049782246538245, "intolerance in heart": 0.0004577343883591784, "update on exercise": 0.0004416357764713315, "parameters for diagnosis": 0.00048559230043647075, "provides an update": 0.0004416357764713315, "pressure of end": 0.00041377786439403925, "addition to prognosis": 0.0004651893055262403, "underlie these exercise": 0.0004790893831875676, "evaluating the effect": 0.0004651893055262403, "effect of interventions": 0.0004790893831875676, "surgery in heart": 0.00042363905952128787, "treatment for end": 0.0004329022284738763, "consultations and procedures": 0.0005091458294913794, "year of oht": 0.00036638758934942785, "oht in recipients": 0.0004329022284738763, "bridged to transplantation": 0.00049782246538245, "interval from transplantation": 0.0005145076249870338, "transplantation to consultation": 0.0005246977664040327, "interval from consultation": 0.00049782246538245, "consultation to operation": 0.0004918297171970689, "problems in patients": 0.0004577343883591784, "bridged to transplant": 0.0004651893055262403, "consultations and operations": 0.0005091458294913794, "oxygenation as bridge": 0.0004651893055262403, "bridge to recovery": 0.0004416357764713315, "recovery in infarction": 0.00047229735422974975, "arrest in need": 0.00040323606461105735, "failure with therapy": 0.0004577343883591784, "half of patients": 0.00042363905952128787, "incidence and mortality": 0.0004790893831875676, "outcomes of heart": 0.0004329022284738763, "support this contention": 0.0004790893831875676, "ratio for death": 0.00041377786439403925, "year after discharge": 0.0004577343883591784, "% of incident": 0.00039191270050212794, "lack of improvement": 0.00044989700417746083, "therapy during exercise": 0.0004790893831875676, "assessed the feasibility": 0.00048559230043647075, "testosterone or placebo": 0.0004790893831875676, "assessed in terms": 0.0004329022284738763, "terms of recruitment": 0.0004577343883591784, "compliance to exercise": 0.00047229735422974975, "exercise and injections": 0.0004790893831875676, "injections in patients": 0.00047229735422974975, "completed the study": 0.00044989700417746083, "improvements in shuttle": 0.0004790893831875676, "improvements from baseline": 0.00049782246538245, "baseline in peak": 0.00042363905952128787, "exercise with placebo": 0.0004651893055262403, "status in heart": 0.00041377786439403925, "investigate the effects": 0.0004790893831875676, "parameters in patients": 0.00047229735422974975, "program or placebo": 0.0004416357764713315, "completion of training": 0.00047229735422974975, "warrants further investigation": 0.0005196876292743613, "candidates for cell": 0.00044989700417746083, "affects the explant": 0.00044989700417746083, "determine the effect": 0.0004577343883591784, "number and phenotype": 0.0004577343883591784, "level of epithelial": 0.00044989700417746083, "expression of pluripotency": 0.00049782246538245, "compared with shams": 0.00044989700417746083, "stimulated the pluripotency": 0.0005035890173865145, "phenotype and function": 0.00047229735422974975, "function and cell": 0.0004329022284738763, "arrest in humans": 0.00042363905952128787, "effect on pb": 0.00037968253555614875, "period or amplitude": 0.00044989700417746083, "anticoagulants or antiplatelet": 0.0005196876292743613, "role in treating": 0.00042363905952128787, "progress in anticoagulation": 0.0005035890173865145, "patients in sinus": 0.0004329022284738763, "agents or anticoagulants": 0.00048559230043647075, "tools for risk": 0.00040323606461105735, "stratification and clarity": 0.00049782246538245, "regarding the need": 0.0004416357764713315, "agents in combination": 0.0004651893055262403, "combination with anticoagulants": 0.0005246977664040327, "nutrition in heart": 0.0004416357764713315, "points to alterations": 0.0004651893055262403, "provides an overview": 0.0004577343883591784, "imbalance as seen": 0.0004329022284738763, "regulation of feeding": 0.0004651893055262403, "role for inflammation": 0.0004651893055262403, "interventions in heart": 0.00047229735422974975, "cardiomyocytes in response": 0.00049782246538245, "biomarkers in patients": 0.00047229735422974975, "sensitivity and time": 0.0004577343883591784, "indicated an increase": 0.0004651893055262403, "levels by dnx": 0.00039191270050212794, "bolus of metoprolol": 0.00044989700417746083, "metoprolol or atropine": 0.00047229735422974975, "tachycardia in response": 0.0004790893831875676, "prevented the increase": 0.00047229735422974975, "increase in circulating": 0.0004790893831875676, "centers to evaluate": 0.00044989700417746083, "evaluate the effect": 0.00044989700417746083, "evidence of left": 0.00042363905952128787, "composite of death": 0.0004416357764713315, "hospitalization for worsening": 0.0005145076249870338, "stopped for futility": 0.0004577343883591784, "data and safety": 0.00041377786439403925, "reduce the rate": 0.00041377786439403925, "rate of death": 0.00039191270050212794, "device and extracorporeal": 0.0004918297171970689, "investigate the impact": 0.00047229735422974975, "study in children": 0.0004329022284738763, "followed by vad": 0.00041377786439403925, "comparison of baseline": 0.00047229735422974975, "during the study": 0.00042363905952128787, "group until day": 0.00041377786439403925, "continued until day": 0.00044989700417746083, "decline in egfr": 0.00041377786439403925, "scores for hospitalized": 0.0004790893831875676, "mandate to ensure": 0.0004329022284738763, "outcomes of nursing": 0.00044989700417746083, "aspects of nursing": 0.0004416357764713315, "difference in outcome": 0.0004651893055262403, "exists from admission": 0.0004651893055262403, "records of patients": 0.00044989700417746083, "improvement in outcome": 0.00047229735422974975, "ratings from admission": 0.00047229735422974975, "nursing to outcomes": 0.00044989700417746083, "outcomes of hospitalized": 0.00048559230043647075, "advancement of science": 0.00047229735422974975, "highlighting the contribution": 0.0005145076249870338, "care to outcomes": 0.00042363905952128787, "response and progression": 0.00048559230043647075, "actions on adenylyl": 0.00044989700417746083, "desensitization and downregulation": 0.0005388119933541983, "activation of \u03b21ars": 0.00044989700417746083, "action on camp": 0.00040323606461105735, "overexpressing both \u03b21ar": 0.00048559230043647075, "occur after stimulation": 0.0004790893831875676, "triggered by isoproterenol": 0.00049782246538245, "regulation in mouse": 0.00044989700417746083, "demonstrate that restoration": 0.0005091458294913794, "overstimulation in heart": 0.00048559230043647075, "impact of physician": 0.00044989700417746083, "continuity on death": 0.00044989700417746083, "readmission after discharge": 0.0005035890173865145, "rates of death": 0.00040323606461105735, "death and readmission": 0.0004651893055262403, "continuity further influences": 0.0005145076249870338, "outcomes after discharge": 0.00048559230043647075, "data from linked": 0.00042363905952128787, "models with time": 0.00042363905952128787, "covariates to analyze": 0.0004651893055262403, "analyze the effect": 0.0004416357764713315, "effect of follow": 0.00042363905952128787, "seen the patient": 0.00042363905952128787, "taking into account": 0.00044989700417746083, "discharge and physician": 0.0004790893831875676, "examine the state": 0.0004329022284738763, "phosphorylation and ser23/24": 0.0005091458294913794, "demonstrated no change": 0.00047229735422974975, "change in type": 0.00040323606461105735, "expression of type": 0.0004416357764713315, "focusing of ri\u03b1": 0.00041377786439403925, "blots with site": 0.00041377786439403925, "mutant as compared": 0.0004416357764713315, "instability in patients": 0.0004790893831875676, "investigate the role": 0.0004577343883591784, "records of surface": 0.0004416357764713315, "ecgs at baseline": 0.00042363905952128787, "pacing and esmolol": 0.0004416357764713315, "normalized to heart": 0.00044989700417746083, "group during fixed": 0.0004416357764713315, "compared with baseline": 0.00047229735422974975, "blockade with esmolol": 0.0004651893055262403, "fluctuations in beat": 0.0004577343883591784, "consequence of heart": 0.0004577343883591784, "failure in survivors": 0.0004577343883591784, "risk for developing": 0.00044989700417746083, "exposure to anthracyclines": 0.00049782246538245, "examined the association": 0.00048559230043647075, "frame for selecting": 0.00044989700417746083, "length of follow": 0.00042363905952128787, "variants of genes": 0.0004329022284738763, "web of complicity": 0.0004329022284738763, "in this guideline": 0.0004329022284738763, "moves a step": 0.00037968253555614875, "language to describe": 0.0004577343883591784, "describe the development": 0.00048559230043647075, "development and defects": 0.0004790893831875676, "foundation for describing": 0.0004918297171970689, "describing a uniform": 0.0004577343883591784, "view to foster": 0.00040323606461105735, "effort to provide": 0.0004329022284738763, "insight into mechanisms": 0.0004790893831875676, "mechanisms of disease": 0.0004651893055262403, "inhibitor in heart": 0.0004416357764713315, "system by preventing": 0.0004577343883591784, "preventing the breakdown": 0.00048559230043647075, "peptide and b": 0.00039191270050212794, "signs of heart": 0.00040323606461105735, "diagnosis and initiation": 0.00048559230043647075, "initiation of therapy": 0.0004651893055262403, "stabilize the patient": 0.0004651893055262403, "summarizes the principles": 0.0004918297171970689, "implications of biomarkers": 0.00049782246538245, "results from dysfunction": 0.00048559230043647075, "focus of research": 0.0004329022284738763, "measurement and modification": 0.0005091458294913794, "provide a window": 0.00042363905952128787, "use of biomarkers": 0.0004329022284738763, "result of shortcomings": 0.00047229735422974975, "shortcomings in research": 0.00048559230043647075, "dearth of biomarker": 0.00044989700417746083, "implications of promising": 0.0004918297171970689, "discuss the need": 0.00042363905952128787, "standards in biomarker": 0.00047229735422974975, "provide an overview": 0.00044989700417746083, "overview of biomarker": 0.0004651893055262403, "micrornas in heart": 0.0004416357764713315, "targets in disease": 0.0004416357764713315, "body of evidence": 0.00042363905952128787, "pathogenesis and progression": 0.0005091458294913794, "expression of target": 0.0004577343883591784, "genes by sequence": 0.0004329022284738763, "region of messenger": 0.00044989700417746083, "results in degradation": 0.00047229735422974975, "remodeling and heart": 0.0004577343883591784, "give an overview": 0.00042363905952128787, "potential of mirnas": 0.00044989700417746083, "targets for heart": 0.0004329022284738763, "inhibitors in heart": 0.00044989700417746083, "abnormalities and exercise": 0.00049782246538245, "capacity in adults": 0.0004416357764713315, "filling during exercise": 0.0004790893831875676, "spectroscopy as did": 0.00044989700417746083, "% of predicted": 0.00040323606461105735, "compared with age": 0.0004329022284738763, "derived from comparison": 0.0004790893831875676, "in a sample": 0.00036638758934942785, "analysis to determine": 0.0004651893055262403, "determine the presence": 0.00047229735422974975, "practice and research": 0.0004651893055262403, "fragments of n": 0.00040323606461105735, "peptides in plasma": 0.0004416357764713315, "misdiagnosis of heart": 0.0004651893055262403, "plasma by use": 0.00039191270050212794, "use of immunoprecipitation": 0.00049782246538245, "identified the presence": 0.0004790893831875676, "forms of circulating": 0.0004577343883591784, "concentration of circulating": 0.0005091458294913794, "increased with antibodies": 0.0004918297171970689, "use of antibodies": 0.0004329022284738763, "support the development": 0.0004790893831875676, "hypertrophy in heart": 0.0004577343883591784, "rates of hypertension": 0.0004651893055262403, "adjustment for covariates": 0.0004918297171970689, "pressure to end": 0.00041377786439403925, "-1.5 to -0.5": 0.00037968253555614875, "evaluate the effects": 0.0004577343883591784, "effects of carvedilol": 0.0004651893055262403, "patients with devices": 0.0004651893055262403, "received a device": 0.0004329022284738763, "types of beta": 0.00039191270050212794, "delivered as antitachycardia": 0.0005091458294913794, "reduction in risk": 0.0004329022284738763, "reduced in patients": 0.00044989700417746083, "use of beta": 0.00036638758934942785, "rate in patients": 0.00042363905952128787, "investigate the occurrence": 0.00049782246538245, "occurrence of heart": 0.00044989700417746083, "users of bisphosphonates": 0.00048559230043647075, "bisphosphonates and raloxifene": 0.0005196876292743613, "comprised the control": 0.0004651893055262403, "years for alendronate-": 0.00047229735422974975, "etidronate- and raloxifene": 0.00049782246538245, "increased in users": 0.0004416357764713315, "users of bisphophonates": 0.0004790893831875676, "mechanism of action": 0.00044989700417746083, "alendronate and etidronate": 0.00049782246538245, "compliance for etidronate": 0.0004918297171970689, "decreased for alendronate": 0.0004918297171970689, "compared to age-": 0.00042363905952128787, "age- and gender": 0.00041377786439403925, "users of alendronate": 0.0004577343883591784, "showed a dose": 0.00039191270050212794, "alterations by metoprolol": 0.0004918297171970689, "metoprolol in heart": 0.00044989700417746083, "order to examine": 0.00042363905952128787, "examine the reversibility": 0.0004918297171970689, "reversibility of heart": 0.00047229735422974975, "rates of changes": 0.00042363905952128787, "changes in pressure": 0.00044989700417746083, "decreases in septum": 0.00044989700417746083, "animals with metoprolol": 0.0004790893831875676, "norepinephrine and dopamine": 0.0005035890173865145, "levels of epinephrine": 0.0004651893055262403, "level for \u03b2": 0.00036638758934942785, "performance by \u03b2": 0.00042363905952128787, "stages of heart": 0.00041377786439403925, "reversal of changes": 0.00044989700417746083, "associated with atherosclerosis": 0.0005246977664040327, "atherosclerosis and incident": 0.0005091458294913794, "within the population": 0.0004651893055262403, "association between psoriasis": 0.0005145076249870338, "events for psoriasis": 0.0004577343883591784, "pressure and body": 0.0004329022284738763, "risk of incident": 0.00042363905952128787, "increased in psoriasis": 0.00047229735422974975, "events as subjects": 0.0004416357764713315, "dysfunction in patients": 0.0004790893831875676, "prevalence and characteristics": 0.0005196876292743613, "patients had brain": 0.0004416357764713315, "associated with age": 0.00044989700417746083, "quartile of e": 0.00039191270050212794, "highlighting these patients": 0.0005035890173865145, "addition to indicating": 0.00047229735422974975, "training of patients": 0.0004577343883591784, "variability in risk": 0.00044989700417746083, "majority of studies": 0.00044989700417746083, "risk of mortality": 0.0004329022284738763, "used in risk": 0.00037968253555614875, "variability to identify": 0.0004790893831875676, "order to assess": 0.00041377786439403925, "assess the risk": 0.00041377786439403925, "tool for risk": 0.00039191270050212794, "present with hypertension": 0.0004918297171970689, "hypertension and end": 0.0004577343883591784, "foundation of management": 0.00048559230043647075, "revascularization with angioplasty": 0.0005388119933541983, "angioplasty and stenting": 0.00048559230043647075, "benefit for patients": 0.0004577343883591784, "regarding the role": 0.0004416357764713315, "role of stenting": 0.00042363905952128787, "guidelines on evaluation": 0.00048559230043647075, "evaluation and management": 0.0004918297171970689, "provide the framework": 0.0004651893055262403, "framework for determining": 0.0004918297171970689, "assessment and treatment": 0.00048559230043647075, "plans for patients": 0.0004416357764713315, "analysis of microarray": 0.00047229735422974975, "related to heart": 0.00042363905952128787, "used for diagnosis": 0.0004416357764713315, "diagnosis and treatment": 0.0004790893831875676, "observe the difference": 0.00047229735422974975, "groups of samples": 0.0004329022284738763, "regulation of programmed": 0.00048559230043647075, "biomarkers to distinguish": 0.0004918297171970689, "types of heart": 0.00040323606461105735, "targets to develop": 0.0004416357764713315, "effects of care": 0.00041377786439403925, "mortality and healthcare": 0.00048559230043647075, "integrates a content": 0.0004577343883591784, "system with care": 0.00042363905952128787, "intervention and survival": 0.0004918297171970689, "survival and utilization": 0.00048559230043647075, "groups after matching": 0.0004651893055262403, "admissions from baseline": 0.00048559230043647075, "use or number": 0.00039191270050212794, "number of hospital": 0.0004416357764713315, "days for participants": 0.0004651893055262403, "admissions for individuals": 0.00049782246538245, "disease and mortality": 0.0004651893055262403, "coupled with content": 0.0004577343883591784, "technology has potential": 0.00048559230043647075, "potential to improve": 0.0004577343883591784, "strength of race": 0.00042363905952128787, "association with exercise": 0.0004918297171970689, "association between race": 0.00048559230043647075, "race and outcomes": 0.0004329022284738763, "interactions with exercise": 0.00049782246538245, "performed an analysis": 0.0004651893055262403, "explored an interaction": 0.0004790893831875676, "interaction with exercise": 0.0004918297171970689, "significantly more hypertension": 0.0005246977664040327, "hypertension and diabetes": 0.0004918297171970689, "interaction between race": 0.00048559230043647075, "race in patients": 0.00042363905952128787, "rationale and design": 0.0004577343883591784, "anticoagulation and rate": 0.00048559230043647075, "offset by side": 0.00040323606461105735, "effects of repeated": 0.00044989700417746083, "practice of delayed": 0.00044989700417746083, "safety of rhythm": 0.00042363905952128787, "af at risk": 0.00035182462347885647, "spent in hospital": 0.0004329022284738763, "consist of anticoagulation": 0.00049782246538245, "therapy of underlying": 0.0004651893055262403, "device to monitor": 0.0004329022284738763, "function and quality": 0.0004577343883591784, "bleeding in patients": 0.0004577343883591784, "treated with implantation": 0.0004918297171970689, "as the use": 0.00035182462347885647, "housed on units": 0.00041377786439403925, "managing the device": 0.00044989700417746083, "develop an understanding": 0.00048559230043647075, "groups to manage": 0.00042363905952128787, "manage this population": 0.00047229735422974975, "management of end": 0.0004329022284738763, "increase in incidence": 0.0004651893055262403, "incidence and prevalence": 0.00048559230043647075, "causes of death": 0.00041377786439403925, "death and hospitalisation": 0.0004918297171970689, "as a consequence": 0.00042363905952128787, "increase in life": 0.00042363905952128787, "patients with end": 0.0004329022284738763, "fall into stage": 0.00041377786439403925, "failure at rest": 0.00041377786439403925, "in this article": 0.00041377786439403925, "treatment of end": 0.00042363905952128787, "inhibition of l": 0.00041377786439403925, "supports the plateau": 0.0004577343883591784, "trigger for excitation": 0.00047229735422974975, "failure in humans": 0.0004329022284738763, "modes of l": 0.00035182462347885647, "contributes to cardiomyopathy": 0.0005145076249870338, "via a mechanism": 0.00041377786439403925, "efficacy in vivo": 0.00042363905952128787, "situations in pediatrics": 0.00048559230043647075, "preclude the provision": 0.00047229735422974975, "provision of life": 0.0004329022284738763, "reached the age": 0.00041377786439403925, "decisions about life": 0.0004577343883591784, "presents a case": 0.00041377786439403925, "disease has life": 0.00042363905952128787, "going into heart": 0.00042363905952128787, "reporting on quality": 0.0004577343883591784, "aims to help": 0.00037968253555614875, "based on outcome": 0.00042363905952128787, "measure for heart": 0.0004329022284738763, "created a cohort": 0.00042363905952128787, "estimated the odds": 0.0004416357764713315, "odds of future": 0.00040323606461105735, "quintile of hospitals": 0.0004651893055262403, "repeated this analysis": 0.00047229735422974975, "performance on existing": 0.0004790893831875676, "chosen a hospital": 0.0004329022284738763, "quintile of performance": 0.0004790893831875676, "odds of dying": 0.00039191270050212794, "value for difference": 0.0004577343883591784, "measures of quality": 0.00044989700417746083, "measures at explaining": 0.00047229735422974975, "influences the safety": 0.0004651893055262403, "efficacy of spironolactone": 0.00049782246538245, "incidence of hyperkalemia": 0.0004918297171970689, "caused by mineralocorticoid": 0.0005035890173865145, "vary by race": 0.00037968253555614875, "antagonists in heart": 0.0004577343883591784, "hyperkalemia and outcomes": 0.0004918297171970689, "randomized to spironolactone": 0.0005091458294913794, "rate and heart": 0.00040323606461105735, "increased with spironolactone": 0.0005145076249870338, "race by treatment": 0.0004329022284738763, "throughout the trial": 0.0004577343883591784, "compared with aas": 0.0004329022284738763, "rates of hyperkalemia": 0.0004651893055262403, "rates of hypokalemia": 0.0004577343883591784, "adjustment for differences": 0.00049782246538245, "point of death": 0.00040323606461105735, "hypokalemia with spironolactone": 0.0005246977664040327, "differ by race": 0.00040323606461105735, "proteomics and pathway": 0.00047229735422974975, "analysis of pressure": 0.0004577343883591784, "approach to evaluate": 0.0004577343883591784, "categories of actin": 0.00044989700417746083, "effects on heart": 0.00042363905952128787, "changed in pressure": 0.00044989700417746083, "alterations in tac": 0.0004416357764713315, "rehospitalization of medicare": 0.0005145076249870338, "analyze the relationship": 0.00048559230043647075, "relationship between length": 0.0005035890173865145, "stay and rehospitalization": 0.00049782246538245, "using the implementation": 0.00048559230043647075, "declines in length": 0.0004416357764713315, "decrease in length": 0.0004416357764713315, "hospitalized for ami": 0.0004577343883591784, "reduction in hospital": 0.0004651893055262403, "rate of rehospitalization": 0.0004918297171970689, "outcomes of care": 0.00042363905952128787, "need to improve": 0.00041377786439403925, "costs for patients": 0.0004416357764713315, "association with outcomes": 0.0004918297171970689, "physicians into quintiles": 0.0004918297171970689, "volume of patients": 0.0004416357764713315, "regression to compare": 0.0004651893055262403, "strata of hospital": 0.0004416357764713315, "volume and physician": 0.0004577343883591784, "relationship between physician": 0.0005196876292743613, "volume and mortality": 0.0004577343883591784, "antagonism in heart": 0.00044989700417746083, "using an aldosterone": 0.0004577343883591784, "groups with heart": 0.0004329022284738763, "therapy with beta": 0.0004329022284738763, "reduction in mortality": 0.00047229735422974975, "mortality and hospitalizations": 0.0005196876292743613, "hospitalizations for patients": 0.0005145076249870338, "provide the background": 0.00047229735422974975, "background for aldosterone": 0.00049782246538245, "impact of evidence": 0.0004416357764713315, "improvement in survival": 0.0004790893831875676, "changes in prognosis": 0.0004577343883591784, "basis of heart": 0.00040323606461105735, "dilatation and dysfunction": 0.00049782246538245, "decreases in heart": 0.0004416357764713315, "p<001 and hr": 0.00037968253555614875, "benefits of controlled": 0.00047229735422974975, "emphasizing the importance": 0.00049782246538245, "importance of tailored": 0.00047229735422974975, "continuity of care": 0.0004416357764713315, "threshold in heart": 0.0004416357764713315, "patients with systolic": 0.00047229735422974975, "investigations at study": 0.0004790893831875676, "based on lack": 0.00039191270050212794, "lack of achievement": 0.00044989700417746083, "failure in detecting": 0.0004577343883591784, "modification of diet": 0.0004577343883591784, "associated to prognosis": 0.0004790893831875676, "compared with metabolic": 0.0004790893831875676, "inability to identify": 0.0004651893055262403, "mortality in men": 0.00042363905952128787, "without a history": 0.0004329022284738763, "underwent a baseline": 0.0004577343883591784, "quantified as duration": 0.00047229735422974975, "divided into age": 0.00042363905952128787, "grouped into categories": 0.0004790893831875676, "risk in men": 0.00036638758934942785, "goal of achieving": 0.0004329022284738763, "failure after pressure": 0.00047229735422974975, "alterations in energy": 0.0004651893055262403, "changes in energy": 0.0004329022284738763, "rates of energy": 0.00041377786439403925, "increase in e": 0.00039191270050212794, "decrease in %": 0.00039191270050212794, "decrease in insulin": 0.00044989700417746083, "rates of glycolysis": 0.00044989700417746083, "glycolysis and glucose": 0.00047229735422974975, "translocation of glucose": 0.00048559230043647075, "oxidation of glucose": 0.0004577343883591784, "ratio of phosphocreatine": 0.00048559230043647075, "create an energy": 0.00042363905952128787, "progression from hypertrophy": 0.0005091458294913794, "hypertrophy to heart": 0.0004577343883591784, "reality of heart": 0.00042363905952128787, "factors of developed": 0.0004577343883591784, "risk of raised": 0.00040323606461105735, "% of cases": 0.00035182462347885647, "paradox of having": 0.0004329022284738763, "epidemiology of developed": 0.0004918297171970689, "linked to heart": 0.00041377786439403925, "assessing the link": 0.0004416357764713315, "link between air": 0.00042363905952128787, "pollution and heart": 0.00044989700417746083, "effects of air": 0.00040323606461105735, "pollution on heart": 0.0004416357764713315, "physicians and professionals": 0.0005091458294913794, "lead to hospitalisation": 0.0004790893831875676, "hospitalisation and death": 0.0004918297171970689, "failure in mice": 0.00041377786439403925, "implicated in heart": 0.00044989700417746083, "dysfunction with conduction": 0.0005035890173865145, "abnormalities and hypertrophy": 0.0005145076249870338, "in these studies": 0.00042363905952128787, "decreases in ejection": 0.0004651893055262403, "dilatation and hypertrophy": 0.00049782246538245, "hearts with increased": 0.0004651893055262403, "spite of developments": 0.0004651893055262403, "requires the collaboration": 0.00049782246538245, "collaboration of professionals": 0.0005196876292743613, "indicated by guidelines": 0.0004790893831875676, "communication and collaboration": 0.0005246977664040327, "country has physicians": 0.00047229735422974975, "across the country": 0.0004416357764713315, "strengthen the connection": 0.0004918297171970689, "connection between certified": 0.0005091458294913794, "phase and healthcare": 0.0004577343883591784, "risk for hospitalized": 0.0004651893055262403, "examine the associations": 0.00048559230043647075, "saxagliptin and sitagliptin": 0.0005035890173865145, "insurance and health": 0.0004577343883591784, "therapy with saxagliptin": 0.00048559230043647075, "contributed an average": 0.00047229735422974975, "observed in users": 0.0004329022284738763, "users of saxagliptin": 0.0004577343883591784, "saxagliptin or sitagliptin": 0.00049782246538245, "effectiveness of implementation": 0.0005246977664040327, "strategies in improving": 0.0004790893831875676, "adherence to guideline": 0.00047229735422974975, "recommendations in heart": 0.00048559230043647075, "review to identify": 0.0004416357764713315, "adherence to class": 0.0004416357764713315, "outweigh the risks": 0.0004416357764713315, "methods and analysis": 0.0004577343883591784, "conduct a literature": 0.0004577343883591784, "uptake of class": 0.00041377786439403925, "data in duplicate": 0.0004329022284738763, "level of application": 0.0004577343883591784, "intervention on adherence": 0.0004918297171970689, "referred for device": 0.00044989700417746083, "education at discharge": 0.00047229735422974975, "readmissions and mortality": 0.00049782246538245, "examine the context": 0.00044989700417746083, "synthesise the results": 0.00047229735422974975, "results for meta": 0.00042363905952128787, "discussion and dissemination": 0.0005091458294913794, "impact of implementation": 0.00048559230043647075, "factors on physician": 0.0004577343883591784, "findings through briefing": 0.0004918297171970689, "publications and presentations": 0.0005196876292743613, "discussions to occur": 0.0004577343883591784, "occur between physicians": 0.00048559230043647075, "physicians and heart": 0.0004577343883591784, "reported the patient": 0.0004577343883591784, "preferences and timing": 0.00047229735422974975, "mind to engage": 0.00040323606461105735, "wished further review": 0.0004651893055262403, "preferences and decisions": 0.0004918297171970689, "support the need": 0.00042363905952128787, "need to include": 0.00041377786439403925, "deactivation at implant": 0.0004790893831875676, "discussions about end": 0.0004651893055262403, "using this process": 0.0004416357764713315, "process to help": 0.00041377786439403925, "reduce the number": 0.0004329022284738763, "shocks at end": 0.00039191270050212794, "symptoms and disease": 0.0004577343883591784, "compared with control": 0.0004651893055262403, "change in distribution": 0.00047229735422974975, "burden of heart": 0.00041377786439403925, "report of using": 0.00041377786439403925, "rehabilitation in patients": 0.00049782246538245, "rehabilitation in patient": 0.0004918297171970689, "guide to prescribe": 0.0004416357764713315, "patients as control": 0.00044989700417746083, "intensity to exercise": 0.0004651893055262403, "min after rehabilitation": 0.00048559230043647075, "changes in control": 0.0004416357764713315, "classified as heart": 0.00044989700417746083, "function in hfpef": 0.0004329022284738763, "changes on exercise": 0.00044989700417746083, "history of hypertension": 0.0004790893831875676, "include the patient": 0.00044989700417746083, "rate and rhythm": 0.00041377786439403925, "pressure and auscultation": 0.0004918297171970689, "auscultation to rule": 0.0004577343883591784, "referred to heart": 0.0004329022284738763, "hypertension and hyperlipidaemia": 0.0005295488244016098, "benefits of exercise": 0.0004577343883591784, "depression and dementia": 0.0004790893831875676, "volumes of exercise": 0.00044989700417746083, "individuals with established": 0.0005091458294913794, "death in athletes": 0.0004329022284738763, "death during sport": 0.0004416357764713315, "occur in males": 0.00040323606461105735, "ability to detect": 0.0004329022284738763, "pathways and ion": 0.00042363905952128787, "individuals with cardiomyopathy": 0.0005246977664040327, "system in heart": 0.00041377786439403925, "strength by measuring": 0.0004651893055262403, "measuring the peak": 0.0004416357764713315, "improvement in peak": 0.00044989700417746083, "aerobic and resistance": 0.00047229735422974975, "resulted in benefits": 0.0004577343883591784, "benefits in exercise": 0.0004577343883591784, "strength and quality": 0.0004577343883591784, "need further validation": 0.0004790893831875676, "adherence with exercise": 0.0004790893831875676, "describe the association": 0.00048559230043647075, "barriers to participation": 0.0004918297171970689, "participation with exercise": 0.0005035890173865145, "surveys to assess": 0.0004329022284738763, "indicated more barriers": 0.0004790893831875676, "association between increasing": 0.0005196876292743613, "impact the effect": 0.0004329022284738763, "impact on patients": 0.0004416357764713315, "given that exercise": 0.00044989700417746083, "assessment of perceived": 0.0004790893831875676, "approaches to implement": 0.0004790893831875676, "reduction and exercise": 0.00047229735422974975, "arguments for beta": 0.0004416357764713315, "readmissions in heart": 0.0004651893055262403, "effect on heart": 0.00041377786439403925, "assessed the impact": 0.00044989700417746083, "impact of hr": 0.00037968253555614875, "blockers on exercise": 0.0004577343883591784, "analysis at baseline": 0.0004577343883591784, "doses for beta": 0.00040323606461105735, "patients with resting": 0.0004651893055262403, "versus the latter": 0.0004329022284738763, "decreased at follow": 0.00044989700417746083, "compared to baseline": 0.0004577343883591784, "increase in patients": 0.0004577343883591784, "bpm with beta": 0.00039191270050212794, "achieve this target": 0.00044989700417746083, "shunting for treatment": 0.00047229735422974975, "treatment of patients": 0.0004651893055262403, "safety and proof": 0.00042363905952128787, "interventions to reduce": 0.0004790893831875676, "risk of hospital": 0.00042363905952128787, "shunting in patients": 0.0004577343883591784, "catheterisation with transoesophageal": 0.0005517319811087641, "evaluations at baseline": 0.0004790893831875676, "baseline and months": 0.00044989700417746083, "thrombosis or migration": 0.0004790893831875676, "hospital for worsening": 0.00047229735422974975, "bleeding at month": 0.0004329022284738763, "in this regard": 0.00040323606461105735, "results of studies": 0.0004416357764713315, "receptors and neprilysin": 0.00048559230043647075, "individuals with stabilized": 0.0005035890173865145, "without a need": 0.00040323606461105735, "need to interrupt": 0.0004329022284738763, "interrupt the treatment": 0.0004790893831875676, "become a change": 0.00041377786439403925, "form of heart": 0.00039191270050212794, "excluded by inclusion": 0.0004651893055262403, "weeks of diet": 0.00039191270050212794, "consisted of telephone": 0.00047229735422974975, "completed the trial": 0.00044989700417746083, "combination of exercise": 0.0004790893831875676, "score with exercise": 0.00044989700417746083, "change in peak": 0.00040323606461105735, "change in percent": 0.0004329022284738763, "change in thigh": 0.00041377786439403925, "effect on quality": 0.0004329022284738763, "life as measured": 0.00042363905952128787, "support to patients": 0.00044989700417746083, "hemocompatibility by incorporating": 0.0005388119933541983, "evaluate the performance": 0.00048559230043647075, "performance and safety": 0.00047229735422974975, "adults with ejection": 0.0004577343883591784, "listed for transplant": 0.0004651893055262403, "continued on support": 0.0004577343883591784, "reoperation for bleeding": 0.00048559230043647075, "effectiveness of disease": 0.00048559230043647075, "costs and survival": 0.0004416357764713315, "approach to extrapolating": 0.0004918297171970689, "costs to generate": 0.0004329022284738763, "projections of resource": 0.0004790893831875676, "relationships with time": 0.0004790893831875676, "estimates of resource": 0.0004651893055262403, "ratios from user": 0.00042363905952128787, "validity in replicating": 0.0004790893831875676, "simulations to evaluate": 0.0004790893831875676, "effectiveness of heart": 0.00047229735422974975, "design a program": 0.00042363905952128787, "improvements in functioning": 0.0005035890173865145, "functioning and use": 0.00044989700417746083, "researchers and providers": 0.0004918297171970689, "tool for conducting": 0.00044989700417746083, "analyses of disease": 0.00044989700417746083, "role in supporting": 0.0004416357764713315, "patients in managing": 0.0004577343883591784, "managing this disease": 0.0004651893055262403, "describes the pathophysiology": 0.0005145076249870338, "nurses to understand": 0.0004577343883591784, "understand the pathophysiology": 0.0005196876292743613, "management to alleviate": 0.0004790893831875676, "deter the advancement": 0.0004651893055262403, "heart failure": 0.39034504970011946, "patients with": 0.11012746884109796, "ejection fraction": 0.09870170809204379, "left ventricular": 0.07117136199957635, "associated with": 0.04923956586289067, "hazard ratio": 0.03569015834227798, "% confidence": 0.033412063128941086, "confidence interval": 0.03599176033419687, "compared with": 0.028609627136655342, "myocardial infarction": 0.03256325138683682, "ventricular ejection": 0.032041407185142486, "chronic heart": 0.025082412832136188, "non -": 0.014754891515912067, "preserved ejection": 0.026498146588279894, "p <": 0.010071780347730288, "congestive heart": 0.02372378733319212, "\u03b2 -": 0.00940032832454827, "risk of": 0.014271662387075303, "heart rate": 0.016887581926985112, "natriuretic peptide": 0.02159505620051812, "exercise training": 0.01991350250979831, "this study": 0.015480283433069683, "failure with": 0.016706031564470543, "heart disease": 0.01724415882209363, "ventricular assist": 0.01943197416473859, "% ci": 0.009320059309468333, "failure patients": 0.01779284049989409, "implantable cardioverter": 0.02039487661833177, "post -": 0.011498456368384723, "atrial fibrillation": 0.017995880167098435, "reduced ejection": 0.016945562380851514, "right ventricular": 0.016450284682007297, "acute heart": 0.013922728395278259, "functional capacity": 0.01619629215038859, "p =": 0.005707342197047163, "body mass": 0.011414684394094326, "quality of": 0.011610212574802263, "changes in": 0.011258387951323407, "renal function": 0.012903554067553835, "risk factors": 0.01214984113779676, "assist device": 0.012541206416068094, "type natriuretic": 0.013556449904681212, "systolic heart": 0.012903554067553835, "treatment of": 0.011390476066684464, "resynchronization therapy": 0.014754891515912067, "blood pressure": 0.01209708193833172, "primary outcome": 0.012413335931821179, "mass index": 0.010554738704365694, "increase in": 0.010625240091133407, "pro -": 0.0068856160407589646, "renal dysfunction": 0.012121262397268536, "end point": 0.00940032832454827, "coronary artery": 0.0115857802030331, "in conclusion": 0.010973555614059584, "control group": 0.010973555614059584, "% of": 0.005507307773776742, "cause mortality": 0.01075822447424502, "cardiac resynchronization": 0.01278757264712379, "among patients": 0.010484137679887493, "increased risk": 0.010484137679887493, "in patients": 0.009526077323085124, "in addition": 0.009526077323085124, "terminal pro": 0.009871745924459868, "right heart": 0.009526077323085124, "failure in": 0.00879561558697141, "adverse events": 0.009677665550665376, "cardiovascular events": 0.011164543332629768, "use of": 0.006570546496219842, "glomerular filtration": 0.011164543332629768, "filtration rate": 0.009930668745456941, "development of": 0.009677665550665376, "independently associated": 0.011654215210475298, "consecutive patients": 0.010985625320620283, "- blocker": 0.008057424278184231, "exercise capacity": 0.010389653483373031, "effects of": 0.007740141716534842, "acute myocardial": 0.009320059309468333, "clinical trials": 0.009103113016668864, "estimated glomerular": 0.010070156543901925, "effect of": 0.0073859722550022105, "impact of": 0.0073859722550022105, "dilated cardiomyopathy": 0.010390541793054495, "advanced heart": 0.008871193421443262, "% versus": 0.0069900444821012495, "diastolic mitral": 0.009320059309468333, "mitral valve": 0.008353015782235271, "systolic hf": 0.008060526965687412, "functional class": 0.009320059309468333, "hazard ratios": 0.008622079411046814, "mortality in": 0.007973333246679124, "risk for": 0.006672315187460284, "body composition": 0.008472781190425757, "preserved left": 0.008064721292221149, "diastolic dysfunction": 0.009303786110524806, "left ventricle": 0.008064721292221149, "% vs.": 0.004918297171970689, "change in": 0.006714520231820191, "gene expression": 0.008275557287880786, "outcomes in": 0.007327751786988557, "odds ratio": 0.007036492469577129, "cardiac function": 0.008472781190425757, "functional ms": 0.00783825401004256, "diabetes mellitus": 0.008658044569477526, "pre -": 0.004918297171970689, "adrenergic receptor": 0.008997940083549217, "patients undergoing": 0.008997940083549217, "converting enzyme": 0.008658044569477526, "magnetic resonance": 0.00883271552942663, "peak oxygen": 0.007327751786988557, "reduction in": 0.007213968175566825, "patients in": 0.006961364197639129, "treated with": 0.007213968175566825, "term mortality": 0.007258249162999033, "assist devices": 0.007258249162999033, "risk stratification": 0.008098146075194296, "usual care": 0.006332843222619416, "cardiovascular death": 0.008239218990465211, "reverse remodeling": 0.007949443976483967, "% \u00b1": 0.003021534104319086, "angiotensin receptor": 0.008239218990465211, "artery disease": 0.007258249162999033, "cohort study": 0.006834285640010678, "cardiopulmonary exercise": 0.008740661407856473, "clinical practice": 0.006926435655582021, "systematic review": 0.006926435655582021, "management of": 0.006270603208034047, "cardiac hypertrophy": 0.007198352066839373, "older patients": 0.006451777033776918, "day readmission": 0.006620445830304628, "% vs": 0.003389112476170303, "- b": 0.0026858080927280766, "ventricular dysfunction": 0.0076654301310010815, "a total": 0.004757220795691767, "stage heart": 0.005862201429590846, "medical treatment": 0.006926435655582021, "systolic dysfunction": 0.007323750213746855, "adjusted hazard": 0.006620445830304628, "patients treated": 0.006778224952340606, "improvement in": 0.006451777033776918, "early diastolic": 0.006620445830304628, "pulmonary arterial": 0.007066172423541304, "arterial coupling": 0.006926435655582021, "aortic valve": 0.00607492056889838, "pulmonary hypertension": 0.007556757667675996, "patients receiving": 0.007066172423541304, "receptor blockers": 0.006926435655582021, "type 2": 0.004380364330813228, "the risk": 0.005083668714255455, "rhythm control": 0.006451777033776918, "control therapy": 0.006620445830304628, "defibrillator deactivation": 0.0079651594461192, "role of": 0.004459894495961032, "adults with": 0.005495813840241418, "rates of": 0.004765939419614488, "patients hospitalized": 0.006512650277367364, "diagnosis of": 0.005315555497786082, "function in": 0.00512942625089199, "clinical outcomes": 0.006060631198634268, "proportional hazards": 0.006408281437028498, "mean age": 0.004448210124973522, "levels of": 0.004700164162274135, "blocker therapy": 0.00579289010151655, "therapy in": 0.004925544728703991, "cause of": 0.004448210124973522, "year survival": 0.005486777807029792, "correlated with": 0.00579289010151655, "valve plasty": 0.005315555497786082, "ratio of": 0.004448210124973522, "diastolic function": 0.006182900870598641, "e /": 0.0023500820811370674, "older adults": 0.005315555497786082, "enzyme inhibitors": 0.006060631198634268, "day follow": 0.004925544728703991, "induced heart": 0.005486777807029792, "biological phenotype": 0.006408281437028498, "skeletal muscle": 0.00579289010151655, "based on": 0.004130480830332557, "suggest that": 0.004935872962229934, "according to": 0.004935872962229934, "event rates": 0.004396651072193134, "role in": 0.003567915596768826, "assessed by": 0.004396651072193134, "emergency department": 0.005492812660310141, "predictors of": 0.004702952406025535, "association between": 0.00539876405012953, "dose dopamine": 0.004702952406025535, "systolic blood": 0.004838832775332688, "% to": 0.0025418343571277273, "co -": 0.0025418343571277273, "% in": 0.0025418343571277273, "walk test": 0.004028712139092116, "endothelial function": 0.005492812660310141, "number of": 0.004028712139092116, "treatment for": 0.004702952406025535, "mitral regurgitation": 0.005492812660310141, "diastolic volume": 0.005083668714255455, "min per": 0.003567915596768826, "diastolic pressure": 0.005299629317655978, "oxygen consumption": 0.005299629317655978, "median follow": 0.004702952406025535, "the objective": 0.004702952406025535, "systolic pressure": 0.005194826741686516, "myocardial ischemia": 0.00539876405012953, "albumin levels": 0.004838832775332688, "study sought": 0.004556190426673786, "cardiovascular mortality": 0.005827107605237649, "brain natriuretic": 0.005194826741686516, "interquartile range": 0.00539876405012953, "outcome measures": 0.005083668714255455, "the aim": 0.003567915596768826, "insulin resistance": 0.005299629317655978, "breast cancer": 0.004702952406025535, "dash diet": 0.004028712139092116, "cardiac transplant": 0.005299629317655978, "cardiac magnetic": 0.005083668714255455, "cv events": 0.004028712139092116, "sinus rhythm": 0.004556190426673786, "deficit index": 0.004702952406025535, "chronic hf": 0.004221895481746278, "exercise testing": 0.005083668714255455, "sympathetic tone": 0.005083668714255455, "oxygen uptake": 0.004702952406025535, "peak early": 0.004221895481746278, "prediction rule": 0.0049653343727284706, "biomedical treatment": 0.005492812660310141, "acute care": 0.004221895481746278, "exercise rehabilitation": 0.005749072598250811, "inappropriate therapy": 0.005582271666314884, "hr variability": 0.004838832775332688, "gastrointestinal bleeding": 0.005901956606364827, "idiopathic dilated": 0.005299629317655978, "defined as": 0.003870070858267421, "analysis of": 0.004030263482843706, "hospitalization for": 0.004948867045952069, "showed that": 0.004030263482843706, "adverse event": 0.00391912700502128, "the results": 0.0036638758934942786, "natriuretic peptides": 0.004577343883591784, "filling pressures": 0.004329022284738763, "cardiac death": 0.00391912700502128, "patient population": 0.004416357764713315, "coronary heart": 0.004032360646110574, "clinical trial": 0.004032360646110574, "health outcomes": 0.004137778643940393, "mortality rates": 0.004137778643940393, "chronic obstructive": 0.004498970041774609, "obstructive pulmonary": 0.004651893055262403, "pulmonary disease": 0.004329022284738763, "dose nesiritide": 0.004137778643940393, "effect on": 0.0033572601159100957, "present study": 0.00391912700502128, "left bundle": 0.0036638758934942786, "bundle branch": 0.00391912700502128, "branch block": 0.0037968253555614876, "analysis showed": 0.004137778643940393, "independent predictor": 0.004651893055262403, "hospital discharge": 0.004416357764713315, "determine whether": 0.004329022284738763, "beneficial effect": 0.004329022284738763, "model of": 0.003177292946409659, "increased in": 0.0037968253555614876, "significantly younger": 0.004651893055262403, "ci ]": 0.0021181952976064393, "medical management": 0.004416357764713315, "time of": 0.0029732629973073543, "cardiovascular disease": 0.004722973542297498, "significantly improved": 0.004722973542297498, "acute hf": 0.003177292946409659, "salt loading": 0.0037968253555614876, "clinical characteristics": 0.004855923004364708, "patients requiring": 0.004416357764713315, "the purpose": 0.0036638758934942786, "all patients": 0.0037968253555614876, "history of": 0.0035182462347885645, "degenerative mr": 0.004137778643940393, "quality improvement": 0.004498970041774609, "hazards models": 0.004032360646110574, "dose bb": 0.0029732629973073543, "protein kinase": 0.004032360646110574, "failing hearts": 0.004032360646110574, "regression analysis": 0.004498970041774609, "device implantation": 0.004498970041774609, "right atrial": 0.0037968253555614876, "receptor antagonists": 0.004577343883591784, "acute kidney": 0.0037968253555614876, "kidney injury": 0.00391912700502128, "recommended medications": 0.004790893831875675, "growth factor": 0.00391912700502128, "- adrenergic": 0.0037968253555614876, "analysis revealed": 0.004329022284738763, "higher risk": 0.0036638758934942786, "severe heart": 0.0037968253555614876, "ventricular contractile": 0.004790893831875675, "- brain": 0.0029732629973073543, "ischemic heart": 0.004032360646110574, "hr reduction": 0.0037968253555614876, "significant improvement": 0.004790893831875675, "nordic walking": 0.004032360646110574, "pulmonary embolism": 0.004416357764713315, "transcription factor": 0.004577343883591784, "diet scores": 0.0036638758934942786, "term outcomes": 0.00391912700502128, "significantly associated": 0.004855923004364708, "criteria cardiac": 0.004236390595212879, "baseline characteristics": 0.004855923004364708, "readmission rate": 0.004236390595212879, "per patient": 0.0036638758934942786, "dialysis patients": 0.004329022284738763, "ventricular diastolic": 0.004651893055262403, "resistin levels": 0.004137778643940393, "catheter ablation": 0.004329022284738763, "major complications": 0.004498970041774609, "treatment strategies": 0.004577343883591784, "sympathetic activity": 0.004577343883591784, "health care": 0.0036638758934942786, "contextual reasons": 0.004416357764713315, "severe cad": 0.0035182462347885645, "high risk": 0.0033572601159100957, "this review": 0.0036638758934942786, "membrane oxygenation": 0.004577343883591784, "familiar physician": 0.004416357764713315, "sudden cardiac": 0.004032360646110574, "disease management": 0.004416357764713315, "end stage": 0.0033572601159100957, "recent onset": 0.0037968253555614876, "physician volume": 0.004236390595212879, "social support": 0.004032360646110574, "occurred in": 0.0032974883041448507, "rate of": 0.002675936697576619, "efficacy of": 0.0032974883041448507, "treatment with": 0.0036291245814995166, "decrease in": 0.0032974883041448507, "observed in": 0.0032974883041448507, "relationship between": 0.0041196094952326056, "found that": 0.003166421611309708, "addition to": 0.0032974883041448507, "subjects with": 0.003527214304519152, "related to": 0.003166421611309708, "led to": 0.002190182165406614, "cardiac cachexia": 0.003389112476170303, "individuals with": 0.003389112476170303, "body weight": 0.002931100714795423, "the prevalence": 0.003225888516888459, "presence of": 0.002931100714795423, "fraction of": 0.002931100714795423, "adult patients": 0.003225888516888459, "impact on": 0.0026858080927280766, "% increase": 0.0028145969878308518, "strongly associated": 0.0035991760334196867, "randomized trial": 0.003389112476170303, "end points": 0.0028145969878308518, "significant effect": 0.003533086211770652, "vs placebo": 0.0028145969878308518, "therapy with": 0.00303746028444919, "resulted in": 0.002931100714795423, "multivariate analysis": 0.0037215144442099223, "severely reduced": 0.003389112476170303, "among older": 0.002931100714795423, "hospitalized for": 0.003389112476170303, "reduced mortality": 0.0034632178277910104, "level of": 0.0025418343571277273, "statistically significant": 0.003934637737576551, "measured by": 0.002931100714795423, "significant difference": 0.003778378833837998, "activation of": 0.0031353016040170235, "ambulatory patients": 0.0035991760334196867, "spironolactone use": 0.003533086211770652, "- blockers": 0.0028145969878308518, "inhospital mortality": 0.0036618751068734274, "assessment of": 0.0031353016040170235, "cohort of": 0.0026858080927280766, "declined from": 0.0031353016040170235, "retrospective cohort": 0.0036618751068734274, "ed visits": 0.0026858080927280766, "the rates": 0.0026858080927280766, "hypothesized that": 0.0034632178277910104, "vascular resistance": 0.0035991760334196867, "cardiac index": 0.0031353016040170235, "cardiac output": 0.003225888516888459, "adverse outcomes": 0.003389112476170303, "patients had": 0.00303746028444919, "protective effects": 0.003533086211770652, "mediated dilatation": 0.0035991760334196867, "these results": 0.0031353016040170235, "beneficial effects": 0.003533086211770652, "term survival": 0.0031353016040170235, "objective of": 0.00303746028444919, "% sensitivity": 0.0031353016040170235, "study aimed": 0.002931100714795423, "lung weight": 0.002931100714795423, "mean follow": 0.002931100714795423, "biventricular support": 0.0037215144442099223, "total of": 0.0025418343571277273, "medical therapy": 0.003310222915152314, "pulmonary artery": 0.003389112476170303, "rs synchrony": 0.00303746028444919, "mitral stenosis": 0.003310222915152314, "ring annuloplasty": 0.0034632178277910104, "annular size": 0.00303746028444919, "size reduction": 0.003225888516888459, "volume index": 0.00303746028444919, "systolic volume": 0.003310222915152314, "significant ms": 0.003225888516888459, "coronary angiography": 0.0036618751068734274, "the patient": 0.002931100714795423, "reasons for": 0.002931100714795423, "patient with": 0.00303746028444919, "cause hospitalization": 0.0037215144442099223, "patients developed": 0.003533086211770652, "health status": 0.0031353016040170235, "low sst2": 0.0025418343571277273, "cardiovascular event": 0.0036618751068734274, "high sst2": 0.0026858080927280766, "similar results": 0.003310222915152314, "systolic elastance": 0.003533086211770652, "stroke volume": 0.0031353016040170235, "echocardiographic score": 0.0038327150655005407, "safety of": 0.0026858080927280766, "newly diagnosed": 0.003310222915152314, "findings suggest": 0.003389112476170303, "volume eds": 0.0028145969878308518, "less likely": 0.002931100714795423, "adjusted odds": 0.0031353016040170235, "contractile function": 0.0036618751068734274, "effects on": 0.0028145969878308518, "ventricular filling": 0.0035991760334196867, "blood flow": 0.0028145969878308518, "flow velocity": 0.0031353016040170235, "bottleneck stent": 0.003389112476170303, "arterial elastance": 0.003533086211770652, "treated patients": 0.003389112476170303, "significantly reduced": 0.0037215144442099223, "contribute to": 0.0031353016040170235, "revealed that": 0.0031353016040170235, "month survival": 0.003225888516888459, "patients underwent": 0.003533086211770652, "outcomes of": 0.002931100714795423, "young adults": 0.00303746028444919, "year mortality": 0.003225888516888459, "cardiac rehabilitation": 0.003778378833837998, "randomized controlled": 0.0037215144442099223, "randomly assigned": 0.0034632178277910104, "grip strength": 0.0031353016040170235, "regression models": 0.0034632178277910104, "receptor antagonist": 0.0035991760334196867, "cardiac dysfunction": 0.0035991760334196867, "angiotensin converting": 0.003778378833837998, "mineralocorticoid receptor": 0.0039825797230596, "beta blockers": 0.0031353016040170235, "followed up": 0.002931100714795423, "trend toward": 0.00303746028444919, "adjustment for": 0.003225888516888459, "after adjustment": 0.003389112476170303, "improvement initiative": 0.003778378833837998, "extracellular matrix": 0.0036618751068734274, "obese zsf1": 0.0028145969878308518, "cardioverter defibrillator": 0.0039825797230596, "weight loss": 0.002931100714795423, "length of": 0.0026858080927280766, "dependent patients": 0.003533086211770652, "human resistin": 0.003225888516888459, "increased significantly": 0.0038327150655005407, "results suggest": 0.003310222915152314, "mitochondrial oxidative": 0.0038327150655005407, "medical records": 0.003310222915152314, "aortic constriction": 0.0035991760334196867, "human hf": 0.0025418343571277273, "contrast agent": 0.003225888516888459, "contractile reserve": 0.0035991760334196867, "survival rates": 0.003225888516888459, "systolic function": 0.0034632178277910104, "acute rv": 0.0025418343571277273, "onset hf": 0.0025418343571277273, "cardiac remodeling": 0.003533086211770652, "remodeling aspects": 0.003533086211770652, "dyssynchronous hf": 0.0034632178277910104, "myofiber shortening": 0.0035991760334196867, "mitral annular": 0.003225888516888459, "annular velocity": 0.003389112476170303, "exercise time": 0.0031353016040170235, "- ar": 0.0016945562380851515, "extracorporeal membrane": 0.0038327150655005407, "male patients": 0.0031353016040170235, "therapeutic implications": 0.003884738403491766, "autonomic balance": 0.0034632178277910104, "renal dnx": 0.0026858080927280766, "mechanical cardiac": 0.003533086211770652, "cardiac support": 0.003310222915152314, "ecmo+vad group": 0.003225888516888459, "physician continuity": 0.0036618751068734274, "- hct": 0.0019673188687882757, "muscle mass": 0.002931100714795423, "shock therapy": 0.0031353016040170235, "high bnp": 0.0025418343571277273, "- ischemic": 0.0028145969878308518, "care management": 0.003310222915152314, "black race": 0.0028145969878308518, "type channel": 0.00303746028444919, "volume physicians": 0.0034632178277910104, "aldosterone antagonist": 0.003778378833837998, "air pollution": 0.0031353016040170235, "saxagliptin versus": 0.003533086211770652, "deactivation discussions": 0.003884738403491766, "exercise group": 0.003225888516888459, "management programs": 0.0035991760334196867, "resource use": 0.00303746028444919, "suggests that": 0.002743388903514896, "alterations in": 0.0028226524522774014, "caused by": 0.0023500820811370674, "prevalence of": 0.002743388903514896, "predictor of": 0.002657777748893041, "expression of": 0.002743388903514896, "compared to": 0.002564713125445995, "accompanied by": 0.0028226524522774014, "age of": 0.0019164093947307873, "data from": 0.0023500820811370674, "value of": 0.002224105062486761, "purpose of": 0.0024627723643519954, "effectiveness of": 0.002965473416649015, "lack of": 0.002081284098115148, "inhibition of": 0.002743388903514896, "improvements in": 0.002896445050758275, "trends in": 0.002014356069546058, "patient safety": 0.002419416387666344, "patients admitted": 0.002597413370843258, "fat mass": 0.0019063757678457953, "x -": 0.001007178034773029, "- ray": 0.0014754891515912068, "ray absorptiometry": 0.002649814658827989, "general population": 0.002649814658827989, "iron deficiency": 0.0024826671863642353, "exercise tolerance": 0.002649814658827989, "thromboembolic events": 0.002791135833157442, "hospitalized patients": 0.002791135833157442, "stimulating agents": 0.002649814658827989, "the benefits": 0.002278095213336893, "benefits of": 0.002198325536096567, "observational studies": 0.002791135833157442, "strength evidence": 0.002597413370843258, "relative risk": 0.0023514762030127675, "trial of": 0.0019063757678457953, "acute coronary": 0.002419416387666344, "admitted to": 0.002198325536096567, "clinical studies": 0.0025418343571277273, "factors associated": 0.002649814658827989, "peripheral vascular": 0.002699382025064765, "vascular disease": 0.0025418343571277273, "ischemic cardiomyopathy": 0.0028745362991254055, "independent predictors": 0.0028337841253784986, "diuretic therapy": 0.0025418343571277273, "placebo group": 0.0023514762030127675, "hour cumulative": 0.0024826671863642353, "cumulative urine": 0.0025418343571277273, "urine volume": 0.002278095213336893, "cystatin c": 0.002110947740873139, "chromatin structure": 0.002699382025064765, "association with": 0.0025418343571277273, "outcomes associated": 0.002699382025064765, "events in": 0.002014356069546058, "enrolled in": 0.002198325536096567, "study patients": 0.002419416387666344, "death in": 0.0019063757678457953, "artery bypass": 0.0023514762030127675, "data suggest": 0.002278095213336893, "value for": 0.002014356069546058, "older age": 0.002014356069546058, "age group": 0.002014356069546058, "progenitor cells": 0.0025418343571277273, "prognostic factor": 0.002597413370843258, "cardiovascular diseases": 0.0028745362991254055, "+ cells": 0.001783957798384413, "patients without": 0.0025418343571277273, "increased peak": 0.002419416387666344, "cause readmission": 0.002597413370843258, "readmission rates": 0.002597413370843258, "differences in": 0.002419416387666344, "improve outcomes": 0.0025418343571277273, "office hours": 0.002278095213336893, "study assessed": 0.002419416387666344, "related quality": 0.0024826671863642353, "induced by": 0.002110947740873139, "treating patients": 0.002597413370843258, "incidence of": 0.002278095213336893, "the patients": 0.002278095213336893, "ejection fractions": 0.002649814658827989, "recommended target": 0.002649814658827989, "blocker dose": 0.002278095213336893, "point of": 0.0019063757678457953, "levels in": 0.002014356069546058, "primary end": 0.002198325536096567, "multivariate models": 0.002699382025064765, "odds ratios": 0.002198325536096567, "% female": 0.0019063757678457953, "median bnp": 0.002110947740873139, "difference among": 0.0025418343571277273, "clinical variables": 0.002649814658827989, "this article": 0.002278095213336893, "cognitive impairment": 0.0027464063301550707, "confidence intervals": 0.0027464063301550707, "\u00b1 14": 0.0012709171785638637, "ventricular function": 0.0027464063301550707, "\u00b1 6": 0.001007178034773029, "major cause": 0.002198325536096567, "identify patients": 0.002597413370843258, "minute walk": 0.002198325536096567, "adherence to": 0.002278095213336893, "functional status": 0.002597413370843258, "no production": 0.0023514762030127675, "hdl function": 0.002278095213336893, "predictive cutoff": 0.002597413370843258, "cutoff value": 0.002278095213336893, "% specificity": 0.0023514762030127675, "hypertensive heart": 0.002649814658827989, "new therapeutic": 0.0024826671863642353, "fractional shortening": 0.002791135833157442, "oxidative stress": 0.0025418343571277273, "significantly impaired": 0.0028337841253784986, "laboratory report": 0.002597413370843258, "cardiogenic shock": 0.002597413370843258, "duration of": 0.002198325536096567, "heart transplantation": 0.002791135833157442, "used in": 0.001783957798384413, "basis of": 0.0019063757678457953, "% for": 0.0014754891515912068, "acute right": 0.002198325536096567, "old man": 0.001783957798384413, "years later": 0.002198325536096567, "developed heart": 0.0024826671863642353, "severe hypertension": 0.002699382025064765, "aggressive medical": 0.002649814658827989, "develop even": 0.002278095213336893, "successful valve": 0.0025418343571277273, "another disease": 0.0024826671863642353, "index of": 0.0019063757678457953, "valve opening": 0.0023514762030127675, "mean pressure": 0.0023514762030127675, "pressure gradient": 0.002597413370843258, "without major": 0.0023514762030127675, "mild mr": 0.001783957798384413, "resulting in": 0.002278095213336893, "clinic outpatients": 0.002649814658827989, "renal disease": 0.0023514762030127675, "hazard models": 0.0023514762030127675, "median age": 0.002110947740873139, "measure of": 0.002110947740873139, "significant interaction": 0.0028745362991254055, "prognosis in": 0.002278095213336893, "ventricular systolic": 0.0027464063301550707, "event rate": 0.002110947740873139, "failure hospitalization": 0.0028745362991254055, "myocardial function": 0.002699382025064765, "months of": 0.002014356069546058, "left atrial": 0.002198325536096567, "atrial area": 0.002198325536096567, "during follow": 0.0023514762030127675, "randomized trials": 0.002597413370843258, "seen in": 0.001783957798384413, "- fold": 0.0016426366240549605, "vascular endothelial": 0.0027464063301550707, "endothelial growth": 0.002649814658827989, "- myocardial": 0.002278095213336893, "infarction heart": 0.0025418343571277273, "receptor blocker": 0.0025418343571277273, "increased cardiac": 0.002597413370843258, "cardiac angiogenesis": 0.0027464063301550707, "signaling pathway": 0.002597413370843258, "of patients": 0.002198325536096567, "cases exhibited": 0.0024826671863642353, "volume overload": 0.0024826671863642353, "wall stress": 0.002198325536096567, "filling pressure": 0.0025418343571277273, "severe systolic": 0.0024826671863642353, "mitral annulus": 0.002419416387666344, "/ e": 0.001007178034773029, "cardiac catheterization": 0.0028745362991254055, "measurement of": 0.002419416387666344, "diagnostic performance": 0.0028337841253784986, "chronic myocardial": 0.002649814658827989, "left anterior": 0.0023514762030127675, "anterior descending": 0.002699382025064765, "collateral growth": 0.002597413370843258, "sudden death": 0.002278095213336893, "the study": 0.002014356069546058, "at baseline": 0.002198325536096567, "preoperative hypoalbuminemia": 0.003054874976948276, "improved survival": 0.002597413370843258, "poor prognosis": 0.002419416387666344, "- lvad": 0.0016426366240549605, "lvad ai": 0.001783957798384413, "well defined": 0.002278095213336893, "severe ai": 0.002014356069546058, "valve replacement": 0.002597413370843258, "controlled trial": 0.0025418343571277273, "standard cardiac": 0.0025418343571277273, "rehabilitation care": 0.002699382025064765, "mean ejection": 0.0023514762030127675, "per week": 0.0019063757678457953, "physical activity": 0.002597413370843258, "right ventricle": 0.0024826671863642353, "day mortality": 0.0023514762030127675, "followed by": 0.002198325536096567, "right atrium": 0.002278095213336893, "retest reliability": 0.002649814658827989, "standard error": 0.002419416387666344, "total sample": 0.002278095213336893, "mean difference": 0.0024826671863642353, "users of": 0.0019063757678457953, "significant improvements": 0.0029135538026188244, "expressed in": 0.002278095213336893, "secondary outcomes": 0.002649814658827989, "aim of": 0.0016426366240549605, "pathophysiology of": 0.002649814658827989, "the use": 0.001783957798384413, "gene programs": 0.0023514762030127675, "transcription factors": 0.002791135833157442, "demonstrated that": 0.002597413370843258, "energy metabolism": 0.002597413370843258, "optimal combined": 0.0025418343571277273, "combined treatment": 0.002649814658827989, "cancer patients": 0.0024826671863642353, "patients at": 0.002198325536096567, "years old": 0.002014356069546058, "in total": 0.0019063757678457953, "diet score": 0.002110947740873139, "lower mortality": 0.0024826671863642353, "heart transplant": 0.0025418343571277273, "standard criteria": 0.002597413370843258, "chart review": 0.002278095213336893, "t1 mapping": 0.002110947740873139, "resonance imaging": 0.002597413370843258, "first hf": 0.0019063757678457953, "clinical benefit": 0.0025418343571277273, "myocardial dd": 0.0023514762030127675, "myocardial collagen": 0.002699382025064765, "adverse cv": 0.002110947740873139, "clinical status": 0.0024826671863642353, "enzyme inhibitor": 0.0025418343571277273, "matched controls": 0.0025418343571277273, "echocardiographic measures": 0.0029869347922947, "\u00b1 0.4": 0.0014754891515912068, "induced cardiotoxicity": 0.0028337841253784986, "mrna levels": 0.002198325536096567, "remained elevated": 0.002597413370843258, "strain rate": 0.002198325536096567, "mitochondrial dysfunction": 0.0029509783031824136, "anti -": 0.0016426366240549605, "ultrastructural changes": 0.0028745362991254055, "logistic regression": 0.002699382025064765, "leading cause": 0.0023514762030127675, "the deficit": 0.002198325536096567, "recent years": 0.002278095213336893, "recent studies": 0.002419416387666344, "risk patients": 0.0023514762030127675, "signal transduction": 0.002699382025064765, "transverse aortic": 0.002597413370843258, "cardiac gene": 0.002278095213336893, "clinically significant": 0.0028337841253784986, "arterial hypertension": 0.002791135833157442, "significantly lower": 0.002699382025064765, "peak o2": 0.001783957798384413, "per kilogram": 0.002278095213336893, "common cause": 0.002278095213336893, "human heart": 0.002198325536096567, "channel mrna": 0.002278095213336893, "important role": 0.002419416387666344, "high mortality": 0.002419416387666344, "cardiac sympathetic": 0.002699382025064765, "receptor haplotype": 0.002649814658827989, "patient preferences": 0.002699382025064765, "lean mass": 0.002014356069546058, "mitral flow": 0.002198325536096567, "unclear etiology": 0.0025418343571277273, "acute \u03b2": 0.001783957798384413, "risk factor": 0.002198325536096567, "antiarrhythmic drugs": 0.0027464063301550707, "sarcomeric microstructure": 0.0029509783031824136, "pilot study": 0.002198325536096567, "adjunctive treatment": 0.0027464063301550707, "treatment alone": 0.0024826671863642353, "effective rate": 0.002419416387666344, "exercise intolerance": 0.0027464063301550707, "exercise variables": 0.002649814658827989, "low testosterone": 0.0025418343571277273, "testosterone status": 0.002699382025064765, "the exercise": 0.002278095213336893, "improves exercise": 0.002597413370843258, "group compared": 0.002419416387666344, "rate variability": 0.0025418343571277273, "group included": 0.002419416387666344, "included patients": 0.002597413370843258, "study period": 0.002278095213336893, "hospitalized older": 0.002649814658827989, "nursing care": 0.002278095213336893, "proportional hazard": 0.002699382025064765, "first month": 0.002198325536096567, "adjusted hr": 0.002198325536096567, "- translational": 0.0024826671863642353, "ventricular tachycardia": 0.0028745362991254055, "- adrenoceptor": 0.002419416387666344, "adrenoceptor blockade": 0.002791135833157442, "< 0\u00b701": 0.0016426366240549605, "receptor neprilysin": 0.002699382025064765, "neprilysin inhibitor": 0.0027464063301550707, "\u03b2 coefficient": 0.0023514762030127675, "primary endpoint": 0.0025418343571277273, "% lower": 0.001783957798384413, "partially reversed": 0.002649814658827989, "elevated levels": 0.0024826671863642353, "cardiac patients": 0.0025418343571277273, "public health": 0.0023514762030127675, "service beneficiaries": 0.002791135833157442, "lower risk": 0.002110947740873139, "exercise performance": 0.0027464063301550707, "rate control": 0.002278095213336893, "cardiovascular complications": 0.003054874976948276, "- aas": 0.0014754891515912068, "global proteomics": 0.002597413370843258, "pathway analysis": 0.0025418343571277273, "day rehospitalization": 0.002791135833157442, "volume groups": 0.0023514762030127675, "hospital volume": 0.0024826671863642353, "therapeutic options": 0.002699382025064765, "period 4": 0.0019063757678457953, "exercise test": 0.0023514762030127675, "study end": 0.002014356069546058, "cardiovascular risk": 0.002699382025064765, "unfit men": 0.002014356069546058, "cardiac insulin": 0.0024826671863642353, "weeks post": 0.002110947740873139, "- aac": 0.0014754891515912068, "per capita": 0.002110947740873139, "cardiovascular health": 0.002791135833157442, "sitagliptin versus": 0.002649814658827989, "implementation strategies": 0.0029509783031824136, "physician adherence": 0.002699382025064765, "life score": 0.002110947740873139, "aerobic exercise": 0.0025418343571277273, "resting hr": 0.002110947740873139, "right interatrial": 0.002597413370843258, "magnetically levitated": 0.0028337841253784986, "decline in": 0.0017591231173942823, "symptoms of": 0.0018319379467471393, "years after": 0.0018319379467471393, "reductions in": 0.00195956350251064, "difference in": 0.00195956350251064, "involved in": 0.0018319379467471393, "decreased in": 0.0018984126777807438, "used for": 0.0015886464732048295, "performed in": 0.0018984126777807438, "percentage of": 0.00195956350251064, "disease in": 0.0017591231173942823, "patients having": 0.0020688893219701966, "survival of": 0.0018319379467471393, "results in": 0.0017591231173942823, "understanding of": 0.0021181952976064393, "reversed by": 0.0018319379467471393, "outpatients with": 0.0021181952976064393, "time to": 0.0014866314986536771, "rate at": 0.0014866314986536771, "end of": 0.0013688638533791337, "randomized to": 0.00195956350251064, "absence of": 0.0017591231173942823, "variation in": 0.0018984126777807438, "days of": 0.0014866314986536771, "contribution of": 0.0020688893219701966, "onset of": 0.0015886464732048295, "occur in": 0.0015886464732048295, "training on": 0.0018319379467471393, "national trends": 0.001655111457576157, "study used": 0.0014072984939154259, "hospitalized with": 0.0017316089138955052, "results show": 0.001518730142224595, "cross -": 0.0011893051989229418, "adipose tissue": 0.0016129442584442294, "prospective study": 0.0017316089138955052, "free mass": 0.0013429040463640383, "energy x": 0.0012709171785638637, "followed for": 0.001518730142224595, "total adiponectin": 0.0017316089138955052, "correlated inversely": 0.0018309375534367137, "developed countries": 0.0017995880167098433, "lv diastolic": 0.001518730142224595, "mechanism of": 0.001518730142224595, "increases in": 0.001518730142224595, "leading to": 0.0014072984939154259, "evidence of": 0.0014655503573977114, "anemia in": 0.0013429040463640383, "this guideline": 0.0016129442584442294, "identified using": 0.0016945562380851515, "acp recommends": 0.0016129442584442294, "hemoglobin levels": 0.0017316089138955052, "quality evidence": 0.0016945562380851515, "moderate anemia": 0.001655111457576157, "treatment in": 0.001518730142224595, "trials of": 0.0013429040463640383, "blood transfusions": 0.001766543105885326, "study design": 0.001518730142224595, "risk among": 0.0014072984939154259, "decreased mortality": 0.0017995880167098433, "intravenous iron": 0.0016945562380851515, "alleviate symptoms": 0.001766543105885326, "cardioverter defibrillators": 0.002014356069546058, "cardiac transplantation": 0.0019163575327502704, "low left": 0.0012709171785638637, "outpatient settings": 0.0017995880167098433, "important component": 0.0017995880167098433, "focused on": 0.0014072984939154259, "studies in": 0.0014072984939154259, "implantable cardiac": 0.0017995880167098433, "mortality using": 0.001655111457576157, "studies evaluating": 0.001766543105885326, "found for": 0.0013429040463640383, "male sex": 0.0012709171785638637, "this meta": 0.0013429040463640383, "enhance decongestion": 0.0018309375534367137, "preserve renal": 0.0016129442584442294, "addition of": 0.0014655503573977114, "main outcomes": 0.0015676508020085118, "c level": 0.0011893051989229418, "secondary end": 0.0015676508020085118, "patient outcomes": 0.0016945562380851515, "associated proteins": 0.0017995880167098433, "proteins alter": 0.0016129442584442294, "alter chromatin": 0.001655111457576157, "expression profile": 0.001766543105885326, "altered expression": 0.001766543105885326, "protein expression": 0.001766543105885326, "protein 4": 0.0013429040463640383, "mouse heart": 0.0014655503573977114, "ischemic events": 0.001655111457576157, "receive cardiac": 0.001655111457576157, "limited data": 0.001518730142224595, "data regarding": 0.0016129442584442294, "study population": 0.0016945562380851515, "population comprised": 0.0018309375534367137, "coronary syndromes": 0.001766543105885326, "among study": 0.0014655503573977114, "dependent analysis": 0.001766543105885326, "subsequent heart": 0.0016945562380851515, "d recipients": 0.001518730142224595, "percutaneous coronary": 0.0018607572221049612, "benefit of": 0.0014072984939154259, "outcomes among": 0.0016129442584442294, "differential effect": 0.0017995880167098433, "\u226550 %": 0.0009836594343941379, "patients enrolled": 0.0017316089138955052, "risk associated": 0.001655111457576157, "p value": 0.0011893051989229418, "circulating progenitor": 0.001889189416918999, "ambulatory hf": 0.0015676508020085118, "hospital admissions": 0.0017995880167098433, "cd34+vegfr2 +": 0.0015676508020085118, "without diabetes": 0.0016945562380851515, "higher eo": 0.0013429040463640383, "improved functional": 0.0017995880167098433, "metric choice": 0.0015676508020085118, "readmission metrics": 0.0017995880167098433, "percent of": 0.0014072984939154259, "hospitals in": 0.001518730142224595, "remote monitoring": 0.0017316089138955052, "recent hospital": 0.001655111457576157, "network meta": 0.001518730142224595, "outcomes for": 0.001518730142224595, "recently discharged": 0.0017995880167098433, "electronic databases": 0.0018309375534367137, "observational cohort": 0.0018309375534367137, "studies with": 0.001518730142224595, "implanted monitoring": 0.0018309375534367137, "monitoring devices": 0.001766543105885326, "medical support": 0.001655111457576157, "support provided": 0.0016945562380851515, "inclusion criteria": 0.001766543105885326, "mortality for": 0.0015676508020085118, "% cri": 0.0009836594343941379, "protein levels": 0.0016129442584442294, "western blot": 0.001518730142224595, "dna fragmentation": 0.0017316089138955052, "remained unchanged": 0.001766543105885326, "found in": 0.0012709171785638637, "widely used": 0.0014655503573977114, "pump replacement": 0.0016945562380851515, "redo sternotomy": 0.001655111457576157, "angiotensin system": 0.001766543105885326, "target dose": 0.0014655503573977114, "blocker uptitrations": 0.0018309375534367137, "hospital admission": 0.001766543105885326, "significant reductions": 0.001889189416918999, "composite end": 0.0015676508020085118, "remained significant": 0.0018309375534367137, "blocker uptitration": 0.0017995880167098433, "younger patients": 0.0016945562380851515, "predicts clinical": 0.0017316089138955052, "clinical outcome": 0.0016945562380851515, "peptide levels": 0.0016129442584442294, "in heart": 0.0012709171785638637, "higher mortality": 0.0016945562380851515, "adjusting for": 0.0015676508020085118, "ability of": 0.0014072984939154259, "predict inhospital": 0.001766543105885326, "p for": 0.0009836594343941379, "mortality among": 0.001655111457576157, "pediatric heart": 0.001655111457576157, "the guidelines": 0.0016129442584442294, "children with": 0.0015676508020085118, "patients presenting": 0.0017995880167098433, "patients as": 0.0014655503573977114, "regression analyses": 0.0017995880167098433, "relative decrease": 0.0017316089138955052, "correlation coefficient": 0.0019163575327502704, "intubation rates": 0.0016945562380851515, "rates declined": 0.0016129442584442294, "adult population": 0.0016945562380851515, "liver disease": 0.0015676508020085118, "systemic vascular": 0.0017316089138955052, "underwent catheterization": 0.0019673188687882757, "randomly selected": 0.0017316089138955052, "venous pressure": 0.001655111457576157, "\u00b1 3": 0.0006714520231820191, "comparison of": 0.0015676508020085118, "using data": 0.0014072984939154259, "outcome of": 0.0014072984939154259, "distance covered": 0.0016945562380851515, "training in": 0.0014655503573977114, "density lipoprotein": 0.0017995880167098433, "stimulation of": 0.0016129442584442294, "nitric oxide": 0.001518730142224595, "molecular pathways": 0.001766543105885326, "healthy individuals": 0.0017995880167098433, "vascular effects": 0.0016945562380851515, "year follow": 0.0014655503573977114, "patients died": 0.0015676508020085118, "area under": 0.0014072984939154259, "case of": 0.0011893051989229418, "therapeutic targets": 0.0017995880167098433, "experimental procedures": 0.0019163575327502704, "male mice": 0.0013429040463640383, "significant differences": 0.0019163575327502704, "mice showed": 0.0014655503573977114, "showed significant": 0.001766543105885326, "decreases in": 0.001518730142224595, "severe lv": 0.0013429040463640383, "mouse model": 0.0014655503573977114, "failure risk": 0.001518730142224595, "significant value": 0.0017316089138955052, "evaluated whether": 0.0017316089138955052, "risk prediction": 0.001655111457576157, "includes age": 0.001518730142224595, "receiver operating": 0.001766543105885326, "operating characteristic": 0.001942369201745883, "characteristic curve": 0.0018309375534367137, "integrated discrimination": 0.0019673188687882757, "discrimination improvement": 0.0019912898615298, "net reclassification": 0.0018309375534367137, "reclassification improvement": 0.0020365833179655174, "participants developed": 0.001889189416918999, "adding ctnt": 0.0014655503573977114, "failure after": 0.0015676508020085118, "poor outcomes": 0.0015676508020085118, "for patients": 0.001518730142224595, "requiring biventricular": 0.0019163575327502704, "requiring isolated": 0.001766543105885326, "favorable outcome": 0.0017316089138955052, "ineligible patients": 0.0017995880167098433, "destination therapy": 0.0017995880167098433, "highly effective": 0.0016945562380851515, "transplantation eligibility": 0.002014356069546058, "eligibility status": 0.001766543105885326, "porcine model": 0.0015676508020085118, "improves cardiac": 0.0016945562380851515, "linear models": 0.0015676508020085118, "during rvpo": 0.0014655503573977114, "free wall": 0.0013429040463640383, "functional mitral": 0.0017316089138955052, "frequently develops": 0.0017995880167098433, "ischemic mitral": 0.001655111457576157, "the mechanism": 0.0015676508020085118, "combination of": 0.0016129442584442294, "reduction by": 0.001518730142224595, "valve tethering": 0.001655111457576157, "anterior leaflet": 0.0016945562380851515, "leaflet opening": 0.001655111457576157, "opening due": 0.0014655503573977114, "posteriorly displaced": 0.0018607572221049612, "displaced papillary": 0.0017995880167098433, "papillary muscles": 0.0017316089138955052, "ventricular dilatation": 0.001889189416918999, "plasty for": 0.0014072984939154259, "degenerative mitral": 0.0017995880167098433, "edge anastomosis": 0.0016945562380851515, "gradient of": 0.0014655503573977114, "mitral filling": 0.0016129442584442294, "filling flow": 0.001518730142224595, "clear organic": 0.0015676508020085118, "organic lesion": 0.0016129442584442294, "improvement of": 0.0016129442584442294, "also confirmed": 0.0016129442584442294, "causes of": 0.0013429040463640383, "surgical indications": 0.0018309375534367137, "case report": 0.0014655503573977114, "hospitalization in": 0.001766543105885326, "clinical data": 0.0015676508020085118, "month risk": 0.0014072984939154259, "cause medical": 0.0015676508020085118, "medical hospitalization": 0.0019163575327502704, "risk group": 0.0014072984939154259, "month event": 0.0014655503573977114, "stage renal": 0.0014655503573977114, "important prognostic": 0.0018309375534367137, "identified in": 0.0015676508020085118, "included in": 0.0014655503573977114, "egfr group": 0.0014072984939154259, "uncontrolled hypertension": 0.0019673188687882757, "reduced ef": 0.0014072984939154259, "commonly used": 0.0015676508020085118, "year event": 0.0014072984939154259, "internal consistency": 0.0018309375534367137, "sst2 concentrations": 0.0017995880167098433, "remains unclear": 0.001655111457576157, "mg daily": 0.0012709171785638637, "cumulative hazard": 0.0017316089138955052, "sst2 treated": 0.001518730142224595, "ratios for": 0.0014072984939154259, "benefit from": 0.001518730142224595, "pure hno": 0.0012709171785638637, "reduced left": 0.001518730142224595, "ventricular end": 0.001655111457576157, "in conscious": 0.001518730142224595, "arterial pressure": 0.0017316089138955052, "these data": 0.0014072984939154259, "data show": 0.0013429040463640383, "potential usefulness": 0.0018309375534367137, "echocardiographic predictors": 0.0020365833179655174, "multiparametric echocardiographic": 0.0021370023805797303, "global longitudinal": 0.0017995880167098433, "longitudinal strain": 0.0017995880167098433, "% reduction": 0.0014655503573977114, "diastolic dimension": 0.0017995880167098433, "index <": 0.0011893051989229418, "cause death": 0.0014655503573977114, "reduce morbidity": 0.0016945562380851515, "spironolactone in": 0.0017316089138955052, "diagnosed heart": 0.001655111457576157, "excluded patients": 0.0017316089138955052, "serum potassium": 0.001655111457576157, "severe hyperkalemia": 0.0017995880167098433, "eligible patients": 0.0017316089138955052, "fold increased": 0.0016129442584442294, "reduced compared": 0.0016945562380851515, "contributes to": 0.0016129442584442294, "cardiac failure": 0.001655111457576157, "myocardial perfusion": 0.0018309375534367137, "failing heart": 0.0015676508020085118, "revealed reduced": 0.0016945562380851515, "reduced cardiac": 0.001655111457576157, "b treatment": 0.0014655503573977114, "coronary perfusion": 0.001766543105885326, "test whether": 0.001518730142224595, "via activation": 0.0016129442584442294, "failure via": 0.0014655503573977114, "twofold increase": 0.0016945562380851515, "isolated cardiomyocytes": 0.0019163575327502704, "improve symptoms": 0.0016945562380851515, "hospitalizations in": 0.0017995880167098433, "stable severe": 0.0015676508020085118, "the ratio": 0.0013429040463640383, "early transmitral": 0.0017316089138955052, "annulus velocity": 0.0016945562380851515, "pulmonary capillary": 0.0017995880167098433, "capillary wedge": 0.001655111457576157, "wedge pressure": 0.0016129442584442294, "stable hf": 0.0013429040463640383, "transmitral flow": 0.0016945562380851515, "p values": 0.0012709171785638637, "predictive value": 0.0016945562380851515, "showed good": 0.0014655503573977114, "good diagnostic": 0.001655111457576157, "annular plane": 0.0015676508020085118, "plane systolic": 0.0016129442584442294, "systolic excursion": 0.001766543105885326, "arterial systolic": 0.0017316089138955052, "force relationship": 0.001766543105885326, "regression line": 0.001655111457576157, "patients exhibited": 0.001766543105885326, "similar distribution": 0.0018309375534367137, "study shows": 0.0014655503573977114, "step forward": 0.001518730142224595, "the bottleneck": 0.0016129442584442294, "novel therapeutic": 0.0017316089138955052, "therapeutic approaches": 0.001889189416918999, "vessel model": 0.001518730142224595, "proximal left": 0.0015676508020085118, "timing of": 0.0013429040463640383, "ventricle in": 0.001518730142224595, "proximal lad": 0.001518730142224595, "rate reduction": 0.0016129442584442294, "reduction with": 0.0016129442584442294, "isolated heart": 0.0016129442584442294, "effective arterial": 0.001766543105885326, "derived from": 0.001518730142224595, "fraction \u226435": 0.001518730142224595, "\u226435 %": 0.0009836594343941379, "ivabradine group": 0.0016945562380851515, "isolated hr": 0.0014655503573977114, "prognostic indicator": 0.0018309375534367137, "postoperative survival": 0.001889189416918999, "normal albumin": 0.0016129442584442294, "postoperative normalization": 0.002014356069546058, "survival compared": 0.0017316089138955052, "lvad implantation": 0.0017316089138955052, "circulatory support": 0.0017995880167098433, "surgical intervention": 0.0018607572221049612, "patient died": 0.001518730142224595, "few studies": 0.0014655503573977114, "youngest patients": 0.0017316089138955052, "vs. oldest": 0.0014072984939154259, "radiological signs": 0.001766543105885326, "multivariable adjustment": 0.001942369201745883, "hospitalization rates": 0.0018607572221049612, "less common": 0.0014655503573977114, "assigned to": 0.0014655503573977114, "exercise per": 0.001518730142224595, "kg vs": 0.0009836594343941379, "\u00b1 3.1": 0.0009836594343941379, "depressive symptoms": 0.0017995880167098433, "aerobic capacity": 0.0016945562380851515, "hand grip": 0.0013429040463640383, "ejection time": 0.0015676508020085118, "arterial tonometry": 0.001766543105885326, "prognostic value": 0.0016945562380851515, "precapillary ph": 0.001655111457576157, "clinical deterioration": 0.001889189416918999, "unfavorable outcome": 0.0017995880167098433, "prognostic factors": 0.001766543105885326, "higher serum": 0.001518730142224595, "serum levels": 0.001518730142224595, "higher furosemide": 0.0017316089138955052, "furosemide dose": 0.001655111457576157, "oxygen flow": 0.0014655503573977114, "the change": 0.0014072984939154259, "atrial myxoma": 0.0015676508020085118, "day test": 0.0012709171785638637, "advanced chronic": 0.0016945562380851515, "% men": 0.0009836594343941379, "advanced copd": 0.0015676508020085118, "ranging from": 0.001518730142224595, "absolute value": 0.0016129442584442294, "confidence level": 0.0016945562380851515, "rheumatoid arthritis": 0.0018309375534367137, "severe hf": 0.0013429040463640383, "used data": 0.0013429040463640383, "study cohort": 0.001518730142224595, "these groups": 0.001518730142224595, "propensity score": 0.0016945562380851515, "adjusted for": 0.001518730142224595, "new users": 0.0013429040463640383, "the hr": 0.001095091082703307, "mg hr": 0.0009836594343941379, "chronic disease": 0.001655111457576157, "methods study": 0.0015676508020085118, "secondary outcome": 0.0017316089138955052, "demonstrated significant": 0.001942369201745883, "sub -": 0.0009836594343941379, "groups based": 0.001518730142224595, "prognosis of": 0.001518730142224595, "improved clinical": 0.0017316089138955052, "vasopressin receptor": 0.0018309375534367137, "antagonist therapy": 0.001766543105885326, "embryonic gene": 0.0016129442584442294, "linked to": 0.0013429040463640383, "induction of": 0.001518730142224595, "occurs in": 0.0013429040463640383, "inotropic effect": 0.0016945562380851515, "long time": 0.0013429040463640383, "decrease mortality": 0.001766543105885326, "molecular mechanism": 0.0017995880167098433, "specific irs1": 0.0015676508020085118, "impaired cardiac": 0.0016945562380851515, "ventricular cardiomyocytes": 0.0019912898615298, "dysfunction during": 0.001766543105885326, "level variation": 0.001655111457576157, "median rate": 0.0014655503573977114, "rate ratio": 0.0014072984939154259, "blockers therapy": 0.0016945562380851515, "improves outcomes": 0.0017316089138955052, "among trastuzumab": 0.0017316089138955052, "% compared": 0.0014072984939154259, "nontrastuzumab users": 0.0018309375534367137, "large cohort": 0.001518730142224595, "frequency of": 0.001518730142224595, "women with": 0.0014072984939154259, "dietary recommendations": 0.0019163575327502704, "across quartiles": 0.0016945562380851515, "randomized 2331": 0.001655111457576157, "plasma samples": 0.0016129442584442294, "modestly associated": 0.0017995880167098433, "measures of": 0.0014655503573977114, "extended criteria": 0.0017316089138955052, "transplant recipients": 0.0018607572221049612, "chronic kidney": 0.0016129442584442294, "kidney disease": 0.0016129442584442294, "- transplant": 0.001518730142224595, "part of": 0.0011893051989229418, "hospital quality": 0.0016945562380851515, "review of": 0.0013429040463640383, "average age": 0.0014655503573977114, "cause readmissions": 0.001766543105885326, "increased from": 0.0016129442584442294, "resonance postcontrast": 0.001889189416918999, "myocardial extracellular": 0.001942369201745883, "major role": 0.0014072984939154259, "resonance t1": 0.001518730142224595, "observational study": 0.0017995880167098433, "invasive hemodynamic": 0.0018309375534367137, "pulmonary vascular": 0.001766543105885326, "cardiac events": 0.0016129442584442294, "greater risk": 0.001518730142224595, "heart magnetic": 0.0016129442584442294, "chelation choices": 0.0017316089138955052, "patient compliance": 0.001766543105885326, "response to": 0.0014655503573977114, "mild heart": 0.0014072984939154259, "current guidelines": 0.001766543105885326, "less severe": 0.0014655503573977114, "% subgroup": 0.0014072984939154259, "clinical composite": 0.001766543105885326, "composite response": 0.001766543105885326, "titin hypophosphorylation": 0.0019673188687882757, "hypophosphorylation importantly": 0.0020987910656161306, "metabolic risk": 0.0016129442584442294, "collagen deposition": 0.0017995880167098433, "titin modification": 0.001766543105885326, "lean zsf1": 0.0013429040463640383, "underlying myocardial": 0.0018607572221049612, "global left": 0.0014655503573977114, "ventricular longitudinal": 0.001942369201745883, "longitudinal systolic": 0.0018607572221049612, "systolic strain": 0.001655111457576157, "persistent af": 0.0015676508020085118, "- fatal": 0.0011893051989229418, "fatal stroke": 0.001518730142224595, "predicting adverse": 0.001766543105885326, "the impact": 0.0014072984939154259, "interaction between": 0.0017995880167098433, "assessed in": 0.0014655503573977114, "significant reduction": 0.0018607572221049612, "continuous relationship": 0.0019163575327502704, "extent of": 0.0013429040463640383, "reduced hospitalizations": 0.001942369201745883, "peritoneal dialysis": 0.0017995880167098433, "consecutive case": 0.0016945562380851515, "case series": 0.0014655503573977114, "potential benefit": 0.0017316089138955052, "- pd": 0.0008472781190425757, "majority of": 0.0014655503573977114, "significant decrease": 0.0018309375534367137, "control analysis": 0.0016945562380851515, "patients demonstrated": 0.0018607572221049612, "cause hospitalizations": 0.001889189416918999, "animal models": 0.0015676508020085118, "hypertensive hfpef": 0.001766543105885326, "cardiovascular function": 0.0019163575327502704, "diastolic filling": 0.0017316089138955052, "e -": 0.0006714520231820191, "- wave": 0.001095091082703307, "\u00b1 16": 0.0008472781190425757, "\u00b1 18": 0.0008472781190425757, "elevated resistin": 0.0017316089138955052, "explored whether": 0.0016945562380851515, "serum resistin": 0.0016129442584442294, "showed increased": 0.0016945562380851515, "factor for": 0.0014072984939154259, "month follow": 0.001518730142224595, "complications occurred": 0.001889189416918999, "dysfunction in": 0.0016129442584442294, "several cancers": 0.001655111457576157, "administration of": 0.0017316089138955052, "aortic blood": 0.001518730142224595, "adenine nucleotides": 0.0017995880167098433, "nucleotides contents": 0.0018309375534367137, "oxidative phosphorylation": 0.0019673188687882757, "phosphorylation capacity": 0.001942369201745883, "creatine kinase": 0.001655111457576157, "kinase activity": 0.001655111457576157, "preoperative renal": 0.001766543105885326, "bypass grafting": 0.001655111457576157, "primary isolated": 0.0016945562380851515, "isolated cabg": 0.0015676508020085118, "significantly increased": 0.0019163575327502704, "coronary disease": 0.0016945562380851515, "onset heart": 0.0014655503573977114, "maladaptive remodelling": 0.0019163575327502704, "maladaptive cardiac": 0.0017995880167098433, "cardiac remodelling": 0.0017995880167098433, "erk1/2 signalling": 0.0017316089138955052, "proportion of": 0.0015676508020085118, "% male": 0.001095091082703307, "recent trials": 0.0015676508020085118, "current status": 0.0016129442584442294, "clinical care": 0.0015676508020085118, "care delivery": 0.0015676508020085118, "care systems": 0.001518730142224595, "day risk": 0.0012709171785638637, "show that": 0.0013429040463640383, "bromodomain proteins": 0.0018309375534367137, "pathological changes": 0.0018309375534367137, "pathological gene": 0.0017316089138955052, "in vivo": 0.0011893051989229418, "- activating": 0.001518730142224595, "activating transcription": 0.001942369201745883, "nuclear factor": 0.0016129442584442294, "tidal respiration": 0.0017316089138955052, "myocardial t1": 0.0015676508020085118, "mapping values": 0.0016129442584442294, "myocardial tissue": 0.0017316089138955052, "control animals": 0.001655111457576157, "healthy control": 0.001655111457576157, "prognostic relevance": 0.0018309375534367137, "severe pulmonary": 0.0016945562380851515, "\u00b1 1.8": 0.0009836594343941379, "multivariate analyses": 0.0018607572221049612, "low pasp": 0.0012709171785638637, "significantly different": 0.0019163575327502704, "independent prognostic": 0.001889189416918999, "hypertension patients": 0.0018607572221049612, "data in": 0.0011893051989229418, "fluid overload": 0.0016129442584442294, "cardiovascular hospitalization": 0.002078750517097445, "unfolded protein": 0.0016945562380851515, "protein response": 0.0016945562380851515, "mrna splicing": 0.0015676508020085118, "cardiac na+": 0.0014655503573977114, "tested whether": 0.0016129442584442294, "stem cell": 0.0013429040463640383, "na+ channel": 0.0014655503573977114, "mrna splice": 0.0014655503573977114, "splice variants": 0.001655111457576157, "reduction of": 0.001518730142224595, "diagnostic procedures": 0.0018607572221049612, "management strategies": 0.0018607572221049612, "assess whether": 0.0016129442584442294, "differential response": 0.0018607572221049612, "stable heart": 0.001518730142224595, "outcomes included": 0.0017316089138955052, "carvedilol resulted": 0.0017995880167098433, "lower von": 0.0013429040463640383, "contextual factors": 0.001766543105885326, "biomedical reasons": 0.001766543105885326, "parasympathetic tone": 0.0018309375534367137, "evidence suggests": 0.0017316089138955052, "sympathovagal balance": 0.0018607572221049612, "response caused": 0.001655111457576157, "vagal tone": 0.0014072984939154259, "reduced sympathetic": 0.0017995880167098433, "cardiac vagal": 0.0015676508020085118, "electromechanical delay": 0.0019163575327502704, "dyssynchronous heart": 0.0018309375534367137, "electrical activation": 0.0018607572221049612, "abnormal ca(2": 0.0015676508020085118, "the goal": 0.0012709171785638637, "advanced hf": 0.0014655503573977114, "lower fat": 0.0013429040463640383, "lean body": 0.0013429040463640383, "channel inhibition": 0.001766543105885326, "hemodynamic status": 0.001766543105885326, "clinical tool": 0.0015676508020085118, "clinical prediction": 0.0017995880167098433, "derivation cohort": 0.0017316089138955052, "multivariate logistic": 0.0018607572221049612, "diuretic use": 0.001518730142224595, "current knowledge": 0.0017316089138955052, "aged 20": 0.0011893051989229418, "diseased cardiomyocytes": 0.0019163575327502704, "cross talk": 0.0014072984939154259, "poorly understood": 0.0017316089138955052, "chronic \u03b2": 0.0013429040463640383, "therapeutic strategy": 0.0018309375534367137, "worsening renal": 0.001655111457576157, "potassium <": 0.0014655503573977114, "optimal therapy": 0.001655111457576157, "- specified": 0.0014655503573977114, "potassium >": 0.0014655503573977114, "exclusion criteria": 0.001766543105885326, "treatment group": 0.001655111457576157, "control strategies": 0.001766543105885326, "rich cocoa": 0.0014072984939154259, "detrimental alterations": 0.0019163575327502704, "mitochondrial structure": 0.0019163575327502704, "chinese herbal": 0.0016129442584442294, "herbal medicine": 0.001655111457576157, "diastolic end": 0.0015676508020085118, "end diameter": 0.001518730142224595, "analysis indicated": 0.001766543105885326, "week follow": 0.0014655503573977114, "metabolic enzymes": 0.0017316089138955052, "healthy volunteers": 0.001766543105885326, "biosynthetic enzymes": 0.0018309375534367137, "therapeutic interventions": 0.0019673188687882757, "review provides": 0.001655111457576157, "pathophysiological origin": 0.0019673188687882757, "care surgery": 0.001518730142224595, "abdominal problems": 0.001766543105885326, "cardiac arrest": 0.0016129442584442294, "posterior wall": 0.0016129442584442294, "refractory cardiogenic": 0.001889189416918999, "heart team": 0.0014072984939154259, "effective treatment": 0.0017995880167098433, "complicating ami": 0.0016945562380851515, "linked administrative": 0.0018607572221049612, "fatality rate": 0.0015676508020085118, "concurrent hf": 0.0015676508020085118, "day survivors": 0.0015676508020085118, "rehabilitation in": 0.0017316089138955052, "testosterone supplementation": 0.0020365833179655174, "key health": 0.0014072984939154259, "shuttle walk": 0.001518730142224595, "muscular strength": 0.0017316089138955052, "inflammatory markers": 0.0018309375534367137, "living with": 0.0014655503573977114, "functional electrical": 0.0018607572221049612, "electrical stimulation": 0.001889189416918999, "emotional status": 0.0016945562380851515, "minute walked": 0.0015676508020085118, "walked distance": 0.001655111457576157, "transforming growth": 0.0017995880167098433, "derived c": 0.0013429040463640383, "cardiac explant": 0.001655111457576157, "improve cardiac": 0.001655111457576157, "mesenchymal transition": 0.001889189416918999, "transition markers": 0.001766543105885326, "clinical application": 0.0018309375534367137, "periodic breathing": 0.001766543105885326, "defibrillator device": 0.0018309375534367137, "antiplatelet agents": 0.0017995880167098433, "prognostic information": 0.001889189416918999, "unilateral renal": 0.0016945562380851515, "renal denervation": 0.0017316089138955052, "increased sympathetic": 0.0018607572221049612, "cardiac autonomic": 0.0017316089138955052, "- dnx": 0.0009836594343941379, "sham levels": 0.0014655503573977114, "narrow qrs": 0.0014072984939154259, "primary efficacy": 0.0016945562380851515, "worsening heart": 0.001655111457576157, "mean of": 0.0011893051989229418, "divided into": 0.001518730142224595, "sensitive outcome": 0.0017316089138955052, "outcome ratings": 0.001655111457576157, "provide insight": 0.001655111457576157, "phosphate receptor": 0.001766543105885326, "receptor 1": 0.0014072984939154259, "coupled receptors": 0.0017316089138955052, "coupled receptor": 0.0016945562380851515, "plasma membrane": 0.001655111457576157, "urgent readmission": 0.001766543105885326, "early physician": 0.001655111457576157, "physician follow": 0.0016945562380851515, "lower rates": 0.0014655503573977114, "index admission": 0.001655111457576157, "better outcomes": 0.001655111457576157, "subunit expression": 0.001766543105885326, "disease progression": 0.0017995880167098433, "significantly decreased": 0.0019163575327502704, "autonomic nervous": 0.0017316089138955052, "nervous system": 0.0016129442584442294, "spontaneous vt": 0.0016129442584442294, "atrial pacing": 0.0015676508020085118, "higher baseline": 0.001655111457576157, "cell transplantation": 0.0018309375534367137, "performed better": 0.0016945562380851515, "outcomes trial": 0.0016129442584442294, "pharmacological treatment": 0.0019673188687882757, "new targets": 0.0014655503573977114, "the treatment": 0.0015676508020085118, "clinical symptoms": 0.0017316089138955052, "guided clinical": 0.001655111457576157, "aldosterone system": 0.001766543105885326, "cardiac filling": 0.001655111457576157, "score <": 0.0011893051989229418, "factor analysis": 0.001655111457576157, "forms of": 0.0012709171785638637, "antibodies targeting": 0.0018309375534367137, "nonterminal epitopes": 0.0018309375534367137, "these findings": 0.0016129442584442294, "wall thickness": 0.0016129442584442294, "inappropriate implantable": 0.0019673188687882757, "defibrillator therapy": 0.0018607572221049612, "therapy due": 0.0014655503573977114, "therapy compared": 0.0016945562380851515, "inappropriate atp": 0.0017316089138955052, "receiving carvedilol": 0.0018309375534367137, "carvedilol compared": 0.0017995880167098433, "lower rate": 0.0014072984939154259, "refill compliance": 0.0017316089138955052, "trend <": 0.0011893051989229418, "matched control": 0.001655111457576157, "failure due": 0.0014655503573977114, "myosin heavy": 0.001518730142224595, "heavy chain": 0.0014655503573977114, "reference subjects": 0.001766543105885326, "psoriasis patients": 0.001766543105885326, "brachial index": 0.0016129442584442294, "peripheral artery": 0.0017316089138955052, "index \u2264": 0.0011893051989229418, "intensive transitions": 0.0018607572221049612, "care program": 0.001518730142224595, "care system": 0.0014655503573977114, "abnormal hr": 0.0014655503573977114, "various measures": 0.0016945562380851515, "- linear": 0.0012709171785638637, "artery stenosis": 0.001655111457576157, "common form": 0.0014655503573977114, "progressive disease": 0.0017995880167098433, "major public": 0.001518730142224595, "health problem": 0.0016129442584442294, "differentially expressed": 0.001942369201745883, "failure samples": 0.001655111457576157, "functional enrichment": 0.0018607572221049612, "enrichment analysis": 0.0017995880167098433, "analysis using": 0.0016129442584442294, "driven telehealth": 0.0017316089138955052, "inpatient admissions": 0.0018309375534367137, "hospital days": 0.0015676508020085118, "without exercise": 0.0016945562380851515, "walk distance": 0.0015676508020085118, "increased mortality": 0.0017995880167098433, "the hazard": 0.0014072984939154259, "lower exercise": 0.0016129442584442294, "early treatment": 0.001655111457576157, "applied early": 0.0015676508020085118, "early rhythm": 0.001518730142224595, "cardiac nurses": 0.0016129442584442294, "article describes": 0.0017316089138955052, "life expectancy": 0.001655111457576157, "terminal heart": 0.0016129442584442294, "ventricular action": 0.001766543105885326, "sustaining treatment": 0.0018309375534367137, "composite quality": 0.0017316089138955052, "quality measures": 0.0016945562380851515, "help patients": 0.0015676508020085118, "future high": 0.0014655503573977114, "low performers": 0.0016129442584442294, "adjusted mortality": 0.001766543105885326, "versus best": 0.0014655503573977114, "best quintile": 0.0015676508020085118, "using 2005": 0.0014072984939154259, "vs. hospital": 0.001518730142224595, "race influences": 0.001655111457576157, "aa participants": 0.001655111457576157, "combined end": 0.001518730142224595, "signaling pathways": 0.001766543105885326, "proteomics changes": 0.001766543105885326, "ingenuity pathway": 0.0017316089138955052, "significantly changed": 0.0018607572221049612, "actin cytoskeleton": 0.001766543105885326, "mitochondrial function": 0.001889189416918999, "global attenuation": 0.001766543105885326, "targeted peptide": 0.0016945562380851515, "- acute": 0.0011893051989229418, "care transfer": 0.0015676508020085118, "transfer policy": 0.001655111457576157, "percentage points": 0.0017316089138955052, "kidney infection": 0.0016945562380851515, "patients cared": 0.0016129442584442294, "across hospital": 0.001655111457576157, "chronic advanced": 0.0016945562380851515, "anaerobic threshold": 0.0017995880167098433, "primary study": 0.0015676508020085118, "at multivariable": 0.0016945562380851515, "metabolic exercise": 0.001766543105885326, "kidney index": 0.001518730142224595, "index score": 0.0014655503573977114, "following variables": 0.0017995880167098433, "cardiorespiratory fitness": 0.0019673188687882757, "lower hf": 0.0012709171785638637, "mortality risk": 0.0016129442584442294, "decreased mitochondrial": 0.0019163575327502704, "% decrease": 0.0014072984939154259, "health service": 0.0016129442584442294, "lower total": 0.0014655503573977114, "total expenditure": 0.0017316089138955052, "health per": 0.0014072984939154259, "rheumatic fever": 0.001655111457576157, "cardiac injury": 0.0016129442584442294, "terminal phase": 0.0016129442584442294, "antihyperglycemic agents": 0.001942369201745883, "versus pioglitazone": 0.0017995880167098433, "versus insulin": 0.0016129442584442294, "parasympathetic activity": 0.001942369201745883, "ongoing gdmt": 0.001518730142224595, "major adverse": 0.0015676508020085118, "adverse neurological": 0.0018309375534367137, "physical examination": 0.0018309375534367137, "young athletes": 0.0016129442584442294, "atherosclerotic cad": 0.0017995880167098433, "assisted gait": 0.0015676508020085118, "gait therapy": 0.001518730142224595, "resistance training": 0.0017995880167098433, "inflammatory biomarkers": 0.0019163575327502704, "peak quadriceps": 0.001655111457576157, "quadriceps force": 0.0016945562380851515, "events occurred": 0.001655111457576157, "higher psss": 0.0014655503573977114, "lower btes": 0.0014072984939154259, "resting hr<70": 0.0015676508020085118, "versus \u226570": 0.0014072984939154259, "\u226570 bpm": 0.0011893051989229418, "dose uptitration": 0.0016945562380851515, "kg increase": 0.0014655503573977114, "interatrial shunting": 0.0018309375534367137, "principle cohort": 0.0016945562380851515, "atrial pressure": 0.001655111457576157, "mean score": 0.0014072984939154259, "min walk": 0.0012709171785638637, "caloric restriction": 0.0017995880167098433, "obese older": 0.0014655503573977114, "stable hfpef": 0.001518730142224595, "- primary": 0.0013429040463640383, "diet group": 0.0014072984939154259, "performance goal": 0.0016945562380851515, "failure disease": 0.001655111457576157, "the model": 0.0013429040463640383, "attention to": 0.0011390476066684464, "talk between": 0.0011390476066684464, "loss of": 0.0008919788991922065, "follow up": 0.001007178034773029, "agents in": 0.001007178034773029, "studies of": 0.0010554738704365695, "data on": 0.0008919788991922065, "evidence from": 0.0011757381015063838, "symptoms in": 0.0010991627680482835, "participating in": 0.0012709171785638637, "known about": 0.0010991627680482835, "setting of": 0.0010554738704365695, "hearts of": 0.001007178034773029, "mortality at": 0.0011390476066684464, "outcome in": 0.0010554738704365695, "factor in": 0.001007178034773029, "increase of": 0.0010991627680482835, "implications of": 0.0012413335931821176, "performance of": 0.001209708193833172, "approaches to": 0.0011757381015063838, "hospital for": 0.0011390476066684464, "supplemented by": 0.0012413335931821176, "months after": 0.0011390476066684464, "findings from": 0.0011757381015063838, "accounting for": 0.001209708193833172, "recommendations for": 0.0013496910125323826, "association of": 0.001209708193833172, "presenting to": 0.0011757381015063838, "phenotype of": 0.0011390476066684464, "characterized by": 0.0012709171785638637, "recognized as": 0.0011757381015063838, "median of": 0.001007178034773029, "effects in": 0.0010554738704365695, "determination of": 0.0012709171785638637, "survival in": 0.0010991627680482835, "admission to": 0.0011390476066684464, "measured in": 0.0010991627680482835, "targets for": 0.0010991627680482835, "wk after": 0.0009531878839228976, "hypertrophy to": 0.001209708193833172, "group of": 0.0009531878839228976, "bridge to": 0.001007178034773029, "types of": 0.0009531878839228976, "importance of": 0.0011757381015063838, "annuloplasty for": 0.0012709171785638637, "dilated by": 0.0010554738704365695, "evaluated in": 0.0011390476066684464, "developed for": 0.0011757381015063838, "need of": 0.0008919788991922065, "dose of": 0.0008919788991922065, "evidence for": 0.0011390476066684464, "prediction of": 0.0011757381015063838, "remodeling in": 0.0011757381015063838, "echocardiography at": 0.0013496910125323826, "failure of": 0.0010554738704365695, "pressure in": 0.0010991627680482835, "% had": 0.0007377445757956034, "reduced in": 0.0010554738704365695, "normalization of": 0.0012709171785638637, "analyzed in": 0.0010991627680482835, "levels by": 0.001007178034773029, "signs of": 0.0009531878839228976, "care in": 0.0008919788991922065, "error of": 0.0009531878839228976, "found between": 0.0011757381015063838, "worsening of": 0.0011390476066684464, "result in": 0.001007178034773029, "programs in": 0.0010991627680482835, "years of": 0.0009531878839228976, "documented in": 0.0011757381015063838, "insights from": 0.0011757381015063838, "patients from": 0.0011757381015063838, "care for": 0.0009531878839228976, "associations of": 0.0012413335931821176, "study of": 0.0009531878839228976, "subset of": 0.001007178034773029, "outcomes after": 0.001209708193833172, "experience with": 0.0012413335931821176, "rate for": 0.0009531878839228976, "parallel with": 0.0011757381015063838, "contributions of": 0.0012709171785638637, "results from": 0.0011390476066684464, "average of": 0.0010554738704365695, "coupling in": 0.0010991627680482835, "reserve in": 0.0010554738704365695, "maintenance of": 0.001209708193833172, "composite of": 0.0011390476066684464, "days after": 0.0010554738704365695, "result of": 0.001007178034773029, "testing of": 0.0010554738704365695, "consequence of": 0.001209708193833172, "tissue from": 0.0010991627680482835, "means of": 0.0009531878839228976, "tool for": 0.0009531878839228976, "drugs for": 0.001007178034773029, "declines in": 0.0010991627680482835, "blockers on": 0.0010991627680482835, "progression of": 0.001209708193833172, "insight into": 0.0011390476066684464, "goal of": 0.0008919788991922065, "aspects of": 0.0010554738704365695, "suggesting that": 0.0012413335931821176, "need for": 0.0009531878839228976, "potential of": 0.0011390476066684464, "stratification of": 0.001298706685421629, "eplerenone in": 0.0011757381015063838, "reversal of": 0.0010991627680482835, "exercise with": 0.0011757381015063838, "period of": 0.001007178034773029, "phase of": 0.0009531878839228976, "overview of": 0.0010991627680482835, "lead to": 0.0008919788991922065, "regulation of": 0.0011757381015063838, "biomarkers in": 0.0011757381015063838, "modification of": 0.0012413335931821176, "odds of": 0.0008919788991922065, "fragments of": 0.0011390476066684464, "metoprolol on": 0.0011757381015063838, "baseline to": 0.0010991627680482835, "consist of": 0.0010554738704365695, "attenuation of": 0.001209708193833172, "done in": 0.0008919788991922065, "subjected to": 0.0011390476066684464, "score of": 0.0009531878839228976, "common conditions": 0.0008658044569477526, "the effects": 0.0007327751786988557, "decade of": 0.0006714520231820191, "national efforts": 0.0008472781190425757, "efforts dedicated": 0.0008658044569477526, "improve patient": 0.0008275557287880785, "safety remain": 0.0007838254010042559, "remain largely": 0.0008064721292221147, "largely unclear": 0.0008275557287880785, "assess national": 0.0008275557287880785, "conditions requiring": 0.0009154687767183569, "requiring surgery": 0.0008658044569477526, "the analysis": 0.0007593650711122975, "analysis included": 0.0008658044569477526, "large study": 0.0007327751786988557, "study sample": 0.0007593650711122975, "patients across": 0.0008275557287880785, "significant decline": 0.0008997940083549217, "rates for": 0.0006714520231820191, "estimated 81,000": 0.0008472781190425757, "hospital adverse": 0.0008472781190425757, "events averted": 0.0008064721292221147, "measurable overall": 0.000883271552942663, "overall improvements": 0.0009154687767183569, "surgical conditions": 0.0008997940083549217, "some events": 0.0007327751786988557, "pressure ulcers": 0.0008275557287880785, "surgical patients": 0.0008658044569477526, "actually increased": 0.000883271552942663, "increased despite": 0.0008658044569477526, "considerable national": 0.0009303786110524806, "national attention": 0.000883271552942663, "study suggests": 0.0008064721292221147, "national patient": 0.0008472781190425757, "safety initiatives": 0.000883271552942663, "real progress": 0.0007838254010042559, "progress in": 0.0007327751786988557, "created across": 0.0008064721292221147, "board improvements": 0.000883271552942663, "- talk": 0.0005475455413516535, "cachectic heart": 0.0008275557287880785, "increased energy": 0.0008472781190425757, "energy expenditure": 0.000883271552942663, "expenditure caused": 0.000883271552942663, "b natriuretic": 0.0007838254010042559, "progressive loss": 0.0008472781190425757, "fat free": 0.0006354585892819318, "takes place": 0.0007327751786988557, "body fat": 0.0006354585892819318, "fat distribution": 0.0008472781190425757, "dual energy": 0.0007327751786988557, "- diabetic": 0.0007036492469577129, "diabetic patients": 0.0008658044569477526, "- cachectic": 0.0007327751786988557, "cachectic chf": 0.0007838254010042559, "prior myocardial": 0.0008472781190425757, "neurohormonal stimulation": 0.0009836594343941379, "endothelial dysfunction": 0.0009581787663751352, "midregional proanp": 0.000883271552942663, "elevated in": 0.0007327751786988557, "inverse correlation": 0.0008997940083549217, "- adrenomedullin": 0.0008472781190425757, "groups even": 0.0007327751786988557, "increased by": 0.0007593650711122975, "decreased by": 0.0007593650711122975, "cc patients": 0.0007327751786988557, "latter correlated": 0.0008658044569477526, "baseline nt": 0.0007327751786988557, "no correlation": 0.0008064721292221147, "plasma nps": 0.0007036492469577129, "stable body": 0.0007327751786988557, "clinical doppler": 0.0008472781190425757, "failure show": 0.0007593650711122975, "show preserved": 0.0008064721292221147, "steadily increasing": 0.0008997940083549217, "combination with": 0.0008472781190425757, "figure 1": 0.0006354585892819318, "major underlying": 0.0008472781190425757, "underlying mechanism": 0.0009154687767183569, "even mild": 0.0006714520231820191, "mild clinical": 0.0007838254010042559, "clinical diastolic": 0.000883271552942663, "pronounced increases": 0.0009154687767183569, "dysfunction leading": 0.0008997940083549217, "critical importance": 0.0008997940083549217, "guidelines based": 0.0008472781190425757, "based definition": 0.0008472781190425757, "definition of": 0.0007838254010042559, "- dilated": 0.0006714520231820191, "dilated left": 0.0007593650711122975, "impaired lv": 0.0007327751786988557, "diastolic stiffness": 0.0008997940083549217, "elevated lv": 0.0007327751786988557, "assessed non": 0.0007593650711122975, "- invasively": 0.0007593650711122975, "invasively using": 0.0008472781190425757, "practice guideline": 0.000883271552942663, "provide clinical": 0.0008472781190425757, "clinical recommendations": 0.0009711846008729415, "recommendations on": 0.000883271552942663, "published literature": 0.0009154687767183569, "english language": 0.0008472781190425757, "additional studies": 0.000883271552942663, "outcomes evaluated": 0.000883271552942663, "evaluated for": 0.0007838254010042559, "guideline included": 0.000883271552942663, "included mortality": 0.000883271552942663, "failure exacerbation": 0.0009154687767183569, "including hypertension": 0.0009445947084594995, "venous thromboembolic": 0.0009303786110524806, "ischemic cerebrovascular": 0.0009711846008729415, "cerebrovascular events": 0.0009445947084594995, "the target": 0.0007036492469577129, "target audience": 0.0008275557287880785, "guideline includes": 0.000883271552942663, "target patient": 0.0008064721292221147, "population is": 0.0007838254010042559, "deficient adult": 0.0008275557287880785, "guideline grades": 0.0008472781190425757, "recommendations using": 0.0009303786110524806, "practice guidelines": 0.0008997940083549217, "guidelines grading": 0.000883271552942663, "grading system": 0.0008064721292221147, "recommendation 1": 0.0008472781190425757, "recommends using": 0.0008472781190425757, "restrictive red": 0.0008275557287880785, "red blood": 0.0006714520231820191, "blood cell": 0.0007036492469577129, "cell transfusion": 0.0008472781190425757, "transfusion strategy": 0.0009154687767183569, "trigger hemoglobin": 0.000883271552942663, "hemoglobin threshold": 0.0009154687767183569, "higher hemoglobin": 0.0008658044569477526, "weak recommendation": 0.0008997940083549217, "recommendation 2": 0.0008472781190425757, "strong recommendation": 0.0009303786110524806, "anemia treatment": 0.0008472781190425757, "treatments for": 0.0008064721292221147, "trial registries": 0.0008472781190425757, "reference lists": 0.0008275557287880785, "technical advisors": 0.000883271552942663, "study selection": 0.0008275557287880785, "language trials": 0.0008275557287880785, "population characteristics": 0.0009956449307649, "assessed for": 0.0007593650711122975, "studies suggests": 0.0008472781190425757, "liberal transfusion": 0.0008997940083549217, "transfusion protocols": 0.0009303786110524806, "improve short": 0.0007838254010042559, "rates compared": 0.0008064721292221147, "less aggressive": 0.0008275557287880785, "aggressive protocols": 0.0009154687767183569, "combined relative": 0.0008658044569477526, "among trials": 0.0007593650711122975, "rates occurred": 0.0008064721292221147, "small trial": 0.0007327751786988557, "coronary syndrome": 0.0008658044569477526, "iron found": 0.0007036492469577129, "found improved": 0.0008064721292221147, "improved short": 0.0008064721292221147, "term exercise": 0.0007838254010042559, "life in": 0.0005946525994614709, "stimulating agent": 0.0008658044569477526, "agent therapy": 0.0007838254010042559, "therapy found": 0.0007838254010042559, "consistent benefits": 0.0008997940083549217, "venous thromboembolism": 0.0009445947084594995, "few trials": 0.0007036492469577129, "examined transfusions": 0.0009303786110524806, "potentially confounded": 0.0009445947084594995, "data supporting": 0.0008275557287880785, "supporting iron": 0.0008275557287880785, "iron use": 0.0006354585892819318, "use come": 0.0006354585892819318, "come mainly": 0.0007327751786988557, "large trial": 0.0007327751786988557, "term effects": 0.0007593650711122975, "higher transfusion": 0.000883271552942663, "transfusion thresholds": 0.0009445947084594995, "consistently improve": 0.0009154687767183569, "improve mortality": 0.0008658044569477526, "large trials": 0.0007593650711122975, "also warrants": 0.0007838254010042559, "warrants further": 0.0008472781190425757, "benefit patients": 0.0008472781190425757, "serious harms": 0.0007838254010042559, "remote ischemic": 0.0008275557287880785, "ischemic conditioning": 0.0009303786110524806, "nonischemic cardiomyopathies": 0.0010182916589827587, "inroads made": 0.0007593650711122975, "pharmacological armamentarium": 0.0010290152499740676, "eventual resort": 0.0008275557287880785, "both patients": 0.0007838254010042559, "hospital frequently": 0.0008997940083549217, "keep physicians": 0.0008275557287880785, "physicians busy": 0.0008275557287880785, "also prompting": 0.0008064721292221147, "better ways": 0.0007327751786988557, "worldwide epidemic": 0.000883271552942663, "medical resources": 0.0008658044569477526, "financial costs": 0.0008275557287880785, "failure clinical": 0.0008472781190425757, "enriching patient": 0.0008658044569477526, "patient identification": 0.0009445947084594995, "authors suggest": 0.0008275557287880785, "patient categorization": 0.0009445947084594995, "modern acute": 0.0007593650711122975, "highly heterogeneous": 0.0009154687767183569, "appropriate risk": 0.0008472781190425757, "conducting studies": 0.000883271552942663, "cardiac defibrillator": 0.0009303786110524806, "many current": 0.0007593650711122975, "current predictors": 0.000883271552942663, "identify factors": 0.0008472781190425757, "reviewers selected": 0.000883271552942663, "selected citations": 0.000883271552942663, "included ambulatory": 0.0008997940083549217, "ambulatory icd": 0.0008064721292221147, "using multivariable": 0.0008997940083549217, "multivariable regression": 0.0009711846008729415, "analyzed mortality": 0.000883271552942663, "using random": 0.0007593650711122975, "effects models": 0.0008064721292221147, "studies reviewed": 0.0008472781190425757, "evaluating 63": 0.0007838254010042559, "patients proved": 0.0008275557287880785, "proved eligible": 0.0008275557287880785, "high confidence": 0.0008275557287880785, "confidence in": 0.0007838254010042559, "year increase": 0.0007838254010042559, "baseline glomerular": 0.0008997940083549217, "min decrease": 0.0007593650711122975, "inappropriate icd": 0.0008658044569477526, "congestive hf": 0.0007838254010042559, "analysis identified": 0.0008997940083549217, "identified strong": 0.0008658044569477526, "strong reliable": 0.0008275557287880785, "reliable mortality": 0.000883271552942663, "mortality predictors": 0.0009154687767183569, "strong predictors": 0.0008658044569477526, "further research": 0.0008472781190425757, "potential predictors": 0.0009154687767183569, "particularly biomarkers": 0.0009581787663751352, "failure randomized": 0.000883271552942663, "small studies": 0.0007838254010042559, "studies suggest": 0.0008275557287880785, "neither strategy": 0.0008472781190425757, "rigorously tested": 0.0008658044569477526, "independent hypotheses": 0.0009445947084594995, "min without": 0.0007327751786988557, "without bolus": 0.0007838254010042559, "controlled clinical": 0.0008997940083549217, "randomized within": 0.0008658044569477526, "enrollment occurred": 0.0008997940083549217, "randomized in": 0.0007838254010042559, "allocation ratio": 0.0008472781190425757, "ratio to": 0.0006354585892819318, "nesiritide strategy": 0.0008997940083549217, "active treatment": 0.0008472781190425757, "the dopamine": 0.0007593650711122975, "independently compared": 0.0009445947084594995, "pooled placebo": 0.0008064721292221147, "points included": 0.0008275557287880785, "included 72": 0.0007327751786988557, "decongestion end": 0.0008472781190425757, "serum cystatin": 0.0008064721292221147, "function end": 0.0007593650711122975, "points reflective": 0.0008658044569477526, "in participants": 0.0008275557287880785, "nesiritide enhanced": 0.0008997940083549217, "enhanced decongestion": 0.0009303786110524806, "improved renal": 0.0008064721292221147, "added to": 0.0006354585892819318, "multihospital study": 0.0008997940083549217, "promote adoption": 0.0008472781190425757, "failure guidelines": 0.000883271552942663, "nurse leaders": 0.0007838254010042559, "many multisite": 0.0008064721292221147, "multisite studies": 0.0008658044569477526, "practice settings": 0.0008658044569477526, "settings focus": 0.0008064721292221147, "focus on": 0.0006354585892819318, "improving processes": 0.0008997940083549217, "processes of": 0.0007593650711122975, "adopting evidence": 0.0008658044569477526, "based practices": 0.0008275557287880785, "improving patient": 0.0008658044569477526, "specific research": 0.0008658044569477526, "research questions": 0.000883271552942663, "implementation issues": 0.0009303786110524806, "profoundly transformed": 0.0009445947084594995, "utilizing voluntary": 0.0008997940083549217, "voluntary testimonies": 0.0009303786110524806, "participating nurses": 0.0009154687767183569, "multisite study": 0.0008275557287880785, "study extend": 0.0007593650711122975, "extend beyond": 0.0007838254010042559, "beyond meeting": 0.0008064721292221147, "meeting magnet": 0.0008064721292221147, "research requirements": 0.0009303786110524806, "systems proteomics": 0.000883271552942663, "cardiac chromatin": 0.0008658044569477526, "chromatin identifies": 0.0009154687767183569, "identifies nucleolin": 0.0009154687767183569, "regulator of": 0.0007593650711122975, "cellular plasticity": 0.0008997940083549217, "plasticity in": 0.0007838254010042559, "hypertrophy antecedent": 0.0009445947084594995, "failure involves": 0.0008472781190425757, "involves changes": 0.0008472781190425757, "global gene": 0.0007327751786988557, "preceding mechanisms": 0.0009154687767183569, "coordinate dna": 0.0008064721292221147, "dna accessibility": 0.0008658044569477526, "genomic scale": 0.0007838254010042559, "thereby altering": 0.0008472781190425757, "global changes": 0.0008064721292221147, "chromatin subproteomes": 0.0009445947084594995, "accompany heart": 0.0008275557287880785, "study tests": 0.0007327751786988557, "fundamental hypothesis": 0.0009445947084594995, "cardiac growth": 0.0008064721292221147, "disease recapitulates": 0.0009303786110524806, "recapitulates conserved": 0.0009581787663751352, "conserved developmental": 0.0009581787663751352, "developmental chromatin": 0.0009581787663751352, "chromatin remodeling": 0.0009154687767183569, "remodeling events": 0.0008658044569477526, "used quantitative": 0.0008658044569477526, "quantitative proteomics": 0.0009581787663751352, "identify chromatin": 0.000883271552942663, "proteins extracted": 0.000883271552942663, "extracted via": 0.0007838254010042559, "via detergent": 0.0007838254010042559, "quantify changes": 0.0008472781190425757, "study identified": 0.0008472781190425757, "identified 321": 0.0008064721292221147, "modest conservation": 0.0008997940083549217, "revealed using": 0.0008064721292221147, "using strong": 0.0007593650711122975, "strong acid": 0.0007327751786988557, "exhibited altered": 0.0008658044569477526, "conducted extensive": 0.0008997940083549217, "extensive functional": 0.0009154687767183569, "functional characterization": 0.001007178034773029, "based knockdown": 0.0008275557287880785, "knockdown of": 0.0007593650711122975, "nucleolin nearly": 0.0008472781190425757, "nearly abolished": 0.0008472781190425757, "abolished protein": 0.0008658044569477526, "little impact": 0.0007838254010042559, "gross morphological": 0.0008997940083549217, "morphological development": 0.0009836594343941379, "fish lacking": 0.0007593650711122975, "displayed severe": 0.0008472781190425757, "severe developmental": 0.0009154687767183569, "developmental impairment": 0.0009711846008729415, "abnormal chamber": 0.0008472781190425757, "chamber patterning": 0.000883271552942663, "functional deficits": 0.0008997940083549217, "cardiac looping": 0.0008275557287880785, "myocyte differentiation": 0.0009581787663751352, "the mechanisms": 0.0008064721292221147, "mechanisms underlying": 0.0009303786110524806, "defects involve": 0.0008275557287880785, "involve perturbed": 0.0008658044569477526, "perturbed bone": 0.0008064721292221147, "bone morphogenetic": 0.000883271552942663, "morphogenetic protein": 0.0009303786110524806, "decreased rrna": 0.0008064721292221147, "rrna transcription": 0.000883271552942663, "heterochromatic chromatin": 0.0009836594343941379, "study reports": 0.0007838254010042559, "quantitative analysis": 0.0009303786110524806, "new chromatin": 0.0007838254010042559, "chromatin subproteome": 0.0009303786110524806, "diseased mouse": 0.0008064721292221147, "validation studies": 0.000883271552942663, "complementary model": 0.0008997940083549217, "model system": 0.0007593650711122975, "zebrafish examine": 0.0008658044569477526, "orchestrate genomic": 0.0008997940083549217, "genomic reprogramming": 0.0009303786110524806, "reprogramming events": 0.0009154687767183569, "events shared": 0.0007838254010042559, "myocardial ischemic": 0.0008997940083549217, "regarding risk": 0.0008064721292221147, "factors for": 0.0007327751786988557, "comprised 1,045": 0.0008275557287880785, "used multivariate": 0.0008658044569477526, "hazards regression": 0.000883271552942663, "regression modeling": 0.0008997940083549217, "identify risk": 0.0007838254010042559, "comprising hospitalization": 0.0009956449307649, "coronary interventions": 0.0009445947084594995, "patients included": 0.0008658044569477526, "included previous": 0.0008658044569477526, "previous revascularization": 0.0009956449307649, "bypass surgery": 0.0008064721292221147, "coronary intervention": 0.0009303786110524806, "increased systolic": 0.000883271552942663, "block pattern": 0.0007838254010042559, "baseline electrocardiogram": 0.0009956449307649, "reduced risk": 0.0007593650711122975, "risk compared": 0.0007838254010042559, "ies among": 0.0006714520231820191, "dependent effect": 0.0008472781190425757, "fraction on": 0.0007327751786988557, "contemporary heart": 0.000883271552942663, "improved outcomes": 0.0008658044569477526, "mortality after": 0.0008275557287880785, "acute decompensated": 0.0008997940083549217, "decompensated hf": 0.0008472781190425757, "world setting": 0.0007838254010042559, "categorized as": 0.0008064721292221147, "severe reductions": 0.0008658044569477526, "similar risk": 0.0007593650711122975, "mortality as": 0.0007593650711122975, "moderate reduction": 0.000883271552942663, "conferred increased": 0.0008997940083549217, "increased increase": 0.000883271552942663, "increase rate": 0.0007838254010042559, "rate compared": 0.0007838254010042559, "interaction term": 0.0008472781190425757, "term analysis": 0.0007838254010042559, "patients \u226475": 0.0007593650711122975, "\u226475 years": 0.0006714520231820191, "preserved versus": 0.0008472781190425757, "experience similar": 0.000883271552942663, "similar long": 0.0007593650711122975, "moderate reductions": 0.0008997940083549217, "significantly attenuated": 0.0009711846008729415, "longitudinal study": 0.000883271552942663, "endothelial repair": 0.000883271552942663, "serial measurements": 0.0008997940083549217, "included 156": 0.0007593650711122975, "consecutive consenting": 0.0009445947084594995, "consenting ambulatory": 0.0009303786110524806, "measured as": 0.0007327751786988557, "outgrowth colony": 0.0008472781190425757, "forming units": 0.0007838254010042559, "cd133 +": 0.0005946525994614709, "recorded mortality": 0.000883271552942663, "a decrease": 0.0007036492469577129, "increased functional": 0.0009154687767183569, "cell decrease": 0.0007838254010042559, "interaction effect": 0.000883271552942663, "noted differential": 0.000883271552942663, "differential relations": 0.0009445947084594995, "lower cd34+vegfr2": 0.0008658044569477526, "nondiabetic patients": 0.0009154687767183569, "lower eo": 0.0006354585892819318, "the basis": 0.0006714520231820191, "differences requires": 0.0009154687767183569, "choice for": 0.0007036492469577129, "common applications": 0.0008997940083549217, "differential impact": 0.0008997940083549217, "hospital performance": 0.0009154687767183569, "calculated 30": 0.0007838254010042559, "rates using": 0.0007327751786988557, "using three": 0.0007327751786988557, "disease groups": 0.0008064721292221147, "absolute change": 0.0008275557287880785, "correlation between": 0.0008997940083549217, "hospitals remaining": 0.0008997940083549217, "extreme deciles": 0.0008275557287880785, "longitudinal performance": 0.0009711846008729415, "principal findings": 0.000883271552942663, "average hospital": 0.0008472781190425757, "hospital rates": 0.0008064721292221147, "generally higher": 0.0008472781190425757, "rates calculated": 0.0008472781190425757, "calculated using": 0.0008472781190425757, "moderately correlated": 0.0009303786110524806, "extreme decile": 0.0008064721292221147, "decile according": 0.0008472781190425757, "metric remained": 0.0008275557287880785, "different metric": 0.0008472781190425757, "correlations among": 0.000883271552942663, "among metrics": 0.0007838254010042559, "measuring hospital": 0.000883271552942663, "hospital longitudinal": 0.0009303786110524806, "longitudinal change": 0.0008997940083549217, "different approaches": 0.0009154687767183569, "computing readmissions": 0.0009445947084594995, "produce different": 0.0008658044569477526, "different hospital": 0.000883271552942663, "hospital rankings": 0.0008658044569477526, "impact pay": 0.0007036492469577129, "careful consideration": 0.0009303786110524806, "readmission metric": 0.000883271552942663, "discharge in": 0.0007593650711122975, "recent discharge": 0.0008472781190425757, "deliver specialised": 0.0008997940083549217, "specialised care": 0.0008472781190425757, "growing needs": 0.0007838254010042559, "failure population": 0.000883271552942663, "strategies improve": 0.000883271552942663, "unplanned admission": 0.0008997940083549217, "admission due": 0.0007838254010042559, "searching relevant": 0.000883271552942663, "relevant articles": 0.0008658044569477526, "all randomised": 0.0008064721292221147, "controlled trials": 0.0008658044569477526, "cohort studies": 0.0008064721292221147, "contemporaneous control": 0.0009581787663751352, "rm interventions": 0.0008472781190425757, "interventions included": 0.0009445947084594995, "included home": 0.0007838254010042559, "home telemonitoring": 0.0008997940083549217, "including implanted": 0.0008997940083549217, "provided during": 0.0008275557287880785, "structured telephone": 0.0009154687767183569, "telephone support": 0.0008658044569477526, "programmes delivered": 0.0009154687767183569, "delivered via": 0.0007838254010042559, "via human": 0.0006714520231820191, "human contact": 0.0007838254010042559, "machine interface": 0.0008658044569477526, "assessed independently": 0.0009445947084594995, "enrolled 6317": 0.0007838254010042559, "studies evaluated": 0.0008658044569477526, "studies assessed": 0.0008472781190425757, "no trial": 0.0006354585892819318, "devices met": 0.0007327751786988557, "reaching statitistical": 0.0009445947084594995, "statitistical significance": 0.0009956449307649, "% credible": 0.0007036492469577129, "credible interval": 0.0008658044569477526, "provided better": 0.0008275557287880785, "usual support": 0.0007838254010042559, "support to": 0.0007036492469577129, "group rendered": 0.0008064721292221147, "comparisons statistically": 0.0009836594343941379, "also observed": 0.0007838254010042559, "cause hospitalisations": 0.0009445947084594995, "hospitalisations for": 0.0009154687767183569, "care packages": 0.0007838254010042559, "packages generally": 0.000883271552942663, "generally improved": 0.000883271552942663, "improved health": 0.0008275557287880785, "hours showed": 0.0007593650711122975, "showed beneficial": 0.0008658044569477526, "beneficial trends": 0.0008658044569477526, "discharged patients": 0.0008997940083549217, "care is": 0.0005946525994614709, "less good": 0.0006714520231820191, "apoptosis in": 0.0007593650711122975, "canine model": 0.0007593650711122975, "failure induced": 0.0008275557287880785, "induced dilated": 0.0008275557287880785, "fully understood": 0.0008472781190425757, "weeks rapid": 0.0007327751786988557, "rapid right": 0.0007327751786988557, "ventricular pacing": 0.000883271552942663, "gene expressions": 0.0008472781190425757, "interventricular septum": 0.0009581787663751352, "septum biopsies": 0.0008275557287880785, "taken weekly": 0.0007593650711122975, "beagle dogs": 0.0007327751786988557, "evaluated protein": 0.0008658044569477526, "genes by": 0.0006354585892819318, "autopsy samples": 0.0008275557287880785, "pacing period": 0.0007838254010042559, "expression transiently": 0.0009445947084594995, "transiently decreased": 0.0009303786110524806, "moderate heart": 0.0008064721292221147, "significantly altered": 0.0009303786110524806, "expression increased": 0.0009154687767183569, "weeks of": 0.0006354585892819318, "no band": 0.0005946525994614709, "paced myocardium": 0.0008472781190425757, "difference between": 0.000883271552942663, "apoptotic cells": 0.0008275557287880785, "cells in": 0.0006354585892819318, "positive cells": 0.0008064721292221147, "paced groups": 0.0007593650711122975, "pump sternal": 0.0007593650711122975, "sternal sparing": 0.0008275557287880785, "sparing approach": 0.0008472781190425757, "approach for": 0.0007593650711122975, "pump dysfunction": 0.0008472781190425757, "dysfunction requiring": 0.0009303786110524806, "requiring pump": 0.0008064721292221147, "when dysfunction": 0.0008472781190425757, "pump failure": 0.0007593650711122975, "driveline injury": 0.0008472781190425757, "isolated pump": 0.0007838254010042559, "safe pump": 0.0006714520231820191, "exchange technique": 0.000883271552942663, "cardiopulmonary bypass": 0.0009445947084594995, "exchange malfunctioning": 0.0009581787663751352, "extubated within": 0.0008472781190425757, "blood loss": 0.0007036492469577129, "transfusion requirements": 0.0009711846008729415, "periprocedural deaths": 0.0009303786110524806, "system blocker": 0.0008064721292221147, "reduced versus": 0.0008064721292221147, "in ambulatory": 0.0007838254010042559, "dose reduce": 0.0007327751786988557, "benefits in": 0.0007327751786988557, "remain uncertain": 0.0008472781190425757, "study assesses": 0.0008064721292221147, "in consecutive": 0.0008064721292221147, "dose changes": 0.0007593650711122975, "followed during": 0.0008275557287880785, "dose increase": 0.0007838254010042559, "\u226510 %": 0.0004918297171970689, "without uptitration": 0.0008997940083549217, "received uptitration": 0.0009154687767183569, "higher heart": 0.0007593650711122975, "better renal": 0.0007593650711122975, "received spironolactone": 0.0009581787663751352, "readmissions in": 0.0008275557287880785, "hr 0.51": 0.0005946525994614709, "after correction": 0.0008472781190425757, "association remained": 0.0009154687767183569, "ci 0.39": 0.0005946525994614709, "no benefit": 0.0007036492469577129, "neurohumoral blockers": 0.0009303786110524806, "frequently performed": 0.0009154687767183569, "low co": 0.0005475455413516535, "- morbidity": 0.0007327751786988557, "morbidity burden": 0.0008472781190425757, "uptitration independently": 0.0009836594343941379, "independently predicts": 0.0009445947084594995, "inhospital outcomes": 0.0008997940083549217, "get with": 0.0006354585892819318, "known differences": 0.0008658044569477526, "plasma b": 0.0006354585892819318, "explored sex": 0.0007593650711122975, "sex differences": 0.0008275557287880785, "determine prognostic": 0.0009154687767183569, "prognostic significance": 0.0009581787663751352, "included hospitals": 0.000883271552942663, "admitted 99,930": 0.0008275557287880785, "compute odds": 0.0007593650711122975, "hospital clustering": 0.0008997940083549217, "women compared": 0.0008064721292221147, "men had": 0.0005946525994614709, "higher admission": 0.0008472781190425757, "admission median": 0.0008472781190425757, "levels with": 0.0007327751786988557, "greatest difference": 0.0008997940083549217, "smallest difference": 0.0008997940083549217, "women vs": 0.0006354585892819318, "vs men": 0.0005475455413516535, "ef reduced": 0.0007036492469577129, "reduced 1,259": 0.0007838254010042559, "preserved 559": 0.0007838254010042559, "heterogeneity =": 0.0008275557287880785, "= .47": 0.0004918297171970689, "large registry": 0.0008064721292221147, "important cause": 0.0008275557287880785, "article presents": 0.0008472781190425757, "presents guidelines": 0.0008997940083549217, "early medical": 0.0007838254010042559, "assist practitioners": 0.0009154687767183569, "emergency room": 0.0008064721292221147, "room practice": 0.0007838254010042559, "encounter children": 0.000883271552942663, "undiagnosed heart": 0.0008658044569477526, "possible hf": 0.0007327751786988557, "already received": 0.0008472781190425757, "received surgical": 0.0008658044569477526, "surgical palliation": 0.0008997940083549217, "developed using": 0.0008275557287880785, "practical recommendations": 0.0009836594343941379, "clinical setting": 0.0008472781190425757, "online material": 0.0008275557287880785, "this work": 0.0006714520231820191, "include recommendations": 0.0009581787663751352, "advanced management": 0.0008997940083549217, "management involving": 0.0009154687767183569, "involving ventricular": 0.0009303786110524806, "device therapies": 0.0008472781190425757, "relationships with": 0.000883271552942663, "the authors": 0.0007327751786988557, "authors evaluated": 0.0008658044569477526, "nurse assessment": 0.0008472781190425757, "elderly patients": 0.0008472781190425757, "authors analyzed": 0.0008472781190425757, "month mortality": 0.0008275557287880785, "failure declined": 0.0008472781190425757, "many advances": 0.0007838254010042559, "made recently": 0.0007838254010042559, "fewer chf": 0.0006714520231820191, "patients seen": 0.0007838254010042559, "suburban hospitals": 0.000883271552942663, "classified patients": 0.0008997940083549217, "year of": 0.0005946525994614709, "determined chf": 0.0008064721292221147, "chf visit": 0.0006714520231820191, "visit rates": 0.0007327751786988557, "total ed": 0.0006354585892819318, "patients intubated": 0.000883271552942663, "calculated 95": 0.0007838254010042559, "performed regression": 0.0009154687767183569, "% were": 0.0005475455413516535, "failure visits": 0.0008064721292221147, "visits declined": 0.0008275557287880785, "% relative": 0.0007036492469577129, "coefficient r(2": 0.0008275557287880785, "annual ed": 0.0006714520231820191, "these decreases": 0.0008275557287880785, "better chf": 0.0007036492469577129, "chf treatments": 0.0008064721292221147, "hemodynamic phenotype": 0.0009303786110524806, "occur even": 0.0007036492469577129, "normal systolic": 0.0008275557287880785, "systolic ventricular": 0.0009154687767183569, "context of": 0.0007036492469577129, "significant liver": 0.0008658044569477526, "hemodynamically distinct": 0.0009711846008729415, "traditional heart": 0.0008658044569477526, "low systemic": 0.0007593650711122975, "preserved cardiac": 0.0008658044569477526, "symptomatic adult": 0.0008658044569477526, "study group": 0.0007327751786988557, "predominantly asymptomatic": 0.0009956449307649, "asymptomatic pediatric": 0.0009445947084594995, "pediatric fontan": 0.0008472781190425757, "case cohort": 0.0007327751786988557, "cohort analysis": 0.0008275557287880785, "clinical comparisons": 0.0009154687767183569, "made between": 0.0007593650711122975, "the adults": 0.0007036492469577129, "mean catheterization": 0.0009154687767183569, "catheterization findings": 0.0009711846008729415, "central venous": 0.0008064721292221147, "pressure 18": 0.0007327751786988557, "index 1,680": 0.0007327751786988557, "\u00b1 368": 0.0004918297171970689, "index 2.7": 0.0006714520231820191, "\u00b1 0.8": 0.0004918297171970689, "\u00b1 0.7": 0.0004918297171970689, "by imaging": 0.0007036492469577129, "cohort demonstrated": 0.0008997940083549217, "greater incidence": 0.0008658044569477526, "abnormal liver": 0.0008064721292221147, "liver texture": 0.0007838254010042559, "texture changes": 0.0008275557287880785, "lower svr": 0.0006714520231820191, "similar cardiac": 0.0008275557287880785, "index compared": 0.0008064721292221147, "pediatric cohort": 0.0008472781190425757, "distinct circulatory": 0.0009154687767183569, "circulatory derangement": 0.0009581787663751352, "hemodynamic features": 0.0009154687767183569, "features similar": 0.0008472781190425757, "portal hypertension": 0.0008997940083549217, "limited ability": 0.0008275557287880785, "augment cardiac": 0.0008275557287880785, "related hospitalization": 0.0009581787663751352, "versus without": 0.0008064721292221147, "cardiovascular morbidity": 0.0009711846008729415, "an ability": 0.0007036492469577129, "careful management": 0.000883271552942663, "enrolled 902": 0.0007593650711122975, "recently hospitalized": 0.0009303786110524806, "management counseling": 0.0009303786110524806, "final multivariate": 0.000883271552942663, "male gender": 0.0007327751786988557, "covered on": 0.0007036492469577129, "% adherence": 0.0007327751786988557, "prescribed medications": 0.0009445947084594995, "- morbidities": 0.0007838254010042559, "age >": 0.0004918297171970689, "prescribed therapy": 0.000883271552942663, "predicting death": 0.0008472781190425757, "failure promotes": 0.0008472781190425757, "promotes restoration": 0.0009154687767183569, "restoration of": 0.0008064721292221147, "lipoprotein functional": 0.0009445947084594995, "functional properties": 0.0009303786110524806, "exerts endothelial": 0.000883271552942663, "effects via": 0.0007327751786988557, "via stimulation": 0.0008275557287880785, "endothelial cell": 0.0008472781190425757, "this function": 0.0007838254010042559, "impaired in": 0.0007327751786988557, "mediated protective": 0.0008997940083549217, "respective molecular": 0.0009154687767183569, "isolated from": 0.0007838254010042559, "healthy controls": 0.0008472781190425757, "bound malondialdehyde": 0.0009303786110524806, "the proteome": 0.0007593650711122975, "hdl particles": 0.0007838254010042559, "lower stimulation": 0.0008658044569477526, "phosphorylation at": 0.000883271552942663, "higher phosphorylation": 0.0009445947084594995, "elevated activation": 0.0008997940083549217, "higher amount": 0.0007838254010042559, "amount of": 0.0006714520231820191, "malondialdehyde bound": 0.0009303786110524806, "in healthy": 0.0007036492469577129, "improved hdl": 0.0007593650711122975, "a correlation": 0.0007838254010042559, "dilatation improvement": 0.0009445947084594995, "results demonstrate": 0.0008997940083549217, "demonstrate that": 0.0008472781190425757, "mediated vascular": 0.0008658044569477526, "exerts beneficial": 0.0008658044569477526, "main objective": 0.0008064721292221147, "plasma n": 0.0006354585892819318, "successfully predict": 0.0009154687767183569, "best knowledge": 0.0008064721292221147, "first research": 0.0008064721292221147, "research done": 0.0007838254010042559, "plasma obtained": 0.0008275557287880785, "obtained from": 0.0007838254010042559, "the end": 0.0005946525994614709, "\u00b1 10.3": 0.0005475455413516535, "- survivors": 0.0007327751786988557, "years vs": 0.0006354585892819318, "\u00b1 11.07": 0.0005946525994614709, "optimal nt": 0.0007036492469577129, "cutoff point": 0.0007593650711122975, "predicting 4": 0.0007593650711122975, "elevated nt": 0.0007327751786988557, "optimal cutoff": 0.0008064721292221147, "cutoff level": 0.0007593650711122975, "predict 4": 0.0006714520231820191, "high sensitivity": 0.0008472781190425757, "additional prospective": 0.0009445947084594995, "multicenter studies": 0.0008997940083549217, "novel heart": 0.0007327751786988557, "failure mice": 0.0007593650711122975, "mice model": 0.0007036492469577129, "model using": 0.0007327751786988557, "using simple": 0.0007593650711122975, "simple experimental": 0.0008997940083549217, "stable phenotypes": 0.0008658044569477526, "novel mouse": 0.0007327751786988557, "combining salt": 0.0008064721292221147, "old c57bl/6": 0.0007327751786988557, "significantly elevated": 0.0009445947084594995, "significant decreases": 0.0009303786110524806, "high incidence": 0.0008064721292221147, "this phenotype": 0.0008064721292221147, "early deaths": 0.0007593650711122975, "deaths in": 0.0006714520231820191, "small gtpase": 0.0007593650711122975, "rac1 activity": 0.0007838254010042559, "infusion mouse": 0.0008064721292221147, "mice developed": 0.0008064721292221147, "useful mouse": 0.0007593650711122975, "transition from": 0.0008275557287880785, "biomarker approach": 0.000883271552942663, "predict heart": 0.0007838254010042559, "atherosclerosis risk": 0.0009154687767183569, "risk in": 0.0005946525994614709, "communities study": 0.0008658044569477526, "various cardiovascular": 0.0009445947084594995, "largest increases": 0.0008658044569477526, "coming decades": 0.0008064721292221147, "cardiac troponin": 0.0008472781190425757, "troponin t": 0.0007036492469577129, "sensitivity assay": 0.0008658044569477526, "biomarkers strongly": 0.0008997940083549217, "using sex": 0.0006714520231820191, "specific models": 0.0008275557287880785, "added ctnt": 0.0007036492469577129, "antihypertensive medication": 0.001007178034773029, "medication use": 0.0008064721292221147, "former smoking": 0.0008064721292221147, "prevalent coronary": 0.000883271552942663, "participants without": 0.0009154687767183569, "without prevalent": 0.0008658044569477526, "prevalent hf": 0.0007593650711122975, "model fit": 0.0006714520231820191, "developed incident": 0.000883271552942663, "model significantly": 0.0008997940083549217, "statistical parameters": 0.0009445947084594995, "aucs increased": 0.0008064721292221147, "continuous nris": 0.0008275557287880785, "simpler laboratory": 0.000883271552942663, "report model": 0.0007593650711122975, "value in": 0.0006354585892819318, "simple sex": 0.0007036492469577129, "specific model": 0.0008064721292221147, "good model": 0.0007036492469577129, "characteristics results": 0.0009581787663751352, "excellent hf": 0.0007593650711122975, "prediction model": 0.0008472781190425757, "survival after": 0.0008064721292221147, "without temporary": 0.0008658044569477526, "temporary right": 0.0008275557287880785, "ventricular support": 0.0008997940083549217, "historically results": 0.0009154687767183569, "requiring temporary": 0.0008997940083549217, "temporary rv": 0.0007593650711122975, "heterogeneous group": 0.0008997940083549217, "patients consisting": 0.0008997940083549217, "consisting of": 0.0007838254010042559, "chronic decompensated": 0.0009303786110524806, "decompensated heart": 0.0008997940083549217, "hybrid system": 0.0007838254010042559, "system consisting": 0.0008658044569477526, "isolated lvad": 0.0007838254010042559, "temporary centrimag": 0.0008997940083549217, "preoperative demographics": 0.0009836594343941379, "operative outcomes": 0.000883271552942663, "patients required": 0.0008658044569477526, "required biventricular": 0.0009445947084594995, "mean duration": 0.0007838254010042559, "\u00b1 11.9": 0.0005475455413516535, "successfully explanted": 0.0009445947084594995, "significantly greater": 0.0009303786110524806, "required isolated": 0.0008658044569477526, "support using": 0.0007838254010042559, "limited mortality": 0.0008658044569477526, "however biventricular": 0.0009303786110524806, "biventricular dysfunction": 0.0009836594343941379, "isolated heartmate": 0.000883271552942663, "device use": 0.0007036492469577129, "recommendations based": 0.0009303786110524806, "chronic end": 0.0007327751786988557, "evidence on": 0.0007327751786988557, "clinical effects": 0.0008472781190425757, "systematically searched": 0.0009581787663751352, "scientific literature": 0.0009303786110524806, "identified 14": 0.0007838254010042559, "economic evaluations": 0.0009154687767183569, "using simulation": 0.0008472781190425757, "simulation models": 0.0008658044569477526, "studies per": 0.0007327751786988557, "per outcome": 0.0007327751786988557, "made policy": 0.0007327751786988557, "policy recommendations": 0.0009445947084594995, "across transplantation": 0.0009445947084594995, "survival reaching": 0.0008658044569477526, "reaching 86": 0.0007327751786988557, "currently meet": 0.0008064721292221147, "meet traditional": 0.0008472781190425757, "traditional cost": 0.0008472781190425757, "effectiveness limits": 0.0009154687767183569, "models using": 0.0007593650711122975, "using historical": 0.0008472781190425757, "historical data": 0.0008275557287880785, "standard practice": 0.0008658044569477526, "limited number": 0.0008064721292221147, "many regions": 0.0007593650711122975, "implantation strategies": 0.0009581787663751352, "strategies tend": 0.0008275557287880785, "mutually exclusive": 0.000883271552942663, "carefully selected": 0.000883271552942663, "program infrastructure": 0.0009445947084594995, "evidence gaps": 0.0007838254010042559, "economic models": 0.0008275557287880785, "canadian data": 0.0007838254010042559, "data point": 0.0007036492469577129, "systematic monitoring": 0.0009303786110524806, "monitoring of": 0.0007838254010042559, "biventricular pacing": 0.0009154687767183569, "left heart": 0.0007036492469577129, "heart twist": 0.0007327751786988557, "selected cardiac": 0.0008472781190425757, "cardiac surgery": 0.0008275557287880785, "surgery patients": 0.0008472781190425757, "response remains": 0.0008472781190425757, "remains variable": 0.0008472781190425757, "better understanding": 0.0009154687767183569, "used speckle": 0.0007593650711122975, "speckle tracking": 0.0008472781190425757, "tracking echocardiography": 0.0009836594343941379, "analyze bivp": 0.0007593650711122975, "ventricular pressure": 0.0009154687767183569, "pressure overload": 0.0008658044569477526, "inferior vena": 0.0007838254010042559, "vena cava": 0.0006714520231820191, "control model": 0.0007838254010042559, "heart block": 0.0007327751786988557, "artery snared": 0.0007838254010042559, "ventricular midpapillary": 0.0009711846008729415, "midpapillary level": 0.000883271552942663, "varying atrioventricular": 0.0009711846008729415, "atrioventricular delay": 0.0009445947084594995, "interventricular delay": 0.0009445947084594995, "regional circumferential": 0.0009711846008729415, "circumferential strain": 0.0009445947084594995, "radial strain": 0.0007838254010042559, "ventricular base": 0.0008472781190425757, "bivp setting": 0.0007593650711122975, "basal rotations": 0.0008275557287880785, "mixed linear": 0.0007593650711122975, "apical rotation": 0.0008275557287880785, "wall rs": 0.0005946525994614709, "septal wall": 0.0007327751786988557, "open chest": 0.0007036492469577129, "chest model": 0.0007327751786988557, "noninvasive surrogates": 0.0009445947084594995, "varying regional": 0.0008472781190425757, "regional strain": 0.0008275557287880785, "strain contributions": 0.0009154687767183569, "primary mechanism": 0.0008658044569477526, "remaining indices": 0.0008658044569477526, "reflect postsystolic": 0.0009154687767183569, "postsystolic function": 0.0009303786110524806, "stenosis reversed": 0.0008658044569477526, "stenosis frequently": 0.0008997940083549217, "develops after": 0.0008064721292221147, "muscles with": 0.0007593650711122975, "successful mitral": 0.0008658044569477526, "mild mitral": 0.0007327751786988557, "significant mitral": 0.000883271552942663, "reported in": 0.0007327751786988557, "potentially improve": 0.0008997940083549217, "severe mr": 0.0006714520231820191, "grade 4/6": 0.0006714520231820191, "holosystolic murmur": 0.0008997940083549217, "third heart": 0.0007327751786988557, "heart sound": 0.0007327751786988557, "underwent mitral": 0.0008472781190425757, "chordal ruptures": 0.0008472781190425757, "underwent triangular": 0.0009154687767183569, "triangular resection": 0.0009154687767183569, "postoperative echocardiography": 0.0010393752585487225, "echocardiography confirmed": 0.0009956449307649, "normal sized": 0.0007593650711122975, "sized lv": 0.0006354585892819318, "normal lv": 0.0006714520231820191, "preserved mitral": 0.0008472781190425757, "valve area": 0.0007036492469577129, "continuity equation": 0.0008997940083549217, "lv end": 0.0005475455413516535, "flow volume": 0.0007327751786988557, "\u00d7 velocity": 0.0007036492469577129, "velocity time": 0.0007838254010042559, "time integral": 0.0007838254010042559, "continuous wave": 0.0008275557287880785, "utilized even": 0.0007838254010042559, "successfully performed": 0.0009445947084594995, "performed without": 0.0008658044569477526, "major concerns": 0.0008064721292221147, "this time": 0.0006714520231820191, "grade 2": 0.0005946525994614709, "diastolic murmurs": 0.0008658044569477526, "demonstrated moderately": 0.0009581787663751352, "moderately dilated": 0.000883271552942663, "dilated lv": 0.0007036492469577129, "limited mitral": 0.0008064721292221147, "angiography revealed": 0.0009154687767183569, "significant lesions": 0.0008997940083549217, "lesions in": 0.0007036492469577129, "major branches": 0.0008064721292221147, "diagnosed as": 0.0007593650711122975, "hypertensive lv": 0.0008275557287880785, "dysfunction with": 0.0008472781190425757, "mitral leaflet": 0.0008064721292221147, "leaflet motions": 0.0008275557287880785, "restricted without": 0.000883271552942663, "the etiology": 0.0007593650711122975, "etiology of": 0.0007327751786988557, "as significant": 0.0008064721292221147, "surgical indication": 0.0008997940083549217, "the possibility": 0.0008275557287880785, "highly dynamic": 0.0008064721292221147, "potentially respond": 0.0008997940083549217, "cardiac murmurs": 0.0008275557287880785, "murmurs disappeared": 0.0008997940083549217, "repeated echocardiography": 0.0009836594343941379, "echocardiography 4": 0.000883271552942663, "months later": 0.0007593650711122975, "later demonstrated": 0.000883271552942663, "volume of": 0.0006714520231820191, "direct observation": 0.000883271552942663, "surgery also": 0.0007593650711122975, "possible reasons": 0.0008472781190425757, "modest reduction": 0.0008472781190425757, "surgical ring": 0.0007838254010042559, "ring implantation": 0.0008658044569477526, "mild restriction": 0.0008472781190425757, "leaflet motion": 0.0008064721292221147, "leaflet resection": 0.0008658044569477526, "degree of": 0.0006714520231820191, "symptoms disappeared": 0.0009154687767183569, "patient developed": 0.0008658044569477526, "moderate lv": 0.0007327751786988557, "valve demonstrated": 0.000883271552942663, "demonstrated restricted": 0.0009581787663751352, "restricted closure": 0.000883271552942663, "opening without": 0.0008275557287880785, "diastolic tethering": 0.0008997940083549217, "functional etiology": 0.0008997940083549217, "reports demonstrating": 0.0009303786110524806, "demonstrating development": 0.0009836594343941379, "following ring": 0.0008064721292221147, "ischemic mr": 0.0007327751786988557, "this patient": 0.0007593650711122975, "patient showed": 0.0008064721292221147, "potentially vary": 0.0008472781190425757, "vary considerably": 0.0008658044569477526, "second hf": 0.0006714520231820191, "considered indicative": 0.0009303786110524806, "after aggressive": 0.0008472781190425757, "symptom disappeared": 0.0008997940083549217, "insignificant ms": 0.0008472781190425757, "considered as": 0.0007838254010042559, "indications need": 0.0008472781190425757, "carefully evaluated": 0.0008997940083549217, "leaflet configurations": 0.0009445947084594995, "serial evaluation": 0.0008658044569477526, "evaluation strongly": 0.0008997940083549217, "strongly suggested": 0.000883271552942663, "therefore dynamic": 0.0008658044569477526, "annular ms": 0.0007036492469577129, "fixed ring": 0.0007036492469577129, "ring size": 0.0006714520231820191, "this case": 0.0006714520231820191, "report demonstrates": 0.0008997940083549217, "thus requires": 0.0007838254010042559, "requires careful": 0.0008472781190425757, "careful evaluation": 0.000883271552942663, "evaluation of": 0.0007838254010042559, "failure clinic": 0.0008064721292221147, "most heart": 0.0007036492469577129, "stratification models": 0.0009303786110524806, "inpatient use": 0.0007838254010042559, "available outpatient": 0.0009154687767183569, "outpatient models": 0.0008658044569477526, "models use": 0.0007036492469577129, "complex set": 0.0007327751786988557, "set of": 0.0005475455413516535, "routinely collected": 0.0008997940083549217, "collected clinical": 0.000883271552942663, "improvement database": 0.0009154687767183569, "multivariable cox": 0.0008658044569477526, "reached primary": 0.0008275557287880785, "externally validated": 0.0009154687767183569, "patients for": 0.0007593650711122975, "recently calculated": 0.0008997940083549217, "arbitrary start": 0.0008275557287880785, "start date": 0.0007036492469577129, "model included": 0.0008064721292221147, "included blood": 0.0008064721292221147, "blood urea": 0.0007036492469577129, "urea nitrogen": 0.0007838254010042559, "diabetes status": 0.0008275557287880785, "hospitalization within": 0.0009445947084594995, "the concordance": 0.0008275557287880785, "concordance c": 0.0007838254010042559, "c statistics": 0.0007593650711122975, "rank testing": 0.0007593650711122975, "testing demonstrated": 0.0009154687767183569, "demonstrated excellent": 0.0009445947084594995, "excellent risk": 0.0008064721292221147, "rates in": 0.0006354585892819318, "cohorts 8%/12%/12": 0.0008658044569477526, "cohorts 57%/58%/79": 0.000883271552942663, "uses readily": 0.0007593650711122975, "readily available": 0.0008658044569477526, "available data": 0.0008064721292221147, "potentially help": 0.0008472781190425757, "help allocate": 0.0007838254010042559, "allocate specialized": 0.0009154687767183569, "resources within": 0.0008472781190425757, "within health": 0.0007838254010042559, "health systems": 0.0008064721292221147, "dysfunction progresses": 0.0009445947084594995, "examined incidence": 0.000883271552942663, "onset esrd": 0.0007036492469577129, "estimated by": 0.0007593650711122975, "patients grouped": 0.0008472781190425757, "group iii": 0.0006714520231820191, "group iv": 0.0006354585892819318, "median left": 0.0007327751786988557, "median egfr": 0.0007327751786988557, "mainly observed": 0.0008275557287880785, "low egfr": 0.0006354585892819318, "hypertension identify": 0.0009303786110524806, "comparable performance": 0.0009445947084594995, "growing epidemic": 0.0008472781190425757, "valid measure": 0.0007838254010042559, "validated measure": 0.0008658044569477526, "prospective hf": 0.0008064721292221147, "dichotomized patients": 0.0009303786110524806, "the associations": 0.0008472781190425757, "used criterion": 0.0008064721292221147, "criterion standard": 0.000883271552942663, "total symptom": 0.0007838254010042559, "evaluated using": 0.0008275557287880785, "using spearman": 0.0008064721292221147, "spearman correlations": 0.0009303786110524806, "interaction terms": 0.0008658044569477526, "predictive validity": 0.0008997940083549217, "validity of": 0.0007327751786988557, "assessed with": 0.0007838254010042559, "made using": 0.0007036492469577129, "internal reliability": 0.0009154687767183569, "summary scores": 0.0008064721292221147, "free rates": 0.0007036492469577129, "category among": 0.0008064721292221147, "log rank": 0.0006354585892819318, "domains demonstrated": 0.0009154687767183569, "demonstrated high": 0.0008658044569477526, "high internal": 0.0007838254010042559, "consistency among": 0.0008658044569477526, "overall summary": 0.0008275557287880785, "reliable measure": 0.0008472781190425757, "offers excellent": 0.0008472781190425757, "excellent prognostic": 0.0009154687767183569, "prognostic ability": 0.000883271552942663, "future studies": 0.0008064721292221147, "clinical change": 0.0008275557287880785, "soluble concentrations": 0.0009445947084594995, "interleukin receptor": 0.0009154687767183569, "receptor family": 0.0008275557287880785, "family member": 0.0007838254010042559, "predict prognosis": 0.0008658044569477526, "recently found": 0.0008064721292221147, "found changing": 0.0008064721292221147, "changing doses": 0.0008064721292221147, "doses of": 0.0006354585892819318, "affect sst2": 0.0007327751786988557, "concentrations identify": 0.0009581787663751352, "identify benefit": 0.0008472781190425757, "failure attributable": 0.0009154687767183569, "post hoc": 0.0006354585892819318, "hoc analysis": 0.0007593650711122975, "taking bb": 0.0006714520231820191, "medication regimen": 0.000883271552942663, "sst2 values": 0.0007327751786988557, "function of": 0.0007327751786988557, "baseline sst2": 0.0007838254010042559, "sst2 status": 0.0007327751786988557, "low \u226435": 0.0005946525994614709, "versus high": 0.0007327751786988557, "final achieved": 0.0008064721292221147, "versus low": 0.0007036492469577129, "daily equivalent": 0.0008472781190425757, "equivalent dose": 0.0008275557287880785, "metoprolol succinate": 0.0009154687767183569, "sst2 titrated": 0.0007838254010042559, "titrated to": 0.0007327751786988557, "bb had": 0.0005475455413516535, "lowest cardiovascular": 0.0009303786110524806, "lowest cumulative": 0.0008658044569477526, "intermediate outcomes": 0.0009303786110524806, "highest cardiovascular": 0.0009445947084594995, "highest cumulative": 0.000883271552942663, "intermediate odds": 0.0008658044569477526, "therapy exerted": 0.0008275557287880785, "exerted dose": 0.0007593650711122975, "related benefits": 0.0008472781190425757, "benefits across": 0.0008275557287880785, "study participants": 0.000883271552942663, "sst2 measurement": 0.0008472781190425757, "measurement identifies": 0.0009445947084594995, "identifies patients": 0.0008997940083549217, "particularly benefit": 0.0009154687767183569, "higher bb": 0.0006714520231820191, "novel approach": 0.0008064721292221147, "acute treatment": 0.0008275557287880785, "the nitroxyl": 0.0007593650711122975, "exerts positive": 0.0008275557287880785, "positive inotropic": 0.000883271552942663, "vasodilator effects": 0.0008997940083549217, "camp independent": 0.0008472781190425757, "clinical usefulness": 0.0008997940083549217, "limited by": 0.0007036492469577129, "chemical instability": 0.0009154687767183569, "isolated myoctyes": 0.0008658044569477526, "intact hearts": 0.0007838254010042559, "experimental models": 0.0008997940083549217, "converts solely": 0.0008275557287880785, "inactive cxl-1051": 0.0008658044569477526, "in adult": 0.0006354585892819318, "adult mouse": 0.0007327751786988557, "mouse ventricular": 0.0008658044569477526, "ventricular myocytes": 0.0009154687767183569, "dose dependently": 0.0008472781190425757, "dependently increased": 0.0009303786110524806, "increased sarcomere": 0.0008997940083549217, "sarcomere shortening": 0.0009154687767183569, "% rise": 0.0005475455413516535, "rise in": 0.0005946525994614709, "higher doses": 0.0007593650711122975, "neither inhibition": 0.000883271552942663, "kinase a": 0.0006354585892819318, "soluble guanylate": 0.0008658044569477526, "guanylate cyclase": 0.0008658044569477526, "cyclase altered": 0.0008275557287880785, "contractile response": 0.0009154687767183569, "unlike isoproterenol": 0.0009154687767183569, "equally effective": 0.0008658044569477526, "anesthetized dogs": 0.0008658044569477526, "dogs with": 0.0006714520231820191, "coronary microembolization": 0.0009956449307649, "myocardial oxygen": 0.0008658044569477526, "increasing ejection": 0.0008997940083549217, "maximal ventricular": 0.0008997940083549217, "ventricular power": 0.0008658044569477526, "power index": 0.0007327751786988557, "conscious dogs": 0.0008064721292221147, "increased contractility": 0.0009581787663751352, "contractility assessed": 0.0009445947084594995, "provided venoarterial": 0.0009303786110524806, "venoarterial dilation": 0.0009303786110524806, "minimally altered": 0.0008658044569477526, "heart filling": 0.0007838254010042559, "increasing cardiac": 0.000883271552942663, "pressure declined": 0.0008658044569477526, "declined modestly": 0.0008658044569477526, "functional efficacy": 0.0008997940083549217, "novel pure": 0.0007036492469577129, "enhance myocardial": 0.000883271552942663, "present first": 0.0007838254010042559, "man evidence": 0.0007593650711122975, "remodeling after": 0.0008472781190425757, "subsequent events": 0.0008658044569477526, "largely involved": 0.0008472781190425757, "involved single": 0.0008275557287880785, "single parameters": 0.0008658044569477526, "combining parameters": 0.0009154687767183569, "score for": 0.0006714520231820191, "strain of": 0.0006714520231820191, "standard echocardiographic": 0.0009956449307649, "echocardiographic measurements": 0.0010393752585487225, "underwent baseline": 0.000883271552942663, "baseline echocardiography": 0.0009836594343941379, "underwent follow": 0.0008472781190425757, "score with": 0.0007036492469577129, "57\u00b122 months": 0.0007593650711122975, "lv reverse": 0.0007036492469577129, "- crt": 0.0004918297171970689, "dimension index": 0.0008275557287880785, "ventricle <": 0.0007327751786988557, "diastolic area": 0.0008064721292221147, "area index": 0.0007036492469577129, "ventricular fractional": 0.0009445947084594995, "fractional area": 0.0008275557287880785, "area change": 0.0007327751786988557, "change \u226535": 0.0007036492469577129, "\u226535 %": 0.0004918297171970689, "score allowed": 0.0007838254010042559, "allowed prediction": 0.000883271552942663, "heart transplantations": 0.0009445947084594995, "lv assist": 0.0006714520231820191, "device implantations": 0.0009154687767183569, "failure admissions": 0.000883271552942663, "the score": 0.0006714520231820191, "failure admission": 0.0008658044569477526, "ischemic cause": 0.0008064721292221147, "initial functional": 0.000883271552942663, "selecting patients": 0.000883271552942663, "patients likely": 0.0008275557287880785, "undergo reverse": 0.0008275557287880785, "symptomatic systolic": 0.0009154687767183569, "diagnosed systolic": 0.000883271552942663, "previous spironolactone": 0.0009581787663751352, "baseline serum": 0.0008064721292221147, "serum creatinine": 0.0008472781190425757, "creatinine level": 0.0008472781190425757, "potassium level": 0.0008275557287880785, "varying covariates": 0.000883271552942663, "independent association": 0.0009581787663751352, "initiated spironolactone": 0.0009711846008729415, "ratio 0.91": 0.0007036492469577129, "interval 0.77": 0.0007838254010042559, "ratio 0.93": 0.0007036492469577129, "interval 0.60": 0.0007838254010042559, "crude rates": 0.0007327751786988557, "diverse community": 0.0008658044569477526, "based cohort": 0.0007593650711122975, "incident systolic": 0.0008658044569477526, "factor blockade": 0.0008275557287880785, "blockade prevents": 0.0008658044569477526, "therapy on": 0.0007036492469577129, "impaired angiogenesis": 0.0009303786110524806, "angiogenesis in": 0.0008275557287880785, "heart contributes": 0.0008658044569477526, "progression to": 0.0008064721292221147, "the inhibition": 0.0008064721292221147, "compensatory hypertrophy": 0.0009711846008729415, "also shown": 0.0007036492469577129, "improve myocardial": 0.000883271552942663, "enhancing neoangiogenesis": 0.0009836594343941379, "surgically induced": 0.000883271552942663, "induced myocardial": 0.000883271552942663, "failure rats": 0.0007593650711122975, "week treatment": 0.0008064721292221147, "treatment period": 0.0008472781190425757, "echocardiography revealed": 0.0009836594343941379, "cardiac diameters": 0.0008658044569477526, "improved cardiac": 0.0008472781190425757, "treated compared": 0.0008472781190425757, "treated rats": 0.0007593650711122975, "vivo coronary": 0.0007838254010042559, "cardiac fibrosis": 0.0008472781190425757, "weeks after": 0.0007327751786988557, "cardiac vegf": 0.0007593650711122975, "no synthase": 0.0007327751786988557, "synthase activation": 0.0008997940083549217, "comparing b": 0.0007327751786988557, "untreated failing": 0.0008658044569477526, "proangiogenic effects": 0.0009303786110524806, "b act": 0.0004918297171970689, "act via": 0.0005946525994614709, "intravenously injected": 0.0009445947084594995, "adenoviral vector": 0.0008658044569477526, "vector encoding": 0.0008275557287880785, "control adenovirus": 0.000883271552942663, "histological analysis": 0.0009303786110524806, "reduced capillary": 0.0008658044569477526, "rats compared": 0.0007838254010042559, "c rats": 0.0005475455413516535, "inhibition counteracted": 0.0009581787663751352, "positive effects": 0.0008472781190425757, "promotes cardiac": 0.0008472781190425757, "induced enhancement": 0.0008997940083549217, "enhancement of": 0.0008064721292221147, "favorable effects": 0.0008658044569477526, "do outcomes": 0.0007327751786988557, "failure vary": 0.0007593650711122975, "vary by": 0.0005946525994614709, "department volume": 0.0008658044569477526, "common emergency": 0.0008472781190425757, "volume influences": 0.0008658044569477526, "influences patient": 0.000883271552942663, "adults presenting": 0.0008658044569477526, "responsible diagnosis": 0.0009303786110524806, "cases seen": 0.0007036492469577129, "less comorbidities": 0.000883271552942663, "aor ]": 0.0004918297171970689, "exhibited higher": 0.0008472781190425757, "day death": 0.0006714520231820191, "discharge patients": 0.000883271552942663, "failure home": 0.0007593650711122975, "exhibited worse": 0.0008275557287880785, "worse outcomes": 0.0008064721292221147, "driven largely": 0.0008064721292221147, "repeat ed": 0.0006714520231820191, "improve management": 0.000883271552942663, "volume sites": 0.0007593650711122975, "oxidase inhibition": 0.000883271552942663, "inhibition preserves": 0.0009154687767183569, "preserves left": 0.0008064721292221147, "cardiac volume": 0.0008064721292221147, "rat left": 0.0006354585892819318, "aortocaval fistula": 0.000883271552942663, "decrease mitochondrial": 0.0009445947084594995, "mitochondrial respiration": 0.0009836594343941379, "inhibition improves": 0.0008997940083549217, "improves cardiomyocyte": 0.0009445947084594995, "cardiomyocyte bioenergetics": 0.001007178034773029, "chronic acf": 0.0007327751786988557, "acf \u00b1": 0.0004918297171970689, "\u00b1 allopurinol": 0.0007838254010042559, "wk demonstrated": 0.0008275557287880785, "groups versus": 0.0007838254010042559, "sham group": 0.0007036492469577129, "lv ejection": 0.0007327751786988557, "circumferential shortening": 0.0009956449307649, "maximal systolic": 0.0008472781190425757, "contractile efficiency": 0.0009445947084594995, "significantly depressed": 0.0009581787663751352, "improved in": 0.0007327751786988557, "allopurinol rats": 0.0008472781190425757, "maximum o2": 0.0007036492469577129, "consumption rate": 0.0008472781190425757, "rate measured": 0.0007838254010042559, "cardiomyocytes using": 0.0009154687767183569, "extracellular flux": 0.000883271552942663, "flux analyzer": 0.0007838254010042559, "allopurinol improves": 0.0009154687767183569, "efficiency possibly": 0.0008997940083549217, "myofilament ca(2": 0.0008472781190425757, "diastolic properties": 0.0009154687767183569, "usefulness of": 0.0007838254010042559, "assessing left": 0.0008064721292221147, "transmitral blood": 0.0008658044569477526, "found unreliable": 0.0008472781190425757, "estimating pulmonary": 0.0009154687767183569, "decompensated systolic": 0.0009445947084594995, "underwent right": 0.0008275557287880785, "sided cardiac": 0.0007838254010042559, "transthoracic echocardiography": 0.0010393752585487225, "flow velocities": 0.0008275557287880785, "annulus velocities": 0.000883271552942663, "\u00b1 8": 0.00033572601159100957, "/ e'mean": 0.0006354585892819318, "the area": 0.0006354585892819318, "ci 0.70": 0.0005946525994614709, "negative predictive": 0.0008997940083549217, "negative likelihood": 0.0008997940083549217, "likelihood ratio": 0.0008472781190425757, "e'lateral showed": 0.0008472781190425757, "e'septal showed": 0.0008275557287880785, "detecting normal": 0.0008472781190425757, "normal filling": 0.0008064721292221147, "pressure relationship": 0.0009303786110524806, "derived pulmonary": 0.0008658044569477526, "tricuspid annular": 0.0008658044569477526, "basic relevance": 0.0008275557287880785, "relevance in": 0.0007593650711122975, "clinical follow": 0.0008275557287880785, "carrying two-": 0.0007838254010042559, "threefold increase": 0.000883271552942663, "cardiac risk": 0.0007593650711122975, "longitudinal rv": 0.0008275557287880785, "fiber shortening": 0.0008472781190425757, "force generated": 0.0008275557287880785, "vivo rv": 0.0005946525994614709, "ratio better": 0.0007593650711122975, "better disclosing": 0.0008658044569477526, "disclosing prognosis": 0.0009154687767183569, "underwent echo": 0.0008064721292221147, "peptide assessment": 0.000883271552942663, "relationship showed": 0.0008997940083549217, "downward regression": 0.0008997940083549217, "line shift": 0.0007036492469577129, "shift in": 0.0006354585892819318, "frequently presenting": 0.0009303786110524806, "higher pasp": 0.0007327751786988557, "lower tapse": 0.0007327751786988557, "distribution along": 0.000883271552942663, "separate cox": 0.0007593650711122975, "individual measures": 0.0008997940083549217, "ratio form": 0.0007036492469577129, "variables retained": 0.000883271552942663, "multivariate regression": 0.0009581787663751352, "class <": 0.0005946525994614709, "< /\u2265": 0.00042363905952128787, "/\u2265 3": 0.00042363905952128787, "shows that": 0.0007036492469577129, "shifted downward": 0.0008472781190425757, "ratio improves": 0.0008064721292221147, "improves prognostic": 0.0008997940083549217, "prognostic resolution": 0.0009303786110524806, "possible index": 0.0008064721292221147, "efficient rv": 0.0007593650711122975, "function evaluation": 0.0008997940083549217, "stent model": 0.0007327751786988557, "model for": 0.0006714520231820191, "large animal": 0.0007593650711122975, "animal model": 0.0007593650711122975, "novel percutaneous": 0.000883271552942663, "percutaneous one-": 0.0008658044569477526, "ischemia using": 0.0008064721292221147, "stent coated": 0.0007593650711122975, "polytetrafluoroethylene tube": 0.0010182916589827587, "tube formed": 0.0007327751786988557, "bottleneck shape": 0.0008472781190425757, "implanted in": 0.0007593650711122975, "proximal circumflex": 0.0008997940083549217, "circumflex artery": 0.0008658044569477526, "proximal lcx": 0.0007593650711122975, "mid lad": 0.0005946525994614709, "wk later": 0.0006354585892819318, "infarct size": 0.0007593650711122975, "given antiarrhythmic": 0.0009154687767183569, "antiarrhythmic medication": 0.0009836594343941379, "prevent sudden": 0.0008064721292221147, "the occlusion": 0.0007838254010042559, "occlusion time": 0.0008064721292221147, "modulated by": 0.0007593650711122975, "antiplatelet medication": 0.0009581787663751352, "fractional flow": 0.0008275557287880785, "flow reserve": 0.0007593650711122975, "reserve measurements": 0.0009154687767183569, "positron emission": 0.0008658044569477526, "emission tomography": 0.0008997940083549217, "tomography imaging": 0.000883271552942663, "imaging showed": 0.0008064721292221147, "showed severe": 0.0007838254010042559, "severe ischemia": 0.0008275557287880785, "bottleneck stenting": 0.0008997940083549217, "stenting covering": 0.0008658044569477526, "complete coronary": 0.0008658044569477526, "coronary occlusion": 0.000883271552942663, "significant collateral": 0.0009445947084594995, "occurred already": 0.0008472781190425757, "first wk": 0.0006354585892819318, "stent occlusion": 0.0008275557287880785, "competitive collateral": 0.0009445947084594995, "growth patterns": 0.0008275557287880785, "model 4": 0.0005946525994614709, "% infarcted": 0.0007327751786988557, "infarcted left": 0.0008064721292221147, "the mortality": 0.0007838254010042559, "vessel disease": 0.0008064721292221147, "disease model": 0.0007838254010042559, "the implantation": 0.0008472781190425757, "implantation of": 0.0008275557287880785, "novel bottleneck": 0.0008472781190425757, "novel porcine": 0.0007838254010042559, "reversible myocardial": 0.0009303786110524806, "open stent": 0.0007036492469577129, "occluded stent": 0.0008064721292221147, "selective heart": 0.0008275557287880785, "ivabradine unloads": 0.000883271552942663, "ivabradine reduces": 0.000883271552942663, "reduces afterload": 0.0008658044569477526, "afterload of": 0.0007593650711122975, "represents resistive": 0.0009154687767183569, "pulsatile afterload": 0.0008997940083549217, "heart derived": 0.0007838254010042559, "pressure volume": 0.0008275557287880785, "volume relation": 0.0008275557287880785, "hr modulates": 0.0007593650711122975, "afterload burden": 0.0008472781190425757, "ivabradine 7.5": 0.0008064721292221147, "echocardiographic substudy": 0.0009956449307649, "total arterial": 0.0008064721292221147, "arterial compliance": 0.0008997940083549217, "arm cuff": 0.0006354585892819318, "differ significantly": 0.0009154687767183569, "marked reduction": 0.0008472781190425757, "improved tac": 0.0007593650711122975, "contractility remained": 0.0009445947084594995, "markedly improved": 0.0008658044569477526, "higher sv": 0.0006714520231820191, "ivabradine improves": 0.0008997940083549217, "improves tac": 0.0007593650711122975, "thus reducing": 0.0007838254010042559, "improved ventricular": 0.0009154687767183569, "relation of": 0.0007327751786988557, "preoperative serum": 0.000883271552942663, "serum albumin": 0.0007838254010042559, "indicator in": 0.0007593650711122975, "postoperative mortality": 0.0009581787663751352, "undergoing left": 0.0008275557287880785, "studied 272": 0.0007327751786988557, "preoperative clinical": 0.0009303786110524806, "laboratory variables": 0.0009154687767183569, "variables associated": 0.0009154687767183569, "albumin concentration": 0.0009303786110524806, "levels compared": 0.0008275557287880785, "preoperative albumin": 0.0009154687767183569, "ratio 0.521": 0.0007327751786988557, "interval 0.290": 0.0008064721292221147, "levels during": 0.0007838254010042559, "support on": 0.0007036492469577129, "subgroup analysis": 0.0008658044569477526, "showed improved": 0.0008275557287880785, "remained hypoalbuminemia": 0.0009711846008729415, "decreasing albumin": 0.000883271552942663, "albumin level": 0.0007838254010042559, "correcting nutrition": 0.0009154687767183569, "hepatic function": 0.0008472781190425757, "effective way": 0.0007838254010042559, "improve prognosis": 0.0008658044569477526, "patients evaluated": 0.000883271552942663, "surgical correction": 0.0008997940083549217, "valve insufficiency": 0.0008997940083549217, "onset aortic": 0.0007593650711122975, "aortic insufficiency": 0.0009154687767183569, "instituting mechanical": 0.0009445947084594995, "mechanical circulatory": 0.0009445947084594995, "continuous flow": 0.0008275557287880785, "pulsatile devices": 0.0008658044569477526, "treatment algorithms": 0.0009154687767183569, "de novo": 0.0005946525994614709, "present report": 0.0008064721292221147, "described 6": 0.0007327751786988557, "underwent aortic": 0.0008472781190425757, "valve surgery": 0.0007838254010042559, "surgery for": 0.0007327751786988557, "onset post": 0.0007036492469577129, "underwent lvad": 0.0008064721292221147, "cf devices": 0.0007036492469577129, "onset severe": 0.0007593650711122975, "requiring surgical": 0.000883271552942663, "developed new": 0.0007838254010042559, "after medical": 0.0007838254010042559, "valve procedures": 0.0008472781190425757, "bioprosthetic valve": 0.0008997940083549217, "dacron patch": 0.0007593650711122975, "patch closure": 0.0007838254010042559, "valve repairs": 0.0007838254010042559, "underwent transcatheter": 0.0009581787663751352, "transcatheter aortic": 0.0009154687767183569, "valve procedure": 0.0008275557287880785, "requiring revision": 0.000883271552942663, "open surgery": 0.0007593650711122975, "experienced significant": 0.0009581787663751352, "died postoperatively": 0.0009154687767183569, "postoperatively secondary": 0.0009836594343941379, "multiorgan failure": 0.000883271552942663, "surgical treatment": 0.000883271552942663, "valve oversewing": 0.0008472781190425757, "leaflet repair": 0.0008064721292221147, "bioprosthetic aortic": 0.0009154687767183569, "restoring functional": 0.0009154687767183569, "develop symptomatic": 0.0008997940083549217, "performed safely": 0.0008472781190425757, "good results": 0.0007593650711122975, "various transcatheter": 0.0009303786110524806, "transcatheter approaches": 0.0009711846008729415, "difficult problems": 0.000883271552942663, "also available": 0.0008064721292221147, "offer less": 0.0007036492469577129, "less invasive": 0.0007838254010042559, "invasive alternatives": 0.0009303786110524806, "conventional surgery": 0.0009154687767183569, "age groups": 0.0007036492469577129, "index \u226535": 0.0006714520231820191, "black ethnicity": 0.0008275557287880785, "salt intake": 0.0007327751786988557, "dietary measures": 0.0008472781190425757, "youngest age": 0.0007593650711122975, "rates across": 0.0007593650711122975, "respective age": 0.0008064721292221147, "age categories": 0.0008064721292221147, "referent age": 0.0007593650711122975, "youngest group": 0.0008064721292221147, "group even": 0.0007036492469577129, "ages 20": 0.0005946525994614709, "beyond divergent": 0.0008472781190425757, "divergent etiology": 0.000883271552942663, "exhibited striking": 0.000883271552942663, "striking differences": 0.0009154687767183569, "outcomes compared": 0.0008658044569477526, "older counterparts": 0.000883271552942663, "nonfatal outcomes": 0.0008658044569477526, "better survival": 0.0008275557287880785, "higher hospitalization": 0.0009445947084594995, "growing population": 0.000883271552942663, "population within": 0.0008658044569477526, "within cardiac": 0.0008064721292221147, "\u00b1 11.4": 0.0005475455413516535, "groups performed": 0.0008472781190425757, "performed 200": 0.0007838254010042559, "minutes of": 0.0007036492469577129, "measured after": 0.0008064721292221147, "capacity assessed": 0.0008658044569477526, "standard care": 0.0007838254010042559, "walking led": 0.0007327751786988557, "higher functional": 0.0008658044569477526, "\u00b1 59.4": 0.0005475455413516535, "\u00b1 71.3": 0.0005475455413516535, "greater self": 0.0007593650711122975, "reported physical": 0.0008658044569477526, "\u00b1 118.5": 0.0005946525994614709, "minutes vs": 0.0007036492469577129, "\u00b1 125.6": 0.0005946525994614709, "increased right": 0.0008275557287880785, "right grip": 0.0007036492469577129, "\u00b1 3.5": 0.0004918297171970689, "fewer depressive": 0.0008472781190425757, "\u00b1 2.4": 0.0004918297171970689, "peak aerobic": 0.0007593650711122975, "waist circumference": 0.0008997940083549217, "improving functional": 0.0009154687767183569, "important outcomes": 0.000883271552942663, "this exercise": 0.0007838254010042559, "exercise modality": 0.0008658044569477526, "promising alternative": 0.0009303786110524806, "alternative for": 0.0008275557287880785, "failure complicating": 0.0009154687767183569, "complicating precapillary": 0.0009836594343941379, "precapillary pulmonary": 0.0009445947084594995, "noninvasive tools": 0.0008658044569477526, "experiencing heart": 0.000883271552942663, "major right": 0.0007327751786988557, "ventricle overload": 0.000883271552942663, "overload leads": 0.0008064721292221147, "decreased stroke": 0.0008472781190425757, "shortens left": 0.0007838254010042559, "tonometry study": 0.0008275557287880785, "study tested": 0.0007593650711122975, "carries prognostic": 0.000883271552942663, "ph with": 0.0005946525994614709, "radial artery": 0.0007838254010042559, "artery tonometry": 0.0008472781190425757, "tonometry variables": 0.0008997940083549217, "prospectively obtained": 0.0009445947084594995, "day 3": 0.0004918297171970689, "reconstructed aortic": 0.0009154687767183569, "aortic pressure": 0.0008275557287880785, "pressure curve": 0.0008064721292221147, "overall icu": 0.0007327751786988557, "median stay": 0.0007327751786988557, "at admission": 0.0007593650711122975, "tonometric indices": 0.000883271552942663, "specificity for": 0.0008275557287880785, "identifying death": 0.0008658044569477526, "other prognostic": 0.0008472781190425757, "lower natremia": 0.0008064721292221147, "higher oxygen": 0.0007838254010042559, "second evaluation": 0.0008658044569477526, "norepinephrine requirement": 0.0009956449307649, "poor outcome": 0.0007593650711122975, "previously documented": 0.0009303786110524806, "documented prognostic": 0.0009303786110524806, "myxoma complicated": 0.000883271552942663, "common type": 0.0007327751786988557, "type of": 0.0005946525994614709, "cardiac benign": 0.0008064721292221147, "benign tumors": 0.0007838254010042559, "located in": 0.0007036492469577129, "left atrium": 0.0007327751786988557, "rarely embolize": 0.0008275557287880785, "arterial vasculature": 0.0009154687767183569, "report of": 0.0006714520231820191, "massive embolism": 0.0008472781190425757, "pulmonary arteries": 0.000883271552942663, "arteries treated": 0.0008472781190425757, "treated surgically": 0.000883271552942663, "atrial mass": 0.0007327751786988557, "mass removal": 0.0007593650711122975, "pulmonary embolectomy": 0.0009303786110524806, "atrium mass": 0.0007327751786988557, "mass presented": 0.0008064721292221147, "tricuspid valve": 0.0008275557287880785, "valve causing": 0.0007838254010042559, "stenotic physiology": 0.0008997940083549217, "left pulmonary": 0.0008064721292221147, "completed occluded": 0.000883271552942663, "right pulmonary": 0.0008275557287880785, "partially obstructed": 0.0009154687767183569, "surgical tactics": 0.0008472781190425757, "tactics included": 0.0008472781190425757, "brief hypothermic": 0.0008658044569477526, "hypothermic circulatory": 0.0009581787663751352, "circulatory arrest": 0.000883271552942663, "uneventful recovery": 0.0008997940083549217, "reliability of": 0.0008064721292221147, "go test": 0.0005946525994614709, "test in": 0.0005946525994614709, "chronic organ": 0.0007838254010042559, "organ failure": 0.0007838254010042559, "chronic renal": 0.0007838254010042559, "renal failure": 0.0007838254010042559, "- sectional": 0.0007327751786988557, "home environment": 0.0008472781190425757, "median body": 0.0007327751786988557, "performed on": 0.0007593650711122975, "the intraclass": 0.0008064721292221147, "intraclass correlation": 0.0009445947084594995, "kappa coefficient": 0.0008658044569477526, "relative minimal": 0.0008472781190425757, "minimal detectable": 0.000883271552942663, "detectable change": 0.0008658044569477526, "good agreement": 0.0008064721292221147, "values ranging": 0.0008064721292221147, "kappa coefficients": 0.000883271552942663, "statistical improvement": 0.0009581787663751352, "improvement occurred": 0.0009154687767183569, "second trial": 0.0007593650711122975, "large limits": 0.0007593650711122975, "third trial": 0.0007327751786988557, "trial added": 0.0007327751786988557, "added little": 0.0007593650711122975, "measurement value": 0.0008658044569477526, "relative value": 0.0008064721292221147, "similar values": 0.0008064721292221147, "values found": 0.0007593650711122975, "daily clinical": 0.0008064721292221147, "represents true": 0.0008275557287880785, "true change": 0.0007327751786988557, "repeated measures": 0.0008658044569477526, "arthritis starting": 0.000883271552942663, "elevations in": 0.0007838254010042559, "tumor necrosis": 0.0008064721292221147, "necrosis factor": 0.0008275557287880785, "several trials": 0.0008064721292221147, "antagonists showed": 0.000883271552942663, "possibly worsening": 0.000883271552942663, "known severe": 0.0007593650711122975, "recurrent hf": 0.0007593650711122975, "treat rheumatoid": 0.0008472781190425757, "different us": 0.0007593650711122975, "healthcare programmes": 0.0009303786110524806, "receiving methotrexate": 0.0009445947084594995, "- biological": 0.0007593650711122975, "biological disease": 0.000883271552942663, "disease modifying": 0.0008658044569477526, "modifying antirheumatic": 0.0009581787663751352, "antirheumatic drug": 0.000883271552942663, "models stratified": 0.0008658044569477526, "score decile": 0.0007593650711122975, "oral glucocorticoid": 0.0008997940083549217, "glucocorticoid dosage": 0.0009303786110524806, "loop diuretics": 0.0008064721292221147, "compared 8656": 0.0007838254010042559, "similar baseline": 0.0008472781190425757, "baseline covariates": 0.0008997940083549217, "antagonists compared": 0.0009154687767183569, "elevated prior": 0.0008064721292221147, "ci 0.45": 0.0005946525994614709, "test for": 0.0006354585892819318, "oral glucocorticoids": 0.0009154687767183569, "related gradient": 0.0008472781190425757, "hr 1.30": 0.0005946525994614709, "hr 1.54": 0.0005946525994614709, "admissions compared": 0.0008997940083549217, "using exercise": 0.0008064721292221147, "improve quality": 0.0008275557287880785, "current economic": 0.0008472781190425757, "economic climate": 0.0008472781190425757, "climate within": 0.0008064721292221147, "change interventions": 0.0009154687767183569, "interventions in": 0.0008472781190425757, "exercise programmes": 0.0008997940083549217, "limited within": 0.0008064721292221147, "within acute": 0.0007593650711122975, "acute hospital": 0.0008064721292221147, "hospital facilities": 0.0008997940083549217, "the challenge": 0.0007838254010042559, "deliver cost": 0.0007593650711122975, "specific health": 0.0008275557287880785, "health interventions": 0.0009154687767183569, "measurable benefits": 0.0008997940083549217, "structured exercise": 0.0008997940083549217, "exercise programme": 0.000883271552942663, "primary outcomes": 0.0008472781190425757, "measures related": 0.0008472781190425757, "patient satisfaction": 0.0009154687767183569, "intervention post": 0.0008658044569477526, "post study": 0.0007036492469577129, "overall significant": 0.0008997940083549217, "participants demonstrated": 0.0009836594343941379, "others showing": 0.0008064721292221147, "showing minor": 0.0007838254010042559, "minor improvement": 0.0008658044569477526, "anecdotal evidence": 0.000883271552942663, "perceived benefit": 0.0008658044569477526, "participant satisfaction": 0.0009711846008729415, "satisfaction responses": 0.0009445947084594995, "based programmes": 0.0008472781190425757, "completion of": 0.0007838254010042559, "composition study": 0.0008658044569477526, "adverse health": 0.0008064721292221147, "participants aged": 0.0008658044569477526, "aged 70": 0.0005946525994614709, "- frail": 0.0005946525994614709, "frail participants": 0.000883271552942663, "ci 1.08": 0.0005946525994614709, "severe frailty": 0.0008064721292221147, "ci 1.02": 0.0005946525994614709, "linearly associated": 0.0008997940083549217, "per sd": 0.0005475455413516535, "sd decrease": 0.0007327751786988557, "competing risk": 0.0008064721292221147, "across age": 0.0007036492469577129, "- groups": 0.0006354585892819318, "improved discrimination": 0.0009581787663751352, "ci 0.018": 0.0006354585892819318, "appropriately reclassified": 0.0009956449307649, "reclassified 13.4": 0.0008658044569477526, "improvement 0.073": 0.0008658044569477526, "ci 0.021": 0.0006354585892819318, "the role": 0.0006354585892819318, "abnormalities contribute": 0.0009711846008729415, "successful approaches": 0.0009303786110524806, "based largely": 0.0007838254010042559, "therapeutic interruption": 0.0009711846008729415, "activated neurohormonal": 0.0009581787663751352, "neurohormonal systems": 0.0009303786110524806, "sympathetic nervous": 0.0008997940083549217, "nervous systems": 0.0008275557287880785, "excessive secretion": 0.0008997940083549217, "arginine vasopressin": 0.0009154687767183569, "potential for": 0.0007838254010042559, "deleterious effects": 0.0008997940083549217, "various physiologic": 0.0008997940083549217, "physiologic processes": 0.0009303786110524806, "potentially beneficial": 0.0009445947084594995, "beneficial new": 0.0008064721292221147, "therapeutic approach": 0.0009154687767183569, "approach to": 0.0007327751786988557, "mir-25 cooperate": 0.0008472781190425757, "aberrant reactivation": 0.0009303786110524806, "intricately linked": 0.000883271552942663, "pathological heart": 0.000883271552942663, "factors driving": 0.0008275557287880785, "programs remain": 0.0008275557287880785, "remain ill": 0.0007036492469577129, "increased calcineurin": 0.0009303786110524806, "decreased mir-25": 0.0008472781190425757, "expression integrate": 0.0009154687767183569, "- express": 0.0006714520231820191, "basic helix": 0.0007327751786988557, "factor dhand": 0.0007593650711122975, "also known": 0.0007036492469577129, "diseased human": 0.0008064721292221147, "mouse myocardium": 0.0008472781190425757, "in line": 0.0005946525994614709, "mutant mice": 0.0007327751786988557, "mice overexpressing": 0.0008997940083549217, "otherwise healthy": 0.0008658044569477526, "healthy heart": 0.0007838254010042559, "heart muscle": 0.0007593650711122975, "muscle cells": 0.0007593650711122975, "cells developed": 0.0008275557287880785, "pathological hypertrophy": 0.0009711846008729415, "conditional gene": 0.0008472781190425757, "mice demonstrated": 0.0008658044569477526, "marked resistance": 0.0008658044569477526, "induced hypertrophy": 0.0008997940083549217, "fetal gene": 0.0007036492469577129, "gene program": 0.0007593650711122975, "vivo inhibition": 0.0008275557287880785, "specific antagomir": 0.000883271552942663, "antagomir evoked": 0.0008472781190425757, "evoked spontaneous": 0.000883271552942663, "spontaneous cardiac": 0.0008997940083549217, "murine myocardium": 0.0008658044569477526, "dependent manner": 0.0008472781190425757, "results reveal": 0.0008064721292221147, "signalling cascades": 0.0008997940083549217, "cascades integrate": 0.000883271552942663, "bhlh transcription": 0.000883271552942663, "postnatal mammalian": 0.0008997940083549217, "mammalian myocardium": 0.0009154687767183569, "the base": 0.0006354585892819318, "hormonal system": 0.0008275557287880785, "inhibitors intolerance": 0.0009445947084594995, "beta receptor": 0.0007838254010042559, "negative inotropic": 0.000883271552942663, "past decades": 0.0007593650711122975, "decades several": 0.0008275557287880785, "several studies": 0.0008275557287880785, "blockers decrease": 0.0008658044569477526, "the effectiveness": 0.0008658044569477526, "reducing mortality": 0.000883271552942663, "myocardial loss": 0.0008275557287880785, "causes heart": 0.0007593650711122975, "links diabetes": 0.0008064721292221147, "failure remains": 0.0008275557287880785, "hallmark of": 0.0007327751786988557, "insulin receptor": 0.0008472781190425757, "receptor substrates": 0.0008997940083549217, "substrates 1": 0.0007593650711122975, "major insulin": 0.0007838254010042559, "signaling components": 0.0009154687767183569, "components regulating": 0.0009303786110524806, "regulating cellular": 0.0008997940083549217, "cellular metabolism": 0.0008997940083549217, "examine whether": 0.0008275557287880785, "hyperinsulinemia causes": 0.0009581787663751352, "causes myocardial": 0.0008658044569477526, "myocardial insulin": 0.000883271552942663, "cellular dysfunction": 0.0009154687767183569, "dysfunction via": 0.0008275557287880785, "generated heart": 0.0008275557287880785, "gene double": 0.0007327751786988557, "reduced ventricular": 0.0008997940083549217, "ventricular mass": 0.0008472781190425757, "developed cardiac": 0.0008658044569477526, "cardiac apoptosis": 0.0008658044569477526, "showed diminished": 0.0008658044569477526, "box class": 0.0006714520231820191, "class o-1": 0.0006714520231820191, "o-1 signaling": 0.0007838254010042559, "cardiac metabolic": 0.0008658044569477526, "metabolic gene": 0.0008064721292221147, "decreased cardiac": 0.0008658044569477526, "cardiac irs1": 0.0007593650711122975, "exhibited features": 0.000883271552942663, "cardiac energy": 0.0008064721292221147, "metabolism gene": 0.0008275557287880785, "p38\u03b1 mitogen": 0.0007593650711122975, "activated protein": 0.0008658044569477526, "using neonatal": 0.0008064721292221147, "neonatal rat": 0.0007593650711122975, "rat ventricular": 0.0008275557287880785, "chronic insulin": 0.0008275557287880785, "insulin exposure": 0.0008472781190425757, "exposure reduced": 0.0008472781190425757, "prevented insulin": 0.0008658044569477526, "insulin action": 0.0008064721292221147, "fundamental mechanism": 0.0009303786110524806, "medications among": 0.0008658044569477526, "among outpatients": 0.0008658044569477526, "examine practice": 0.0008472781190425757, "recommended treatment": 0.0009303786110524806, "treatment variation": 0.0008997940083549217, "practice site": 0.0007838254010042559, "patient factors": 0.0008275557287880785, "cardiology practices": 0.0009154687767183569, "practices participating": 0.0009581787663751352, "practice rates": 0.0008064721292221147, "treatment measure": 0.0008658044569477526, "documented contraindications": 0.0010182916589827587, "multivariable hierarchical": 0.0009956449307649, "hierarchical regression": 0.0009581787663751352, "insurance status": 0.0008472781190425757, "calculated for": 0.0008064721292221147, "given comorbidities": 0.0008997940083549217, "selected practices": 0.000883271552942663, "identified 12": 0.0007838254010042559, "unadjusted practice": 0.0008997940083549217, "level prescription": 0.000883271552942663, "prescription rates": 0.000883271552942663, "rates ranged": 0.0007593650711122975, "ranged from": 0.0007327751786988557, "adjusted median": 0.0008275557287880785, "fraction exists": 0.0008275557287880785, "exists in": 0.0006714520231820191, "outpatient setting": 0.000883271552942663, "addressing practice": 0.0008997940083549217, "level differences": 0.0008658044569477526, "component of": 0.0007593650711122975, "improving quality": 0.0008658044569477526, "related cardiotoxicity": 0.0009445947084594995, "cardiotoxicity among": 0.0009154687767183569, "adjuvant setting": 0.0008472781190425757, "setting improves": 0.0008472781190425757, "cardiotoxicity manifested": 0.0009836594343941379, "related chf": 0.0007327751786988557, "chf among": 0.0006714520231820191, "full medicare": 0.0007838254010042559, "trastuzumab use": 0.0008275557287880785, "version 9": 0.0006714520231820191, "analyses included": 0.0008658044569477526, "included descriptive": 0.0009154687767183569, "descriptive statistics": 0.0009445947084594995, "received trastuzumab": 0.0009154687767183569, "entire cohort": 0.0007838254010042559, "trastuzumab users": 0.0008658044569477526, "weekly trastuzumab": 0.000883271552942663, "trastuzumab administration": 0.0009956449307649, "older breast": 0.0007593650711122975, "cardiac comorbidities": 0.0009303786110524806, "further studies": 0.0008275557287880785, "studies need": 0.0007593650711122975, "administration plays": 0.0009154687767183569, "current dietary": 0.0008275557287880785, "largely based": 0.0007838254010042559, "- hf": 0.00042363905952128787, "hf populations": 0.0008064721292221147, "dietary patterns": 0.0008472781190425757, "therefore evaluated": 0.0008997940083549217, "evaluated associations": 0.0009445947084594995, "among postmenopausal": 0.0009154687767183569, "postmenopausal women": 0.0009154687767183569, "date of": 0.0005946525994614709, "last participant": 0.0008472781190425757, "participant contact": 0.0008997940083549217, "frequency questionnaires": 0.0009711846008729415, "models adjusted": 0.0008275557287880785, "health behaviors": 0.0008472781190425757, "calculate hazard": 0.0008472781190425757, "hospitalization died": 0.0009154687767183569, "quartiles of": 0.0007593650711122975, "p trend=0.08": 0.0007593650711122975, "p trend=0.01": 0.0007593650711122975, "score components": 0.0008472781190425757, "whole grain": 0.0007327751786988557, "grain intake": 0.0007593650711122975, "inversely associated": 0.0009154687767183569, "higher dash": 0.0007327751786988557, "modestly lower": 0.0008064721292221147, "nonsignificant trend": 0.0009154687767183569, "inverse association": 0.0008997940083549217, "data provide": 0.0007593650711122975, "provide support": 0.0008275557287880785, "support for": 0.0007327751786988557, "recommendations developed": 0.0009836594343941379, "cardiovascular conditions": 0.0009836594343941379, "general populations": 0.0008997940083549217, "cardioprotective signaling": 0.0009956449307649, "signaling in": 0.0007593650711122975, "potentially promising": 0.0009303786110524806, "promising biomarker": 0.0008997940083549217, "term clinical": 0.0007838254010042559, "randomized study": 0.0008472781190425757, "evaluable plasma": 0.0008472781190425757, "relationship among": 0.000883271552942663, "median baseline": 0.0008275557287880785, "in univariable": 0.0008064721292221147, "univariable analysis": 0.0009154687767183569, "log2 ng": 0.0005946525994614709, "in multivariable": 0.0008472781190425757, "multivariable models": 0.0009154687767183569, "add significantly": 0.0008658044569477526, "reclassification of": 0.0008997940083549217, "c statistic": 0.0007327751786988557, "treated cohort": 0.0008064721292221147, "significantly affect": 0.0009154687767183569, "affect reclassification": 0.0009581787663751352, "year experience": 0.0008275557287880785, "programs expand": 0.0008275557287880785, "transplant pool": 0.0008275557287880785, "matching donors": 0.0008275557287880785, "recipients typically": 0.0009154687767183569, "typically excluded": 0.000883271552942663, "excluded from": 0.0007838254010042559, "transplant process": 0.000883271552942663, "data examining": 0.0008064721292221147, "examining long": 0.0008064721292221147, "undergoing isolated": 0.0008997940083549217, "prospectively classified": 0.0009711846008729415, "classified as": 0.0007838254010042559, "prespecified criteria": 0.0009303786110524806, "compared between": 0.0008472781190425757, "identify clinical": 0.0008658044569477526, "variables contributing": 0.0009445947084594995, "contributing to": 0.0008275557287880785, "additional risk": 0.0008275557287880785, "underwent heart": 0.0008275557287880785, "underwent standard": 0.000883271552942663, "years versus": 0.0007593650711122975, "higher frequency": 0.0008472781190425757, "median estimated": 0.0008472781190425757, "transplant survival": 0.0008997940083549217, "multivariate model": 0.000883271552942663, "included listing": 0.0008472781190425757, "listing criteria": 0.0008472781190425757, "significant predictor": 0.0009303786110524806, "transplant mortality": 0.0009154687767183569, "acceptable alternative": 0.0009445947084594995, "failure therapy": 0.0008275557287880785, "select patients": 0.0008275557287880785, "important determinants": 0.0009445947084594995, "transplant morbidity": 0.0009154687767183569, "failure readmission": 0.0008997940083549217, "readmission quality": 0.0008997940083549217, "study objectives": 0.0008472781190425757, "day readmissions": 0.0008472781190425757, "characterize events": 0.0008997940083549217, "events at": 0.0006714520231820191, "some data": 0.0006714520231820191, "outpatient assessments": 0.0009445947084594995, "failure within": 0.0008064721292221147, "prevent readmissions": 0.0009154687767183569, "patient needs": 0.0007838254010042559, "retrospective chart": 0.0008997940083549217, "failure discharges": 0.000883271552942663, "year before": 0.0007327751786988557, "year after": 0.0007036492469577129, "included mandatory": 0.000883271552942663, "readmissions decreased": 0.0009445947084594995, "decreased from": 0.0008064721292221147, "visits increased": 0.0008472781190425757, "day visits": 0.0007036492469577129, "visits occurred": 0.0008275557287880785, "failure nurse": 0.0007838254010042559, "nurse practitioner": 0.000883271552942663, "blood work": 0.0007036492469577129, "work drawn": 0.0007036492469577129, "medication dose": 0.0008275557287880785, "dose changed": 0.0007593650711122975, "medication lists": 0.0008472781190425757, "failure decreased": 0.0008658044569477526, "diagnostic testing": 0.000883271552942663, "medication changes": 0.000883271552942663, "the underlying": 0.0008064721292221147, "underlying pathophysiology": 0.0009956449307649, "incompletely understood": 0.0009581787663751352, "matrix accumulation": 0.0008997940083549217, "estimate myocardial": 0.0008997940083549217, "matrix using": 0.0007593650711122975, "using cardiac": 0.0007838254010042559, "confirmatory diagnostic": 0.0009581787663751352, "diagnostic tests": 0.0008472781190425757, "imaging including": 0.0008658044569477526, "including t1": 0.0007593650711122975, "hemodynamic assessments": 0.0009581787663751352, "performed at": 0.0007593650711122975, "longitudinal outcome": 0.0009154687767183569, "monitoring phase": 0.0008472781190425757, "cardiac event": 0.0007838254010042559, "t1 time": 0.0005946525994614709, "ventricular biopsies": 0.0009154687767183569, "tissuefaxs technology": 0.0009303786110524806, "technology correlated": 0.0009303786110524806, "time also": 0.0006714520231820191, "also correlated": 0.0008275557287880785, "present preliminary": 0.0008997940083549217, "preliminary study": 0.0008658044569477526, "possible biomarker": 0.000883271552942663, "imaging on": 0.0007036492469577129, "compliance with": 0.0008275557287880785, "thalassaemia major": 0.000883271552942663, "institution cohort": 0.000883271552942663, "abnormal cardiac": 0.0008472781190425757, "cardiac t2": 0.0007036492469577129, "values determined": 0.0008658044569477526, "determined changes": 0.000883271552942663, "highly predictive": 0.0008658044569477526, "the choice": 0.0007036492469577129, "chelation regimens": 0.000883271552942663, "regimens known": 0.0008064721292221147, "remove heart": 0.0007593650711122975, "heart iron": 0.0007036492469577129, "iron efficiently": 0.0008472781190425757, "remarkable role": 0.0008275557287880785, "clinical response": 0.0008658044569477526, "guidelines recommend": 0.0009154687767183569, "recommend cardiac": 0.0008658044569477526, "\u226430 %": 0.0004918297171970689, "results of": 0.0007036492469577129, "blinded core": 0.0007593650711122975, "core laboratory": 0.0008275557287880785, "end systolic": 0.0007593650711122975, "\u00b1 21.1": 0.0005475455413516535, "\u00b1 17.6": 0.0005475455413516535, "\u00b1 50.5": 0.0005475455413516535, "\u00b1 42.4": 0.0005475455413516535, "the time": 0.0006354585892819318, "significantly prolonged": 0.0009581787663751352, "remodeling parameters": 0.0009303786110524806, "important covariates": 0.0009154687767183569, "improved time": 0.0007838254010042559, "interaction with": 0.0008472781190425757, "among subjects": 0.0008064721292221147, "mild hf": 0.0005946525994614709, "produced reverse": 0.0008472781190425757, "similar clinical": 0.0008472781190425757, "benefit compared": 0.0008472781190425757, "myocardial titin": 0.0008472781190425757, "importantly contributes": 0.0009581787663751352, "fraction in": 0.0007327751786988557, "rat metabolic": 0.0007838254010042559, "risk model": 0.0007036492469577129, "important metabolic": 0.0008997940083549217, "frequent comorbidities": 0.0009445947084594995, "myocardial diastolic": 0.0009154687767183569, "relative importance": 0.0008997940083549217, "investigated in": 0.0008275557287880785, "diabetic zsf1": 0.0007838254010042559, "fraction development": 0.0009154687767183569, "groups of": 0.0006714520231820191, "fat diet": 0.0006354585892819318, "repeat metabolic": 0.0008472781190425757, "echocardiographic evaluations": 0.0010290152499740676, "hemodynamically assessed": 0.0009711846008729415, "collagen cross": 0.0008064721292221147, "- linking": 0.0006714520231820191, "titin isoforms": 0.0008064721292221147, "also determined": 0.0008275557287880785, "resting tension": 0.0008275557287880785, "fpassive)-sarcomere length": 0.0009956449307649, "length relations": 0.0008472781190425757, "small muscle": 0.0007593650711122975, "muscle strips": 0.0007838254010042559, "unanchors titin": 0.0008275557287880785, "allows contributions": 0.0009154687767183569, "increased lung": 0.0008064721292221147, "ventricular dd": 0.0008064721292221147, "high muscle": 0.0007327751786988557, "muscle strip": 0.0007593650711122975, "strip stiffness": 0.0008275557287880785, "latter occurred": 0.0008275557287880785, "occurred specifically": 0.0009303786110524806, "site of": 0.0005946525994614709, "elastic n2bus": 0.0007838254010042559, "n2bus segment": 0.0007838254010042559, "rats developed": 0.0008064721292221147, "week time": 0.0006714520231820191, "time span": 0.0006714520231820191, "importantly contributed": 0.0009581787663751352, "contributed to": 0.0008064721292221147, "major predictor": 0.0008275557287880785, "sensitive measure": 0.0008658044569477526, "ventricular mechanics": 0.0009303786110524806, "adverse cardiovascular": 0.0009445947084594995, "predicting cv": 0.0007838254010042559, "university hospital": 0.0008997940083549217, "patients referred": 0.0008658044569477526, "referred for": 0.0007593650711122975, "echocardiographic examination": 0.0010290152499740676, "index beat": 0.0007036492469577129, "beat method": 0.0007327751786988557, "hazards analyses": 0.0008472781190425757, "average follow": 0.0008064721292221147, "\u00b1 10": 0.00042363905952128787, "showed worsening": 0.0008472781190425757, "in direct": 0.0006714520231820191, "direct comparison": 0.0008658044569477526, "outperformed left": 0.0008658044569477526, "systolic mitral": 0.0008275557287880785, "p \u2264": 0.00033572601159100957, "\u2264 0.043": 0.0005946525994614709, "model containing": 0.0008472781190425757, "containing chronic": 0.000883271552942663, "age \u2265": 0.0004918297171970689, "prior stroke": 0.0007593650711122975, "stroke score": 0.0007593650711122975, "additional benefit": 0.000883271552942663, "major parameter": 0.0008275557287880785, "additional prognostic": 0.0009303786110524806, "prognostic benefit": 0.000883271552942663, "conventional clinical": 0.0009303786110524806, "echocardiographic systolic": 0.0009956449307649, "systolic parameters": 0.0008997940083549217, "parameters in": 0.0007838254010042559, "duration on": 0.0007327751786988557, "usually assessed": 0.0008472781190425757, "assessed separately": 0.0008997940083549217, "the interaction": 0.0008275557287880785, "simple ecg": 0.0007036492469577129, "systematically assessed": 0.0009581787663751352, "scale clinical": 0.0008064721292221147, "previous pacemaker": 0.000883271552942663, "all baseline": 0.0007593650711122975, "baseline ecgs": 0.0007838254010042559, "panel of": 0.0006354585892819318, "experienced electrocardiographers": 0.0010685011902898652, "receiving implantable": 0.0009303786110524806, "individual component": 0.0009154687767183569, "- lbbb": 0.0005475455413516535, "ratio for": 0.0006714520231820191, "broader qrs": 0.0007327751786988557, "greater benefit": 0.0008275557287880785, "delayed benefit": 0.0008275557287880785, "refractory congestive": 0.0009303786110524806, "term management": 0.0008275557287880785, "diuretic resistant": 0.000883271552942663, "resistant volume": 0.0008472781190425757, "provide potential": 0.0008658044569477526, "adverse consequences": 0.0009154687767183569, "status hospitalizations": 0.0009581787663751352, "severe end": 0.0007036492469577129, "series of": 0.0006714520231820191, "transplant ineligible": 0.0009303786110524806, "volume management": 0.0008658044569477526, "data reviewed": 0.0007838254010042559, "reviewed pre-": 0.0007838254010042559, "pd initiation": 0.0007838254010042559, "\u00b1 6.0": 0.0004918297171970689, "% with": 0.0005475455413516535, "severe right": 0.0007593650711122975, "average weight": 0.0008064721292221147, "diuretic response": 0.0008658044569477526, "peripheral edema": 0.0008472781190425757, "- hospitalization": 0.0008658044569477526, "\u00b1 2.5": 0.0004918297171970689, "admissions per": 0.0008064721292221147, "reduced average": 0.0008275557287880785, "average length": 0.0008064721292221147, "\u00b1 36.7": 0.0005475455413516535, "\u00b1 2.3": 0.0004918297171970689, "objective criteriabased": 0.0009581787663751352, "criteriabased institution": 0.0009836594343941379, "diuretic refractory": 0.0008997940083549217, "refractory severe": 0.0008658044569477526, "well tolerated": 0.0008064721292221147, "demonstrated favorable": 0.0009445947084594995, "favorable outcomes": 0.000883271552942663, "included improved": 0.0008658044569477526, "easily treatable": 0.0008472781190425757, "treatable pdrelated": 0.0008997940083549217, "pdrelated complications": 0.0009581787663751352, "viable option": 0.0007838254010042559, "stage congestive": 0.0008472781190425757, "often deferred": 0.0008064721292221147, "perceived lack": 0.0008064721292221147, "potentially higher": 0.000883271552942663, "higher risks": 0.0007593650711122975, "therefore studied": 0.0008658044569477526, "descriptive assessment": 0.0009445947084594995, "analysis matching": 0.0008658044569477526, "branch morphology": 0.0008658044569477526, "cardiomyopathy origin": 0.0009303786110524806, "angiotensin ii": 0.0008064721292221147, "blocker use": 0.0007327751786988557, "month echocardiograms": 0.0009303786110524806, "term complications": 0.000883271552942663, "observed among": 0.0008064721292221147, "among dialysis": 0.0008064721292221147, "heterogenous improvement": 0.0009711846008729415, "+3.1 \u00b1": 0.0005475455413516535, "\u00b1 9.2": 0.0004918297171970689, "patients derived": 0.0008472781190425757, "derived absolute": 0.0008472781190425757, "absolute improvements": 0.0009303786110524806, "following 3": 0.0007327751786988557, "controls demonstrated": 0.0009303786110524806, "demonstrated superior": 0.0009303786110524806, "superior reverse": 0.0008472781190425757, "+9.2 \u00b1": 0.0005475455413516535, "\u00b1 9.5": 0.0004918297171970689, "serious complications": 0.0009303786110524806, "certain dialysis": 0.0008472781190425757, "demonstrated compelling": 0.0009581787663751352, "compelling improvement": 0.0009445947084594995, "worsened echocardiographic": 0.0009956449307649, "echocardiographic outcomes": 0.0009956449307649, "sodium dash": 0.0007327751786988557, "diet improves": 0.0007838254010042559, "improves diastolic": 0.000883271552942663, "involves failure": 0.0008472781190425757, "cardiovascular reserve": 0.0009445947084594995, "multiple domains": 0.0008472781190425757, "dietary sodium": 0.0008064721292221147, "sodium restriction": 0.000883271552942663, "restriction improves": 0.0009154687767183569, "improves ventricular": 0.0009154687767183569, "vascular stiffness": 0.000883271552942663, "restricted dietary": 0.000883271552942663, "dietary approaches": 0.000883271552942663, "stop hypertension": 0.0008658044569477526, "hypertension diet": 0.0008658044569477526, "improve left": 0.0007593650711122975, "treated hypertension": 0.0009154687767183569, "target sodium": 0.0007838254010042559, "mmol/2100 kcal": 0.0008064721292221147, "measured baseline": 0.0008658044569477526, "- dash": 0.0005475455413516535, "central blood": 0.0007838254010042559, "via radial": 0.0007036492469577129, "radial arterial": 0.0008275557287880785, "invasively validated": 0.0009154687767183569, "quantified via": 0.0008064721292221147, "parametrized diastolic": 0.0009445947084594995, "filling formalism": 0.0008658044569477526, "yields relaxation": 0.0008658044569477526, "mitral inflow": 0.0007838254010042559, "inflow velocity": 0.0008275557287880785, "ratio ees": 0.0006714520231820191, "determined using": 0.0008472781190425757, "using previously": 0.0008472781190425757, "previously published": 0.0009154687767183569, "published techniques": 0.0009154687767183569, "pairs signed": 0.0007593650711122975, "rank tests": 0.0007036492469577129, "- post": 0.0005475455413516535, "post comparisons": 0.0008472781190425757, "the dash": 0.0006354585892819318, "reduced clinic": 0.0008064721292221147, "hour brachial": 0.0007838254010042559, "brachial systolic": 0.0008658044569477526, "\u00b1 35": 0.00042363905952128787, "\u00b1 30": 0.00042363905952128787, "central end": 0.0007327751786988557, "pressure trended": 0.0008472781190425757, "trended lower": 0.0007838254010042559, "in conjunction": 0.0008064721292221147, "function improved": 0.0008658044569477526, "\u00b1 8.1": 0.0004918297171970689, "\u00b1 37": 0.00042363905952128787, "coupling improved": 0.0008658044569477526, "restricted dash": 0.0008275557287880785, "favorable changes": 0.0008658044569477526, "resistin in": 0.0007327751786988557, "humanized male": 0.0008064721292221147, "women treated": 0.0007838254010042559, "circulating mediator": 0.0009154687767183569, "resistance mainly": 0.0008658044569477526, "mainly expressed": 0.0008472781190425757, "human monocytes": 0.0008275557287880785, "inflammatory stimuli": 0.0009154687767183569, "recent clinical": 0.0008275557287880785, "connected elevated": 0.000883271552942663, "humanized mouse": 0.0008275557287880785, "model lacking": 0.0007838254010042559, "lacking murine": 0.0008064721292221147, "murine resistin": 0.0008275557287880785, "human retn": 0.0007036492469577129, "exhibits basal": 0.0008064721292221147, "stimulated resistin": 0.0008997940083549217, "levels similar": 0.0008064721292221147, "resistin underlies": 0.000883271552942663, "underlies acute": 0.0008275557287880785, "acute anthracycline": 0.0008997940083549217, "kg ip": 0.0004918297171970689, "fold induction": 0.0008064721292221147, "littermate controls": 0.0008997940083549217, "expressing human": 0.0008472781190425757, "cardiac mrna": 0.0007593650711122975, "cell adhesion": 0.0007838254010042559, "adhesion genes": 0.0008064721292221147, "genes compared": 0.0008064721292221147, "mice treated": 0.0007593650711122975, "doxorubicin in": 0.0008064721292221147, "showed dramatic": 0.0008275557287880785, "dramatic induction": 0.000883271552942663, "also examined": 0.0007838254010042559, "examined resistin": 0.0008658044569477526, "treated breast": 0.0008064721292221147, "without cardiotoxicity": 0.0009445947084594995, "women undergoing": 0.0008472781190425757, "undergoing anthracycline": 0.0009711846008729415, "containing chemotherapy": 0.0009581787663751352, "chemotherapy increased": 0.0009445947084594995, "subsequent cardiotoxicity": 0.0009836594343941379, "resistin correlated": 0.0008997940083549217, "direct effects": 0.0008064721292221147, "implicate resistin": 0.000883271552942663, "link between": 0.0007593650711122975, "ablation for": 0.0007593650711122975, "precipitating factor": 0.0009154687767183569, "free probability": 0.0008472781190425757, "factors relating": 0.0008472781190425757, "procedure drug": 0.0008064721292221147, "free success": 0.0007593650711122975, "success rates": 0.0007838254010042559, "multiple procedures": 0.0008997940083549217, "pharmaceutically assisted": 0.0009836594343941379, "assisted success": 0.0008472781190425757, "success rate": 0.0007593650711122975, "occurred during": 0.0008275557287880785, "analyses revealed": 0.0008658044569477526, "standing persistent": 0.0008997940083549217, "lv systolic": 0.0007327751786988557, "systolic indices": 0.0008472781190425757, "diastolic indices": 0.0008658044569477526, "patients maintaining": 0.0009154687767183569, "maintaining sinus": 0.0008658044569477526, "safely treated": 0.0008064721292221147, "repeat procedures": 0.0008658044569477526, "current study": 0.0007838254010042559, "arm analysis": 0.0007593650711122975, "larger randomized": 0.0008658044569477526, "randomized control": 0.000883271552942663, "control studies": 0.0008275557287880785, "ameliorates mitochondrial": 0.0009836594343941379, "possible mechanism": 0.000883271552942663, "known cardiotoxicity": 0.0009154687767183569, "effective anti": 0.0008064721292221147, "- neoplastic": 0.0007593650711122975, "neoplastic agent": 0.0008472781190425757, "cardioprotective effect": 0.0009581787663751352, "hemodynamic alterations": 0.0009581787663751352, "dysfunction induced": 0.0008997940083549217, "cumulative administration": 0.0009836594343941379, "cumulative dose": 0.0008275557287880785, "given orally": 0.0007593650711122975, "without doxorubicin": 0.0008997940083549217, "doxorubicin treatment": 0.0009303786110524806, "recorded 24": 0.0007327751786988557, "last dose": 0.0006714520231820191, "rapidly excised": 0.0008275557287880785, "cytochrome c": 0.0007593650711122975, "caspase 3": 0.0006714520231820191, "stress markers": 0.0008064721292221147, "measured together": 0.0008658044569477526, "examination of": 0.0008064721292221147, "state of": 0.0006354585892819318, "stress induced": 0.0008064721292221147, "doxorubicin cardiotoxicity": 0.0009956449307649, "also preserved": 0.0008064721292221147, "preserved phosphocreatine": 0.0009836594343941379, "restoring mitochondrial": 0.0009581787663751352, "significant cardioprotection": 0.0010182916589827587, "cardioprotection via": 0.0009154687767183569, "via inhibition": 0.0008064721292221147, "apoptotic signaling": 0.0008997940083549217, "mitochondrial ultrastructural": 0.0010290152499740676, "cytotoxic effect": 0.0008472781190425757, "solid ehrlich": 0.0007838254010042559, "ehrlich carcinoma": 0.0008658044569477526, "indicated by": 0.0007593650711122975, "hemodynamic perturbations": 0.0009836594343941379, "changes without": 0.0008275557287880785, "antitumor activity": 0.000883271552942663, "isolated coronary": 0.0008658044569477526, "early risk": 0.0007036492469577129, "swedish web": 0.0007327751786988557, "based care": 0.0007036492469577129, "disease evaluated": 0.0008658044569477526, "evaluated according": 0.0008997940083549217, "underwent primary": 0.0008658044569477526, "failure \u226490": 0.0007327751786988557, "\u226490 days": 0.0006354585892819318, "death from": 0.0007036492469577129, "developed acute": 0.0008275557287880785, "injury postoperatively": 0.0009445947084594995, "became nonsignificant": 0.0009303786110524806, "statistical model": 0.0008658044569477526, "ratio 1.76": 0.0007036492469577129, "interval 1.38": 0.0007838254010042559, "postoperative months": 0.0009154687767183569, "enormous clinical": 0.0008658044569477526, "clinical burden": 0.0008275557287880785, "adult medicine": 0.0008064721292221147, "atheromatous coronary": 0.0009303786110524806, "in children": 0.0007327751786988557, "important disease": 0.0008658044569477526, "paediatric cardiac": 0.000883271552942663, "cardiac transplants": 0.0008997940083549217, "cardiac symptoms": 0.0008472781190425757, "congenital lesions": 0.000883271552942663, "septal defects": 0.0008064721292221147, "congenital heart": 0.0008472781190425757, "heart lesions": 0.0007838254010042559, "small subgroup": 0.0008064721292221147, "diastolic failure": 0.0008658044569477526, "failure from": 0.0007593650711122975, "cardiomyopathic restriction": 0.001007178034773029, "the remaining": 0.0007838254010042559, "remaining patients": 0.000883271552942663, "principally related": 0.0008997940083549217, "poor myocardial": 0.0008275557287880785, "largely comprise": 0.0008472781190425757, "dilated poorly": 0.0008064721292221147, "poorly contracting": 0.000883271552942663, "contracting ventricles": 0.0009445947084594995, "specific aetiologies": 0.0009154687767183569, "particular topics": 0.0008658044569477526, "paediatric heart": 0.0008472781190425757, "failure concern": 0.0008275557287880785, "versus dilated": 0.0008064721292221147, "appropriate investigations": 0.0009956449307649, "new onset": 0.0006714520231820191, "cellular responses": 0.000883271552942663, "increasing population": 0.0009303786110524806, "population of": 0.0007838254010042559, "anthracycline treated": 0.0009303786110524806, "treated survivors": 0.0008658044569477526, "survivors of": 0.0007593650711122975, "childhood malignant": 0.0008997940083549217, "malignant disease": 0.0008658044569477526, "key role": 0.0006354585892819318, "molecular scaffolds": 0.0008997940083549217, "heart pathology": 0.0008275557287880785, "the ability": 0.0007327751786988557, "detect mechanical": 0.0008658044569477526, "humoral stimuli": 0.0008275557287880785, "new conditions": 0.0008064721292221147, "increased workload": 0.000883271552942663, "certain stimuli": 0.0008275557287880785, "stimuli mediate": 0.0008275557287880785, "beneficial adaptation": 0.0009303786110524806, "stress conditions": 0.0008658044569477526, "others result": 0.0007838254010042559, "ultimately leading": 0.000883271552942663, "specific signalling": 0.0008997940083549217, "signalling pathways": 0.0008997940083549217, "pathways activating": 0.0008997940083549217, "transduction pathways": 0.0009303786110524806, "pathways involved": 0.0008658044569477526, "opposing responses": 0.000883271552942663, "responses engage": 0.0008472781190425757, "signalling proteins": 0.0008997940083549217, "notable example": 0.0008275557287880785, "signalling pathway": 0.000883271552942663, "signalling requires": 0.0008997940083549217, "signalosome complex": 0.0008997940083549217, "scaffold protein": 0.0008472781190425757, "protein drives": 0.0008064721292221147, "linear pathway": 0.0008064721292221147, "sequential phosphorylation": 0.0009956449307649, "ultimately targeting": 0.0009154687767183569, "targeting specific": 0.000883271552942663, "specific effector": 0.0008658044569477526, "effector molecules": 0.000883271552942663, "different raf": 0.0007838254010042559, "erk1/2 scaffold": 0.0008275557287880785, "scaffold proteins": 0.0008658044569477526, "promising field": 0.0008275557287880785, "therapeutic strategies": 0.0009445947084594995, "strategies capable": 0.000883271552942663, "selectively potentiating": 0.0009711846008729415, "adaptive response": 0.0008658044569477526, "cardiac amyloidosis": 0.0008997940083549217, "atypical case": 0.0007838254010042559, "the described": 0.0007838254010042559, "described report": 0.0008472781190425757, "report deals": 0.0007593650711122975, "hypertensive cardiomyiopathy": 0.0010182916589827587, "cardiomyiopathy based": 0.0009303786110524806, "inducible myocardial": 0.0009154687767183569, "normal coronary": 0.0008275557287880785, "coronary arteries": 0.0008658044569477526, "typical amyloidotic": 0.0008997940083549217, "amyloidotic pattern": 0.0008997940083549217, "final diagnosis": 0.0008275557287880785, "multiple myeloma": 0.0008472781190425757, "osteomedullary biopsy": 0.0009303786110524806, "measuring frailty": 0.0008658044569477526, "community perspective": 0.0009303786110524806, "each method": 0.0007327751786988557, "recruited from": 0.0008064721292221147, "frailty according": 0.0008658044569477526, "weak grip": 0.0006714520231820191, "physical exhaustion": 0.0008997940083549217, "low activity": 0.0007593650711122975, "unintentional weight": 0.0009154687767183569, "intermediate frailty": 0.0009154687767183569, "deficits present": 0.0008472781190425757, "age 71": 0.0005475455413516535, "% intermediate": 0.0008064721292221147, "intermediate frail": 0.000883271552942663, "frail according": 0.0008275557287880785, "index ranged": 0.0007593650711122975, "patients categorized": 0.0009154687767183569, "death compared": 0.0008064721292221147, "unit increase": 0.0007838254010042559, "% increased": 0.0007327751786988557, "both measures": 0.0007838254010042559, "measures predicted": 0.000883271552942663, "predicted death": 0.0008275557287880785, "death equally": 0.0007838254010042559, "phenotype equally": 0.0008658044569477526, "equally predict": 0.0008275557287880785, "predict mortality": 0.0008658044569477526, "routinely assessed": 0.000883271552942663, "assessed clinically": 0.0008997940083549217, "feasible alternative": 0.0009154687767183569, "ascertain frailty": 0.0008658044569477526, "future of": 0.0006714520231820191, "failure trials": 0.0008064721292221147, "last decade": 0.0007327751786988557, "large phase": 0.0007327751786988557, "phase 2": 0.0005946525994614709, "pharmacologic studies": 0.0009303786110524806, "therapeutics including": 0.0009445947084594995, "including calcium": 0.0008658044569477526, "sensitizing agents": 0.000883271552942663, "pharmacologic management": 0.0009711846008729415, "changed little": 0.0008064721292221147, "rates remain": 0.0007593650711122975, "remain higher": 0.0007838254010042559, "neutral results": 0.0008275557287880785, "many acute": 0.0007036492469577129, "studies including": 0.0008658044569477526, "appropriate timing": 0.000883271552942663, "patient enrollment": 0.000883271552942663, "selecting appropriate": 0.0009303786110524806, "appropriate end": 0.0008275557287880785, "describe lessons": 0.0008472781190425757, "lessons learned": 0.0008275557287880785, "outline strategies": 0.000883271552942663, "future trials": 0.0007838254010042559, "ambulatory setting": 0.000883271552942663, "future perspectives": 0.0008997940083549217, "the measurement": 0.0008275557287880785, "important tool": 0.0008064721292221147, "acute dyspnea": 0.0007838254010042559, "international guidelines": 0.0009711846008729415, "subsequent meta": 0.0008275557287880785, "routine np": 0.0007036492469577129, "used also": 0.0006714520231820191, "guide treatment": 0.0008275557287880785, "assess risk": 0.0007327751786988557, "developing heart": 0.0008472781190425757, "receiving chemotherapy": 0.0009445947084594995, "measurement together": 0.0009154687767183569, "potential contribution": 0.0009445947084594995, "several poc": 0.0007327751786988557, "produce test": 0.0007593650711122975, "test results": 0.0007593650711122975, "results within": 0.0008064721292221147, "appear sufficiently": 0.0008997940083549217, "sufficiently sensitive": 0.0009445947084594995, "used routinely": 0.0008064721292221147, "diagnostic evaluations": 0.0009445947084594995, "community outpatient": 0.0009154687767183569, "time frame": 0.0007036492469577129, "patient consultation": 0.0009154687767183569, "appropriately designed": 0.0009445947084594995, "designed clinical": 0.0008658044569477526, "potential benefits": 0.000883271552942663, "also important": 0.0008064721292221147, "take full": 0.0006714520231820191, "full advantage": 0.0008064721292221147, "advantage of": 0.0007593650711122975, "faster turnaround": 0.0008658044569477526, "turnaround times": 0.0008472781190425757, "times provided": 0.0008064721292221147, "measuring heart": 0.0008275557287880785, "failure care": 0.0007593650711122975, "operationalized hospital": 0.0009711846008729415, "care outcomes": 0.0007838254010042559, "publicly reported": 0.0008658044569477526, "reported 30": 0.0007327751786988557, "standardized mortality": 0.0009445947084594995, "associated penalties": 0.0009154687767183569, "expected rates": 0.0008064721292221147, "motivate hospitals": 0.000883271552942663, "provide patients": 0.0008472781190425757, "expected future": 0.0008275557287880785, "future expansion": 0.0008472781190425757, "inhibition halts": 0.0008472781190425757, "halts heart": 0.0007327751786988557, "modern society": 0.0008064721292221147, "pathological remodelling": 0.0009711846008729415, "involves cardiac": 0.0008472781190425757, "robust predictor": 0.0008472781190425757, "subsequent hf": 0.0007838254010042559, "molecular level": 0.0008275557287880785, "chromatin hyperacetylation": 0.0009956449307649, "family bromodomain": 0.000883271552942663, "family of": 0.0006714520231820191, "lysine reader": 0.0007838254010042559, "reader proteins": 0.0008275557287880785, "promising targets": 0.0008658044569477526, "the remodelling": 0.0008275557287880785, "neuronal stressors": 0.000883271552942663, "these activate": 0.0008064721292221147, "transduction cascade": 0.0009154687767183569, "defined set": 0.0007327751786988557, "cardiomyocytes occur": 0.0009154687767183569, "epigenetic changes": 0.000883271552942663, "histone acetyltransferases": 0.0009956449307649, "histone deacetylases": 0.0009154687767183569, "implicated in": 0.0007838254010042559, "cardiac development": 0.0008997940083549217, "the group": 0.0006714520231820191, "group utilized": 0.0008064721292221147, "recently developed": 0.000883271552942663, "developed first": 0.0008275557287880785, "class inhibitor": 0.0008275557287880785, "displaces bets": 0.0008064721292221147, "downstream signalling": 0.0009303786110524806, "bets in": 0.0005946525994614709, "vitro model": 0.0007327751786988557, "neurohormonally induced": 0.0009581787663751352, "authors showed": 0.0008064721292221147, "nanomolar doses": 0.0008275557287880785, "significantly blocked": 0.0009303786110524806, "blocked phenylephrine": 0.0009303786110524806, "mediated hypertrophy": 0.0009154687767183569, "gene induction": 0.0008064721292221147, "containing protein": 0.000883271552942663, "highly expressed": 0.0008472781190425757, "cardiac tissues": 0.0008275557287880785, "expression profiling": 0.0009154687767183569, "cultured cardiomyocytes": 0.0009581787663751352, "cardiomyocytes in": 0.0008658044569477526, "drug abrogated": 0.0008064721292221147, "substantial subset": 0.000883271552942663, "induced genes": 0.0007838254010042559, "vivo experiments": 0.0008472781190425757, "mice via": 0.0006354585892819318, "via phenylephrine": 0.0008658044569477526, "haemodynamic stress": 0.0008997940083549217, "surgical method": 0.0008275557287880785, "several pathological": 0.0009154687767183569, "including cardiac": 0.0008658044569477526, "systemic blood": 0.0008064721292221147, "detailed transcriptional": 0.0009711846008729415, "transcriptional analysis": 0.0009711846008729415, "cardiac tissue": 0.0008064721292221147, "vehicle revealed": 0.0008472781190425757, "inhibition suppresses": 0.0009303786110524806, "pathological cardiac": 0.0009154687767183569, "expression programme": 0.0009154687767183569, "also found": 0.0007036492469577129, "further molecular": 0.0008658044569477526, "molecular analysis": 0.000883271552942663, "bets play": 0.0006714520231820191, "crucial role": 0.0007593650711122975, "mediated signal": 0.0008275557287880785, "factor networks": 0.0008275557287880785, "including nuclear": 0.0008658044569477526, "activated t": 0.0007327751786988557, "t cells": 0.0005946525994614709, "promoting transcriptional": 0.0009836594343941379, "transcriptional pause": 0.0009303786110524806, "pause release": 0.0007838254010042559, "pathological stress": 0.0008997940083549217, "study implicates": 0.0008472781190425757, "implicates epigenetic": 0.0009303786110524806, "epigenetic readers": 0.000883271552942663, "cardiac biology": 0.0008275557287880785, "gene control": 0.0007593650711122975, "control via": 0.0007327751786988557, "dependent signal": 0.0008472781190425757, "potentially abrogate": 0.0009154687767183569, "abrogate pathological": 0.0009303786110524806, "mapping mri": 0.0007327751786988557, "breathing pulse": 0.0008275557287880785, "pulse sequence": 0.0008064721292221147, "quantify myocardial": 0.0008997940083549217, "t1 changes": 0.0007036492469577129, "swine model": 0.0007327751786988557, "ventricularly paced": 0.0008997940083549217, "induce heart": 0.0007593650711122975, "scanned twice": 0.0007838254010042559, "t mri": 0.0004918297171970689, "mri scanner": 0.0007327751786988557, "mapping sequence": 0.0008472781190425757, "chelate contrast": 0.0008472781190425757, "failure scans": 0.0007838254010042559, "the percentage": 0.0008064721292221147, "failure myocardial": 0.000883271552942663, "similar left": 0.0007593650711122975, "ventricular tissue": 0.000883271552942663, "animals using": 0.0007838254010042559, "using trichrome": 0.0008275557287880785, "trichrome blue": 0.0008064721292221147, "blue histologic": 0.0008275557287880785, "histologic analysis": 0.0008997940083549217, "failure t1": 0.0007036492469577129, "\u00b1 96": 0.00042363905952128787, "\u00b1 94": 0.00042363905952128787, "agent administration": 0.0009154687767183569, "\u00b1 180": 0.0004918297171970689, "\u00b1 171": 0.0004918297171970689, "the animals": 0.0007327751786988557, "animals with": 0.0007593650711122975, "failure also": 0.0007593650711122975, "difference histologically": 0.0009836594343941379, "collagen compared": 0.0008658044569477526, "the proposed": 0.0007593650711122975, "mapping technique": 0.0008658044569477526, "quantify diffuse": 0.0008472781190425757, "diffuse myocardial": 0.000883271552942663, "myocardial changes": 0.000883271552942663, "changes associated": 0.000883271552942663, "failure without": 0.0008275557287880785, "without breath": 0.0008064721292221147, "changes appear": 0.0008064721292221147, "traditional myocardial": 0.0009445947084594995, "myocardial delayed": 0.000883271552942663, "delayed enhancement": 0.0008997940083549217, "enhancement imaging": 0.0008997940083549217, "useful technique": 0.0008472781190425757, "detecting early": 0.0008275557287880785, "significant myocardial": 0.0009445947084594995, "myocardial fibrosis": 0.0008997940083549217, "new approach": 0.0007593650711122975, "assess exercise": 0.0008275557287880785, "induced pulmonary": 0.0008658044569477526, "artery systolic": 0.0008275557287880785, "possible measure": 0.0008472781190425757, "invasively diagnosed": 0.0009154687767183569, "diagnosed pulmonary": 0.0008997940083549217, "inoperable chronic": 0.000883271552942663, "chronic thromboembolic": 0.0009445947084594995, "thromboembolic pulmonary": 0.0009711846008729415, "impaired right": 0.0008064721292221147, "ventricular pump": 0.0008472781190425757, "pump function": 0.0007838254010042559, "stable targeted": 0.0008275557287880785, "targeted pulmonary": 0.000883271552942663, "hypertension medication": 0.0009581787663751352, "medication underwent": 0.0009154687767183569, "broad panel": 0.0007327751786988557, "noninvasive assessments": 0.0009581787663751352, "including stress": 0.0008472781190425757, "stress echocardiography": 0.0009581787663751352, "groups according": 0.0008472781190425757, "factors predicting": 0.000883271552942663, "predicting survival": 0.0008997940083549217, "median exercise": 0.0008275557287880785, "high pasp": 0.0006714520231820191, "terms of": 0.0006354585892819318, "resting hemodynamics": 0.0009154687767183569, "minute walking": 0.0008064721292221147, "walking distance": 0.0008472781190425757, "model analysis": 0.0008064721292221147, "analysis adjusted": 0.0008658044569477526, "kilogram remained": 0.0008658044569477526, "remained independent": 0.0009154687767183569, "prognostic markers": 0.000883271552942663, "high clinical": 0.0007838254010042559, "indicate right": 0.0008064721292221147, "useful tool": 0.0007327751786988557, "prognostic assessment": 0.0009303786110524806, "contemporary use": 0.0008472781190425757, "improves symptoms": 0.0008658044569477526, "most data": 0.0006714520231820191, "preserved systolic": 0.000883271552942663, "interesting therapeutic": 0.0009581787663751352, "therapeutic concepts": 0.0009154687767183569, "therapeutic functions": 0.0009303786110524806, "diagnostic features": 0.0008997940083549217, "early detection": 0.0008275557287880785, "alone diagnostic": 0.0008472781190425757, "diagnostic devices": 0.000883271552942663, "disease complex": 0.0008275557287880785, "challenging therapeutics": 0.0009711846008729415, "significant portion": 0.0008997940083549217, "care budget": 0.0007327751786988557, "commoner among": 0.0008064721292221147, "among women": 0.0007327751786988557, "underlying hypertension": 0.0009581787663751352, "significant progress": 0.0009154687767183569, "lifesaving drugs": 0.0008472781190425757, "still poses": 0.0007327751786988557, "poses significant": 0.0008658044569477526, "significant challenges": 0.0009445947084594995, "response regulates": 0.000883271552942663, "regulates cardiac": 0.0008658044569477526, "cardiac sodium": 0.0008064721292221147, "sodium current": 0.0008064721292221147, "systolic human": 0.0008064721292221147, "increases alternative": 0.0009303786110524806, "alternative mrna": 0.0008472781190425757, "type v": 0.0005475455413516535, "gated cardiac": 0.0007838254010042559, "channel \u03b1": 0.0006714520231820191, "generating variants": 0.0008997940083549217, "variants encoding": 0.0008658044569477526, "encoding truncated": 0.000883271552942663, "nonfunctional channels": 0.0009445947084594995, "endoplasmic reticulum": 0.0009303786110524806, "channels activate": 0.0008658044569477526, "electric remodeling": 0.0008997940083549217, "human ventricular": 0.0008658044569477526, "tissue samples": 0.0008064721292221147, "human induced": 0.0007838254010042559, "induced pluripotent": 0.0008997940083549217, "pluripotent stem": 0.0008472781190425757, "derived cardiomyocytes": 0.0009445947084594995, "known activators": 0.0008472781190425757, "abnormal scn5a": 0.0008064721292221147, "kinase r": 0.0006354585892819318, "like er": 0.0005946525994614709, "exogenous variants": 0.000883271552942663, "variants induced": 0.0008472781190425757, "concomitant downregulation": 0.0009956449307649, "downregulation of": 0.0008658044569477526, "perk activation": 0.0008275557287880785, "activation destabilized": 0.0009581787663751352, "transient receptor": 0.000883271552942663, "receptor potential": 0.000883271552942663, "potential cation": 0.0008472781190425757, "cation channel": 0.0008064721292221147, "channel m7": 0.0007036492469577129, "perk inhibition": 0.0008275557287880785, "inhibition prevented": 0.0009154687767183569, "kv4.3 mrna": 0.0007036492469577129, "levels resulting": 0.0008472781190425757, "entirely specific": 0.0008658044569477526, "multiple cardiac": 0.0008472781190425757, "cardiac genes": 0.0007838254010042559, "normal cardiac": 0.0008064721292221147, "receives little": 0.0008275557287880785, "little attention": 0.0008472781190425757, "attention in": 0.0007593650711122975, "medical literature": 0.000883271552942663, "etiologic causes": 0.0008472781190425757, "failure often": 0.0007838254010042559, "often differ": 0.0007593650711122975, "differ from": 0.0007327751786988557, "failure frequently": 0.000883271552942663, "frequently requires": 0.0008997940083549217, "requires diagnostic": 0.0008997940083549217, "routinely used": 0.0008064721292221147, "intrinsic left": 0.0008064721292221147, "pathophysiologic mechanisms": 0.001007178034773029, "mechanisms behind": 0.0008658044569477526, "distinct populations": 0.0009154687767183569, "chronic pulmonary": 0.0008658044569477526, "acute pulmonary": 0.0008275557287880785, "in chronic": 0.0007036492469577129, "chronic pah": 0.0007327751786988557, "examine clinical": 0.0008472781190425757, "clinical circumstances": 0.0009445947084594995, "circumstances common": 0.0009154687767183569, "provoke acute": 0.0007838254010042559, "pharmacologic therapies": 0.0009581787663751352, "failure management": 0.000883271552942663, "embolism represent": 0.000883271552942663, "particularly high": 0.0008658044569477526, "specific diagnostic": 0.0008997940083549217, "contemporary trends": 0.0008997940083549217, "community study": 0.0008275557287880785, "major changes": 0.0007838254010042559, "recently occurred": 0.0008658044569477526, "epidemiology of": 0.0008275557287880785, "possibly affect": 0.0008275557287880785, "affect outcomes": 0.0008275557287880785, "outcomes such": 0.0007838254010042559, "data describing": 0.0008275557287880785, "describing trends": 0.0008658044569477526, "evaluated temporal": 0.000883271552942663, "temporal trends": 0.0008275557287880785, "all residents": 0.0007838254010042559, "classified according": 0.0009154687767183569, "patient presentation": 0.0009154687767183569, "including fewer": 0.0008275557287880785, "fewer st": 0.0006354585892819318, "elevation mis": 0.0007838254010042559, "lower killip": 0.0007593650711122975, "comorbid conditions": 0.0008997940083549217, "first week": 0.0007036492469577129, "adjusted risk": 0.0007838254010042559, "risk declined": 0.0007838254010042559, "ratios of": 0.0006714520231820191, "further adjustment": 0.000883271552942663, "characteristics yielded": 0.0009581787663751352, "yielded hazard": 0.0008064721292221147, "case mix": 0.0006354585892819318, "requires new": 0.0007593650711122975, "new prevention": 0.0008064721292221147, "prevention strategies": 0.0009303786110524806, "differential effects": 0.0009154687767183569, "versus selective": 0.0008472781190425757, "selective beta": 0.0008064721292221147, "nonselective \u03b2": 0.0008064721292221147, "selective \u03b2": 0.0007327751786988557, "blocker metoprolol": 0.000883271552942663, "metoprolol in": 0.0007838254010042559, "assessed whether": 0.0008472781190425757, "response correlates": 0.0008997940083549217, "correlates with": 0.0008275557287880785, "various serum": 0.0007838254010042559, "serum factors": 0.0007838254010042559, "label crossover": 0.0008275557287880785, "crossover study": 0.0008275557287880785, "masked outcome": 0.0008064721292221147, "outcome assessments": 0.0008997940083549217, "equipotent dosages": 0.000883271552942663, "wk periods": 0.0007036492469577129, "myocardial washout": 0.000883271552942663, "included markers": 0.0008472781190425757, "markers of": 0.0007036492469577129, "cardiac washout": 0.0008275557287880785, "metoprolol treatment": 0.0009154687767183569, "\u00b1 13": 0.00042363905952128787, "greater reduction": 0.0008658044569477526, "wk of": 0.0004918297171970689, "factor concentrations": 0.0009303786110524806, "haplotype status": 0.0008472781190425757, "prescribing guideline": 0.0009303786110524806, "often contextual": 0.0008472781190425757, "factors such": 0.0007593650711122975, "competing priorities": 0.0009154687767183569, "priorities impact": 0.0008658044569477526, "impact prescribing": 0.000883271552942663, "performance measurement": 0.0009581787663751352, "measurement systems": 0.0008997940083549217, "veterans aged": 0.0007838254010042559, "aged 50": 0.0005946525994614709, "identified from": 0.0008275557287880785, "clinic notes": 0.0007593650711122975, "primary care": 0.0007593650711122975, "care clinicians": 0.0008275557287880785, "clinicians caring": 0.0008658044569477526, "these reasons": 0.0007838254010042559, "classified using": 0.0008472781190425757, "published taxonomy": 0.000883271552942663, "receiving guideline": 0.0008997940083549217, "recommended drugs": 0.0008658044569477526, "review identified": 0.0008658044569477526, "identified biomedical": 0.0009303786110524806, "reasons in": 0.0007036492469577129, "clinician interviews": 0.0009154687767183569, "interviews identified": 0.0009303786110524806, "identified twice": 0.0008472781190425757, "many reasons": 0.0007593650711122975, "mean 1.6": 0.0006354585892819318, "reasons per": 0.0007327751786988557, "common contextual": 0.0008658044569477526, "clinician belief": 0.0008472781190425757, "prescribing angiotensin": 0.0009581787663751352, "poorly documented": 0.0008658044569477526, "the structure": 0.0007838254010042559, "structure of": 0.0007593650711122975, "facilitate documentation": 0.0009711846008729415, "providing guideline": 0.0008997940083549217, "recommended care": 0.0008472781190425757, "pyridostigmine prevents": 0.0009581787663751352, "prevents ventricular": 0.0009154687767183569, "elevated sympathetic": 0.0009154687767183569, "reduced parasympathetic": 0.0009581787663751352, "parasympathetic control": 0.0009581787663751352, "control of": 0.0007036492469577129, "experimental evidence": 0.0009303786110524806, "parasympathetic function": 0.0009711846008729415, "therapeutic alternative": 0.0009581787663751352, "parasympathetic neurotransmission": 0.0010685011902898652, "acetylcholinesterase inhibition": 0.0010493955328080653, "acetylcholinesterase inhibitor": 0.0010393752585487225, "inhibitor pyridostigmine": 0.0009711846008729415, "following myocardial": 0.0009154687767183569, "adult male": 0.0007036492469577129, "pyridostigmine administration": 0.0010290152499740676, "per os": 0.0005475455413516535, "cardiac sympathovagal": 0.0009303786110524806, "tachycardic response": 0.0009154687767183569, "bradycardic response": 0.0009154687767183569, "conscious hf": 0.0007593650711122975, "pyridostigmine reduced": 0.0009445947084594995, "basal heart": 0.0007327751786988557, "increased vagal": 0.0008275557287880785, "sympathetic control": 0.0008997940083549217, "myocyte diameter": 0.0008472781190425757, "collagen density": 0.0008472781190425757, "surviving left": 0.0008064721292221147, "also increased": 0.0008064721292221147, "increased vascular": 0.000883271552942663, "factor protein": 0.0008064721292221147, "suggesting myocardial": 0.0009303786110524806, "myocardial angiogenesis": 0.0009581787663751352, "volume conductance": 0.000883271552942663, "conductance catheter": 0.0009154687767183569, "catheter system": 0.0008275557287880785, "rats treated": 0.0007593650711122975, "pyridostigmine exhibited": 0.0009711846008729415, "higher stroke": 0.0007838254010042559, "term administration": 0.0008997940083549217, "pyridostigmine started": 0.0009445947084594995, "started right": 0.0007838254010042559, "artery ligation": 0.0008275557287880785, "ligation augmented": 0.000883271552942663, "augmented cardiac": 0.0008658044569477526, "attenuating cardiac": 0.0008997940083549217, "mechanistic insight": 0.0008997940083549217, "prolonged electromechanical": 0.001007178034773029, "computational study": 0.0008997940083549217, "block type": 0.0007036492469577129, "aspects associated": 0.000883271552942663, "electromechanical behavior": 0.0009956449307649, "altered ventricular": 0.0008997940083549217, "ventricular structure": 0.0009303786110524806, "sheet orientation": 0.0008658044569477526, "slowed conduction": 0.0008658044569477526, "reduced wall": 0.0007593650711122975, "wall stiffness": 0.0008064721292221147, "in dyssynchronous": 0.0008658044569477526, "time interval": 0.0007838254010042559, "local myocyte": 0.0007838254010042559, "myocyte depolarization": 0.0009445947084594995, "shortening onset": 0.0008472781190425757, "major hf": 0.0006354585892819318, "dyssynchronous failing": 0.0009445947084594995, "heart remain": 0.0007593650711122975, "remain unknown": 0.0008064721292221147, "combined contributions": 0.0009445947084594995, "induced remodeling": 0.000883271552942663, "used mri": 0.0006354585892819318, "based models": 0.0007593650711122975, "dyssynchronous nonfailing": 0.0009836594343941379, "canine electromechanics": 0.0009581787663751352, "constructed additional": 0.0009445947084594995, "additional models": 0.0008658044569477526, "varying combinations": 0.0009154687767183569, "block electrical": 0.0008472781190425757, "activation sequence": 0.0008997940083549217, "the simulation": 0.0008064721292221147, "simulation results": 0.000883271552942663, "results revealed": 0.0008472781190425757, "primary culprit": 0.0008275557287880785, "remodeling contributing": 0.0009581787663751352, "contributing insignificantly": 0.0010182916589827587, "slows myofiber": 0.0008064721292221147, "shortening velocity": 0.0008997940083549217, "activated septum": 0.0008472781190425757, "stretch rate": 0.0007593650711122975, "activated lateral": 0.0008658044569477526, "lateral wall": 0.0007593650711122975, "these changes": 0.0007838254010042559, "myofiber dynamics": 0.0008658044569477526, "dynamics delay": 0.0008064721292221147, "thus giving": 0.0007327751786988557, "giving rise": 0.0007327751786988557, "prolonged emd": 0.0007838254010042559, "relationships between": 0.0009303786110524806, "previous studies": 0.0008472781190425757, "studies investigating": 0.0009303786110524806, "related cachexia": 0.0008472781190425757, "abnormal body": 0.0007838254010042559, "worsened prognosis": 0.000883271552942663, "underwent prospective": 0.0009303786110524806, "prospective assessment": 0.0009445947084594995, "skinfold thickness": 0.000883271552942663, "comprehensive echocardiography": 0.0010393752585487225, "blood testing": 0.0007838254010042559, "circulatory assist": 0.000883271552942663, "lower body": 0.0007036492469577129, "display cachexia": 0.0008472781190425757, "the extent": 0.0007036492469577129, "dysfunction correlated": 0.0009445947084594995, "greater antecedent": 0.000883271552942663, "antecedent weight": 0.0008658044569477526, "mass ratio": 0.0007036492469577129, "increased body": 0.0008064721292221147, "lower event": 0.0007327751786988557, "hr per": 0.0005475455413516535, "higher fat": 0.0007036492469577129, "cachexia often": 0.0008064721292221147, "often coexist": 0.0007838254010042559, "additive adverse": 0.0008472781190425757, "adverse impact": 0.0008064721292221147, "mechanistically interrelated": 0.0010182916589827587, "adverse outcome": 0.0008275557287880785, "fat loss": 0.0006354585892819318, "enhanced catabolism": 0.0008997940083549217, "typically exertional": 0.0009154687767183569, "filling time": 0.0007593650711122975, "controlling heart": 0.0008658044569477526, "ivabradine 5": 0.0007593650711122975, "mg twice": 0.0006354585892819318, "twice daily": 0.0007327751786988557, "blind trial": 0.0007327751786988557, "echocardiographic assessment": 0.0010182916589827587, "the ivabradine": 0.0008064721292221147, "group demonstrated": 0.000883271552942663, "mets vs.": 0.0006354585892819318, "\u00b1 1.9": 0.0004918297171970689, "\u00b1 6.1": 0.0004918297171970689, "kg vs.": 0.0005475455413516535, "\u00b1 3.3": 0.0004918297171970689, "simultaneous reduction": 0.0009445947084594995, "induced increase": 0.0008472781190425757, "\u00b1 2.7": 0.0004918297171970689, "work load": 0.0006714520231820191, "corrected chronotropic": 0.0009445947084594995, "chronotropic response": 0.0009303786110524806, "time at": 0.0005946525994614709, "slower increase": 0.0008275557287880785, "treated group": 0.0007838254010042559, "exertional increase": 0.0008997940083549217, "independent correlates": 0.0009445947084594995, "independently correlated": 0.0009711846008729415, "term treatment": 0.0008064721292221147, "ivabradine increased": 0.0009154687767183569, "increased exercise": 0.000883271552942663, "improved left": 0.0007838254010042559, "pressure response": 0.0008658044569477526, "therapeutic treatments": 0.0009445947084594995, "treatments targeting": 0.0009154687767183569, "targeting abnormal": 0.000883271552942663, "abnormal exercise": 0.0008658044569477526, "exercise hemodynamic": 0.0009154687767183569, "prove useful": 0.0007593650711122975, "simple validated": 0.0008472781190425757, "validated clinical": 0.000883271552942663, "treatment implications": 0.0009445947084594995, "undergo coronary": 0.0008472781190425757, "a derivation": 0.0007593650711122975, "undergone coronary": 0.000883271552942663, "primary diagnosis": 0.0008658044569477526, "using multivariate": 0.000883271552942663, "% diameter": 0.0007036492469577129, "diameter stenosis": 0.0008658044569477526, "left main": 0.0006714520231820191, "descending artery": 0.0008658044569477526, "defined prediction": 0.000883271552942663, "prospectively validated": 0.0009581787663751352, "separate cohort": 0.0008275557287880785, "cohort recruited": 0.0008472781190425757, "including 15": 0.0007593650711122975, "included diabetes": 0.0008658044569477526, "ratio 5.1": 0.0006714520231820191, "electrocardiographic q": 0.0009445947084594995, "q waves": 0.0005946525994614709, "ratio 3.8": 0.0006714520231820191, "nondiabetes risk": 0.0008472781190425757, "tobacco use": 0.0007327751786988557, "ratio 4.8": 0.0006714520231820191, "a prediction": 0.0007593650711122975, "predictor identified": 0.0009154687767183569, "identified 97": 0.0007838254010042559, "prospective validation": 0.0009445947084594995, "validation cohort": 0.0008658044569477526, "simple clinical": 0.0008275557287880785, "accurately identify": 0.0008997940083549217, "substantial proportion": 0.0009445947084594995, "potentially significant": 0.0009581787663751352, "significant cost": 0.0008472781190425757, "cost savings": 0.0007593650711122975, "risk avoidance": 0.0008064721292221147, "unique indication": 0.0008658044569477526, "japanese heart": 0.0008064721292221147, "vasopressin type": 0.0008472781190425757, "severe hyponatremia": 0.0008997940083549217, "optimal diuretic": 0.0008472781190425757, "serum sodium": 0.0007593650711122975, "sodium levels": 0.0007838254010042559, "newly introduced": 0.0008472781190425757, "introduced drug": 0.0008275557287880785, "use in": 0.0005475455413516535, "frequently administered": 0.0009581787663751352, "relieve congestive": 0.000883271552942663, "congestive symptoms": 0.0008997940083549217, "widespread use": 0.0008064721292221147, "prospective data": 0.0008472781190425757, "related morbidity": 0.0008658044569477526, "diuretic efficacy": 0.0008658044569477526, "adverse neurohormonal": 0.0009303786110524806, "neurohormonal activation": 0.0009711846008729415, "risk patient": 0.0007593650711122975, "treatment options": 0.0008658044569477526, "an estimated": 0.0007593650711122975, "estimated 5.1": 0.0007838254010042559, "heart failure.(1": 0.0008472781190425757, "with therapies": 0.0008064721292221147, "therapies ranging": 0.0008658044569477526, "physical therapy": 0.0008472781190425757, "implantable defibrillators": 0.0009956449307649, "possibly transplantation": 0.0009711846008729415, "accurate risk": 0.0007838254010042559, "therapies appropriate": 0.0009303786110524806, "disease severity": 0.0008472781190425757, "becoming increasingly": 0.0009303786110524806, "increasingly important": 0.0009445947084594995, "associated treatment": 0.0009154687767183569, "brief review": 0.0007593650711122975, "regulated in": 0.0007593650711122975, "human failing": 0.0007838254010042559, "blunts beta": 0.0007327751786988557, "adrenergic responses": 0.0009154687767183569, "study investigated": 0.000883271552942663, "investigated whether": 0.0009154687767183569, "myocardial phosphodiesterase-2": 0.0010393752585487225, "mediated effects": 0.0008472781190425757, "diminished cyclic": 0.0008658044569477526, "cyclic adenosine": 0.0008472781190425757, "adenosine monophosphate": 0.0009581787663751352, "augmented cyclic": 0.0008472781190425757, "cyclic guanosine": 0.0008472781190425757, "guanosine monophosphate": 0.0009581787663751352, "unique property": 0.0008275557287880785, "thus leading": 0.0007593650711122975, "remarkable increase": 0.0008997940083549217, "camp hydrolysis": 0.0008275557287880785, "hydrolysis mediating": 0.0009154687767183569, "negative cross": 0.0008064721292221147, "camp signaling": 0.0008064721292221147, "fluorescence resonance": 0.0009445947084594995, "resonance energy": 0.0008472781190425757, "energy transfer": 0.0008275557287880785, "based assays": 0.0007593650711122975, "video edge": 0.0007036492469577129, "edge detection": 0.0008064721292221147, "epifluorescence microscopy": 0.0009956449307649, "current measurements": 0.0009154687767183569, "myocardial tissues": 0.000883271552942663, "experimental hf": 0.0008275557287880785, "fold higher": 0.0007327751786988557, "advanced human": 0.0008064721292221147, "stimulation via": 0.0008275557287880785, "via catecholamine": 0.0008658044569477526, "catecholamine infusions": 0.0009581787663751352, "rats enhanced": 0.0007838254010042559, "camp hydrolytic": 0.0008275557287880785, "hydrolytic activity": 0.0008997940083549217, "blunted cardiac": 0.0008275557287880785, "cardiac \u03b2": 0.0006714520231820191, "in diseased": 0.0007327751786988557, "higher pde2": 0.0007327751786988557, "cgmp synthesis": 0.0008064721292221147, "synthesis via": 0.0007838254010042559, "via nitric": 0.0007036492469577129, "oxide donors": 0.0007593650711122975, "specific pde2": 0.0007838254010042559, "inhibition partially": 0.0009154687767183569, "partially restored": 0.000883271552942663, "restored \u03b2": 0.0007036492469577129, "overexpression in": 0.0008658044569477526, "healthy cardiomyocytes": 0.0009445947084594995, "cardiomyocytes reduced": 0.0009445947084594995, "camp levels": 0.0007327751786988557, "current amplitude": 0.0008658044569477526, "effect following": 0.0008472781190425757, "following acute": 0.0008275557287880785, "affecting basal": 0.0008275557287880785, "basal contractility": 0.0008997940083549217, "overexpressing cardiomyocytes": 0.0010290152499740676, "cardiomyocytes showed": 0.0009303786110524806, "showed marked": 0.0007838254010042559, "marked protection": 0.0008658044569477526, "induced hypertrophic": 0.0009154687767183569, "hypertrophic responses": 0.0009445947084594995, "important defense": 0.0008658044569477526, "defense mechanism": 0.0008658044569477526, "cardiac stress": 0.0008064721292221147, "antagonizing excessive": 0.0009445947084594995, "excessive \u03b2": 0.0007327751786988557, "activating myocardial": 0.0009303786110524806, "myocardial pde2": 0.0008275557287880785, "novel intracellular": 0.0008997940083549217, "intracellular antiadrenergic": 0.0010182916589827587, "antiadrenergic therapeutic": 0.0009956449307649, "analyses of": 0.0007327751786988557, "study subgroups": 0.0008275557287880785, "mild patients": 0.0007838254010042559, "enrolled patients": 0.0008658044569477526, "receiving optimal": 0.0008658044569477526, "cardiovascular reason": 0.0009303786110524806, "reason within": 0.0007838254010042559, "inducing hyperkalemia": 0.0009303786110524806, "specified analysis": 0.000883271552942663, "subgroups of": 0.0007593650711122975, "patients \u2265": 0.0007036492469577129, "pressure <": 0.0007036492469577129, "< median": 0.0006354585892819318, "major safety": 0.0007593650711122975, "safety measures": 0.0008275557287880785, "hyperkalemia leading": 0.0009154687767183569, "drug discontinuation": 0.0009154687767183569, "risk subgroups": 0.0008064721292221147, "study medication": 0.0008472781190425757, "medication due": 0.0008064721292221147, "primary composite": 0.0008658044569477526, "composite endpoint": 0.000883271552942663, "meeting specific": 0.0008472781190425757, "specific inclusion": 0.000883271552942663, "carefully monitored": 0.0008997940083549217, "developing hyperkalemia": 0.0009581787663751352, "a comparison": 0.0007593650711122975, "when treated": 0.0007593650711122975, "status in": 0.0006714520231820191, "prevalence ranging": 0.000883271552942663, "significant gaps": 0.0008472781190425757, "induced changes": 0.0008275557287880785, "measured using": 0.0008064721292221147, "group effects": 0.0007838254010042559, "estimated using": 0.0008275557287880785, "using linear": 0.0007593650711122975, "linear mixed": 0.0007593650711122975, "mixed models": 0.0007593650711122975, "models according": 0.0008472781190425757, "treat principle": 0.0008275557287880785, "baseline kccq": 0.0007838254010042559, "significantly correlated": 0.0009711846008729415, "baseline hrqol.": 0.0008275557287880785, "subscales relative": 0.000883271552942663, "action cohort": 0.0007838254010042559, "baseline hrqol": 0.0008064721292221147, "cost analysis": 0.0007838254010042559, "control vs.": 0.0007327751786988557, "vs. rate": 0.0006354585892819318, "similar efficacy": 0.0008472781190425757, "efficacy outcomes": 0.0008658044569477526, "economic impact": 0.0008275557287880785, "strategies in": 0.0007838254010042559, "province of": 0.0007327751786988557, "care expenditures": 0.0008658044569477526, "control treatment": 0.0008658044569477526, "payer perspective": 0.0008658044569477526, "perspective using": 0.0008658044569477526, "minimization approach": 0.0009303786110524806, "trial resource": 0.0008064721292221147, "resource utilization": 0.0009154687767183569, "unit costs": 0.0007036492469577129, "databases supplemented": 0.0009445947084594995, "specific costs": 0.0008064721292221147, "\u00b1 9": 0.00033572601159100957, "n =": 0.00033572601159100957, "= 149": 0.0004918297171970689, "related costs": 0.0007838254010042559, "costs accounted": 0.0008275557287880785, "total expenditures": 0.000883271552942663, "control patients": 0.0008472781190425757, "fewer cardiac": 0.0007838254010042559, "cardiac procedures": 0.000883271552942663, "fewer cardioversions": 0.0009154687767183569, "lower costs": 0.0007327751786988557, "costs related": 0.0007838254010042559, "offset by": 0.0006714520231820191, "higher expenditures": 0.0008997940083549217, "expenditures due": 0.0008472781190425757, "hospitalizations for": 0.0009154687767183569, "noncardiovascular diagnoses": 0.001007178034773029, "cardiac arrhythmia": 0.000883271552942663, "arrhythmia devices": 0.000883271552942663, "noncardiovascular drugs": 0.0009581787663751352, "total cost": 0.0007036492469577129, "cost per": 0.0006354585892819318, "strategy used": 0.0007838254010042559, "failure appears": 0.0008275557287880785, "little influence": 0.0008472781190425757, "overall financial": 0.0008658044569477526, "financial burden": 0.0008472781190425757, "remains substantial": 0.0008997940083549217, "perturbations in": 0.0008472781190425757, "muscle sarcomere": 0.0008472781190425757, "sarcomere structure": 0.0008997940083549217, "restorative effects": 0.0008997940083549217, "demonstrated recently": 0.0009303786110524806, "improves skm": 0.0007593650711122975, "skm mitochondrial": 0.0008658044569477526, "improved mitochondrial": 0.0009445947084594995, "treadmill testing": 0.0008658044569477526, "maximum oxygen": 0.0008064721292221147, "skm biopsies": 0.0007593650711122975, "blot analysis": 0.0007838254010042559, "electron microscopy": 0.0008997940083549217, "report severe": 0.0007838254010042559, "severe perturbations": 0.0009154687767183569, "components of": 0.0007838254010042559, "associated protein": 0.000883271552942663, "protein complex": 0.0008275557287880785, "induced recovery": 0.0008472781190425757, "- ordinated": 0.0007327751786988557, "ordinated fashion": 0.0008658044569477526, "skm growth": 0.0007036492469577129, "differentiation consistent": 0.0009956449307649, "myofibre regeneration": 0.0009303786110524806, "~24 %": 0.0004918297171970689, "reach statistical": 0.0008658044569477526, "statistical significance": 0.0009711846008729415, "initial results": 0.0008275557287880785, "results warrant": 0.0008275557287880785, "rigorous investigation": 0.0009445947084594995, "pure epicatechin": 0.0008472781190425757, "novel means": 0.0007327751786988557, "improving muscle": 0.0008472781190425757, "muscle function": 0.0008275557287880785, "cardiomyopathy in": 0.0008658044569477526, "versus biomedical": 0.0008658044569477526, "major databases": 0.0008275557287880785, "overall effects": 0.0008275557287880785, "most adverse": 0.0007593650711122975, "events observed": 0.0008275557287880785, "resolved without": 0.0008472781190425757, "without special": 0.0008275557287880785, "special treatment": 0.0008658044569477526, "term follow": 0.0007327751786988557, "systemic adverse": 0.0008472781190425757, "events evaluation": 0.0008658044569477526, "ethnic groups": 0.0007838254010042559, "still required": 0.0008064721292221147, "aimed at": 0.0006354585892819318, "activating factor": 0.0008658044569477526, "matched apparently": 0.000883271552942663, "apparently healthy": 0.000883271552942663, "key biosynthetic": 0.0008472781190425757, "paf acetyltransferase": 0.0009303786110524806, "acetyltransferase [": 0.0008997940083549217, "glycerol cholinephosphotransferase": 0.0010776239867083966, "catabolic isoenzymes": 0.0009154687767183569, "associated phospholipase": 0.0009711846008729415, "lower median": 0.0007593650711122975, "median activities": 0.0008658044569477526, "activities of": 0.0007838254010042559, "higher activities": 0.0008658044569477526, "at follow": 0.0006714520231820191, "levels marginally": 0.0008658044569477526, "marginally increased": 0.0009154687767183569, "remained downregulated": 0.0009445947084594995, "elevated compared": 0.0008658044569477526, "diagnosed patients": 0.000883271552942663, "drug treatment": 0.0008064721292221147, "affected profile": 0.0008472781190425757, "update on": 0.0006714520231820191, "exercise parameters": 0.0008997940083549217, "hallmark feature": 0.0008472781190425757, "prognostically important": 0.0009711846008729415, "widely accepted": 0.0008275557287880785, "accepted peak": 0.0007838254010042559, "exercise oscillatory": 0.0009154687767183569, "oscillatory ventilation": 0.0009581787663751352, "partial pressure": 0.0008472781190425757, "pressure of": 0.0007327751786988557, "gain attention": 0.0008064721292221147, "also discussed": 0.0008064721292221147, "different mechanisms": 0.0009154687767183569, "mechanisms underlie": 0.0008997940083549217, "important contribution": 0.0009445947084594995, "peripheral abnormalities": 0.0009711846008729415, "different pathophysiological": 0.0010182916589827587, "multivariate assessment": 0.0009581787663751352, "aforementioned parameters": 0.0009836594343941379, "prognostic purposes": 0.0008997940083549217, "orthotopic heart": 0.0008472781190425757, "optimal treatment": 0.0008658044569477526, "institutional experience": 0.0009711846008729415, "procedures within": 0.0008658044569477526, "recipients bridged": 0.000883271552942663, "bridged to": 0.0007036492469577129, "including intravenous": 0.0009303786110524806, "intravenous inotropes": 0.0009303786110524806, "the interval": 0.0007593650711122975, "interval from": 0.0007838254010042559, "require consultation": 0.0009154687767183569, "inflammatory abdominal": 0.0009445947084594995, "problems occurred": 0.0008658044569477526, "per cent": 0.0006354585892819318, "deaths occurring": 0.0008472781190425757, "occurring within": 0.0008472781190425757, "in summary": 0.0007036492469577129, "largest series": 0.0008064721292221147, "undergoing oht": 0.0008064721292221147, "oht bridged": 0.0007327751786988557, "with similar": 0.0007593650711122975, "similar incidence": 0.0008658044569477526, "refractory right": 0.0008472781190425757, "arrest in": 0.0006714520231820191, "cardiopulmonary resuscitation": 0.0010290152499740676, "wall infarction": 0.0008275557287880785, "cardiac centre": 0.0008064721292221147, "catheterization showed": 0.0009445947084594995, "thrombotic obstruction": 0.0009445947084594995, "right coronary": 0.0008064721292221147, "after percutaneous": 0.000883271552942663, "coronary revascularization": 0.0009956449307649, "hemodynamically stable": 0.0009445947084594995, "stable situation": 0.0008472781190425757, "intensive care": 0.0008064721292221147, "care unit": 0.0006714520231820191, "patient became": 0.0008064721292221147, "hemodynamically unstable": 0.0009711846008729415, "therapy refractory": 0.000883271552942663, "decided within": 0.0008064721292221147, "extra corporeal": 0.0008275557287880785, "corporeal membrane": 0.000883271552942663, "the extracorporeal": 0.000883271552942663, "extracorporeal support": 0.0009445947084594995, "emergency cardiac": 0.0008658044569477526, "intermediate care": 0.0008658044569477526, "extracorporeal life": 0.0008997940083549217, "life support": 0.0007593650711122975, "feasible und": 0.0007593650711122975, "und effective": 0.0007838254010042559, "bridging therapy": 0.0008472781190425757, "acute ischemic": 0.0008064721292221147, "ischemic right": 0.0008064721292221147, "successful reperfusion": 0.0009445947084594995, "reperfusion therapy": 0.0008997940083549217, "half of": 0.0005946525994614709, "values observed": 0.0008275557287880785, "early research": 0.0008064721292221147, "research focused": 0.0008472781190425757, "multiple non": 0.0007593650711122975, "- diastolic": 0.0007327751786988557, "diastolic abnormalities": 0.0009581787663751352, "function also": 0.0007838254010042559, "also contribute": 0.0008275557287880785, "frequently challenging": 0.0009445947084594995, "relies upon": 0.0007327751786988557, "careful clinical": 0.0008472781190425757, "clinical evaluation": 0.0008997940083549217, "invasive haemodynamic": 0.0009303786110524806, "haemodynamic assessment": 0.0009581787663751352, "principal mechanisms": 0.0009154687767183569, "diagnostic approaches": 0.0009303786110524806, "novel treatment": 0.0008275557287880785, "hold promise": 0.0007593650711122975, "mortality outcomes": 0.000883271552942663, "based study": 0.0007327751786988557, "first acute": 0.0007327751786988557, "advances in": 0.0007327751786988557, "beneficial impact": 0.0008658044569477526, "deaths attributable": 0.0008997940083549217, "western australian": 0.000883271552942663, "administrative health": 0.0009303786110524806, "health data": 0.0007327751786988557, "identify 20": 0.0007327751786988557, "aged 40": 0.0005946525994614709, "temporal incidence": 0.000883271552942663, "death associated": 0.0008472781190425757, "comprised 75": 0.0007593650711122975, "day case": 0.0006354585892819318, "declined marginally": 0.0008997940083549217, "without concurrent": 0.000883271552942663, "rate declined": 0.0007838254010042559, "occurrence of": 0.0007838254010042559, "index ami": 0.0006714520231820191, "encouraging declines": 0.0009154687767183569, "common problem": 0.0008064721292221147, "increased attention": 0.0008997940083549217, "needed given": 0.0007593650711122975, "term prognosis": 0.0008064721292221147, "blind randomized": 0.0008472781190425757, "controlled feasibility": 0.0009445947084594995, "feasibility study": 0.0008658044569477526, "week program": 0.0007593650711122975, "program of": 0.0007036492469577129, "without intramuscular": 0.0009303786110524806, "intramuscular testosterone": 0.0009956449307649, "collected preliminary": 0.0009303786110524806, "preliminary data": 0.0008472781190425757, "age 67.2": 0.0006354585892819318, "range 51": 0.0006354585892819318, "mean \u00b1": 0.0005475455413516535, "\u00b1 sd": 0.00042363905952128787, "sd testosterone": 0.0008275557287880785, "testosterone levels": 0.0008997940083549217, "\u00b1 2.6": 0.0004918297171970689, "randomly allocated": 0.000883271552942663, "placebo groups": 0.0008064721292221147, "intervention compliance": 0.0009581787663751352, "incremental shuttle": 0.0008997940083549217, "% compliance": 0.0007593650711122975, "similar improvements": 0.0009154687767183569, "testosterone group": 0.000883271552942663, "group showed": 0.0007593650711122975, "showed improvements": 0.0008997940083549217, "leg strength": 0.0007593650711122975, "several medical": 0.0008275557287880785, "form quality": 0.0007593650711122975, "life domains": 0.0007593650711122975, "mostly unchanged": 0.0008472781190425757, "first time": 0.0007036492469577129, "positively impact": 0.0008658044569477526, "elderly male": 0.0007593650711122975, "peripheral muscles": 0.000883271552942663, "muscles improves": 0.0008472781190425757, "improves endothelial": 0.0009154687767183569, "emotional stress": 0.0008472781190425757, "impaired systolic": 0.0008658044569477526, "fraction 63": 0.0007327751786988557, "training protocol": 0.0008658044569477526, "included 6": 0.0007036492469577129, "rated depression": 0.0008472781190425757, "depression scores": 0.0008658044569477526, "dilatation diameter": 0.0008997940083549217, "peptide also": 0.0007593650711122975, "also declined": 0.0007838254010042559, "tendency toward": 0.0008275557287880785, "toward lower": 0.0007593650711122975, "lower mitral": 0.0007593650711122975, "mitral e": 0.0006354585892819318, "wave ratio": 0.0007036492469577129, "also improves": 0.0007838254010042559, "effective evidence": 0.000883271552942663, "based therapies": 0.0008275557287880785, "factor beta": 0.0007327751786988557, "dependent yield": 0.0008275557287880785, "functional decline": 0.000883271552942663, "atrial explant": 0.0008064721292221147, "kit+ cells": 0.0007036492469577129, "cells isolated": 0.0008064721292221147, "derived cells": 0.0007838254010042559, "cells modestly": 0.0008064721292221147, "modestly improve": 0.0008472781190425757, "cardiac functions": 0.0008658044569477526, "full potential": 0.0008064721292221147, "for instance": 0.0007593650711122975, "potential candidates": 0.0009154687767183569, "cell therapy": 0.0007593650711122975, "therapy suffer": 0.0008064721292221147, "disease affects": 0.0008275557287880785, "derived progenitor": 0.000883271552942663, "explant c": 0.0006714520231820191, "kit+ progenitors": 0.0008472781190425757, "elucidate mechanisms": 0.0009154687767183569, "mechanisms of": 0.0007838254010042559, "descending coronary": 0.0008997940083549217, "artery occlusion": 0.0008472781190425757, "operated animals": 0.0008472781190425757, "developed infarcted": 0.0008997940083549217, "infarcted animals": 0.0008658044569477526, "ventricle end": 0.0007838254010042559, "pressure \u2265": 0.0007036492469577129, "scar size": 0.0006714520231820191, "size \u2265": 0.0005475455413516535, "atrial explants": 0.0008275557287880785, "explants produced": 0.0008658044569477526, "produced less": 0.0007838254010042559, "less c": 0.0005475455413516535, "sham explants": 0.0007838254010042559, "cells exhibited": 0.0008275557287880785, "exhibited upregulated": 0.0009303786110524806, "upregulated transforming": 0.0009711846008729415, "increased level": 0.0008275557287880785, "diminished expression": 0.0009303786110524806, "pluripotency markers": 0.0009154687767183569, "markers compared": 0.0008472781190425757, "intervention with": 0.0008658044569477526, "\u03b2 signaling": 0.0007327751786988557, "\u03b2 receptor": 0.0007036492469577129, "receptor type": 0.0007838254010042559, "using small": 0.0007327751786988557, "molecule inhibitors": 0.0008997940083549217, "inhibitors improved": 0.0008997940083549217, "cell yield": 0.0007036492469577129, "attenuated epithelial": 0.0009303786110524806, "pluripotency marker": 0.0008997940083549217, "improved efficiency": 0.0008997940083549217, "cell differentiation": 0.0009154687767183569, "differentiation toward": 0.0009445947084594995, "toward cardiomyocyte": 0.0009154687767183569, "like cells": 0.0007036492469577129, "taken together": 0.0008064721292221147, "\u03b2 inhibition": 0.0007593650711122975, "inhibition positively": 0.0009303786110524806, "positively modulates": 0.0009154687767183569, "cell phenotype": 0.0008064721292221147, "optimizing cardiac": 0.000883271552942663, "cardiac progenitor": 0.000883271552942663, "progenitor function": 0.0008997940083549217, "cell expansion": 0.0008064721292221147, "expansion protocols": 0.0008997940083549217, "heart beat": 0.0007036492469577129, "a protocol": 0.0007036492469577129, "originally designed": 0.0008997940083549217, "study breathing": 0.0008275557287880785, "breathing control": 0.0008658044569477526, "following cardiac": 0.0008658044569477526, "taking advantage": 0.0008472781190425757, "pulseless ventricular": 0.0009303786110524806, "ventricular fibrillation": 0.0009711846008729415, "newly implanted": 0.0008275557287880785, "implanted cardioverter": 0.0009445947084594995, "a patient": 0.0006714520231820191, "patient aged": 0.0007593650711122975, "class iii": 0.0006714520231820191, "originally part": 0.0008275557287880785, "study displayed": 0.0008275557287880785, "displayed permanent": 0.0008997940083549217, "permanent periodic": 0.000883271552942663, "final data": 0.0007036492469577129, "data analysis": 0.0007838254010042559, "incidentally produced": 0.0009303786110524806, "ascending phase": 0.0008275557287880785, "pb cycle": 0.0006354585892819318, "recovery period": 0.0008275557287880785, "low bp": 0.0005475455413516535, "pb characteristics": 0.000883271552942663, "this occurred": 0.0007838254010042559, "occurred despite": 0.0008472781190425757, "profound change": 0.0008275557287880785, "cerebral blood": 0.0008064721292221147, "carotid bodies": 0.0008064721292221147, "primary oscillations": 0.0009154687767183569, "oscillations originating": 0.0009711846008729415, "central pattern": 0.0008275557287880785, "pattern generator": 0.0008658044569477526, "antiplatelet drugs": 0.000883271552942663, "treating heart": 0.0008064721292221147, "new options": 0.0007327751786988557, "much work": 0.0006714520231820191, "work remains": 0.0007593650711122975, "establish efficacy": 0.000883271552942663, "additional progress": 0.0008997940083549217, "including better": 0.0008472781190425757, "better tools": 0.0007593650711122975, "tools for": 0.0006714520231820191, "clarity regarding": 0.0008658044569477526, "vascular diseases": 0.0008658044569477526, "increasingly recognized": 0.0009581787663751352, "multisystem disease": 0.0008997940083549217, "important comorbidities": 0.0009581787663751352, "autonomic dysbalance": 0.0009154687767183569, "recent findings": 0.0008275557287880785, "increasing evidence": 0.0008997940083549217, "evidence points": 0.0008275557287880785, "intestinal morphology": 0.0009303786110524806, "absorption function": 0.0008997940083549217, "functional abnormalities": 0.0009711846008729415, "abnormalities of": 0.0008472781190425757, "different gastrointestinal": 0.0009956449307649, "gastrointestinal regions": 0.0009711846008729415, "intestinal dysfunction": 0.0009445947084594995, "disturbed intestinal": 0.0009154687767183569, "intestinal barrier": 0.000883271552942663, "chronic inflammatory": 0.0009154687767183569, "inflammatory state": 0.000883271552942663, "anabolic imbalance": 0.000883271552942663, "terminal stage": 0.0008064721292221147, "particularly poor": 0.0008658044569477526, "review highlights": 0.0008658044569477526, "nutritional abnormalities": 0.0009836594343941379, "including fat": 0.0007838254010042559, "the regulation": 0.0008064721292221147, "nutritional strategies": 0.0009445947084594995, "potentially anti": 0.0008472781190425757, "- inflammatory": 0.0008064721292221147, "inflammatory effects": 0.0009154687767183569, "the gut": 0.0005946525994614709, "role for": 0.0006354585892819318, "dietary interventions": 0.0009303786110524806, "crucial target": 0.0008064721292221147, "failure research": 0.0008472781190425757, "diagnostic role": 0.0008275557287880785, "stable coronary": 0.0008275557287880785, "terminal fragment": 0.0008658044569477526, "ventricular wall": 0.0008472781190425757, "reliable diagnostic": 0.0008997940083549217, "prognostic biomarkers": 0.0009303786110524806, "diagnostic roles": 0.0008472781190425757, "great number": 0.0007593650711122975, "stable cad": 0.0007036492469577129, "limited amount": 0.0008064721292221147, "recent data": 0.0007327751786988557, "data is": 0.0005946525994614709, "thus providing": 0.0008064721292221147, "providing prognostic": 0.0009154687767183569, "unfavourable clinical": 0.0009303786110524806, "denervation improves": 0.0009154687767183569, "improves autonomic": 0.000883271552942663, "balance in": 0.0007036492469577129, "conscious rabbits": 0.0008658044569477526, "a hallmark": 0.0007036492469577129, "tone resulting": 0.0008064721292221147, "autonomic imbalance": 0.0008997940083549217, "symptomatic improvement": 0.0009581787663751352, "protective mechanisms": 0.0009303786110524806, "mechanisms remain": 0.0008658044569477526, "remain unclear": 0.0008064721292221147, "used conscious": 0.0008064721292221147, "chronically instrumented": 0.0009711846008729415, "white rabbits": 0.0007838254010042559, "rabbits undergoing": 0.000883271552942663, "undergoing renal": 0.0008472781190425757, "dnx prior": 0.0006714520231820191, "treatment groups": 0.0008472781190425757, "nonpace dnx": 0.0007327751786988557, "pace non": 0.0006354585892819318, "examined several": 0.0008472781190425757, "several markers": 0.0008275557287880785, "markers indicative": 0.000883271552942663, "time domain": 0.0007327751786988557, "domain heart": 0.0007593650711122975, "power spectral": 0.0008064721292221147, "spectral analysis": 0.0008658044569477526, "ratio in": 0.0006354585892819318, "normalized to": 0.0007838254010042559, "rate response": 0.0007838254010042559, "intravenous bolus": 0.0008658044569477526, "intravenous metoprolol": 0.0009445947084594995, "rabbits compared": 0.0008472781190425757, "intravenous atropine": 0.0009154687767183569, "also prevented": 0.0008064721292221147, "circulating plasma": 0.000883271552942663, "suggest renal": 0.0007838254010042559, "dnx improves": 0.0007593650711122975, "reduces morbidity": 0.0008658044569477526, "chronic systolic": 0.0008472781190425757, "wide qrs": 0.0006354585892819318, "mechanical dyssynchrony": 0.0009581787663751352, "dyssynchrony also": 0.0008658044569477526, "also occurs": 0.0007327751786988557, "trial involving": 0.0008275557287880785, "involving 115": 0.0007838254010042559, "echocardiographic evidence": 0.0009956449307649, "ventricular dyssynchrony": 0.0009711846008729415, "underwent device": 0.0008472781190425757, "capability turned": 0.0008658044569477526, "efficacy outcome": 0.0008472781190425757, "first hospitalization": 0.0009303786110524806, "safety monitoring": 0.0008658044569477526, "monitoring board": 0.0008472781190425757, "at study": 0.0006354585892819318, "study closure": 0.0007838254010042559, "undergone randomization": 0.0009581787663751352, "outcome occurred": 0.0008472781190425757, "increase mortality": 0.000883271552942663, "comparative effects": 0.0008997940083549217, "single center": 0.0007838254010042559, "center retrospective": 0.0009154687767183569, "retrospective observational": 0.001007178034773029, "failure supported": 0.0008658044569477526, "pediatric mechanical": 0.0009154687767183569, "receiving ventricular": 0.0009303786110524806, "device support": 0.0008064721292221147, "receiving extracorporeal": 0.0009711846008729415, "oxygenation membrane": 0.0009154687767183569, "membrane support": 0.0008472781190425757, "vad support": 0.0007327751786988557, "steady improvement": 0.000883271552942663, "egfr in": 0.0005946525994614709, "day 7": 0.0004918297171970689, "egfr continued": 0.0008064721292221147, "day 28": 0.0005475455413516535, "steady decline": 0.0008064721292221147, "much higher": 0.0007327751786988557, "dysfunction improves": 0.0009154687767183569, "improves early": 0.0008064721292221147, "outcome change": 0.0008064721292221147, "change scores": 0.0007838254010042559, "preliminary descriptive": 0.0009581787663751352, "descriptive study": 0.0008658044569477526, "social mandate": 0.0008064721292221147, "ensure effective": 0.0008472781190425757, "effective practice": 0.000883271552942663, "practice within": 0.0008275557287880785, "using standardized": 0.000883271552942663, "standardized nursing": 0.0009154687767183569, "nursing terminologies": 0.0009303786110524806, "terminologies makes": 0.0008997940083549217, "measure aspects": 0.0008275557287880785, "ratings exists": 0.0008064721292221147, "retrospective descriptive": 0.0009836594343941379, "descriptive research": 0.0009154687767183569, "research design": 0.0008275557287880785, "inpatient records": 0.0008658044569477526, "records of": 0.0007036492469577129, "patients discharged": 0.0008997940083549217, "year period": 0.0007327751786988557, "outcomes demonstrated": 0.0009303786110524806, "demonstrated statistically": 0.0009956449307649, "study provide": 0.0007838254010042559, "possible contribution": 0.0009303786110524806, "incorporating nursing": 0.0009303786110524806, "future prospective": 0.000883271552942663, "prospective experimental": 0.0009711846008729415, "experimental research": 0.0009303786110524806, "advancement of": 0.0008064721292221147, "science regarding": 0.0008658044569477526, "regarding effective": 0.0008997940083549217, "adults hospitalized": 0.0008997940083549217, "reciprocal downregulation": 0.0009836594343941379, "downregulation influences": 0.0009836594343941379, "influences cardiac": 0.000883271552942663, "cardiac hypertrophic": 0.0009154687767183569, "hypertrophic response": 0.0009303786110524806, "protective role": 0.0008275557287880785, "gene therapy": 0.0007593650711122975, "receptors expressed": 0.0008997940083549217, "opposing actions": 0.0008472781190425757, "adenylyl cyclase": 0.0008472781190425757, "differential g": 0.0008064721292221147, "protein coupling": 0.0008472781190425757, "actions of": 0.0007036492469577129, "triggers desensitization": 0.0009711846008729415, "downregulation processes": 0.0009711846008729415, "classic signaling": 0.0008658044569477526, "signaling paradigms": 0.0008997940083549217, "paradigms suggest": 0.0008658044569477526, "simultaneous activation": 0.0009581787663751352, "simply result": 0.0007838254010042559, "opposing action": 0.0008275557287880785, "camp production": 0.0008275557287880785, "direct interaction": 0.000883271552942663, "regulatory involvement": 0.0009445947084594995, "human embryonic": 0.0008275557287880785, "embryonic kidney": 0.0008472781190425757, "cells overexpressing": 0.0009154687767183569, "\u03b21ar downregulation": 0.0008997940083549217, "receptor agonist": 0.0008472781190425757, "this cross": 0.0007036492469577129, "distinct g": 0.0007036492469577129, "receptors appears": 0.0008658044569477526, "physiological significance": 0.0009956449307649, "show reciprocal": 0.0008275557287880785, "reciprocal regulation": 0.0009303786110524806, "mouse hearts": 0.0007593650711122975, "hearts undergoing": 0.0008658044569477526, "undergoing chronic": 0.000883271552942663, "receptor stimulation": 0.0009154687767183569, "rat model": 0.0006714520231820191, "postischemic heart": 0.000883271552942663, "cardiac plasma": 0.0008064721292221147, "membrane levels": 0.0008275557287880785, "produces beneficial": 0.0008997940083549217, "deleterious \u03b21ar": 0.0008472781190425757, "\u03b21ar overstimulation": 0.0009154687767183569, "discharge among": 0.0008275557287880785, "readmission among": 0.0008658044569477526, "influences outcomes": 0.0008997940083549217, "administrative databases": 0.0009711846008729415, "adults aged": 0.0007327751786988557, "discharged alive": 0.0008472781190425757, "time diagnosis": 0.0008064721292221147, "dependent covariates": 0.0009154687767183569, "physician within": 0.0008472781190425757, "month after": 0.0007327751786988557, "least twice": 0.0007327751786988557, "identified patients": 0.0008997940083549217, "saw unfamiliar": 0.0008064721292221147, "unfamiliar physician(s": 0.0009445947084594995, "unplanned readmission": 0.0009303786110524806, "month observation": 0.0008658044569477526, "observation period": 0.000883271552942663, "unfamiliar physician": 0.0009154687767183569, "hr 0.90": 0.0005946525994614709, "early follow": 0.0007593650711122975, "month period": 0.0007593650711122975, "unfamiliar physicians": 0.0009303786110524806, "hr 0.91": 0.0005946525994614709, "explore whether": 0.0008275557287880785, "altered protein": 0.0008275557287880785, "a subunit": 0.0006714520231820191, "translational state": 0.0008997940083549217, "receptor blockade": 0.0008658044569477526, "blockade reduces": 0.0008472781190425757, "reduces total": 0.0007838254010042559, "total mortality": 0.0008275557287880785, "halt disease": 0.0007593650711122975, "dependent protein": 0.0008658044569477526, "signaling downstream": 0.0009154687767183569, "receptor activation": 0.0008997940083549217, "unique post": 0.0007327751786988557, "translational states": 0.0009154687767183569, "human myocardial": 0.0008472781190425757, "total myosin": 0.0007593650711122975, "myosin binding": 0.0008064721292221147, "binding protein": 0.0008275557287880785, "c phosphorylation": 0.0008658044569477526, "ser23/24 troponin": 0.0008658044569477526, "phosphorylation significantly": 0.0010290152499740676, "subunits demonstrated": 0.0009303786110524806, "type ii": 0.0005946525994614709, "site specific": 0.0007838254010042559, "specific rii\u03b1": 0.0007838254010042559, "regulatory subunit": 0.000883271552942663, "ri\u03b1 demonstrated": 0.0008472781190425757, "vivo phosphorylation": 0.0009154687767183569, "phosphorylation sites": 0.0009303786110524806, "western blots": 0.0007838254010042559, "specific monoclonal": 0.0008997940083549217, "monoclonal antibodies": 0.0009303786110524806, "antibodies showed": 0.0008658044569477526, "camp binding": 0.0007593650711122975, "wild type": 0.0006714520231820191, "mutant ri\u03b1": 0.0007036492469577129, "ri\u03b1 proteins": 0.0007593650711122975, "proteins demonstrated": 0.0009303786110524806, "demonstrated reduced": 0.0009154687767183569, "double mutant": 0.0007838254010042559, "failing myocardium": 0.000883271552942663, "myocardium displays": 0.0008997940083549217, "displays altered": 0.0008472781190425757, "translational modification": 0.0009956449307649, "impact downstream": 0.0008658044569477526, "downstream signaling": 0.0009154687767183569, "autonomic modulation": 0.0009154687767183569, "repolarization instability": 0.0009956449307649, "failure prone": 0.0007838254010042559, "qt variability": 0.0008064721292221147, "signifies repolarization": 0.0009711846008729415, "repolarization lability": 0.0009581787663751352, "risk predictor": 0.0008064721292221147, "system activity": 0.0008275557287880785, "spontaneous ventricular": 0.0009581787663751352, "tachycardia [": 0.0007838254010042559, "without spontaneous": 0.0008997940083549217, "structurally normal": 0.0008997940083549217, "normal hearts": 0.0007838254010042559, "the beat": 0.0006354585892819318, "beat qt": 0.0005946525994614709, "qt interval": 0.0007327751786988557, "min records": 0.0007327751786988557, "surface ecgs": 0.0007593650711122975, "atropine infusion": 0.0008658044569477526, "variability in": 0.0008064721292221147, "rr intervals": 0.0007593650711122975, "sdrr ratio": 0.0007036492469577129, "groups compared": 0.0008275557287880785, "rate atrial": 0.0007327751786988557, "isoprenaline infusion": 0.0009303786110524806, "infusion increased": 0.000883271552942663, "group relative": 0.0008064721292221147, "larger fluctuations": 0.0008997940083549217, "this appears": 0.0007593650711122975, "genuine effect": 0.0008064721292221147, "rate variation": 0.0008064721292221147, "the effect": 0.0007036492469577129, "acute autonomic": 0.0008275557287880785, "system modulation": 0.0008658044569477526, "genetic susceptibility": 0.0009445947084594995, "related congestive": 0.000883271552942663, "haematopoietic cell": 0.0008997940083549217, "developing congestive": 0.0009303786110524806, "primarily due": 0.0007838254010042559, "hct exposure": 0.0007593650711122975, "candidate genes": 0.0008275557287880785, "genes involved": 0.0008064721292221147, "anthracycline metabolism": 0.0009711846008729415, "iron homeostasis": 0.0008472781190425757, "- oxidant": 0.0006714520231820191, "oxidant defence": 0.0008275557287880785, "myocardial remodelling": 0.0009445947084594995, "nested case": 0.0007327751786988557, "control study": 0.0007838254010042559, "this cohort": 0.0007327751786988557, "cohort formed": 0.0007838254010042559, "sampling frame": 0.0008064721292221147, "selecting controls": 0.000883271552942663, "cumulative anthracycline": 0.0009711846008729415, "anthracycline exposure": 0.0009445947084594995, "cell source": 0.0007327751786988557, "germline dna": 0.0007593650711122975, "chest radiation": 0.0008275557287880785, "genes coding": 0.0007593650711122975, "oxidase subunit": 0.0008275557287880785, "doxorubicin efflux": 0.000883271552942663, "efflux transporter": 0.000883271552942663, "a combined": 0.0007036492469577129, "chf predictive": 0.0008064721292221147, "predictive model": 0.0008472781190425757, "model performed": 0.0008275557287880785, "models alone": 0.0007593650711122975, "common language": 0.0008275557287880785, "common syndrome": 0.0008275557287880785, "first propose": 0.0007838254010042559, "propose fundamental": 0.0008997940083549217, "fundamental definitions": 0.0009581787663751352, "distinctive components": 0.0009445947084594995, "heart circulation": 0.0008658044569477526, "provide consensus": 0.0008658044569477526, "universal definition": 0.0009154687767183569, "these definitions": 0.0008658044569477526, "uniform nomenclature": 0.0009154687767183569, "heart circulatory": 0.0008658044569477526, "circulatory failure": 0.0008997940083549217, "foster collaborative": 0.0009154687767183569, "collaborative research": 0.0009445947084594995, "research initiatives": 0.0009154687767183569, "conjoint education": 0.000883271552942663, "disease unique": 0.0008064721292221147, "class angiotensin": 0.0008658044569477526, "inhibitors augment": 0.000883271552942663, "peptide system": 0.0008064721292221147, "atrial natriuretic": 0.000883271552942663, "inhibitor composed": 0.000883271552942663, "inhibitor prodrug": 0.0008658044569477526, "antagonist valsartan": 0.0009154687767183569, "proven effective": 0.0008472781190425757, "shown promise": 0.0007838254010042559, "pilot trial": 0.0007327751786988557, "large outcomes": 0.0008064721292221147, "a preserved": 0.0007327751786988557, "fraction outcomes": 0.0008658044569477526, "current treatment": 0.0008658044569477526, "rapid onset": 0.0007327751786988557, "threatening situation": 0.0009303786110524806, "treatment aims": 0.0008064721292221147, "improve clinical": 0.0008472781190425757, "increase long": 0.0007838254010042559, "few treatments": 0.0008064721292221147, "review summarizes": 0.0008658044569477526, "pharmacologic treatment": 0.0009581787663751352, "underlying clinical": 0.0008997940083549217, "new pharmacologic": 0.0008658044569477526, "pharmacologic targets": 0.0009303786110524806, "purely hemodynamic": 0.000883271552942663, "hemodynamic disorder": 0.0009154687767183569, "interconnected molecular": 0.0009711846008729415, "research investigations": 0.0009581787663751352, "maladaptive molecular": 0.0009303786110524806, "molecular processes": 0.0008997940083549217, "accumulating evidence": 0.0009303786110524806, "evidence shows": 0.0008064721292221147, "molecular biomarkers": 0.0009154687767183569, "biomarkers provide": 0.000883271552942663, "important therapeutic": 0.0009303786110524806, "research studies": 0.0008472781190425757, "potential therapeutic": 0.0009303786110524806, "promising biomarkers": 0.0009154687767183569, "uniquely capture": 0.0008472781190425757, "molecular dysfunction": 0.0009303786110524806, "strict statistical": 0.000883271552942663, "statistical standards": 0.0009303786110524806, "biomarker studies": 0.0008658044569477526, "trial design": 0.0007593650711122975, "therapeutic potential": 0.0009303786110524806, "based strategy": 0.0008064721292221147, "western society": 0.0008275557287880785, "fastest growing": 0.0008275557287880785, "growing subclass": 0.0008472781190425757, "an increasing": 0.0007838254010042559, "increasing body": 0.0008275557287880785, "evidence indicates": 0.000883271552942663, "small noncoding": 0.0008275557287880785, "noncoding rnas": 0.0008064721292221147, "regulate expression": 0.0008997940083549217, "target genes": 0.0007593650711122975, "specific binding": 0.0008472781190425757, "untranslated region": 0.0008997940083549217, "region of": 0.0006714520231820191, "translational repression": 0.0009711846008729415, "to date": 0.0005946525994614709, "many mirnas": 0.0007327751786988557, "diverse aspects": 0.0008275557287880785, "failure development": 0.0008997940083549217, "cardiac pathogenesis": 0.0009154687767183569, "provide brief": 0.0007838254010042559, "brief insight": 0.0007838254010042559, "system inhibitors": 0.0008658044569477526, "common condition": 0.0008472781190425757, "carries significant": 0.0008997940083549217, "significant morbidity": 0.0009303786110524806, "good evidence": 0.0007838254010042559, "the renin": 0.0006714520231820191, "effective target": 0.0008472781190425757, "using angiotensin": 0.0008658044569477526, "aldosterone blockade": 0.0009154687767183569, "less clear": 0.0007036492469577129, "review aims": 0.0007327751786988557, "look first": 0.0007036492469577129, "newer drugs": 0.0007327751786988557, "direct renin": 0.0007593650711122975, "renin inhibitors": 0.0008472781190425757, "neutral endopeptidase": 0.0009303786110524806, "endopeptidase inhibitors": 0.0009711846008729415, "vasopeptidase inhibitors": 0.0009711846008729415, "muscle abnormalities": 0.0009154687767183569, "capacity in": 0.0007327751786988557, "peripheral muscle": 0.0008658044569477526, "muscle pump": 0.0007327751786988557, "promoting cardiac": 0.0008658044569477526, "subpulmonary ventricle": 0.0009445947084594995, "a muscle": 0.0006354585892819318, "wasting syndrome": 0.0008472781190425757, "syndrome exists": 0.0008275557287880785, "acquired heart": 0.0008064721292221147, "investigate whether": 0.0008997940083549217, "circulation exhibit": 0.0008997940083549217, "exhibit reduced": 0.0008275557287880785, "reduced skeletal": 0.0008472781190425757, "metabolic abnormalities": 0.0009581787663751352, "underwent cardiopulmonary": 0.0009836594343941379, "mass quantification": 0.0008997940083549217, "dual x": 0.0005475455413516535, "calf muscle": 0.0007327751786988557, "resonance spectroscopy": 0.0009445947084594995, "healthy age": 0.0007327751786988557, "australian reference": 0.0009154687767183569, "reference data": 0.0008064721292221147, "single tertiary": 0.0008275557287880785, "tertiary referral": 0.0008658044569477526, "referral centre": 0.0008275557287880785, "predicted values": 0.0008472781190425757, "mass assessed": 0.0007838254010042559, "relative appendicular": 0.0009303786110524806, "appendicular lean": 0.0008658044569477526, "matched reference": 0.0008658044569477526, "reference values": 0.0008472781190425757, "score -1.46\u00b10.22": 0.0008472781190425757, "low skeletal": 0.0007593650711122975, "mass correlated": 0.0008275557287880785, "poorer vo2": 0.0007036492469577129, "mass t": 0.0005475455413516535, "young normal": 0.0007593650711122975, "normal reference": 0.0008472781190425757, "reference mean": 0.0008064721292221147, "sarcopenic range": 0.0008472781190425757, "range muscle": 0.0007593650711122975, "muscle wasting": 0.0008064721292221147, "less marked": 0.0007327751786988557, "significant wasting": 0.0008997940083549217, "muscle aerobic": 0.0008064721292221147, "rate constant": 0.0007838254010042559, "postexercise phosphocreatine": 0.0010182916589827587, "phosphocreatine resynthesis": 0.001007178034773029, "adults versus": 0.0007838254010042559, "versus controls": 0.0008275557287880785, "the self": 0.0006354585892819318, "psychometric profile": 0.0009154687767183569, "still questioned": 0.0008472781190425757, "performed confirmatory": 0.0009445947084594995, "confirmatory factor": 0.0008997940083549217, "original construct": 0.000883271552942663, "v.6.2 scales": 0.0007593650711122975, "limited success": 0.0008275557287880785, "used exploratory": 0.0008472781190425757, "exploratory factor": 0.000883271552942663, "separate scale": 0.0008064721292221147, "scale dimensions": 0.0008472781190425757, "separate sub": 0.0007593650711122975, "- sample": 0.0006354585892819318, "construct validity": 0.000883271552942663, "individual scales": 0.0008658044569477526, "scales showed": 0.0007838254010042559, "showed excellent": 0.0008472781190425757, "excellent fit": 0.0007838254010042559, "fit indices": 0.0007327751786988557, "confidence scale": 0.0008472781190425757, "contrasting groups": 0.000883271552942663, "groups validity": 0.0008275557287880785, "this evidence": 0.0007838254010042559, "evidence provides": 0.0008658044569477526, "new understanding": 0.0008658044569477526, "circulating fragments": 0.0009303786110524806, "nonstandardized n": 0.0008658044569477526, "common consensus": 0.0008472781190425757, "consensus regarding": 0.0008997940083549217, "circulating forms": 0.0008658044569477526, "current assays": 0.0008064721292221147, "various forms": 0.0007838254010042559, "collected from": 0.0008064721292221147, "\u00b0 c": 0.00033572601159100957, "patient plasma": 0.0008064721292221147, "immunoprecipitation followed": 0.0010182916589827587, "mass spectrometric": 0.000883271552942663, "spectrometric analysis": 0.0009445947084594995, "customized homogeneous": 0.0009445947084594995, "homogeneous sandwich": 0.0009154687767183569, "sandwich alphalisa": 0.000883271552942663, "\u00ae immunoassays": 0.0008064721292221147, "quantify 6": 0.0007036492469577129, "spectrometry identified": 0.0009581787663751352, "several n-": 0.0007036492469577129, "terminally processed": 0.0009154687767183569, "processed forms": 0.0008275557287880785, "physiological proteolysis": 0.0009836594343941379, "immunoassays demonstrated": 0.0009836594343941379, "extreme n": 0.0006714520231820191, "termini measured": 0.0008472781190425757, "low apparent": 0.0007593650711122975, "apparent concentration": 0.0009445947084594995, "apparent circulating": 0.0009154687767183569, "circulating nt": 0.0008064721292221147, "increased with": 0.0008064721292221147, "targeting nonglycosylated": 0.0009836594343941379, "in plasma": 0.0006714520231820191, "plasma collected": 0.0008472781190425757, "immunoreactive nt": 0.0008658044569477526, "multiple n-": 0.0007327751786988557, "terminally truncated": 0.0009154687767183569, "truncated fragments": 0.0008997940083549217, "full length": 0.0007327751786988557, "terminal regions": 0.0008472781190425757, "findings support": 0.0008472781190425757, "next generation": 0.0008275557287880785, "assay targeting": 0.0008275557287880785, "targeting nonterminal": 0.0009303786110524806, "central glycosylated": 0.0009154687767183569, "glycosylated region": 0.0008997940083549217, "versus concentric": 0.0008658044569477526, "concentric left": 0.0008275557287880785, "ventricular hypertrophy": 0.0009581787663751352, "hypertrophy in": 0.0008064721292221147, "concentric remodeling": 0.0009303786110524806, "concentric hypertrophy": 0.0009445947084594995, "common forms": 0.0007593650711122975, "eccentric hypertrophy": 0.0009303786110524806, "also occur": 0.0007036492469577129, "well described": 0.0008064721292221147, "prospectively studied": 0.0009303786110524806, "studied 402": 0.0007327751786988557, "normal geometry": 0.0008275557287880785, "relative wall": 0.0007838254010042559, "compared clinical": 0.0008658044569477526, "outcome data": 0.0007593650711122975, "data among": 0.0007036492469577129, "among groups": 0.0007593650711122975, "lower systolic": 0.0008064721292221147, "less renal": 0.0007036492469577129, "renal impairment": 0.0008472781190425757, "similar rates": 0.0007838254010042559, "contractility compared": 0.0009445947084594995, "lower lvef": 0.0007036492469577129, "-1.1 %": 0.0005475455413516535, "also associated": 0.0008275557287880785, "compliance compared": 0.0008997940083549217, "similarly elevated": 0.000883271552942663, "elevated cardiac": 0.0008472781190425757, "equivalent adverse": 0.000883271552942663, "distinct subset": 0.0008275557287880785, "pathophysiologically similar": 0.0010182916589827587, "endpoint of": 0.0007327751786988557, "using time": 0.0007036492469577129, "dependent cox": 0.0007838254010042559, "compared patients": 0.0008658044569477526, "different types": 0.0008275557287880785, "antitachycardia pacing": 0.0009445947084594995, "secondary endpoints": 0.0008997940083549217, "atrial tachyarrhythmias": 0.0009581787663751352, "also evaluated": 0.0008064721292221147, "therapy occurred": 0.0008472781190425757, "\u00b1 1.1": 0.0004918297171970689, "decreased risk": 0.0008064721292221147, "the reduction": 0.0007838254010042559, "inappropriate shock": 0.0008997940083549217, "therapy caused": 0.0008064721292221147, "also reduced": 0.0007593650711122975, "general use": 0.0007327751786988557, "rate in": 0.0005946525994614709, "receiving metoprolol": 0.0009154687767183569, "nationwide retrospective": 0.0009711846008729415, "matched subjects": 0.0008472781190425757, "hazard analyses": 0.0008275557287880785, "absolute risk": 0.0007838254010042559, "exposed group": 0.0007838254010042559, "crude rr": 0.0006354585892819318, "rr 1.71": 0.0005946525994614709, "ci 1.34": 0.0005946525994614709, "by comparison": 0.0007838254010042559, "different mechanism": 0.0008997940083549217, "hr 1.07": 0.0005946525994614709, "ci 0.76": 0.0005946525994614709, "used bisphosphonates": 0.0009154687767183569, "analysed separately": 0.0008997940083549217, "significant trends": 0.000883271552942663, "observed across": 0.0008275557287880785, "across refill": 0.0007838254010042559, "compliance strata": 0.0008658044569477526, "failure increased": 0.0008658044569477526, "increasing refill": 0.0008658044569477526, "failure compared": 0.0008472781190425757, "control subjects": 0.0008472781190425757, "alendronate showed": 0.000883271552942663, "dependent reduction": 0.0008997940083549217, "subcellular alterations": 0.0009581787663751352, "alterations by": 0.0008064721292221147, "in order": 0.0006354585892819318, "weeks infarcted": 0.0008275557287880785, "infarcted rats": 0.0008064721292221147, "without metoprolol": 0.000883271552942663, "depressed left": 0.0008064721292221147, "negative rates": 0.0008064721292221147, "pressure development": 0.0009154687767183569, "weeks mi": 0.0006354585892819318, "mi animals": 0.0007036492469577129, "induced decreases": 0.0008658044569477526, "internal diameter": 0.0008658044569477526, "fully reversible": 0.0008472781190425757, "metoprolol partially": 0.0009154687767183569, "plasma norepinephrine": 0.0009303786110524806, "dopamine without": 0.0008472781190425757, "sarcoplasmic reticular": 0.0009445947084594995, "protein content": 0.0008275557287880785, "infarcted hearts": 0.0008472781190425757, "partially reversible": 0.0009154687767183569, "depressed myofibrillar": 0.0009445947084594995, "myofibrillar ca(2+)-stimulated": 0.0010393752585487225, "increased mrna": 0.0008064721292221147, "mrna level": 0.0007036492469577129, "- myosin": 0.0006354585892819318, "partial improvement": 0.0008997940083549217, "cardiac performance": 0.0008997940083549217, "advanced stages": 0.0008275557287880785, "partial reversal": 0.0008472781190425757, "complete reverse": 0.0008472781190425757, "reverse cardiac": 0.0008275557287880785, "partial reduction": 0.0008658044569477526, "plasma catecholamines": 0.0009303786110524806, "incident cardiovascular": 0.0009581787663751352, "independent risk": 0.0008472781190425757, "available studies": 0.0008658044569477526, "shown inconsistent": 0.000883271552942663, "inconsistent results": 0.0009154687767183569, "embedded within": 0.0008275557287880785, "cardiovascular outcomes": 0.0009581787663751352, "adjusted means": 0.0008064721292221147, "subclinical atherosclerosis": 0.001007178034773029, "atherosclerosis using": 0.0009303786110524806, "using general": 0.0007838254010042559, "general linear": 0.0008064721292221147, "dependent variable": 0.000883271552942663, "% systemic": 0.0007036492469577129, "uv treatment": 0.0007593650711122975, "higher diastolic": 0.0008472781190425757, "diastolic blood": 0.0008275557287880785, "index levels": 0.0007593650711122975, "adjusted carotid": 0.0008472781190425757, "carotid intima": 0.0008064721292221147, "media thickness": 0.0008275557287880785, "adjusted ankle": 0.0008064721292221147, "wave velocity": 0.0007838254010042559, "artery calcium": 0.0008064721292221147, "calcium scores": 0.0008064721292221147, "ratio 0.73": 0.0007036492469577129, "interval 0.50": 0.0007838254010042559, "analyzed separately": 0.0008997940083549217, "predominantly mild": 0.000883271552942663, "mild disease": 0.0007593650711122975, "develop atherosclerosis": 0.0009581787663751352, "subjects without": 0.0008472781190425757, "without psoriasis": 0.0008658044569477526, "share many": 0.0007036492469577129, "many risk": 0.0006714520231820191, "fully examined": 0.0008064721292221147, "investigated 120": 0.0008472781190425757, "defined by": 0.0007036492469577129, "levels \u2265": 0.0006354585892819318, "low bnp": 0.0005946525994614709, "transmitral e": 0.0007838254010042559, "analysis established": 0.0009154687767183569, "highest quartile": 0.0008472781190425757, "pad suggests": 0.0007593650711122975, "routine bnp": 0.0007327751786988557, "hospital readmission": 0.0009154687767183569, "readmission reduction": 0.0009303786110524806, "reduction program": 0.0008658044569477526, "rate following": 0.0008064721292221147, "following hospital": 0.000883271552942663, "hospital stay": 0.0007838254010042559, "approaches 30": 0.0007838254010042559, "percent nationally": 0.000883271552942663, "indicating possible": 0.0008997940083549217, "possible suboptimal": 0.0008997940083549217, "suboptimal care": 0.0008275557287880785, "care of": 0.0005946525994614709, "significant economic": 0.0009154687767183569, "economic considerations": 0.0009581787663751352, "- randomized": 0.0007593650711122975, "center pilot": 0.0007593650711122975, "pilot project": 0.0007838254010042559, "cardiac specialty": 0.0008658044569477526, "specialty hospital": 0.000883271552942663, "predominantly rural": 0.0008997940083549217, "rural south": 0.0007327751786988557, "transitions of": 0.0008064721292221147, "ensure adequate": 0.0008275557287880785, "adequate self": 0.0007838254010042559, "management training": 0.0008997940083549217, "training of": 0.0007327751786988557, "patient follow": 0.0008064721292221147, "percent relative": 0.0008472781190425757, "relative reduction": 0.000883271552942663, "patients participating": 0.0009445947084594995, "pilot program": 0.0007838254010042559, "this represented": 0.0008472781190425757, "net economic": 0.0007593650711122975, "economic savings": 0.0008472781190425757, "even accounting": 0.0008275557287880785, "added cost": 0.0007036492469577129, "program decreases": 0.0008658044569477526, "- urbanized": 0.0007327751786988557, "urbanized midwestern": 0.0009154687767183569, "midwestern state": 0.0008472781190425757, "state like": 0.0007036492469577129, "extensively studied": 0.0008997940083549217, "patients surviving": 0.000883271552942663, "the majority": 0.0007593650711122975, "mortality within": 0.0008472781190425757, "hr dynamics": 0.0007327751786988557, "linear measures": 0.0008275557287880785, "prognostic power": 0.0008472781190425757, "reflecting rapid": 0.0008472781190425757, "rapid r": 0.0005946525994614709, "r interval": 0.0007036492469577129, "interval oscillations": 0.0009303786110524806, "almost identical": 0.0008472781190425757, "linear hr": 0.0006714520231820191, "variability measures": 0.0009154687767183569, "term fractal": 0.0007593650711122975, "fractal scaling": 0.0008275557287880785, "scaling exponent": 0.0008472781190425757, "provided somewhat": 0.0008658044569477526, "somewhat better": 0.0008275557287880785, "better prognostic": 0.0008658044569477526, "variability predicts": 0.0009154687767183569, "- sudden": 0.0006354585892819318, "arrhythmia substrate": 0.0009154687767183569, "early measurement": 0.0008658044569477526, "repeated later": 0.0008064721292221147, "fatal arrhythmia": 0.0008472781190425757, "arrhythmia events": 0.0008658044569477526, "future randomized": 0.0008658044569477526, "trials using": 0.0007593650711122975, "using hr": 0.0006354585892819318, "- defined": 0.0006714520231820191, "defined inclusion": 0.0008658044569477526, "show whether": 0.0007593650711122975, "routine measurement": 0.0008997940083549217, "routine clinical": 0.0008472781190425757, "renal artery": 0.0007593650711122975, "form of": 0.0005946525994614709, "peripheral arterial": 0.0008997940083549217, "arterial disease": 0.0008472781190425757, "predominantly unilateral": 0.0009711846008729415, "pathophysiologic mechanism": 0.0009956449307649, "mechanism stems": 0.0008275557287880785, "renal underperfusion": 0.0009154687767183569, "underperfusion resulting": 0.0009711846008729415, "renin- angiotensin": 0.000883271552942663, "aldosterone pathway": 0.0008997940083549217, "clinically present": 0.000883271552942663, "resistant hypertension": 0.0009445947084594995, "stage kidney": 0.0007593650711122975, "kidney failure": 0.0008064721292221147, "screening patients": 0.000883271552942663, "computed tomographic": 0.0009154687767183569, "tomographic angiography": 0.0009581787663751352, "resonance angiography": 0.0009303786110524806, "adequate blood": 0.0008064721292221147, "pressure control": 0.0008472781190425757, "directed lipid": 0.0008064721292221147, "lowering therapy": 0.0008472781190425757, "smoking cessation": 0.0008658044569477526, "preventive measures": 0.0008997940083549217, "measures form": 0.0007838254010042559, "based percutaneous": 0.000883271552942663, "percutaneous revascularization": 0.0010393752585487225, "stenting showed": 0.0008275557287880785, "showed modest": 0.0007838254010042559, "modest clinical": 0.0008275557287880785, "small retrospective": 0.0008997940083549217, "retrospective studies": 0.0009303786110524806, "randomized clinical": 0.0008997940083549217, "trials failed": 0.0007838254010042559, "beneficial results": 0.000883271552942663, "current ongoing": 0.0008275557287880785, "ongoing cardiovascular": 0.0009445947084594995, "concrete data": 0.0007838254010042559, "surgical revascularization": 0.0009956449307649, "based revascularization": 0.0009581787663751352, "determining individualized": 0.0009956449307649, "individualized assessment": 0.0009836594343941379, "treatment plans": 0.0008275557287880785, "bioinformatic analysis": 0.0009445947084594995, "microarray data": 0.0008275557287880785, "data reveals": 0.0007593650711122975, "reveals several": 0.0008275557287880785, "several key": 0.0007327751786988557, "key genes": 0.0006714520231820191, "genes related": 0.0007838254010042559, "problem worldwide": 0.0008658044569477526, "still unclear": 0.0007838254010042559, "study aims": 0.0007036492469577129, "discover differentially": 0.0009581787663751352, "expressed genes": 0.0008275557287880785, "including 3": 0.0007327751786988557, "normal samples": 0.0008064721292221147, "ischemic samples": 0.0008472781190425757, "data processing": 0.0008275557287880785, "differential analysis": 0.0009303786110524806, "also performed": 0.0008064721292221147, "globally observe": 0.0008472781190425757, "overlapping part": 0.0008472781190425757, "obtained for": 0.0007593650711122975, "programmed cell": 0.0008275557287880785, "cell death": 0.0007036492469577129, "common degs": 0.0007327751786988557, "develop treatments": 0.000883271552942663, "longitudinal analysis": 0.0009303786110524806, "using medicare": 0.0008064721292221147, "medicare data": 0.0007838254010042559, "evaluate mortality": 0.000883271552942663, "healthcare utilization": 0.0009445947084594995, "utilization effects": 0.0008997940083549217, "combined care": 0.0007838254010042559, "targeting individuals": 0.0009303786110524806, "retrospective matched": 0.0009303786110524806, "matched cohort": 0.0008064721292221147, "demonstration participating": 0.001007178034773029, "participating clinics": 0.0009303786110524806, "score matched": 0.0007838254010042559, "telehealth system": 0.0008658044569477526, "year study": 0.0007036492469577129, "negative binomial": 0.0008658044569477526, "binomial regression": 0.0008997940083549217, "controlling for": 0.0008275557287880785, "health characteristics": 0.0009445947084594995, "statistically different": 0.0009581787663751352, "participants offered": 0.0009154687767183569, "quarterly inpatient": 0.0008997940083549217, "% greater": 0.0006714520231820191, "time period": 0.0007327751786988557, "no relationship": 0.0008275557287880785, "fewer admissions": 0.0008472781190425757, "management coupled": 0.000883271552942663, "telehealth technology": 0.0009303786110524806, "improve health": 0.0008064721292221147, "the strength": 0.0007593650711122975, "contemporary chronic": 0.0009154687767183569, "training response": 0.0008658044569477526, "well established": 0.0008472781190425757, "explore interactions": 0.0009154687767183569, "examined characteristics": 0.0009711846008729415, "race using": 0.0007036492469577129, "using adjusted": 0.0008064721292221147, "identified black": 0.0008472781190425757, "black patients": 0.0008064721292221147, "less ischemic": 0.0007838254010042559, "ischemic etiology": 0.0008658044569477526, "lower socioeconomic": 0.0008997940083549217, "socioeconomic status": 0.0009154687767183569, "status versus": 0.0007838254010042559, "versus whites": 0.0007838254010042559, "lower peak": 0.0007036492469577129, "after multivariable": 0.0008997940083549217, "hazard associated": 0.0008658044569477526, "largely caused": 0.0008064721292221147, "given similar": 0.0007838254010042559, "similar cardiovascular": 0.0009445947084594995, "increased prevalence": 0.0009154687767183569, "modifiable risk": 0.0008275557287880785, "improving outcomes": 0.000883271552942663, "fibrillation for": 0.0008472781190425757, "therapy including": 0.0008658044569477526, "including anticoagulation": 0.0009836594343941379, "major cardiovascular": 0.0009154687767183569, "prevent adverse": 0.0008275557287880785, "outcomes related": 0.0008472781190425757, "moderately effective": 0.0009154687767183569, "published trials": 0.0008472781190425757, "side effects": 0.0007593650711122975, "repeated interventions": 0.0009445947084594995, "therapy applied": 0.0008275557287880785, "first diagnosis": 0.0008275557287880785, "preserve atrial": 0.0008275557287880785, "atrial structure": 0.0008472781190425757, "maintain sinus": 0.0008064721292221147, "current practice": 0.0008472781190425757, "delayed rhythm": 0.0008064721292221147, "symptoms persist": 0.0008472781190425757, "otherwise effective": 0.0008997940083549217, "new antiarrhythmic": 0.000883271552942663, "potential effectiveness": 0.0009581787663751352, "modern rhythm": 0.0007838254010042559, "reduce cardiovascular": 0.0009303786110524806, "randomize approximately": 0.0009581787663751352, "onset af": 0.0006354585892819318, "mandated usual": 0.0008064721292221147, "blinded outcome": 0.0008275557287880785, "outcome assessment": 0.000883271552942663, "assessment trial": 0.0008472781190425757, "composite primary": 0.0008658044569477526, "nights spent": 0.0007593650711122975, "coprimary outcome": 0.0008658044569477526, "underlying heart": 0.0008472781190425757, "initial approach": 0.0008472781190425757, "operated electrocardiographic": 0.0010290152499740676, "electrocardiographic device": 0.001007178034773029, "ongoing rhythm": 0.0008064721292221147, "key secondary": 0.0007838254010042559, "outcomes include": 0.0008472781190425757, "include cognitive": 0.0008658044569477526, "cognitive function": 0.000883271552942663, "initial diagnosis": 0.0008658044569477526, "prevent cardiovascular": 0.0009445947084594995, "complications associated": 0.0009711846008729415, "bleeding in": 0.0007327751786988557, "cardiac nurse": 0.0007838254010042559, "term ventricular": 0.0008472781190425757, "care providers": 0.0008064721292221147, "managing clinically": 0.0008997940083549217, "significant gastrointestinal": 0.0010182916589827587, "units accustomed": 0.0008472781190425757, "often asked": 0.0007327751786988557, "possible causes": 0.0008275557287880785, "subspecialty groups": 0.0008997940083549217, "dependent increase": 0.000883271552942663, "leading causes": 0.0008064721292221147, "hospitalisation among": 0.0009303786110524806, "worldwide increase": 0.000883271552942663, "advanced phase": 0.0008064721292221147, "called end": 0.0007036492469577129, "steadily growing": 0.0008472781190425757, "failure fall": 0.0007593650711122975, "functional classification": 0.0009836594343941379, "advanced structural": 0.0008997940083549217, "structural heart": 0.0008472781190425757, "pronounced symptoms": 0.0008997940083549217, "minimal physical": 0.0008472781190425757, "physical exertion": 0.0008658044569477526, "maximal medical": 0.0008275557287880785, "treatment according": 0.0008997940083549217, "mortality rate": 0.0008064721292221147, "requires special": 0.0008472781190425757, "special therapeutic": 0.0008997940083549217, "every attempt": 0.0007838254010042559, "correct reversible": 0.000883271552942663, "reversible causes": 0.0008658044569477526, "poor patient": 0.0007593650711122975, "myocardial ischaemia": 0.0009154687767183569, "valvular regurgitation": 0.0009445947084594995, "describe current": 0.0008472781190425757, "current strategies": 0.000883271552942663, "potent inhibition": 0.0008658044569477526, "type ca2": 0.0006354585892819318, "variant associated": 0.000883271552942663, "influx via": 0.0007036492469577129, "via l": 0.0004918297171970689, "type voltage": 0.0007593650711122975, "channels supports": 0.0008658044569477526, "plateau phase": 0.0007838254010042559, "action potentials": 0.0008658044569477526, "monomeric g": 0.0007327751786988557, "g proteins": 0.0007036492469577129, "regulates ventricular": 0.0009303786110524806, "action potential": 0.0008472781190425757, "potential duration": 0.000883271552942663, "coupling gain": 0.0007838254010042559, "inhibit cardiac": 0.0008275557287880785, "cardiac l": 0.0006714520231820191, "channel activity": 0.0008472781190425757, "potential dysfunction": 0.0009303786110524806, "naturally occurring": 0.0008997940083549217, "occurring rad": 0.0007838254010042559, "rad variant": 0.0007327751786988557, "even eliminates": 0.0008275557287880785, "inhibitory actions": 0.000883271552942663, "channel isoforms": 0.0008472781190425757, "isoforms known": 0.0008064721292221147, "murine equivalent": 0.0008658044569477526, "human rad": 0.0006714520231820191, "inhibits l": 0.0007036492469577129, "type currents": 0.0007838254010042559, "currents conducted": 0.000883271552942663, "cav1.3 channels": 0.0008275557287880785, "channels as": 0.0007327751786988557, "% inhibition": 0.0007593650711122975, "gating movement": 0.0008275557287880785, "differentially impair": 0.0009303786110524806, "described modes": 0.0008275557287880785, "inhibit l": 0.0006714520231820191, "dependent processes": 0.0008997940083549217, "processes per": 0.0007838254010042559, "per se": 0.0005475455413516535, "rule out": 0.0006354585892819318, "decreased expression": 0.0009154687767183569, "altered regulation": 0.000883271552942663, "young adult": 0.0007327751786988557, "severe anemia": 0.0007838254010042559, "ethically complex": 0.0008658044569477526, "complex situations": 0.000883271552942663, "involving families": 0.000883271552942663, "religious beliefs": 0.0008658044569477526, "beliefs preclude": 0.0008472781190425757, "involving young": 0.0008275557287880785, "legal majority": 0.0008064721292221147, "face decisions": 0.0008064721292221147, "decisions about": 0.0008275557287880785, "this month": 0.0007036492469577129, "complexities overlapped": 0.0009581787663751352, "old jehovah": 0.0007327751786988557, "sickle cell": 0.0007327751786988557, "cell disease": 0.0007593650711122975, "threatening anemia": 0.000883271552942663, "doctors urgently": 0.0008472781190425757, "urgently recommend": 0.000883271552942663, "recommend blood": 0.0008275557287880785, "young woman": 0.0007327751786988557, "family adamantly": 0.0008472781190425757, "adamantly refuse": 0.0008472781190425757, "doctors let": 0.0007327751786988557, "common inpatient": 0.0008472781190425757, "inpatient medical": 0.0008658044569477526, "medical conditions": 0.000883271552942663, "public reporting": 0.0008472781190425757, "quality aims": 0.0007593650711122975, "patients select": 0.0008275557287880785, "select better": 0.0007838254010042559, "better hospitals": 0.0008472781190425757, "individual quality": 0.000883271552942663, "identifying superior": 0.0009154687767183569, "inferior hospitals": 0.000883271552942663, "hospitals based": 0.0008275557287880785, "outcome performance": 0.0008997940083549217, "combine structure": 0.0008658044569477526, "empirically derived": 0.0008997940083549217, "derived composite": 0.0008658044569477526, "quality measure": 0.0008275557287880785, "composite measure": 0.0008658044569477526, "measure predicts": 0.0008472781190425757, "predicts future": 0.0008275557287880785, "explains variance": 0.0008658044569477526, "future hospital": 0.0008275557287880785, "hospital mortality": 0.000883271552942663, "using national": 0.0008064721292221147, "national medicare": 0.0008658044569477526, "care hospital": 0.0007838254010042559, "ranked hospitals": 0.0008472781190425757, "performance on": 0.0008064721292221147, "quintile of": 0.0007327751786988557, "existing quality": 0.0008472781190425757, "quality indicators": 0.000883271552942663, "including mortality": 0.0008997940083549217, "the composite": 0.0007838254010042559, "explained 68": 0.0007593650711122975, "future ami": 0.0007036492469577129, "performance using": 0.0008658044569477526, "composite measures": 0.000883271552942663, "existing measures": 0.0008658044569477526, "explaining variation": 0.0009154687767183569, "future mortality": 0.0008472781190425757, "predicting future": 0.0008658044569477526, "the incidence": 0.0007838254010042559, "hyperkalemia caused": 0.0008997940083549217, "influences efficacy": 0.0008997940083549217, "assessed hyperkalemia": 0.0009303786110524806, "african americans": 0.0008658044569477526, "ischemic hf": 0.0007327751786988557, "class iv": 0.0006354585892819318, "higher estimated": 0.0008472781190425757, "less hypertension": 0.0008658044569477526, "infarction compared": 0.0008997940083549217, "- aa": 0.00042363905952128787, "potassium increased": 0.0008997940083549217, "treatment interaction": 0.0009303786110524806, "remained higher": 0.0008275557287880785, "attain maximal": 0.0008064721292221147, "maximal spironolactone": 0.0009445947084594995, "spironolactone dose": 0.0008997940083549217, "higher rates": 0.0007593650711122975, "achieved study": 0.0008064721292221147, "study drug": 0.0007036492469577129, "drug dose": 0.0006714520231820191, "spironolactone reduced": 0.0009445947084594995, "exhibited less": 0.0008064721292221147, "less hyperkalemia": 0.0008658044569477526, "spironolactone compared": 0.0009581787663751352, "derive less": 0.0007327751786988557, "less clinical": 0.0007838254010042559, "these hypothesis": 0.0008472781190425757, "generating findings": 0.0008997940083549217, "targeted peptides": 0.0008658044569477526, "targeted antioxidant": 0.0009154687767183569, "protective peptides": 0.0008997940083549217, "proteomic remodeling": 0.0009154687767183569, "improved label": 0.0008064721292221147, "free shotgun": 0.0007593650711122975, "shotgun proteomics": 0.000883271552942663, "proteomics approach": 0.0008997940083549217, "tac)-induced heart": 0.000883271552942663, "associated signaling": 0.0009154687767183569, "pathway changes": 0.0008275557287880785, "changes using": 0.0007838254010042559, "using ingenuity": 0.0008275557287880785, "proteins significantly": 0.0009445947084594995, "top pathways": 0.0007593650711122975, "categories of": 0.0007838254010042559, "intermediate metabolism": 0.0009581787663751352, "citrate cycle": 0.0007838254010042559, "concomitant treatment": 0.0009303786110524806, "failure phenotypes": 0.000883271552942663, "mitochondrial damage": 0.0009154687767183569, "damage induced": 0.0008064721292221147, "mitochondrial proteome": 0.0009445947084594995, "proteome changes": 0.0008472781190425757, "% protection": 0.0007593650711122975, "nonmitochondrial protein": 0.0009711846008729415, "protein changes": 0.0008275557287880785, "this included": 0.0007838254010042559, "included significant": 0.0009154687767183569, "significant amelioration": 0.0009711846008729415, "analysis noted": 0.0008064721292221147, "modest effects": 0.0008064721292221147, "partial attenuation": 0.0008997940083549217, "cytoskeleton pathways": 0.0009303786110524806, "significantly protected": 0.0009581787663751352, "metabolic pathways": 0.000883271552942663, "pathways essentially": 0.0009154687767183569, "study elucidates": 0.0008472781190425757, "pathways significantly": 0.0009445947084594995, "induced proteomic": 0.0008658044569477526, "proteomic alterations": 0.0009303786110524806, "perturbed mitochondrial": 0.0009581787663751352, "upstream signal": 0.0008275557287880785, "pathway alterations": 0.0008997940083549217, "potential clinical": 0.000883271552942663, "peptide drugs": 0.0007838254010042559, "treatment heart": 0.0008275557287880785, "reducing length": 0.0008275557287880785, "stay increase": 0.0007838254010042559, "increase rehospitalization": 0.0009956449307649, "rehospitalization of": 0.0009154687767183569, "medicare fee": 0.0007593650711122975, "beneficiaries discharged": 0.0009711846008729415, "skilled nursing": 0.0008275557287880785, "nursing facilities": 0.000883271552942663, "hospitals nationwide": 0.0009154687767183569, "beneficiaries associated": 0.0009711846008729415, "rehospitalization derived": 0.0009836594343941379, "hospital claims": 0.0008275557287880785, "claims using": 0.0007593650711122975, "quasi -": 0.0005946525994614709, "- experiment": 0.0007593650711122975, "policy led": 0.0007036492469577129, "immediate declines": 0.000883271552942663, "day decrease": 0.0007593650711122975, "absolute increase": 0.0008658044569477526, "= 0.03": 0.0005475455413516535, "urinary tract": 0.0007838254010042559, "tract infection": 0.0008275557287880785, "individuals hospitalized": 0.0009711846008729415, "ami without": 0.0007327751786988557, "day reduction": 0.0007838254010042559, "hospital length": 0.0008275557287880785, "consistently associated": 0.0009581787663751352, "higher rate": 0.0007327751786988557, "urgent need": 0.0007327751786988557, "reduce costs": 0.0007593650711122975, "undergoing procedures": 0.0009303786110524806, "medically managed": 0.0008658044569477526, "managed diseases": 0.0008472781190425757, "well understood": 0.0008275557287880785, "inpatient data": 0.0008064721292221147, "care hospitals": 0.0008064721292221147, "divided physicians": 0.000883271552942663, "quintiles according": 0.0008997940083549217, "used patient": 0.0007593650711122975, "level regression": 0.0008472781190425757, "compare 30": 0.0007036492469577129, "costs across": 0.0007593650711122975, "across volume": 0.0007838254010042559, "hospital characteristics": 0.0009711846008729415, "examined physician": 0.000883271552942663, "volume within": 0.0007838254010042559, "within strata": 0.0007838254010042559, "physician specialty": 0.0008997940083549217, "cared for": 0.0006714520231820191, "physicians had": 0.0008064721292221147, "volume hospitals": 0.0008472781190425757, "in contrast": 0.0007327751786988557, "higher readmission": 0.000883271552942663, "the relationship": 0.0008472781190425757, "volume institutions": 0.0008997940083549217, "among noncardiologist": 0.0009303786110524806, "noncardiologist physicians": 0.0009956449307649, "clinician expertise": 0.0008997940083549217, "neurohormone known": 0.000883271552942663, "affect electrolytes": 0.0008997940083549217, "major clinical": 0.0008064721292221147, "trials designed": 0.0008275557287880785, "analyze clinical": 0.0008472781190425757, "outcomes using": 0.0008064721292221147, "symptomatic chronic": 0.0008997940083549217, "mortality significantly": 0.0009581787663751352, "significantly compared": 0.0009445947084594995, "standard therapy": 0.0008472781190425757, "beta blockade": 0.0007838254010042559, "another study": 0.0007838254010042559, "infarction patients": 0.0008997940083549217, "patients randomized": 0.0008997940083549217, "antagonist eplerenone": 0.0009303786110524806, "these trial": 0.0007327751786988557, "trial results": 0.0007838254010042559, "results provide": 0.0008275557287880785, "improving survival": 0.000883271552942663, "based management": 0.0008472781190425757, "contemporary therapeutic": 0.0009711846008729415, "substantial improvement": 0.0009581787663751352, "limited evidence": 0.0008472781190425757, "available specifically": 0.0009445947084594995, "thus examined": 0.0007838254010042559, "examined changes": 0.0008472781190425757, "large idiopathic": 0.0008472781190425757, "cardiomyopathy cohort": 0.0009303786110524806, "cohort systematically": 0.0009303786110524806, "systematically followed": 0.0009581787663751352, "53\u00b112 years": 0.0007327751786988557, "32\u00b110 %": 0.0005946525994614709, "including negative": 0.000883271552942663, "negative coronary": 0.0008658044569477526, "enrollment periods": 0.000883271552942663, "failure treatment": 0.0008658044569477526, "treatment eras": 0.0008064721292221147, "receiving angiotensin": 0.0009303786110524806, "angiotensin receptors": 0.0009303786110524806, "receptors blockers": 0.000883271552942663, "final evaluation": 0.0008472781190425757, "evaluation increased": 0.0009154687767183569, "period 1": 0.0006354585892819318, "toward enrollment": 0.0008658044569477526, "severe left": 0.0007327751786988557, "point including": 0.0008275557287880785, "including death": 0.0008275557287880785, "failure related": 0.0008275557287880785, "recent enrollment": 0.0008658044569477526, "enrollment period": 0.0008658044569477526, "period represented": 0.000883271552942663, "powerful independent": 0.0009154687767183569, "period 2": 0.0006354585892819318, "period 3": 0.0006354585892819318, "each period": 0.0007327751786988557, "% risk": 0.0005475455413516535, "risk reduction": 0.0008064721292221147, "reduction versus": 0.0008472781190425757, "reflecting marked": 0.0008658044569477526, "marked decreases": 0.0008472781190425757, "related mortality": 0.0008658044569477526, "based treatment": 0.0008275557287880785, "dramatic improvement": 0.0009154687767183569, "controlled randomized": 0.0009303786110524806, "real world": 0.0007036492469577129, "tailored follow": 0.0008275557287880785, "term continuity": 0.0008275557287880785, "indeterminable anaerobic": 0.0009711846008729415, "maximal cardiopulmonary": 0.0009581787663751352, "always identified": 0.0008658044569477526, "prognostic meaning": 0.000883271552942663, "prospectively followed": 0.0009445947084594995, "dedicated hf": 0.0007593650711122975, "stable clinical": 0.0008275557287880785, "clinical conditions": 0.0008997940083549217, "underwent clinical": 0.000883271552942663, "test investigations": 0.0008997940083549217, "study enrollment": 0.0008472781190425757, "excluded 921": 0.0007593650711122975, "maximal exercise": 0.0008472781190425757, "anaerobic metabolism": 0.0009154687767183569, "peak respiratory": 0.0008472781190425757, "respiratory quotient": 0.0009154687767183569, "quotient \u22641.05": 0.0008064721292221147, "urgent cardiac": 0.0008064721292221147, "multivariable logistic": 0.0009445947084594995, "logistic analysis": 0.0008658044569477526, "resulted significantly": 0.0009445947084594995, "reduced peak": 0.0007593650711122975, "higher metabolic": 0.0008472781190425757, "score value": 0.0007327751786988557, "powerful prognostic": 0.0008997940083549217, "prognostic composite": 0.0009154687767183569, "composite hf": 0.0007593650711122975, "multivariable analysis": 0.0009445947084594995, "% pred": 0.0005475455413516535, "ventilatory efficiency": 0.0009445947084594995, "efficiency slope": 0.0008472781190425757, "at nonidentification": 0.0009154687767183569, "prognosis also": 0.0008064721292221147, "secondary study": 0.0008275557287880785, "the inability": 0.0007838254010042559, "identify at": 0.0007327751786988557, "often occurs": 0.0007593650711122975, "prognostic role": 0.0008275557287880785, "failure mortality": 0.0008658044569477526, "joint associations": 0.000883271552942663, "associations among": 0.000883271552942663, "among cardiorespiratory": 0.0009581787663751352, "additive effect": 0.0008275557287880785, "increasing number": 0.0008658044569477526, "factors on": 0.0007036492469577129, "versus unfit": 0.0007593650711122975, "men without": 0.0007327751786988557, "disease underwent": 0.0008658044569477526, "baseline examination": 0.0009154687767183569, "measures included": 0.0008658044569477526, "included body": 0.0007838254010042559, "maximal treadmill": 0.0008658044569477526, "treadmill exercise": 0.000883271552942663, "specific low": 0.0007593650711122975, "high crf": 0.0006354585892819318, "deaths occurred": 0.0008275557287880785, "ratios across": 0.0007838254010042559, "across high": 0.0007327751786988557, "low crf": 0.0005946525994614709, "obese body": 0.0007036492469577129, "index categories": 0.0008472781190425757, "when grouped": 0.0007593650711122975, "fit compared": 0.0007593650711122975, "overweight body": 0.0008275557287880785, "index strata": 0.0007593650711122975, "obese men": 0.0006714520231820191, "within men": 0.0007036492469577129, "men matched": 0.0007327751786988557, "fit men": 0.0005946525994614709, "factors present": 0.0008275557287880785, "moderate level": 0.0008064721292221147, "presumably decreasing": 0.0009303786110524806, "mitochondrial energy": 0.0009154687767183569, "energy production": 0.0008658044569477526, "production precede": 0.000883271552942663, "overload hypertrophy": 0.0009154687767183569, "significant alterations": 0.0009581787663751352, "metabolism precede": 0.000883271552942663, "hypertrophied heart": 0.0008997940083549217, "hypertrophy secondary": 0.0009303786110524806, "abdominal aortic": 0.0008472781190425757, "energy substrate": 0.0008472781190425757, "substrate metabolism": 0.0009154687767183569, "isolated working": 0.0008472781190425757, "working hearts": 0.0008064721292221147, "hearts obtained": 0.0008275557287880785, "obtained 1": 0.0007036492469577129, "mice subjected": 0.0008064721292221147, "progressive development": 0.0009581787663751352, "vivo assessment": 0.0008275557287880785, "via echocardiography": 0.0009154687767183569, "demonstrated diastolic": 0.0009445947084594995, "dysfunction by": 0.0008064721292221147, "% ejection": 0.0007036492469577129, "marked cardiac": 0.0008064721292221147, "stimulated rates": 0.0008472781190425757, "glucose oxidation": 0.0008658044569477526, "membrane translocation": 0.0009445947084594995, "glucose transporter": 0.0008997940083549217, "transporter 4": 0.0007838254010042559, "overall atp": 0.0007327751786988557, "production rates": 0.0008472781190425757, "decreased at": 0.0007593650711122975, "mitochondrial oxidation": 0.0009581787663751352, "fatty acids": 0.0007327751786988557, "myocardial glycolysis": 0.0009303786110524806, "glycolysis rates": 0.0008472781190425757, "reduced mitochondrial": 0.0009303786110524806, "mitochondrial complex": 0.0009303786110524806, "complex v": 0.0006714520231820191, "v activity": 0.0007036492469577129, "the development": 0.0008275557287880785, "oxidative metabolism": 0.0009154687767183569, "early metabolic": 0.0008275557287880785, "metabolic changes": 0.0008658044569477526, "energy deficit": 0.0008064721292221147, "the reality": 0.0007327751786988557, "guide health": 0.0007593650711122975, "service planning": 0.0008472781190425757, "relevant health": 0.0008275557287880785, "service provision": 0.0008658044569477526, "provision related": 0.0008658044569477526, "well delineated": 0.0008275557287880785, "systematic search": 0.0008658044569477526, "reduced gross": 0.0007838254010042559, "gross income": 0.0007593650711122975, "expenditure on": 0.0008064721292221147, "heterogeneous region": 0.0009154687767183569, "factors of": 0.0007036492469577129, "nondeveloped countries": 0.0009445947084594995, "including lower": 0.0008275557287880785, "raised blood": 0.0007593650711122975, "blood glucose": 0.0007838254010042559, "glucose levels": 0.0008064721292221147, "systemic hypertension": 0.0009303786110524806, "main etiologies": 0.0008275557287880785, "alcohol related": 0.0008275557287880785, "the prognosis": 0.0007838254010042559, "main cause": 0.0007036492469577129, "awful paradox": 0.0007838254010042559, "added factors": 0.0007838254010042559, "lower gross": 0.0007327751786988557, "gross national": 0.0008064721292221147, "national income": 0.0008275557287880785, "income per": 0.0007036492469577129, "new strategies": 0.0008064721292221147, "previously linked": 0.0008658044569477526, "individuals aged": 0.0008472781190425757, "renal chloride": 0.0008064721292221147, "chloride channel": 0.0008472781190425757, "channel gene": 0.0007593650711122975, "the following": 0.0007838254010042559, "total cholesterol": 0.0008658044569477526, "novel finding": 0.0007838254010042559, "partly explain": 0.0008064721292221147, "reported greater": 0.0008472781190425757, "failure linked": 0.0008064721292221147, "requires confirmation": 0.0009303786110524806, "ambient air": 0.0007327751786988557, "recognised risk": 0.0008275557287880785, "important trigger": 0.0008658044569477526, "colleagues provide": 0.000883271552942663, "new systematic": 0.0008064721292221147, "common disorder": 0.0008275557287880785, "disorder associated": 0.0008997940083549217, "high morbidity": 0.0008064721292221147, "elderly people": 0.0008064721292221147, "pollution experienced": 0.0009303786110524806, "experienced in": 0.0008064721292221147, "industrial areas": 0.0008472781190425757, "aggravate cardiovascular": 0.0009711846008729415, "cardiac overexpression": 0.0009445947084594995, "exacerbates heart": 0.0008658044569477526, "key regulator": 0.0007838254010042559, "cytoskeletal actin": 0.000883271552942663, "actin dynamics": 0.0008064721292221147, "previously demonstrated": 0.0009581787663751352, "cardiac mena": 0.0007593650711122975, "deletion produced": 0.0008658044569477526, "produced cardiac": 0.0008472781190425757, "conduction abnormalities": 0.0009711846008729415, "expression correlates": 0.0009303786110524806, "precise role": 0.0007593650711122975, "cardiac pathophysiology": 0.0009581787663751352, "evaluated mice": 0.0008064721292221147, "cardiac myocyte": 0.0008275557287880785, "specific mena": 0.0007838254010042559, "cardiac pathology": 0.0008658044569477526, "morphologically comparable": 0.0009956449307649, "type littermates": 0.0008472781190425757, "mildly increased": 0.0008472781190425757, "increased heart": 0.0008275557287880785, "heart mass": 0.0007036492469577129, "transgenic mice": 0.0008275557287880785, "particularly susceptible": 0.0009711846008729415, "animals experienced": 0.0008997940083549217, "experienced pronounced": 0.0009445947084594995, "pronounced decreases": 0.0009154687767183569, "heart dilatation": 0.0008472781190425757, "levels eliminated": 0.0008658044569477526, "eliminated cardiac": 0.000883271552942663, "preclude post": 0.0007838254010042559, "- tac": 0.0004918297171970689, "tac cardiac": 0.0007327751786988557, "cardiac functional": 0.000883271552942663, "functional deterioration": 0.0009711846008729415, "findings indicate": 0.0008658044569477526, "increased levels": 0.0008472781190425757, "fare worse": 0.0007036492469577129, "mechanical support": 0.000883271552942663, "support devices": 0.0008275557287880785, "a cardiology": 0.0007593650711122975, "considerable number": 0.0008997940083549217, "patients eventually": 0.0008997940083549217, "eventually reach": 0.0008472781190425757, "diagnostic procedure": 0.0009154687767183569, "alternative treatments": 0.0009445947084594995, "slow progression": 0.0008472781190425757, "palliative care": 0.0008275557287880785, "accurate recognition": 0.0009154687767183569, "advanced disease": 0.0008472781190425757, "overall management": 0.000883271552942663, "failure requires": 0.0008472781190425757, "multiple disciplines": 0.0009154687767183569, "collaboration among": 0.0008997940083549217, "among cardiologists": 0.0008997940083549217, "cardiovascular surgeons": 0.0009581787663751352, "medical staff": 0.0007838254010042559, "staff responsible": 0.0008658044569477526, "patient care": 0.0007593650711122975, "physicians experienced": 0.0009445947084594995, "distributed evenly": 0.000883271552942663, "equitable access": 0.0008472781190425757, "made regarding": 0.0008064721292221147, "regarding appropriate": 0.0009303786110524806, "appropriate referrals": 0.0009303786110524806, "patient circulation": 0.0008997940083549217, "the aims": 0.0006354585892819318, "present consensus": 0.0008658044569477526, "consensus report": 0.0008472781190425757, "experienced centers": 0.0008997940083549217, "patients irrespective": 0.0009303786110524806, "disease phase": 0.0007838254010042559, "healthcare staff": 0.0008472781190425757, "raise awareness": 0.0008275557287880785, "provide information": 0.0008997940083549217, "information regarding": 0.0009303786110524806, "regarding conditions": 0.0009154687767183569, "other antihyperglycemic": 0.0009581787663751352, "recent postmarketing": 0.0009154687767183569, "postmarketing trials": 0.0009154687767183569, "trials produced": 0.0008275557287880785, "produced conflicting": 0.0009154687767183569, "conflicting results": 0.0008997940083549217, "hospitalized heart": 0.000883271552942663, "dipeptidyl peptidase-4": 0.0009445947084594995, "creating uncertainty": 0.0009154687767183569, "user cohort": 0.0007327751786988557, "health insurance": 0.0008472781190425757, "health system": 0.0007838254010042559, "system data": 0.0007327751786988557, "data partners": 0.0007838254010042559, "patients aged": 0.0007838254010042559, "aged 18": 0.0005946525994614709, "initiated therapy": 0.0008658044569477526, "generation sulfonylureas": 0.0009711846008729415, "acting insulin": 0.0008064721292221147, "insulin products": 0.0008472781190425757, "codes 402.x1": 0.0007593650711122975, "principal discharge": 0.0008997940083549217, "discharge diagnosis": 0.0008997940083549217, "saxagliptin users": 0.0008658044569477526, "sitagliptin users": 0.0008658044569477526, "users contributed": 0.0008658044569477526, "pairwise comparisons": 0.0009154687767183569, "study drugs": 0.0007327751786988557, "ratios from": 0.0007327751786988557, "disease risk": 0.0007593650711122975, "risk score": 0.0007036492469577129, "versus sitagliptin": 0.000883271552942663, "stratified hazard": 0.0008658044569477526, "matched analyses": 0.0008472781190425757, "also similar": 0.0007593650711122975, "without prior": 0.0007838254010042559, "prior cardiovascular": 0.0009154687767183569, "subgroup defined": 0.0008472781190425757, "highest drs": 0.0007327751786988557, "residual confounding": 0.0009154687767183569, "short follow": 0.0007593650711122975, "sitagliptin compared": 0.0009154687767183569, "selected antihyperglycemic": 0.0009956449307649, "improving physician": 0.0008997940083549217, "guideline recommendations": 0.0009836594343941379, "recommendations in": 0.000883271552942663, "review protocol": 0.0008275557287880785, "the uptake": 0.0007036492469577129, "uptake of": 0.0006714520231820191, "remains suboptimal": 0.000883271552942663, "identify implementation": 0.0009581787663751352, "improve physician": 0.0008658044569477526, "clear evidence": 0.0008064721292221147, "benefits outweigh": 0.0008658044569477526, "use american": 0.0007593650711122975, "literature search": 0.0008658044569477526, "include prospective": 0.0008997940083549217, "prospective studies": 0.0008997940083549217, "evaluating implementation": 0.0009836594343941379, "implementation interventions": 0.0010182916589827587, "interventions aimed": 0.0008997940083549217, "improving uptake": 0.0008472781190425757, "extract data": 0.0007593650711122975, "classify interventions": 0.0009445947084594995, "interventions according": 0.0009581787663751352, "systems level": 0.0007838254010042559, "common underlying": 0.0008658044569477526, "underlying characteristics": 0.0009956449307649, "financial incentives": 0.0009154687767183569, "include proportion": 0.000883271552942663, "recommended pharmacological": 0.001007178034773029, "device consideration": 0.0009154687767183569, "provided self": 0.0007838254010042559, "care education": 0.0008064721292221147, "provided left": 0.0007838254010042559, "function assessment": 0.0008997940083549217, "include clinical": 0.0008472781190425757, "common elements": 0.0008275557287880785, "failing interventions": 0.0009303786110524806, "contextual framework": 0.0009154687767183569, "results narratively": 0.0008997940083549217, "pool results": 0.0007593650711122975, "briefing reports": 0.0008472781190425757, "patient perceptions": 0.0008997940083549217, "qualitative study": 0.0008658044569477526, "determine patient": 0.0008658044569477526, "patient awareness": 0.0008658044569477526, "grounded theory": 0.0008275557287880785, "analyze interview": 0.0008658044569477526, "interview data": 0.0008064721292221147, "the sample": 0.0007036492469577129, "predominately male": 0.000883271552942663, "patients identified": 0.0008997940083549217, "identified three": 0.0008472781190425757, "felt implantable": 0.0008472781190425757, "significant deterioration": 0.0009836594343941379, "sound mind": 0.0007036492469577129, "engage in": 0.0006714520231820191, "patients wished": 0.0008275557287880785, "previously established": 0.0009445947084594995, "established preferences": 0.0009581787663751352, "most patients": 0.0007838254010042559, "consider deactivation": 0.0009303786110524806, "never turn": 0.0007036492469577129, "preferences identified": 0.0009445947084594995, "study support": 0.0007838254010042559, "include information": 0.0008997940083549217, "within broader": 0.0008064721292221147, "broader discussions": 0.0008997940083549217, "life treatment": 0.0008064721292221147, "treatment preferences": 0.0009303786110524806, "patients determine": 0.000883271552942663, "deactivation preferences": 0.0009711846008729415, "patients experiencing": 0.0009303786110524806, "experiencing distressing": 0.0009711846008729415, "distressing implantable": 0.0009581787663751352, "defibrillator shocks": 0.0009154687767183569, "carotid baroreflex": 0.000883271552942663, "baroreflex activation": 0.0009303786110524806, "activation therapy": 0.000883271552942663, "decreased parasympathetic": 0.0009836594343941379, "activity contribute": 0.0008997940083549217, "bat results": 0.0007327751786988557, "centrally mediated": 0.000883271552942663, "mediated reduction": 0.000883271552942663, "sympathetic outflow": 0.0008997940083549217, "increased parasympathetic": 0.0009836594343941379, "fractions <": 0.0007327751786988557, "chronic stable": 0.0008064721292221147, "stable guideline": 0.0008472781190425757, "directed medical": 0.0008472781190425757, "enrolled at": 0.0007327751786988557, "receive ongoing": 0.0008275557287880785, "gdmt alone": 0.0007036492469577129, "primary safety": 0.0008064721292221147, "safety end": 0.0007036492469577129, "related major": 0.0007838254010042559, "efficacy end": 0.0007593650711122975, "minute hall": 0.0007327751786988557, "hall walk": 0.0006714520231820191, "free rate": 0.0006714520231820191, "confidence bound": 0.0008472781190425757, "bound 91.4": 0.0007036492469577129, "patients assigned": 0.0008658044569477526, "group patients": 0.0008064721292221147, "experienced improvements": 0.0009711846008729415, "distance walked": 0.0008275557287880785, "\u00b1 13.2": 0.0005475455413516535, "points vs.": 0.0007036492469577129, "class ranking": 0.0007838254010042559, "bat significantly": 0.0008658044569477526, "reduced n": 0.0006714520231820191, "toward fewer": 0.0007593650711122975, "fewer days": 0.0007036492469577129, "days hospitalized": 0.0008658044569477526, "improves functional": 0.0008997940083549217, "failure hospitalizations": 0.0009711846008729415, "preliminary report": 0.000883271552942663, "using cardiopulmonary": 0.0009303786110524806, "testing guide": 0.0007838254010042559, "guide exercise": 0.0008064721292221147, "standard clinical": 0.0008658044569477526, "rare using": 0.0007036492469577129, "prescribe exercise": 0.000883271552942663, "performed symptom": 0.0008658044569477526, "symptom limited": 0.0008275557287880785, "limited maximal": 0.0008275557287880785, "maximal cpet": 0.0007593650711122975, "randomly divided": 0.0008472781190425757, "control without": 0.0008275557287880785, "exercise patients": 0.0008658044569477526, "patients used": 0.0007838254010042559, "used \u03b450%w": 0.0007036492469577129, "\u03b450%w intensity": 0.0008275557287880785, "exercise 30": 0.0007327751786988557, "x12 w.": 0.0005475455413516535, "w rehabilitation": 0.0008472781190425757, "evaluated functions": 0.0008997940083549217, "groups patients": 0.0008275557287880785, "exercise duration": 0.0008658044569477526, "distance 6": 0.0007036492469577129, "minutes walking": 0.0008275557287880785, "nosignificant changes": 0.0009303786110524806, "guiding exercise": 0.0008472781190425757, "failure affects": 0.0008275557287880785, "affects nearly": 0.0008064721292221147, "newer imaging": 0.0007838254010042559, "imaging techniques": 0.000883271552942663, "hfpef patients": 0.0008064721292221147, "completely normal": 0.0008658044569477526, "reduced long": 0.0007593650711122975, "long axis": 0.0006714520231820191, "axis function": 0.0007838254010042559, "subtle changes": 0.0008064721292221147, "older women": 0.0007327751786988557, "other cardiovascular": 0.0009154687767183569, "often nonspecific": 0.0008658044569477526, "primary symptoms": 0.0008472781190425757, "fluid retention": 0.0008275557287880785, "single diagnostic": 0.0008658044569477526, "diagnostic test": 0.0008275557287880785, "assessment remains": 0.000883271552942663, "thorough medical": 0.0008472781190425757, "medical history": 0.0008275557287880785, "the duration": 0.0007593650711122975, "classify patients": 0.0008658044569477526, "patients according": 0.000883271552942663, "functional assessment": 0.0009303786110524806, "standing blood": 0.0008064721292221147, "valvular disease": 0.0008472781190425757, "pulmonary congestion": 0.0009154687767183569, "jugular venous": 0.0008064721292221147, "peripheral oedema": 0.0008658044569477526, "oedema allows": 0.0007838254010042559, "allows assessment": 0.0008658044569477526, "volume status": 0.0007838254010042559, "failure nurses": 0.0008064721292221147, "local cardiology": 0.0008472781190425757, "cardiology services": 0.0008997940083549217, "reduce mortality": 0.0008472781190425757, "regular physical": 0.0008472781190425757, "activity controls": 0.0008658044569477526, "controls acquired": 0.0008658044569477526, "acquired cardiovascular": 0.0009581787663751352, "generally associated": 0.0009154687767183569, "exercise extend": 0.0008275557287880785, "extend well": 0.0007327751786988557, "cardiovascular system": 0.0009303786110524806, "recent evidence": 0.0008275557287880785, "exercise prevents": 0.0008658044569477526, "prevents cell": 0.0007838254010042559, "cell senescence": 0.0008275557287880785, "active individuals": 0.000883271552942663, "developing certain": 0.000883271552942663, "certain malignancies": 0.0009154687767183569, "malignancies including": 0.0009445947084594995, "including cancer": 0.0008472781190425757, "exercise regularly": 0.000883271552942663, "regularly extend": 0.0008472781190425757, "even lower": 0.0007036492469577129, "lower volumes": 0.0007838254010042559, "recommendations confer": 0.0009445947084594995, "confer health": 0.0007838254010042559, "health benefits": 0.0008275557287880785, "highly relevant": 0.0008275557287880785, "established cardiac": 0.0008997940083549217, "cardiac disease": 0.0008275557287880785, "disease including": 0.0008658044569477526, "including heart": 0.0008275557287880785, "rare with.estimates": 0.0008997940083549217, "with.estimates ranging": 0.0009445947084594995, "congenital abnormalities": 0.0009711846008729415, "nontraumatic death": 0.000883271552942663, "in middle": 0.0006714520231820191, "aged recreational": 0.0008658044569477526, "recreational athletes": 0.0009303786110524806, "cardiac deaths": 0.0008064721292221147, "deaths occur": 0.0007593650711122975, "advocate pre": 0.0007593650711122975, "- participation": 0.0008275557287880785, "participation screening": 0.0009581787663751352, "detect congenital": 0.0008658044569477526, "congenital accessory": 0.0009154687767183569, "accessory pathways": 0.000883271552942663, "ion channelopathies": 0.0008997940083549217, "frequently abnormal": 0.0008997940083549217, "older athletes": 0.0008064721292221147, "limited value": 0.0007838254010042559, "value given": 0.0007327751786988557, "overwhelming contribution": 0.0009836594343941379, "assisted training": 0.0008658044569477526, "training for": 0.0007593650711122975, "small pilot": 0.0007327751786988557, "assess robot": 0.0007593650711122975, "\u00ae system": 0.0006354585892819318, "% completed": 0.0007327751786988557, "week aerobic": 0.0007593650711122975, "aerobic training": 0.0008472781190425757, "training period": 0.0008275557287880785, "trainings per": 0.0007838254010042559, "integrated dynamic": 0.000883271552942663, "dynamic resistance": 0.000883271552942663, "lower limbs": 0.0007327751786988557, "underwent testing": 0.0008658044569477526, "combined training": 0.0008658044569477526, "training resulted": 0.0008658044569477526, "peak work": 0.0006714520231820191, "work rate": 0.0006714520231820191, "+ 61": 0.00042363905952128787, "oxygen pulse": 0.0007593650711122975, "+ 44": 0.00042363905952128787, "the quality": 0.0007327751786988557, "life assessment": 0.0008275557287880785, "assessment indicated": 0.0009154687767183569, "indicated better": 0.0008472781190425757, "better well": 0.0007327751786988557, "combined aerobic": 0.0008472781190425757, "training intervention": 0.0009303786110524806, "augmented feedback": 0.000883271552942663, "feedback resulted": 0.0008658044569477526, "muscle strength": 0.0008275557287880785, "larger studies": 0.0008064721292221147, "psychosocial factors": 0.0009154687767183569, "influence adherence": 0.0008997940083549217, "exercise adherence": 0.000883271552942663, "completed surveys": 0.0008658044569477526, "assess social": 0.0007838254010042559, "perceived social": 0.0008472781190425757, "support score": 0.0007838254010042559, "exercise score": 0.0008064721292221147, "indicated higher": 0.0008472781190425757, "higher levels": 0.0007838254010042559, "higher btes": 0.0007327751786988557, "btes indicated": 0.0008064721292221147, "months correlated": 0.0008658044569477526, "r= 0.13": 0.0005946525994614709, "higher exercise": 0.0008275557287880785, "time associated": 0.0008275557287880785, "for cardiovascular": 0.000883271552942663, "randomization group": 0.0008997940083549217, "borderline association": 0.0009445947084594995, "increasing btes": 0.0008275557287880785, "ratio 1.25": 0.0007036492469577129, "interval 0.99": 0.0007838254010042559, "care group": 0.0007036492469577129, "ratio 0.83": 0.0007036492469577129, "interval 0.66": 0.0007838254010042559, "poor social": 0.0007327751786988557, "high barriers": 0.0007838254010042559, "greater impact": 0.0008064721292221147, "training improves": 0.0008658044569477526, "perceived barriers": 0.000883271552942663, "facilitate individualized": 0.0009836594343941379, "individualized approaches": 0.0009836594343941379, "implement exercise": 0.000883271552942663, "training therapy": 0.0008472781190425757, "blocker hypo": 0.0007593650711122975, "hypo -": 0.0005475455413516535, "- response": 0.0007036492469577129, "blockers reduce": 0.0008275557287880785, "standardized exercise": 0.0009303786110524806, "exercise protocol": 0.0008658044569477526, "respiratory gas": 0.0008275557287880785, "gas analysis": 0.0007593650711122975, "patients participated": 0.0009303786110524806, "care programme": 0.0008064721292221147, "programme aiming": 0.0008472781190425757, "achieve guideline": 0.0008658044569477526, "target doses": 0.0007593650711122975, "hr<70 bpm": 0.0006714520231820191, "hr<70 versus": 0.0007593650711122975, "similar dose": 0.0007593650711122975, "significantly larger": 0.0009154687767183569, "larger hr": 0.0006714520231820191, "17\u00b122 versus": 0.0007593650711122975, "significantly higher": 0.0009154687767183569, "lower resting": 0.0007838254010042559, "in recent": 0.0006714520231820191, "controlled <": 0.0007593650711122975, "aggressive dose": 0.0008275557287880785, "many patients": 0.0007838254010042559, "little hr": 0.0006714520231820191, "unidirectional left": 0.0008997940083549217, "reduce elevated": 0.0008275557287880785, "elevated left": 0.0007838254010042559, "pressure improve": 0.0008472781190425757, "potential efficacy": 0.000883271552942663, "therapeutic left": 0.0008472781190425757, "aged \u226518": 0.0006354585892819318, "canadian special": 0.0008472781190425757, "special access": 0.0008064721292221147, "access programme": 0.0008472781190425757, "shunt implants": 0.0008064721292221147, "transseptal catheterisation": 0.001007178034773029, "transoesophageal echocardiographic": 0.0010776239867083966, "echocardiographic guidance": 0.0009956449307649, "general anaesthesia": 0.0008997940083549217, "echocardiography evaluations": 0.0010182916589827587, "months 1": 0.0006354585892819318, "shunt implantation": 0.000883271552942663, "enrolled ten": 0.0007593650711122975, "the device": 0.0007036492469577129, "successfully implanted": 0.0009445947084594995, "procedural adverse": 0.000883271552942663, "month showed": 0.0007593650711122975, "from baseline": 0.0007838254010042559, "recorded improvements": 0.0009303786110524806, "sd 6\u00b72": 0.0005475455413516535, "[ 12\u00b79": 0.0005475455413516535, "sd 9\u00b78": 0.0005475455413516535, "test distance": 0.0007838254010042559, "sd 112": 0.0005475455413516535, "pulmonary resistance": 0.0009154687767183569, "no patient": 0.0007036492469577129, "month 1": 0.0005946525994614709, "incessant ventricular": 0.0009303786110524806, "tachycardia storm": 0.0008658044569477526, "failure 2": 0.0006714520231820191, "months post": 0.0007327751786988557, "- procedure": 0.0007327751786988557, "man experience": 0.0008064721292221147, "implanted left": 0.0008064721292221147, "interatrial shunt": 0.0008658044569477526, "shunt demonstrates": 0.000883271552942663, "demonstrates initial": 0.0009154687767183569, "initial safety": 0.0008064721292221147, "early beneficial": 0.0008472781190425757, "beneficial clinical": 0.0008997940083549217, "haemodynamic outcomes": 0.0009303786110524806, "further large": 0.0007838254010042559, "scale randomised": 0.0008472781190425757, "randomised studies": 0.000883271552942663, "study paradigm": 0.0008064721292221147, "paradigm shift": 0.0008064721292221147, "crucial problem": 0.0008275557287880785, "current cardiology": 0.000883271552942663, "major development": 0.0008658044569477526, "first results": 0.0007838254010042559, "neprilysin inhibitors": 0.0009303786110524806, "considered hopeful": 0.000883271552942663, "dual inhibition": 0.0008275557287880785, "neprilysin blocks": 0.0008658044569477526, "blocks renin": 0.0007593650711122975, "concurrently supports": 0.0009303786110524806, "supports natural": 0.0008472781190425757, "natural vasodilatory": 0.0009154687767183569, "diuretic effect": 0.0008275557287880785, "scale prospective": 0.0008658044569477526, "prospective randomized": 0.0009445947084594995, "randomized multicenter": 0.0009445947084594995, "multicenter trial": 0.0008658044569477526, "trial paradigm": 0.0008064721292221147, "stabilized chronic": 0.000883271552942663, "elevated bnp": 0.0007593650711122975, "pro bnp": 0.0005946525994614709, "shown 20": 0.0006354585892819318, "group treated": 0.0007838254010042559, "consistent also": 0.0008275557287880785, "specified subgroup": 0.000883271552942663, "subgroup analyses": 0.0008658044569477526, "including quality": 0.0008658044569477526, "typical adverse": 0.0008275557287880785, "dual ras": 0.0006354585892819318, "neprilysin inhibition": 0.0009303786110524806, "time become": 0.0007327751786988557, "stable chronic": 0.0008064721292221147, "dysfunction treatment": 0.0009303786110524806, "significantly contributed": 0.0009836594343941379, "study sites": 0.0007327751786988557, "quality work": 0.0007593650711122975, "work provided": 0.0007838254010042559, "failure among": 0.0007838254010042559, "older persons": 0.0007838254010042559, "primary symptom": 0.0008275557287880785, "chronic hfpef": 0.0007838254010042559, "major determinant": 0.0008658044569477526, "reduced quality": 0.0008275557287880785, "factorial trial": 0.0008275557287880785, "trial conducted": 0.0008275557287880785, "urban academic": 0.0008064721292221147, "academic medical": 0.0008472781190425757, "medical center": 0.0008064721292221147, "initially screened": 0.000883271552942663, "screened participants": 0.0009303786110524806, "older obese": 0.0007327751786988557, "obese participants": 0.000883271552942663, "declined participation": 0.0009445947084594995, "attention control": 0.0008658044569477526, "control consisted": 0.0008658044569477526, "telephone calls": 0.0008275557287880785, "capacity measured": 0.0008658044569477526, "score range": 0.0007327751786988557, "higher scores": 0.0007838254010042559, "scores indicate": 0.0008275557287880785, "indicate worse": 0.0008064721292221147, "worse heart": 0.0007327751786988557, "enrolled participants": 0.0009303786110524806, "participants completed": 0.0009445947084594995, "exercise attendance": 0.0008997940083549217, "diet adherence": 0.0008064721292221147, "by main": 0.0005946525994614709, "main effects": 0.0007593650711122975, "effects analysis": 0.0008472781190425757, "kg body": 0.0005946525994614709, "the combination": 0.0008275557287880785, "joint effect": 0.0007593650711122975, "significant change": 0.000883271552942663, "total score": 0.0007327751786988557, "main effect": 0.0007327751786988557, "-1 unit": 0.0005946525994614709, "-6 units": 0.0006354585892819318, "positively correlated": 0.0009303786110524806, "percent lean": 0.0007593650711122975, "thigh muscle": 0.0007593650711122975, "intermuscular fat": 0.0008658044569477526, "fat ratio": 0.0006714520231820191, "related serious": 0.0008275557287880785, "serious adverse": 0.0008275557287880785, "weight decreased": 0.0008472781190425757, "among obese": 0.0007327751786988557, "clinically stable": 0.0008658044569477526, "training increased": 0.000883271552942663, "neither intervention": 0.0009154687767183569, "assist system": 0.0007838254010042559, "provide long": 0.0007593650711122975, "term support": 0.0007593650711122975, "centrifugal flow": 0.0008472781190425757, "flow pump": 0.0006714520231820191, "enhanced hemocompatibility": 0.0009956449307649, "levitated rotor": 0.0008275557287880785, "wide blood": 0.0007036492469577129, "flow paths": 0.0007036492469577129, "artificial pulse": 0.0008472781190425757, "multicenter study": 0.0008658044569477526, "support)-derived performance": 0.0010182916589827587, "fraction \u2264": 0.0007036492469577129, "without inotropes": 0.0008658044569477526, "optimal medical": 0.0008275557287880785, "the indications": 0.0008275557287880785, "patients continued": 0.000883271552942663, "% received": 0.0007036492469577129, "received transplants": 0.0009154687767183569, "% died": 0.0005475455413516535, "survival 92": 0.0007327751786988557, "% performance": 0.0007838254010042559, "levitated lvas": 0.0008064721292221147, "predicted survival": 0.000883271552942663, "key adverse": 0.0007327751786988557, "events included": 0.0008275557287880785, "included reoperation": 0.0009154687767183569, "driveline infection": 0.0008997940083549217, "debilitating stroke": 0.0008997940083549217, "pump exchanges": 0.0008064721292221147, "pump malfunctions": 0.0008658044569477526, "pump thrombosis": 0.0008275557287880785, "hemolysis events": 0.0008472781190425757, "life scores": 0.0007327751786988557, "scores showed": 0.0007838254010042559, "showed progressive": 0.000883271552942663, "sustained improvement": 0.0009303786110524806, "levitated centrifugal": 0.0009303786110524806, "flow chronic": 0.0007593650711122975, "favorable adverse": 0.0008658044569477526, "event profile": 0.0007838254010042559, "improved quality": 0.0008472781190425757, "a web": 0.0004918297171970689, "based program": 0.0007838254010042559, "program designed": 0.0008472781190425757, "influence medical": 0.0008658044569477526, "medical resource": 0.0008472781190425757, "adjusted survival": 0.0008658044569477526, "projecting long": 0.0008275557287880785, "term costs": 0.0007036492469577129, "valid approach": 0.0008064721292221147, "extrapolating short": 0.0008997940083549217, "based simulation": 0.0008472781190425757, "simulation tool": 0.0008275557287880785, "tool designed": 0.0007838254010042559, "integrate data": 0.0008064721292221147, "laboratory characteristics": 0.0009956449307649, "based medications": 0.0008658044569477526, "generate predicted": 0.000883271552942663, "predicted outcomes": 0.000883271552942663, "survival projections": 0.0009154687767183569, "modified seattle": 0.0008472781190425757, "modeled using": 0.0007838254010042559, "using relationships": 0.0008997940083549217, "evaluate parallel": 0.0008658044569477526, "study designs": 0.0007838254010042559, "hypothetical programs": 0.0009303786110524806, "simulations consist": 0.0008997940083549217, "virtual cohorts": 0.0008275557287880785, "cohorts used": 0.0007593650711122975, "generate estimates": 0.000883271552942663, "incremental cost": 0.0008472781190425757, "effectiveness ratios": 0.0009154687767183569, "user inputs": 0.0007327751786988557, "model demonstrated": 0.000883271552942663, "demonstrated acceptable": 0.0009581787663751352, "acceptable internal": 0.0008997940083549217, "external validity": 0.0008658044569477526, "replicating resource": 0.0009154687767183569, "survival estimates": 0.000883271552942663, "programs across": 0.0008275557287880785, "scenarios demonstrate": 0.0009303786110524806, "term improvements": 0.0008658044569477526, "based treatments": 0.0008472781190425757, "demonstrate good": 0.0008472781190425757, "good long": 0.0006714520231820191, "term value": 0.0007036492469577129, "provides researchers": 0.0009154687767183569, "conducting long": 0.0008275557287880785, "term cost": 0.0006714520231820191, "effectiveness analyses": 0.0009445947084594995, "debilitating chronic": 0.0009154687767183569, "upcoming years": 0.0008064721292221147, "years due": 0.0006714520231820191, "demographic changes": 0.0008997940083549217, "essential role": 0.0008064721292221147, "supporting patients": 0.0008997940083549217, "nursing interventions": 0.0009303786110524806, "nursing actions": 0.0008275557287880785, "enhancing medical": 0.0008658044569477526, "pathophysiologic state": 0.0009445947084594995, "ultimately reduce": 0.0008658044569477526, "optimize quality": 0.0008472781190425757, "safety for": 0.00035182462347885647, "rates between": 0.00039191270050212794, "sample with": 0.00036638758934942785, "translating to": 0.00040323606461105735, "averted in": 0.00035182462347885647, "improvements for": 0.00042363905952128787, "admitted with": 0.00039191270050212794, "ulcers in": 0.00033572601159100957, "tissue in": 0.00033572601159100957, "respect to": 0.00035182462347885647, "composition in": 0.00040323606461105735, "composition with": 0.00042363905952128787, "regard to": 0.00033572601159100957, "biomarkers of": 0.00039191270050212794, "observed between": 0.00042363905952128787, "correlation to": 0.00040323606461105735, "adiponectin at": 0.00040323606461105735, "correlate to": 0.00037968253555614875, "adiponectin during": 0.0004416357764713315, "weight in": 0.00033572601159100957, "prognosis is": 0.00037968253555614875, "guideline from": 0.00040323606461105735, "deficiency in": 0.00039191270050212794, "literature in": 0.00039191270050212794, "language on": 0.00036638758934942785, "deficiency from": 0.00041377786439403925, "reassessed in": 0.00039191270050212794, "audience for": 0.00037968253555614875, "threshold of": 0.00037968253555614875, "recommends against": 0.0004416357764713315, "harms of": 0.0003177292946409659, "transfusions in": 0.00041377786439403925, "confounded by": 0.00039191270050212794, "effects are": 0.00036638758934942785, "conditioning for": 0.00042363905952128787, "stemming from": 0.00039191270050212794, "made in": 0.00029732629973073545, "resort to": 0.00033572601159100957, "search for": 0.00035182462347885647, "deal with": 0.00033572601159100957, "comments on": 0.00036638758934942785, "department in": 0.00039191270050212794, "categorization in": 0.0004329022284738763, "single most": 0.00036638758934942785, "stratification is": 0.0004329022284738763, "evaluated before": 0.00042363905952128787, "searched in": 0.00036638758934942785, "predictors on": 0.00039191270050212794, "estimates was": 0.00039191270050212794, "predictors in": 0.00039191270050212794, "shocks during": 0.00039191270050212794, "sex were": 0.0003177292946409659, "study other": 0.00036638758934942785, "nesiritide in": 0.00039191270050212794, "hours of": 0.0003177292946409659, "occurred from": 0.00039191270050212794, "sites in": 0.0003177292946409659, "c from": 0.00027377277067582674, "enrollment to": 0.00039191270050212794, "dopamine had": 0.00037968253555614875, "nesiritide had": 0.00040323606461105735, "nesiritide on": 0.00039191270050212794, "participants with": 0.0004329022284738763, "function when": 0.00039191270050212794, "adoption of": 0.00036638758934942785, "lessons for": 0.00036638758934942785, "reveal how": 0.00035182462347885647, "conversations with": 0.0004416357764713315, "involvement in": 0.00040323606461105735, "proteomics of": 0.00039191270050212794, "nucleolin as": 0.00037968253555614875, "accessibility on": 0.00042363905952128787, "structure by": 0.00037968253555614875, "mechanisms by": 0.00039191270050212794, "abundance during": 0.00042363905952128787, "proteins in": 0.00036638758934942785, "expression during": 0.0004329022284738763, "characterization of": 0.00044989700417746083, "surprisingly had": 0.00042363905952128787, "defects in": 0.00035182462347885647, "shift to": 0.0003177292946409659, "subproteome in": 0.00040323606461105735, "system of": 0.00033572601159100957, "shared between": 0.00040323606461105735, "interventions during": 0.0004577343883591784, "predictors for": 0.00040323606461105735, "pattern on": 0.00035182462347885647, "attenuated after": 0.00042363905952128787, "ies in": 0.00027377277067582674, "evident only": 0.00037968253555614875, "mortality between": 0.0004329022284738763, "attenuated in": 0.00039191270050212794, "process of": 0.00035182462347885647, "measurements of": 0.00041377786439403925, "months for": 0.00035182462347885647, "min in": 0.00027377277067582674, "relations between": 0.0004329022284738763, "basis for": 0.00033572601159100957, "requires further": 0.00042363905952128787, "applications of": 0.00041377786439403925, "remaining in": 0.00037968253555614875, "correlations between": 0.0004577343883591784, "remained when": 0.00039191270050212794, "modest when": 0.00036638758934942785, "placed on": 0.00033572601159100957, "monitoring after": 0.00042363905952128787, "readmission to": 0.00040323606461105735, "strategies have": 0.00041377786439403925, "needs of": 0.0003177292946409659, "searched to": 0.00036638758934942785, "exclusion of": 0.00037968253555614875, "observed with": 0.00039191270050212794, "investigation of": 0.00042363905952128787, "participation of": 0.00042363905952128787, "apoptosis during": 0.00042363905952128787, "expressions of": 0.00040323606461105735, "dogs during": 0.00036638758934942785, "fragmentation by": 0.00042363905952128787, "method from": 0.00036638758934942785, "dogs only": 0.00033572601159100957, "band of": 0.00029732629973073545, "numbers of": 0.00035182462347885647, "detected in": 0.00036638758934942785, "favour of": 0.00033572601159100957, "pathogenesis of": 0.00041377786439403925, "attributed to": 0.00039191270050212794, "become more": 0.00036638758934942785, "dysfunction is": 0.00040323606461105735, "requirements were": 0.0004329022284738763, "blockers at": 0.00036638758934942785, "uptitration after": 0.0004329022284738763, "uptitrations in": 0.00041377786439403925, "hfpef with": 0.00035182462347885647, "spironolactone more": 0.00044989700417746083, "correction for": 0.00040323606461105735, "uptitration of": 0.00040323606461105735, "blockers after": 0.00040323606461105735, "associations with": 0.0004329022284738763, "levels between": 0.00040323606461105735, "significance of": 0.00041377786439403925, "relates to": 0.00035182462347885647, "patients above": 0.00040323606461105735, "level had": 0.00033572601159100957, "guidelines for": 0.00040323606461105735, "practitioners in": 0.00042363905952128787, "application in": 0.00040323606461105735, "article by": 0.00035182462347885647, "evaluated how": 0.00039191270050212794, "impairment at": 0.00039191270050212794, "documented by": 0.00039191270050212794, "physician at": 0.00037968253555614875, "impairment with": 0.00041377786439403925, "intubations for": 0.00041377786439403925, "hypothesize that": 0.00042363905952128787, "seen by": 0.00029732629973073545, "physicians in": 0.00039191270050212794, "visits in": 0.00033572601159100957, "visits for": 0.00035182462347885647, "catheterization from": 0.0004577343883591784, "catheterization during": 0.00047229735422974975, "dyn s": 0.00024591485859853446, "circulation had": 0.00041377786439403925, "derangement with": 0.00042363905952128787, "counseling on": 0.00039191270050212794, "indicators of": 0.00039191270050212794, "therapy were": 0.00037968253555614875, "pathways in": 0.00036638758934942785, "incubated with": 0.00040323606461105735, "phosphorylation of": 0.0004416357764713315, "production by": 0.00039191270050212794, "proteome of": 0.00036638758934942785, "profiled by": 0.00036638758934942785, "incubation of": 0.00039191270050212794, "production of": 0.00039191270050212794, "bound to": 0.0003177292946409659, "improvement by": 0.00040323606461105735, "mechanism how": 0.00039191270050212794, "testing for": 0.00036638758934942785, "survival from": 0.00039191270050212794, "inclusion through": 0.0004329022284738763, "point for": 0.00033572601159100957, "survival at": 0.00036638758934942785, "levels at": 0.00033572601159100957, "survival had": 0.00037968253555614875, "disease by": 0.00035182462347885647, "uninephrectomy with": 0.00044989700417746083, "parameters between": 0.0004416357764713315, "weight with": 0.00036638758934942785, "upregulated in": 0.00040323606461105735, "uninephrectomy to": 0.0004329022284738763, "incidence over": 0.00040323606461105735, "measured with": 0.00039191270050212794, "prediction in": 0.00039191270050212794, "incorporated in": 0.00041377786439403925, "device with": 0.00036638758934942785, "insertion of": 0.00037968253555614875, "support after": 0.00039191270050212794, "insertion are": 0.00039191270050212794, "shock after": 0.00036638758934942785, "conjunction with": 0.00042363905952128787, "examined from": 0.00039191270050212794, "support at": 0.00035182462347885647, "survival to": 0.00036638758934942785, "outcome at": 0.00035182462347885647, "year when": 0.00033572601159100957, "eligibility for": 0.00041377786439403925, "transplantation be": 0.0004416357764713315, "requirement for": 0.00041377786439403925, "failure as": 0.00035182462347885647, "limited to": 0.00035182462347885647, "complications after": 0.00044989700417746083, "implantation are": 0.00042363905952128787, "limits in": 0.00033572601159100957, "practice for": 0.00037968253555614875, "budget are": 0.00035182462347885647, "limitations in": 0.00040323606461105735, "point to": 0.0003177292946409659, "pacing on": 0.00033572601159100957, "strain in": 0.00033572601159100957, "bivp during": 0.00036638758934942785, "taken at": 0.0003177292946409659, "taken of": 0.0003177292946409659, "setting for": 0.00036638758934942785, "correlated against": 0.0004416357764713315, "rvpo with": 0.00033572601159100957, "analyzed by": 0.00036638758934942785, "surrogates for": 0.00040323606461105735, "mechanism in": 0.00037968253555614875, "correlation of": 0.00040323606461105735, "reported that": 0.00039191270050212794, "reduction for": 0.00039191270050212794, "improve such": 0.00037968253555614875, "man had": 0.00029732629973073545, "prolapse of": 0.00036638758934942785, "valve in": 0.0003177292946409659, "sound in": 0.0003177292946409659, "prolapse with": 0.00039191270050212794, "annuloplasty with": 0.0004329022284738763, "opening with": 0.00037968253555614875, "obtained by": 0.00036638758934942785, "flow by": 0.00029732629973073545, "hypertension of": 0.00041377786439403925, "systolic as": 0.00036638758934942785, "indication for": 0.00040323606461105735, "possibility of": 0.00040323606461105735, "improve after": 0.00039191270050212794, "considered because": 0.0004416357764713315, "respond to": 0.00035182462347885647, "hypertension with": 0.0004329022284738763, "symptom as": 0.00035182462347885647, "disappeared with": 0.00042363905952128787, "pressure to": 0.00036638758934942785, "disappearance of": 0.00042363905952128787, "opening to": 0.00035182462347885647, "surgery by": 0.00035182462347885647, "observation at": 0.00040323606461105735, "findings of": 0.00036638758934942785, "restriction of": 0.00040323606461105735, "motion by": 0.00033572601159100957, "regurgitation as": 0.00042363905952128787, "disappeared after": 0.0004329022284738763, "reversed to": 0.00036638758934942785, "suggested that": 0.00040323606461105735, "opposed to": 0.00035182462347885647, "demonstrates that": 0.0004329022284738763, "stratification for": 0.0004416357764713315, "months from": 0.00036638758934942785, "date for": 0.0003177292946409659, "statistics in": 0.00039191270050212794, "grouped by": 0.00035182462347885647, "models for": 0.00035182462347885647, "fraction was": 0.00037968253555614875, "egfr was": 0.0003177292946409659, "epidemic of": 0.00036638758934942785, "patients into": 0.00039191270050212794, "associations between": 0.0004577343883591784, "differences between": 0.00044989700417746083, "tested with": 0.00036638758934942785, "curves for": 0.00035182462347885647, "class in": 0.0003177292946409659, "p=0.27 for": 0.00035182462347885647, "rates by": 0.0003177292946409659, "interaction by": 0.00040323606461105735, "establishment of": 0.00042363905952128787, "responsiveness to": 0.0004329022284738763, "concentrations of": 0.0004329022284738763, "examined in": 0.00036638758934942785, "bb at": 0.00024591485859853446, "obtained during": 0.00041377786439403925, "examined as": 0.00036638758934942785, "cogeneration of": 0.00041377786439403925, "report on": 0.00033572601159100957, "hearts in": 0.00033572601159100957, "shortening by": 0.00039191270050212794, "transient only": 0.00040323606461105735, "myocytes from": 0.00039191270050212794, "fraction from": 0.00039191270050212794, "index by": 0.0003177292946409659, "usefulness in": 0.00039191270050212794, "response after": 0.00040323606461105735, "measurements in": 0.00041377786439403925, "echocardiography before": 0.0004790893831875676, "echocardiograms at": 0.0004416357764713315, "hospitalization during": 0.00047229735422974975, "remodeling with": 0.00041377786439403925, "sensitivity of": 0.00040323606461105735, "specificity of": 0.00040323606461105735, "spironolactone for": 0.0004416357764713315, "shown in": 0.0003177292946409659, "use from": 0.0003177292946409659, "regression with": 0.00041377786439403925, "injury during": 0.00039191270050212794, "cohort with": 0.00036638758934942785, "risks of": 0.0003177292946409659, "perfusion by": 0.00037968253555614875, "neoangiogenesis in": 0.0004416357764713315, "weeks from": 0.00035182462347885647, "observed by": 0.00036638758934942785, "injected with": 0.00039191270050212794, "start of": 0.0003177292946409659, "perfusion in": 0.00037968253555614875, "b on": 0.00021181952976064393, "eds between": 0.00036638758934942785, "eds had": 0.00029732629973073545, "visit in": 0.0003177292946409659, "hospitalized at": 0.00041377786439403925, "required at": 0.00036638758934942785, "myocytes with": 0.00039191270050212794, "velocity of": 0.00036638758934942785, "paralleled by": 0.00039191270050212794, "attenuation in": 0.00040323606461105735, "imaging for": 0.00036638758934942785, "velocity over": 0.00039191270050212794, "reliability in": 0.00040323606461105735, "echocardiography with": 0.0004651893055262403, "velocities during": 0.0004329022284738763, "correlated more": 0.00041377786439403925, "aucs of": 0.00029732629973073545, "vary with": 0.00033572601159100957, "cutoff of": 0.00033572601159100957, "performance only": 0.00042363905952128787, "s'lateral of": 0.00037968253555614875, "performance for": 0.00041377786439403925, "relationship in": 0.00041377786439403925, "two- to": 0.00029732629973073545, "risk when": 0.00033572601159100957, "generated by": 0.00037968253555614875, "tracked for": 0.00036638758934942785, "presenting with": 0.00041377786439403925, "retained in": 0.00036638758934942785, "nonsurvivors with": 0.0004329022284738763, "distribution in": 0.00041377786439403925, "relationship as": 0.00041377786439403925, "affected by": 0.00036638758934942785, "coated with": 0.00036638758934942785, "formed in": 0.00033572601159100957, "ischemia after": 0.00040323606461105735, "covering over": 0.00039191270050212794, "stenting with": 0.00039191270050212794, "stent in": 0.0003177292946409659, "ivabradine in": 0.00039191270050212794, "calculated at": 0.00039191270050212794, "unloading of": 0.00037968253555614875, "levels to": 0.00033572601159100957, "hypoalbuminemia with": 0.0004577343883591784, "implantation from": 0.0004329022284738763, "surgery was": 0.00036638758934942785, "hypoalbuminemia before": 0.00047229735422974975, "prognosis after": 0.00041377786439403925, "correction of": 0.00039191270050212794, "insufficiency after": 0.00044989700417746083, "encountered after": 0.0004329022284738763, "seems more": 0.00035182462347885647, "algorithms for": 0.00040323606461105735, "examined for": 0.00037968253555614875, "sternotomy for": 0.00040323606461105735, "revision by": 0.00036638758934942785, "replacement is": 0.00040323606461105735, "capacity for": 0.00037968253555614875, "alternatives to": 0.00041377786439403925, "categorized into": 0.00042363905952128787, "adhere to": 0.00033572601159100957, "nonadherence in": 0.00041377786439403925, "mortality was": 0.00039191270050212794, "life was": 0.0003177292946409659, "walking in": 0.00035182462347885647, "care on": 0.00029732629973073545, "week for": 0.0003177292946409659, "travelled during": 0.00042363905952128787, "time in": 0.00029732629973073545, "leads to": 0.0003177292946409659, "obtained at": 0.00036638758934942785, "measured from": 0.00039191270050212794, "indices were": 0.00037968253555614875, "factors at": 0.00035182462347885647, "confirmed in": 0.00037968253555614875, "complicated by": 0.00040323606461105735, "revealed by": 0.00036638758934942785, "embolize to": 0.00036638758934942785, "embolism to": 0.00036638758934942785, "presented with": 0.00040323606461105735, "prolapse through": 0.00042363905952128787, "patient had": 0.00036638758934942785, "coefficients from": 0.0004329022284738763, "sample from": 0.00036638758934942785, "trial with": 0.00035182462347885647, "limits of": 0.00033572601159100957, "information to": 0.00040323606461105735, "values of": 0.00033572601159100957, "practice with": 0.00039191270050212794, "switched to": 0.00036638758934942785, "compared in": 0.00036638758934942785, "stratified by": 0.00039191270050212794, "antagonist with": 0.00041377786439403925, "hr for": 0.00027377277067582674, "life for": 0.0003177292946409659, "people with": 0.00036638758934942785, "disease such": 0.00037968253555614875, "participation in": 0.00042363905952128787, "programme for": 0.00039191270050212794, "sustainability of": 0.0004329022284738763, "improvements with": 0.0004329022284738763, "met in": 0.00027377277067582674, "relation to": 0.00036638758934942785, "sustainability with": 0.00044989700417746083, "commissioning of": 0.00042363905952128787, "programmes on": 0.00039191270050212794, "frailty on": 0.00035182462347885647, "risk after": 0.00035182462347885647, "significant when": 0.00042363905952128787, "controlled for": 0.00040323606461105735, "death as": 0.0003177292946409659, "disease at": 0.00035182462347885647, "scores to": 0.00033572601159100957, "vasopressin in": 0.00040323606461105735, "interruption of": 0.00041377786439403925, "inhibitors of": 0.00039191270050212794, "secretion of": 0.00037968253555614875, "processes in": 0.00037968253555614875, "therapy is": 0.00035182462347885647, "reactivation of": 0.00041377786439403925, "report that": 0.00036638758934942785, "known as": 0.0003177292946409659, "resistance to": 0.00039191270050212794, "mir-25 by": 0.00033572601159100957, "myocardium to": 0.00039191270050212794, "reveal that": 0.00036638758934942785, "integrate with": 0.00040323606461105735, "myocardium with": 0.00041377786439403925, "subjects over": 0.00039191270050212794, "base of": 0.00029732629973073545, "blockade of": 0.00036638758934942785, "blockers in": 0.00036638758934942785, "neglected for": 0.00039191270050212794, "time from": 0.00033572601159100957, "bisoprolol in": 0.00039191270050212794, "controlled by": 0.00039191270050212794, "diabetes to": 0.00036638758934942785, "features of": 0.00036638758934942785, "action through": 0.00040323606461105735, "registry from": 0.00039191270050212794, "determined for": 0.00040323606461105735, "differ at": 0.00033572601159100957, "medications for": 0.00041377786439403925, "trastuzumab in": 0.00040323606461105735, "manifested as": 0.00039191270050212794, "diagnosed with": 0.00040323606461105735, "cancer between": 0.00040323606461105735, "plays in": 0.0003177292946409659, "patterns with": 0.00039191270050212794, "scores with": 0.00036638758934942785, "hospitalization through": 0.0004790893831875676, "contact before": 0.00040323606461105735, "calculated from": 0.00041377786439403925, "also be": 0.00029732629973073545, "identified as": 0.00039191270050212794, "biomarker in": 0.00037968253555614875, "risk as": 0.00029732629973073545, "pool by": 0.00029732629973073545, "paucity of": 0.00035182462347885647, "outcomes with": 0.00039191270050212794, "survival between": 0.00042363905952128787, "assignment to": 0.00039191270050212794, "determinants of": 0.00041377786439403925, "visits as": 0.00033572601159100957, "readmissions as": 0.00041377786439403925, "assessments of": 0.00040323606461105735, "needs at": 0.0003177292946409659, "discharges at": 0.00039191270050212794, "rate after": 0.00035182462347885647, "years in": 0.0003177292946409659, "% having": 0.0003177292946409659, "% after": 0.00029732629973073545, "discrepancy between": 0.00044989700417746083, "often had": 0.00033572601159100957, "changes at": 0.00035182462347885647, "times below": 0.00036638758934942785, "rest of": 0.00029732629973073545, "matrix of": 0.00033572601159100957, "quantified by": 0.00039191270050212794, "biomarker for": 0.00039191270050212794, "compliance in": 0.00039191270050212794, "cohort as": 0.00033572601159100957, "year for": 0.0003177292946409659, "choice of": 0.00033572601159100957, "treatment had": 0.00039191270050212794, "determined by": 0.00039191270050212794, "trend for": 0.00033572601159100957, "response with": 0.00039191270050212794, "prolonged with": 0.00040323606461105735, "comorbidities in": 0.00042363905952128787, "importance for": 0.00040323606461105735, "dd of": 0.00024591485859853446, "rats after": 0.00035182462347885647, "development at": 0.00040323606461105735, "weeks with": 0.00035182462347885647, "assessed at": 0.00036638758934942785, "obtained in": 0.00036638758934942785, "strips before": 0.00039191270050212794, "matrix to": 0.00033572601159100957, "groups were": 0.00036638758934942785, "fraction during": 0.00041377786439403925, "strain as": 0.00033572601159100957, "relationship with": 0.0004329022284738763, "cardiology in": 0.00039191270050212794, "method for": 0.00035182462347885647, "hospitalisation for": 0.00044989700417746083, "failure during": 0.00040323606461105735, "benefit in": 0.00035182462347885647, "benefit over": 0.00037968253555614875, "reviewed by": 0.00036638758934942785, "duration is": 0.00036638758934942785, "benefit when": 0.00037968253555614875, "needs further": 0.00039191270050212794, "overload in": 0.00036638758934942785, "benefit with": 0.00037968253555614875, "complications of": 0.00042363905952128787, "management between": 0.0004416357764713315, "evaluated with": 0.00040323606461105735, "hospitalization from": 0.0004577343883591784, "stay from": 0.00033572601159100957, "institution of": 0.00040323606461105735, "option in": 0.00033572601159100957, "consequences of": 0.00041377786439403925, "deferred in": 0.00036638758934942785, "matching for": 0.00037968253555614875, "improvements of": 0.00041377786439403925, "improvement after": 0.0004329022284738763, "function with": 0.00039191270050212794, "constants through": 0.0004329022284738763, "treated for": 0.00036638758934942785, "mediator of": 0.00036638758934942785, "severity of": 0.00036638758934942785, "transgenic for": 0.00040323606461105735, "months in": 0.00033572601159100957, "elevation in": 0.00037968253555614875, "biomarker of": 0.00037968253555614875, "contribute in": 0.00039191270050212794, "results further": 0.00041377786439403925, "resistin as": 0.00036638758934942785, "ablation of": 0.00036638758934942785, "fibrillation in": 0.00041377786439403925, "deterioration of": 0.00042363905952128787, "probability after": 0.0004329022284738763, "relating to": 0.00036638758934942785, "diastole with": 0.00039191270050212794, "improved only": 0.00039191270050212794, "rhythm at": 0.00033572601159100957, "pharmaceuticals in": 0.0004416357764713315, "ablation in": 0.00036638758934942785, "agent in": 0.0003177292946409659, "investigated on": 0.00041377786439403925, "h after": 0.00029732629973073545, "excised for": 0.00036638758934942785, "estimation of": 0.00039191270050212794, "contents in": 0.00036638758934942785, "decrement of": 0.00037968253555614875, "contents by": 0.00036638758934942785, "interfere with": 0.00040323606461105735, "doxorubicin against": 0.00044989700417746083, "growth of": 0.00033572601159100957, "rats as": 0.00029732629973073545, "relation between": 0.00042363905952128787, "infarction after": 0.00042363905952128787, "system for": 0.00035182462347885647, "cabg from": 0.00033572601159100957, "rehospitalization for": 0.0004651893055262403, "ratios with": 0.00036638758934942785, "intervals for": 0.00039191270050212794, "events after": 0.00037968253555614875, "stroke was": 0.00035182462347885647, "introduced into": 0.00041377786439403925, "events during": 0.00039191270050212794, "burden in": 0.00033572601159100957, "transplants in": 0.00040323606461105735, "expand on": 0.00033572601159100957, "subgroup of": 0.00036638758934942785, "aetiologies in": 0.00040323606461105735, "topics of": 0.00033572601159100957, "debate in": 0.00033572601159100957, "investigations for": 0.0004416357764713315, "responses to": 0.00037968253555614875, "scaffolds in": 0.00037968253555614875, "adaptation of": 0.00039191270050212794, "myocardium in": 0.00039191270050212794, "workload during": 0.00041377786439403925, "adaptation to": 0.00039191270050212794, "complex where": 0.00039191270050212794, "assembly of": 0.00036638758934942785, "kinases into": 0.00037968253555614875, "remodelling is": 0.00040323606461105735, "field of": 0.0003177292946409659, "investigation for": 0.0004329022284738763, "deals with": 0.00035182462347885647, "ischemia with": 0.00039191270050212794, "made at": 0.00029732629973073545, "frailty in": 0.00035182462347885647, "accumulation of": 0.00041377786439403925, "method has": 0.00035182462347885647, "residents with": 0.00040323606461105735, "lb in": 0.00024591485859853446, "phenotype had": 0.00039191270050212794, "ascertained from": 0.00042363905952128787, "learning from": 0.00039191270050212794, "disappointments in": 0.0004416357764713315, "antagonists of": 0.00040323606461105735, "management for": 0.00040323606461105735, "learned from": 0.00037968253555614875, "trials in": 0.00033572601159100957, "success in": 0.00035182462347885647, "peptides at": 0.00036638758934942785, "tool in": 0.00029732629973073545, "mixed on": 0.0003177292946409659, "like other": 0.00035182462347885647, "measured at": 0.00036638758934942785, "status of": 0.00033572601159100957, "nps to": 0.00027377277067582674, "delivery in": 0.00036638758934942785, "systems for": 0.00036638758934942785, "frame of": 0.0003177292946409659, "consultation in": 0.00041377786439403925, "disposition of": 0.00040323606461105735, "provided by": 0.00036638758934942785, "care by": 0.00029732629973073545, "outcomes through": 0.00042363905952128787, "penalties for": 0.00039191270050212794, "conditions such": 0.00041377786439403925, "expansion to": 0.00037968253555614875, "remodelling of": 0.00040323606461105735, "reporting in": 0.00037968253555614875, "prevention of": 0.00039191270050212794, "converges on": 0.00037968253555614875, "occur through": 0.00039191270050212794, "interplay between": 0.0004329022284738763, "bets from": 0.00033572601159100957, "suppression of": 0.00040323606461105735, "signalling to": 0.00039191270050212794, "hypertrophy of": 0.00040323606461105735, "achieved through": 0.00042363905952128787, "profiling of": 0.00037968253555614875, "experiments of": 0.00040323606461105735, "induced in": 0.00035182462347885647, "method of": 0.00033572601159100957, "protected against": 0.0004329022284738763, "targets of": 0.00035182462347885647, "transduction to": 0.00041377786439403925, "factor of": 0.00033572601159100957, "thereby re": 0.00035182462347885647, "readers in": 0.00035182462347885647, "manipulation of": 0.00041377786439403925, "targeting of": 0.00037968253555614875, "mri during": 0.00035182462347885647, "respiration for": 0.00041377786439403925, "quantification of": 0.0004329022284738763, "t1 in": 0.00024591485859853446, "swine with": 0.00035182462347885647, "implanted with": 0.00040323606461105735, "paced at": 0.0003177292946409659, "performed during": 0.00042363905952128787, "respiration before": 0.0004416357764713315, "minutes after": 0.00039191270050212794, "fibrosis of": 0.00036638758934942785, "values before": 0.00039191270050212794, "also had": 0.0003177292946409659, "detected by": 0.00036638758934942785, "technique for": 0.00039191270050212794, "relevance of": 0.00037968253555614875, "increase by": 0.00036638758934942785, "echocardiography as": 0.00044989700417746083, "classified into": 0.00041377786439403925, "increase above": 0.00040323606461105735, "patients were": 0.00039191270050212794, "increase during": 0.00041377786439403925, "assessment in": 0.00039191270050212794, "devices in": 0.00035182462347885647, "cornerstone of": 0.00040323606461105735, "collected in": 0.00037968253555614875, "features such": 0.00039191270050212794, "detection of": 0.00037968253555614875, "portion of": 0.00035182462347885647, "achieved in": 0.00036638758934942785, "current in": 0.00035182462347885647, "splicing of": 0.00036638758934942785, "trapped in": 0.00035182462347885647, "exposed to": 0.00035182462347885647, "activators of": 0.00039191270050212794, "induced to": 0.00035182462347885647, "variants with": 0.00039191270050212794, "resulting from": 0.00040323606461105735, "initiated by": 0.00037968253555614875, "effect is": 0.00033572601159100957, "genes in": 0.0003177292946409659, "encountered in": 0.00040323606461105735, "concentrating on": 0.00042363905952128787, "populations of": 0.00040323606461105735, "management in": 0.00039191270050212794, "group with": 0.00035182462347885647, "fraction after": 0.00040323606461105735, "distinguish between": 0.00044989700417746083, "residents of": 0.00037968253555614875, "diagnosed in": 0.00037968253555614875, "days to": 0.00029732629973073545, "observed for": 0.00037968253555614875, "mix of": 0.00027377277067582674, "hemostasis in": 0.00039191270050212794, "response in": 0.00036638758934942785, "activity by": 0.00036638758934942785, "imaging when": 0.00037968253555614875, "serve as": 0.0003177292946409659, "markers for": 0.00036638758934942785, "study with": 0.00035182462347885647, "dosages of": 0.00035182462347885647, "metoprolol for": 0.00040323606461105735, "activity as": 0.00036638758934942785, "washout was": 0.00036638758934942785, "activity after": 0.00040323606461105735, "concentrations in": 0.0004329022284738763, "medications to": 0.00040323606461105735, "prescribing of": 0.00040323606461105735, "interviews with": 0.00041377786439403925, "caring for": 0.00035182462347885647, "nonprescribing in": 0.0004329022284738763, "nonprescribing as": 0.0004329022284738763, "cited in": 0.0003177292946409659, "indicated in": 0.00037968253555614875, "blockers are": 0.00037968253555614875, "thirds of": 0.00033572601159100957, "documentation of": 0.00042363905952128787, "tone by": 0.00029732629973073545, "improved by": 0.00036638758934942785, "pyridostigmine on": 0.0004329022284738763, "elicited in": 0.00036638758934942785, "density of": 0.00035182462347885647, "protein in": 0.00035182462347885647, "contractility of": 0.00042363905952128787, "delay in": 0.0003177292946409659, "behavior of": 0.00036638758934942785, "interval between": 0.00042363905952128787, "aspects in": 0.00035182462347885647, "aspects to": 0.00035182462347885647, "models of": 0.00033572601159100957, "models in": 0.00033572601159100957, "combinations of": 0.00041377786439403925, "simulated in": 0.00037968253555614875, "culprit in": 0.00035182462347885647, "handling in": 0.00036638758934942785, "velocity at": 0.00036638758934942785, "rise to": 0.00029732629973073545, "function on": 0.00036638758934942785, "mediated by": 0.00036638758934942785, "wasting of": 0.00035182462347885647, "surrogate of": 0.00037968253555614875, "inhibition on": 0.00039191270050212794, "tolerance in": 0.00037968253555614875, "ivabradine on": 0.00039191270050212794, "filling in": 0.00035182462347885647, "optimization of": 0.00041377786439403925, "time by": 0.00029732629973073545, "days in": 0.00029732629973073545, "testing with": 0.00037968253555614875, "undertaken at": 0.00039191270050212794, "improvement between": 0.00044989700417746083, "rate during": 0.00036638758934942785, "change with": 0.00036638758934942785, "correlates of": 0.00039191270050212794, "contribution from": 0.0004329022284738763, "exercise as": 0.00036638758934942785, "reflected by": 0.00037968253555614875, "formed of": 0.00033572601159100957, "angiography with": 0.00042363905952128787, "rule for": 0.0003177292946409659, "stenosis in": 0.00036638758934942785, "validated in": 0.00037968253555614875, "rule of": 0.00029732629973073545, "rule had": 0.0003177292946409659, "sensitivity for": 0.00041377786439403925, "angiography in": 0.00040323606461105735, "experience of": 0.00039191270050212794, "indication in": 0.00039191270050212794, "indicated for": 0.00039191270050212794, "hyponatremia in": 0.00041377786439403925, "indication is": 0.00039191270050212794, "experience in": 0.00039191270050212794, "knowledge on": 0.00037968253555614875, "older have": 0.00035182462347885647, "therapy to": 0.00035182462347885647, "delivery of": 0.00036638758934942785, "subject of": 0.00035182462347885647, "responses in": 0.00037968253555614875, "altered in": 0.00035182462347885647, "property of": 0.00036638758934942785, "stimulated by": 0.00039191270050212794, "cardiomyocytes from": 0.00044989700417746083, "infusions in": 0.00037968253555614875, "enhanced by": 0.00036638758934942785, "protection from": 0.00041377786439403925, "desensitizes against": 0.0004577343883591784, "mechanism during": 0.00042363905952128787, "strategy in": 0.00036638758934942785, "underuse of": 0.00036638758934942785, "fear of": 0.00029732629973073545, "discontinuation of": 0.0004416357764713315, "endpoint in": 0.00036638758934942785, "safe when": 0.00033572601159100957, "subgroups at": 0.00037968253555614875, "gaps in": 0.00029732629973073545, "hrqol in": 0.0003177292946409659, "correlation with": 0.00042363905952128787, "hrqol as": 0.0003177292946409659, "hrqol from": 0.00035182462347885647, "substudy of": 0.00036638758934942785, "expenditures of": 0.00041377786439403925, "compared from": 0.00039191270050212794, "estimated from": 0.00040323606461105735, "costs from": 0.00035182462347885647, "accounted for": 0.00039191270050212794, "driven by": 0.00033572601159100957, "drugs in": 0.0003177292946409659, "influence on": 0.00037968253555614875, "structure in": 0.00037968253555614875, "microstructure at": 0.0004329022284738763, "warrant further": 0.00041377786439403925, "medicine as": 0.00036638758934942785, "studies on": 0.00035182462347885647, "retrieved from": 0.00040323606461105735, "indicated that": 0.00040323606461105735, "activity of": 0.00036638758934942785, "enzymes in": 0.00035182462347885647, "enzymes over": 0.00037968253555614875, "period in": 0.00033572601159100957, "leukocytes of": 0.00039191270050212794, "treatment have": 0.00040323606461105735, "profile of": 0.00035182462347885647, "intolerance in": 0.00040323606461105735, "parameters for": 0.00040323606461105735, "feature of": 0.00035182462347885647, "interpretation of": 0.0004329022284738763, "variables with": 0.00040323606461105735, "assessment with": 0.00041377786439403925, "inclusion of": 0.00037968253555614875, "surgery in": 0.00035182462347885647, "experience between": 0.0004416357764713315, "oht in": 0.00027377277067582674, "transplantation with": 0.0004577343883591784, "required in": 0.00036638758934942785, "transplantation to": 0.0004416357764713315, "consultation to": 0.00041377786439403925, "operation was": 0.00039191270050212794, "consultation for": 0.00042363905952128787, "occurred after": 0.00040323606461105735, "cent with": 0.00033572601159100957, "problems in": 0.00036638758934942785, "transplant with": 0.00041377786439403925, "incidence in": 0.00037968253555614875, "oxygenation as": 0.00040323606461105735, "recovery in": 0.00036638758934942785, "man with": 0.0003177292946409659, "hospitalized in": 0.00041377786439403925, "obstruction of": 0.00040323606461105735, "became again": 0.00037968253555614875, "team for": 0.0003177292946409659, "applied during": 0.00040323606461105735, "needed for": 0.00035182462347885647, "transferred to": 0.00040323606461105735, "support is": 0.00035182462347885647, "abnormalities in": 0.00042363905952128787, "discussion of": 0.00039191270050212794, "promise for": 0.00036638758934942785, "trends from": 0.00036638758934942785, "infarction in": 0.00039191270050212794, "data are": 0.0003177292946409659, "ami between": 0.00036638758934942785, "concurrent with": 0.00041377786439403925, "problem with": 0.00037968253555614875, "therapy during": 0.00040323606461105735, "feasibility of": 0.00040323606461105735, "data for": 0.0003177292946409659, "injections in": 0.00039191270050212794, "improvements from": 0.0004329022284738763, "baseline in": 0.00036638758934942785, "shows for": 0.00033572601159100957, "supplementation during": 0.00047229735422974975, "rehabilitation is": 0.0004329022284738763, "range of": 0.0003177292946409659, "therapies in": 0.00037968253555614875, "functions after": 0.00041377786439403925, "candidates for": 0.00040323606461105735, "suffer from": 0.00036638758934942785, "unclear how": 0.00036638758934942785, "created by": 0.00035182462347885647, "used as": 0.00029732629973073545, "selected on": 0.00036638758934942785, "signaling by": 0.00037968253555614875, "efficiency of": 0.00039191270050212794, "considered in": 0.00039191270050212794, "protocols for": 0.00039191270050212794, "breathing with": 0.00040323606461105735, "control during": 0.00040323606461105735, "produced while": 0.00040323606461105735, "aged in": 0.00029732629973073545, "60s with": 0.0003177292946409659, "presented in": 0.00037968253555614875, "produced during": 0.00041377786439403925, "recovery had": 0.00037968253555614875, "perfusion of": 0.00037968253555614875, "concluded that": 0.00040323606461105735, "produced by": 0.00036638758934942785, "originating from": 0.00042363905952128787, "drugs have": 0.00035182462347885647, "options for": 0.00036638758934942785, "anticoagulants for": 0.0004416357764713315, "nutrition in": 0.00037968253555614875, "disease with": 0.00037968253555614875, "comorbidities such": 0.0004416357764713315, "points to": 0.00033572601159100957, "imbalance as": 0.00037968253555614875, "stage of": 0.0003177292946409659, "knowledge of": 0.00037968253555614875, "strategies with": 0.00041377786439403925, "target of": 0.00033572601159100957, "released from": 0.00039191270050212794, "roles of": 0.0003177292946409659, "information for": 0.00041377786439403925, "elucidated in": 0.00039191270050212794, "rabbits with": 0.00037968253555614875, "hypothesized in": 0.00041377786439403925, "restored to": 0.00036638758934942785, "withdrawal of": 0.00039191270050212794, "bolus of": 0.0003177292946409659, "exacerbated in": 0.00040323606461105735, "normalized in": 0.00039191270050212794, "tachycardia in": 0.00040323606461105735, "turned on": 0.00033572601159100957, "stopped for": 0.00036638758934942785, "futility on": 0.00036638758934942785, "recommendation of": 0.0004329022284738763, "oxygenation on": 0.00040323606461105735, "study in": 0.0003177292946409659, "supported on": 0.00037968253555614875, "group until": 0.00036638758934942785, "continued until": 0.00041377786439403925, "group in": 0.0003177292946409659, "scores for": 0.00035182462347885647, "exists from": 0.00036638758934942785, "discharge for": 0.00039191270050212794, "discharged with": 0.00041377786439403925, "ratings from": 0.00037968253555614875, "insight on": 0.00035182462347885647, "nursing to": 0.00035182462347885647, "measures in": 0.00036638758934942785, "care to": 0.00029732629973073545, "actions on": 0.00035182462347885647, "regulated by": 0.00037968253555614875, "action on": 0.00033572601159100957, "involvement of": 0.00040323606461105735, "occur after": 0.00036638758934942785, "stimulation with": 0.00042363905952128787, "triggered by": 0.00037968253555614875, "regulation in": 0.00039191270050212794, "overstimulation in": 0.0004416357764713315, "continuity on": 0.00039191270050212794, "readmission after": 0.0004329022284738763, "continuity further": 0.0004416357764713315, "databases for": 0.00039191270050212794, "hospital between": 0.00042363905952128787, "models with": 0.00036638758934942785, "discharge on": 0.00037968253555614875, "readmission over": 0.00042363905952128787, "patient at": 0.00035182462347885647, "readmission during": 0.0004416357764713315, "taking into": 0.00036638758934942785, "visits over": 0.00036638758934942785, "visits with": 0.00036638758934942785, "settings other": 0.00040323606461105735, "persist through": 0.00041377786439403925, "focusing of": 0.00036638758934942785, "demonstrated up": 0.00041377786439403925, "blots with": 0.00035182462347885647, "phosphorylation in": 0.0004416357764713315, "binding by": 0.00035182462347885647, "mutant as": 0.00033572601159100957, "modulation of": 0.00039191270050212794, "instability in": 0.00040323606461105735, "predictor for": 0.00039191270050212794, "activity on": 0.00036638758934942785, "measured on": 0.00036638758934942785, "ecgs at": 0.00029732629973073545, "expressed as": 0.00037968253555614875, "sd of": 0.00024591485859853446, "calculated as": 0.00039191270050212794, "group during": 0.00037968253555614875, "blockade with": 0.00039191270050212794, "fluctuations in": 0.00041377786439403925, "modulation on": 0.00039191270050212794, "limited in": 0.00035182462347885647, "susceptibility to": 0.0004329022284738763, "exposure to": 0.00036638758934942785, "polymorphisms in": 0.00042363905952128787, "frame for": 0.00033572601159100957, "matched on": 0.00035182462347885647, "cases with": 0.00035182462347885647, "variants of": 0.00036638758934942785, "coding for": 0.00035182462347885647, "web of": 0.00027377277067582674, "syndrome of": 0.00036638758934942785, "definitions of": 0.00040323606461105735, "consensus on": 0.00037968253555614875, "foundation for": 0.00040323606461105735, "nomenclature for": 0.00042363905952128787, "view to": 0.00029732629973073545, "education in": 0.00037968253555614875, "inhibitor in": 0.00037968253555614875, "system by": 0.00033572601159100957, "breakdown of": 0.00037968253555614875, "composed of": 0.00036638758934942785, "promise in": 0.00035182462347885647, "tested in": 0.00033572601159100957, "situation in": 0.00037968253555614875, "initiation of": 0.00039191270050212794, "therapy are": 0.00036638758934942785, "principles of": 0.00039191270050212794, "progressed from": 0.00041377786439403925, "concept of": 0.00035182462347885647, "disorder to": 0.00036638758934942785, "focus of": 0.0003177292946409659, "window into": 0.00036638758934942785, "therefore have": 0.00040323606461105735, "remains in": 0.00035182462347885647, "shortcomings in": 0.00041377786439403925, "dearth of": 0.00033572601159100957, "standards in": 0.00037968253555614875, "micrornas in": 0.00037968253555614875, "targets in": 0.00035182462347885647, "subclass of": 0.00036638758934942785, "body of": 0.00029732629973073545, "binding to": 0.00035182462347885647, "mirnas as": 0.00033572601159100957, "inhibitors in": 0.00039191270050212794, "target in": 0.00033572601159100957, "evidence in": 0.00036638758934942785, "act on": 0.00027377277067582674, "filling during": 0.00040323606461105735, "quantification with": 0.00044989700417746083, "spectroscopy as": 0.00041377786439403925, "comparison with": 0.00041377786439403925, "subjects had": 0.00037968253555614875, "sample of": 0.00033572601159100957, "construct of": 0.00037968253555614875, "supported as": 0.00037968253555614875, "peptides in": 0.00036638758934942785, "plasma of": 0.00033572601159100957, "misdiagnosis of": 0.00041377786439403925, "circulation of": 0.00040323606461105735, "stored at": 0.00033572601159100957, "enriched from": 0.00039191270050212794, "plasma by": 0.00033572601159100957, "proteolysis between": 0.00044989700417746083, "concentration of": 0.00042363905952128787, "immunodetection of": 0.0004416357764713315, "improved with": 0.00039191270050212794, "epitopes as": 0.00036638758934942785, "described in": 0.00037968253555614875, "volume at": 0.00033572601159100957, "delivered as": 0.00037968253555614875, "evaluated as": 0.00037968253555614875, "patients during": 0.00041377786439403925, "adherence in": 0.00037968253555614875, "study from": 0.00035182462347885647, "raloxifene between": 0.0004416357764713315, "years for": 0.00033572601159100957, "compliance for": 0.00040323606461105735, "decreased for": 0.00039191270050212794, "reversibility of": 0.00042363905952128787, "thickness as": 0.00037968253555614875, "diameter were": 0.00039191270050212794, "content for": 0.00036638758934942785, "levels for": 0.00035182462347885647, "level for": 0.00033572601159100957, "performance by": 0.00040323606461105735, "blockade at": 0.00036638758934942785, "stages of": 0.00033572601159100957, "hazards of": 0.00035182462347885647, "events for": 0.00035182462347885647, "smoked more": 0.00036638758934942785, "differ between": 0.00040323606461105735, "similar when": 0.00037968253555614875, "disease from": 0.00037968253555614875, "events as": 0.00033572601159100957, "characteristics of": 0.0004416357764713315, "established that": 0.00042363905952128787, "quartile of": 0.00036638758934942785, "program for": 0.00036638758934942785, "stay for": 0.0003177292946409659, "community of": 0.00037968253555614875, "population in": 0.00039191270050212794, "admitted between": 0.00042363905952128787, "appropriate out": 0.00041377786439403925, "patient by": 0.00035182462347885647, "documented for": 0.00040323606461105735, "cost of": 0.00029732629973073545, "studied in": 0.00035182462347885647, "shown that": 0.00035182462347885647, "variability have": 0.00042363905952128787, "power of": 0.0003177292946409659, "remodeling of": 0.00039191270050212794, "substrate after": 0.00041377786439403925, "turbulence as": 0.00039191270050212794, "stems from": 0.00035182462347885647, "present with": 0.00037968253555614875, "angiography is": 0.00040323606461105735, "foundation of": 0.00039191270050212794, "revascularization with": 0.00047229735422974975, "benefit for": 0.00036638758934942785, "provide more": 0.00037968253555614875, "stenting in": 0.00036638758934942785, "considered only": 0.00041377786439403925, "revascularization is": 0.0004577343883591784, "guidelines on": 0.00039191270050212794, "framework for": 0.00039191270050212794, "plans for": 0.00033572601159100957, "downloaded from": 0.00041377786439403925, "carried out": 0.00036638758934942785, "packages of": 0.00036638758934942785, "performed for": 0.00039191270050212794, "interactors of": 0.00040323606461105735, "retrieved with": 0.00040323606461105735, "selected out": 0.00037968253555614875, "applied with": 0.00037968253555614875, "represented in": 0.00040323606461105735, "system with": 0.00036638758934942785, "visits during": 0.00039191270050212794, "groups after": 0.00037968253555614875, "admissions from": 0.00041377786439403925, "controls during": 0.00041377786439403925, "days for": 0.0003177292946409659, "admissions for": 0.00040323606461105735, "coupled with": 0.00037968253555614875, "technology has": 0.00040323606461105735, "strength of": 0.00036638758934942785, "race as": 0.00029732629973073545, "interactions with": 0.0004329022284738763, "care with": 0.00033572601159100957, "significantly more": 0.0004416357764713315, "blacks had": 0.00035182462347885647, "race in": 0.00029732629973073545, "design of": 0.00033572601159100957, "rhythm more": 0.00036638758934942785, "practice of": 0.00036638758934942785, "persist after": 0.00039191270050212794, "complications in": 0.00042363905952128787, "af at": 0.00024591485859853446, "trial for": 0.00033572601159100957, "spent in": 0.0003177292946409659, "counted as": 0.00035182462347885647, "therapy of": 0.00035182462347885647, "control as": 0.00035182462347885647, "therapy by": 0.00035182462347885647, "faced with": 0.00035182462347885647, "housed on": 0.00033572601159100957, "accustomed to": 0.00039191270050212794, "asked about": 0.00036638758934942785, "array of": 0.0003177292946409659, "procedures for": 0.00040323606461105735, "topic so": 0.0003177292946409659, "partner with": 0.00037968253555614875, "fall into": 0.00033572601159100957, "classification of": 0.0004329022284738763, "characterised by": 0.00042363905952128787, "failure at": 0.00035182462347885647, "population has": 0.00040323606461105735, "causes for": 0.00035182462347885647, "strategies for": 0.00040323606461105735, "currents by": 0.00036638758934942785, "trigger for": 0.00036638758934942785, "member of": 0.00033572601159100957, "gain through": 0.00037968253555614875, "dysfunction of": 0.00040323606461105735, "equivalent of": 0.00039191270050212794, "conducted by": 0.00037968253555614875, "movement of": 0.00036638758934942785, "indicating that": 0.00041377786439403925, "modes of": 0.0003177292946409659, "inhibition by": 0.00039191270050212794, "conclude that": 0.00039191270050212794, "efficacy in": 0.00036638758934942785, "situations in": 0.00039191270050212794, "provision of": 0.00037968253555614875, "case in": 0.00029732629973073545, "disease has": 0.00036638758934942785, "going into": 0.00035182462347885647, "measures for": 0.00037968253555614875, "reporting on": 0.00037968253555614875, "measures into": 0.00039191270050212794, "measure for": 0.00036638758934942785, "assess how": 0.00035182462347885647, "variance in": 0.00036638758934942785, "treated at": 0.00035182462347885647, "hospitals on": 0.00037968253555614875, "hospital in": 0.00036638758934942785, "dying in": 0.0003177292946409659, "quality for": 0.00036638758934942785, "measures at": 0.00036638758934942785, "antagonists in": 0.00040323606461105735, "race by": 0.00029732629973073545, "aas with": 0.0003177292946409659, "hypokalemia with": 0.00042363905952128787, "differ by": 0.00033572601159100957, "attenuation by": 0.00040323606461105735, "changed after": 0.00039191270050212794, "mapped to": 0.00033572601159100957, "protection of": 0.00039191270050212794, "amelioration of": 0.00041377786439403925, "noted above": 0.00036638758934942785, "tracked with": 0.00037968253555614875, "protected in": 0.00037968253555614875, "essentially were": 0.00042363905952128787, "changed in": 0.00035182462347885647, "signal to": 0.00033572601159100957, "application of": 0.00040323606461105735, "discharged to": 0.00039191270050212794, "implementation of": 0.0004329022284738763, "policy as": 0.00033572601159100957, "complications had": 0.0004329022284738763, "costs for": 0.00033572601159100957, "admissions to": 0.00039191270050212794, "physicians into": 0.00041377786439403925, "strata of": 0.00033572601159100957, "antagonism in": 0.00039191270050212794, "implicated as": 0.00039191270050212794, "groups with": 0.00036638758934942785, "very few": 0.0003177292946409659, "background for": 0.00040323606461105735, "criteria for": 0.00037968253555614875, "subdivided in": 0.00039191270050212794, "periods on": 0.00035182462347885647, "devices at": 0.00035182462347885647, "enrollment of": 0.00039191270050212794, "cardiomyopathy during": 0.0004651893055262403, "replicated in": 0.00039191270050212794, "continuity of": 0.00039191270050212794, "threshold in": 0.00037968253555614875, "finding has": 0.00036638758934942785, "investigations at": 0.0004329022284738763, "achievement of": 0.00040323606461105735, "point was": 0.00033572601159100957, "diet in": 0.00029732629973073545, "associated to": 0.00039191270050212794, "examination between": 0.00044989700417746083, "quantified as": 0.00039191270050212794, "computed with": 0.00039191270050212794, "categories were": 0.00041377786439403925, "grouped into": 0.00037968253555614875, "men in": 0.00027377277067582674, "matched for": 0.00036638758934942785, "counseled on": 0.00037968253555614875, "activity with": 0.00039191270050212794, "achieving at": 0.00037968253555614875, "overload as": 0.00036638758934942785, "resistance by": 0.00039191270050212794, "evidenced by": 0.00037968253555614875, "translocation of": 0.00042363905952128787, "oxidation of": 0.00037968253555614875, "phosphocreatine to": 0.0004416357764713315, "progression from": 0.00042363905952128787, "reality of": 0.00035182462347885647, "planning in": 0.00036638758934942785, "adequacy of": 0.00036638758934942785, "search of": 0.00033572601159100957, "undertaken for": 0.00040323606461105735, "region with": 0.00036638758934942785, "etiologies of": 0.00039191270050212794, "varies from": 0.00036638758934942785, "paradox of": 0.00035182462347885647, "countries with": 0.00040323606461105735, "scenario of": 0.00036638758934942785, "genotyped for": 0.00039191270050212794, "confirmation on": 0.00041377786439403925, "trigger of": 0.00035182462347885647, "pollution on": 0.00037968253555614875, "professionals in": 0.00042363905952128787, "overexpression of": 0.0004329022284738763, "pathophysiology is": 0.0004416357764713315, "mice with": 0.00033572601159100957, "mass in": 0.00029732629973073545, "shortening as": 0.00039191270050212794, "hypertrophy after": 0.0004329022284738763, "turning off": 0.00036638758934942785, "discovered that": 0.00041377786439403925, "indicate that": 0.00039191270050212794, "hearts with": 0.00036638758934942785, "worse when": 0.00035182462347885647, "spite of": 0.0003177292946409659, "developments in": 0.00041377786439403925, "recognition of": 0.00040323606461105735, "collaboration of": 0.00042363905952128787, "professionals from": 0.0004416357764713315, "managed by": 0.00035182462347885647, "country has": 0.00036638758934942785, "access to": 0.00033572601159100957, "progress has": 0.00037968253555614875, "aims of": 0.00029732629973073545, "connection between": 0.0004416357764713315, "conditions in": 0.00039191270050212794, "results about": 0.00039191270050212794, "uncertainty about": 0.0004329022284738763, "partners in": 0.00036638758934942785, "products from": 0.00039191270050212794, "identified by": 0.00039191270050212794, "recorded as": 0.00036638758934942785, "data to": 0.00029732629973073545, "guidelines as": 0.00039191270050212794, "search in": 0.00033572601159100957, "databases of": 0.00037968253555614875, "intervention on": 0.00041377786439403925, "education at": 0.00037968253555614875, "elements of": 0.00036638758934942785, "context in": 0.00035182462347885647, "results for": 0.00036638758934942785, "explore why": 0.00036638758934942785, "succeed in": 0.00035182462347885647, "fail in": 0.00029732629973073545, "findings through": 0.00042363905952128787, "perceptions of": 0.00040323606461105735, "recommendation for": 0.0004416357764713315, "occur between": 0.00039191270050212794, "perspective on": 0.00040323606461105735, "stages where": 0.00037968253555614875, "wished further": 0.00040323606461105735, "information on": 0.00040323606461105735, "deactivation at": 0.00041377786439403925, "discussions about": 0.0004329022284738763, "shocks at": 0.00033572601159100957, "comment on": 0.00035182462347885647, "% on": 0.00021181952976064393, "centers in": 0.00035182462347885647, "walked in": 0.00033572601159100957, "burden of": 0.00033572601159100957, "cpet in": 0.00029732629973073545, "min to": 0.00027377277067582674, "min after": 0.00033572601159100957, "changes were": 0.00037968253555614875, "people in": 0.00033572601159100957, "patients have": 0.00039191270050212794, "confirmed that": 0.00040323606461105735, "changes on": 0.00035182462347885647, "signs in": 0.0003177292946409659, "symptoms are": 0.00037968253555614875, "cornerstone in": 0.00040323606461105735, "referred to": 0.00036638758934942785, "services as": 0.00036638758934942785, "events from": 0.00036638758934942785, "individuals are": 0.00041377786439403925, "cancer of": 0.00033572601159100957, "expectancy by": 0.00039191270050212794, "volumes of": 0.00035182462347885647, "exercise below": 0.00040323606461105735, "athletes under": 0.00040323606461105735, "death during": 0.00037968253555614875, "sport in": 0.0003177292946409659, "athletes more": 0.00039191270050212794, "screening of": 0.00037968253555614875, "screening with": 0.00040323606461105735, "system in": 0.00033572601159100957, "period with": 0.00036638758934942785, "strength by": 0.00036638758934942785, "+0.5 to": 0.00029732629973073545, "+0.2 to": 0.00029732629973073545, "need further": 0.00037968253555614875, "validation in": 0.00039191270050212794, "adherence with": 0.00040323606461105735, "participation with": 0.0004416357764713315, "indicated more": 0.00040323606461105735, "corresponded to": 0.00041377786439403925, "association in": 0.00040323606461105735, "training had": 0.00037968253555614875, "performance in": 0.00040323606461105735, "arguments for": 0.00039191270050212794, "explained by": 0.00037968253555614875, "protocol with": 0.00039191270050212794, "analysis at": 0.00036638758934942785, "baseline as": 0.00036638758934942785, "participated in": 0.00041377786439403925, "doses for": 0.00033572601159100957, "dose after": 0.00035182462347885647, "latter had": 0.00035182462347885647, "higher when": 0.00036638758934942785, "hr was": 0.00027377277067582674, "observed after": 0.00040323606461105735, "baseline had": 0.00037968253555614875, "better when": 0.00036638758934942785, "bpm with": 0.0003177292946409659, "target as": 0.00033572601159100957, "shunting for": 0.00037968253555614875, "shunting in": 0.00036638758934942785, "study at": 0.0003177292946409659, "centre in": 0.00033572601159100957, "enrolled under": 0.00040323606461105735, "done after": 0.00035182462347885647, "catheterisation with": 0.0004577343883591784, "guidance under": 0.00040323606461105735, "evaluations at": 0.00040323606461105735, "reduced from": 0.00037968253555614875, "hospital with": 0.00039191270050212794, "bleeding at": 0.00036638758934942785, "died after": 0.00035182462347885647, "problem of": 0.00035182462347885647, "treated by": 0.00035182462347885647, "thanked for": 0.00036638758934942785, "symptom of": 0.00035182462347885647, "determinant of": 0.00040323606461105735, "conducted from": 0.00040323606461105735, "excluded by": 0.00036638758934942785, "consisted of": 0.00037968253555614875, "adherence was": 0.00039191270050212794, "-8 to": 0.00024591485859853446, "intervention had": 0.00042363905952128787, "life as": 0.00029732629973073545, "designed for": 0.00037968253555614875, "hemocompatibility by": 0.0004577343883591784, "rotor with": 0.00035182462347885647, "listed for": 0.00035182462347885647, "indications for": 0.00041377786439403925, "continued on": 0.00037968253555614875, "support with": 0.00037968253555614875, "risk by": 0.00029732629973073545, "reoperation for": 0.00041377786439403925, "projections of": 0.00040323606461105735, "pairs of": 0.0003177292946409659, "estimates of": 0.00037968253555614875, "validity in": 0.00036638758934942785, "estimates from": 0.00040323606461105735, "demonstrate how": 0.00041377786439403925, "program in": 0.00035182462347885647, "treatments are": 0.00040323606461105735, "value to": 0.0003177292946409659, "providers with": 0.00040323606461105735, "nurses in": 0.00033572601159100957, "settings have": 0.00039191270050212794, "actions have": 0.00037968253555614875, "heart": 0.16009057294764592, "patients": 0.1900021181952976, "failure": 0.16620540154948113, "%": 0.0, "hf": 0.03918661300571913, "the": 0.042972929483649225, "-": 0.0, "/": 0.0, "cardiac": 0.05500536545018606, "p": 0.0, "study": 0.038362717941371374, "ventricular": 0.05202703768761875, "risk": 0.030078373226011437, "95": 0.014827367083245075, "exercise": 0.04257572548188943, "results": 0.038949745264726346, "associated": 0.04468172718181477, "mortality": 0.04263720347205822, "in": 0.013238720610040246, "ejection": 0.03876297394619784, "treatment": 0.03961566936773913, "left": 0.02478288498199534, "fraction": 0.036856598178352046, "ci": 0.012073713196356703, "outcomes": 0.034314763821224316, "=": 0.0, "clinical": 0.03209065875873755, "disease": 0.028840651073881337, "therapy": 0.027948672174689132, "compared": 0.028595636517686932, "hr": 0.009214149544588011, "reduced": 0.025570061776843248, "function": 0.0270069900444821, "increased": 0.028200984973644806, "ratio": 0.020656848122276892, "group": 0.02041093326367836, "\u00b1": 0.0, "methods": 0.023191451378997367, "years": 0.019181358970685687, "<": 0.0, "patient": 0.02289412507926663, "rate": 0.016310103791569584, "systolic": 0.024465155687354374, "myocardial": 0.02673867138439309, "chf": 0.012757588440458364, "lv": 0.007943232366024148, "may": 0.012421862428867354, "conclusions": 0.02674629402250823, "care": 0.015039186613005719, "chronic": 0.020812840981151482, "dysfunction": 0.02564713125445995, "death": 0.01721404010189741, "hfpef": 0.016968125243298878, "background": 0.024275899020041094, "acute": 0.016722210384700342, "end": 0.01124682138829882, "analysis": 0.020652404151662782, "hazard": 0.01779523009392874, "follow": 0.01752145732325291, "cardiovascular": 0.02580710813510767, "using": 0.01549263609170767, "significant": 0.022716030539664527, "n": 0.0, "higher": 0.016700139011225433, "2": 0.0, "functional": 0.021461302032210243, "this": 0.012709171785638636, "preserved": 0.019807834683869565, "data": 0.012497352255877992, "a": 0.0, "hospitalization": 0.023999116134854274, "6": 0.0, "high": 0.012285532726117349, "index": 0.014263061798714996, "used": 0.012073713196356703, "baseline": 0.018110569794535056, "among": 0.014017146940116465, "significantly": 0.022339023928621294, "control": 0.01694759908465192, "1": 0.0, "versus": 0.015331275157846299, "diastolic": 0.01846493063750553, "low": 0.009232465318752764, "quality": 0.016055620185459713, "right": 0.01327940236432086, "age": 0.00906460231295726, "pressure": 0.01683965261597119, "model": 0.013033487505722325, "events": 0.01423618407514299, "levels": 0.01423618407514299, "health": 0.01423618407514299, "volume": 0.01423618407514299, "lower": 0.01278757264712379, "studies": 0.015163641286267508, "use": 0.008561013295570746, "ml": 0.00540139800889642, "time": 0.01080279601779284, "changes": 0.014866314986536773, "confidence": 0.01759123117394282, "trial": 0.012049828071328187, "3": 0.0, "new": 0.008225287283979735, "renal": 0.012049828071328187, "\u03b2": 0.0, "rates": 0.011557998354131118, "cause": 0.011557998354131118, "management": 0.016535757303506253, "outcome": 0.013974336087344566, "however": 0.01367700978761383, "interval": 0.014615547553484431, "type": 0.00974369836898962, "hospital": 0.014297818258843466, "association": 0.016487441520724254, "and": 0.007553835260797716, "day": 0.007553835260797716, "effects": 0.013082357188152361, "groups": 0.012046001909736377, "increase": 0.013980088964202499, "30": 0.004660029654734167, "cohort": 0.01177222913906055, "induced": 0.012785030888421624, "survival": 0.013662359669561534, "receptor": 0.013662359669561534, "life": 0.008896420249947044, "severe": 0.011498456368384723, "class": 0.010082509202539912, "support": 0.012190378288960154, "ii": 0.0043423003600932, "crt": 0.006714520231820191, "pulmonary": 0.013093314452049374, "dose": 0.008260961660665114, "effect": 0.010677138056357243, "ms": 0.004130480830332557, "based": 0.009344764626744308, "hypertension": 0.01442793635113365, "term": 0.00804914213090447, "also": 0.00804914213090447, "treated": 0.011298399389767946, "infarction": 0.013017511068717688, "mass": 0.007837322601143825, "long": 0.007837322601143825, "models": 0.01012959251500559, "reduction": 0.012421862428867354, "peak": 0.007837322601143825, "primary": 0.011001073090037212, "training": 0.011755983901715738, "improvement": 0.013556340805928829, "evidence": 0.011438254607074773, "coronary": 0.011438254607074773, "medical": 0.010703746790306477, "year": 0.007625503071383181, "atrial": 0.009855819744329761, "randomized": 0.012665686445238833, "development": 0.013189953216579403, "4": 0.0, "early": 0.00885293490954724, "mean": 0.007625503071383181, "mitral": 0.009855819744329761, "included": 0.011120525312433807, "months": 0.009582046973653936, "trials": 0.009582046973653936, "improved": 0.011120525312433807, "impact": 0.009582046973653936, "well": 0.0074136835416225375, "score": 0.008607020050948705, "assessed": 0.01080279601779284, "probnp": 0.009308274202978108, "nt": 0.003600932005930947, "participants": 0.012909206208909058, "capacity": 0.01080279601779284, "body": 0.0069900444821012495, "factors": 0.00981176789111427, "without": 0.00981176789111427, "showed": 0.009034501432302283, "respectively": 0.012529523673352909, "similar": 0.00981176789111427, "angiotensin": 0.012090790448531119, "median": 0.009034501432302283, "common": 0.008760728661626456, "adverse": 0.009514441591383534, "role": 0.006778224952340606, "kg": 0.003389112476170303, "developed": 0.010743232370912306, "min": 0.005371616185456153, "diabetes": 0.01016733742851091, "expression": 0.011258387951323407, "e": 0.0, "congestive": 0.01090656332784455, "non": 0.0052037531796606485, "conclusion": 0.01090656332784455, "performed": 0.010407506359321297, "related": 0.0092171152916528, "first": 0.007623360616554567, "major": 0.007377445757956034, "identified": 0.010554738704365694, "vs": 0.003177292946409659, "l": 0.0, "ef": 0.003177292946409659, "demonstrated": 0.011390476066684464, "mice": 0.006354585892819318, "at": 0.003177292946409659, "natriuretic": 0.010625240091133407, "found": 0.007131530899357498, "population": 0.010202914080886836, "vs.": 0.004868027168069639, "remodeling": 0.010202914080886836, "one": 0.004868027168069639, "device": 0.007939410349598976, "adjusted": 0.009214149544588011, "total": 0.0068856160407589646, "evaluated": 0.00940032832454827, "blood": 0.0068856160407589646, "assist": 0.007665637578923149, "within": 0.007665637578923149, "measures": 0.008896420249947044, "change": 0.007665637578923149, "older": 0.0068856160407589646, "days": 0.00593094683329803, "status": 0.007665637578923149, "b": 0.0, "prognostic": 0.009499264833929124, "symptoms": 0.008578690955306079, "including": 0.00906460231295726, "ischemic": 0.008578690955306079, "adults": 0.007391864808247322, "defibrillator": 0.010581642913557454, "objective": 0.00906460231295726, "period": 0.007391864808247322, "effective": 0.00906460231295726, "ed": 0.002859563651768693, "per": 0.00453230115647863, "measured": 0.008260961660665114, "decreased": 0.00872887630136625, "review": 0.007118092037571495, "10": 0.002753653886888371, "test": 0.005507307773776742, "interventions": 0.010189730213055326, "human": 0.006393786323561895, "advanced": 0.008260961660665114, "blockers": 0.008260961660665114, "peptide": 0.007730483792999123, "bnp": 0.004364438150683125, "response": 0.008260961660665114, "safety": 0.006844319266895669, "improve": 0.007433157493268386, "hospitalized": 0.009492063388903718, "surgery": 0.007433157493268386, "less": 0.005295488244016098, "important": 0.00839315028977524, "level": 0.006147871464963361, "protein": 0.007433157493268386, "artery": 0.006844319266895669, "lvef": 0.005295488244016098, "factor": 0.006844319266895669, "readmission": 0.009159689733735696, "blocker": 0.007433157493268386, "visits": 0.006844319266895669, "underwent": 0.00839315028977524, "activity": 0.007943232366024148, "valve": 0.006147871464963361, "post": 0.005295488244016098, "system": 0.006570546496219842, "12": 0.0025418343571277273, "diagnosis": 0.008057424278184231, "practice": 0.007625503071383181, "implantable": 0.008793302144386268, "devices": 0.007135831193537652, "potential": 0.008057424278184231, "strategies": 0.008443790963492556, "c": 0.0, "flow": 0.005083668714255455, "therapeutic": 0.008793302144386268, "lvad": 0.005083668714255455, "arterial": 0.007625503071383181, "mitochondrial": 0.00940590481205107, "diet": 0.005083668714255455, "7": 0.0, "design": 0.006296773725544015, "resynchronization": 0.009956751254899155, "two": 0.00386084913329661, "cardiomyopathy": 0.00927442948605432, "placebo": 0.006838504893806915, "hypertrophy": 0.00842691455503684, "gene": 0.00487184918449481, "implantation": 0.00873269831779142, "cox": 0.00386084913329661, "physician": 0.00772169826659322, "mm": 0.002435924592247405, "rv": 0.002435924592247405, "onset": 0.005656041747766292, "subjects": 0.007307773776742216, "af": 0.002435924592247405, "guideline": 0.0073859722550022105, "cardioverter": 0.008353015782235271, "current": 0.0065411785940761805, "fibrillation": 0.008353015782235271, "admission": 0.0073859722550022105, "recent": 0.006023000954868189, "weeks": 0.005410126889167757, "assessment": 0.007740141716534842, "nyha": 0.004660029654734167, "metoprolol": 0.007740141716534842, "assess": 0.005749228184192361, "followed": 0.006672315187460284, "terminal": 0.006672315187460284, "p<0.001": 0.006243852294345444, "observed": 0.006672315187460284, "echocardiography": 0.008896420249947044, "prognosis": 0.007050246243411201, "benefit": 0.006243852294345444, "york": 0.004448210124973522, "setting": 0.006243852294345444, "point": 0.005164212030569223, "difference": 0.007388317093055986, "due": 0.0035251231217056007, "20": 0.002224105062486761, "performance": 0.007694139376337985, "discharge": 0.007050246243411201, "could": 0.005164212030569223, "beta": 0.004448210124973522, "inhibition": 0.007388317093055986, "rats": 0.004448210124973522, "pasp": 0.004448210124973522, "5": 0.0, "rhythm": 0.005749228184192361, "cad": 0.0035251231217056007, "objectives": 0.007036492469577129, "mr": 0.0021181952976064393, "elevated": 0.006354585892819318, "defined": 0.0059465259946147086, "characteristics": 0.008275557287880786, "regression": 0.007036492469577129, "specific": 0.006354585892819318, "proteins": 0.006354585892819318, "normal": 0.005475455413516535, "0.001": 0.004918297171970689, "+": 0.0, "three": 0.004918297171970689, "likely": 0.005475455413516535, "relationship": 0.007593650711122975, "month": 0.004918297171970689, "these": 0.004918297171970689, "iii": 0.0033572601159100957, "m(2": 0.0033572601159100957, "improves": 0.006354585892819318, "echocardiographic": 0.008658044569477526, "correlated": 0.006684667846098272, "8": 0.0, "moderate": 0.006036856598178352, "addition": 0.006036856598178352, "efficacy": 0.006036856598178352, "value": 0.004672382313372154, "cells": 0.004672382313372154, "after": 0.004672382313372154, "hfref": 0.004672382313372154, "race": 0.004024571065452235, "stage": 0.004672382313372154, "stroke": 0.005201682642840709, "estimated": 0.006043068208638172, "stable": 0.0049279098721648805, "occurred": 0.005719127303537386, "of": 0.0019063757678457953, "limited": 0.005351873395153238, "multivariate": 0.006834285640010678, "dependent": 0.006043068208638172, "transplant": 0.006332843222619416, "ami": 0.003021534104319086, "spironolactone": 0.007258249162999033, "men": 0.003021534104319086, "case": 0.0038127515356915906, "hg": 0.0019063757678457953, "diagnostic": 0.006332843222619416, "inhibitors": 0.006332843222619416, "muscle": 0.0049279098721648805, "t1": 0.0019063757678457953, "paf": 0.003021534104319086, "medicare": 0.00540139800889642, "dilated": 0.005054547095422503, "present": 0.005054547095422503, "cell": 0.003600932005930947, "better": 0.004654137101489054, "predictors": 0.0059810185991405595, "identify": 0.00540139800889642, "decrease": 0.00540139800889642, "sex": 0.0028536710985235816, "independent": 0.0062285890189402735, "mg": 0.0018004660029654735, "via": 0.0028536710985235816, "reduce": 0.004654137101489054, "findings": 0.00540139800889642, "isolated": 0.00540139800889642, "composite": 0.005707342197047163, "odds": 0.003600932005930947, "resistance": 0.0059810185991405595, "50": 0.0018004660029654735, "cost": 0.003600932005930947, "effectiveness": 0.006662515908536175, "standard": 0.00540139800889642, "program": 0.005054547095422503, "signaling": 0.005707342197047163, "insulin": 0.005054547095422503, "event": 0.003934637737576551, "large": 0.003934637737576551, "across": 0.004380364330813228, "individuals": 0.005862201429590846, "no": 0.0016945562380851515, "mild": 0.003389112476170303, "provide": 0.004757220795691767, "evaluate": 0.005083668714255455, "examined": 0.005083668714255455, "transplantation": 0.006620445830304628, "controlled": 0.0056291939756617036, "independently": 0.006270603208034047, "cardiomyocytes": 0.006451777033776918, "40": 0.0016945562380851515, "consecutive": 0.005862201429590846, "determine": 0.005371616185456153, "activation": 0.0056291939756617036, "ratios": 0.004380364330813228, "2008": 0.003389112476170303, "or": 0.0016945562380851515, "testing": 0.004757220795691767, "novel": 0.003934637737576551, "report": 0.004380364330813228, "oxygen": 0.004380364330813228, "qrs": 0.0026858080927280766, "aortic": 0.004380364330813228, "sd": 0.0016945562380851515, "prospective": 0.005495813840241418, "pro": 0.002517945086932572, "even": 0.003177292946409659, "guidelines": 0.005277369352182847, "filling": 0.004459894495961032, "benefits": 0.004765939419614488, "suggest": 0.004459894495961032, "15": 0.0015886464732048295, "research": 0.004765939419614488, "0.01": 0.003177292946409659, "hearts": 0.0041065915601374015, "enrolled": 0.004765939419614488, "differences": 0.005495813840241418, "remained": 0.004765939419614488, "different": 0.005035890173865144, "beneficial": 0.005277369352182847, "co": 0.0015886464732048295, "women": 0.003688722878978017, "analyses": 0.004765939419614488, "stress": 0.0041065915601374015, "therefore": 0.005035890173865144, "range": 0.003688722878978017, "velocity": 0.004765939419614488, "future": 0.0041065915601374015, "receiving": 0.005035890173865144, "sympathetic": 0.005495813840241418, "action": 0.0041065915601374015, "matched": 0.004459894495961032, "resistin": 0.004765939419614488, "dnx": 0.002517945086932572, "conditions": 0.004925544728703991, "surgical": 0.004448210124973522, "endothelial": 0.00512942625089199, "during": 0.0038328187894615747, "plasma": 0.0038328187894615747, "either": 0.0038328187894615747, "mechanism": 0.004700164162274135, "ventricle": 0.004700164162274135, "anemia": 0.0038328187894615747, "physicians": 0.004925544728703991, "recommendations": 0.00579289010151655, "vascular": 0.004448210124973522, "male": 0.002965473416649015, "chromatin": 0.004700164162274135, "structure": 0.004700164162274135, "known": 0.0034428080203794823, "intervention": 0.005315555497786082, "0.02": 0.002965473416649015, "interaction": 0.00512942625089199, "morbidity": 0.004700164162274135, "values": 0.0038328187894615747, "fontan": 0.0038328187894615747, "self": 0.002965473416649015, "duration": 0.004448210124973522, "complications": 0.005486777807029792, "reasons": 0.004162568196230296, "derived": 0.004162568196230296, "kidney": 0.0038328187894615747, "egfr": 0.002965473416649015, "scores": 0.0038328187894615747, "bb": 0.0014827367083245075, "measurement": 0.00512942625089199, "hyperkalemia": 0.005315555497786082, "ivabradine": 0.004925544728703991, "obese": 0.0034428080203794823, "users": 0.0034428080203794823, "2011": 0.002753653886888371, "hospitals": 0.004364438150683125, "overall": 0.0038652418964995614, "improvements": 0.004935872962229934, "fat": 0.0021822190753415624, "controls": 0.004130480830332557, "biomarkers": 0.004573720105225134, "weight": 0.0035590460187857474, "relative": 0.004130480830332557, "as": 0.0013768269434441855, "inappropriate": 0.005094865106527663, "evaluation": 0.004573720105225134, "24": 0.0013768269434441855, "revealed": 0.004130480830332557, "vo2": 0.0021822190753415624, "calculated": 0.004573720105225134, "according": 0.004364438150683125, "criteria": 0.004130480830332557, "greater": 0.0038652418964995614, "incidence": 0.004364438150683125, "ras": 0.0021822190753415624, "recommended": 0.004763038661542562, "with": 0.002753653886888371, ".001": 0.002753653886888371, "18": 0.0013768269434441855, ">": 0.0, "mediated": 0.004130480830332557, "dilatation": 0.004573720105225134, "procedures": 0.004573720105225134, "prediction": 0.004573720105225134, "medication": 0.004573720105225134, "number": 0.0035590460187857474, "strain": 0.0035590460187857474, "need": 0.002753653886888371, "dialysis": 0.004130480830332557, "measure": 0.0038652418964995614, "sst2": 0.002753653886888371, "sham": 0.002753653886888371, "100": 0.0021822190753415624, "length": 0.0035590460187857474, "tac": 0.0021822190753415624, "undergoing": 0.004573720105225134, "aged": 0.002753653886888371, "frailty": 0.0038652418964995614, "doxorubicin": 0.004763038661542562, "carvedilol": 0.004573720105225134, "variability": 0.004763038661542562, "nursing": 0.0038652418964995614, "rad": 0.0021822190753415624, "four": 0.0025418343571277273, "g": 0.0, "strength": 0.0038127515356915906, "potentially": 0.004396651072193134, "costs": 0.0029509783031824136, "emergency": 0.004028712139092116, "et": 0.0012709171785638637, "single": 0.003285273248109921, "glomerular": 0.004221895481746278, "filtration": 0.004221895481746278, "serum": 0.0029509783031824136, "growth": 0.003285273248109921, "examine": 0.003567915596768826, "proportional": 0.004556190426673786, "sought": 0.003285273248109921, "all": 0.002014356069546058, "readmissions": 0.004556190426673786, "recently": 0.0038127515356915906, "provided": 0.0038127515356915906, "pump": 0.0025418343571277273, "heartmate": 0.004028712139092116, "cardiopulmonary": 0.0049653343727284706, "14": 0.0012709171785638637, "often": 0.0029509783031824136, "variables": 0.004028712139092116, "declined": 0.0038127515356915906, "retrospective": 0.004702952406025535, "phenotype": 0.004028712139092116, "adherence": 0.004028712139092116, "hdl": 0.002014356069546058, "16": 0.0012709171785638637, "phosphorylation": 0.0049653343727284706, "investigate": 0.004396651072193134, "aimed": 0.0029509783031824136, "week": 0.0025418343571277273, "overload": 0.0038127515356915906, "history": 0.003567915596768826, "st2": 0.002014356069546058, "aldosterone": 0.004396651072193134, "tapse": 0.0029509783031824136, "young": 0.0029509783031824136, "rehabilitation": 0.004838832775332688, "drugs": 0.0029509783031824136, "channel": 0.003567915596768826, "mi": 0.0012709171785638637, "pde2": 0.0025418343571277273, "prior": 0.0027050634445838786, "stimulation": 0.004030263482843706, "doppler": 0.0032705892970380903, "prevalence": 0.003870070858267421, "impaired": 0.0034950222410506247, "adult": 0.0027050634445838786, "target": 0.0030115004774340943, "systematic": 0.003870070858267421, "combined": 0.0034950222410506247, "appropriate": 0.004030263482843706, "area": 0.0023300148273670833, "meta": 0.0023300148273670833, "peripheral": 0.003870070858267421, "dopamine": 0.0034950222410506247, "main": 0.0023300148273670833, "0.05": 0.0023300148273670833, "secondary": 0.0036929861275011053, "improving": 0.0036929861275011053, "global": 0.0030115004774340943, "37": 0.0011650074136835417, "abnormal": 0.0034950222410506247, "mouse": 0.0027050634445838786, "25": 0.0011650074136835417, "remains": 0.0032705892970380903, "longitudinal": 0.004176507891117636, "2009": 0.0023300148273670833, "28": 0.0011650074136835417, "usual": 0.0027050634445838786, "genes": 0.0027050634445838786, "mrna": 0.0023300148273670833, "failing": 0.0032705892970380903, "pathways": 0.0034950222410506247, "healthy": 0.0032705892970380903, "pathophysiology": 0.004551556508334432, "develop": 0.0032705892970380903, "wall": 0.0023300148273670833, "annular": 0.0032705892970380903, "thus": 0.0023300148273670833, "questionnaire": 0.004311039705523407, "kccq": 0.0023300148273670833, "adjustment": 0.003870070858267421, "reverse": 0.0032705892970380903, "would": 0.0027050634445838786, "adrenergic": 0.003870070858267421, "pathway": 0.0032705892970380903, "cases": 0.0027050634445838786, "hospitalizations": 0.004660029654734167, "coupling": 0.0034950222410506247, "crf": 0.0018464930637505526, "antagonist": 0.003870070858267421, "metabolic": 0.0036929861275011053, "trastuzumab": 0.004030263482843706, "dash": 0.0023300148273670833, "resonance": 0.0036929861275011053, "investigated": 0.004176507891117636, "markers": 0.0032705892970380903, "animals": 0.0032705892970380903, "unclear": 0.0029732629973073543, "tissue": 0.0027377277067582675, "alterations": 0.0036638758934942786, "composition": 0.0036638758934942786, "energy": 0.0027377277067582675, "free": 0.0021181952976064393, "poor": 0.0021181952976064393, "iron": 0.0021181952976064393, "short": 0.0024591485859853444, "small": 0.0024591485859853444, "and/or": 0.0027377277067582675, "many": 0.0021181952976064393, "ambulatory": 0.0035182462347885645, "predictor": 0.0033572601159100957, "nesiritide": 0.0035182462347885645, "diuretic": 0.003177292946409659, "multicenter": 0.0036638758934942786, "systems": 0.0029732629973073543, "exhibited": 0.0033572601159100957, "transcription": 0.00391912700502128, "circulating": 0.0036638758934942786, "r": 0.0, "approaches": 0.0035182462347885645, "pacing": 0.0027377277067582675, "samples": 0.0029732629973073543, "safe": 0.0021181952976064393, "deaths": 0.0027377277067582675, "registry": 0.003177292946409659, "ability": 0.0029732629973073543, "predict": 0.0029732629973073543, "subgroups": 0.0033572601159100957, "children": 0.003177292946409659, "possible": 0.003177292946409659, "1996": 0.0021181952976064393, "distance": 0.003177292946409659, "molecular": 0.0033572601159100957, "optimal": 0.0029732629973073543, "parameters": 0.0035182462347885645, "wk": 0.0010590976488032196, "shortening": 0.0035182462347885645, "mva": 0.0016786300579550478, "mellitus": 0.003177292946409659, "considered": 0.0035182462347885645, "available": 0.0033572601159100957, "complex": 0.0029732629973073543, "va": 0.0010590976488032196, "esrd": 0.0021181952976064393, "contractile": 0.0036638758934942786, "pre": 0.0016786300579550478, "antagonists": 0.0036638758934942786, "shown": 0.0024591485859853444, "blockade": 0.003177292946409659, "progression": 0.0036638758934942786, "given": 0.0024591485859853444, "compliance": 0.0035182462347885645, "contribute": 0.0035182462347885645, "several": 0.0029732629973073543, "converting": 0.0035182462347885645, "enzyme": 0.0027377277067582675, "metabolism": 0.0035182462347885645, "magnetic": 0.003177292946409659, "cv": 0.0010590976488032196, "inflammatory": 0.0037968253555614876, "tone": 0.0021181952976064393, "eplerenone": 0.0035182462347885645, "$": 0.0, "vad": 0.0016786300579550478, "inv": 0.0016786300579550478, "psoriasis": 0.0033572601159100957, "aas": 0.0016786300579550478, "mena": 0.0021181952976064393, "national": 0.002859563651768693, "2005": 0.0019063757678457953, "largely": 0.002675936697576619, "monitoring": 0.003166421611309708, "requiring": 0.003021534104319086, "show": 0.0019063757678457953, "admitted": 0.002859563651768693, "loss": 0.0019063757678457953, "an": 0.0009531878839228976, "increasing": 0.003166421611309708, "underlying": 0.003166421611309708, "general": 0.002675936697576619, "presence": 0.002859563651768693, "cardiology": 0.003166421611309708, "requires": 0.002859563651768693, "strategy": 0.002859563651768693, "agents": 0.0024639549360824403, "reference": 0.003021534104319086, "26": 0.0009531878839228976, "consistent": 0.003166421611309708, "made": 0.0019063757678457953, "frequently": 0.003166421611309708, "department": 0.003166421611309708, "enrollment": 0.003166421611309708, "stratification": 0.0036291245814995166, "multivariable": 0.003527214304519152, "analyzed": 0.002859563651768693, "reviewed": 0.002859563651768693, "particularly": 0.003417142820005339, "points": 0.0024639549360824403, "mechanisms": 0.003166421611309708, "scale": 0.00221323372738681, "little": 0.0024639549360824403, "altered": 0.002675936697576619, "resulted": 0.002859563651768693, "differential": 0.003417142820005339, "average": 0.002675936697576619, "following": 0.003021534104319086, "9": 0.0, "approach": 0.002859563651768693, "uptitration": 0.0032974883041448507, "48": 0.0009531878839228976, "hemodynamic": 0.0032974883041448507, "occur": 0.00221323372738681, "hypothesized": 0.003417142820005339, "randomly": 0.002859563651768693, "imaging": 0.002675936697576619, "predictive": 0.003166421611309708, "obtained": 0.002859563651768693, "sensitivity": 0.0032974883041448507, "hypertensive": 0.003417142820005339, "infusion": 0.002859563651768693, "targets": 0.002675936697576619, "preoperative": 0.003417142820005339, "economic": 0.002859563651768693, "rs": 0.0009531878839228976, "variation": 0.003021534104319086, "reported": 0.002859563651768693, "size": 0.0019063757678457953, "diagnosed": 0.003021534104319086, "summary": 0.002675936697576619, "camp": 0.0019063757678457953, "drug": 0.0019063757678457953, "sudden": 0.0024639549360824403, "ea": 0.0009531878839228976, "inhibitor": 0.003021534104319086, "albumin": 0.002675936697576619, "13": 0.0009531878839228976, "physical": 0.002859563651768693, "stay": 0.0019063757678457953, "result": 0.0024639549360824403, "abnormalities": 0.003527214304519152, "programs": 0.002859563651768693, "pathological": 0.003417142820005339, "45": 0.0009531878839228976, "cardiotoxicity": 0.0036291245814995166, "administration": 0.0036291245814995166, "center": 0.0024639549360824403, "catheter": 0.002859563651768693, "indicated": 0.003021534104319086, "key": 0.001510767052159543, "scn5a": 0.00221323372738681, "mmol": 0.0019063757678457953, "testosterone": 0.003417142820005339, "autonomic": 0.003021534104319086, "eh": 0.0009531878839228976, "la": 0.0009531878839228976, "saxagliptin": 0.0032974883041448507, "sitagliptin": 0.0032974883041448507, "deactivation": 0.003417142820005339, "trends": 0.002190182165406614, "suggests": 0.0025418343571277273, "led": 0.0013429040463640383, "cachexia": 0.0025418343571277273, "tested": 0.002190182165406614, "fm": 0.0008472781190425757, "correlation": 0.002931100714795423, "p<0.05": 0.002190182165406614, "alone": 0.0019673188687882757, "leading": 0.0023786103978458836, "importance": 0.0028145969878308518, "treatments": 0.0028145969878308518, "databases": 0.0026858080927280766, "17": 0.0008472781190425757, "unknown": 0.0023786103978458836, "needed": 0.002190182165406614, "selected": 0.0025418343571277273, "0.83": 0.0016945562380851515, "60": 0.0008472781190425757, "cumulative": 0.0028145969878308518, "hazards": 0.0023786103978458836, "therapies": 0.0026858080927280766, "diseases": 0.0025418343571277273, "measurements": 0.00303746028444919, "admissions": 0.0028145969878308518, "11": 0.0008472781190425757, "good": 0.0016945562380851515, "21": 0.0008472781190425757, "myocardium": 0.0028145969878308518, "injury": 0.002190182165406614, "younger": 0.0023786103978458836, "fewer": 0.0019673188687882757, "seen": 0.0016945562380851515, "classification": 0.003225888516888459, "for": 0.0013429040463640383, "76": 0.0008472781190425757, "seven": 0.0019673188687882757, "iv": 0.0008472781190425757, "studied": 0.0023786103978458836, "walk": 0.0016945562380851515, "medications": 0.002931100714795423, "0.0001": 0.002190182165406614, "predicting": 0.0028145969878308518, "required": 0.0025418343571277273, "useful": 0.002190182165406614, "old": 0.0013429040463640383, "laboratory": 0.0028145969878308518, "biventricular": 0.0031353016040170235, "approximately": 0.0031353016040170235, "lack": 0.0016945562380851515, "cs": 0.0008472781190425757, "successful": 0.0028145969878308518, "0.70": 0.0016945562380851515, "84": 0.0008472781190425757, "clinic": 0.002190182165406614, "outpatients": 0.002931100714795423, "35": 0.0008472781190425757, "vivo": 0.0016945562380851515, "minutes": 0.0023786103978458836, "kinase": 0.002190182165406614, "consumption": 0.002931100714795423, "maximal": 0.0023786103978458836, "elastance": 0.0026858080927280766, "importantly": 0.002931100714795423, "moreover": 0.0025418343571277273, "plus": 0.0016945562380851515, "comorbidities": 0.0031353016040170235, "aor": 0.0013429040463640383, "atp": 0.0013429040463640383, "stent": 0.0019673188687882757, "44": 0.0008472781190425757, "mechanical": 0.0028145969878308518, "experienced": 0.002931100714795423, "dietary": 0.0023786103978458836, "yet": 0.0013429040463640383, "\u03b4": 0.0, "depression": 0.0028145969878308518, "aerobic": 0.0023786103978458836, "worsening": 0.0026858080927280766, "biological": 0.0028145969878308518, "0.85": 0.0016945562380851515, "expressed": 0.0026858080927280766, "irs1": 0.0016945562380851515, "irs2": 0.0016945562380851515, "cancer": 0.002190182165406614, "initiative": 0.0028145969878308518, "trend": 0.0019673188687882757, "ecct": 0.0016945562380851515, "mapping": 0.0023786103978458836, "phase": 0.0019673188687882757, "titin": 0.0019673188687882757, "zsf1": 0.0016945562380851515, "resting": 0.0023786103978458836, "pd": 0.0008472781190425757, "sodium": 0.002190182165406614, "multiple": 0.0025418343571277273, "anthracycline": 0.0031353016040170235, "ablation": 0.0025418343571277273, "nicorandil": 0.0028145969878308518, "targeting": 0.0026858080927280766, "variants": 0.0025418343571277273, "contextual": 0.0028145969878308518, "preferences": 0.002931100714795423, "biomedical": 0.0028145969878308518, "pyridostigmine": 0.003225888516888459, "dyssynchronous": 0.003225888516888459, "uptake": 0.002190182165406614, "rule": 0.0016945562380851515, "membrane": 0.0025418343571277273, "ecmo": 0.0016945562380851515, "f": 0.0, "kit+": 0.0016945562380851515, "sample": 0.0019164093947307873, "attention": 0.0023500820811370674, "caused": 0.0019164093947307873, "peptides": 0.002224105062486761, "2012": 0.0014827367083245075, "additional": 0.0024627723643519954, "purpose": 0.002081284098115148, "observational": 0.002743388903514896, "both": 0.0014827367083245075, "highly": 0.0019164093947307873, "strongly": 0.002224105062486761, "further": 0.002081284098115148, "double": 0.0019164093947307873, "2010": 0.0014827367083245075, "enhanced": 0.002224105062486761, "added": 0.0017214040101897411, "quantify": 0.002224105062486761, "regarding": 0.0023500820811370674, "d": 0.0, "ie": 0.0007413683541622537, "subsequent": 0.0024627723643519954, "experience": 0.0024627723643519954, "eo": 0.0007413683541622537, "basis": 0.0017214040101897411, "examination": 0.002564713125445995, "metrics": 0.002081284098115148, "centers": 0.002081284098115148, "absolute": 0.002224105062486761, "percent": 0.002081284098115148, "0.50": 0.0014827367083245075, "implanted": 0.0023500820811370674, "sts": 0.0011750410405685337, "inclusion": 0.0023500820811370674, "renin": 0.0017214040101897411, "accompanied": 0.002564713125445995, "work": 0.0014827367083245075, "include": 0.002081284098115148, "documented": 0.0024627723643519954, "determined": 0.0024627723643519954, "percentage": 0.0024627723643519954, "intervals": 0.0023500820811370674, "symptomatic": 0.002564713125445995, "circulation": 0.002564713125445995, "circulatory": 0.002564713125445995, "minute": 0.0019164093947307873, "80": 0.0007413683541622537, "diuretics": 0.0023500820811370674, "protective": 0.0024627723643519954, "production": 0.0024627723643519954, "survivors": 0.0023500820811370674, "furthermore": 0.002564713125445995, "especially": 0.0024627723643519954, "salt": 0.0014827367083245075, "established": 0.002564713125445995, "fibrosis": 0.002224105062486761, "t": 0.0, "biomarker": 0.0023500820811370674, "various": 0.002081284098115148, "incident": 0.002224105062486761, "auc": 0.0011750410405685337, "shock": 0.0017214040101897411, "31": 0.0007413683541622537, "stenosis": 0.002224105062486761, "reversed": 0.002224105062486761, "ring": 0.0014827367083245075, "regurgitation": 0.002743388903514896, "leaflet": 0.002081284098115148, "plasty": 0.0019164093947307873, "degenerative": 0.002657777748893041, "later": 0.0017214040101897411, "another": 0.002081284098115148, "postoperative": 0.002743388903514896, "resulting": 0.0023500820811370674, "angiography": 0.002564713125445995, "etiology": 0.002224105062486761, "causes": 0.0019164093947307873, "second": 0.0019164093947307873, "inpatient": 0.0023500820811370674, "70": 0.0007413683541622537, "city": 0.0014827367083245075, "ca(2": 0.0014827367083245075, "27": 0.0007413683541622537, "0.98": 0.0014827367083245075, "potassium": 0.0023500820811370674, "community": 0.0023500820811370674, "crucial": 0.002081284098115148, "negative": 0.002224105062486761, "brain": 0.0017214040101897411, "form": 0.0014827367083245075, "ischemia": 0.002224105062486761, "lad": 0.0011750410405685337, "hypoalbuminemia": 0.002896445050758275, "ai": 0.0007413683541622537, "69": 0.0007413683541622537, "idiopathic": 0.0024627723643519954, "walking": 0.002081284098115148, "alternative": 0.002564713125445995, "lvet": 0.0014827367083245075, "partially": 0.0023500820811370674, "aim": 0.0011750410405685337, "signalling": 0.0024627723643519954, "frequency": 0.0023500820811370674, "investigating": 0.002743388903514896, "produced": 0.002224105062486761, "collagen": 0.002224105062486761, "lean": 0.0014827367083245075, "gls": 0.0011750410405685337, "refractory": 0.0024627723643519954, "still": 0.0017214040101897411, "rehospitalization": 0.003030315599317134, "remodelling": 0.002564713125445995, "minnesota": 0.0023500820811370674, "deficit": 0.002081284098115148, "np": 0.0007413683541622537, "parasympathetic": 0.002896445050758275, "aspects": 0.002081284098115148, "ar": 0.0007413683541622537, "hrqol": 0.0017214040101897411, "hgb": 0.0011750410405685337, "skeletal": 0.002224105062486761, "mt": 0.0007413683541622537, "gastrointestinal": 0.002965473416649015, "s1pr1": 0.0017214040101897411, "receptors": 0.0023500820811370674, "hct": 0.0011750410405685337, "neprilysin": 0.0024627723643519954, "bleeding": 0.002224105062486761, "btes": 0.0014827367083245075, "remain": 0.0016426366240549605, "cc": 0.0006354585892819318, "nps": 0.001007178034773029, "play": 0.0012709171785638637, "ffm": 0.001007178034773029, "19": 0.0006354585892819318, "inflammation": 0.002278095213336893, "prospectively": 0.0023514762030127675, "least": 0.0014754891515912068, "combination": 0.002198325536096567, "american": 0.0019063757678457953, "recommendation": 0.002419416387666344, "hemoglobin": 0.002110947740873139, "dl": 0.0006354585892819318, "1.8": 0.001007178034773029, "intravenous": 0.002198325536096567, "agent": 0.0014754891515912068, "settings": 0.0019063757678457953, "icd": 0.001007178034773029, "min/1.73": 0.0019063757678457953, "hours": 0.0014754891515912068, "open": 0.0012709171785638637, "processes": 0.002014356069546058, "implementation": 0.002419416387666344, "nurses": 0.0016426366240549605, "proteomics": 0.002110947740873139, "myocyte": 0.001783957798384413, "dna": 0.001007178034773029, "recipients": 0.002110947740873139, "bundle": 0.0016426366240549605, "branch": 0.0016426366240549605, "block": 0.0014754891515912068, "0.87": 0.0012709171785638637, "reductions": 0.002110947740873139, "0.92": 0.0012709171785638637, "involved": 0.0019063757678457953, "cfus": 0.0012709171785638637, "implications": 0.002278095213336893, "metric": 0.0016426366240549605, "cms": 0.001007178034773029, "0.67": 0.0012709171785638637, "75": 0.0006354585892819318, "tm": 0.0006354585892819318, "hm": 0.0006354585892819318, "1.08": 0.0012709171785638637, "statistically": 0.0023514762030127675, "reducing": 0.0019063757678457953, "investigation": 0.0023514762030127675, "tachycardia": 0.002198325536096567, "fully": 0.0014754891515912068, "western": 0.001783957798384413, "activated": 0.002014356069546058, "pathogenesis": 0.002278095213336893, "lvads": 0.0014754891515912068, "received": 0.0019063757678457953, "]": 0.0, "0.54": 0.0012709171785638637, "associations": 0.002278095213336893, "female": 0.0016426366240549605, "pg": 0.0006354585892819318, "article": 0.001783957798384413, "elderly": 0.001783957798384413, "protocol": 0.0019063757678457953, "classified": 0.002110947740873139, "coefficient": 0.002198325536096567, "1.7": 0.001007178034773029, "decreases": 0.002014356069546058, "systemic": 0.0019063757678457953, "catheterization": 0.0024826671863642353, "central": 0.001783957798384413, "comparison": 0.002110947740873139, "facilitate": 0.002110947740873139, "gender": 0.0016426366240549605, "0.004": 0.0014754891515912068, "unique": 0.0016426366240549605, "ec": 0.0006354585892819318, "iiib": 0.0012709171785638637, "demonstrate": 0.002198325536096567, "cutoff": 0.0016426366240549605, "died": 0.0012709171785638637, "experimental": 0.002278095213336893, "ang": 0.001007178034773029, "oxidative": 0.002014356069546058, "atherosclerosis": 0.0024826671863642353, "ctnt": 0.0012709171785638637, "fit": 0.001007178034773029, "continuous": 0.002110947740873139, "provides": 0.0019063757678457953, "favorable": 0.002014356069546058, "btt": 0.001007178034773029, "bivp": 0.0012709171785638637, "understanding": 0.0023514762030127675, "analyze": 0.001783957798384413, "delay": 0.0014754891515912068, "occlusion": 0.002014356069546058, "indices": 0.001783957798384413, "linear": 0.0016426366240549605, "opening": 0.001783957798384413, "dynamic": 0.001783957798384413, "confirmed": 0.002014356069546058, "cm2": 0.001007178034773029, "continuity": 0.002110947740873139, "modestly": 0.0019063757678457953, "restriction": 0.002198325536096567, "hfpsi": 0.0014754891515912068, "validated": 0.002014356069546058, "1.73": 0.0012709171785638637, "kansas": 0.0016426366240549605, "intermediate": 0.002278095213336893, "cxl-1020": 0.0019063757678457953, "0.96": 0.0012709171785638637, "newly": 0.0014754891515912068, "excluded": 0.0019063757678457953, "2.5": 0.001007178034773029, "fold": 0.0012709171785638637, "angiogenesis": 0.002278095213336893, "vegf": 0.0012709171785638637, "worse": 0.0014754891515912068, "acf": 0.001007178034773029, "0.63": 0.0012709171785638637, "individual": 0.002110947740873139, "bottleneck": 0.002110947740873139, "proximal": 0.0019063757678457953, "lcx": 0.001007178034773029, "reserve": 0.001783957798384413, "ees": 0.001007178034773029, "differ": 0.0016426366240549605, "marked": 0.0016426366240549605, "subgroup": 0.0019063757678457953, "procedure": 0.002014356069546058, "youngest": 0.0019063757678457953, "black": 0.0014754891515912068, "categories": 0.002110947740873139, "1.00": 0.0012709171785638637, "assigned": 0.0019063757678457953, "tools": 0.0014754891515912068, "icu": 0.001007178034773029, "90": 0.0006354585892819318, "previously": 0.002110947740873139, "embolism": 0.0019063757678457953, "interquartile": 0.0023514762030127675, "tnf": 0.001007178034773029, "vasopressin": 0.002198325536096567, "hand2": 0.0014754891515912068, "linked": 0.0016426366240549605, "targeted": 0.0019063757678457953, "induction": 0.002014356069546058, "breast": 0.0016426366240549605, "toward": 0.0016426366240549605, "aims": 0.0012709171785638637, "0.99": 0.0012709171785638637, "modification": 0.002278095213336893, "beat": 0.0012709171785638637, "lbbb": 0.0012709171785638637, "2007": 0.0012709171785638637, "retn": 0.0012709171785638637, "sinus": 0.0014754891515912068, "state": 0.0014754891515912068, "clinically": 0.002110947740873139, "records": 0.001783957798384413, "tool": 0.0012709171785638637, "contribution": 0.002278095213336893, "designed": 0.0019063757678457953, "bets": 0.0012709171785638637, "prevention": 0.002110947740873139, "na+": 0.001007178034773029, "channels": 0.0019063757678457953, "upr": 0.001007178034773029, "downregulation": 0.002419416387666344, "balance": 0.001783957798384413, "diameter": 0.0019063757678457953, "goal": 0.0012709171785638637, "states": 0.0016426366240549605, "pilot": 0.0014754891515912068, "five": 0.0012709171785638637, "partial": 0.001783957798384413, "extracorporeal": 0.002419416387666344, "applied": 0.001783957798384413, "fes": 0.001007178034773029, "social": 0.0016426366240549605, "sdqt": 0.0012709171785638637, "ch": 0.0006354585892819318, "aac": 0.001007178034773029, "bat": 0.001007178034773029, "barriers": 0.0019063757678457953, "pneumonia": 0.0016786300579550478, "decline": 0.0014866314986536771, "problems": 0.0015886464732048295, "progress": 0.0015886464732048295, "cross": 0.0012295742929926722, "hypothesis": 0.0017591231173942823, "progressive": 0.0018319379467471393, "distribution": 0.0018984126777807438, "dual": 0.0010590976488032196, "countries": 0.0016786300579550478, "increases": 0.0016786300579550478, "signs": 0.0012295742929926722, "stiffness": 0.0016786300579550478, "pressures": 0.0016786300579550478, "literature": 0.0017591231173942823, "medline": 0.0014866314986536771, "2013": 0.0010590976488032196, "arrhythmia": 0.0017591231173942823, "transfusion": 0.0018319379467471393, "grade": 0.0012295742929926722, "strong": 0.0013688638533791337, "aggressive": 0.0017591231173942823, "indication": 0.0017591231173942823, "outpatient": 0.0017591231173942823, "conducted": 0.0016786300579550478, "72": 0.0005295488244016098, "obstructive": 0.0018319379467471393, "1.2": 0.0008393150289775239, "0.77": 0.0010590976488032196, "decongestion": 0.0018984126777807438, "neither": 0.0014866314986536771, "sites": 0.0012295742929926722, "relevance": 0.0016786300579550478, "participating": 0.00195956350251064, "nucleolin": 0.0016786300579550478, "profile": 0.0014866314986536771, "modest": 0.0013688638533791337, "impairment": 0.0017591231173942823, "receive": 0.0014866314986536771, "previous": 0.0015886464732048295, "revascularization": 0.0021645111423693815, "contemporary": 0.0018984126777807438, "severely": 0.0015886464732048295, "0.04": 0.0010590976488032196, "1.02": 0.0010590976488032196, "cpcs": 0.0010590976488032196, "process": 0.0014866314986536771, "2000": 0.0010590976488032196, "office": 0.0013688638533791337, "highest": 0.0014866314986536771, "between": 0.0014866314986536771, "measuring": 0.0016786300579550478, "rm": 0.0005295488244016098, "growing": 0.0014866314986536771, "discharged": 0.0017591231173942823, "january": 0.0014866314986536771, "relevant": 0.0015886464732048295, "validity": 0.0015886464732048295, "comparisons": 0.0018319379467471393, "participation": 0.00195956350251064, "understood": 0.0017591231173942823, "bax": 0.0008393150289775239, "treating": 0.0015886464732048295, "replacement": 0.0018319379467471393, "ras-": 0.0010590976488032196, "0.81": 0.0010590976488032196, "burden": 0.0013688638533791337, "inhospital": 0.0017591231173942823, "explored": 0.0015886464732048295, "pediatric": 0.0016786300579550478, "involving": 0.0016786300579550478, "international": 0.00195956350251064, "1.3": 0.0008393150289775239, "1.6": 0.0008393150289775239, "distinct": 0.0015886464732048295, "77": 0.0005295488244016098, "final": 0.0012295742929926722, "hdl(nyha": 0.0015886464732048295, "quantified": 0.0017591231173942823, "done": 0.0010590976488032196, "curve": 0.0012295742929926722, "loading": 0.0014866314986536771, "simple": 0.0013688638533791337, "ans": 0.0008393150289775239, "fractional": 0.0017591231173942823, "lung": 0.0010590976488032196, "reclassification": 0.0021181952976064393, "described": 0.0016786300579550478, "over": 0.0010590976488032196, "statistical": 0.0018319379467471393, "interestingly": 0.00195956350251064, "dt": 0.0005295488244016098, "june": 0.0010590976488032196, "varying": 0.0014866314986536771, "synchrony": 0.0016786300579550478, "mixed": 0.0012295742929926722, "anterior": 0.0015886464732048295, "man": 0.0008393150289775239, "edge": 0.0010590976488032196, "wave": 0.0010590976488032196, "lesions": 0.0014866314986536771, "clear": 0.0012295742929926722, "discussed": 0.0016786300579550478, "symptom": 0.0014866314986536771, "repeated": 0.0015886464732048295, "66": 0.0005295488244016098, "direct": 0.0013688638533791337, "indicative": 0.0017591231173942823, "most": 0.0010590976488032196, "collected": 0.0016786300579550478, "university": 0.0017591231173942823, "epidemiology": 0.0018984126777807438, "59": 0.0005295488244016098, "68": 0.0005295488244016098, "comparable": 0.0017591231173942823, "domains": 0.0014866314986536771, "internal": 0.0015886464732048295, "reliability": 0.0018319379467471393, "concentrations": 0.002016180323055287, "family": 0.0013688638533791337, "doses": 0.0012295742929926722, "affect": 0.0013688638533791337, "ng": 0.0005295488244016098, "achieved": 0.0015886464732048295, "hno": 0.0008393150289775239, "usefulness": 0.0017591231173942823, "here": 0.0010590976488032196, "contractility": 0.00195956350251064, "3.1": 0.0008393150289775239, "0.97": 0.0010590976488032196, "initial": 0.0014866314986536771, "5.0": 0.0008393150289775239, "covariates": 0.0017591231173942823, "22": 0.0005295488244016098, "0.91": 0.0010590976488032196, "perfusion": 0.0016786300579550478, "influences": 0.0017591231173942823, "eds": 0.0008393150289775239, "driven": 0.0013688638533791337, "xo": 0.0005295488244016098, "rat": 0.0008393150289775239, "absence": 0.0014866314986536771, "extracellular": 0.00195956350251064, "attenuation": 0.0018319379467471393, "possibly": 0.0015886464732048295, "force": 0.0012295742929926722, "vessel": 0.0013688638533791337, "feasible": 0.0015886464732048295, "relation": 0.0015886464732048295, "twice": 0.0012295742929926722, "0.002": 0.0012295742929926722, "from": 0.0010590976488032196, "programme": 0.0016786300579550478, "nordic": 0.0013688638533791337, "centre": 0.0013688638533791337, "parallel": 0.0015886464732048295, "promising": 0.0016786300579550478, "milliseconds": 0.0018984126777807438, "73": 0.0005295488244016098, "completed": 0.0016786300579550478, "recovery": 0.0015886464732048295, "information": 0.0018319379467471393, "populations": 0.0018319379467471393, "expected": 0.0015886464732048295, "responses": 0.0016786300579550478, "site": 0.0010590976488032196, "92": 0.0005295488244016098, "full": 0.0010590976488032196, "chemotherapy": 0.0018984126777807438, "mediterranean": 0.00195956350251064, "p<0.0001": 0.0015886464732048295, "part": 0.0010590976488032196, "thirty": 0.0013688638533791337, "p<0.01": 0.0013688638533791337, "p=0.03": 0.0013688638533791337, "preliminary": 0.0018319379467471393, "suggesting": 0.0017591231173942823, "on": 0.0005295488244016098, "dd": 0.0005295488244016098, "\u2265": 0.0, "extent": 0.0013688638533791337, "majority": 0.0015886464732048295, "appears": 0.0014866314986536771, "hum": 0.0008393150289775239, "maintenance": 0.0018319379467471393, "assisted": 0.0015886464732048295, "cabg": 0.0010590976488032196, "maladaptive": 0.0018319379467471393, "activating": 0.0017591231173942823, "pharmacologic": 0.00195956350251064, "like": 0.0010590976488032196, "poc": 0.0008393150289775239, "consultation": 0.0018984126777807438, "haemodynamic": 0.0018984126777807438, "jq1": 0.0008393150289775239, "contrast": 0.0015886464732048295, "subunit": 0.0014866314986536771, "late": 0.0010590976488032196, "emd": 0.0008393150289775239, "myofiber": 0.0015886464732048295, "thickness": 0.0016786300579550478, "united": 0.0013688638533791337, "options": 0.0014866314986536771, "wrf": 0.0008393150289775239, "endpoint": 0.0015886464732048295, "resource": 0.0015886464732048295, "chm": 0.0008393150289775239, "lyso": 0.0010590976488032196, ".05": 0.0008393150289775239, "acs": 0.0008393150289775239, "oxygenation": 0.0018319379467471393, "concurrent": 0.0017591231173942823, "regulation": 0.0017591231173942823, "divided": 0.0014866314986536771, "ecmo+vad": 0.0015886464732048295, "coupled": 0.0014866314986536771, "urgent": 0.0013688638533791337, "familiar": 0.0015886464732048295, "qt": 0.0005295488244016098, "qtv": 0.0008393150289775239, "hnorm": 0.0012295742929926722, "mirnas": 0.0013688638533791337, "service": 0.0014866314986536771, "infection": 0.0016786300579550478, "q66p": 0.0010590976488032196, "tta": 0.0008393150289775239, "tgtetmena": 0.0016786300579550478, "discussions": 0.0018319379467471393, "athletes": 0.0015886464732048295, "psss": 0.0010590976488032196, "bpm": 0.0008393150289775239, "lvas": 0.0010590976488032196, "real": 0.0008472781190425757, "neurohormonal": 0.0015676508020085118, "society": 0.0011893051989229418, "college": 0.0011893051989229418, "acp": 0.0006714520231820191, "published": 0.0013429040463640383, "july": 0.0008472781190425757, "cochrane": 0.0012709171785638637, "harms": 0.0009836594343941379, "venous": 0.001095091082703307, "thromboembolic": 0.0016129442584442294, "includes": 0.0012709171785638637, "erythropoiesis": 0.0016129442584442294, "stimulating": 0.0014655503573977114, "embase": 0.001095091082703307, "syndrome": 0.0012709171785638637, "few": 0.0006714520231820191, "help": 0.0008472781190425757, "defibrillators": 0.0016129442584442294, "al": 0.00042363905952128787, "authors": 0.0011893051989229418, "focused": 0.0011893051989229418, "ahf": 0.0006714520231820191, "essential": 0.0013429040463640383, "evaluating": 0.0014072984939154259, "eligible": 0.0012709171785638637, "estimates": 0.0013429040463640383, "1.56": 0.0008472781190425757, "1.71": 0.0008472781190425757, "0.73": 0.0008472781190425757, "reliable": 0.0012709171785638637, "0.005": 0.0009836594343941379, "blind": 0.0009836594343941379, "m2": 0.00042363905952128787, "america": 0.0011893051989229418, "hour": 0.0008472781190425757, "0.13": 0.0008472781190425757, "nurse": 0.0009836594343941379, "focus": 0.0009836594343941379, "practices": 0.0013429040463640383, "extend": 0.001095091082703307, "\u00ae": 0.0, "cellular": 0.0012709171785638637, "tests": 0.0009836594343941379, "deficits": 0.0012709171785638637, "defects": 0.0011893051989229418, "shift": 0.0009836594343941379, "reports": 0.0011893051989229418, "diseased": 0.0012709171785638637, "automatic": 0.0013429040463640383, "bypass": 0.001095091082703307, "percutaneous": 0.001518730142224595, "decompensated": 0.0015676508020085118, "world": 0.0009836594343941379, "\u226550": 0.0006714520231820191, "49": 0.00042363905952128787, "moderately": 0.0014072984939154259, "39": 0.00042363905952128787, "1.01": 0.0008472781190425757, "evident": 0.0011893051989229418, "0.86": 0.0008472781190425757, "0.03": 0.0008472781190425757, "progenitor": 0.0014072984939154259, "every": 0.0009836594343941379, "units": 0.0009836594343941379, "recorded": 0.0012709171785638637, "55": 0.00042363905952128787, "noted": 0.0009836594343941379, "generally": 0.0013429040463640383, "correlations": 0.001518730142224595, "careful": 0.0011893051989229418, "network": 0.0011893051989229418, "context": 0.0011893051989229418, "home": 0.0008472781190425757, "programmes": 0.0014072984939154259, "hh": 0.00042363905952128787, "twenty": 0.001095091082703307, "significance": 0.001518730142224595, "1.18": 0.0008472781190425757, "hospitalisations": 0.0016945562380851515, "apoptosis": 0.0013429040463640383, "bcl-2": 0.0009836594343941379, "taken": 0.0009836594343941379, "dogs": 0.0008472781190425757, "method": 0.001095091082703307, "unchanged": 0.0013429040463640383, "positive": 0.0012709171785638637, "become": 0.001095091082703307, "when": 0.0008472781190425757, "technique": 0.0013429040463640383, "ref": 0.0006714520231820191, "0.36": 0.0008472781190425757, "0.32": 0.0008472781190425757, "predicts": 0.0012709171785638637, "borderline": 0.0014072984939154259, "2.7": 0.0006714520231820191, "adjusting": 0.0013429040463640383, "presentation": 0.001518730142224595, "canadian": 0.0012709171785638637, "application": 0.0014655503573977114, "cognitive": 0.0013429040463640383, "relationships": 0.0015676508020085118, "presenting": 0.0014072984939154259, "liver": 0.0009836594343941379, "hemodynamically": 0.001655111457576157, "saf": 0.0006714520231820191, "fifty": 0.0009836594343941379, "predominantly": 0.0015676508020085118, "pf": 0.00042363905952128787, "2.8": 0.0006714520231820191, "by": 0.00042363905952128787, "96": 0.00042363905952128787, "42": 0.00042363905952128787, "output": 0.001095091082703307, "0.008": 0.0009836594343941379, "prescribed": 0.0014072984939154259, "enos": 0.0008472781190425757, "successfully": 0.001518730142224595, "specificity": 0.0014655503573977114, "confirm": 0.0011893051989229418, "hhd": 0.0006714520231820191, "uninephrectomy": 0.0016129442584442294, "eight": 0.0009836594343941379, "might": 0.0009836594343941379, "transition": 0.0014072984939154259, "decades": 0.0011893051989229418, "aric": 0.0008472781190425757, "net": 0.0006714520231820191, "excellent": 0.0013429040463640383, "2006": 0.0008472781190425757, "56": 0.00042363905952128787, "200": 0.0006714520231820191, "evaluations": 0.0014655503573977114, "86": 0.00042363905952128787, "78": 0.00042363905952128787, "twist": 0.0009836594343941379, "ste": 0.0006714520231820191, "pigs": 0.0008472781190425757, "initiated": 0.0013429040463640383, "echocardiograms": 0.001655111457576157, "basal": 0.0009836594343941379, "contributions": 0.0015676508020085118, "annuloplasty": 0.001518730142224595, "disappeared": 0.0014655503573977114, "71": 0.00042363905952128787, "gradient": 0.0012709171785638637, "restricted": 0.0014072984939154259, "vary": 0.0008472781190425757, "routinely": 0.0013429040463640383, "um": 0.00042363905952128787, "rt": 0.00042363905952128787, "date": 0.0008472781190425757, "cohorts": 0.0011893051989229418, "collaboration": 0.0015676508020085118, "constructed": 0.0014655503573977114, "q": 0.0, "61": 0.00042363905952128787, "51": 0.00042363905952128787, "exists": 0.001095091082703307, "soluble": 0.0011893051989229418, "daily": 0.0009836594343941379, "conscious": 0.0013429040463640383, "93": 0.00042363905952128787, "creatinine": 0.0014072984939154259, "crude": 0.0009836594343941379, "3.5": 0.0006714520231820191, "contributes": 0.0014655503573977114, "ad": 0.00042363905952128787, "enhancement": 0.0014655503573977114, "efficiency": 0.0014072984939154259, "o2": 0.00042363905952128787, "transmitral": 0.0014655503573977114, "pcwp": 0.0008472781190425757, "130": 0.0006714520231820191, "e'septal": 0.0012709171785638637, "89": 0.00042363905952128787, "separate": 0.0012709171785638637, "5.1": 0.0006714520231820191, "antiarrhythmic": 0.0016129442584442294, "prevent": 0.0011893051989229418, "timing": 0.001095091082703307, "antiplatelet": 0.001518730142224595, "stenting": 0.0012709171785638637, "infarcted": 0.0013429040463640383, "reversible": 0.0014072984939154259, "cf": 0.00042363905952128787, "invasive": 0.0012709171785638637, "\u226570": 0.0006714520231820191, "23": 0.00042363905952128787, "62": 0.00042363905952128787, "fatal": 0.0009836594343941379, "compare": 0.0011893051989229418, "grip": 0.0008472781190425757, "ph": 0.00042363905952128787, "deterioration": 0.0015676508020085118, "atrium": 0.001095091082703307, "copd": 0.0008472781190425757, "mdc": 0.0006714520231820191, "ranging": 0.0011893051989229418, "healthcare": 0.0014072984939154259, "perceived": 0.0013429040463640383, "battery": 0.0011893051989229418, "frail": 0.0009836594343941379, "1.24": 0.0008472781190425757, "spontaneous": 0.0014655503573977114, "occurs": 0.001095091082703307, "intolerance": 0.0014655503573977114, "mineralocorticoid": 0.0017316089138955052, "components": 0.0014072984939154259, "dko": 0.0006714520231820191, "content": 0.0011893051989229418, "1.05": 0.0008472781190425757, "i": 0.0, "descriptive": 0.0014655503573977114, "assessments": 0.0014655503573977114, "changed": 0.0011893051989229418, "matrix": 0.001095091082703307, "1.03": 0.0008472781190425757, "times": 0.0009836594343941379, "rest": 0.0008472781190425757, "influence": 0.0013429040463640383, "p=0.04": 0.001095091082703307, "prolonged": 0.0013429040463640383, "p=0.02": 0.001095091082703307, "n=11": 0.0008472781190425757, "specifically": 0.001518730142224595, "sensitive": 0.0013429040463640383, "univariate": 0.0014072984939154259, "\u2264": 0.0, "morphology": 0.0014072984939154259, "srd": 0.0006714520231820191, "brachial": 0.0012709171785638637, "stimulated": 0.0014072984939154259, "vitro": 0.0009836594343941379, "success": 0.0011893051989229418, "larger": 0.001095091082703307, "phosphocreatine": 0.001655111457576157, "perturbations": 0.0015676508020085118, "web": 0.0006714520231820191, "logistic": 0.0012709171785638637, "congenital": 0.0014072984939154259, "poorly": 0.001095091082703307, "investigations": 0.0016129442584442294, "erk1/2": 0.001095091082703307, "adaptive": 0.0012709171785638637, "transduction": 0.001518730142224595, "proportion": 0.0014072984939154259, "unit": 0.0008472781190425757, "predicted": 0.0013429040463640383, "describe": 0.0012709171785638637, "routine": 0.0011893051989229418, "guide": 0.0009836594343941379, "developing": 0.0014072984939154259, "bromodomain": 0.0014655503573977114, "signal": 0.001095091082703307, "epigenetic": 0.0014072984939154259, "substantial": 0.0014655503573977114, "constriction": 0.001518730142224595, "breathing": 0.0013429040463640383, "pulse": 0.0009836594343941379, "sequence": 0.0012709171785638637, "means": 0.0009836594343941379, "age-": 0.0008472781190425757, "123)i": 0.0009836594343941379, "haplotype": 0.0013429040463640383, "\u03b22": 0.00042363905952128787, "irrespective": 0.001518730142224595, "vagal": 0.0009836594343941379, "insight": 0.0011893051989229418, "electrical": 0.0014072984939154259, "represented": 0.0014655503573977114, "additive": 0.0012709171785638637, "wasting": 0.0011893051989229418, "million": 0.0011893051989229418, "cgmp": 0.0008472781190425757, "overexpression": 0.0016129442584442294, "explore": 0.0011893051989229418, "canada": 0.001095091082703307, "skm": 0.0006714520231820191, "vo2max": 0.001095091082703307, "dcm": 0.0006714520231820191, "enzymes": 0.0011893051989229418, "[": 0.0, "update": 0.001095091082703307, "problem": 0.0011893051989229418, "beck": 0.0008472781190425757, "inventory": 0.0013429040463640383, "living": 0.001095091082703307, "explant": 0.0011893051989229418, "tgf": 0.0006714520231820191, "pb": 0.00042363905952128787, "lead": 0.0008472781190425757, "rabbits": 0.0011893051989229418, "\u03b21ar": 0.0008472781190425757, "actions": 0.0011893051989229418, "translational": 0.0015676508020085118, "pka": 0.0006714520231820191, "antibodies": 0.0014072984939154259, "wild": 0.0008472781190425757, "hfvt(+": 0.001095091082703307, "0\u00b701": 0.0008472781190425757, "consensus": 0.0013429040463640383, "supports": 0.0012709171785638637, "forms": 0.0009836594343941379, "lvh": 0.0006714520231820191, "rwt": 0.0006714520231820191, "madit": 0.0009836594343941379, "0.64": 0.0008472781190425757, "36": 0.00042363905952128787, "bisphosphonates": 0.001655111457576157, "alendronate": 0.0014655503573977114, "sr": 0.00042363905952128787, "pad": 0.0006714520231820191, "ongoing": 0.0011893051989229418, "public": 0.001095091082703307, "degs": 0.0008472781190425757, "telehealth": 0.0014072984939154259, "beneficiaries": 0.0015676508020085118, "buddy": 0.0009836594343941379, "pna": 0.0006714520231820191, "unfit": 0.0009836594343941379, "glucose": 0.0011893051989229418, "c'd": 0.0006714520231820191, "clcnka": 0.001095091082703307, "air": 0.0006714520231820191, "pollution": 0.0013429040463640383, "hhf": 0.0006714520231820191, "gdmt": 0.0008472781190425757, "paradigm": 0.0012709171785638637, "qol": 0.0006714520231820191, "magnetically": 0.001518730142224595, "levitated": 0.0013429040463640383, "database": 0.0009531878839228976, "created": 0.0008919788991922065, "board": 0.0007377445757956034, "talk": 0.0006354585892819318, "expenditure": 0.0010991627680482835, "suggested": 0.001007178034773029, "x": 0.0, "ray": 0.0005035890173865145, "absorptiometry": 0.001209708193833172, "dxa": 0.0005035890173865145, "diabetic": 0.0009531878839228976, "proanp": 0.0008213183120274803, "adiponectin": 0.0010991627680482835, "inversely": 0.001007178034773029, "bmi": 0.0005035890173865145, "1.35": 0.0006354585892819318, "latter": 0.0008213183120274803, "pronounced": 0.0010554738704365695, "critical": 0.0009531878839228976, "invasively": 0.0010554738704365695, "deficiency": 0.0010554738704365695, "language": 0.0009531878839228976, "tolerance": 0.001007178034773029, "clinicians": 0.0010554738704365695, "trigger": 0.0008919788991922065, "threshold": 0.001007178034773029, "sources": 0.0008919788991922065, "transfusions": 0.0011390476066684464, "extracted": 0.001007178034773029, "protocols": 0.001007178034773029, "limitations": 0.0010991627680482835, "mainly": 0.0008213183120274803, "serious": 0.0008919788991922065, "remote": 0.0008213183120274803, "pharmacological": 0.0012413335931821176, "search": 0.0008213183120274803, "worldwide": 0.001007178034773029, "financial": 0.001007178034773029, "component": 0.001007178034773029, "modern": 0.0008213183120274803, "heterogeneous": 0.0011757381015063838, "searched": 0.0009531878839228976, "63": 0.0003177292946409659, "1.38": 0.0006354585892819318, "shocks": 0.0008213183120274803, "enhance": 0.0008919788991922065, "preserve": 0.0009531878839228976, "march": 0.0007377445757956034, "1:1": 0.0005035890173865145, "urine": 0.0007377445757956034, "cystatin": 0.0009531878839228976, "0.06": 0.0006354585892819318, "similarly": 0.001007178034773029, "beyond": 0.0008213183120274803, "involves": 0.0009531878839228976, "thereby": 0.0008919788991922065, "fundamental": 0.0010991627680482835, "gross": 0.0007377445757956034, "differentiation": 0.0012413335931821176, "validation": 0.0010554738704365695, "ies": 0.0005035890173865145, "ic": 0.0003177292946409659, "comprised": 0.001007178034773029, "0.003": 0.0007377445757956034, "pattern": 0.0008919788991922065, "twofold": 0.0008919788991922065, "attenuated": 0.0010554738704365695, "categorized": 0.0010991627680482835, "0.90": 0.0006354585892819318, "1.20": 0.0006354585892819318, "cd34+vegfr2": 0.0010991627680482835, "0.25": 0.0006354585892819318, "0.09": 0.0006354585892819318, "0.69": 0.0006354585892819318, "choice": 0.0008213183120274803, "acr": 0.0005035890173865145, "medicaid": 0.0009531878839228976, "remaining": 0.001007178034773029, "extreme": 0.0008919788991922065, "agreement": 0.001007178034773029, "principal": 0.001007178034773029, "47": 0.0003177292946409659, "way": 0.0005035890173865145, "needs": 0.0007377445757956034, "supplemented": 0.0011390476066684464, "hand": 0.0006354585892819318, "cri": 0.0005035890173865145, "0.55": 0.0006354585892819318, "0.49": 0.0006354585892819318, "exclusion": 0.001007178034773029, "acceptable": 0.0010554738704365695, "rapid": 0.0007377445757956034, "caspase-3": 0.001007178034773029, "septum": 0.0008213183120274803, "biopsies": 0.0009531878839228976, "fragmentation": 0.0011757381015063838, "tunel": 0.0007377445757956034, "paced": 0.0007377445757956034, "assay": 0.0007377445757956034, "exchange": 0.0009531878839228976, "widely": 0.0008213183120274803, "fractions": 0.001007178034773029, "immediately": 0.0010991627680482835, "0.60": 0.0006354585892819318, "1.09": 0.0006354585892819318, "accounting": 0.0010554738704365695, "childhood": 0.001007178034773029, "advances": 0.0009531878839228976, "intubated": 0.001007178034773029, "revision": 0.0009531878839228976, "codes": 0.0007377445757956034, "visit": 0.0007377445757956034, "2.4": 0.0005035890173865145, "53": 0.0003177292946409659, "traditional": 0.0010991627680482835, "characterized": 0.0011757381015063838, "svr": 0.0005035890173865145, "asymptomatic": 0.0011390476066684464, "0.8": 0.0005035890173865145, "features": 0.0009531878839228976, "recognized": 0.0010554738704365695, "hart": 0.0006354585892819318, "mwt": 0.0005035890173865145, "1.63": 0.0006354585892819318, "density": 0.0008919788991922065, "lipoprotein": 0.0010991627680482835, "rationale": 0.001007178034773029, "exerts": 0.0008213183120274803, "hdl(healthy": 0.0010991627680482835, "bound": 0.0007377445757956034, "k": 0.0, "determination": 0.0011757381015063838, "to": 0.0003177292946409659, "best": 0.0006354585892819318, "knowledge": 0.001007178034773029, "combining": 0.001007178034773029, "compensated": 0.0010991627680482835, "troponin": 0.0009531878839228976, "prevalent": 0.001007178034773029, "characteristic": 0.001209708193833172, "integrated": 0.0010554738704365695, "discrimination": 0.001209708193833172, "temporary": 0.001007178034773029, "insertion": 0.001007178034773029, "cardiogenic": 0.0010991627680482835, "centrimag": 0.001007178034773029, "rvad": 0.0006354585892819318, "demographics": 0.0011390476066684464, "eligibility": 0.0010991627680482835, "requirement": 0.0010991627680482835, "bridge": 0.0008213183120274803, "types": 0.0007377445757956034, "heartware": 0.001007178034773029, "systematically": 0.001209708193833172, "simulation": 0.0010554738704365695, "policy": 0.0008213183120274803, "currently": 0.001007178034773029, "limits": 0.0008213183120274803, "regions": 0.0008919788991922065, "sufficient": 0.0010554738704365695, "regardless": 0.0010554738704365695, "carefully": 0.001007178034773029, "adequate": 0.0009531878839228976, "rvpo": 0.0006354585892819318, "materials": 0.001007178034773029, "ivc": 0.0005035890173865145, "avd": 0.0005035890173865145, "vvd": 0.0005035890173865145, "radial": 0.0008213183120274803, "apex": 0.0006354585892819318, "noninvasive": 0.0010991627680482835, "tethering": 0.001007178034773029, "muscles": 0.0008919788991922065, "prolapse": 0.0009531878839228976, "4.4": 0.0005035890173865145, "fig": 0.0005035890173865145, "started": 0.0008919788991922065, "rheumatic": 0.001007178034773029, "closure": 0.0008919788991922065, "indications": 0.0010991627680482835, "severity": 0.0009531878839228976, "reached": 0.0008919788991922065, "statistics": 0.0010554738704365695, "kaplan": 0.0008213183120274803, "meier": 0.0007377445757956034, "rank": 0.0006354585892819318, "85": 0.0003177292946409659, "rare": 0.0006354585892819318, "valid": 0.0007377445757956034, "terms": 0.0007377445757956034, "\u03b1": 0.0, "0": 0.0, "responsiveness": 0.001209708193833172, "attributable": 0.0011390476066684464, "taking": 0.0008213183120274803, "\u226435": 0.0005035890173865145, "equivalent": 0.0010554738704365695, "lowest": 0.0008213183120274803, "p=0.001": 0.0008919788991922065, "donor": 0.0007377445757956034, "inotropic": 0.001007178034773029, "pure": 0.0006354585892819318, "solely": 0.0008213183120274803, "myocytes": 0.0009531878839228976, "rise": 0.0006354585892819318, "equally": 0.0008919788991922065, "power": 0.0007377445757956034, "robust": 0.0008213183120274803, "cm": 0.0003177292946409659, "79": 0.0003177292946409659, "selecting": 0.001007178034773029, "risks": 0.0007377445757956034, "prevents": 0.0009531878839228976, "bisoprolol": 0.0010554738704365695, "vehicle": 0.0008919788991922065, "capillary": 0.001007178034773029, "1999": 0.0006354585892819318, "responsible": 0.0010991627680482835, "medium": 0.0008213183120274803, "1.16": 0.0006354585892819318, "0.79": 0.0006354585892819318, "repeat": 0.0008213183120274803, "oxidase": 0.0008919788991922065, "respiration": 0.0010991627680482835, "allopurinol": 0.0010991627680482835, "depressed": 0.001007178034773029, "annulus": 0.0008919788991922065, "estimating": 0.0010554738704365695, "systole": 0.0008919788991922065, "diastole": 0.0009531878839228976, "0.71": 0.0006354585892819318, "detecting": 0.001007178034773029, "tricuspid": 0.001007178034773029, "echo": 0.0006354585892819318, "hundred": 0.0008919788991922065, "line": 0.0006354585892819318, "/\u2265": 0.0003177292946409659, "shows": 0.0007377445757956034, "animal": 0.0008213183120274803, "formed": 0.0008213183120274803, "descending": 0.0010554738704365695, "collateral": 0.0010554738704365695, "complete": 0.0009531878839228976, "mostly": 0.0008213183120274803, "64": 0.0003177292946409659, "41": 0.0003177292946409659, "selective": 0.001007178034773029, "reduces": 0.0008919788991922065, "afterload": 0.001007178034773029, "represents": 0.0010554738704365695, "substudy": 0.0009531878839228976, "arm": 0.0005035890173865145, "sv": 0.0003177292946409659, "institution": 0.0010991627680482835, "concentration": 0.0011757381015063838, "normalization": 0.0011757381015063838, "safely": 0.0008213183120274803, "0.42": 0.0006354585892819318, "54": 0.0003177292946409659, "0.3": 0.0005035890173865145, "superior": 0.0009531878839228976, "complicating": 0.0011390476066684464, "precapillary": 0.0011390476066684464, "tonometry": 0.001007178034773029, "carries": 0.0008919788991922065, "shorter": 0.0008919788991922065, "identifying": 0.0010991627680482835, "other": 0.0007377445757956034, "norepinephrine": 0.001209708193833172, "brief": 0.0007377445757956034, "arrest": 0.0008213183120274803, "retest": 0.0008213183120274803, "tug": 0.0005035890173865145, "error": 0.0007377445757956034, "ra": 0.0003177292946409659, "nbdmard": 0.0008919788991922065, "propensity": 0.0010554738704365695, "0.45": 0.0006354585892819318, "people": 0.0008213183120274803, "undertaken": 0.0010554738704365695, "others": 0.0008213183120274803, "abc": 0.0005035890173865145, "habc": 0.0006354585892819318, "74": 0.0003177292946409659, "white": 0.0007377445757956034, "1.13": 0.0006354585892819318, "nervous": 0.0008919788991922065, "nfat": 0.0006354585892819318, "mir-25": 0.0008213183120274803, "embryonic": 0.001007178034773029, "integrate": 0.001007178034773029, "mutant": 0.0008213183120274803, "overexpressing": 0.001209708193833172, "murine": 0.0008213183120274803, "micrornas": 0.001007178034773029, "mammalian": 0.001007178034773029, "past": 0.0006354585892819318, "hallmark": 0.0009531878839228976, "h": 0.0, "diminished": 0.0010554738704365695, "exposure": 0.0009531878839228976, "prevented": 0.001007178034773029, "december": 0.0009531878839228976, "insurance": 0.001007178034773029, "describes": 0.001007178034773029, "1.11": 0.0006354585892819318, "version": 0.0008919788991922065, "1.34": 0.0006354585892819318, "last": 0.0006354585892819318, "cardioprotective": 0.0012709171785638637, "subset": 0.0008213183120274803, "matching": 0.0009531878839228976, "contributing": 0.0011390476066684464, "p=0.035": 0.0008919788991922065, "0.1": 0.0005035890173865145, "chart": 0.0007377445757956034, "postcontrast": 0.0011390476066684464, "technology": 0.0010554738704365695, "p=0.01": 0.0008213183120274803, "chelation": 0.001007178034773029, "verify": 0.0008213183120274803, "prolongation": 0.0011390476066684464, "2.1": 0.0005035890173865145, "hypophosphorylation": 0.0013496910125323826, "obesity": 0.0008919788991922065, "segment": 0.0008919788991922065, "contributed": 0.0010991627680482835, "referred": 0.0009531878839228976, "hospitalisation": 0.0012413335931821176, "sa": 0.0003177292946409659, "containing": 0.0010554738704365695, "separately": 0.0010554738704365695, "ecg": 0.0005035890173865145, "0.88": 0.0006354585892819318, "broader": 0.0008919788991922065, "delayed": 0.0008919788991922065, "series": 0.0008213183120274803, "initiation": 0.0010554738704365695, "6.0": 0.0005035890173865145, "origin": 0.0008213183120274803, "certain": 0.0008919788991922065, "0.4": 0.0005035890173865145, "stimuli": 0.0008919788991922065, "humans": 0.0008213183120274803, "effectively": 0.0010991627680482835, "anti": 0.0006354585892819318, "together": 0.0009531878839228976, "ultrastructural": 0.0012413335931821176, "affecting": 0.001007178034773029, "1.06": 0.0006354585892819318, "medicine": 0.0009531878839228976, "detect": 0.0008213183120274803, "sustaining": 0.0010554738704365695, "ultimately": 0.0010554738704365695, "opposing": 0.0009531878839228976, "engage": 0.0008213183120274803, "perspective": 0.0010991627680482835, "recruited": 0.001007178034773029, "delivery": 0.0009531878839228976, "services": 0.0009531878839228976, "standardized": 0.0011390476066684464, "consequence": 0.0010991627680482835, "bet": 0.0005035890173865145, "implicated": 0.0010554738704365695, "downstream": 0.0010554738704365695, "phenylephrine": 0.0011757381015063838, "tissues": 0.0008919788991922065, "transverse": 0.0010554738704365695, "operated": 0.0009531878839228976, "networks": 0.0009531878839228976, "mri": 0.0005035890173865145, "tidal": 0.0007377445757956034, "swine": 0.0007377445757956034, "1.0": 0.0005035890173865145, "124": 0.0005035890173865145, "kilogram": 0.0009531878839228976, "indicate": 0.0009531878839228976, "scarce": 0.0008213183120274803, "functions": 0.001007178034773029, "fluid": 0.0007377445757956034, "challenging": 0.0010991627680482835, "truncated": 0.001007178034773029, "exposed": 0.0008919788991922065, "perk": 0.0006354585892819318, "concomitant": 0.0010991627680482835, "pathophysiologic": 0.0012709171785638637, "pah": 0.0005035890173865145, "represent": 0.001007178034773029, "1990": 0.0006354585892819318, "0.66": 0.0006354585892819318, "declines": 0.0009531878839228976, "indicating": 0.0010554738704365695, "mibg": 0.0006354585892819318, "correlates": 0.0010554738704365695, "periods": 0.0008919788991922065, "prescribing": 0.0010991627680482835, "interviews": 0.0010554738704365695, "nonprescribing": 0.001209708193833172, "clinician": 0.001007178034773029, "augmented": 0.001007178034773029, "electromechanical": 0.001298706685421629, "handling": 0.0009531878839228976, "dynamics": 0.0009531878839228976, "protection": 0.0010554738704365695, "exertional": 0.0010554738704365695, "controlling": 0.0010991627680482835, "congestion": 0.0010554738704365695, "tolvaptan": 0.001007178034773029, "increasingly": 0.0011390476066684464, "regulated": 0.001007178034773029, "transfer": 0.0009531878839228976, "assays": 0.0008213183120274803, "emphasis": 0.0009531878839228976, "5.5": 0.0005035890173865145, "principle": 0.001007178034773029, "scales": 0.0008213183120274803, "qu\u00e9bec": 0.0008213183120274803, "expenditures": 0.0011390476066684464, "utilization": 0.0010991627680482835, "reversal": 0.0009531878839228976, "sarcomeric": 0.0010554738704365695, "microstructure": 0.001209708193833172, "erc": 0.0005035890173865145, "reach": 0.0007377445757956034, "adjunctive": 0.0010554738704365695, "special": 0.0008919788991922065, "cpt": 0.0005035890173865145, "ah": 0.0003177292946409659, "lp": 0.0003177292946409659, "pla2": 0.0006354585892819318, ".02": 0.0005035890173865145, "proven": 0.0008213183120274803, "interpretation": 0.001209708193833172, "oht": 0.0005035890173865145, "consultations": 0.0011757381015063838, "abdominal": 0.001007178034773029, "88": 0.0003177292946409659, "cpr": 0.0005035890173865145, "intensive": 0.001007178034773029, "2.2": 0.0005035890173865145, "feasibility": 0.0010991627680482835, "apparent": 0.0009531878839228976, "positively": 0.0010554738704365695, "emotional": 0.001007178034773029, "walked": 0.0008213183120274803, "molecule": 0.0009531878839228976, "pvf": 0.0005035890173865145, "carotid": 0.0008919788991922065, "anticoagulants": 0.001209708193833172, "anticoagulation": 0.0012413335931821176, "intestinal": 0.0010554738704365695, "overview": 0.0009531878839228976, "unilateral": 0.0010554738704365695, "baroreflex": 0.0010554738704365695, "domain": 0.0008213183120274803, "normalized": 0.0010554738704365695, "atropine": 0.0009531878839228976, "sphingosine-1": 0.0011757381015063838, "phosphate": 0.001007178034773029, "regulatory": 0.0010554738704365695, "saw": 0.0005035890173865145, "unfamiliar": 0.0010554738704365695, "subunits": 0.0009531878839228976, "myosin": 0.0008213183120274803, "binding": 0.0008919788991922065, "ri\u03b1": 0.0005035890173865145, "ser83": 0.0007377445757956034, "hfvt(-": 0.0008213183120274803, "rr": 0.0003177292946409659, "adrenoceptor": 0.0011390476066684464, "genetic": 0.0008919788991922065, "foundation": 0.0010554738704365695, "education": 0.001007178034773029, "region": 0.0008213183120274803, "schfi": 0.0007377445757956034, "v.6.2": 0.0007377445757956034, "cfi": 0.0005035890173865145, "rmsea": 0.0007377445757956034, "fragments": 0.001007178034773029, "concentric": 0.0010554738704365695, "raloxifene": 0.0010554738704365695, "strata": 0.0008213183120274803, "ca(2+)-pump": 0.0010991627680482835, "suboptimal": 0.0010554738704365695, "specialty": 0.001007178034773029, "screening": 0.001007178034773029, "atherosclerotic": 0.0012413335931821176, "differentially": 0.001209708193833172, "fee": 0.0005035890173865145, "demographic": 0.0010991627680482835, "east": 0.0006354585892819318, "consist": 0.0008919788991922065, "managing": 0.0009531878839228976, "valvular": 0.0009531878839228976, "rgk": 0.0005035890173865145, "q65p": 0.0006354585892819318, "ss20": 0.0006354585892819318, "actin": 0.0007377445757956034, "glycolysis": 0.0010554738704365695, "six": 0.0005035890173865145, "anaerobic": 0.001007178034773029, "overweight": 0.0010554738704365695, "subjected": 0.001007178034773029, "capita": 0.0008213183120274803, "sh": 0.0003177292946409659, "professionals": 0.0011757381015063838, "antihyperglycemic": 0.001298706685421629, "pioglitazone": 0.0011390476066684464, "sulfonylureas": 0.0011757381015063838, "cpg": 0.0005035890173865145, "cpet": 0.0006354585892819318, "robot": 0.0007377445757956034, "hscrp": 0.0007377445757956034, "interatrial": 0.0010991627680482835, "shunt": 0.0007377445757956034, "arni": 0.0006354585892819318, "caloric": 0.0008919788991922065, "mlhf": 0.0006354585892819318, "seattle": 0.0008919788991922065, "decade": 0.0005475455413516535, "dedicated": 0.0006714520231820191, "measurable": 0.0007036492469577129, "some": 0.00042363905952128787, "considerable": 0.0007593650711122975, "initiatives": 0.0007327751786988557, "areas": 0.0004918297171970689, "adipose": 0.0005946525994614709, "cachectic": 0.0006714520231820191, "regard": 0.0005475455413516535, "inverse": 0.0005946525994614709, "proadm": 0.0005475455413516535, "unaltered": 0.0006714520231820191, "steadily": 0.0006354585892819318, "hence": 0.0004918297171970689, "european": 0.0006354585892819318, "definition": 0.0007036492469577129, "relaxation": 0.0007036492469577129, "english": 0.0005946525994614709, "library": 0.0005946525994614709, "grading": 0.0005946525994614709, "recommends": 0.0007036492469577129, "weak": 0.00042363905952128787, "uncertain": 0.0006714520231820191, "registries": 0.0007036492469577129, "lists": 0.0004918297171970689, "selection": 0.0006714520231820191, "extraction": 0.0007036492469577129, "synthesis": 0.0006714520231820191, "0.94": 0.00042363905952128787, "0.61": 0.00042363905952128787, "13.0": 0.00042363905952128787, "offered": 0.0005946525994614709, "supporting": 0.0007036492469577129, "consistently": 0.0007593650711122975, "alleviate": 0.0006714520231820191, "warrants": 0.0006354585892819318, "epidemic": 0.0006354585892819318, "resources": 0.0006714520231820191, "conducting": 0.0007036492469577129, "icds": 0.00042363905952128787, "cinahl": 0.0005475455413516535, "reviewers": 0.0006714520231820191, "1.45": 0.00042363905952128787, "1.25": 0.00042363905952128787, "1.15": 0.00042363905952128787, "1.54": 0.00042363905952128787, "1.79": 0.00042363905952128787, "1.59": 0.00042363905952128787, "rose": 0.00042363905952128787, "\u03bcg": 0.00021181952976064393, "bolus": 0.0004918297171970689, "optimization": 0.0007593650711122975, "september": 0.0006714520231820191, "north": 0.0004918297171970689, "active": 0.0005475455413516535, "119": 0.00033572601159100957, "coprimary": 0.0006714520231820191, "8296": 0.00042363905952128787, "7762": 0.00042363905952128787, "8830": 0.00042363905952128787, "0.11": 0.00042363905952128787, "0.16": 0.00042363905952128787, "0.10": 0.00042363905952128787, ".49": 0.00033572601159100957, "lessons": 0.0005946525994614709, "multisite": 0.0006714520231820191, "reveal": 0.0005475455413516535, "involvement": 0.0007327751786988557, "meeting": 0.0005946525994614709, "requirements": 0.0007593650711122975, "identifies": 0.0007036492469577129, "regulator": 0.0006714520231820191, "plasticity": 0.0007036492469577129, "antecedent": 0.0007036492469577129, "genomic": 0.0005946525994614709, "alter": 0.0004918297171970689, "changing": 0.0006354585892819318, "developmental": 0.0007838254010042559, "quantitative": 0.0007593650711122975, "subproteome": 0.0007327751786988557, "demonstrating": 0.0007838254010042559, "extensive": 0.0006714520231820191, "knockdown": 0.0006714520231820191, "nearly": 0.0005475455413516535, "abolished": 0.0006714520231820191, "surprisingly": 0.0007593650711122975, "lacking": 0.0005946525994614709, "displayed": 0.0006714520231820191, "perturbed": 0.0006714520231820191, "complementary": 0.0007838254010042559, "modeling": 0.0006354585892819318, "syndromes": 0.0006714520231820191, "1.88": 0.00042363905952128787, "0.51": 0.00042363905952128787, "survey": 0.0005475455413516535, "israel": 0.0005475455413516535, "mildly": 0.0005475455413516535, "0.40": 0.00042363905952128787, "repair": 0.0005475455413516535, "serial": 0.0005475455413516535, "0.2": 0.00033572601159100957, "relations": 0.0006714520231820191, "applications": 0.0007593650711122975, "ppr": 0.00033572601159100957, "california": 0.0007036492469577129, "planning": 0.0006354585892819318, "deciles": 0.0005946525994614709, "0.84": 0.00042363905952128787, "decile": 0.0005475455413516535, "produce": 0.0005946525994614709, "rankings": 0.0006354585892819318, "consideration": 0.0007838254010042559, "deliver": 0.0005946525994614709, "meet": 0.00042363905952128787, "unplanned": 0.0006714520231820191, "electronic": 0.0007036492469577129, "randomised": 0.0007036492469577129, "rcts": 0.00042363905952128787, "structured": 0.0007036492469577129, "telephone": 0.0006714520231820191, "delivered": 0.0006714520231820191, "contact": 0.0005946525994614709, "met": 0.00033572601159100957, "reaching": 0.0006354585892819318, "trended": 0.0005946525994614709, "0.76": 0.00042363905952128787, "packages": 0.0006354585892819318, "canine": 0.0005475455413516535, "interventricular": 0.0008472781190425757, "weekly": 0.0005475455413516535, "blot": 0.00042363905952128787, "caspase": 0.0005946525994614709, "apoptotic": 0.0006714520231820191, "detected": 0.0006354585892819318, "driveline": 0.0006714520231820191, "redo": 0.00042363905952128787, "sternotomy": 0.0007036492469577129, "extubated": 0.0006714520231820191, "periprocedural": 0.0008064721292221147, "uptitrations": 0.0007593650711122975, "correction": 0.0007036492469577129, "0.93": 0.00042363905952128787, "0.39": 0.00042363905952128787, "get": 0.00033572601159100957, "65": 0.00021181952976064393, "presents": 0.0006354585892819318, "recognition": 0.0007327751786988557, "infancy": 0.0005946525994614709, "intended": 0.0006354585892819318, "rather": 0.0005475455413516535, "already": 0.0005946525994614709, "methodology": 0.0007327751786988557, "ninth": 0.0004918297171970689, "57": 0.00021181952976064393, "r(2": 0.00033572601159100957, "intubation": 0.0007036492469577129, "2001": 0.00042363905952128787, "perform": 0.0005946525994614709, "52": 0.00021181952976064393, "94": 0.00021181952976064393, "0.7": 0.00033572601159100957, "augment": 0.0005946525994614709, "retention": 0.0006714520231820191, "covered": 0.0005946525994614709, "620": 0.00033572601159100957, "feet": 0.00042363905952128787, "0.018": 0.0004918297171970689, "indicators": 0.0007036492469577129, "promotes": 0.0006354585892819318, "restoration": 0.0007327751786988557, "properties": 0.0007036492469577129, "nitric": 0.0005475455413516535, "oxide": 0.0004918297171970689, "respective": 0.0007036492469577129, "ser(1177": 0.0006354585892819318, "thr(495": 0.0005946525994614709, "pkc": 0.00033572601159100957, "\u03b2ii": 0.00033572601159100957, "malondialdehyde": 0.0008275557287880785, "proteome": 0.0006354585892819318, "shotgun": 0.0005946525994614709, "triggered": 0.0006714520231820191, "amount": 0.0005475455413516535, "99": 0.00021181952976064393, "dyspnea": 0.0005946525994614709, ".002": 0.00042363905952128787, "phenotypes": 0.0007036492469577129, "upregulated": 0.0007327751786988557, "communities": 0.0007327751786988557, "largest": 0.0005946525994614709, "former": 0.0005475455413516535, "smoking": 0.0005946525994614709, "receiver": 0.0006354585892819318, "operating": 0.0006714520231820191, "10.4": 0.00042363905952128787, "adding": 0.0005475455413516535, "aucs": 0.00042363905952128787, "consisting": 0.0007036492469577129, "conjunction": 0.0007327751786988557, "34": 0.00021181952976064393, "should": 0.0005475455413516535, "ineligible": 0.0007036492469577129, "destination": 0.0007327751786988557, "frequent": 0.0006354585892819318, "longer": 0.0005475455413516535, "conclude": 0.0006354585892819318, "budget": 0.0005475455413516535, "gaps": 0.00042363905952128787, "mandatory": 0.0006714520231820191, "porcine": 0.0005946525994614709, "variable": 0.0006354585892819318, "accordingly": 0.0007327751786988557, "tracking": 0.0006354585892819318, "nine": 0.00042363905952128787, "inferior": 0.0006354585892819318, "snared": 0.0005475455413516535, "establish": 0.0006714520231820191, "midpapillary": 0.0007593650711122975, "regional": 0.0006354585892819318, "circumferential": 0.0008275557287880785, "base": 0.00042363905952128787, "apical": 0.0005475455413516535, "septal": 0.0005475455413516535, "chest": 0.0004918297171970689, "develops": 0.0006354585892819318, "restricting": 0.0007327751786988557, "posteriorly": 0.0007327751786988557, "displaced": 0.0006714520231820191, "papillary": 0.0006714520231820191, "acting": 0.0005475455413516535, "third": 0.0004918297171970689, "sound": 0.0004918297171970689, "resection": 0.0006714520231820191, "anastomosis": 0.0007327751786988557, "equation": 0.0006354585892819318, "\u00d7": 0.0, "integral": 0.0006354585892819318, "utilized": 0.0006354585892819318, "murmurs": 0.0005946525994614709, "organic": 0.0005946525994614709, "lesion": 0.0005475455413516535, "possibility": 0.0007327751786988557, "4.6": 0.00033572601159100957, "observation": 0.0007327751786988557, "degree": 0.0005475455413516535, "fixed": 0.0004918297171970689, "demonstrates": 0.0007593650711122975, "set": 0.00033572601159100957, "veterans": 0.0006354585892819318, "start": 0.0004918297171970689, "curves": 0.0005475455413516535, "log": 0.00033572601159100957, "danish": 0.0005475455413516535, "grouped": 0.0005946525994614709, "29": 0.00021181952976064393, "forty": 0.0004918297171970689, "uncontrolled": 0.0007593650711122975, "commonly": 0.0006354585892819318, "cronbach": 0.0006354585892819318, "consistency": 0.0007327751786988557, "seems": 0.0004918297171970689, "member": 0.0005475455413516535, "titrated": 0.0006354585892819318, "0.53": 0.00042363905952128787, "1.19": 0.00042363905952128787, "p=0.18": 0.0005475455413516535, "nitroxyl": 0.0006354585892819318, "instability": 0.0007327751786988557, "sarcomere": 0.0006714520231820191, "transient": 0.0006714520231820191, "cyclase": 0.0005946525994614709, "isoproterenol": 0.0007838254010042559, "multiparametric": 0.0008275557287880785, "create": 0.0005475455413516535, "dimension": 0.0006714520231820191, "cm(2": 0.00042363905952128787, "\u226535": 0.00033572601159100957, "134": 0.00033572601159100957, "0.95": 0.00042363905952128787, "undergo": 0.0005946525994614709, "l.": 0.00021181952976064393, "diverse": 0.0005946525994614709, "enhancing": 0.0006714520231820191, "surgically": 0.0007036492469577129, "untreated": 0.0006714520231820191, "act": 0.00033572601159100957, "injected": 0.0006354585892819318, "encoding": 0.0006354585892819318, "flk": 0.00033572601159100957, "histological": 0.0007593650711122975, "do": 0.00021181952976064393, "1.95": 0.00042363905952128787, "released": 0.0006354585892819318, "21.9": 0.00042363905952128787, "xanthine": 0.0006354585892819318, "ros": 0.00033572601159100957, "cardiomyocyte": 0.0007838254010042559, "maximum": 0.0005946525994614709, "explain": 0.0005946525994614709, "assessing": 0.0006714520231820191, "wedge": 0.0004918297171970689, "velocities": 0.0007036492469577129, "e'lateral": 0.0006714520231820191, "estimation": 0.0007036492469577129, "0.82": 0.00042363905952128787, "emean": 0.0004918297171970689, "likelihood": 0.0007036492469577129, "s'lateral": 0.0006714520231820191, "4.5": 0.00033572601159100957, "plane": 0.0004918297171970689, "excursion": 0.0006714520231820191, "abstract": 0.0006354585892819318, "basic": 0.0004918297171970689, "fiber": 0.0004918297171970689, "generated": 0.0006714520231820191, "46": 0.00021181952976064393, "tracked": 0.0005946525994614709, "downward": 0.0006354585892819318, "nonsurvivors": 0.0007593650711122975, "along": 0.0004918297171970689, "shifted": 0.0005946525994614709, "step": 0.00042363905952128787, "forward": 0.0005946525994614709, "affected": 0.0006354585892819318, "modulated": 0.0006714520231820191, "necessary": 0.0006714520231820191, "patterns": 0.0006354585892819318, "32": 0.00021181952976064393, "occluded": 0.0006354585892819318, "pulsatile": 0.0006714520231820191, "modulates": 0.0006714520231820191, "143": 0.00033572601159100957, "markedly": 0.0006354585892819318, "indicator": 0.0006714520231820191, "decreasing": 0.0007036492469577129, "nutrition": 0.0006714520231820191, "insufficiency": 0.0007838254010042559, "encountered": 0.0007327751786988557, "271": 0.00033572601159100957, "framingham": 0.0007036492469577129, "failed": 0.0005475455413516535, "bioprosthetic": 0.0007838254010042559, "transcatheter": 0.0007838254010042559, "postoperatively": 0.0008275557287880785, "restoring": 0.0006714520231820191, "offer": 0.0004918297171970689, "conventional": 0.0007593650711122975, "oldest": 0.0005475455413516535, "ethnicity": 0.0006714520231820191, "nonadherence": 0.0007593650711122975, "intake": 0.0005475455413516535, "radiological": 0.0007593650711122975, "0.049": 0.0004918297171970689, "11.4": 0.00042363905952128787, "6mwt": 0.00042363905952128787, "125.6": 0.0004918297171970689, "2.3": 0.00033572601159100957, "depressive": 0.0007036492469577129, "anxiety": 0.0005946525994614709, "0.014": 0.0004918297171970689, "experiencing": 0.0007593650711122975, "unfavorable": 0.0007327751786988557, "237": 0.00033572601159100957, "dobutamine": 0.0007036492469577129, "furosemide": 0.0007036492469577129, "myxoma": 0.0005475455413516535, "myxomas": 0.0005946525994614709, "located": 0.0005946525994614709, "arteries": 0.0006354585892819318, "presented": 0.0006714520231820191, "timed": 0.0004918297171970689, "up": 0.00021181952976064393, "&": 0.0, "go": 0.00021181952976064393, "icc": 0.00033572601159100957, "kappa": 0.0004918297171970689, "minimal": 0.0005946525994614709, "seconds": 0.0005946525994614709, "define": 0.0005475455413516535, "rheumatoid": 0.0007036492469577129, "arthritis": 0.0006714520231820191, "elevations": 0.0007036492469577129, "treat": 0.0004918297171970689, "stratified": 0.0007036492469577129, "oral": 0.00042363905952128787, "loop": 0.00042363905952128787, "2.17": 0.00042363905952128787, "1.30": 0.00042363905952128787, "facilities": 0.0007036492469577129, "satisfaction": 0.0007593650711122975, "sustainability": 0.0008064721292221147, "participant": 0.0007327751786988557, "completion": 0.0007036492469577129, "aging": 0.0004918297171970689, "gill": 0.00042363905952128787, "1.36": 0.00042363905952128787, "competing": 0.0006714520231820191, "sub": 0.00033572601159100957, "appropriately": 0.0007838254010042559, ".006": 0.00042363905952128787, "excessive": 0.0006714520231820191, "avp": 0.00033572601159100957, "deleterious": 0.0007327751786988557, "helix": 0.0004918297171970689, "bhlh": 0.00042363905952128787, "otherwise": 0.0006714520231820191, "conversely": 0.0007036492469577129, "induce": 0.0005475455413516535, "knockout": 0.0006354585892819318, "p38": 0.00033572601159100957, "insights": 0.0006354585892819318, "ranged": 0.0005475455413516535, "1.17": 0.00042363905952128787, "1.26": 0.00042363905952128787, "coding": 0.0005475455413516535, "nontrastuzumab": 0.0008064721292221147, "1.50": 0.00042363905952128787, "1.33": 0.00042363905952128787, "stop": 0.00042363905952128787, "food": 0.00042363905952128787, "0.89": 0.00042363905952128787, "quartiles": 0.0006714520231820191, "nonsignificant": 0.0008064721292221147, "concept": 0.0005946525994614709, "2331": 0.00042363905952128787, "0.35": 0.00042363905952128787, "1.48": 0.00042363905952128787, "2.14": 0.00042363905952128787, "add": 0.00033572601159100957, "ten": 0.00033572601159100957, "extended": 0.0006354585892819318, "expand": 0.0005475455413516535, "pool": 0.00042363905952128787, "donors": 0.0005475455413516535, "typically": 0.0006714520231820191, "examining": 0.0006714520231820191, "assignment": 0.0007036492469577129, "select": 0.0005475455413516535, "characterize": 0.0007593650711122975, "connecticut": 0.0007327751786988557, "19.1": 0.00042363905952128787, ".01": 0.00033572601159100957, "only": 0.00042363905952128787, "accumulation": 0.0007593650711122975, "estimate": 0.0006354585892819318, "confirmatory": 0.0007593650711122975, "sixty": 0.0004918297171970689, "choices": 0.0005946525994614709, "arrhythmias": 0.0007327751786988557, "t2": 0.00021181952976064393, "remarkable": 0.0007036492469577129, "recommend": 0.0006714520231820191, "\u226430": 0.00033572601159100957, "blinded": 0.0005946525994614709, "0.58": 0.00042363905952128787, "deposition": 0.0007036492469577129, "wistar": 0.0005475455413516535, "isoforms": 0.0006354585892819318, "allows": 0.0005475455413516535, "persistent": 0.0007036492469577129, "besides": 0.0005946525994614709, "defibrillation": 0.0008064721292221147, "usually": 0.0005946525994614709, "ecgs": 0.00042363905952128787, "panel": 0.0004918297171970689, "\u2265160": 0.00042363905952128787, "160": 0.00033572601159100957, "peritoneal": 0.0007036492469577129, "resistant": 0.0006714520231820191, "consequences": 0.0007593650711122975, "almost": 0.0005475455413516535, "0.007": 0.0004918297171970689, "0.78": 0.00042363905952128787, "9.2": 0.00033572601159100957, "82": 0.00021181952976064393, "worsened": 0.0006354585892819318, "consumed": 0.0006354585892819318, "techniques": 0.0007036492469577129, "pairs": 0.0004918297171970689, "155": 0.00033572601159100957, "123": 0.00033572601159100957, "116": 0.00033572601159100957, "115": 0.00033572601159100957, "2.0": 0.00033572601159100957, "humanized": 0.0006714520231820191, "transgenic": 0.0007036492469577129, "expressing": 0.0007036492469577129, "retn(-/-": 0.0006354585892819318, "macrophages": 0.0007327751786988557, "dramatic": 0.0006354585892819318, "elevation": 0.0006714520231820191, "link": 0.00042363905952128787, "33": 0.00021181952976064393, "standing": 0.0006354585892819318, "1.81": 0.00042363905952128787, "cardioprotection": 0.0008472781190425757, "cancers": 0.0005946525994614709, "obtain": 0.0005475455413516535, "adenine": 0.0005946525994614709, "nucleotides": 0.0007327751786988557, "contents": 0.0006354585892819318, "creatine": 0.0006354585892819318, "grafting": 0.0006354585892819318, "swedish": 0.0005946525994614709, "confounders": 0.0007327751786988557, "became": 0.0005475455413516535, "introduced": 0.0007036492469577129, "paediatric": 0.0007036492469577129, "transplants": 0.0007327751786988557, "pathology": 0.0006714520231820191, "adaptation": 0.0007036492469577129, "example": 0.0005946525994614709, "raf": 0.00033572601159100957, "mek1/2": 0.0005475455413516535, "scaffold": 0.0006354585892819318, "determining": 0.0007327751786988557, "typical": 0.0005946525994614709, "each": 0.00042363905952128787, "never": 0.0004918297171970689, "residents": 0.0006714520231820191, "therapeutics": 0.0007593650711122975, "calcium": 0.0005946525994614709, "adenosine": 0.0006714520231820191, "neutral": 0.0005946525994614709, "appear": 0.0005475455413516535, "monitor": 0.0005946525994614709, "frame": 0.0004918297171970689, "advantage": 0.0006714520231820191, "expansion": 0.0006714520231820191, "reporting": 0.0006714520231820191, "acetyl": 0.0005475455413516535, "activate": 0.0006354585892819318, "histone": 0.0005946525994614709, "readers": 0.0005946525994614709, "rna": 0.00033572601159100957, "pol": 0.00033572601159100957, "protected": 0.0006714520231820191, "transcriptional": 0.0008275557287880785, "nuclear": 0.0005946525994614709, "\u03bab": 0.00021181952976064393, "promoting": 0.0006714520231820191, "quantification": 0.0008064721292221147, "1.5": 0.00033572601159100957, "180": 0.00033572601159100957, "9.4": 0.00033572601159100957, "breath": 0.0005475455413516535, "cornerstone": 0.0007327751786988557, "detection": 0.0006714520231820191, "challenges": 0.0007036492469577129, "unfolded": 0.0006354585892819318, "regulates": 0.0006714520231820191, "splicing": 0.0006354585892819318, "v": 0.0, "voltage": 0.0005946525994614709, "gated": 0.0004918297171970689, "generating": 0.0007036492469577129, "stem": 0.00042363905952128787, "angii": 0.0004918297171970689, "hypoxia": 0.0005946525994614709, "kv4.3": 0.0004918297171970689, "splice": 0.0005475455413516535, "describing": 0.0007036492469577129, "conflicting": 0.0007327751786988557, "distinguish": 0.0007327751786988557, "temporal": 0.0006354585892819318, "nonselective": 0.0007593650711122975, "hemostasis": 0.0007036492469577129, "label": 0.0004918297171970689, "arg16": 0.0004918297171970689, "gln27": 0.0004918297171970689, "gly16": 0.0004918297171970689, "glu27": 0.0004918297171970689, "8)": 0.00021181952976064393, "washout": 0.0005946525994614709, "von": 0.00033572601159100957, "willebrand": 0.0007036492469577129, "149": 0.00033572601159100957, "295": 0.00033572601159100957, "taxonomy": 0.0006354585892819318, "providing": 0.0006714520231820191, "slow": 0.00042363905952128787, "acetylcholinesterase": 0.0009154687767183569, "sympathovagal": 0.0007838254010042559, "methylatropine": 0.0008064721292221147, "propranolol": 0.0007327751786988557, "surviving": 0.0006714520231820191, "geometry": 0.0006354585892819318, "conduction": 0.0007036492469577129, "local": 0.0004918297171970689, "extending": 0.0006714520231820191, "mechanistically": 0.0008275557287880785, "150": 0.00033572601159100957, "4.2": 0.00033572601159100957, "mets": 0.00042363905952128787, "simultaneous": 0.0007593650711122975, "exertion": 0.0006354585892819318, "derive": 0.0005475455413516535, "derivation": 0.0007036492469577129, "undergone": 0.0006714520231820191, "institutions": 0.0007593650711122975, "electrocardiographic": 0.0009154687767183569, "\u22652": 0.00021181952976064393, "tobacco": 0.0005946525994614709, "4.8": 0.00033572601159100957, "\u22651": 0.00021181952976064393, "97": 0.00021181952976064393, "savings": 0.0005946525994614709, "japan": 0.0004918297171970689, "americans": 0.0006714520231820191, "accurate": 0.0006354585892819318, "phosphodiesterase-2": 0.0008997940083549217, "cyclic": 0.0005475455413516535, "monophosphate": 0.0007838254010042559, "microscopy": 0.0007036492469577129, "ca2(+": 0.0004918297171970689, "restored": 0.0006354585892819318, "amplitude": 0.0006714520231820191, "hypertrophic": 0.0007593650711122975, "specified": 0.0006714520231820191, "discontinuation": 0.0008275557287880785, "hrqol.": 0.0005475455413516535, "province": 0.0006354585892819318, "offset": 0.0005475455413516535, "noncardiovascular": 0.0008658044569477526, "manage": 0.0005475455413516535, "rich": 0.00042363905952128787, "cocoa": 0.0004918297171970689, "t2d": 0.00033572601159100957, "detrimental": 0.0007327751786988557, "epicatechin": 0.0007327751786988557, "treadmill": 0.0006714520231820191, "dapc": 0.00042363905952128787, "chinese": 0.0005946525994614709, "herbal": 0.0005475455413516535, "retrieved": 0.0006714520231820191, "volunteers": 0.0007036492469577129, "biosynthetic": 0.0007593650711122975, "catabolic": 0.0006714520231820191, "activities": 0.0007036492469577129, ".07": 0.00033572601159100957, "marginally": 0.0007036492469577129, "slope": 0.0004918297171970689, "gain": 0.00042363905952128787, "pathophysiological": 0.000883271552942663, "bridged": 0.0005946525994614709, "inotropes": 0.0006714520231820191, "operation": 0.0006714520231820191, "occurring": 0.0006714520231820191, "posterior": 0.0006714520231820191, "situation": 0.0006714520231820191, "team": 0.00042363905952128787, "half": 0.00042363905952128787, "discussion": 0.0007036492469577129, "promise": 0.0005946525994614709, "australian": 0.0007036492469577129, "administrative": 0.0008064721292221147, "fatality": 0.0006354585892819318, "occurrence": 0.0007036492469577129, "supplementation": 0.0008275557287880785, "attrition": 0.0006714520231820191, "incremental": 0.0007327751786988557, "shuttle": 0.0005946525994614709, "muscular": 0.0006354585892819318, "zung": 0.00042363905952128787, "transforming": 0.0007593650711122975, "yield": 0.0004918297171970689, "affects": 0.0005946525994614709, "explants": 0.0006354585892819318, "epithelial": 0.0007036492469577129, "mesenchymal": 0.0007327751786988557, "pluripotency": 0.0007593650711122975, "periodic": 0.0006354585892819318, "originally": 0.0007036492469577129, "cycle": 0.0004918297171970689, "oscillations": 0.0007593650711122975, "much": 0.00042363905952128787, "imbalance": 0.0006714520231820191, "nutritional": 0.0007327751786988557, "denervation": 0.0007327751786988557, "nonpace": 0.0005946525994614709, "pace": 0.00042363905952128787, "spectral": 0.0006354585892819318, "narrow": 0.0005475455413516535, "wide": 0.00042363905952128787, "dyssynchrony": 0.0007593650711122975, "msec": 0.00042363905952128787, "randomization": 0.0007838254010042559, "102": 0.00033572601159100957, "6.4": 0.00033572601159100957, "supported": 0.0006714520231820191, "smaller": 0.0005946525994614709, "steady": 0.0005475455413516535, "continued": 0.0006714520231820191, "ensure": 0.0005475455413516535, "ratings": 0.0005946525994614709, "noc": 0.00033572601159100957, "top": 0.00033572601159100957, "incorporating": 0.0007838254010042559, "advancement": 0.0007327751786988557, "highlighting": 0.0007593650711122975, "reciprocal": 0.0007036492469577129, "kinase-2": 0.0006354585892819318, "293": 0.00033572601159100957, "agonist": 0.0005946525994614709, "physiological": 0.0007838254010042559, "43.6": 0.00042363905952128787, "persist": 0.0005946525994614709, "rii\u03b1": 0.00042363905952128787, "c\u03b1": 0.00021181952976064393, "ser77": 0.0004918297171970689, "modulation": 0.0007036492469577129, "repolarization": 0.0008064721292221147, "vt": 0.00021181952976064393, "esmolol": 0.0005946525994614709, "isoprenaline": 0.0007593650711122975, "sdrr": 0.00042363905952128787, "haematopoietic": 0.0008064721292221147, "genotyped": 0.0006714520231820191, "2\u00b79": 0.00033572601159100957, "0\u00b705": 0.00042363905952128787, "transporter": 0.0007327751786988557, "working": 0.0005946525994614709, "definitions": 0.0007327751786988557, "lcz696": 0.0005475455413516535, "valsartan": 0.0006714520231820191, "threatening": 0.0007327751786988557, "disorder": 0.0006354585892819318, "partly": 0.0005475455413516535, "guided": 0.0005475455413516535, "discuss": 0.0005946525994614709, "condition": 0.0006714520231820191, "raas": 0.00042363905952128787, "newer": 0.0004918297171970689, "acquired": 0.0006354585892819318, "psychometric": 0.0007593650711122975, "6.2": 0.00033572601159100957, "cfa": 0.00033572601159100957, "construct": 0.0006714520231820191, "alphalisa": 0.0006714520231820191, "immunoassays": 0.0007593650711122975, "n-": 0.00021181952976064393, "terminally": 0.0007036492469577129, "leu3": 0.00042363905952128787, "nonterminal": 0.0007327751786988557, "epitopes": 0.0006354585892819318, "generation": 0.0007036492469577129, "eccentric": 0.0006714520231820191, "cr": 0.00021181952976064393, "402": 0.00033572601159100957, "\u22640.42": 0.0004918297171970689, "1,790": 0.0004918297171970689, "1.1": 0.00033572601159100957, "0.48": 0.00042363905952128787, "nationwide": 0.0007036492469577129, "1.07": 0.00042363905952128787, "etidronate": 0.0007036492469577129, "refill": 0.0005475455413516535, "order": 0.0004918297171970689, "phospholamban": 0.0007838254010042559, "heavy": 0.0004918297171970689, "chain": 0.0004918297171970689, "stages": 0.0005475455413516535, "rotterdam": 0.0006714520231820191, "cvd": 0.00033572601159100957, "ankle": 0.0004918297171970689, "south": 0.0004918297171970689, "dakota": 0.0005475455413516535, "transitions": 0.0007327751786988557, "reflecting": 0.0007036492469577129, "substrate": 0.0006714520231820191, "turbulence": 0.0007036492469577129, "computed": 0.0006354585892819318, "directed": 0.0006354585892819318, "framework": 0.0006714520231820191, "individualized": 0.0008064721292221147, "enrichment": 0.0007036492469577129, "0.74": 0.00042363905952128787, "blacks": 0.0005475455413516535, "providers": 0.0006714520231820191, "europe": 0.0005475455413516535, "expectancy": 0.0007036492469577129, "aha": 0.00033572601159100957, "currents": 0.0006354585892819318, "variant": 0.0005946525994614709, "inhibit": 0.0005946525994614709, "cav1.2": 0.0005475455413516535, "cav1.3": 0.0005475455413516535, "jehovah": 0.0005946525994614709, "witness": 0.0005946525994614709, "preclude": 0.0006354585892819318, "provision": 0.0006714520231820191, "decisions": 0.0006714520231820191, "doctors": 0.0005946525994614709, "performers": 0.0007036492469577129, "worst": 0.0004918297171970689, "quintile": 0.0006354585892819318, "existing": 0.0006354585892819318, "explained": 0.0006714520231820191, "1.39": 0.00042363905952128787, "aldactone": 0.0006714520231820191, "aa": 0.00021181952976064393, "9.7": 0.00033572601159100957, "hypokalemia": 0.0007327751786988557, "5.6": 0.00033572601159100957, "proteomic": 0.0006714520231820191, "ingenuity": 0.0006714520231820191, "cytoskeleton": 0.0007593650711122975, "ss31": 0.00042363905952128787, "uti": 0.00033572601159100957, "managed": 0.0005946525994614709, "cared": 0.0004918297171970689, "strongest": 0.0006714520231820191, "cardiologists": 0.0007838254010042559, "playing": 0.0005946525994614709, "1977": 0.00042363905952128787, "organization": 0.0007593650711122975, "powerful": 0.0006354585892819318, "p<001": 0.0004918297171970689, "finding": 0.0005946525994614709, "respiratory": 0.0007327751786988557, "ci=0.94": 0.0005946525994614709, "nonidentification": 0.0008658044569477526, "cardiorespiratory": 0.0008658044569477526, "fitness": 0.0005946525994614709, "joint": 0.0004918297171970689, "precede": 0.0005946525994614709, "oxidation": 0.0006714520231820191, "latin": 0.0004918297171970689, "income": 0.0005475455413516535, "fever": 0.0004918297171970689, "etiologies": 0.0007036492469577129, "rs10927887": 0.0007036492469577129, "snp": 0.00033572601159100957, "cholesterol": 0.0007327751786988557, "urban": 0.0004918297171970689, "enabled": 0.0005946525994614709, "staff": 0.0004918297171970689, "country": 0.0005946525994614709, "access": 0.0005475455413516535, "awareness": 0.0006714520231820191, "dpp-4": 0.0004918297171970689, "user": 0.00042363905952128787, "drs": 0.00033572601159100957, "conduct": 0.0005946525994614709, "dissemination": 0.0007838254010042559, "classify": 0.0006354585892819318, "organisation": 0.0007593650711122975, "cpgs": 0.00042363905952128787, "communicate": 0.0007327751786988557, "neurological": 0.0007593650711122975, "intensity": 0.0006714520231820191, "w": 0.0, "axis": 0.00042363905952128787, "gait": 0.00042363905952128787, "lokomat": 0.0005946525994614709, "quadriceps": 0.0007036492469577129, "il6": 0.00033572601159100957, "psychosocial": 0.0007593650711122975, "r=": 0.00021181952976064393, "achieve": 0.0005946525994614709, "hr<70": 0.0004918297171970689, "shunting": 0.0006354585892819318, "proof": 0.0004918297171970689, "transoesophageal": 0.0008472781190425757, "thrombosis": 0.0007036492469577129, "p=0\u00b7016": 0.0005946525994614709, "centrifugal": 0.0007327751786988557, "debilitating": 0.0007593650711122975, "modified": 0.0006354585892819318, "generate": 0.0006354585892819318, "projections": 0.0007327751786988557, "simulations": 0.0007327751786988557, "efforts": 0.00029732629973073545, "mpsms": 0.00024591485859853446, "60,000": 0.00027377277067582674, "4372": 0.00021181952976064393, "translating": 0.00036638758934942785, "81,000": 0.00027377277067582674, "averted": 0.00029732629973073545, "2010\u20132011": 0.00033572601159100957, "ulcers": 0.00027377277067582674, "actually": 0.0003177292946409659, "respect": 0.00029732629973073545, "lipolysis": 0.00033572601159100957, "a-": 0.00010590976488032197, "neurohormones": 0.00039191270050212794, "adipokines": 0.00035182462347885647, "takes": 0.00024591485859853446, "place": 0.00024591485859853446, "38": 0.00010590976488032197, "midregional": 0.00036638758934942785, "adrenomedullin": 0.00040323606461105735, "0.5": 0.00016786300579550478, "correlate": 0.00033572601159100957, "38\u201354": 0.00024591485859853446, "figure": 0.00027377277067582674, "description": 0.00036638758934942785, "1947": 0.00021181952976064393, "reassessed": 0.00035182462347885647, "april": 0.00024591485859853446, "exacerbation": 0.00037968253555614875, "cerebrovascular": 0.00041377786439403925, "audience": 0.0003177292946409659, "anemic": 0.00027377277067582674, "deficient": 0.00033572601159100957, "grades": 0.00027377277067582674, "restrictive": 0.00036638758934942785, "red": 0.00016786300579550478, "technical": 0.00033572601159100957, "advisors": 0.0003177292946409659, "liberal": 0.00029732629973073545, "1.42": 0.00021181952976064393, "i2": 0.00010590976488032197, "16.8": 0.00021181952976064393, "0.032": 0.00024591485859853446, "moderate-": 0.00033572601159100957, "thromboembolism": 0.00041377786439403925, "confounded": 0.00035182462347885647, "come": 0.00021181952976064393, "thresholds": 0.00035182462347885647, "seem": 0.00021181952976064393, "conditioning": 0.00037968253555614875, "stemming": 0.0003177292946409659, "nonischemic": 0.00036638758934942785, "cardiomyopathies": 0.00042363905952128787, "continues": 0.00033572601159100957, "problematic": 0.00036638758934942785, "inroads": 0.00029732629973073545, "armamentarium": 0.00039191270050212794, "eventual": 0.0003177292946409659, "resort": 0.00027377277067582674, "serially": 0.0003177292946409659, "keep": 0.00021181952976064393, "busy": 0.00021181952976064393, "prompting": 0.00033572601159100957, "ways": 0.00021181952976064393, "deal": 0.00021181952976064393, "comments": 0.0003177292946409659, "enriching": 0.00033572601159100957, "identification": 0.00040323606461105735, "collins": 0.00029732629973073545, "categorization": 0.00040323606461105735, "perhaps": 0.00029732629973073545, "citations": 0.00033572601159100957, "addressed": 0.00033572601159100957, "random": 0.00027377277067582674, "10,420": 0.00027377277067582674, "257,692": 0.00029732629973073545, "proved": 0.00027377277067582674, "1.37": 0.00021181952976064393, "1.43": 0.00021181952976064393, "1.72": 0.00021181952976064393, "2.34": 0.00021181952976064393, "3.44": 0.00021181952976064393, "rigorously": 0.00035182462347885647, "hypotheses": 0.00035182462347885647, "360": 0.00016786300579550478, "allocation": 0.00035182462347885647, "2:1": 0.00016786300579550478, "122": 0.00016786300579550478, "pooled": 0.00027377277067582674, "8524": 0.00021181952976064393, "7917": 0.00021181952976064393, "9131": 0.00021181952976064393, "229": 0.00016786300579550478, "-714": 0.00021181952976064393, "1171": 0.00021181952976064393, ".59": 0.00016786300579550478, "0.12": 0.00021181952976064393, "0.18": 0.00021181952976064393, "-0.08": 0.00024591485859853446, ".72": 0.00016786300579550478, "8574": 0.00021181952976064393, "8014": 0.00021181952976064393, "9134": 0.00021181952976064393, "279": 0.00016786300579550478, "-618": 0.00021181952976064393, "1176": 0.00021181952976064393, "0.07": 0.00021181952976064393, "-0.04": 0.00024591485859853446, "-0.13": 0.00024591485859853446, ".36": 0.00016786300579550478, "reflective": 0.00035182462347885647, "multihospital": 0.00039191270050212794, "promote": 0.00029732629973073545, "adoption": 0.0003177292946409659, "leaders": 0.00029732629973073545, "adopting": 0.0003177292946409659, "questions": 0.00033572601159100957, "issues": 0.00027377277067582674, "organizations": 0.00039191270050212794, "profoundly": 0.00035182462347885647, "transformed": 0.00036638758934942785, "utilizing": 0.00033572601159100957, "voluntary": 0.00033572601159100957, "testimonies": 0.00036638758934942785, "conversations": 0.00039191270050212794, "magnet": 0.00027377277067582674, "preceding": 0.00033572601159100957, "coordinate": 0.00035182462347885647, "accessibility": 0.00039191270050212794, "altering": 0.0003177292946409659, "subproteomes": 0.00037968253555614875, "accompany": 0.00033572601159100957, "recapitulates": 0.00039191270050212794, "conserved": 0.00033572601159100957, "detergent": 0.00033572601159100957, "abundance": 0.00033572601159100957, "321": 0.00016786300579550478, "conservation": 0.00037968253555614875, "acid": 0.00021181952976064393, "176": 0.00016786300579550478, "characterization": 0.00042363905952128787, "morpholino": 0.00035182462347885647, "morphological": 0.00039191270050212794, "fish": 0.00021181952976064393, "chamber": 0.00029732629973073545, "patterning": 0.00035182462347885647, "ostensibly": 0.00035182462347885647, "looping": 0.00029732629973073545, "involve": 0.00029732629973073545, "bone": 0.00021181952976064393, "morphogenetic": 0.00039191270050212794, "rrna": 0.00021181952976064393, "heterochromatic": 0.00041377786439403925, "zebrafish": 0.00033572601159100957, "orchestrate": 0.00036638758934942785, "reprogramming": 0.00039191270050212794, "shared": 0.00027377277067582674, "1,045": 0.00024591485859853446, "comprising": 0.00035182462347885647, "3.21": 0.00021181952976064393, "1.67": 0.00021181952976064393, "electrocardiogram": 0.0004329022284738763, "0.62": 0.00021181952976064393, "1,620": 0.00024591485859853446, "conferred": 0.00033572601159100957, "\u226475": 0.00016786300579550478, "1.49": 0.00021181952976064393, "156": 0.00016786300579550478, "consenting": 0.00035182462347885647, "outgrowth": 0.00033572601159100957, "colony": 0.00027377277067582674, "forming": 0.00029732629973073545, "cd34": 0.00021181952976064393, "vegfr2": 0.00027377277067582674, "cd133": 0.00024591485859853446, "cfu": 0.00016786300579550478, "0.28": 0.00021181952976064393, "nondiabetic": 0.00036638758934942785, "m": 0.0, "preventable": 0.00036638758934942785, "statewide": 0.00033572601159100957, "nonpublic": 0.00033572601159100957, "file": 0.00021181952976064393, "computing": 0.00033572601159100957, "pay": 0.00016786300579550478, "placed": 0.00027377277067582674, "specialised": 0.00036638758934942785, "fourteen": 0.0003177292946409659, "psycinfo": 0.0003177292946409659, "searching": 0.00033572601159100957, "articles": 0.0003177292946409659, "contemporaneous": 0.00041377786439403925, "telemonitoring": 0.00040323606461105735, "24/7": 0.00021181952976064393, "machine": 0.00029732629973073545, "interface": 0.00033572601159100957, "6317": 0.00021181952976064393, "statitistical": 0.00039191270050212794, "credible": 0.0003177292946409659, "tm24/7": 0.00027377277067582674, "0.20": 0.00021181952976064393, "rendered": 0.0003177292946409659, "where": 0.00024591485859853446, "expressions": 0.00036638758934942785, "rtq": 0.00016786300579550478, "pcr": 0.00016786300579550478, "beagle": 0.00027377277067582674, "autopsy": 0.00029732629973073545, "transiently": 0.00036638758934942785, "band": 0.00021181952976064393, "numbers": 0.00029732629973073545, "favour": 0.00027377277067582674, "attributed": 0.00035182462347885647, "sternal": 0.00029732629973073545, "sparing": 0.00029732629973073545, "curative": 0.0003177292946409659, "quick": 0.00024591485859853446, "avoids": 0.00027377277067582674, "malfunctioning": 0.00040323606461105735, "nominal": 0.00029732629973073545, "strokes": 0.00029732629973073545, "pef": 0.00016786300579550478, "assesses": 0.0003177292946409659, "209": 0.00016786300579550478, "108": 0.00016786300579550478, "\u226540": 0.00016786300579550478, "\u226510": 0.00016786300579550478, "0.22": 0.00021181952976064393, "0.31": 0.00021181952976064393, "0.027": 0.00024591485859853446, "0.65": 0.00021181952976064393, "0.101": 0.00024591485859853446, "neurohumoral": 0.00037968253555614875, "relates": 0.00029732629973073545, "99,930": 0.00027377277067582674, "40%-49": 0.00027377277067582674, "compute": 0.00029732629973073545, "clustering": 0.00035182462347885647, "47,025": 0.00027377277067582674, "13,950": 0.00027377277067582674, "38,955": 0.00027377277067582674, "greatest": 0.0003177292946409659, "smallest": 0.0003177292946409659, "1,259": 0.00024591485859853446, "1,113": 0.00024591485859853446, "821": 0.00016786300579550478, "732": 0.00016786300579550478, "559": 0.00016786300579550478, "540": 0.00016786300579550478, "heterogeneity": 0.00039191270050212794, ".47": 0.00016786300579550478, "adolescence": 0.00036638758934942785, "practitioners": 0.00039191270050212794, "room": 0.00021181952976064393, "encounter": 0.00033572601159100957, "undiagnosed": 0.00036638758934942785, "palliation": 0.00035182462347885647, "practical": 0.00033572601159100957, "online": 0.00027377277067582674, "material": 0.0003177292946409659, "read": 0.00021181952976064393, "dodson": 0.00027377277067582674, "interest": 0.0003177292946409659, "subsequently": 0.00037968253555614875, "intubations": 0.00036638758934942785, "hypothesize": 0.00036638758934942785, "suburban": 0.0003177292946409659, "jersey": 0.00027377277067582674, "student": 0.00029732629973073545, "cis": 0.00016786300579550478, "2,374,428": 0.00033572601159100957, "32,036": 0.00027377277067582674, "21%-30": 0.00027377277067582674, "778": 0.00016786300579550478, "3.6": 0.00016786300579550478, "31%-68": 0.00027377277067582674, "annual": 0.00027377277067582674, "constituted": 0.00036638758934942785, "classes": 0.00029732629973073545, "1,680": 0.00024591485859853446, "368": 0.00016786300579550478, "1,960": 0.00024591485859853446, "550": 0.00016786300579550478, "dyn": 0.00016786300579550478, "cm(5)/m(2": 0.00033572601159100957, "texture": 0.00029732629973073545, "nodularity": 0.00035182462347885647, "derangement": 0.00036638758934942785, "portal": 0.00027377277067582674, "902": 0.00016786300579550478, "counseling": 0.00035182462347885647, "208": 0.00016786300579550478, "692": 0.00016786300579550478, "1,080": 0.00024591485859853446, "3.45": 0.00021181952976064393, "3.05": 0.00021181952976064393, "2.81": 0.00021181952976064393, "0.013": 0.00024591485859853446, "2.61": 0.00021181952976064393, "3.06": 0.00021181952976064393, "\u22653": 0.00010590976488032197, "morbidities": 0.00036638758934942785, "2.11": 0.00021181952976064393, "1.94": 0.00021181952976064393, "1.90": 0.00021181952976064393, "ecs": 0.00016786300579550478, "incubated": 0.00033572601159100957, "ser(660": 0.00029732629973073545, "p70s6k": 0.00027377277067582674, "ser(411": 0.00029732629973073545, "particles": 0.00033572601159100957, "profiled": 0.0003177292946409659, "lc": 0.00010590976488032197, "incubation": 0.00035182462347885647, "p70s6": 0.00024591485859853446, "prescriptive": 0.00037968253555614875, "71.1": 0.00021181952976064393, "10.3": 0.00021181952976064393, "64.26": 0.00024591485859853446, "11.42": 0.00024591485859853446, "72.83": 0.00024591485859853446, "11.07": 0.00024591485859853446, "2300": 0.00021181952976064393, "85.9": 0.00021181952976064393, "39.1": 0.00021181952976064393, "0.639": 0.00024591485859853446, ".044": 0.00021181952976064393, "nephrectomy": 0.00036638758934942785, "c57bl/6": 0.00029732629973073545, "reproducible": 0.00037968253555614875, "perioperative": 0.00039191270050212794, "gtpase": 0.00027377277067582674, "rac1": 0.00021181952976064393, "projected": 0.00033572601159100957, "coming": 0.00027377277067582674, "antihypertensive": 0.00042363905952128787, "9868": 0.00021181952976064393, "nri": 0.00016786300579550478, "970": 0.00016786300579550478, "0.040": 0.00024591485859853446, "0.057": 0.00024591485859853446, "nris": 0.00021181952976064393, "50.7": 0.00021181952976064393, "54.7": 0.00021181952976064393, "simpler": 0.00029732629973073545, "incorporated": 0.00037968253555614875, "historically": 0.00037968253555614875, "hybrid": 0.00027377277067582674, "operative": 0.00033572601159100957, "139": 0.00016786300579550478, "11.9": 0.00021181952976064393, "91.8": 0.00021181952976064393, "rvads": 0.00024591485859853446, "explanted": 0.00033572601159100957, "95.2": 0.00021181952976064393, "88.2": 0.00021181952976064393, "87": 0.00010590976488032197, "scientific": 0.00035182462347885647, "2900": 0.00021181952976064393, "historical": 0.00035182462347885647, "tend": 0.00021181952976064393, "mutually": 0.0003177292946409659, "exclusive": 0.00033572601159100957, "infrastructure": 0.00040323606461105735, "necessitating": 0.00039191270050212794, "speckle": 0.00029732629973073545, "vena": 0.00021181952976064393, "cava": 0.00021181952976064393, "atrioventricular": 0.00042363905952128787, "rotations": 0.00033572601159100957, "rotation": 0.0003177292946409659, "variations": 0.00035182462347885647, "surrogates": 0.00035182462347885647, "reflect": 0.00029732629973073545, "postsystolic": 0.00037968253555614875, "4/6": 0.00016786300579550478, "holosystolic": 0.00037968253555614875, "murmur": 0.00027377277067582674, "120/70": 0.00027377277067582674, "p3": 0.00010590976488032197, "chordal": 0.00029732629973073545, "ruptures": 0.0003177292946409659, "triangular": 0.00035182462347885647, "physio": 0.00027377277067582674, "edwards": 0.00029732629973073545, "lifesciences": 0.00037968253555614875, "irvine": 0.00027377277067582674, "ca": 0.00010590976488032197, "sized": 0.00024591485859853446, "1a": 0.00010590976488032197, "concerns": 0.0003177292946409659, "191/104": 0.00029732629973073545, "3/6": 0.00016786300579550478, "audible": 0.00029732629973073545, "8.4": 0.00016786300579550478, "1b": 0.00010590976488032197, "branches": 0.0003177292946409659, "motions": 0.00029732629973073545, "respond": 0.00029732629973073545, "consequently": 0.00037968253555614875, "vasodilators": 0.00037968253555614875, "140/80": 0.00027377277067582674, "disappearance": 0.00039191270050212794, "1c": 0.00010590976488032197, "motion": 0.00027377277067582674, "considerably": 0.00037968253555614875, "insignificant": 0.00039191270050212794, "configurations": 0.00040323606461105735, "subvalvular": 0.00036638758934942785, "opposed": 0.00029732629973073545, "michigan": 0.0003177292946409659, "1,536": 0.00024591485859853446, "314": 0.00016786300579550478, "externally": 0.00035182462347885647, "ann": 0.00016786300579550478, "arbor": 0.00024591485859853446, "affairs": 0.00029732629973073545, "445": 0.00016786300579550478, "106": 0.00016786300579550478, "486": 0.00016786300579550478, "141": 0.00016786300579550478, "arbitrary": 0.00033572601159100957, "urea": 0.00021181952976064393, "nitrogen": 0.0003177292946409659, "flutter": 0.00029732629973073545, "concordance": 0.00036638758934942785, "0.71/0.68/0.74": 0.00040323606461105735, "8%/12%/12": 0.00033572601159100957, "57%/58%/79": 0.00035182462347885647, "uses": 0.00021181952976064393, "readily": 0.00029732629973073545, "allocate": 0.0003177292946409659, "specialized": 0.00036638758934942785, "progresses": 0.00035182462347885647, "egfr)-group": 0.00036638758934942785, "\u226560": 0.00016786300579550478, "8204": 0.00021181952976064393, "1.3/1000": 0.0003177292946409659, "p=0.049": 0.00029732629973073545, "p=0.016": 0.00029732629973073545, "dichotomized": 0.00037968253555614875, "ef\u2264": 0.00016786300579550478, "ef\u226550": 0.00024591485859853446, "criterion": 0.00033572601159100957, "spearman": 0.0003177292946409659, "anova": 0.00024591485859853446, "covariate": 0.00033572601159100957, "849": 0.00016786300579550478, "r=-0.62": 0.00029732629973073545, "r=-0.55": 0.00029732629973073545, "p=0.27": 0.00027377277067582674, "category": 0.0003177292946409659, "25=13.8": 0.00029732629973073545, "50=59.1": 0.00029732629973073545, "75=73.8": 0.00029732629973073545, "100=77.8": 0.0003177292946409659, "p=0.37": 0.00027377277067582674, "\u03b1=0.96": 0.00027377277067582674, "\u22650.69": 0.00024591485859853446, "subdomains": 0.00035182462347885647, "offers": 0.00027377277067582674, "replicate": 0.00033572601159100957, "establishment": 0.00039191270050212794, "interleukin": 0.00036638758934942785, "s)st2": 0.00024591485859853446, "151": 0.00016786300579550478, "hoc": 0.00016786300579550478, "regimen": 0.00029732629973073545, "succinate": 0.00033572601159100957, "p=0.003": 0.00029732629973073545, "those": 0.00024591485859853446, "2.08": 0.00021181952976064393, "6.77": 0.00021181952976064393, "exerted": 0.00029732629973073545, "angeli": 0.00027377277067582674, "lusitropic": 0.00035182462347885647, "vasodilator": 0.00036638758934942785, "chemical": 0.0003177292946409659, "cogeneration": 0.00037968253555614875, "nitrite": 0.00029732629973073545, "myoctyes": 0.0003177292946409659, "intact": 0.00027377277067582674, "converts": 0.0003177292946409659, "inactive": 0.0003177292946409659, "cxl-1051": 0.0003177292946409659, "t1/2": 0.00021181952976064393, "dependently": 0.00036638758934942785, "210": 0.00016786300579550478, "500": 0.00016786300579550478, "\u03bcmol": 0.00021181952976064393, "\u224830": 0.00016786300579550478, "guanylate": 0.00033572601159100957, "unlike": 0.00027377277067582674, "anesthetized": 0.00037968253555614875, "microembolization": 0.0004329022284738763, "tachypacing": 0.00036638758934942785, "venoarterial": 0.00037968253555614875, "dilation": 0.0003177292946409659, "minimally": 0.00033572601159100957, "334": 0.00016786300579550478, "224": 0.00016786300579550478, "65\u00b112": 0.00024591485859853446, "\u226515": 0.00016786300579550478, "57\u00b122": 0.00024591485859853446, "n=161": 0.00024591485859853446, "-7": 0.00010590976488032197, "10.0": 0.00021181952976064393, "cm(2)/m(2": 0.00033572601159100957, "allowed": 0.00029732629973073545, "transplantations": 0.00042363905952128787, "implantations": 0.00039191270050212794, "helpful": 0.00029732629973073545, "kaiser": 0.00027377277067582674, "permanente": 0.00035182462347885647, "northern": 0.0003177292946409659, "meq": 0.00016786300579550478, "2,538": 0.00024591485859853446, "521": 0.00016786300579550478, "1.44": 0.00021181952976064393, "compensatory": 0.00037968253555614875, "neoangiogenesis": 0.00041377786439403925, "diameters": 0.00033572601159100957, "akt": 0.00016786300579550478, "synthase": 0.0003177292946409659, "comparing": 0.00033572601159100957, "proangiogenic": 0.00039191270050212794, "intravenously": 0.00039191270050212794, "adenoviral": 0.00035182462347885647, "vector": 0.00027377277067582674, "decoy": 0.00024591485859853446, "adenovirus": 0.00035182462347885647, "b.": 0.00010590976488032197, "counteracted": 0.00037968253555614875, "n=44": 0.00021181952976064393, "925": 0.00016786300579550478, "76.4": 0.00021181952976064393, "54.5": 0.00021181952976064393, "61.8": 0.00021181952976064393, "1.10\u20131.23": 0.00033572601159100957, "73.6": 0.00021181952976064393, "1.83\u20132.07": 0.00033572601159100957, "22.0": 0.00021181952976064393, "44.9": 0.00021181952976064393, "16.3": 0.00021181952976064393, "0.73\u20130.90": 0.00033572601159100957, "35.3": 0.00021181952976064393, "0.73\u20130.86": 0.00033572601159100957, "0.61\u20130.78": 0.00033572601159100957, "30.2": 0.00021181952976064393, "0.61\u20130.74": 0.00033572601159100957, "24.3": 0.00021181952976064393, "0.76\u20130.91": 0.00033572601159100957, "18.1": 0.00021181952976064393, "0.70\u20130.85": 0.00033572601159100957, "preserves": 0.00033572601159100957, "vo": 0.00010590976488032197, "aortocaval": 0.00035182462347885647, "fistula": 0.00029732629973073545, "demand": 0.00027377277067582674, "bioenergetics": 0.00039191270050212794, "sprague": 0.00029732629973073545, "dawley": 0.00027377277067582674, "mg\u00b7kg(-1)\u00b7day(-1": 0.00042363905952128787, "\u22657": 0.00010590976488032197, "flux": 0.00021181952976064393, "analyzer": 0.0003177292946409659, "paralleled": 0.00035182462347885647, "diminishing": 0.00036638758934942785, "myofilament": 0.00036638758934942785, "unreliable": 0.00035182462347885647, "sided": 0.00024591485859853446, "transthoracic": 0.00039191270050212794, "0.41": 0.00021181952976064393, "e'mean": 0.00027377277067582674, "0.72": 0.00021181952976064393, "elateral": 0.0003177292946409659, "eseptal": 0.00029732629973073545, "s'septal": 0.0003177292946409659, "width": 0.00024591485859853446, "0.15": 0.00021181952976064393, "\u22644.5": 0.00021181952976064393, "0.38": 0.00021181952976064393, "carrying": 0.0003177292946409659, "two-": 0.00021181952976064393, "threefold": 0.00033572601159100957, "disclosing": 0.00035182462347885647, "ninety": 0.00027377277067582674, "247": 0.00016786300579550478, "20.8": 0.00021181952976064393, "mo": 0.00010590976488032197, "collinearity": 0.00037968253555614875, "retained": 0.0003177292946409659, "follows": 0.00029732629973073545, "mmhg": 0.00021181952976064393, "4.1": 0.00016786300579550478, "resolution": 0.00035182462347885647, "efficient": 0.00033572601159100957, "one-": 0.00021181952976064393, "coated": 0.00027377277067582674, "polytetrafluoroethylene": 0.0004790893831875676, "tube": 0.00021181952976064393, "shape": 0.00024591485859853446, "circumflex": 0.00035182462347885647, "mid": 0.00016786300579550478, "infarct": 0.00029732629973073545, "positron": 0.0003177292946409659, "emission": 0.0003177292946409659, "tomography": 0.00035182462347885647, "covering": 0.0003177292946409659, "competitive": 0.00036638758934942785, "unloads": 0.00029732629973073545, "resistive": 0.00033572601159100957, "275": 0.00016786300579550478, "132": 0.00016786300579550478, "7.5": 0.00016786300579550478, "cuff": 0.00021181952976064393, "ivabradine-": 0.00036638758934942785, "unloading": 0.00033572601159100957, "272": 0.00016786300579550478, "125": 0.00016786300579550478, "\u22653.5": 0.00021181952976064393, "147": 0.00016786300579550478, "93.2": 0.00021181952976064393, "82.4": 0.00021181952976064393, "88.4": 0.00021181952976064393, "75.2": 0.00021181952976064393, "0.521": 0.00024591485859853446, "0.290": 0.00024591485859853446, "0.934": 0.00024591485859853446, "0.029": 0.00024591485859853446, "81": 0.00010590976488032197, "92.6": 0.00021181952976064393, "63.6": 0.00021181952976064393, "65.0": 0.00021181952976064393, "correcting": 0.00035182462347885647, "hepatic": 0.00029732629973073545, "instituting": 0.00036638758934942785, "algorithms": 0.00035182462347885647, "de": 0.00010590976488032197, "novo": 0.00021181952976064393, "225": 0.00016786300579550478, "203": 0.00016786300579550478, "thoratec": 0.0003177292946409659, "corp": 0.00021181952976064393, "pleasanton": 0.00035182462347885647, "calif": 0.00024591485859853446, "hvad": 0.00021181952976064393, "intl": 0.00021181952976064393, "inc": 0.00016786300579550478, "dacron": 0.00027377277067582674, "patch": 0.00024591485859853446, "repairs": 0.00029732629973073545, "multiorgan": 0.00035182462347885647, "sepsis": 0.00027377277067582674, "oversewing": 0.00035182462347885647, "difficult": 0.00033572601159100957, "alternatives": 0.00037968253555614875, "charm": 0.00024591485859853446, "candesartan": 0.00036638758934942785, "adhere": 0.00027377277067582674, "referent": 0.0003177292946409659, "0.186": 0.00024591485859853446, "ages": 0.00021181952976064393, "divergent": 0.00033572601159100957, "striking": 0.0003177292946409659, "counterparts": 0.00037968253555614875, "nonfatal": 0.0003177292946409659, "discordant": 0.00035182462347885647, "62.4": 0.00021181952976064393, "26.9": 0.00021181952976064393, "400": 0.00016786300579550478, "59.4": 0.00021181952976064393, "57.0": 0.00021181952976064393, "71.3": 0.00021181952976064393, "travelled": 0.00033572601159100957, "158.5": 0.00024591485859853446, "118.5": 0.00024591485859853446, "155.5": 0.00024591485859853446, "0.026": 0.00024591485859853446, "-1.7": 0.00021181952976064393, "waist": 0.00024591485859853446, "circumference": 0.00039191270050212794, "modality": 0.0003177292946409659, "leads": 0.00024591485859853446, "shortens": 0.0003177292946409659, "biologic": 0.0003177292946409659, "reconstructed": 0.00039191270050212794, "228": 0.00016786300579550478, "25th-75th": 0.00033572601159100957, "percentiles": 0.00036638758934942785, "212": 0.00016786300579550478, "278": 0.00016786300579550478, "257": 0.00016786300579550478, "277": 0.00016786300579550478, ".032": 0.00021181952976064393, "tonometric": 0.00035182462347885647, "entry": 0.00024591485859853446, "natremia": 0.0003177292946409659, "shortened": 0.00033572601159100957, "complicated": 0.00036638758934942785, "benign": 0.00027377277067582674, "tumors": 0.00027377277067582674, "rarely": 0.00027377277067582674, "embolize": 0.0003177292946409659, "vasculature": 0.00036638758934942785, "massive": 0.00029732629973073545, "removal": 0.00029732629973073545, "embolectomy": 0.00036638758934942785, "causing": 0.00029732629973073545, "stenotic": 0.0003177292946409659, "physiology": 0.00035182462347885647, "obstructed": 0.00035182462347885647, "tactics": 0.00029732629973073545, "hypothermic": 0.00036638758934942785, "uneventful": 0.00035182462347885647, "organ": 0.00024591485859853446, "sectional": 0.00033572601159100957, "environment": 0.00036638758934942785, "n=235": 0.00024591485859853446, "70y": 0.00016786300579550478, "77y": 0.00016786300579550478, "25.6kg": 0.00027377277067582674, "22.8": 0.00021181952976064393, "29.4kg": 0.00027377277067582674, "n=95": 0.00021181952976064393, "n=68": 0.00021181952976064393, "n=72": 0.00021181952976064393, "applicable": 0.00035182462347885647, "assessors": 0.00033572601159100957, "intraclass": 0.00035182462347885647, "detectable": 0.00035182462347885647, ".85": 0.00016786300579550478, ".98": 0.00016786300579550478, "coefficients": 0.00037968253555614875, "3.00": 0.00021181952976064393, "-4.94s": 0.00027377277067582674, "p<.01": 0.00024591485859853446, "mdc95": 0.00024591485859853446, "mdc95%%": 0.00029732629973073545, "true": 0.00021181952976064393, "starting": 0.0003177292946409659, "tumor": 0.00024591485859853446, "necrosis": 0.0003177292946409659, "tnf)\u03b1": 0.00024591485859853446, "recurrent": 0.00033572601159100957, "us": 0.00010590976488032197, "methotrexate": 0.00037968253555614875, "enter": 0.00024591485859853446, "switched": 0.0003177292946409659, "modifying": 0.00033572601159100957, "antirheumatic": 0.00039191270050212794, "glucocorticoid": 0.00040323606461105735, "dosage": 0.00027377277067582674, "8656": 0.00021181952976064393, "587": 0.00016786300579550478, "1.14": 0.00021181952976064393, "but": 0.00016786300579550478, "2002": 0.00021181952976064393, "10.50": 0.00024591485859853446, "p=0.036": 0.00029732629973073545, "glucocorticoids": 0.00041377786439403925, "1\u22645": 0.00016786300579550478, "1.85": 0.00021181952976064393, "\u22655": 0.00010590976488032197, "2.19": 0.00021181952976064393, "nbdmards": 0.0003177292946409659, "climate": 0.00029732629973073545, "nhs": 0.00016786300579550478, "behavioural": 0.00036638758934942785, "challenge": 0.00033572601159100957, "participatory": 0.00039191270050212794, "showing": 0.00029732629973073545, "minor": 0.00024591485859853446, "anecdotal": 0.00033572601159100957, "commissioning": 0.00039191270050212794, "hospital-": 0.00033572601159100957, "2825": 0.00021181952976064393, "7.1": 0.00016786300579550478, "11.7": 0.00021181952976064393, "466": 0.00016786300579550478, "3.47": 0.00021181952976064393, "linearly": 0.0003177292946409659, "1.55": 0.00021181952976064393, "0.010": 0.00024591485859853446, "reclassified": 0.00037968253555614875, "13.4": 0.00021181952976064393, "0.073": 0.00024591485859853446, "0.021": 0.00024591485859853446, "0.125": 0.00024591485859853446, "8.3": 0.00016786300579550478, "interruption": 0.00037968253555614875, "secretion": 0.00033572601159100957, "arginine": 0.0003177292946409659, "physiologic": 0.00036638758934942785, "cooperate": 0.00033572601159100957, "reactivate": 0.00035182462347885647, "aberrant": 0.0003177292946409659, "reactivation": 0.00037968253555614875, "intricately": 0.00036638758934942785, "driving": 0.00029732629973073545, "ill": 0.00016786300579550478, "calcineurin": 0.00036638758934942785, "express": 0.00029732629973073545, "dhand": 0.00024591485859853446, "conditional": 0.00036638758934942785, "fetal": 0.00024591485859853446, "antagomir": 0.00033572601159100957, "evoked": 0.00027377277067582674, "sensitized": 0.00035182462347885647, "manner": 0.00027377277067582674, "cascades": 0.0003177292946409659, "postnatal": 0.00033572601159100957, "hungary": 0.00029732629973073545, "neuro": 0.00024591485859853446, "hormonal": 0.0003177292946409659, "neglected": 0.00033572601159100957, "p38alpha": 0.0003177292946409659, "mapk": 0.00021181952976064393, "links": 0.00024591485859853446, "substrates": 0.00035182462347885647, "regulating": 0.00035182462347885647, "hyperinsulinemia": 0.00042363905952128787, "akt\u2192forkhead": 0.00037968253555614875, "box": 0.00016786300579550478, "o-1": 0.00016786300579550478, "p38\u03b1": 0.00021181952976064393, "mitogen": 0.00029732629973073545, "neonatal": 0.0003177292946409659, "revealing": 0.00033572601159100957, "ncdr": 0.00021181952976064393, "pinnacle": 0.0003177292946409659, "innovation": 0.00035182462347885647, "excellence": 0.00035182462347885647, "contraindications": 0.0004329022284738763, "hierarchical": 0.00037968253555614875, "556": 0.00016786300579550478, "unadjusted": 0.00035182462347885647, "prescription": 0.00037968253555614875, "75%-89": 0.00027377277067582674, "83%-95": 0.00027377277067582674, "66%-85": 0.00027377277067582674, "addressing": 0.00035182462347885647, "adjuvant": 0.0003177292946409659, "manifested": 0.00035182462347885647, "coverage": 0.0003177292946409659, "seer": 0.00021181952976064393, "texas": 0.00024591485859853446, "9,535": 0.00024591485859853446, "2,203": 0.00024591485859853446, "23.1": 0.00021181952976064393, "entire": 0.00027377277067582674, "29.4": 0.00021181952976064393, "18.9": 0.00021181952976064393, "1.75": 0.00021181952976064393, "1.53": 0.00021181952976064393, "2.10": 0.00021181952976064393, "1.82": 0.00021181952976064393, "2.48": 0.00021181952976064393, "1.68": 0.00021181952976064393, "trastuzumb": 0.00035182462347885647, "plays": 0.00024591485859853446, "postmenopausal": 0.00040323606461105735, "august": 0.00027377277067582674, "questionnaires": 0.00040323606461105735, "behaviors": 0.00033572601159100957, "calculate": 0.00033572601159100957, "1385": 0.00021181952976064393, "3215": 0.00021181952976064393, "43.1": 0.00021181952976064393, "trend=0.08": 0.00035182462347885647, "1.04": 0.00021181952976064393, "1.21": 0.00021181952976064393, "trend=0.01": 0.00035182462347885647, "vegetables": 0.00035182462347885647, "nuts": 0.00021181952976064393, "whole": 0.00024591485859853446, "grain": 0.00024591485859853446, "910": 0.00016786300579550478, "evaluable": 0.00033572601159100957, "23.7": 0.00021181952976064393, "18.6": 0.00021181952976064393, "31.8": 0.00021181952976064393, "univariable": 0.00036638758934942785, "2.33": 0.00021181952976064393, "log2": 0.00021181952976064393, "amino": 0.00024591485859853446, "statistic": 0.00033572601159100957, "comorbidity": 0.00036638758934942785, "paucity": 0.00029732629973073545, "prespecified": 0.00037968253555614875, "454": 0.00016786300579550478, "18.5": 0.00021181952976064393, "66.6": 0.00021181952976064393, "53.2": 0.00021181952976064393, "46.4": 0.00021181952976064393, "24.6": 0.00021181952976064393, "61.6": 0.00021181952976064393, "listing": 0.00029732629973073545, "determinants": 0.00037968253555614875, "discharges": 0.00035182462347885647, "398": 0.00016786300579550478, "79.9": 0.00021181952976064393, "45.9": 0.00021181952976064393, "27.5": 0.00021181952976064393, ".024": 0.00021181952976064393, "19.6": 0.00021181952976064393, "46.9": 0.00021181952976064393, "eighty": 0.00027377277067582674, "cardiologist": 0.00037968253555614875, "practitioner": 0.00037968253555614875, "drawn": 0.00024591485859853446, "discrepancy": 0.00036638758934942785, "incompletely": 0.00037968253555614875, "thought": 0.00029732629973073545, "pathobiology": 0.00037968253555614875, "suspected": 0.00033572601159100957, "n=100": 0.00024591485859853446, "entered": 0.00029732629973073545, "22.9\u00b15.0": 0.0003177292946409659, "p=0.046": 0.00029732629973073545, "388.3": 0.00024591485859853446, "n=9": 0.00016786300579550478, "tissuefaxs": 0.00035182462347885647, "r=0.98": 0.00027377277067582674, "r=-0.36": 0.00029732629973073545, "r=0.28": 0.00027377277067582674, "thalassaemia": 0.00037968253555614875, "regimens": 0.0003177292946409659, "remove": 0.00027377277067582674, "efficiently": 0.00036638758934942785, "reverses": 0.0003177292946409659, "n=177": 0.00024591485859853446, "n=431": 0.00024591485859853446, "core": 0.00021181952976064393, "off": 0.00016786300579550478, "p=0.06": 0.00027377277067582674, "-6.7": 0.00021181952976064393, "21.1": 0.00021181952976064393, "17.6": 0.00021181952976064393, "50.5": 0.00021181952976064393, "42.4": 0.00021181952976064393, "0.26": 0.00021181952976064393, "p=0.012": 0.00029732629973073545, "p=0.047": 0.00029732629973073545, "kyoto": 0.00024591485859853446, "euthanization": 0.00039191270050212794, "linking": 0.00029732629973073545, "tension": 0.00029732629973073545, "fpassive)-sarcomere": 0.00044989700417746083, "strips": 0.00027377277067582674, "kcl": 0.00016786300579550478, "ki": 0.00010590976488032197, "unanchors": 0.00033572601159100957, "fpassive": 0.0003177292946409659, "discerned": 0.00033572601159100957, "obvious": 0.00029732629973073545, "strip": 0.00024591485859853446, "\u00b180": 0.00016786300579550478, "s3991": 0.00024591485859853446, "elastic": 0.00029732629973073545, "n2bus": 0.00024591485859853446, "s12884": 0.00027377277067582674, "pevk": 0.00021181952976064393, "span": 0.00021181952976064393, "mechanics": 0.00033572601159100957, "196": 0.00016786300579550478, "1.121": 0.00024591485859853446, "1.023": 0.00024591485859853446, "1.228": 0.00024591485859853446, "p=0.014": 0.00029732629973073545, "outperformed": 0.00037968253555614875, "0.043": 0.00024591485859853446, "p=0.022": 0.00029732629973073545, "parameter": 0.00033572601159100957, "stronger": 0.0003177292946409659, "raft": 0.00021181952976064393, "pacemaker": 0.00033572601159100957, "electrocardiographers": 0.0004651893055262403, "1483": 0.00021181952976064393, "1175": 0.00021181952976064393, "308": 0.00016786300579550478, "0.52": 0.00021181952976064393, "0.29": 0.00021181952976064393, "p=0.033": 0.00029732629973073545, "p=0.155": 0.00029732629973073545, "pre-": 0.00021181952976064393, "24.5": 0.00021181952976064393, "9/10": 0.00021181952976064393, "ckd": 0.00016786300579550478, "0.016": 0.00024591485859853446, "edema": 0.00024591485859853446, "3.2": 0.00016786300579550478, "36.7": 0.00021181952976064393, "0.019": 0.00024591485859853446, "criteriabased": 0.00039191270050212794, "tolerated": 0.00033572601159100957, "easily": 0.00027377277067582674, "treatable": 0.00033572601159100957, "pdrelated": 0.00033572601159100957, "viable": 0.00027377277067582674, "option": 0.00027377277067582674, "deferred": 0.0003177292946409659, "heterogenous": 0.00037968253555614875, "+3.1": 0.00021181952976064393, "+9.2": 0.00021181952976064393, "9.5": 0.00016786300579550478, "0.038": 0.00024591485859853446, "0.047": 0.00024591485859853446, "compelling": 0.00035182462347885647, "thirteen": 0.0003177292946409659, "mmol/2100": 0.00033572601159100957, "kcal": 0.00021181952976064393, "parametrized": 0.00037968253555614875, "formalism": 0.00033572601159100957, "yields": 0.00027377277067582674, "viscoelastic": 0.00037968253555614875, "passive": 0.00029732629973073545, "constants": 0.00033572601159100957, "inflow": 0.00027377277067582674, "contours": 0.0003177292946409659, "wilcoxon": 0.0003177292946409659, "signed": 0.00027377277067582674, "138": 0.00016786300579550478, "111": 0.00016786300579550478, "p=0.12": 0.00027377277067582674, "c=24.3": 0.00027377277067582674, "5.3": 0.00016786300579550478, "22.7": 0.00021181952976064393, "8.1": 0.00016786300579550478, "k=252": 0.00024591485859853446, "170": 0.00016786300579550478, "s(2": 0.00016786300579550478, "p=0.007": 0.00029732629973073545, "ea=1.5": 0.00027377277067582674, "mediator": 0.0003177292946409659, "monocytes": 0.00033572601159100957, "responsive": 0.00035182462347885647, "connected": 0.00033572601159100957, "exhibits": 0.0003177292946409659, "underlies": 0.00033572601159100957, "remarkably": 0.00035182462347885647, "25mg": 0.00021181952976064393, "ip": 0.00010590976488032197, "littermate": 0.00035182462347885647, "adhesion": 0.0003177292946409659, "hretn": 0.00024591485859853446, "intriguingly": 0.00037968253555614875, "implicate": 0.00033572601159100957, "precipitating": 0.00039191270050212794, "probability": 0.00036638758934942785, "relating": 0.0003177292946409659, "single-": 0.00029732629973073545, "pharmaceutically": 0.00042363905952128787, "3.17": 0.00021181952976064393, "0.24": 0.00021181952976064393, "maintaining": 0.00036638758934942785, "pharmaceuticals": 0.00041377786439403925, "ameliorates": 0.00036638758934942785, "neoplastic": 0.00035182462347885647, "orally": 0.00027377277067582674, "sacrificed": 0.00035182462347885647, "rapidly": 0.00029732629973073545, "excised": 0.00029732629973073545, "cytochrome": 0.00035182462347885647, "bcl2": 0.00021181952976064393, "alleviating": 0.00036638758934942785, "decrement": 0.00033572601159100957, "interfere": 0.00033572601159100957, "cytotoxic": 0.00033572601159100957, "solid": 0.00024591485859853446, "ehrlich": 0.00029732629973073545, "carcinoma": 0.00033572601159100957, "antitumor": 0.00033572601159100957, "36,284": 0.00027377277067582674, "sweden": 0.00027377277067582674, "\u226490": 0.00016786300579550478, "2,462": 0.00024591485859853446, "617": 0.00016786300579550478, "1.76": 0.00021181952976064393, "2.25": 0.00021181952976064393, "enormous": 0.0003177292946409659, "atheromatous": 0.00037968253555614875, "amenable": 0.0003177292946409659, "cardiomyopathic": 0.00041377786439403925, "principally": 0.00036638758934942785, "comprise": 0.0003177292946409659, "contracting": 0.00036638758934942785, "ventricles": 0.00035182462347885647, "aetiologies": 0.00036638758934942785, "particular": 0.00035182462347885647, "topics": 0.00027377277067582674, "debate": 0.00027377277067582674, "concern": 0.00029732629973073545, "myocarditis": 0.00036638758934942785, "malignant": 0.00033572601159100957, "scaffolds": 0.00033572601159100957, "humoral": 0.00029732629973073545, "workload": 0.0003177292946409659, "mediate": 0.00029732629973073545, "paradoxically": 0.00039191270050212794, "notable": 0.00029732629973073545, "signalosome": 0.00036638758934942785, "drives": 0.00027377277067582674, "assembly": 0.0003177292946409659, "kinases": 0.00029732629973073545, "sequential": 0.00035182462347885647, "effector": 0.0003177292946409659, "molecules": 0.00033572601159100957, "field": 0.00024591485859853446, "capable": 0.00029732629973073545, "selectively": 0.00036638758934942785, "potentiating": 0.00037968253555614875, "amyloidosis": 0.00036638758934942785, "atypical": 0.0003177292946409659, "deals": 0.00024591485859853446, "cardiomyiopathy": 0.00041377786439403925, "angina": 0.00027377277067582674, "inducible": 0.00033572601159100957, "amyloidotic": 0.00036638758934942785, "myeloma": 0.00029732629973073545, "osteomedullary": 0.00040323606461105735, "biopsy": 0.00027377277067582674, "strengths": 0.00033572601159100957, "utility": 0.00029732629973073545, "southeastern": 0.00037968253555614875, "exhaustion": 0.00035182462347885647, "slowness": 0.0003177292946409659, "unintentional": 0.00039191270050212794, "lb": 0.00010590976488032197, "223": 0.00016786300579550478, "0.75": 0.00021181952976064393, "0.687": 0.00024591485859853446, "0.700": 0.00024591485859853446, "ascertained": 0.00036638758934942785, "ascertain": 0.00033572601159100957, "learning": 0.0003177292946409659, "shaping": 0.00029732629973073545, "disappointments": 0.00041377786439403925, "sensitizing": 0.00036638758934942785, "endothelin": 0.00035182462347885647, "relax": 0.00024591485859853446, "astronaut": 0.00033572601159100957, "pronto": 0.00027377277067582674, "highlighted": 0.00036638758934942785, "learned": 0.00029732629973073545, "outline": 0.00029732629973073545, "perspectives": 0.00037968253555614875, "sufficiently": 0.00037968253555614875, "accelerate": 0.00035182462347885647, "throughput": 0.00035182462347885647, "disposition": 0.00036638758934942785, "redesigned": 0.00035182462347885647, "take": 0.00021181952976064393, "faster": 0.00027377277067582674, "turnaround": 0.00035182462347885647, "rethinking": 0.00035182462347885647, "operationalized": 0.00041377786439403925, "publicly": 0.0003177292946409659, "penalties": 0.00033572601159100957, "motivate": 0.0003177292946409659, "halts": 0.00024591485859853446, "hyperacetylation": 0.00042363905952128787, "now": 0.00016786300579550478, "anand": 0.00024591485859853446, "lysine": 0.00027377277067582674, "reader": 0.00027377277067582674, "precedes": 0.0003177292946409659, "neuronal": 0.0003177292946409659, "stressors": 0.00033572601159100957, "cascade": 0.00029732629973073545, "converges": 0.00033572601159100957, "interplay": 0.00033572601159100957, "writer": 0.00027377277067582674, "acetyltransferases": 0.0004416357764713315, "erasers": 0.00029732629973073545, "deacetylases": 0.00037968253555614875, "displaces": 0.00033572601159100957, "suppression": 0.00036638758934942785, "polymerase": 0.00035182462347885647, "neurohormonally": 0.00041377786439403925, "nanomolar": 0.00033572601159100957, "blocked": 0.00029732629973073545, "brd4": 0.00021181952976064393, "profiling": 0.00033572601159100957, "cultured": 0.0003177292946409659, "abrogated": 0.00033572601159100957, "experiments": 0.00036638758934942785, "toxicity": 0.0003177292946409659, "detailed": 0.0003177292946409659, "tac-": 0.00021181952976064393, "suppresses": 0.00035182462347885647, "causal": 0.00027377277067582674, "nf": 0.00010590976488032197, "gata4": 0.00024591485859853446, "pause": 0.00024591485859853446, "release": 0.00029732629973073545, "implicates": 0.00035182462347885647, "biology": 0.00029732629973073545, "manipulation": 0.00037968253555614875, "abrogate": 0.0003177292946409659, "multiacquisition": 0.00042363905952128787, "yorkshire": 0.00033572601159100957, "pacemakers": 0.00035182462347885647, "ventricularly": 0.00039191270050212794, "beats": 0.00024591485859853446, "scanned": 0.00029732629973073545, "scanner": 0.00029732629973073545, "gadolinium": 0.00035182462347885647, "chelate": 0.00029732629973073545, "scans": 0.00024591485859853446, "trichrome": 0.00033572601159100957, "blue": 0.00021181952976064393, "histologic": 0.00035182462347885647, "960": 0.00016786300579550478, "726": 0.00016786300579550478, "546": 0.00016786300579550478, "300": 0.00016786300579550478, "171": 0.00016786300579550478, "histologically": 0.00040323606461105735, "5.4": 0.00016786300579550478, "proposed": 0.0003177292946409659, "diffuse": 0.00029732629973073545, "holding": 0.00029732629973073545, "inoperable": 0.00035182462347885647, "broad": 0.00024591485859853446, "assumption": 0.00035182462347885647, "3.0": 0.00016786300579550478, "58": 0.00010590976488032197, "hemodynamics": 0.00037968253555614875, "1-": 0.00010590976488032197, "3-": 0.00010590976488032197, "2.56": 0.00021181952976064393, "2.84": 0.00021181952976064393, "interesting": 0.00036638758934942785, "concepts": 0.0003177292946409659, "evolving": 0.0003177292946409659, "stand": 0.00024591485859853446, "consumes": 0.0003177292946409659, "portion": 0.00029732629973073545, "commoner": 0.0003177292946409659, "lifesaving": 0.00035182462347885647, "poses": 0.00024591485859853446, "nonfunctional": 0.00039191270050212794, "trapped": 0.00029732629973073545, "endoplasmic": 0.00036638758934942785, "reticulum": 0.00033572601159100957, "electric": 0.0003177292946409659, "pluripotent": 0.00036638758934942785, "hipsc": 0.00024591485859853446, "activators": 0.00035182462347885647, "overexpress": 0.00036638758934942785, "effectors": 0.00033572601159100957, "er": 0.00010590976488032197, "calreticulin": 0.00037968253555614875, "chop": 0.00021181952976064393, "exogenous": 0.00033572601159100957, "destabilized": 0.00037968253555614875, "mrnas": 0.00024591485859853446, "cation": 0.00027377277067582674, "m7": 0.00010590976488032197, "trpm7": 0.00024591485859853446, "entirely": 0.0003177292946409659, "transcript": 0.00035182462347885647, "receives": 0.0003177292946409659, "etiologic": 0.00033572601159100957, "intrinsic": 0.00033572601159100957, "concentrating": 0.00039191270050212794, "behind": 0.00027377277067582674, "circumstances": 0.00039191270050212794, "provoke": 0.00029732629973073545, "decompensation": 0.00040323606461105735, "olmsted": 0.00029732629973073545, "county": 0.00027377277067582674, "2,596": 0.00024591485859853446, "ever": 0.00021181952976064393, "st": 0.00010590976488032197, "mis": 0.00016786300579550478, "killip": 0.00027377277067582674, "comorbid": 0.0003177292946409659, "715": 0.00016786300579550478, "475": 0.00016786300579550478, "2004": 0.00021181952976064393, "yielded": 0.00029732629973073545, "early-": 0.00027377277067582674, "mix": 0.00016786300579550478, "iodobenzylguanidine": 0.00044989700417746083, "serve": 0.00024591485859853446, "coagulability": 0.00039191270050212794, "crossover": 0.00033572601159100957, "masked": 0.00027377277067582674, "homozygous": 0.00035182462347885647, "equipotent": 0.00035182462347885647, "dosages": 0.00029732629973073545, "12.9": 0.00021181952976064393, "3.9": 0.00016786300579550478, "22.1": 0.00021181952976064393, "157": 0.00016786300579550478, "priorities": 0.00035182462347885647, "nontreatment": 0.00037968253555614875, "notes": 0.00024591485859853446, "caring": 0.00027377277067582674, "42%-58": 0.00027377277067582674, "11%-17": 0.00027377277067582674, "cited": 0.00024591485859853446, "50%-70": 0.00027377277067582674, "64%-70": 0.00027377277067582674, "comanagement": 0.00037968253555614875, "32%-35": 0.00027377277067582674, "15%-24": 0.00027377277067582674, "belief": 0.00027377277067582674, "12%-20": 0.00027377277067582674, "thirds": 0.00027377277067582674, "documentation": 0.00039191270050212794, "evolution": 0.00033572601159100957, "neurotransmission": 0.0004329022284738763, "elicited": 0.0003177292946409659, "os": 0.00010590976488032197, "tachycardic": 0.00036638758934942785, "bradycardic": 0.00036638758934942785, "conductance": 0.00036638758934942785, "ligation": 0.0003177292946409659, "attenuating": 0.00036638758934942785, "mechanistic": 0.00036638758934942785, "computational": 0.00039191270050212794, "behavior": 0.0003177292946409659, "sheet": 0.00024591485859853446, "orientation": 0.00036638758934942785, "slowed": 0.00027377277067582674, "depolarization": 0.00040323606461105735, "nonfailing": 0.00035182462347885647, "electromechanics": 0.00042363905952128787, "combinations": 0.00037968253555614875, "simulated": 0.00033572601159100957, "deranged": 0.0003177292946409659, "culprit": 0.00029732629973073545, "insignificantly": 0.00041377786439403925, "slows": 0.00024591485859853446, "depresses": 0.00033572601159100957, "stretch": 0.00029732629973073545, "lateral": 0.00029732629973073545, "giving": 0.00027377277067582674, "408": 0.00016786300579550478, "skinfold": 0.0003177292946409659, "comprehensive": 0.00039191270050212794, "display": 0.00029732629973073545, "541": 0.00016786300579550478, "3.09": 0.00021181952976064393, "2.18": 0.00021181952976064393, "4.45": 0.00021181952976064393, "2.90": 0.00021181952976064393, "2.00": 0.00021181952976064393, "4.12": 0.00021181952976064393, "coexist": 0.00029732629973073545, "interrelated": 0.00037968253555614875, "surrogate": 0.00033572601159100957, "catabolism": 0.00035182462347885647, "5.7": 0.00016786300579550478, "1.9": 0.00016786300579550478, "14.0": 0.00021181952976064393, "6.1": 0.00016786300579550478, "17.0": 0.00021181952976064393, "3.3": 0.00016786300579550478, "load": 0.00021181952976064393, "corrected": 0.00033572601159100957, "chronotropic": 0.00037968253555614875, "slower": 0.00027377277067582674, "0.34": 0.00021181952976064393, "reflected": 0.00033572601159100957, "prove": 0.00024591485859853446, "shortness": 0.00033572601159100957, "actrn12610001087044": 0.00044989700417746083, "controversial": 0.00039191270050212794, "validate": 0.0003177292946409659, "exclude": 0.00029732629973073545, "waves": 0.00024591485859853446, "3.8": 0.00016786300579550478, "nondiabetes": 0.00036638758934942785, "\u226555": 0.00016786300579550478, "\u226565": 0.00016786300579550478, "dyslipidemia": 0.00037968253555614875, "98": 0.00010590976488032197, "accurately": 0.00035182462347885647, "eliminate": 0.00033572601159100957, "avoidance": 0.00033572601159100957, "japanese": 0.0003177292946409659, "hyponatremia": 0.00037968253555614875, "administered": 0.00037968253555614875, "relieve": 0.00029732629973073545, "widespread": 0.00035182462347885647, "modulate": 0.0003177292946409659, "herein": 0.00027377277067582674, "failure.(1": 0.00035182462347885647, "becoming": 0.0003177292946409659, "subject": 0.00029732629973073545, "blunts": 0.00027377277067582674, "guanosine": 0.00033572601159100957, "pde": 0.00016786300579550478, "superfamily": 0.00036638758934942785, "property": 0.0003177292946409659, "able": 0.00021181952976064393, "hydrolysis": 0.00035182462347885647, "mediating": 0.00033572601159100957, "immunoblotting": 0.00040323606461105735, "radioenzymatic-": 0.00041377786439403925, "fluorescence": 0.00037968253555614875, "video": 0.00024591485859853446, "epifluorescence": 0.00041377786439403925, "~2": 0.00010590976488032197, "catecholamine": 0.00039191270050212794, "infusions": 0.00033572601159100957, "hydrolytic": 0.00035182462347885647, "blunted": 0.00029732629973073545, "desensitizes": 0.00037968253555614875, "constitute": 0.00035182462347885647, "defense": 0.00029732629973073545, "antagonizing": 0.00037968253555614875, "drive": 0.00024591485859853446, "intracellular": 0.00039191270050212794, "antiadrenergic": 0.00040323606461105735, "reason": 0.00027377277067582674, "underuse": 0.0003177292946409659, "fear": 0.00021181952976064393, "inducing": 0.0003177292946409659, "efficacious": 0.00036638758934942785, "monitored": 0.00033572601159100957, "medicines": 0.00033572601159100957, "nct00232180": 0.00036638758934942785, "annually": 0.0003177292946409659, "intention": 0.00033572601159100957, "subscales": 0.00033572601159100957, "rhythm-": 0.00029732629973073545, "payer": 0.00024591485859853446, "minimization": 0.00037968253555614875, "ontario": 0.00029732629973073545, "costing": 0.00029732629973073545, "304": 0.00016786300579550478, "accounted": 0.00033572601159100957, "146": 0.00016786300579550478, "238": 0.00016786300579550478, "cardioversions": 0.00040323606461105735, "21-$96": 0.00027377277067582674, "1319": 0.00021181952976064393, "1124-$1522": 0.00035182462347885647, "diagnoses": 0.00033572601159100957, "72,764": 0.00027377277067582674, "61,575-$85,145": 0.00040323606461105735, "78,767": 0.00027377277067582674, "67,101-$92,139": 0.00040323606461105735, "restorative": 0.00036638758934942785, "associate": 0.00033572601159100957, "taub": 0.00021181952976064393, "ramirez": 0.00029732629973073545, "sanchez": 0.00029732629973073545, "ciaraldi": 0.0003177292946409659, "perkins": 0.00029732629973073545, "murphy": 0.00027377277067582674, "naviaux": 0.00029732629973073545, "hogan": 0.00024591485859853446, "ceballos": 0.0003177292946409659, "maisel": 0.00027377277067582674, "henry": 0.00024591485859853446, "clin": 0.00021181952976064393, "trans": 0.00024591485859853446, "sci": 0.00016786300579550478, ".": 0.0, "43": 0.00010590976488032197, "immunohistochemistry": 0.0004577343883591784, "electron": 0.0003177292946409659, "dystrophin": 0.00035182462347885647, "ordinated": 0.00033572601159100957, "fashion": 0.00029732629973073545, "myofibre": 0.0003177292946409659, "regeneration": 0.00037968253555614875, "~24": 0.00016786300579550478, "warrant": 0.00029732629973073545, "rigorous": 0.0003177292946409659, "pubmed": 0.00027377277067582674, "1980": 0.00021181952976064393, "1887": 0.00021181952976064393, "5.88": 0.00021181952976064393, "3.92": 0.00021181952976064393, "7.85": 0.00021181952976064393, "-2.78": 0.00024591485859853446, "-5.15": 0.00024591485859853446, "-0.42": 0.00024591485859853446, "resolved": 0.0003177292946409659, "ethnic": 0.00027377277067582674, "platelet": 0.0003177292946409659, "sex-": 0.00021181952976064393, "apparently": 0.00035182462347885647, "acetyltransferase": 0.0004329022284738763, "dithiothreitol": 0.00040323606461105735, "dtt]-insensitive": 0.00042363905952128787, "cdp": 0.00016786300579550478, "choline": 0.00029732629973073545, "alkyl-2": 0.00029732629973073545, "sn": 0.00010590976488032197, "glycerol": 0.0003177292946409659, "cholinephosphotransferase": 0.0004918297171970689, "isoenzymes": 0.00035182462347885647, "acetylhydrolase": 0.00041377786439403925, "phospholipase": 0.00039191270050212794, "a2": 0.00010590976488032197, "leukocytes": 0.00035182462347885647, ".1": 0.00010590976488032197, "downregulated": 0.00039191270050212794, ".004": 0.00021181952976064393, "feature": 0.00029732629973073545, "prognostically": 0.00040323606461105735, "accepted": 0.0003177292946409659, "ven": 0.00016786300579550478, "vco2": 0.00021181952976064393, "oscillatory": 0.00036638758934942785, "ventilation": 0.00036638758934942785, "eov": 0.00016786300579550478, "co2": 0.00016786300579550478, "petco2": 0.00027377277067582674, "underlie": 0.0003177292946409659, "aforementioned": 0.00040323606461105735, "encouraged": 0.00035182462347885647, "purposes": 0.0003177292946409659, "orthotopic": 0.00035182462347885647, "institutional": 0.00039191270050212794, "169": 0.00016786300579550478, "vads": 0.00021181952976064393, "0.015": 0.00024591485859853446, "require": 0.00029732629973073545, "cent": 0.00021181952976064393, "operations": 0.00035182462347885647, "infrequent": 0.00035182462347885647, "resuscitation": 0.00039191270050212794, "thrombotic": 0.00035182462347885647, "obstruction": 0.00036638758934942785, "course": 0.00027377277067582674, "unstable": 0.0003177292946409659, "decided": 0.00029732629973073545, "extra": 0.00024591485859853446, "corporeal": 0.00033572601159100957, "transferred": 0.00036638758934942785, "und": 0.00016786300579550478, "bridging": 0.0003177292946409659, "reperfusion": 0.00036638758934942785, "relies": 0.00027377277067582674, "cardiography": 0.00037968253555614875, "hold": 0.00021181952976064393, "20,812": 0.00027377277067582674, "australia": 0.00033572601159100957, "contention": 0.00035182462347885647, "812": 0.00016786300579550478, "1998": 0.00021181952976064393, "28.1": 0.00021181952976064393, "16.5": 0.00021181952976064393, "0.44": 0.00021181952976064393, "20.5": 0.00021181952976064393, "15.9": 0.00021181952976064393, "11.0": 0.00021181952976064393, "encouraging": 0.00036638758934942785, "intramuscular": 0.00039191270050212794, "67.2": 0.00021181952976064393, "10.7": 0.00021181952976064393, "2.6": 0.00016786300579550478, "nmol": 0.00021181952976064393, "309": 0.00016786300579550478, "allocated": 0.00033572601159100957, "recruitment": 0.00036638758934942785, "injections": 0.00035182462347885647, "-1.3": 0.00021181952976064393, "leg": 0.00016786300579550478, "rated": 0.00024591485859853446, "21.61": 0.00024591485859853446, "8.68": 0.00021181952976064393, "6.43": 0.00021181952976064393, ".017": 0.00021181952976064393, "6.66": 0.00021181952976064393, ".015": 0.00021181952976064393, "6.25": 0.00021181952976064393, ".019": 0.00021181952976064393, "11.98": 0.00024591485859853446, "0.249": 0.00024591485859853446, ".622": 0.00021181952976064393, "tendency": 0.0003177292946409659, "3.066": 0.00024591485859853446, ".091": 0.00021181952976064393, "realized": 0.0003177292946409659, "instance": 0.0003177292946409659, "candidates": 0.00035182462347885647, "suffer": 0.00027377277067582674, "progenitors": 0.00036638758934942785, "elucidate": 0.00033572601159100957, "scar": 0.00021181952976064393, "shams": 0.00024591485859853446, "inhibiting": 0.00035182462347885647, "smad": 0.00021181952976064393, "2/3": 0.00016786300579550478, "marker": 0.00027377277067582674, "nanog": 0.00024591485859853446, "optimizing": 0.00035182462347885647, "pulseless": 0.00033572601159100957, "60s": 0.00016786300579550478, "permanent": 0.00033572601159100957, "8-": 0.00010590976488032197, "incidentally": 0.00037968253555614875, "ascending": 0.00033572601159100957, "bp": 0.00010590976488032197, "profound": 0.0003177292946409659, "paco2": 0.00024591485859853446, "cerebral": 0.0003177292946409659, "bodies": 0.00027377277067582674, "concluded": 0.00033572601159100957, "originating": 0.00036638758934942785, "generator": 0.00033572601159100957, "clarity": 0.00029732629973073545, "multisystem": 0.00036638758934942785, "dysbalance": 0.00035182462347885647, "apart": 0.00024591485859853446, "permeability": 0.00037968253555614875, "absorption": 0.00035182462347885647, "sonographic": 0.00036638758934942785, "disturbed": 0.00033572601159100957, "barrier": 0.00029732629973073545, "anabolic": 0.0003177292946409659, "highlights": 0.00035182462347885647, "carbohydrates": 0.00039191270050212794, "water": 0.00024591485859853446, "micronutrients": 0.00040323606461105735, "feeding": 0.00029732629973073545, "gut": 0.00016786300579550478, "fragment": 0.0003177292946409659, "roles": 0.00024591485859853446, "great": 0.00024591485859853446, "unfavourable": 0.00037968253555614875, "indistinct": 0.00035182462347885647, "elucidated": 0.00035182462347885647, "chronically": 0.00036638758934942785, "instrumented": 0.00037968253555614875, "zealand": 0.00029732629973073545, "innervated": 0.00035182462347885647, "hrv": 0.00016786300579550478, "lf": 0.00010590976488032197, "withdrawal": 0.00035182462347885647, "bradycardia": 0.00036638758934942785, "exacerbated": 0.00036638758934942785, "ne": 0.00010590976488032197, "capability": 0.00035182462347885647, "turned": 0.00027377277067582674, "stopped": 0.00029732629973073545, "futility": 0.0003177292946409659, "809": 0.00016786300579550478, "19.4": 0.00021181952976064393, "404": 0.00016786300579550478, "405": 0.00016786300579550478, "28.7": 0.00021181952976064393, "25.2": 0.00021181952976064393, "1.57": 0.00021181952976064393, "p=0.15": 0.00027377277067582674, "11.1": 0.00021181952976064393, "2.93": 0.00021181952976064393, "comparative": 0.00036638758934942785, "mandate": 0.00029732629973073545, "accountable": 0.00036638758934942785, "terminologies": 0.00039191270050212794, "makes": 0.00024591485859853446, "268": 0.00016786300579550478, "validating": 0.00035182462347885647, "science": 0.00029732629973073545, "beta1": 0.00024591485859853446, "\u03b21": 0.00010590976488032197, "adenylyl": 0.0003177292946409659, "triggers": 0.0003177292946409659, "desensitization": 0.00041377786439403925, "classic": 0.00029732629973073545, "paradigms": 0.00033572601159100957, "\u03b21ars": 0.00024591485859853446, "s1pr1s": 0.00027377277067582674, "simply": 0.00027377277067582674, "uncovered": 0.00033572601159100957, "hek": 0.00016786300579550478, "interact": 0.0003177292946409659, "postischemic": 0.00037968253555614875, "produces": 0.0003177292946409659, "counterbalance": 0.00040323606461105735, "overstimulation": 0.00041377786439403925, "alberta": 0.00029732629973073545, "alive": 0.00024591485859853446, "5336": 0.00021181952976064393, "373": 0.00016786300579550478, "855": 0.00016786300579550478, "69.2": 0.00021181952976064393, "2182": 0.00021181952976064393, "9.0": 0.00016786300579550478, "physician(s": 0.00036638758934942785, "exclusively": 0.00036638758934942785, "62.9": 0.00021181952976064393, "account": 0.00029732629973073545, "nonetheless": 0.00036638758934942785, "halt": 0.00021181952976064393, "ser23/24": 0.0003177292946409659, "catalytic": 0.00033572601159100957, "ser96": 0.00024591485859853446, "thr197": 0.00027377277067582674, "ri": 0.00010590976488032197, "isoelectric": 0.00036638758934942785, "focusing": 0.0003177292946409659, "blots": 0.00024591485859853446, "monoclonal": 0.00035182462347885647, "fluo": 0.00021181952976064393, "phosphomimic": 0.00037968253555614875, "kd": 0.00010590976488032197, "wt": 0.00010590976488032197, "displays": 0.0003177292946409659, "prone": 0.00024591485859853446, "signifies": 0.00033572601159100957, "lability": 0.0003177292946409659, "structurally": 0.00037968253555614875, "surface": 0.00029732629973073545, "fluctuations": 0.00037968253555614875, "genuine": 0.00029732629973073545, "susceptibility": 0.00040323606461105735, "primarily": 0.00033572601159100957, "anthracyclines": 0.00040323606461105735, "polymorphisms": 0.00039191270050212794, "candidate": 0.00033572601159100957, "homeostasis": 0.00036638758934942785, "oxidant": 0.00029732629973073545, "defence": 0.00029732629973073545, "nested": 0.00027377277067582674, "2950": 0.00021181952976064393, "1988": 0.00021181952976064393, "hope": 0.00021181952976064393, "survived": 0.0003177292946409659, "sampling": 0.0003177292946409659, "source": 0.00027377277067582674, "allogeneic": 0.00035182462347885647, "autologous": 0.00035182462347885647, "seventy": 0.00029732629973073545, "germline": 0.0003177292946409659, "178": 0.00016786300579550478, "females": 0.00029732629973073545, "radiation": 0.00033572601159100957, "4\u00b77": 0.00016786300579550478, "nad(p)h": 0.00029732629973073545, "rac2": 0.00021181952976064393, "rs13058338": 0.00035182462347885647, "7508t\u2192a": 0.00029732629973073545, "2\u00b78": 0.00016786300579550478, "hfe": 0.00016786300579550478, "rs1799945": 0.00033572601159100957, "63c\u2192g": 0.00024591485859853446, "2\u00b75": 0.00016786300579550478, "efflux": 0.00027377277067582674, "abcc2": 0.00024591485859853446, "rs8187710": 0.00033572601159100957, "1515g\u2192a": 0.00029732629973073545, "4\u00b73": 0.00016786300579550478, "0\u00b779": 0.00021181952976064393, "0\u00b767": 0.00021181952976064393, "0\u00b769": 0.00021181952976064393, "complicity": 0.00035182462347885647, "moves": 0.00024591485859853446, "exemplify": 0.00033572601159100957, "propose": 0.00029732629973073545, "distinctive": 0.00036638758934942785, "universal": 0.00033572601159100957, "uniform": 0.00029732629973073545, "nomenclature": 0.00037968253555614875, "view": 0.00021181952976064393, "foster": 0.00027377277067582674, "collaborative": 0.00039191270050212794, "conjoint": 0.0003177292946409659, "effort": 0.00027377277067582674, "preventing": 0.00035182462347885647, "breakdown": 0.00033572601159100957, "composed": 0.0003177292946409659, "prodrug": 0.00029732629973073545, "beginning": 0.00033572601159100957, "stabilize": 0.00033572601159100957, "summarizes": 0.00035182462347885647, "principles": 0.00035182462347885647, "progressed": 0.00035182462347885647, "purely": 0.00027377277067582674, "interconnected": 0.00040323606461105735, "accumulating": 0.00037968253555614875, "window": 0.00027377277067582674, "shortcomings": 0.00037968253555614875, "dearth": 0.00027377277067582674, "summarize": 0.00033572601159100957, "uniquely": 0.0003177292946409659, "capture": 0.00029732629973073545, "strict": 0.00027377277067582674, "standards": 0.00033572601159100957, "multimarker": 0.00036638758934942785, "fastest": 0.00029732629973073545, "subclass": 0.0003177292946409659, "indicates": 0.00033572601159100957, "noncoding": 0.00033572601159100957, "rnas": 0.00021181952976064393, "regulate": 0.0003177292946409659, "untranslated": 0.00037968253555614875, "messenger": 0.00033572601159100957, "degradation": 0.00036638758934942785, "repression": 0.00035182462347885647, "give": 0.00021181952976064393, "look": 0.00021181952976064393, "namely": 0.00027377277067582674, "endopeptidase": 0.00039191270050212794, "vasopeptidase": 0.00039191270050212794, "subpulmonary": 0.00037968253555614875, "exhibit": 0.00029732629973073545, "sixteen": 0.00029732629973073545, "30\u00b12": 0.00021181952976064393, "calf": 0.00021181952976064393, "31)p": 0.00021181952976064393, "spectroscopy": 0.00037968253555614875, "tertiary": 0.0003177292946409659, "referral": 0.0003177292946409659, "1.9\u00b10.1": 0.00029732629973073545, "66\u00b13": 0.00021181952976064393, "appendicular": 0.00037968253555614875, "z": 0.0, "-1.46\u00b10.22": 0.00035182462347885647, "poorer": 0.00027377277067582674, "max": 0.00016786300579550478, "r=0.67": 0.00027377277067582674, "p=0.004": 0.00029732629973073545, "-1.47\u00b10.21": 0.00035182462347885647, "4/16": 0.00021181952976064393, "sarcopenic": 0.00035182462347885647, "-2.0": 0.00021181952976064393, "9/16": 0.00021181952976064393, "\u2265-2.0": 0.00024591485859853446, "constant": 0.0003177292946409659, "postexercise": 0.00037968253555614875, "resynthesis": 0.00036638758934942785, "1.48\u00b10.13": 0.00033572601159100957, "2.40\u00b10.33": 0.00033572601159100957, "min(-1": 0.00027377277067582674, "questioned": 0.00035182462347885647, "659": 0.00016786300579550478, "italy": 0.00024591485859853446, "original": 0.0003177292946409659, "exploratory": 0.00036638758934942785, "dimensions": 0.00035182462347885647, ".92": 0.00016786300579550478, ".95": 0.00016786300579550478, ".99": 0.00016786300579550478, "contrasting": 0.00036638758934942785, "nonstandardized": 0.00041377786439403925, "misdiagnosis": 0.00037968253555614875, "stored": 0.00027377277067582674, "-80": 0.00016786300579550478, "\u00b0": 0.0, "enriched": 0.0003177292946409659, "immunoprecipitation": 0.00044989700417746083, "spectrometric": 0.00039191270050212794, "customized": 0.00035182462347885647, "homogeneous": 0.00036638758934942785, "sandwich": 0.0003177292946409659, "spectrometry": 0.00037968253555614875, "processed": 0.00033572601159100957, "proteolysis": 0.00036638758934942785, "pro2": 0.00021181952976064393, "gly4": 0.00021181952976064393, "pro6": 0.00021181952976064393, "gly7": 0.00021181952976064393, "pro75": 0.00024591485859853446, "arg76": 0.00024591485859853446, "termini": 0.00029732629973073545, "nonglycosylated": 0.00041377786439403925, "immunoreactive": 0.00040323606461105735, "immunodetection": 0.00041377786439403925, "next": 0.00021181952976064393, "avoiding": 0.0003177292946409659, "glycosylated": 0.00037968253555614875, "-3.2": 0.00021181952976064393, "-5.4": 0.00021181952976064393, "-1.1": 0.00021181952976064393, "-1.5": 0.00021181952976064393, "-0.5": 0.00021181952976064393, "idealized": 0.00033572601159100957, "14.2": 0.00021181952976064393, "denotes": 0.00029732629973073545, "pathophysiologically": 0.0004577343883591784, "antitachycardia": 0.00041377786439403925, "endpoints": 0.00033572601159100957, "tachyarrhythmias": 0.00042363905952128787, "253": 0.00016786300579550478, "3.4": 0.00016786300579550478, "0.009": 0.00024591485859853446, "0.80": 0.00021181952976064393, "nct00180271": 0.00036638758934942785, "denmark": 0.00029732629973073545, "342": 0.00016786300579550478, "307.026": 0.00029732629973073545, "4.9": 0.00016786300579550478, "alendronate-": 0.00037968253555614875, "etidronate-": 0.00036638758934942785, "3.7": 0.00016786300579550478, "bisphophonates": 0.00040323606461105735, "1.41": 0.00021181952976064393, "analysed": 0.0003177292946409659, "bisphosphonate": 0.00040323606461105735, "subcellular": 0.00036638758934942785, "reversibility": 0.00039191270050212794, "epinephrine": 0.00036638758934942785, "sarcoplasmic": 0.00037968253555614875, "reticular": 0.00033572601159100957, "ca(2+)-uptake": 0.00039191270050212794, "myofibrillar": 0.00037968253555614875, "ca(2+)-stimulated": 0.0004329022284738763, "atpase": 0.00027377277067582674, "unaffected": 0.00035182462347885647, "catecholamines": 0.00040323606461105735, "inconsistent": 0.00037968253555614875, "embedded": 0.0003177292946409659, "subclinical": 0.00036638758934942785, "262": 0.00016786300579550478, "uv": 0.00010590976488032197, "8,009": 0.00024591485859853446, "smoked": 0.00027377277067582674, "intima": 0.00027377277067582674, "media": 0.00024591485859853446, "1.02\u00b10.18": 0.00033572601159100957, "1.02\u00b10.16": 0.00033572601159100957, "share": 0.00024591485859853446, "120": 0.00016786300579550478, "0.9": 0.00016786300579550478, "quartile": 0.0003177292946409659, "nationally": 0.00035182462347885647, "considerations": 0.00040323606461105735, "project": 0.00029732629973073545, "150,000": 0.00029732629973073545, "rural": 0.00024591485859853446, "implemented": 0.00036638758934942785, "urbanized": 0.00033572601159100957, "midwestern": 0.00035182462347885647, "extensively": 0.00036638758934942785, "identical": 0.00033572601159100957, "fractal": 0.00029732629973073545, "scaling": 0.00029732629973073545, "exponent": 0.0003177292946409659, "somewhat": 0.0003177292946409659, "stems": 0.00024591485859853446, "underperfusion": 0.00040323606461105735, "renin-": 0.00027377277067582674, "nephropathy": 0.00036638758934942785, "ultrasonography": 0.00041377786439403925, "tomographic": 0.00036638758934942785, "preferred": 0.00033572601159100957, "lipid": 0.00024591485859853446, "lowering": 0.0003177292946409659, "cessation": 0.00033572601159100957, "preventive": 0.00035182462347885647, "angioplasty": 0.00036638758934942785, "coral": 0.00024591485859853446, "concrete": 0.0003177292946409659, "unsuitable": 0.00035182462347885647, "unsuccessful": 0.00037968253555614875, "plans": 0.00024591485859853446, "bioinformatic": 0.00039191270050212794, "microarray": 0.00035182462347885647, "reveals": 0.00029732629973073545, "discover": 0.0003177292946409659, "gse9128": 0.00029732629973073545, "downloaded": 0.00035182462347885647, "omnibus": 0.00029732629973073545, "processing": 0.00035182462347885647, "carried": 0.00029732629973073545, "r.": 0.00010590976488032197, "cluster": 0.00029732629973073545, "globally": 0.0003177292946409659, "observe": 0.00029732629973073545, "interactors": 0.00036638758934942785, "osprey": 0.00027377277067582674, "overlapping": 0.00036638758934942785, "cytoscape": 0.00033572601159100957, "david": 0.00024591485859853446, "133": 0.00016786300579550478, "programmed": 0.00035182462347885647, "northwest": 0.00033572601159100957, "1,767": 0.00024591485859853446, "demonstration": 0.00039191270050212794, "clinics": 0.00029732629973073545, "integrates": 0.00035182462347885647, "binomial": 0.0003177292946409659, ".03": 0.00016786300579550478, "quarterly": 0.00033572601159100957, "-0.054": 0.00027377277067582674, "-0.010": 0.00027377277067582674, ".005": 0.00021181952976064393, "interactions": 0.00037968253555614875, "749": 0.00016786300579550478, "socioeconomic": 0.00039191270050212794, "whites": 0.00027377277067582674, "1.46": 0.00021181952976064393, "1.77": 0.00021181952976064393, "1.58": 0.00021181952976064393, "1.27": 0.00021181952976064393, "1.96": 0.00021181952976064393, ".5": 0.00010590976488032197, "modifiable": 0.00035182462347885647, "conceptually": 0.00037968253555614875, "side": 0.00021181952976064393, "maintain": 0.0003177292946409659, "randomize": 0.00033572601159100957, "3,000": 0.00024591485859853446, "cha\u2082ds\u2082vasc": 0.00036638758934942785, "mandated": 0.0003177292946409659, "nights": 0.00027377277067582674, "spent": 0.00024591485859853446, "counted": 0.00029732629973073545, "know": 0.00021181952976064393, "grown": 0.00024591485859853446, "faced": 0.00024591485859853446, "uncommon": 0.0003177292946409659, "housed": 0.00027377277067582674, "accustomed": 0.00035182462347885647, "asked": 0.00024591485859853446, "array": 0.00024591485859853446, "complication": 0.00037968253555614875, "topic": 0.00024591485859853446, "partner": 0.00029732629973073545, "subspecialty": 0.00037968253555614875, "called": 0.00027377277067582674, "fall": 0.00021181952976064393, "abcd": 0.00021181952976064393, "acc)/american": 0.00039191270050212794, "characterised": 0.00039191270050212794, "structural": 0.00035182462347885647, "attempt": 0.00029732629973073545, "correct": 0.00029732629973073545, "ischaemia": 0.00033572601159100957, "tachy-": 0.00027377277067582674, "bradyarrhythmias": 0.00042363905952128787, "potent": 0.00027377277067582674, "ca2": 0.00016786300579550478, "influx": 0.00027377277067582674, "plateau": 0.00029732629973073545, "potentials": 0.00035182462347885647, "excitation": 0.00035182462347885647, "contraction": 0.00036638758934942785, "rem": 0.00016786300579550478, "rem2": 0.00021181952976064393, "gem": 0.00016786300579550478, "kir": 0.00016786300579550478, "monomeric": 0.00033572601159100957, "naturally": 0.00033572601159100957, "eliminates": 0.00035182462347885647, "inhibitory": 0.00035182462347885647, "inhibits": 0.0003177292946409659, "potently": 0.0003177292946409659, "attenuates": 0.00035182462347885647, "gating": 0.00027377277067582674, "movement": 0.0003177292946409659, "substitution": 0.00037968253555614875, "impair": 0.00027377277067582674, "modes": 0.00024591485859853446, "se": 0.00010590976488032197, "mistargeting": 0.00037968253555614875, "ethically": 0.00033572601159100957, "situations": 0.00035182462347885647, "pediatrics": 0.00035182462347885647, "families": 0.0003177292946409659, "whose": 0.00024591485859853446, "religious": 0.00033572601159100957, "beliefs": 0.00029732629973073545, "legal": 0.00024591485859853446, "face": 0.00021181952976064393, "ethics": 0.00027377277067582674, "rounds": 0.00027377277067582674, "complexities": 0.00037968253555614875, "overlapped": 0.00035182462347885647, "sickle": 0.00027377277067582674, "going": 0.00024591485859853446, "urgently": 0.0003177292946409659, "woman": 0.00024591485859853446, "adamantly": 0.00033572601159100957, "refuse": 0.00027377277067582674, "let": 0.00016786300579550478, "die": 0.00016786300579550478, "is": 0.00010590976488032197, "combine": 0.00029732629973073545, "empirically": 0.00036638758934942785, "explains": 0.0003177292946409659, "variance": 0.0003177292946409659, "n=1,203,595": 0.00036638758934942785, "n=625,595": 0.00033572601159100957, "n=1,234,299": 0.00036638758934942785, "ranked": 0.00027377277067582674, "chosen": 0.00027377277067582674, "1.61": 0.00021181952976064393, "dying": 0.00024591485859853446, "explaining": 0.00035182462347885647, "african": 0.00029732629973073545, "n=120": 0.00024591485859853446, "n=1543": 0.00027377277067582674, "rales": 0.00024591485859853446, "4.29\u00b10.5": 0.0003177292946409659, "4.55\u00b10.49": 0.00033572601159100957, "4.32\u00b10.54": 0.00033572601159100957, "4.31\u00b10.49": 0.00033572601159100957, "throughout": 0.00035182462347885647, "attain": 0.00027377277067582674, "13.9": 0.00021181952976064393, "5.8": 0.00016786300579550478, "potassium>5.5": 0.00039191270050212794, "p<0.046": 0.00029732629973073545, "potassium<3.5": 0.00039191270050212794, "17.9": 0.00021181952976064393, "interaction=0.032": 0.0004329022284738763, "seemed": 0.00027377277067582674, "antioxidant": 0.00036638758934942785, "szeto": 0.00024591485859853446, "schiller": 0.0003177292946409659, "ss": 0.00010590976488032197, "tac)-induced": 0.00037968253555614875, "538": 0.00016786300579550478, "mapped": 0.00027377277067582674, "gluconeogenesis": 0.00041377786439403925, "citrate": 0.00029732629973073545, "ameliorated": 0.00036638758934942785, "damage": 0.00027377277067582674, "nonmitochondrial": 0.00042363905952128787, "amelioration": 0.00037968253555614875, "essentially": 0.00036638758934942785, "elucidates": 0.00035182462347885647, "upstream": 0.0003177292946409659, "does": 0.00021181952976064393, "skilled": 0.00029732629973073545, "thousand": 0.0003177292946409659, "2,101,481": 0.00033572601159100957, "claims": 0.00027377277067582674, "quasi": 0.00024591485859853446, "experiment": 0.00035182462347885647, "immediate": 0.00033572601159100957, "0.30": 0.00021181952976064393, "2.82": 0.00021181952976064393, "1.60": 0.00021181952976064393, "urinary": 0.00029732629973073545, "tract": 0.00024591485859853446, "medically": 0.00033572601159100957, "quintiles": 0.00033572601159100957, "8.9": 0.00016786300579550478, "25.8": 0.00021181952976064393, "21.5": 0.00021181952976064393, "p<0001": 0.00027377277067582674, "finally": 0.00029732629973073545, "8982": 0.00021181952976064393, "8731": 0.00021181952976064393, "p=0.002": 0.00029732629973073545, "internists": 0.00035182462347885647, "10.6": 0.00021181952976064393, "weakest": 0.00029732629973073545, "6.7": 0.00016786300579550478, "p=0.485": 0.00029732629973073545, "noncardiologist": 0.00041377786439403925, "expertise": 0.00033572601159100957, "antagonism": 0.00035182462347885647, "neurohormone": 0.00037968253555614875, "electrolytes": 0.00037968253555614875, "very": 0.00021181952976064393, "ephesus": 0.00029732629973073545, "tuscany": 0.00029732629973073545, "603": 0.00016786300579550478, "53\u00b112": 0.00024591485859853446, "32\u00b110": 0.00024591485859853446, "fulfilling": 0.00035182462347885647, "8.8\u00b16.3": 0.00029732629973073545, "subdivided": 0.00035182462347885647, "eras": 0.00021181952976064393, "1984": 0.00021181952976064393, "n=66": 0.00021181952976064393, "1985": 0.00021181952976064393, "n=102": 0.00024591485859853446, "1991": 0.00021181952976064393, "n=197": 0.00024591485859853446, "n=238": 0.00024591485859853446, "n=142": 0.00024591485859853446, "n=71": 0.00021181952976064393, "noncardiac": 0.00035182462347885647, "n=22": 0.00021181952976064393, "n=36": 0.00021181952976064393, "0.14": 0.00021181952976064393, "replicated": 0.00035182462347885647, "emphasizing": 0.00036638758934942785, "tailored": 0.0003177292946409659, "indeterminable": 0.00040323606461105735, "always": 0.00027377277067582674, "meaning": 0.00029732629973073545, "3058": 0.00021181952976064393, "921": 0.00016786300579550478, "achievement": 0.00036638758934942785, "quotient": 0.0003177292946409659, "\u22641.05": 0.00024591485859853446, "3.01": 0.00021181952976064393, "4.98": 0.00021181952976064393, "1935": 0.00021181952976064393, "2137": 0.00021181952976064393, "90.54": 0.00024591485859853446, "pred": 0.00021181952976064393, "hr]=0.977": 0.00033572601159100957, "ci]=0.97": 0.0003177292946409659, "ventilatory": 0.00036638758934942785, "hr=1.02": 0.00029732629973073545, "ci=1.01": 0.00029732629973073545, "hr=0.931": 0.0003177292946409659, "ci=0.87": 0.00029732629973073545, "hr=0.948": 0.0003177292946409659, "hr=0.990": 0.0003177292946409659, "ci=0.98": 0.00029732629973073545, "hr=0.967": 0.0003177292946409659, "hr=1.41": 0.00029732629973073545, "ci=1.06": 0.00029732629973073545, "1.89": 0.00021181952976064393, "hr=1.459": 0.0003177292946409659, "ci=1.09": 0.00029732629973073545, "1.10": 0.00021181952976064393, "inability": 0.00033572601159100957, "cooper": 0.00027377277067582674, "674": 0.00016786300579550478, "1971": 0.00021181952976064393, "19.8\u00b110.4": 0.00033572601159100957, "153": 0.00016786300579550478, "3.97": 0.00021181952976064393, "3.71": 0.00021181952976064393, "upper": 0.00024591485859853446, "p<0.002": 0.00029732629973073545, "p\u22640.02": 0.00027377277067582674, "counseled": 0.00033572601159100957, "achieving": 0.00033572601159100957, "presumably": 0.00035182462347885647, "hypertrophied": 0.00039191270050212794, "evidenced": 0.00033572601159100957, "translocation": 0.00039191270050212794, "lactate": 0.00029732629973073545, "fatty": 0.00024591485859853446, "acids": 0.00024591485859853446, "reality": 0.00029732629973073545, "adequacy": 0.0003177292946409659, "delineated": 0.00035182462347885647, "website": 0.00029732629973073545, "nondeveloped": 0.00037968253555614875, "raised": 0.00027377277067582674, "chagas": 0.00027377277067582674, "alcohol": 0.00029732629973073545, "6.3": 0.00016786300579550478, "varies": 0.00027377277067582674, "awful": 0.00024591485859853446, "paradox": 0.00029732629973073545, "scenario": 0.0003177292946409659, "polymorphism": 0.00037968253555614875, "p.": 0.00010590976488032197, "arg83gly": 0.0003177292946409659, "renastur": 0.0003177292946409659, "569": 0.00016786300579550478, "caucasian": 0.00033572601159100957, "ka": 0.00010590976488032197, "chloride": 0.0003177292946409659, "min./1.73": 0.00033572601159100957, "ldl": 0.00016786300579550478, "gg": 0.00010590976488032197, "genotype": 0.0003177292946409659, "or=1.65": 0.00029732629973073545, "ci=1.04": 0.00029732629973073545, "2.62": 0.00021181952976064393, "confirmation": 0.00037968253555614875, "ambient": 0.00029732629973073545, "recognised": 0.00035182462347885647, "lancet": 0.00027377277067582674, "anoop": 0.00024591485859853446, "shah": 0.00021181952976064393, "colleagues": 0.00035182462347885647, "aware": 0.00024591485859853446, "industrial": 0.00035182462347885647, "aggravate": 0.00033572601159100957, "exacerbates": 0.00036638758934942785, "cytoskeletal": 0.00037968253555614875, "deletion": 0.0003177292946409659, "precise": 0.00029732629973073545, "functionally": 0.00037968253555614875, "morphologically": 0.00041377786439403925, "littermates": 0.00036638758934942785, "susceptible": 0.00036638758934942785, "turning": 0.00029732629973073545, "discovered": 0.00035182462347885647, "normalizing": 0.00036638758934942785, "eliminated": 0.00035182462347885647, "fare": 0.00021181952976064393, "eventually": 0.00035182462347885647, "spite": 0.00024591485859853446, "developments": 0.00037968253555614875, "palliative": 0.00035182462347885647, "vital": 0.00024591485859853446, "disciplines": 0.00036638758934942785, "communication": 0.00039191270050212794, "surgeons": 0.0003177292946409659, "distributed": 0.00036638758934942785, "evenly": 0.00027377277067582674, "equitable": 0.00033572601159100957, "referrals": 0.00033572601159100957, "strengthen": 0.00035182462347885647, "connection": 0.00035182462347885647, "certified": 0.00033572601159100957, "raise": 0.00024591485859853446, "turkey": 0.00027377277067582674, "postmarketing": 0.00039191270050212794, "dipeptidyl": 0.00035182462347885647, "peptidase-4": 0.00036638758934942785, "creating": 0.0003177292946409659, "uncertainty": 0.00036638758934942785, "partners": 0.0003177292946409659, "u.s.": 0.00021181952976064393, "mini": 0.00021181952976064393, "sentinel": 0.0003177292946409659, "products": 0.0003177292946409659, "402.x1": 0.00027377277067582674, "404.x1": 0.00027377277067582674, "404.x3": 0.00027377277067582674, "428.xx": 0.00027377277067582674, "553": 0.00016786300579550478, "298": 0.00016786300579550478, "pairwise": 0.0003177292946409659, "drs)-stratified": 0.00041377786439403925, "0.47": 0.00021181952976064393, "limitation": 0.00035182462347885647, "residual": 0.0003177292946409659, "confounding": 0.00036638758934942785, "introduction": 0.00037968253555614875, "outweigh": 0.0003177292946409659, "healthstar": 0.00035182462347885647, "campbell": 0.0003177292946409659, "joanna": 0.00027377277067582674, "briggs": 0.00027377277067582674, "institute": 0.00033572601159100957, "reviews": 0.00029732629973073545, "centres": 0.00029732629973073545, "extract": 0.00029732629973073545, "duplicate": 0.00033572601159100957, "provider": 0.0003177292946409659, "eg": 0.00010590976488032197, "decision": 0.0003177292946409659, "incentives": 0.00035182462347885647, "elements": 0.0003177292946409659, "redesign": 0.0003177292946409659, "synthesise": 0.00035182462347885647, "narratively": 0.00036638758934942785, "succeed": 0.00029732629973073545, "fail": 0.00021181952976064393, "disseminate": 0.00036638758934942785, "briefing": 0.0003177292946409659, "publications": 0.00037968253555614875, "presentations": 0.00039191270050212794, "perceptions": 0.00036638758934942785, "qualitative": 0.00036638758934942785, "grounded": 0.0003177292946409659, "theory": 0.00027377277067582674, "collect": 0.00029732629973073545, "interview": 0.00033572601159100957, "toronto": 0.00029732629973073545, "predominately": 0.00039191270050212794, "felt": 0.00021181952976064393, "mind": 0.00021181952976064393, "wished": 0.00027377277067582674, "said": 0.00021181952976064393, "consider": 0.0003177292946409659, "undecided": 0.00033572601159100957, "adamant": 0.00029732629973073545, "turn": 0.00021181952976064393, "implant": 0.00029732629973073545, "distressing": 0.00036638758934942785, "comment": 0.00029732629973073545, "centrally": 0.00033572601159100957, "outflow": 0.00029732629973073545, "system-": 0.00029732629973073545, "hall": 0.00021181952976064393, "97.2": 0.00021181952976064393, "91.4": 0.00021181952976064393, "59.6": 0.00021181952976064393, "13.2": 0.00021181952976064393, "17.4": 0.00021181952976064393, "ranking": 0.00029732629973073545, "0.08": 0.00021181952976064393, "prescribe": 0.00033572601159100957, "china": 0.00024591485859853446, "\u03b450%w": 0.00024591485859853446, "x12": 0.00016786300579550478, "w.": 0.00010590976488032197, "before": 0.00027377277067582674, "394": 0.00016786300579550478, "470": 0.00016786300579550478, "nosignificant": 0.00039191270050212794, "p>0.05": 0.00027377277067582674, "guiding": 0.00029732629973073545, "uk": 0.00010590976488032197, "completely": 0.00035182462347885647, "subtle": 0.00027377277067582674, "nonspecific": 0.00036638758934942785, "breathlessness": 0.00040323606461105735, "fatigue": 0.00029732629973073545, "thorough": 0.0003177292946409659, "lying": 0.00024591485859853446, "auscultation": 0.00037968253555614875, "jugular": 0.00029732629973073545, "oedema": 0.00027377277067582674, "regular": 0.00029732629973073545, "hyperlipidaemia": 0.00041377786439403925, "senescence": 0.00035182462347885647, "malignancies": 0.00037968253555614875, "prostate": 0.0003177292946409659, "colon": 0.00024591485859853446, "osteoporosis": 0.00037968253555614875, "dementia": 0.0003177292946409659, "regularly": 0.00033572601159100957, "volumes": 0.00029732629973073545, "confer": 0.00027377277067582674, "with.estimates": 0.00040323606461105735, "50,000": 0.00027377277067582674, "200,000": 0.00029732629973073545, "hereditary": 0.00035182462347885647, "nontraumatic": 0.00037968253555614875, "sport": 0.00024591485859853446, "middle": 0.00027377277067582674, "recreational": 0.00037968253555614875, "males": 0.00024591485859853446, "esc": 0.00016786300579550478, "advocate": 0.0003177292946409659, "accessory": 0.00033572601159100957, "ion": 0.00016786300579550478, "channelopathies": 0.00041377786439403925, "overwhelming": 0.00037968253555614875, "trainings": 0.00033572601159100957, "limbs": 0.00024591485859853446, "+233": 0.00021181952976064393, "733": 0.00016786300579550478, "il": 0.00010590976488032197, "+0.5": 0.00021181952976064393, "+0.2": 0.00021181952976064393, "6.5": 0.00016786300579550478, "feedback": 0.0003177292946409659, "2279": 0.00021181952976064393, "97.8": 0.00021181952976064393, "surveys": 0.00029732629973073545, "r=-0.11": 0.00029732629973073545, "r=-0.12": 0.00029732629973073545, "p<0.005": 0.00029732629973073545, "corresponded": 0.00037968253555614875, "implement": 0.00033572601159100957, "arguments": 0.00033572601159100957, "hypo": 0.00021181952976064393, "gas": 0.00016786300579550478, "participated": 0.00037968253555614875, "aiming": 0.00027377277067582674, "value=0.631": 0.00036638758934942785, "17\u00b122": 0.00024591485859853446, "4\u00b115": 0.00021181952976064393, "value=0.027": 0.00036638758934942785, "17.5\u00b15.5": 0.0003177292946409659, "14.4\u00b13.3": 0.0003177292946409659, "value=0.038": 0.00036638758934942785, "2.0\u00b13.2": 0.00029732629973073545, "1.2\u00b17.7": 0.00029732629973073545, "value=0.033": 0.00036638758934942785, "unidirectional": 0.00040323606461105735, "\u226518": 0.00016786300579550478, "implants": 0.0003177292946409659, "transseptal": 0.00036638758934942785, "catheterisation": 0.00041377786439403925, "guidance": 0.0003177292946409659, "anaesthesia": 0.00036638758934942785, "oct": 0.00016786300579550478, "2015": 0.00021181952976064393, "procedural": 0.00035182462347885647, "shunts": 0.00027377277067582674, "patent": 0.00027377277067582674, "migration": 0.00033572601159100957, "p=0\u00b70004": 0.0003177292946409659, "duke": 0.00021181952976064393, "6\u00b72": 0.00016786300579550478, "24\u00b78": 0.00021181952976064393, "12\u00b79": 0.00021181952976064393, "44\u00b73": 0.00021181952976064393, "9\u00b78": 0.00016786300579550478, "79\u00b71": 0.00021181952976064393, "13\u00b70": 0.00021181952976064393, "p=0\u00b70001": 0.0003177292946409659, "244": 0.00016786300579550478, "112": 0.00016786300579550478, "318": 0.00016786300579550478, "p=0\u00b7035": 0.00029732629973073545, "incessant": 0.00033572601159100957, "storm": 0.00024591485859853446, "warranted": 0.00033572601159100957, "hopeful": 0.00029732629973073545, "at1": 0.00016786300579550478, "blocks": 0.00027377277067582674, "aldosteron": 0.00035182462347885647, "concurrently": 0.00037968253555614875, "natural": 0.00029732629973073545, "vasodilatory": 0.00037968253555614875, "8000": 0.00021181952976064393, "stabilized": 0.00035182462347885647, "sacubiltril": 0.00036638758934942785, "hypotension": 0.00036638758934942785, "interrupt": 0.00033572601159100957, "czech": 0.00024591485859853446, "republic": 0.0003177292946409659, "congratulated": 0.00039191270050212794, "thanked": 0.00029732629973073545, "more": 0.00021181952976064393, "persons": 0.00029732629973073545, "determinant": 0.00036638758934942785, "factorial": 0.00033572601159100957, "february": 0.0003177292946409659, "november": 0.0003177292946409659, "2014": 0.00021181952976064393, "academic": 0.0003177292946409659, "577": 0.00016786300579550478, "initially": 0.00033572601159100957, "screened": 0.0003177292946409659, "67": 0.00010590976488032197, "39.3": 0.00021181952976064393, "366": 0.00016786300579550478, "consisted": 0.00033572601159100957, "calls": 0.00024591485859853446, "105": 0.00016786300579550478, "attendance": 0.00035182462347885647, "-1": 0.00010590976488032197, "-8": 0.00010590976488032197, ".70": 0.00016786300579550478, "-6": 0.00010590976488032197, "-12": 0.00016786300579550478, ".08": 0.00016786300579550478, ".003": 0.00021181952976064393, "thigh": 0.00024591485859853446, "intermuscular": 0.00039191270050212794, "0.27": 0.00021181952976064393, "hemocompatibility": 0.0004329022284738763, "rotor": 0.00024591485859853446, "paths": 0.00024591485859853446, "artificial": 0.00035182462347885647, "intermacs": 0.00033572601159100957, "interagency": 0.00036638758934942785, "mechanically": 0.00037968253555614875, "support)-derived": 0.00042363905952128787, "inotrope": 0.0003177292946409659, "listed": 0.00027377277067582674, "exceeded": 0.0003177292946409659, "0.0093": 0.00027377277067582674, "reoperation": 0.00036638758934942785, "rankin": 0.00027377277067582674, "exchanges": 0.00033572601159100957, "malfunctions": 0.00037968253555614875, "hemolysis": 0.00033572601159100957, "sustained": 0.00033572601159100957, "projecting": 0.00035182462347885647, "extrapolating": 0.00039191270050212794, "valuable": 0.0003177292946409659, "modeled": 0.00029732629973073545, "designs": 0.00029732629973073545, "hypothetical": 0.00037968253555614875, "10,000": 0.00027377277067582674, "virtual": 0.00029732629973073545, "inputs": 0.00027377277067582674, "external": 0.0003177292946409659, "replicating": 0.00036638758934942785, "scenarios": 0.00033572601159100957, "functioning": 0.00036638758934942785, "researchers": 0.00036638758934942785, "upcoming": 0.0003177292946409659, "understand": 0.00035182462347885647, "deter": 0.00024591485859853446, "such": 0.00021181952976064393, "optimize": 0.0003177292946409659}